<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
<head>

<meta charset="utf-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta name="author" content="Tim Woelfle" />

<meta name="date" content="2023-08-07" />


<title>PRISMA 2009 Scores in Cullis 2017: Human Consensus vs LLM (Claude 2) - same prompt as for GPT 3.5</title>

<meta property="og:title" content="PRISMA 2009 Scores in Cullis 2017: Human Consensus vs LLM (Claude 2) - same prompt as for GPT 3.5" />

<meta name='viewport' content='width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no' />

<link rel="icon" href="data:image/x-icon;" type="image/x-icon">


<script type="text/javascript">
window.FlexDashboardComponents = [];
</script>

<script id="flexdashboard-navbar" type="application/json">
[{"title":"Source Code","icon":"fa-code","href":"","align":"right"}]
</script>
<script src="lib/header-attrs-2.21/header-attrs.js"></script>
<script src="lib/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="lib/bootstrap-3.3.5/css/cosmo.min.css" rel="stylesheet" />
<script src="lib/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="lib/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="lib/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="lib/stickytableheaders-0.1.19/jquery.stickytableheaders.min.js"></script>
<link href="lib/font-awesome-6.4.0/css/all.min.css" rel="stylesheet" />
<link href="lib/font-awesome-6.4.0/css/v4-shims.min.css" rel="stylesheet" />
<link href="lib/value-box-accent-static-0.6.1/theme-cosmo-value-box.css" rel="stylesheet" />
<link href="lib/flexdashboard-css-0.6.1/flexdashboard.min.css" rel="stylesheet" />
<link href="lib/flexdashboard-css-0.6.1/theme-cosmo.css" rel="stylesheet" />
<script src="lib/htmlwidgets-1.6.2/htmlwidgets.js"></script>
<link href="lib/datatables-css-0.0.0/datatables-crosstalk.css" rel="stylesheet" />
<script src="lib/datatables-binding-0.28/datatables.js"></script>
<link href="lib/dt-core-1.13.4/css/jquery.dataTables.min.css" rel="stylesheet" />
<link href="lib/dt-core-1.13.4/css/jquery.dataTables.extra.css" rel="stylesheet" />
<script src="lib/dt-core-1.13.4/js/jquery.dataTables.min.js"></script>
<link href="lib/crosstalk-1.2.0/css/crosstalk.min.css" rel="stylesheet" />
<script src="lib/crosstalk-1.2.0/js/crosstalk.min.js"></script>
<style type="text/css">
/*
  CSS for flexdashboard.js' use of Sly(). The sizing/position of this CSS needs to be
  applied _before_ flexdashboard.js initializes, which is why this CSS has been pulled
  out from flexdashboard.scss and inlined in the document's head.
*/

.storyboard-nav button {
  background: transparent;
  border: 0;
  opacity: .3;
  outline: none;
  padding: 0;
}

.storyboard-nav button:hover,
.storyboard-nav button:hover {
  opacity: .5;
}

.storyboard-nav button:disabled,
.storyboard-nav button:disabled {
  opacity: .1;
}

.storyboard-nav .sbnext,
.storyboard-nav .sbprev {
  float: left;
  width: 2%;
  height: 120px;
}

.storyboard-nav .sbprev {
  text-align: left;
  width: 2%;
}

.storyboard-nav .sbnext {
  float: right;
  text-align: right;
  margin-right: 8px;
}

.storyboard-nav .sbframelist {
  margin: 0 auto;
  width: 94%;
  height: 120px;
  overflow: hidden;
  text-shadow: none;
  margin-bottom: 8px;
}

.storyboard-nav .sbframelist ul {
  list-style: none;
  margin: 0;
  padding: 0;
  height: 100%;
}

.storyboard-nav .sbframelist ul li {
  float: left;
  width: 270px;
  height: 100%;
  padding: 10px 10px 10px 10px;
  margin-right: 8px;
  text-align: left;
  cursor: pointer;
}

.storyboard-nav .sbframelist ul li:last-child {
  margin-right: 0px;
}

.sbframe-commentary {
  width: 300px;
}

.sbframe-commentary ul {
  padding-left: 22px;
}

.sbframe.active {
  display: flex;
}

.sbframe:not(.active) {
  display: none;
}
@media only screen and (min-width: 768px) {
html, body {
  height: 100%;
}

#dashboard-container {
  height: 100%;
}
}
</style>



</head>

<body>

<div class="navbar navbar-inverse navbar-fixed-top" role="navigation">
<div class="container-fluid">
<div class="navbar-header">

<span class="navbar-logo pull-left">
  
</span>
<span class="navbar-brand">
  PRISMA 2009 Scores in Cullis 2017: Human Consensus vs LLM (Claude 2) - same prompt as for GPT 3.5
  <span class="navbar-author">
    Tim Woelfle &mdash; 2023-08-07
    </span>
</span>

<button id="navbar-button" type="button" class="navbar-toggle collapsed pull-right" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
<span class="icon-bar"></span>
<span class="icon-bar"></span>
<span class="icon-bar"></span>
</button>

</div>
<div id="navbar" class="navbar-collapse collapse">
<ul class="nav navbar-nav navbar-left">
</ul>
<ul class="nav navbar-nav navbar-right">
</ul>
</div><!--/.nav-collapse-->
</div><!--/.container-->
</div><!--/.navbar-->

<script type="text/javascript">


var FlexDashboard = (function () {

  // initialize options
  var _options = {};

  var FlexDashboard = function() {

    // default options
    _options = $.extend(_options, {
      theme: "cosmo",
      fillPage: false,
      orientation: 'columns',
      storyboard: false,
      defaultFigWidth: 576,
      defaultFigHeight: 461,
      defaultFigWidthMobile: 360,
      defaultFigHeightMobile: 461,
      isMobile: false,
      isPortrait: false,
      resize_reload: true
    });
  };

  function init(options) {

    // extend default options
    $.extend(true, _options, options);

    // add ids to sections that don't have them (pandoc won't assign ids
    // to e.g. sections with titles consisting of only chinese characters)
    var nextId = 1;
    $('.level1:not([id]),.level2:not([id]),.level3:not([id])').each(function() {
      $(this).attr('id', 'dashboard-' + nextId++);
    });

    // find navbar items
    var navbarItems = $('#flexdashboard-navbar');
    if (navbarItems.length)
      navbarItems = JSON.parse(navbarItems.html());
    addNavbarItems(navbarItems);

    // find the main dashboard container
    var dashboardContainer = $('#dashboard-container');

    // resolve mobile classes
    resolveMobileClasses(dashboardContainer);

    // one time global initialization for components
    componentsInit(dashboardContainer);

    // look for a global sidebar
    var globalSidebar = dashboardContainer.find(".section.level1.sidebar");
    if (globalSidebar.length > 0) {

      // global layout for fullscreen displays
      if (!isMobilePhone()) {

         // hoist it up to the top level
         globalSidebar.insertBefore(dashboardContainer);

         // lay it out (set width/positions)
         layoutSidebar(globalSidebar, dashboardContainer);

      // tuck sidebar into first page for mobile phones
      } else {

        // convert it into a level3 section
        globalSidebar.removeClass('sidebar');
        globalSidebar.removeClass('level1');
        globalSidebar.addClass('level3');
        var h1 = globalSidebar.children('h1');
        var h3 = $('<h3></h3>');
        h3.append(h1.contents());
        h3.insertBefore(h1);
        h1.detach();

        // move it into the first page
        var page = dashboardContainer.find('.section.level1').first();
        if (page.length > 0)
          page.prepend(globalSidebar);
      }
    }

    // look for pages to layout
    var pages = $('div.section.level1');
    if (pages.length > 0) {

        // find the navbar and collapse on clicked
        var navbar = $('#navbar');
        navbar.on("click", "a[data-toggle!=dropdown]", null, function () {
           navbar.collapse('hide');
        });

        // envelop the dashboard container in a tab content div
        dashboardContainer.wrapInner('<div class="tab-content"></div>');

        pages.each(function(index) {

          // lay it out
          layoutDashboardPage($(this));

          // add it to the navbar
          addToNavbar($(this), index === 0);

        });

    } else {

      // remove the navbar and navbar button if we don't
      // have any navbuttons
      if (navbarItems.length === 0) {
        $('#navbar').remove();
        $('#navbar-button').remove();
      }

      // add the storyboard class if requested
      if (_options.storyboard)
        dashboardContainer.addClass('storyboard');

      // layout the entire page
      layoutDashboardPage(dashboardContainer);
    }

    // if we are in shiny we need to trigger a window resize event to
    // force correct layout of shiny-bound-output elements
    if (isShinyDoc())
      $(window).trigger('resize');

    // make main components visible
    $('.section.sidebar').css('visibility', 'visible');
    dashboardContainer.css('visibility', 'visible');

    // handle location hash
    handleLocationHash();

    // intialize prism highlighting
    initPrismHighlighting();

    // record mobile and orientation state then register a handler
    // to refresh if resize_reload is set to true and it changes
    _options.isMobile = isMobilePhone();
    _options.isPortrait = isPortrait();
    if (_options.resize_reload) {
      $(window).on('resize', function() {
        if (_options.isMobile !== isMobilePhone() ||
            _options.isPortrait !== isPortrait()) {
          window.location.reload();
        }
      });
    } else {
      // if in desktop mode and resizing to mobile, make sure the heights are 100%
      // This enforces what `fillpage.css` does for "wider" pages.
      // Since we are not reloading once the page becomes small, we need to force the height to 100%
      // This is a new situation introduced when `_options.resize_reload` is `false`
      if (! _options.isMobile) {
        // only add if `fillpage.css` was added in the first place
        if (_options.fillPage) {
          // fillpage.css
          $("html,body,#dashboard").css("height", "100%");
        }
      }
    }
    // trigger layoutcomplete event
    dashboardContainer.trigger('flexdashboard:layoutcomplete');
  }

  function resolveMobileClasses(dashboardContainer) {
     // add top level layout class
    dashboardContainer.addClass(isMobilePhone() ? 'mobile-layout' :
                                                  'desktop-layout');

    // look for .mobile sections and add .no-mobile to their peers
    var mobileSections = $('.section.mobile');
    mobileSections.each(function() {
       var id = $(this).attr('id');
       var nomobileId = id.replace(/-\d+$/, '');
       $('#' + nomobileId).addClass('no-mobile');
    });
  }

  function addNavbarItems(navbarItems) {

    var navbarLeft = $('ul.navbar-left');
    var navbarRight = $('ul.navbar-right');

    for (var i = 0; i<navbarItems.length; i++) {

      // get the item
      var item = navbarItems[i];

      // determine the container
      var container = null;
      if (item.align === "left")
        container = navbarLeft;
      else
        container = navbarRight;

      // navbar menu if we have multiple items
      if (item.items) {
        var menu = navbarMenu(null, item.icon, item.title, container);
        for (var j = 0; j<item.items.length; j++) {
          var subItem = item.items[j];
          var li = $('<li></li>');
          var a = navbarLink(subItem.icon, subItem.title, subItem.href, subItem.target);
          a.removeClass("nav-link").addClass("dropdown-item");
          li.append(a);
          menu.append(li);
        }
      } else {
        var li = $('<li class="nav-item"></li>');
        li.append(navbarLink(item.icon, item.title, item.href, item.target));
        container.append(li);
      }
    }
  }

  // create or get a reference to an existing dropdown menu
  function navbarMenu(id, icon, title, container) {
    var existingMenu = [];
    if (id)
      existingMenu = container.children('#' + id);
    if (existingMenu.length > 0) {
      return existingMenu.children('ul');
    } else {
      var li = $('<li class="nav-item"></li>');
      if (id)
        li.attr('id', id);
      li.addClass('dropdown');
      // auto add "Share" title on mobile if necessary
      if (!title && icon && (icon === "fa-share-alt") && isMobilePhone())
        title = "Share";
      if (title) {
        title = title + ' <span class="caret"></span>';
      }
      var a = navbarLink(icon, title, "#");
      a.addClass('dropdown-toggle');
      a.attr('data-toggle', 'dropdown');
      a.attr('data-bs-toggle', 'dropdown');
      a.attr('role', 'button');
      a.attr('aria-expanded', 'false');
      li.append(a);
      var ul = $('<ul class="dropdown-menu"></ul>');
      ul.attr('role', 'menu');
      li.append(ul);
      container.append(li);
      return ul;
    }
  }

  function addToNavbar(page, active) {

    // capture the id and data-icon attribute (if any)
    var id = page.attr('id');
    var icon = page.attr('data-icon');
    var navmenu = page.attr('data-navmenu');

    // get hidden state (transfer this to navbar)
    var hidden = page.hasClass('hidden');
    page.removeClass('hidden');

    // sanitize the id for use with bootstrap tabs
    id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
    page.attr('id', id);

    // get the wrapper
    var wrapper = page.closest('.dashboard-page-wrapper');

    // move the id to the wrapper
    page.removeAttr('id');
    wrapper.attr('id', id);

    // add the tab-pane class to the wrapper
    wrapper.addClass('tab-pane');
    if (active)
      wrapper.addClass('active');

    // get a reference to the h1, discover its inner contens, then detach it
    var h1 = wrapper.find('h1').first();
    var title = h1.contents();
    h1.detach();

    // create a navbar item
    var li = $('<li></li>');
    var a = navbarLink(icon, title, '#' + id);
    a.attr('data-toggle', 'tab');
    li.append(a);

    // add it to the navbar (or navbar menu if specified)
    var container = $('ul.navbar-left');
    if (navmenu) {
      var menuId = navmenu.replace(/\s+/g, '');
      var menu = navbarMenu(menuId, null, navmenu, container);
      li.find("> a").removeClass("nav-link").addClass("dropdown-item");
      menu.append(li);
    } else {
      li.addClass("nav-item")
      container.append(li);
    }

    // hide it if requested
    if (hidden)
      li.addClass('hidden');
  }

  function navbarLink(icon, title, href, target) {

    var a = $('<a class="nav-link"></a>');
    if (icon) {

      // get the name of the icon set and icon
      var dashPos = icon.indexOf("-");
      var iconSet = null;
      var iconSplit = icon.split(" ");
      if (iconSplit.length > 1) {
        iconSet = iconSplit[0];
        icon = iconSplit.slice(1).join(" ");
      } else {
        iconSet = icon.substring(0, dashPos);
      }
      var iconName = icon.substring(dashPos + 1);

      // create the icon
      var iconElement = $('<span class="' + iconSet + ' ' + icon + '"></span>');
      if (title)
        iconElement.css('margin-right', '7px');
      a.append(iconElement);
      // if href is null see if we can auto-generate based on icon (e.g. social)
      if (!href)
        maybeGenerateLinkFromIcon(iconName, a);
    }
    if (title)
      a.append(title);

    // add the href.
    if (href) {
      if (href === "source_embed") {
        a.attr('href', '#');
        a.attr('data-featherlight', "#flexdashboard-source-code");
        a.featherlight({
            beforeOpen: function(event){
              $('body').addClass('unselectable');
            },
            afterClose: function(event){
              $('body').removeClass('unselectable');
            }
        });
      } else {
        a.attr('href', href);
      }
    }

    // add the arget
    if (target)
      a.attr('target', target);

    return a;
  }

  // auto generate a link from an icon name (e.g. twitter) when possible
  function maybeGenerateLinkFromIcon(iconName, a) {

     var serviceLinks = {
      "twitter": "https://twitter.com/share?text=" + encodeURIComponent(document.title) + "&url="+encodeURIComponent(location.href),
      "facebook": "https://www.facebook.com/sharer/sharer.php?s=100&p[url]="+encodeURIComponent(location.href),
      "linkedin": "https://www.linkedin.com/shareArticle?mini=true&url="+encodeURIComponent(location.href) + "&title=" + encodeURIComponent(document.title),
      "pinterest": "https://pinterest.com/pin/create/link/?url="+encodeURIComponent(location.href) + "&description=" + encodeURIComponent(document.title)
    };

    var makeSocialLink = function(a, href) {
      a.attr('href', '#');
      a.on('click', function(e) {
        e.preventDefault();
        window.open(href);
      });
    };

    $.each(serviceLinks, function(key, value) {
      if (iconName.indexOf(key) !== -1)
        makeSocialLink(a, value);
    });
  }

  // layout a dashboard page
  function layoutDashboardPage(page) {

    // use a page wrapper so that free form content above the
    // dashboard appears at the top rather than the side (as it
    // would without the wrapper in a column orientation)
    var wrapper = $('<div class="dashboard-page-wrapper"></div>');
    page.wrap(wrapper);

    // if there are no level2 or level3 headers synthesize a level3
    // header to contain the (e.g. frame it, scroll container, etc.)
    var headers = page.find('h2,h3');
    if (headers.length === 0)
      page.wrapInner('<div class="section level3"></div>');

    // hoist up any content before level 2 or level 3 headers
    var children = page.children();
    children.each(function(index) {
      if ($(this).hasClass('level2') || $(this).hasClass('level3'))
        return false;
      $(this).insertBefore(page);
    });

    // determine orientation and fillPage behavior for distinct media
    var orientation, fillPage, storyboard;

    // media: mobile phone
    if (isMobilePhone()) {

      // if there is a sidebar we need to ensure it's content
      // is properly framed as an h3
      var sidebar = page.find('.section.sidebar');
      sidebar.removeClass('sidebar');
      sidebar.wrapInner('<div class="section level3"></div>');
      var h2 = sidebar.find('h2');
      var h3 = $('<h3></h3>');
      h3.append(h2.contents());
      h3.insertBefore(h2);
      h2.detach();

      // wipeout h2 elements then enclose them in a single h2
      var level2 = page.find('div.section.level2');
      level2.each(function() {
        level2.children('h2').remove();
        level2.children().unwrap();
      });
      page.wrapInner('<div class="section level2"></div>');

      // substitute mobile images
      if (isPortrait()) {
        var mobileFigures = $('img.mobile-figure');
        mobileFigures.each(function() {
          // get the src (might be base64 encoded)
          var src = $(this).attr('src');

          // find it's peer
          var id = $(this).attr('data-mobile-figure-id');
          var img = $('img[data-figure-id=' + id + "]");
          img.attr('src', src)
             .attr('width', _options.defaultFigWidthMobile)
             .attr('height', _options.defaultFigHeightMobile);
        });
      }

      // hoist storyboard commentary into it's own section
      if (page.hasClass('storyboard')) {
        var commentaryHR = page.find('div.section.level3 hr');
        commentaryHR.each(function() {
          var commentary = $(this).nextAll().detach();
          var commentarySection = $('<div class="section level3"></div>');
          commentarySection.append(commentary);
          commentarySection.insertAfter($(this).closest('div.section.level3'));
          $(this).remove();
        });
      }

      // force a non full screen layout by columns
      orientation = _options.orientation = 'columns';
      fillPage = _options.fillPage = false;
      storyboard = _options.storyboard = false;

    // media: desktop
    } else {

      // determine orientation
      orientation = page.attr('data-orientation');
      if (orientation !== 'rows' && orientation != 'columns')
        orientation = _options.orientation;

      // determine storyboard mode
      storyboard = page.hasClass('storyboard');

      // fillPage based on options (force for storyboard)
      fillPage = _options.fillPage || storyboard;

      // handle sidebar
      var sidebar = page.find('.section.level2.sidebar');
      if (sidebar.length > 0)
        layoutSidebar(sidebar, page);
    }

    // give it and it's parent divs height: 100% if we are in fillPage mode
    if (fillPage) {
      page.addClass('vertical-layout-fill');
      page.css('height', '100%');
      page.parents('div').css('height', '100%');
    } else {
      page.addClass('vertical-layout-scroll');
    }

    // perform the layout
    if (storyboard)
      layoutPageAsStoryboard(page);
    else if (orientation === 'rows')
      layoutPageByRows(page, fillPage);
    else if (orientation === 'columns')
      layoutPageByColumns(page, fillPage);
  }

  function layoutSidebar(sidebar, content) {

    // get it out of the header hierarchy
    sidebar = sidebar.first();
    if (sidebar.hasClass('level1')) {
      sidebar.removeClass('level1');
      sidebar.children('h1').remove();
    } else if (sidebar.hasClass('level2')) {
      sidebar.removeClass('level2');
      sidebar.children('h2').remove();
    }

    // determine width
    var sidebarWidth = isTablet() ? 220 : 250;
    var dataWidth = parseInt(sidebar.attr('data-width'));
    if (dataWidth)
      sidebarWidth = dataWidth;

    // set the width and shift the page right to accomodate the sidebar
    sidebar.css('width', sidebarWidth + 'px');
    content.css('padding-left', sidebarWidth + 'px');

    // wrap it's contents in a form
    sidebar.wrapInner($('<form></form>'));
  }

  function layoutPageAsStoryboard(page) {

    // create storyboard navigation
    var nav = $('<div class="storyboard-nav"></div>');

    // add navigation buttons
    var prev = $('<button class="sbprev"><i class="fa fa-angle-left"></i></button>');
    nav.append(prev);
    var next= $('<button class="sbnext"><i class="fa fa-angle-right"></i></button>');
    nav.append(next);

    // add navigation frame
    var frameList = $('<div class="sbframelist"></div>');
    nav.append(frameList);
    var ul = $('<ul></ul>');
    frameList.append(ul);

     // find all the level3 sections (those are the storyboard frames)
    var frames = page.find('div.section.level3');
    frames.each(function() {

      // mark it
      $(this).addClass('sbframe');

      // divide it into chart content and (optional) commentary
      $(this).addClass('dashboard-column-orientation');

      // stuff the chart into it's own div w/ flex
      $(this).wrapInner('<div class="sbframe-component"></div>');
      setFlex($(this), 1);
      var frame = $(this).children('.sbframe-component');

      // extract the title from the h3
      var li = $('<li></li>');
      var h3 = frame.children('h3');
      li.append(h3.contents());
      h3.detach();
      ul.append(li);

      // extract commentary
      var hr = frame.children('hr');
      if (hr.length) {
        var commentary = hr.nextAll().detach();
        hr.remove();
        var commentaryFrame = $('<div class="sbframe-commentary"></div>');
        commentaryFrame.addClass('flowing-content-shim');
        commentaryFrame.addClass('flowing-content-container');
        commentaryFrame.append(commentary);
        $(this).append(commentaryFrame);

        // look for a data-commentary-width attribute
        var commentaryWidth = $(this).attr('data-commentary-width');
        if (commentaryWidth)
          commentaryFrame.css('width', commentaryWidth + 'px');
      }

      // layout the chart (force flex)
      var result = layoutChart(frame, true);

      // ice the notes if there are none
      if (!result.notes)
        frame.find('.chart-notes').remove();

      // set flex on chart
      setFlex(frame, 1);
    });

    // create a div to hold all the frames
    var frameContent = $('<div class="sbframe-content"></div>');
    frameContent.addClass('dashboard-row-orientation');
    frameContent.append(frames.detach());

    // row orientation to stack nav and frame content
    page.addClass('dashboard-row-orientation');
    page.append(nav);
    page.append(frameContent);
    setFlex(frameContent, 1);

    // initialize sly
    var sly = new Sly(frameList, {
    		horizontal: true,
    		itemNav: 'basic',
    		smart: true,
    		activateOn: 'click',
    		startAt: 0,
    		scrollBy: 1,
    		activatePageOn: 'click',
    		speed: 200,
    		moveBy: 600,
    		dragHandle: true,
    		dynamicHandle: true,
    		clickBar: true,
    		keyboardNavBy: 'items',
    		next: next,
    		prev: prev
    	}).init();

    // make first frame active
    frames.removeClass('active');
    frames.first().addClass('active');

    // subscribe to frame changed events
    sly.on('active', function (eventName, itemIndex) {
      frames.removeClass('active');
      frames.eq(itemIndex).addClass('active')
                          .trigger('shown');
    });
  }

  function layoutPageByRows(page, fillPage) {

    // row orientation
    page.addClass('dashboard-row-orientation');

    // find all the level2 sections (those are the rows)
    var rows = page.find('div.section.level2');

    // if there are no level2 sections then treat the
    // entire page as if it's a level 2 section
    if (rows.length === 0) {
      page.wrapInner('<div class="section level2"></div>');
      rows = page.find('div.section.level2');
    }

    rows.each(function () {

      // flags
      var haveNotes = false;
      var haveFlexHeight = true;

      // remove the h2
      $(this).children('h2').remove();

      // check for a tabset
      var isTabset = $(this).hasClass('tabset');
      if (isTabset)
        layoutTabset($(this));

      // give it row layout semantics if it's not a tabset
      if (!isTabset)
        $(this).addClass('dashboard-row');

      // find all of the level 3 subheads
      var columns = $(this).find('div.section.level3');

      // determine figureSizes sizes
      var figureSizes = chartFigureSizes(columns);

      // fixup the columns
      columns.each(function(index) {

        // layout the chart (force flex if we are in a tabset)
        var result = layoutChart($(this), isTabset);

        // update flexHeight state
        if (!result.flex)
          haveFlexHeight = false;

        // update state
        if (result.notes)
          haveNotes = true;

        // set the column flex based on the figure width
        // (value boxes will just get the default figure width)
        var chartWidth = figureSizes[index].width;
        setFlex($(this), chartWidth + ' ' + chartWidth + ' 0px');

      });

      // remove empty chart note divs
      if (isTabset)
        $(this).find('.chart-notes').filter(function() {
            return $(this).html() === "&nbsp;";
        }).remove();
      if (!haveNotes)
        $(this).find('.chart-notes').remove();

       // make it a flexbox row
      if (haveFlexHeight)
        $(this).addClass('dashboard-row-flex');

      // now we can set the height on all the wrappers (based on maximum
      // figure height + room for title and notes, or data-height on the
      // container if specified). However, don't do this if there is
      // no flex on any of the constituent columns
      var flexHeight = null;
      var dataHeight = parseInt($(this).attr('data-height'));
      if (dataHeight)
        flexHeight = adjustedHeight(dataHeight, columns.first());
      else if (haveFlexHeight)
        flexHeight = maxChartHeight(figureSizes, columns);
      if (flexHeight) {
        if (fillPage)
          setFlex($(this), flexHeight + ' ' + flexHeight + ' 0px');
        else {
          $(this).css('height', flexHeight + 'px');
          setFlex($(this), '0 0 ' + flexHeight + 'px');
        }
      }

    });
  }

  function layoutPageByColumns(page, fillPage) {

    // column orientation
    page.addClass('dashboard-column-orientation');

    // find all the level2 sections (those are the columns)
    var columns = page.find('div.section.level2');

    // if there are no level2 sections then treat the
    // entire page as if it's a level 2 section
    if (columns.length === 0) {
      page.wrapInner('<div class="section level2"></div>');
      columns = page.find('div.section.level2');
    }

    // layout each column
    columns.each(function (index) {

      // remove the h2
      $(this).children('h2').remove();

      // make it a flexbox column
      $(this).addClass('dashboard-column');

      // check for a tabset
      var isTabset = $(this).hasClass('tabset');
      if (isTabset)
        layoutTabset($(this));

      // find all the h3 elements
      var rows = $(this).find('div.section.level3');

      // get the figure sizes for the rows
      var figureSizes = chartFigureSizes(rows);

      // column flex is the max row width (or data-width if specified)
      var flexWidth;
      var dataWidth = parseInt($(this).attr('data-width'));
      if (dataWidth)
        flexWidth = dataWidth;
      else
        flexWidth = maxChartWidth(figureSizes);
      setFlex($(this), flexWidth + ' ' + flexWidth + ' 0px');

      // layout each chart
      rows.each(function(index) {

        // perform the layout
        var result = layoutChart($(this), false);

        // ice the notes if there are none
        if (!result.notes)
          $(this).find('.chart-notes').remove();

        // set flex height based on figHeight, then adjust
        if (result.flex) {
          var chartHeight = figureSizes[index].height;
          chartHeight = adjustedHeight(chartHeight, $(this));
          if (fillPage)
            setFlex($(this), chartHeight + ' ' + chartHeight + ' 0px');
          else {
            $(this).css('height', chartHeight + 'px');
            setFlex($(this), chartHeight + ' ' + chartHeight + ' ' + chartHeight + 'px');
          }
        }
      });
    });
  }

  function chartFigureSizes(charts) {

    // sizes
    var figureSizes = new Array(charts.length);

    // check each chart
    charts.each(function(index) {

      // start with default
      figureSizes[index] = {
        width: _options.defaultFigWidth,
        height: _options.defaultFigHeight
      };

      // look for data-height or data-width then knit options
      var dataWidth = parseInt($(this).attr('data-width'));
      var dataHeight = parseInt($(this).attr('data-height'));
      var knitrOptions = $(this).find('.knitr-options:first');
      var knitrWidth, knitrHeight;
      if (knitrOptions) {
        knitrWidth = parseInt(knitrOptions.attr('data-fig-width'));
        knitrHeight =  parseInt(knitrOptions.attr('data-fig-height'));
      }

      // width
      if (dataWidth)
        figureSizes[index].width = dataWidth;
      else if (knitrWidth)
        figureSizes[index].width = knitrWidth;

      // height
      if (dataHeight)
        figureSizes[index].height = dataHeight;
      else if (knitrHeight)
        figureSizes[index].height = knitrHeight;
    });

    // return sizes
    return figureSizes;
  }

  function maxChartHeight(figureSizes, charts) {

    // first compute the maximum height
    var maxHeight = _options.defaultFigHeight;
    for (var i = 0; i<figureSizes.length; i++)
      if (figureSizes[i].height > maxHeight)
        maxHeight = figureSizes[i].height;

    // now add offests for chart title and chart notes
    if (charts.length)
      maxHeight = adjustedHeight(maxHeight, charts.first());

    return maxHeight;
  }

  function adjustedHeight(height, chart) {
    if (chart.length > 0) {
      var chartTitle = chart.find('.chart-title');
      if (chartTitle.length)
        height += chartTitle.first().outerHeight();
      var chartNotes = chart.find('.chart-notes');
      if (chartNotes.length)
        height += chartNotes.first().outerHeight();
    }
    return height;
  }

  function maxChartWidth(figureSizes) {
    var maxWidth = _options.defaultFigWidth;
    for (var i = 0; i<figureSizes.length; i++)
      if (figureSizes[i].width > maxWidth)
        maxWidth = figureSizes[i].width;
    return maxWidth;
  }

  // layout a chart
  function layoutChart(chart, forceFlex) {

    // state to return
    var result = {
      notes: false,
      flex: false
    };

    // extract the title
    var title = extractTitle(chart);

    // find components that apply to this container
    var components = componentsFind(chart);

    // if it's a custom component then call it and return
    var customComponents = componentsCustom(components);
    if (customComponents.length) {
      componentsLayout(customComponents, title, chart);
      result.notes = false;
      result.flex = forceFlex || componentsFlex(customComponents);
      return result;
    }

    // put all the content in a chart wrapper div
    chart.addClass('chart-wrapper');
    chart.wrapInner('<div class="chart-stage"></div>');
    var chartContent = chart.children('.chart-stage');

    // flex the content if appropriate
    result.flex = forceFlex || componentsFlex(components);
    if (result.flex) {
      // add flex classes
      chart.addClass('chart-wrapper-flex');
      chartContent.addClass('chart-stage-flex');

      // additional shim to break out of flexbox sizing
      chartContent.wrapInner('<div class="chart-shim"></div>');
      chartContent = chartContent.children('.chart-shim');
    }

    // set custom data-padding attribute
    var pad = chart.attr('data-padding');
    if (pad) {
      if (pad === "0")
        chart.addClass('no-padding');
      else {
        pad = pad + 'px';
        chartContent.css('left', pad)
                    .css('top', pad)
                    .css('right', pad)
                    .css('bottom', pad)
      }
    }

    // call compoents
    componentsLayout(components, title, chartContent);

    // also activate components on shiny output
    findShinyOutput(chartContent).on('shiny:value',
      function(event) {
        var element = $(event.target);
        setTimeout(function() {

          // see if we opted out of flex based on our output (for shiny
          // we can't tell what type of output we have until after the
          // value is bound)
          var components = componentsFind(element);
          var flex = forceFlex || componentsFlex(components);
          if (!flex) {
            chart.css('height', "");
            setFlex(chart, "");
            chart.removeClass('chart-wrapper-flex');
            chartContent.removeClass('chart-stage-flex');
            chartContent.children().unwrap();
          }

          // perform layout
          componentsLayout(components, title, element.parent());
        }, 10);
      });

    // add the title
    var chartTitle = $('<div class="chart-title"></div>');
    chartTitle.append(title);
    chart.prepend(chartTitle);

    // add the notes section
    var chartNotes = $('<div class="chart-notes"></div>');
    chartNotes.html('&nbsp;');
    chart.append(chartNotes);

    // attempt to extract notes if we have a component
    if (components.length)
      result.notes = extractChartNotes(chartContent, chartNotes);

    // return result
    return result;
  }

  // build a tabset from a section div with the .tabset class
  function layoutTabset(tabset) {

    // check for fade option
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it and grab it's text
      var heading = tab.find('h' + tabLevel + ':first');
      var headingDom = heading.contents();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab" class="nav-link"></a>');
      a.append(headingDom);
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation" class="nav-item"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      tab.addClass('no-title');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children()[activeTab]).tab("show");
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    // add nav-tabs-custom
    tabset.addClass('nav-tabs-custom');

    // internal layout is dashboard-column with tab-content flexing
    tabset.addClass('dashboard-column');
    setFlex(tabContent, 1);
  }

  // one time global initialization for components
  function componentsInit(dashboardContainer) {
    for (var i=0; i<window.FlexDashboardComponents.length; i++) {
      var component = window.FlexDashboardComponents[i];
      if (component.init)
        component.init(dashboardContainer);
    }
  }

  // find components that apply within a container
  function componentsFind(container) {

    // look for components
    var components = [];
    for (var i=0; i<window.FlexDashboardComponents.length; i++) {
      var component = window.FlexDashboardComponents[i];
      if (component.find(container).length)
        components.push(component);
    }

    // if there were none then use a special flowing content component
    // that just adds a scrollbar in fillPage mode
    if (components.length == 0) {
      components.push({
        find: function(container) {
          return container;
        },

        flex: function(fillPage) {
          return fillPage;
        },

        layout: function(title, container, element, fillPage) {
          if (fillPage) {
            container.addClass('flowing-content-shim');
            container.addClass('flowing-content-container');
          }
        }
      });
    }

    return components;
  }

  // if there is a custom component then pick it out
  function componentsCustom(components) {
    var customComponent = [];
    for (var i=0; i<components.length; i++)
      if (components[i].type === "custom") {
        customComponent.push(components[i]);
        break;
      }
    return customComponent;
  }

  // query all components for flex
  function componentsFlex(components) {

    // no components at all means no flex
    if (components.length === 0)
      return false;

    // otherwise query components (assume true unless we see false)
    var isMobile = isMobilePhone();
    for (var i=0; i<components.length; i++)
      if (components[i].flex && !components[i].flex(_options.fillPage))
        return false;
    return true;
  }

  // layout all components
  function componentsLayout(components, title, container) {
    var isMobile = isMobilePhone();
    for (var i=0; i<components.length; i++) {
      var element = components[i].find(container);
      if (components[i].layout) {
        // call layout (don't call other components if it returns false)
        var result = components[i].layout(title, container, element, _options.fillPage);
        if (result === false)
          return;
      }
    }
  }

  // get a reference to the h3, discover it's inner html, and remove it
  function extractTitle(container) {
    var h3 = container.children('h3').first();
    var title = '';
    if (!container.hasClass('no-title'))
      title = h3.contents();
    h3.detach();
    return title;
  }

  // extract chart notes
  function extractChartNotes(chartContent, chartNotes) {
    // look for a terminating blockquote or image caption
    var blockquote = chartContent.children('blockquote:last-child');
    var caption = chartContent.children('div.image-container')
                              .children('p.caption');
    if (blockquote.length) {
      chartNotes.empty().append(blockquote.children('p:first-child').contents());
      blockquote.remove();
      return true;
    } else if (caption.length) {
      chartNotes.empty().append(caption.contents());
      caption.remove();
      return true;
    } else {
      return false;
    }
  }

  function findShinyOutput(chartContent) {
    return chartContent.find('.shiny-text-output, .shiny-html-output');
  }

  // safely detect rendering on a mobile phone
  function isMobilePhone() {
    try
    {
      return ! window.matchMedia("only screen and (min-width: 768px)").matches;
    }
    catch(e) {
      return false;
    }
  }

  function isFillPage() {
    return _options.fillPage;
  }

  // detect portrait mode
  function isPortrait() {
    return ($(window).width() < $(window).height());
  }

  // safely detect rendering on a tablet
  function isTablet() {
    try
    {
      return window.matchMedia("only screen and (min-width: 769px) and (max-width: 992px)").matches;
    }
    catch(e) {
      return false;
    }
  }

  // test whether this is a shiny doc
  function isShinyDoc() {
    return (typeof(window.Shiny) !== "undefined" && !!window.Shiny.outputBindings);
  }

  // set flex using vendor specific prefixes
  function setFlex(el, flex) {
    el.css('-webkit-box-flex', flex)
      .css('-webkit-flex', flex)
      .css('-ms-flex', flex)
      .css('flex', flex);
  }

  // support bookmarking of pages
  function handleLocationHash() {

    // restore tab/page from bookmark
    var hash = window.decodeURIComponent(window.location.hash);
    if (hash.length > 0)
      $('ul.nav a[href="' + hash + '"]').tab('show');
    FlexDashboardUtils.manageActiveNavbarMenu();

    // navigate to a tab when the history changes
    window.addEventListener("popstate", function(e) {
      var hash = window.decodeURIComponent(window.location.hash);
      var activeTab = $('ul.nav a[href="' + hash + '"]');
      if (activeTab.length) {
        activeTab.tab('show');
      } else {
        $('ul.nav a:first').tab('show');
      }
      FlexDashboardUtils.manageActiveNavbarMenu();
    });

    // add a hash to the URL when the user clicks on a tab/page
    $('.navbar-nav a[data-toggle="tab"]').on('click', function(e) {
      var baseUrl = FlexDashboardUtils.urlWithoutHash(window.location.href);
      var hash = FlexDashboardUtils.urlHash($(this).attr('href'));
      var href = baseUrl + hash;
      FlexDashboardUtils.setLocation(href);
    });

    // handle clicks of other links that should activate pages
    var navPages = $('ul.navbar-nav li a[data-toggle=tab]');
    navPages.each(function() {
      var href =  $(this).attr('href');
      var links = $('a[href="' + href + '"][data-toggle!=tab]');
      links.each(function() {
        $(this).on('click', function(e) {
          window.FlexDashboardUtils.showPage(href);
        });
      });
    });
  }

  // tweak Prism highlighting
  function initPrismHighlighting() {

    if (window.Prism) {
      Prism.languages.insertBefore('r', 'comment', {
        'heading': [
          {
            // title 1
        	  // =======

        	  // title 2
        	  // -------
        	  pattern: /\w+.*(?:\r?\n|\r)(?:====+|----+)/,
            alias: 'operator'
          },
          {
            // ### title 3
            pattern: /(^\s*)###[^#].+/m,
            lookbehind: true,
            alias: 'operator'
          }
        ]
      });

      // prism highlight
      Prism.highlightAll();
    }
  }

  FlexDashboard.prototype = {
    constructor: FlexDashboard,
    init: init,
    isMobilePhone: isMobilePhone,
    isFillPage: isFillPage
  };

  return FlexDashboard;

})();

// utils
window.FlexDashboardUtils = {
  resizableImage: function(img) {
    var src = img.attr('src');
    var url = 'url("' + src + '")';
    img.parent().css('background', url)
                .css('background-size', 'contain')
                .css('background-repeat', 'no-repeat')
                .css('background-position', 'center')
                .addClass('image-container');
  },
  setLocation: function(href) {
    if (history && history.pushState) {
      history.pushState(null, null, href);
    } else {
      window.location.replace(href);
    }
    setTimeout(function() {
        window.scrollTo(0, 0);
    }, 10);
    this.manageActiveNavbarMenu();
  },
  showPage: function(href) {
    $('ul.navbar-nav li a[href="' + href + '"]').tab('show');
    var baseUrl = this.urlWithoutHash(window.location.href);
    var loc = baseUrl + href;
    this.setLocation(loc);
  },
  showLinkedValue: function(href) {
    // check for a page link
    if ($('ul.navbar-nav li a[data-toggle=tab][href="' + href + '"]').length > 0)
      this.showPage(href);
    else
      window.open(href);
  },
  urlWithoutHash: function(url) {
    var hashLoc = url.indexOf('#');
    if (hashLoc != -1)
      return url.substring(0, hashLoc);
    else
      return url;
  },
  urlHash: function(url) {
    var hashLoc = url.indexOf('#');
    if (hashLoc != -1)
      return url.substring(hashLoc);
    else
      return "";
  },
  manageActiveNavbarMenu: function () {
    // remove active from currently active tabs
    $('.navbar ul.nav .active').removeClass('active');
    // find the active tab
    var activeTab = $('.dashboard-page-wrapper.tab-pane.active');
    if (activeTab.length > 0) {
      var tabId = activeTab.attr('id');
      if (tabId)
        $(".navbar ul.nav a[href='#" + tabId + "']").tab("show");
    }
  }
};

window.FlexDashboard = new FlexDashboard();

// empty content
window.FlexDashboardComponents.push({
  find: function(container) {
    if (container.find('p').length == 0)
      return container;
    else
      return $();
  }
})

// plot image
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('p')
                    .children('img:only-child');
  },

  layout: function(title, container, element, fillPage) {
    FlexDashboardUtils.resizableImage(element);
  }
});

// plot image (figure style)
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('div.figure').children('img');
  },

  layout: function(title, container, element, fillPage) {
    FlexDashboardUtils.resizableImage(element);
  }
});

// htmlwidget
window.FlexDashboardComponents.push({

  init: function(dashboardContainer) {
    // trigger "shown" after initial layout to force static htmlwidgets
    // in runtime: shiny to be resized after the dom has been transformed
    dashboardContainer.on('flexdashboard:layoutcomplete', function(event) {
      setTimeout(function() {
        dashboardContainer.trigger('shown');
      }, 200);
    });
  },

  find: function(container) {
    return container.children('div[id^="htmlwidget-"],div.html-widget');
  }
});

// gauge
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('div.html-widget.gauge');
  },

  flex: function(fillPage) {
    return false;
  },

  layout: function(title, container, element, fillPage) {


  }

});

// shiny output
window.FlexDashboardComponents.push({
  find: function(container) {
    return container.children('div[class^="shiny-"]');
  }
});

// bootstrap table
window.FlexDashboardComponents.push({

  find: function(container) {
    var bsTable = container.find('table.table');
    if (bsTable.length !== 0)
      return bsTable;
    else
      return container.find('tr.header').parent('thead').parent('table');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {

    // alias variables
    var bsTable = element;

    // fixup xtable generated tables with a proper thead
    var headerRow = bsTable.find('tbody > tr:first-child > th').parent();
    if (headerRow.length > 0) {
      var thead = $('<thead></thead>');
      bsTable.prepend(thead);
      headerRow.detach().appendTo(thead);
    }

    // improve appearance
    container.addClass('bootstrap-table');

    // for fill page provide scrolling w/ sticky headers
    if (fillPage) {
      // force scrollbar on overflow
      container.addClass('flowing-content-shim');

      // stable table headers when scrolling
      bsTable.stickyTableHeaders({
        scrollableArea: container
      });
    }
  }
});

// embedded shiny app
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.find('iframe.shiny-frame');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {
    if (fillPage) {
      element.attr('height', '100%');
    } else {
      // provide default height if necessary
      var height = element.get(0).style.height;
      if (!height)
        height = element.attr('height');
      if (!height)
        element.attr('height', 500);
    }
  }
});

// shiny fillRow or fillCol
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.find('.flexfill-container');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {
    if (fillPage)
      element.css('height', '100%');
    else {
      // provide default height if necessary
      var height = element.get(0).style.height;
      if (height === "100%" || height === "auto" || height === "initial" ||
          height === "inherit" || !height) {
        element.css('height', 500);
      }
    }
  }
});

// valueBox
window.FlexDashboardComponents.push({

  type: "custom",

  find: function(container) {
    if (container.find('span.value-output, .shiny-valuebox-output').length)
      return container;
    else
      return $();
  },

  flex: function(fillPage) {
    return false;
  },

  layout: function(title, container, element, fillPage) {

    // alias variables
    var chartTitle = title;
    var valueBox = element;

    // add value-box class to container
    container.addClass('value-box');

    // value paragraph
    var value = $('<p class="value"></p>');

    // if we have shiny-text-output then just move it in
    var valueOutputSpan = [];
    var shinyOutput = valueBox.find('.shiny-valuebox-output').detach();
    if (shinyOutput.length) {
      valueBox.children().remove();
      shinyOutput.html("&mdash;");
      value.append(shinyOutput);
    } else {
      // extract the value (remove leading vector index)
      var chartValue = valueBox.text().trim();
      chartValue = chartValue.replace("[1] ", "");
      valueOutputSpan = valueBox.find('span.value-output').detach();
      valueBox.children().remove();
      value.text(chartValue);
    }

    // caption
    var caption = $('<p class="caption"></p>');
    caption.append(chartTitle);

    // build inner div for value box and add it
    var inner = $('<div class="inner"></div>');
    inner.append(value);
    inner.append(caption);
    valueBox.append(inner);

    // add icon if specified
    var icon = $('<div class="icon"><i></i></div>');
    valueBox.append(icon);
    function setIcon(chartIcon) {
      var iconLib = "";
      var iconSplit = chartIcon.split(" ");
      if (iconSplit.length > 1) {
        iconLib = iconSplit[0];
        chartIcon = iconSplit.slice(1).join(" ");
      } else {
        var components = chartIcon.split("-");
        if (components.length > 1)
          iconLib = components[0];
      }
      icon.children('i').attr('class', iconLib + ' ' + chartIcon);
    }
    var chartIcon = valueBox.attr('data-icon');
    if (chartIcon)
      setIcon(chartIcon);

    // handle data attributes in valueOutputSpan
    function handleValueOutput(valueOutput) {

      // caption
      var dataCaption = valueOutput.attr('data-caption');
      if (dataCaption)
        caption.html(dataCaption);

      // icon
      var dataIcon = valueOutput.attr('data-icon');
      if (dataIcon)
        setIcon(dataIcon);

      // If valueBox(color=) was an accent color, this attr should
      // be populated with the accent color and the relevant CSS comes
      // in through HTML dependencies
      var dataColorAccent = valueOutput.attr('data-color-accent');
      var valueBoxClasses = "value-box-" + (["primary", "info", "danger", "warning", "success"].join(" value-box-"));
      if (dataColorAccent) {
        valueBox.removeClass(valueBoxClasses);
        valueBox.addClass('value-box-' + dataColorAccent);
      }

      // If valueBox(color=) was a CSS color, these other data-color-*
      // attrs will be populated
      var dataColor = valueOutput.attr('data-color');
      if (dataColor) {
        valueBox.removeClass(valueBoxClasses);
        valueBox.css('background-color', dataColor);
      }
      var dataColorText = valueOutput.attr('data-color-text');
      if (dataColorText) {
        valueBox.find(".inner").css('color', dataColorText);
      }
      var dataColorIcon = valueOutput.attr('data-color-icon');
      if (dataColorIcon) {
        valueBox.find(".icon").css('color', dataColorIcon);
      }

      // url
      var dataHref = valueOutput.attr('data-href');
      if (dataHref) {
        valueBox.addClass('linked-value');
        valueBox.off('click.value-box');
        valueBox.on('click.value-box', function(e) {
          window.FlexDashboardUtils.showLinkedValue(dataHref);
        });
      }
    }

    // check for a valueOutputSpan
    if (valueOutputSpan.length > 0) {
      handleValueOutput(valueOutputSpan);
    }

    // if we have a shinyOutput then bind a listener to handle
    // new valueOutputSpan values
    shinyOutput.on('shiny:value',
      function(event) {
        var element = $(event.target);
        setTimeout(function() {
          var valueOutputSpan = element.find('span.value-output');
          if (valueOutputSpan.length > 0)
            handleValueOutput(valueOutputSpan);
        }, 10);
      }
    );
  }
});
</script>

<div id="dashboard-container">

<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<style type="text/css">
table {
  margin: auto;
  border-top: 1px solid #666;
  border-bottom: 1px solid #666;
}
table thead th { border-bottom: 1px solid #ddd; }
th, td { padding: 5px; }

pre {
  white-space: pre-wrap;
  word-break: keep-all;
}

/* Hack to make prompt-tab scrollable again */
div.level3.tab-pane .chart-stage {
  overflow: scroll;
}
</style>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<div id="column" class="section level2" data-width="55">
<h2>Column</h2>
<div id="score-comparisons-of-111-publications" class="section level3">
<h3>Score comparisons of 111 publications</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-b9164a22fbea3d82cc7f" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-b9164a22fbea3d82cc7f">{"x":{"filter":"none","vertical":false,"fillContainer":true,"data":[["61","62","63","64","65","66","67","68","69","70","71","72","73","74","75","76","77","78","79","80","81","82","83","84","85","86","87","88","89","90","91","92","93","94","95","96","97","98","99","100","101","102","103","104","105","106","107","108","109","110","111","112","113","114","115","116","117","118","119","120","121","122","123","124","125","126","127","128","129","130","131","132","133","134","135","136","137","138","139","140","141","142","143","144","145","146","147","148","149","150","151","152","153","154","155","156","157","158","159","160","161","162","163","164","165","166","167","168","169","171","172"],["<a href='#61' title='Jump to individual results on the right'>Aikenhead 2011<\/a>","<a href='#62' title='Jump to individual results on the right'>Al-Hozaim 2010<\/a>","<a href='#63' title='Jump to individual results on the right'>Allen 2015<\/a>","<a href='#64' title='Jump to individual results on the right'>Allin 2015<\/a>","<a href='#65' title='Jump to individual results on the right'>Alzahem 2011<\/a>","<a href='#66' title='Jump to individual results on the right'>Apelt 2013<\/a>","<a href='#67' title='Jump to individual results on the right'>Aworanti 2014<\/a>","<a href='#68' title='Jump to individual results on the right'>Baker 2015<\/a>","<a href='#69' title='Jump to individual results on the right'>Berger 2012<\/a>","<a href='#70' title='Jump to individual results on the right'>Billingham 2010<\/a>","<a href='#71' title='Jump to individual results on the right'>Black 2013<\/a>","<a href='#72' title='Jump to individual results on the right'>Borruto 2010<\/a>","<a href='#73' title='Jump to individual results on the right'>Castagnetti 2010<\/a>","<a href='#74' title='Jump to individual results on the right'>Castagnetti 2016<\/a>","<a href='#75' title='Jump to individual results on the right'>Chan 2014 (Pediatr Surg Int)<\/a>","<a href='#76' title='Jump to individual results on the right'>Chan 2014 (J Pediatr Surg)<\/a>","<a href='#77' title='Jump to individual results on the right'>Chang 2015<\/a>","<a href='#78' title='Jump to individual results on the right'>Chen 2013<\/a>","<a href='#79' title='Jump to individual results on the right'>Corbett 2015<\/a>","<a href='#80' title='Jump to individual results on the right'>Cullis 2016<\/a>","<a href='#81' title='Jump to individual results on the right'>Cundy 2014 (BJU Int)<\/a>","<a href='#82' title='Jump to individual results on the right'>Cundy 2014 (J Pediatr Surg)<\/a>","<a href='#83' title='Jump to individual results on the right'>Cundy 2014 (Eur J Pediatr Surg)<\/a>","<a href='#84' title='Jump to individual results on the right'>Ding 2013<\/a>","<a href='#85' title='Jump to individual results on the right'>Dingemann 2014<\/a>","<a href='#86' title='Jump to individual results on the right'>Dingemann 2013<\/a>","<a href='#87' title='Jump to individual results on the right'>Ells 2015<\/a>","<a href='#88' title='Jump to individual results on the right'>Elyas 2010<\/a>","<a href='#89' title='Jump to individual results on the right'>Esposito 2014<\/a>","<a href='#90' title='Jump to individual results on the right'>Feng 2016<\/a>","<a href='#91' title='Jump to individual results on the right'>Feng 2015<\/a>","<a href='#92' title='Jump to individual results on the right'>Friedmacher 2011<\/a>","<a href='#93' title='Jump to individual results on the right'>Friedmacher 2012<\/a>","<a href='#94' title='Jump to individual results on the right'>Frongia 2013<\/a>","<a href='#95' title='Jump to individual results on the right'>Gallo 2012<\/a>","<a href='#96' title='Jump to individual results on the right'>Gosemann 2013<\/a>","<a href='#97' title='Jump to individual results on the right'>Graziano 2015<\/a>","<a href='#98' title='Jump to individual results on the right'>Guo 2011<\/a>","<a href='#99' title='Jump to individual results on the right'>Hall 2011<\/a>","<a href='#100' title='Jump to individual results on the right'>Healy 2015<\/a>","<a href='#101' title='Jump to individual results on the right'>Healy 2016<\/a>","<a href='#102' title='Jump to individual results on the right'>Heloury 2012<\/a>","<a href='#103' title='Jump to individual results on the right'>Huang 2015<\/a>","<a href='#104' title='Jump to individual results on the right'>Ishii 2014<\/a>","<a href='#105' title='Jump to individual results on the right'>Ishii 2015<\/a>","<a href='#106' title='Jump to individual results on the right'>Ito 2014<\/a>","<a href='#107' title='Jump to individual results on the right'>Jia 2011<\/a>","<a href='#108' title='Jump to individual results on the right'>Kapralik 2016<\/a>","<a href='#109' title='Jump to individual results on the right'>Kunz 2013<\/a>","<a href='#110' title='Jump to individual results on the right'>Landisch 2015<\/a>","<a href='#111' title='Jump to individual results on the right'>Lane 2010<\/a>","<a href='#112' title='Jump to individual results on the right'>Lansdale 2010<\/a>","<a href='#113' title='Jump to individual results on the right'>Lee 2010<\/a>","<a href='#114' title='Jump to individual results on the right'>LeeVan 2016<\/a>","<a href='#115' title='Jump to individual results on the right'>Liang 2011<\/a>","<a href='#116' title='Jump to individual results on the right'>Lishuang 2015<\/a>","<a href='#117' title='Jump to individual results on the right'>Livingston 2015<\/a>","<a href='#118' title='Jump to individual results on the right'>Mauritz 2013<\/a>","<a href='#119' title='Jump to individual results on the right'>Mauritz 2011<\/a>","<a href='#120' title='Jump to individual results on the right'>Mei 2011<\/a>","<a href='#121' title='Jump to individual results on the right'>Mullassery 2014<\/a>","<a href='#122' title='Jump to individual results on the right'>Nagler 2011<\/a>","<a href='#123' title='Jump to individual results on the right'>Narayanan 2013<\/a>","<a href='#124' title='Jump to individual results on the right'>Nasr 2010<\/a>","<a href='#125' title='Jump to individual results on the right'>Nasr 2013<\/a>","<a href='#126' title='Jump to individual results on the right'>Nataraja 2013<\/a>","<a href='#127' title='Jump to individual results on the right'>Nicolau 2011<\/a>","<a href='#128' title='Jump to individual results on the right'>Oliveira 2016<\/a>","<a href='#129' title='Jump to individual results on the right'>Oomen 2012<\/a>","<a href='#130' title='Jump to individual results on the right'>Parolini 2016<\/a>","<a href='#131' title='Jump to individual results on the right'>Parolini 2014<\/a>","<a href='#132' title='Jump to individual results on the right'>Peters 2013<\/a>","<a href='#133' title='Jump to individual results on the right'>Peycelon 2014<\/a>","<a href='#134' title='Jump to individual results on the right'>Pfistermuller 2015<\/a>","<a href='#135' title='Jump to individual results on the right'>Puligandla 2015<\/a>","<a href='#136' title='Jump to individual results on the right'>Reddy 2010<\/a>","<a href='#137' title='Jump to individual results on the right'>Romao 2012<\/a>","<a href='#138' title='Jump to individual results on the right'>Ross 2015<\/a>","<a href='#139' title='Jump to individual results on the right'>Ruttenstock 2010<\/a>","<a href='#140' title='Jump to individual results on the right'>Rynja 2011<\/a>","<a href='#141' title='Jump to individual results on the right'>Saldaña 2013<\/a>","<a href='#142' title='Jump to individual results on the right'>Sauerland 2010<\/a>","<a href='#143' title='Jump to individual results on the right'>Scholfield 2016<\/a>","<a href='#144' title='Jump to individual results on the right'>Sharp 2015<\/a>","<a href='#145' title='Jump to individual results on the right'>Shawyer 2014<\/a>","<a href='#146' title='Jump to individual results on the right'>Shawyer 2015<\/a>","<a href='#147' title='Jump to individual results on the right'>Shen 2015<\/a>","<a href='#148' title='Jump to individual results on the right'>Siddiqui 2011<\/a>","<a href='#149' title='Jump to individual results on the right'>Siminas 2015<\/a>","<a href='#150' title='Jump to individual results on the right'>Sklar 2014<\/a>","<a href='#151' title='Jump to individual results on the right'>Sola 2010<\/a>","<a href='#152' title='Jump to individual results on the right'>Symeonidis 2016<\/a>","<a href='#153' title='Jump to individual results on the right'>Tan 2016<\/a>","<a href='#154' title='Jump to individual results on the right'>Terui 2015<\/a>","<a href='#155' title='Jump to individual results on the right'>Thomson 2015<\/a>","<a href='#156' title='Jump to individual results on the right'>Thyoka 2013<\/a>","<a href='#157' title='Jump to individual results on the right'>van Dalen 2015<\/a>","<a href='#158' title='Jump to individual results on the right'>Vanden Berg 2016<\/a>","<a href='#159' title='Jump to individual results on the right'>van den Hondel 2014<\/a>","<a href='#160' title='Jump to individual results on the right'>Vernon-Roberts 2013<\/a>","<a href='#161' title='Jump to individual results on the right'>Wang 2013<\/a>","<a href='#162' title='Jump to individual results on the right'>Wayne 2015<\/a>","<a href='#163' title='Jump to individual results on the right'>Weih 2012<\/a>","<a href='#164' title='Jump to individual results on the right'>Wenk 2015<\/a>","<a href='#165' title='Jump to individual results on the right'>Wilkinson 2012<\/a>","<a href='#166' title='Jump to individual results on the right'>Wright 2013<\/a>","<a href='#167' title='Jump to individual results on the right'>Yang 2011<\/a>","<a href='#168' title='Jump to individual results on the right'>Yang 2013<\/a>","<a href='#169' title='Jump to individual results on the right'>Youssef 2016<\/a>","<a href='#171' title='Jump to individual results on the right'>Zhao 2015<\/a>","<a href='#172' title='Jump to individual results on the right'>Zhu 2016<\/a>"],[0.553191489361702,0.559183673469388,0.609504132231405,0.470588235294118,0.48780487804878,0.659663865546218,0.524461839530333,0.441860465116279,0.199604743083004,0.334702258726899,0.309659090909091,0.315668202764977,0.466403162055336,0.234536082474227,0.622377622377622,0.318181818181818,0.244755244755245,0.292576419213974,0.585526315789474,0.568493150684932,-0.0975609756097562,0.404411764705882,0.51131221719457,0.191616766467066,0.660377358490566,0.427745664739884,0.689655172413793,0.354948805460751,0.557377049180328,0.711229946524064,0.5,0.292134831460674,0.457589285714286,0.530434782608696,0.342920353982301,0.425531914893617,0.705240174672489,0.25,0.513026052104208,0.390322580645161,0.723926380368098,0.677033492822966,0.0620347394540942,0.821978021978022,0.590909090909091,0.328358208955224,0.274193548387097,0.353293413173653,0.177285318559557,0.770700636942675,0.317689530685921,0.538461538461538,0.674044265593561,0.355864811133201,0.224137931034483,0.149606299212598,0.354948805460751,0.446153846153846,0.394618834080717,0.334246575342466,0.479338842975207,0.181818181818182,0.4,0.297872340425532,0.430379746835443,0.470588235294118,0.608695652173913,0.543340380549683,0.305912596401028,0.598726114649682,0.626728110599078,0.365384615384615,0.6484375,0.201183431952663,0.584615384615385,0.635135135135135,0.244,0.167400881057269,0.258823529411765,0.551867219917012,0.643171806167401,-0.0714285714285714,0.274793388429752,0.76,0.4,0.287390029325513,0.366197183098592,0.0930232558139534,0.597014925373134,0.221729490022173,0.0729613733905579,0,0.330578512396694,0.0624999999999999,0.292134831460674,0.766738660907127,0.5625,0.450226244343891,0.524229074889868,0.372093023255814,0.0168067226890757,0.546762589928057,0.765217391304348,0.232227488151659,0,0.438961038961039,0.302816901408451,0.26302729528536,0.256880733944954,0.302816901408451,0.46119733924612],[0.740740740740741,0.703703703703704,0.740740740740741,0.740740740740741,0.740740740740741,0.777777777777778,0.666666666666667,0.703703703703704,0.444444444444444,0.555555555555556,0.666666666666667,0.592592592592593,0.62962962962963,0.592592592592593,0.777777777777778,0.62962962962963,0.555555555555556,0.555555555555556,0.740740740740741,0.740740740740741,0.62962962962963,0.777777777777778,0.703703703703704,0.62962962962963,0.777777777777778,0.592592592592593,0.851851851851852,0.740740740740741,0.703703703703704,0.851851851851852,0.703703703703704,0.481481481481481,0.666666666666667,0.703703703703704,0.592592592592593,0.62962962962963,0.814814814814815,0.592592592592593,0.666666666666667,0.740740740740741,0.814814814814815,0.814814814814815,0.481481481481481,0.888888888888889,0.777777777777778,0.62962962962963,0.62962962962963,0.703703703703704,0.592592592592593,0.851851851851852,0.481481481481481,0.777777777777778,0.777777777777778,0.555555555555556,0.62962962962963,0.555555555555556,0.740740740740741,0.851851851851852,0.62962962962963,0.666666666666667,0.740740740740741,0.777777777777778,0.666666666666667,0.592592592592593,0.62962962962963,0.740740740740741,0.740740740740741,0.703703703703704,0.62962962962963,0.740740740740741,0.777777777777778,0.592592592592593,0.814814814814815,0.444444444444444,0.740740740740741,0.777777777777778,0.481481481481481,0.481481481481481,0.481481481481481,0.703703703703704,0.777777777777778,0.62962962962963,0.518518518518518,0.851851851851852,0.62962962962963,0.666666666666667,0.62962962962963,0.518518518518518,0.777777777777778,0.518518518518518,0.407407407407407,0.518518518518518,0.666666666666667,0.444444444444444,0.740740740740741,0.851851851851852,0.740740740740741,0.666666666666667,0.703703703703704,0.666666666666667,0.518518518518518,0.740740740740741,0.851851851851852,0.555555555555556,0.444444444444444,0.703703703703704,0.592592592592593,0.592592592592593,0.666666666666667,0.592592592592593,0.666666666666667]],"container":"<table class=\"display fill-container\">\n  <thead>\n    <tr>\n      <th>Ref.<\/th>\n      <th>Author & Year<\/th>\n      <th>PRISMA κ<\/th>\n      <th>PRISMA agreement<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"t","order":[[0,"asc"]],"columnDefs":[{"targets":2,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"className":"dt-right","targets":[2,3]}],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render","options.columnDefs.1.render"],"jsHooks":[]}</script>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
</div>
<div id="score-heatmaps" class="section level3" data-height="720">
<h3>Score heatmaps</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<p><img data-figure-id="fig1" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAB4AAAAQ4CAIAAABnsVYUAAAACXBIWXMAABMRAAATEQE5YH/wAAAgAElEQVR4nOzdd3wT5R8H8Oe5y05XuvekhVI2yN4IspUpArIcoKioKEP8KQqCKKIIKg4QxIHKBkFFUBBEBBRkKZQl0HTSkbTZd78/CqUjbS9t0lzaz/vFP6TJ5bl7Pnnu7sndN5TneQIAAAAAAAAAAAAA4GyMuxsAAAAAAAAAAAAAAPUTJqABAAAAAAAAAAAAwCUwAQ0AAAAAAAAAAAAALoEJaAAAAAAAAAAAAABwCUxAAwAAAAAAAAAAAIBLYAIaAAAAAAAAAAAAAFwCE9AAAAAAAAAAAAAA4BKYgAYAAAAAAAAAAAAAl8AENAAAAAAAAAAAAAC4BCagAQAAAAAAAAAAAMAlMAENAAAAAAAAAAAAAC6BCWgAAAAAAAAAAAAAcAlMQAMAAAAAAAAAAACAS2ACGgAAAAAAAAAAAABcAhPQAAAAAAAAAAAAAOASmIAGAAAAAAAAAAAAAJfABDQAAAAAAAAAAAAAuAQmoAEAAAAAAAAAAADAJRr0BDSXurSzjFLl6I0mu3+3nX2tnYwyvg9ut/93z2XNOLJu/sNDOjSODPRSyNV+YUkdBj28YMNfOZy7W1av8OmbxsdEjt2YxRNCuEtvd5VTebd3rlS9kW3nl3SQUXmXty46vzOMR+e1DOz+1hmz05csjPXPF1OklI18fF+VLRDyNNPOSf4MpZSRd16aaqvkSbZ/l3SQUUop4z9pZ/Uf4jL95RKm7Q/6MmzUEz9bCHF/dwCAxzD/+GgoS8thWLl3UHzbAY+8vvNCUWWv5LMOf77ys4PpjuxRXD8YggDi30fUPJY1gVi6gfhDWA4yWe81sExy6QfWvP3Otyf0At8NmayHnJ55jJNQS7XMJN+A2S682UlKiGLUt0a7f7eeWdhWSqjP+G32/+6ZzFc2TW/ty1BCCGUVfiHhoRolSwkhhErD+791rMDdDawvuKwtD0aou7513srzPM/bLi7rIiOyrm9ftlX5Muu/r7eXElnnpalVP69mbcrZNC7Up8c7/1qdv2wBLMfnNZUQJuKxvabaPs24Y6KmOLWyTksv2N9U1vNvdJQVP0kzcUd1H+Jy/eUSxm3jfSgTOX2fufgt3dsdAOAxTD88EsIQKvMLj70jMkgtoYQQQhi/Tq8ctrv3tl15t4dCkvj87xbB7+XiwbDwwtaFE3o2CfVRqvxj2gyZseq3TCFvZLq2b/n0IXfFB3krZErf8OTuY+asPZrtgv2k42q4Rlz+mW9fndinWaRGpVAHxrYZPP3dn9PKdJPo9xEOx9J0be/yJ+/r0CjMTylX+oY37THuf1+dzOOEvJc4Y+l6NW2YsE1d/cdK9CEsx9FM1mZgQSadPOLdXvzO1x+5p2W0RiWTe4ckdR71/Orfy7xBfc9kadZLHw8KZIis18prgkIp1kwKfaHx8vdLp/VvFRPgpQ6Ia9Vr7P82ntM7dQ1qqOYfxqrXyLj9QT9axTSdtN2is1be+Zl3LJPmX56MZqtqXpVEmkmBRyPVDkdu4/CKCw0bL6zHa5VJTEA3rAloLueH6Y1llLKBHR9btS81vzgzlvyLB9Y83T1EQikbPXl7lqBzAaia8fCsZFnohG23xzJRTEDzvPmvl1rIgu//OtMdnez0CWjKsiyVdbY/A21LXdpZRlmWpUImoMv3l0uUm4B2c3cAgMcoPluQtHj5RNkZSqP2j9VTmqkoobLWr5yscC7P3dz7VLKUso5MQLtyMOTyDr3cyY8hlFGHNmnRLFYjo4RK48d+daXqI1jzP6sGh0oooYw6rEnrNs1i/RWUEipPmPDtdffOQdd0jWzXNz/SVE0JpTK/6JQWjUPVLCVUEjZ41bnSOyuR7yMci2XRX0t7B7K3e7FlUqhaQgmhqiaPbLlRbS+KMZYuV+OGCdvUAj9WIg9hOQ5lsnYDCzLp/BGPu/nL3Lt8GEKozDeySfOU+CAVSwmVRo9Yc95852n1OJNlmP9Z3tuPIUTwBLQoMyn0hdzN/S921DCUMl5hTVqkxPrLKSGMptvi44XOXxsH1PzDWP0aGXdMCpBK7GIZSqi867KLxR3v3Mw7lEkue81ABaWUqdBGZYfF56rbCKLMpLBdpMDhyA1qtOLCwyawx2uRSUxAN6QJaC5355RIljCBfd/+u6jCX4v+XNBBRam09aunhF8pBfZx6Z8P85c0evZgSXREMgHN2y6/21Mpb7vwtBs62ekT0LK7enRWVTIDbbv4dlc5VXXqcZes+gnoiv3lEhUmoN3aHQDgMSo5W+B5nufNJ15uJSVE0nL+yVvHhbbc1N++3/D+K1PvjldRQogDE9AuHQwLDz6XLKVMYK/XDmVbeZ7ni85/MSFRRpnAe9dVMd9ju/7JAB9KZY0nfHamoPhA13Rj78s9AxjChE/Z6c77tmq6Rpc/6OdLqTRm6NJf04s7rSh1y8zOAQxVdlh0ylz6mWLeRzgSS8ORuc1klMqTxq0+mVe8aQrPb57Z2Z8hTOCw9WlVnsGIMZauV9OGCdvUwj9W4g5hOQ5ksnYDCzLpghHPePDZRhLKBPR8ac9/huJX3jyxelwjKaW+Az8p9Qb1NZNlGE8u7uxVfMWisAlocWZS4Au59K/HhDJU1uiBT24NW4bLWx5voaRU2fGNamc5XajGK16bNeJydk9NkMibPvNL/u1do1Mz71AmLUfnNpFQ5dD1uY6/kSgzKfBoRPBwVOecu4OoGDahPV7zTGIC2sUT0BZDodGlo6bFZLQI/OLBen5ZVyWlXr1XXrTbJC5z7RAvSiTNX7IzHLmgPc5Qx28nlO3SO90Uksazj9w5jRTLBDRvu76qr5KNf/pA3X+t4vQJaMWgN5b2V1N7W8t2+Z3ucqruv3TJIEW1E9B2+qsia0G+vpZZqzgB7c7uAACPUdXZAm/+9elYtvTBiu7LYYrSN80Jn4AWNBjWEHdzw0g/SlU9ll8sNWAX7H4kiiXSVq+equxYidN+1E9BmeAJ28rMCFmOv5giYIfiSjVdI8vRuckSwsZM+7HMGnFp6+71Z5iQSTt0dx4U9T7CgVgaf3w0jCFsoxn7y1zMZvtvVT8vSuU9V1yt4phHjLF0uRo3TNimduRjJeoQliM8k7UbWJBJBxomdMSz/DGniYSwic8dLr1VuczVA5SUqu77PO/Og/Uzk6UVHvlfGyUb1H/C4HBW2AS0KDMp9IXmP+YkS6ik8bO/li65Ydg3PYYl0lav/O2u0Nf8w1iLNeKydkyJlShav3ik9BjuzMw7lEnd1yPVlG1U9mMpjCgzKfBoxIHhqG45dwdhL2yCe7zGmWzQP0LoIOvRuclSqrzvC12Zh80/PhrKsoFTdt+qws1df6+3nFHf/82VvQvubRzo7aWUyX0jWgyc+eW5IsLrz26YM6xdrL9aodREt73vhc2pxjJLM13bt3LG8C5NwjUquVzlF5HcbdTznxzJKvXrQbeWP2ZjXurGZ/vE+auUMoncOyy595S3fk6zVtF+28UtXx8xUM2gaWPj7NZ1oYHDl+7YtnXTosFBJSVi+IIz37wyoU/zSH+1QqWJaNpjzNx1x7JL/+ib8PbwurMbX53Yp3mURiWTqwNi2wyc9s6+G5ayGznz90+eH9WlcZivSh0Q3bTLqDlrftNaXPB2AntTYLMrbOqNG45YIgcMbi2t+Ecu/8TamUPbxgaolV6BcW2HPPneAW3lSxPeTiFbjxBCmLD+g+9ir27ccKjSn+Ur+uHRCJZKU+YdLxcow55pkcV/sJAabRlnY4IHjeimshzbvO1y2V/Y4q7v3PqHWdl1+MCQ6gc5u/3FXV3eXc74jN9mMl/c9Nw9TQK8Yp/6uXhzC9rOpOjC9kWTeqdE+KmUvmHJPScu3nXFWPHnFwR0BwBAlawWKyGE524Pg8oe87bs3Llz586d2z+a0kQifEH2BkM+59OBCiptMuePkh2CLW37tBQVw/p2mPNzjuBflSn6ZdtP+UTedezouFLDsnfvsUPDWcuZnd9V9nuy1ovnUi28pHGbFurSD7NRsVEs4QvyCxz9XZvqD7QEquEa8VnH/rhkZfx6Du7mXfpxGjZ0RFcZn/X9jsN3du0evI8oHUvu2slT2RwT3GdwR1Xp5zDhPXolS3hr6j+XKvs5YZHGsjLuTpfQTe3Ix8qDQ1hO6UzWamBBJh1omPARj+M4QqhUJi1dqZTKFAqGEM5qK9Xi+pnJO3QHXpryxkm/Ye+8PzHW7jl7ReLMpMAXWo59vfG8VdJ2ytROpT+Oih5Ljl66krp9eiOBG+E2d2e+NmvE39w154l12pRnP3ihfekxvO4yXzaTtv8uXDbzkoTG8Q4cTBYTZSYFH40IH44EcX8m7bAbNuE9XvNMOjhhXa84eAV08Tchins/L3tXlumHR0IYJmDyrltflduurewlo9ImbVt6M7KApE59+3VJ9JdQQtiokS8+00XDKENSuvXr0y7aiyGEypKfP2S4vSjj38v7BrOUUKlvVNM2d7VJidHIKCFU2Xz2na/Pipev6DX5wUZSKg9o1P7ue3q1ilBRQqii2axfK63Vz2WtGaSkVN7ng6pvdCy9gbQ7Hm+upoRQeUBCq3ZtGocoGUqoLH7M+tSSb8yEtqfg4Ly23pRQRhWc2LJdm+RwL5YSKo2bsq2kdIzh9AdDIyWUUFYdktiiRaPiUjuSyMHL/9Q5++0E9qaQZlfcbv+t7CVnNOO2lO6M4iugpS1Gjm3jRSmjCklMjtXIKCWESqPu++Tf218ylbsCWmg7hW29Ypbj81IkbMLM3yr9Ysvw02NRLJGkvHi8zDejhbsfDmOo7K5F56w12jLOvwJ6yGc30z7ur6Kyzm+VuQba9t97vRVU1e/D6zmfDanuCmi7/cXbrrzTTUa9H1i1YXKcTB6U3KX/A8uPWQRuZy7v4MudNQwhhEq8Ixo3jvBiKWVD+w7pqCp3BbSQ7gCAhq6qy1X0B55JkhD7dy8VH+cIvQLa7mDIZa8ZICeSxrOPFC/Clrbj8WYqyvi2n/NztgN3hVhOvNxCQiTJc4+WbQp3c+1gBaW+YzdXVufRaios1Bcay61B3q6Ho1gqa/+6YzfnCjrQEqama2S7/HY3GWECp+wqv18q/GaUmhJZt3dK3yol4n2E8Fjarn33+rNPz1z6g7bcZXym/U/FskTS9IVjlSZUpLG0RwTpErypHfpYiTiE5TgwVNZiYEEmHWmY8BHPcOj5ZCllI4Z/eOpWURTedOOHmW1VlAkYurbsveX1MpPFuJzvpzWSspHjNmo5889PRAm6AlqcmRT4QtulZV1lhE149pAzelMEma/5GnF5ex5vJJEkPb2/YlOdl3lHMmncOdGfslHTt/21+Y1nJo8acHe/oWOfWLD24PVqr3oVZyYFH404MhxVRwyZrKiSsDnS4zXMJCagCWG8whIa2RUdIKc1m4AmhLIRQ5cfy+V4nuet2s0TY1hCCJUmjF17triTDf+svEfDEDbumYO3+ky/ZZw/pbLGD3976XaFZlPanufbKinjP3HH7WnqW8snVN7koa9Tbz2x6PzHw0IZwgRM3FkynV2O5eTLLSSECX30R4F3q3Lar0YFM4QJ6ffafm1xE205R1cMi5ZQ6tN7xe35PmHtsV1d0UtBGf/ei3/PKT6ks+UdWdDNh94pn2A8+lIrBWUCujy36fytj07R5R2zOmkYKk16+he9c99OWG8KaLYduk1jfKmsU9knFE9AE0KY4L6v/ZJm4nme5wov7ZzdxZ8h1Lvn8gvFb1DDCWhhW+8W/aYxPhXmbMsw/vxkDEskzf/3V6nRTf/dlFCGKnuuuGKr2ZZxxQR0ri3to3tUVN7lrVI3otiuf3C3kir7rrpuy61+Atpuf92agJYGh0W1nr718u2PlbDtrNv7RIKEUkXjB1f/ddPK8zxvyfpjxbBoCSWElJ+AvtMdVW0UAGjI7J4tWAszLx7Z+PKAKCklVHHXIjtl2BybgLY7GJY5W7Bpv3uiuYoyvh3mOnSqwPO86bvJAQyR93n/RrnXmfZMC2PKz7pWgsu7/Ofvv+7ZsmbhpHYBDFW3mrk3x6FmCDvQEqbGa1S0++FQhkgazzpcdseUt3NKBEuIJGVemS9/q99lu0tNY3nnudc+GxbMEDbh6QOVb3vxx/I2UaSrElVtagEfK/GGsJyaZdLRgQWZdKhhDox4xvNfTWujYag0IKlT30EDeraKVFOqjL936W8VOqS+ZpLL2DIhmmVjJ2/P4nhe8AS0ODMp8IWmn6aFM0TW+71LV358c0qflHBfpcIrqFHHkbM+PZbtaP+KIvM1XSPj0RdbytiwsRvtXszltMw7kEnb5Xe6yQiVq1WS0lcCE+rd4pFvLlV5ZCnOTFbC3i7SgeGoaqLIZAWVhM2xHq9ZJlGCgxBOr72Yatd/OSZH7+y8jXr1X/Dhk239KCGEsKGDJw+NYAkTMOL1lROSi2/FUDSeOOVuFeVyMrOLr77ncq3B3Qfd+/iCl4bHKW8tRhbWc/zgRJYrzMwqLNsUNu7RD94dnXDricrEiTPHxrKcPl2rq6TJfF5uPk+o2ltN7T+hHFvq5+9uzyJBI5evn9s9tPjWCca/3fRPV02KZAoOvL/6zzLlGappj+3iPxcsvKTliAfv8i++6YTxvWv6krdemjf73iTKE0Lyd73z/t9m/3vf2fjG8MRbdwEoYwcv/uq13mpr6vrVewud+nbC1Gg5tsun/ykiyvhGEXY+XkzQiOWfz+0RJiOEEKqKG7To62WD/anu4IefnqiqgEo1HNt68rjEaNbyz9//VFouQ9559PAY1npu29YzJa3S7/tmZybv1WfiqGjGaVu49pjQQcO7Ks3HNm+7cvs2Fj79uy2/GRWdhw0KEzDCVdVfvOWm9+iVb90be6ueqqDtzGdvXfHZJZu01eyvPp7SSsMSQogk8K4n1n78ULS9O65KusPxlQeAhsT69yutpLSERB2c0GHkK7uvWWXRQ5d9+kyKw/dHllXlzosQYsvY/fQ9o987I+0wZ9uu13oGCDuYKGm8Xldk9yCEqtVqSvhCfVH1uw7zvhe6d+rWd9iUF9ceL0qatGbz4t7+jjTDsQOtatR4jZQ9Jo9PlNjOr5z6zKaLRbcWlvnb2xMe+yzNRghvNJY5+Kx+l+1eNYwln3/ikyn9H9uaxcSMfWN2V4X9Z3lELG8RR7rsqG5TC/hYiT2E5TiaSQcHFmTSsYY5MOJJ/SIbxQcriSXn/OE93+3+5cT1QiLRxDSJD1KV34r1M5PcjQ1PPP5FWtwjq94aHOhAcESaSYEv5Avy83nCZ215uPOAWZ/+ep0JS4j2Nlw5svGNKV07TPz6P0eKzogj8zVbI+7y6jnLT7Ednn3pviB7PeTkzAvKpPXy+UtWwlskTR5ec/hKrtFclPnPT+9Nae1T+Pcnk+5//YS50sWLNJN2VLaLdGA4qpI4Mlm+UZWFzbEer1kmMQFdbQmOmmFj2rQuteNgNAEaSiQpnTv43nlQFhDgTUlJSJjIkcu27Njy9qiokl6x5qfu/fqny3ZGKSa479DOZSoD+fr5MIQQUlnoqLePNyV8oV5YzPm83/afMFPNgPFDgsvUvvHtM25oOGu9ePDg9dLFuKppDxvfJFFOLb8umjRv/a+puRZCCKGaTg/PX/DqrCHxLCHmY3t+vsmret4/NLTMp4CJ6j+wpZTLP3LoTKn52Vq/nUA1Wo7txtXrNiYoLNjO3xn/gROGltmgTMTIhwZpGGvqod/SHK8DdItjW4+wIWHBDF94/b/KKy3JOoweEc9az23bdu5W/Ap++ua7bOI/cOK9wdR5W9gJaNjgEV2V5mObbs9A8xm7thw0yDsNHxwuZICrqr8IE9x7QDv57f8J287moz8f1PPSjpMmt5SXfpZPr4mj7JVfL+kOAY0FgAaMyvzCY0uJi2uU3Lb3Ay98fvTUlsdSKp3BE6rKwdCW8cPM/qNW/l1I1HdNfLRbqdkZ65FZSRJaBVn71/+xEcLf2uFUctzO2QScY0rbTvvw09UfvrNwxoiW6tS1Y+/q+b9fbjpw7C7sQMvla6Ts/NK6+V39jac+GNU4OCSxVeumkQGRXWfu0/TuGsESqlDKSy9SwC7brRyPpS372JqnejTt8OhnZ/mksR/t/nB4aOVncx4Qy1tEkq4yBG1qAR8rsYewHEcz6eDAgkw62DCBIx5/c88zvfo9vzmj8UPvfX/iyk19gfbfg1/O7UkPvjGq26iPL5S9Tqc+ZtJ2ec3UpzZlJ07/6PV+GoemuMSaSWEvtBiNNp5YTu09EvTw+lOZN6+dO/VvWu71A0v6h1oufjHtsbXXhJ8hiyPzNVoj3d433vilMPT+uY8k2T+RdnLmBWWShg+Yu2z5B5sP7n9/UscYP7lUGdS4z+OffL/mgQim6Pjyt3bpKlu8WDNZth2V7iIdG46qJI5MllV52Bzr8ZplspaXy0ClWJapEAwqK1vIvCIu7/TOL77dc+TkuQuXLl++ci1Tb+F5Qoi8/BOZwJAgx749YEMjQlh6JvfipRyehNlvBp91+IsNf+QwCf0fHWC7nmbl2djGjcq/tyShSQJL0tKupdlI7O02VNceJuahFe8eGf3sl3tfn/DTElYd2qRtx87d+gwaNXpQyyAJIbzuv6s5HG/aNMaXjrHzepqVkWW7k9favp1QNVoOV6gv4mmYUmlnI7NxTSpsUEWTlASW/JmRlsGR6Bp9JeTg1iNEqVJSwul1eo6QSiaLpe1GjUh8+/UzW7edm9e8GUvyf/pm900SOnniAA0lztvCzkBDBw3rrNjz6+ZtV2Y8E8/wmbu3/mqQdxo2uJKvXMupqr8IGxoRWrKFhG1nviAtTccx/slNy19/LW3aoqmUXKrwutvdIaS1ANBwsU1m7Do+v6WrhtiqBkPbxXUvv099YuMCr17e98qsb+7bMOb2UToT0umBqdMyKz8/ZGNaayhhvbwUhBQVFRbxxKf0O/BFhYU8oWovAfdnMdHdx07sTgghM2bP+GRY+6k7X5+6ZPDpJR0cuFqg+gOtOlgj7w7zfvijzYrFb3+++48L5/5VhqUMfn7G/OciP2m391fGx8+3zN5DwC7bnRyKpS3r94/mPvXSumPZNnXi4BcXvzl7eGOvKjveA2JZurViSFcx4ZtayMdK5CEsx9Gh0sGBBZl0yYhnOf7W0++fNYWO+Wz3RyNvXauT1OWB17YlSbp0WbBrzgsbh38zptRlkvUuk9bz7z/8/G5dynNbF/bydaiPRZtJgS+UyOUsJVTW4X8bVo67/cPJkpCuz69dfKjx5O0/rf7m8uSZCcJPkd2f+RqsEfff52+s/48mv/DEPZX2vnMzL2iclDYePL1xhUdp8JDH74/dsOzKof0nLfd1tTtQijSTd9pQ5S7S0eGoOu7PZJnWVBE2B3u8RpnEBLQzOOerVz7/8KL77pu/P4v3jmnXtXPnYfc8mJCY0sr/wOP3LjlX4dkMQx3bN9Ggzl0bs3tPHf9pf+6jY+zfWqb7+e3HZ3xbFPfsXY8O8C1+lZ3nMQxDCLGV/cHeatujTHlo/clhL+zbtvX7fb8eOnzkyNZPDmz5ZPG8ltPW7Vxxb7jNZiOE8Wkz+uHekXb2MFTeOqZ0qmv5dlXNTJbtzRosh0plUkIsFsH3IjAsQwiRSB273L50Ox3cesRisRJCZTJZFRtR0nr0yCZLF57euu3fuc2SdT9+830ujXlyQu/bP+Zb8y3sdEzYkBFdnt376+btV2c8HZvz/eb9RfIOw4bY2xR2VN1fZbpF2HYu/oDYI1cpK34vdac7BDUXAMA1qhoMeZ5qur60Y+tDlx5pM2nLptkvfNd39eDiY28mdtgr7w2rdunWiOhIlpzTXk+zkdDSB58GbVouT+URUcH2h07OarbaCCOVScr8XRI3buqgObvWXfnjWAbXQeB4L+xAy9VrVEwZP2DWxwNmlW7dzXWXMzmqSkgsuwsVssv2BPzNQ68/cP/Le9L4oPYPr3zj5Ue6RwjY74k0lvZaI550Vb+pHf1Y1ZcQ3lGLgQWZdMWIx/23/+dUKw3oP35wmTtFibLVuPtbLv7r2K/7jlvG9LsT5HqXSd3hHw/lEZnvnuf6Hrj9GF9wJYMj1j/furfL5zJJk2nrV0+MdfTc042ZZIW9kNUEaCgxJfXr36jMzBQN6tG7hXT7ofNn/rWSBGGnSeLIvONrZP179Qf7i2QdH5rSuvL5ABFlXhLbKFZCLuXezK1sxlSkmSx+/+p2kQ4PR1URRyZLL0NI2MqrpMdrlElMQNea6ebNQp7U+tZXYju78slX9+cE3/ve9+umNS/5SsN2+k8nDTKSpvcNa7ro1KldKz89P3Jm44pdz+f9tO2XQp4J6NK9uZQxRYRJ6Imr5y+ZSbKy9NNsly9cshE2rNSVoYKb4J/cb3Jyv8lzCeGL0o7vfPe5J97cv2r6wmH3fNAtPMyL4c2JIxe8OUJV/ZJq+3Z3V5J8u71Z1XLsdDwTGBLIcHk38+yMyLbL/6SaSJMya2j+9+xFG5VGxUYI36Bl20l9Hdt6XN7NPI5KAoP9qxqiJC1Gj0pZ8vLfW7ednx168usf8pgmj0/oXOb6bQe3jMswYYOHd35278HN264+Mf7glv2FsvbDh0QJPECvqr/KEridvSMjNQx3859z6dzdZS5p565f/s9a8euqku4Q1l4AAJeoajBkwsd/uu2lLv6049JXP/95+p71z84f331Fbx/hS5cktGiqpqcv//V3Ht+mVIkyy+m/Tlt4SUqLFKXd11mPv9ii85LLdy09e7Dc9UIStZeSkgJDkUHoZQDOPdCq6RoRYivKzdFZWLUmwKv0wb/hyIGjZiLv3KlNmZMaYbts0Ss6vmjwwP/9boq9d+nnH83oHCT0iEecsbRDLOkStKkd/VjVkxCWUpuBBZl0xYjHcxzHEyJXKcsHlsqVCkoIV/bKp/qXSUIIIZzu6l+/Xy3/aP7lP3+/TKTWoZWFUqSZFPhCSd0rS90AACAASURBVOOUxlKabq04V1nc6TJ5hVvBKyOSzDu8RuYjn31x1irvfv8Iu18w3HptnWeezzv9454zBd5N776nedmiMFx+bh5HmKDKb0kXaSaJoF2ko8NRVUSSyTuqCpujPV6zTNarMbtO8HqdvtTgz+ft23VI8LlPVQyn/jxrIT59H57SvPQF9YZrVzMcqb1fBUnLx2YPCaBFhxc8tOhIQYU26w8veXVzNsdGjZhwtzehmk7dW0j5nN1ffJdd5qm6X77Yes0mie3WrYoRsjzb6bf6JcY16rPk5O2KOVQV3m70q/8bEcpw2Zev6HhZu56d1aTwwJbvy74dd+OzMYnhES2f+8UkfE2rf7tbD1fTm4KXU4YkPilewudeu1ZxGxPu5u71OzJLP85rN63ensPL2tzdvfIbOapLnYNbz3b96nUbG5XUqOrJarbpyFEtpJaTW7Ye2fnNT/nS1uPH375Pp2ZbxnWY8MHDO8nNf2zedmL3lp/1svbDhgiuZlJVf5UjbDtL2/Ts4kMth9euPVWmUL/51JdfHbfzPXBJdwhsMACAK1Q1GDLeYWE+lBDCxj/09rxOKlvqR08v/r2IEOF167x6DuzhRQy/btyRXmr5pj8277hqkyT2H1BZ0cNGLVNU1HJq7y/pZZtl/ffgbxk2xq9JcrjQuUyBB1ouXiNCinY/nhQWGnXvx6XLQPLajR9uzeK9etw/tOzvFwjcZYub7Z+VT7z2uz5w8Pt7v31W+OwzEWss7RBLugRtakc/VvUihGXUZmBBJl0x4rGRzZsFMFz6zz/8VfaMj0/f9+NJC5WmtGpa+uqh+pdJzcQdFX6UyvzzE1EskfVaec3G8+ajc5Mr2cZizaSwF9LQewa1k9lSd249Uabvuf++/+6EhSrbdGgu9EJNkWTe0TUyH/568xVO1mHY0Kpu56r7zFPJhfXTxt5/38Mf/lO25rH1323bT1uZoG69WlTWNWLNpLBdpIPDUVVEkskSVYbN0R6vWSZxBbRwTFBoEEP+PfTh2wdGv97DnyGEFJ5bO+2ZrzK4yuqAO0IWHOpP+Yzfd/96c+DdxRUyDJd2vfXkY+u0HJFZzU74wVMaMmbFB7uOPfDloVfu6Zb6v8VzJvdt6i8lhC/67+CXS56bvepvIw0dvvCF3mpCCJs4/olBb07c+s1TE9tErH2mUxBLCJf310ePPrr6Kufd44lH2jkQHjY6Pjj3vz2X33tt3ZA1U5p6UUIIl39q/ce7MzhJQsvmfpRKhz85bv6uD7+aNjrBe90LfaPkhBBT2t7Xx8/89mJ+0szhHQR/+Snk7YT1poDl2NvMgW3vSmD3nfv7nJV0Kz8qc1mbnp74ZuS6Z7sESwgx/vf9gvFPb8shoQ88Pd5ucSthqaPBjmw9LuPs2Szeq3v76oZOtvHIUa1f/fOvtU+8eaNA0WXiAyVjWs22jAsxEUOGd57588E1Txmu6GR3DRsaI/jrkSr7q9xTBW1nGjB0+oPx21b+9frYabFfvzO+mQ9DeP0/G54Zv+QvS8WqNne6w/HVBgBwGoGDobTpk+8+/1WXV/5a/tSyMQdfbCkRVreO0MDhMybM/+697+c//Xn39Q8myAjhc36d/8yHqZxPvxmPtirZIVmu7N906Doniek2qmsUQzUDJw0P27rux/89sixl7YyOQRJCCF94ceu8yW+esEoSxz9UUhmq+IU2NqrLyO6x9vZvAg+0BFbiq+kaEeJ199j7Qr9Z98uCx1d0XP9kGz+GWDP2Lx43c0eutOnzLz1Y9pxA8C5bzKwnv/jsmIFNee7VCXEOroa4Yin+dAnb1A58rAipJyEsy8EtUPa1yKQrRjxlr6kPNVu/6NTyCY8kff3upJZ+DCHEePX71ybO2p1Pg8c8Prr0rY31MJO1Ia5M3ul6gS9k4ibOGfv2fWuXjp0Quv79xzsEMIQUXdj0wvh5PxcxsVOfGn67DILHZF7wGhFCCLGe3rP3hk3Som/vqkpYuiPzXndPGRv/9XtHF457Jumb14c3UhNCuIKzG2Y9sPAPs6rD08/0rXTiUaSZFHg0Inw48phM3lJN2Bzr8Zpmsvw3bQ2J7cKbnaSEKEZ9W+ELR57ned56ZmFbKaE+47cV/912bf3wEIYQKg1s0n3g4L53JfjLKOPXrEWMhAmYvMt0a6nXVvaSEUnL+SetpRZ1cn5LCZH3XaXl7jxo+mlaGEO9x20tXrzpxOudfSihkoAm3QbeO7h3u0aBcsa39YQH2isplUV3n7Dguxu2SpbP89ZTr7aSEvk9H2dwfJUKz6wZ11hFCSGEskpNWFREoFpKKSGESiPuWXI4787rbTe2PtpURQlllKFN23doGesno4RQefyY9amWkicJa4/p76U9NAwhlPWKSGnfpVPbJqFqhhKqbPr4d7eewuX9+nJnDUMIlWriWnfs2LpRoIISwgR0e+33Aqe/nbDeFNBsO4z7pkex0o5vnC/VRtvFZV1k1CuxWbySEirxjmjaPDFIyVBCqLrFk7vSby/M+u/r7aVE1nlpqo0X3k6BW69YwaYH/Bj1wDXVRYXneduFpZ1llBBCvYesTS/9/JpsGcvxeU0lhEp8IxrZkzzm02s2gU8z7piooUQx5LPckqZeXdFLQQkhVNb5rVsbj+f53M+GKAi1d1XBHfb6i7ddeaebjEjbv/5vmaQJ285c7oEXO/gyhBAq9Ytp1jwhQE4pE9R35qPtZUzk9H3mUkt0oDsAoIEy/fBICEMkLV4+Yan+yaUUH+ewic//Luh19gZDLnvNADmRNJ59pNQi9L8+11RKqVf3Zf840iDu5r6ZLdWUMurYjgPvG9Kjib+EUknk8E8vll5K/vqhCkKo6v6Nt8ZtLmPnY8kqSihVBDZq1aHjXSmR3hJKKBvS542juvIvJIp7Py+31ysh8EDL5WvE265/+2C8lBIq8YlMadumSYiSEiqNGPL+aUP5txDxPkJwLDntqr5yQqhE4WWXX6dFp62VvlpMsRR9uoRvaqEfK54XdQjLcWSodGQLlINMumbEM5x6f2iUjBLKyDXRKa1bJASrWEoI49d+9k/ZZcNXPzNZQZkroKskpkyW7nqBL+S5nL0zW6kpoVSuiW3WsnGomqWEskE9Fx0u4Mot3yMyL3CNeJ7nreff6CglbPSTv5j5Kjgv8w6Nk/m/v9YjgKGESn0ik9u0b9skVMVQQpVJD35xseqXizGTDhyNCByOPCmTvJCwOdLjNcwkJqAdmIDmeV5/9uu5w++K1ShYSgmh8uj+C/edWNlb5owJaJ7nbh796MmBLSN95TKFb0SLfo+8uftSkS3355d6RXvJ5IH9Vlyw1n4Cmud5vujynpUzx/RqHh3oo5DK1JqwpI5DHn3tmxM5FY7/udy/v3ppXM+m4X5KmcIntHHX0bPXHs0qM08ntD2c7uy38x/s3TxKo5JKpKqAmFZ9J73y9d95ZdpbdHHXm1MHtI4JUMtkSv+Y1gOnLfvxSunucebbCehNgc2usIF/eiyKVfZddaPUbP7FZV1kTMRjezJOfjFvTNfGIT4KuVdwYpf75335d36phZWfgBbaTkFbr/hZP06NYL0GfJImZKywXXqnu5wSJmDMt7nlnu/4limeWa6UrOvbl20Cn1ZxApq3XV3RU0EJlXVaeuHOMC5kAtpef1U2Ac3zQrez/t/NCyb0bBrmq5CrAxM6jZm/NVV/+Z1u5SegHeoOAGiY6mgC2t5gaPdsgefyfnwsXkIZTf8PLzt23Jx/4rNZIzrEB6rlSr+I5v0efXvfjXJts3fQzOX/vWH+pLtbxAT7KGRK37DkbqOf+/BgmtnOC6s6DRB4oOWQGq4Rb9Huf/exwR2ahPuovEMadRg+8+PDmXbeW8z7CMGxtBx7ocrLYyoc1JUloliKPl0ObWpBHyte3CEsx8GhUugWqACZdNWIZ806uu6FsT1TIvyUMrlXUEL7odPf+fFyhS/m6m8myxI+AS2mTJaf8xLwQp7nea7g9IYXH+iaFOKjkKsDYtsNeXLFvv/Knl55VuaFrBHP81zaqr4KSlVD1uVUFWcnZt7RTJpv7H//2ZFdGof5KWVKTWTzPhNf+fpU1VMhPM+LMpOOHY0IGY48K5MCwyawx2uayQY9AV0bVn3GpYtpOkfTAqLk/N40/z67sUTVd9V1h0bR6jilnYU/To2UBNz/TZXjTkPjmv4SAt0BACLivsHQSfRfDfcf9U2hu5vhNNhH8Lx4Ylnf0iUQQmgHMulWyKQdYsmkqyHzngOZrNdqnEn8CGENserguPgwLwd+RgXEy/m9Kb3rsRk9mQNrv0x10i9IEkKc0k4+d/enmzIaPfTMUP+6LtMsZq7pr+qhOwBAVNw1GDqLLe1aRkSjOJm72+Ek2EcUE0ks61m6BEII7UIm3QiZtEskmXQ1ZN7dbXEAMlmP1SKTmIAGcAUmZuL8afF/rVpxoNDdTSnNdnHtO9uZ+156pr0Dv+nYELinv9AdACAyIt15CWI6vmri+HWBMx5qXU9+lQr7iNtEEMt6ly6BEMJKIJNug0xWQgSZdDVk3sMyj0zWW7XJJOV53gVNAgD+5vePtX/g/NPH9jyRII5L5fncnQ+1mqx94cjOqfHiaJGY1Hl/oTsAQIzEt/MSyHr9z8MF0Z2aBtaPswDsI8pwdyzrWboEQgirgky6AzJZFXdn0tWQec/rVWSyPqpdJtn58+c7v00AQKgyoXvPZNYsj08OU4rifhnL9cv5TR58dmJLX1E0R2TqvL/QHQAgRuLbeQnE+ITFBKnqza192EeU4e5Y1rN0CYQQVgWZdAdksiruzqSrIfOeB5msj2qXSVwBDQAAAAAAAAAAAAAu0dCm6wEAAAAAAAAAAACgjmACGgAAAAAAAAAAAABcAhPQAAAAAAAAAAAAAOASmIAGAAAAAAAAAAAAAJfABDQAAAAAAAAAAAAAuAQmoAEAAAAAAAAAAADAJTABDQAAAAAAAAAAAAAugQloAAAAAAAAAAAAAHAJibsb4DYLFy7U6/XubgXcwvO8zWajlLIs6+62ANhhtVoJIRJJwx0zQcxsNhvP8yzLUkrd3Ra4xd/ff9asWbVfzq5duw4cOFD75QjhoUHy3EOIOtuz8DxvNpsVCsXixYtrv7S9e/fu2bOn9ssRApmsY8UbvG6OdkwmE6V02bJltV/UoUOHduzYUfvlCMFxHMdxyGSdqctMms1mq9W6bNmy2r/d0aNHN23a5JRWVas4kwzDMIyHXVxotVo9N5N1MwgUZ3LRokVeXl61XNSpU6e++OILp7SqWh6dSeKBp/x1n8kXX3wxODi4Bi/3sC3rRAcOHFi6dKlnHTrUYzabzWAwSKVSuVzu7rYA2FFYWEgIUavV7m4IgB1Go9FqtapUKo87zquvjEbjggULnDIBnZqaGh8f361bt9ovqlpFRUVms9nb29uzzgatVqter5fJZCqVyt1tcUxBQQHHcX5+fi59l6KiouzsbIZhlixZ4pQFXrp0KTw8vG/fvk5ZWtUMBoPJZPLy8vKss0GbzabT6Twxkzqdzmaz+fr6uvQUqSSTixYtcsoCr169qtFohg4d6pSlVc1oNBqNRrVaLZVK6+DtnIXjuIKCAqlU6nGHsnq93mq1+vj4uPQIx2AwZGdn8zy/dOlSnudrv8C0tDSlUjl69OjaL6paJpPJYDCoVCqZTFYHb+csPM/n5+dLJJLaT63WscLCQovFUmeZXLFihc1mq/0CMzIyeJ6fNGlS7RdVLbPZXFRU5HGZJITk5eWxLOvt7e3uhjimbg7gTSZTdna21Wr9+OOPi2fqa8CTDuaci+f5uLg4TECLBMdxZrOZZVnPOpiDhsNoNFJK8QUJiJPFYrHZbDKZDBPQImEwGJy4tLCwsOTkZCcusDJ6vd5oNPr5+XnWZJ/FYsnPz1coFB53Epubm2uz2QIDA120fJPJpNVqKaVxcXH+/v5vvPGGs5YcEhJSN5ksLCw0GAy+vr6edXxotVrz8vLkcrnHncTm5eVZrdaAgAAXnSKZzWatVksIadeunXMzGRQUVDeZLCoqKioq8vHx8ayJFZvNlpubK5PJfHx83N0Wx+Tn51ssFn9/fxcd4VgsloyMDEJI27Zt/f39ly9f7qwlBwQE1E0mDQZDYWGht7e3Z52n8Dyfk5MjlUp9fX3d3RbHFBQUmM1mjUbjosm+4kzyPN+qVaugoKCPP/7YWUv29/evm0wajUa9Xu/l5aVQKOrg7ZwoOztbIpG4+soAp9PpdCaTyXUH8FarNTMzMy8vr0WLFkFBQV999VWNF+VJJxjORSn18vLCBLRIWCwWs9kslUo97uwRGojiG0WRTxCn4mvWVCqVZ80b1mMMw+AAA9zIZrNlZmbm5uZqNJro6Gh8NQVux3FcdnZ2dna2RqOJjIz0rNssoF4qyaSPj09iYiKOoMDteJ6/efNmRkaGj49PUlISMgluV5JJtVqdmJhY+6sBkGkAAAAAIF5eXp74NZtUKnXdRcQupdFoXLHYvLy89PR0hUKRkJBQdxfEcU64QbgitVKhVipct3zCuGQaVCKReGgmXXTZV3Em5XJ5fHy8x10QV45KpfK4yiqEEJZlPTSTLro8VqfTpaWlyWSyOs0kx7liqUq5XFk81Ltm+YR3yfBLCQnU+BJCiM3iiuUTQgjrkltnXHQbgU6n02q1LMvGxsbW3SBz5YwrlqogREEI0We4YuGEEBKV5KIFe2gmvb29XXHHlV6vL76RLiYmxlnlmzABDQAAAADg8QoLC7VaLcdxERERHlf8Aeolg8Gg1WotFktoaKjH3dQM9ZLRaNRqtWazOSQkBJkEMSiul2U0GoODg/39/d3dHABiNpszMjL0en1xJp14WycmoAEAAAAAPFhxyciCgoLAwMCgoCBUgAG3KykZiUyCSJSuTRQTE4PaROB2NpstOzs7JycH9bJAJEpqE/n5+SUlJTm9XhYmoAEAAAAAPBLHcTk5OVlZWSgZCSLh9JKRALXE83xubm5GRoZKpWrUqJFn/YAk1FfuqZcFULn8/Pz09HSX1ibCQSoAAAAAgOdxT8lIgMq5omQkQG0U1ybieT4qKsoTf+cA6h+DwZCWlmaz2VAvC0SipF6Wq2sTYQIaAAAAAMCToGQkiI3ZbNZqtUVFRU4vGQlQM8W1iXQ6XWBgYGBgIDIJbme1WtPT01EvC8SjpDZR8Tjp6jowmIAGAAAAAPAMKBkJYuPqkpEAjirJpI+PT2JiImoTgduV1Cby9vZGbSIQg+JMZmZm1mVtIozFAAAAAAAeACUjQWzqoGQkgENKahPFxcUplUp3NwcA9bJAdIrrZRFC6rg2ESagAQAE8d+20t1N8CiTX3J3CwAA6g+UjASxqbOSkQACGY1GrVZrMplCQ0ORSRADk8mUnp6O2kQgHmazOSMjQ6/XuyWTmIAGAAAAABAplIwEsSldMhKZBDEoyaRGo4mJiUFtInC70vWyIiMjUZsI3E4MtYkwAQ0AAAAAIDolJSN9fHySkpJQxhTczi0lIwGqVlybSKlUIpMgEqiXBWIjknpZ+G4QAAAAAEBcdDrdhQsX8vLyYmNjIyMjG+rss/G3JaPHvHvC6u52ACFEr9enpqbm5uZGR0fHxMRgpg/crrCwMDU1NSsrKyIiogFn0vjbklFj3v3LU8bJogvbX53QJzkqSKn2DUzsMuKFr0/reXc3ymkMBsOlS5cyMzPDwsJiY2MbzOyz6bcPnhnz6bkKIeT1F36Y9+Sklt26erfo3XT4k0999Xc2544GVqkhZDI9PT0kJCQuLs69v9bQMI9lAQAAAADEqHTJyICAAHc3x534rO9Wvrv9wL3TxHe62rC4t2QkQEUWiyUjI0On0wUGBgYGBjbkTN4eJx/ziHHS8u+HI3rO+KEgrPPIKSOjLRd/3rzpzYn7Dl375cfnWnr4VK3Vas3MzMzLy2uAtYn4m/tXfrrvQL/7y4XQfP6zIaPfOmCN7jf4vkF+hn8O/vDBvMm/XP7w4AvtfNzTUjvqcSZLahMFBAQEBQWJoTYRJqABAAAAANwPJSNvsxmyr5w5tu/zxS99nc6FuLs1DZkYSkYClMZxXE5OTlZWVoPPZMk4+T+PGSf5vG2vzv8xN2byxgMfDw5hCCHcCz8922fge6+/uGH89omhHjplW1KbyMvLKzExUSqVurtFdYYz5N44c/L3z9979+ssvkIIC3d98MkBffxz33y1pI2SEEKsD749bvTM9au+mPLRY6HunwwlpP5nUmz1shrseA0AAAAAIBYoGVmCz1w7LHbqD6bi/4njHLVBEknJSIASOp1Oq9WyLBsbG6tSqdzdHHfiM9cOi33Uw8ZJ698HDuexLWbMHBByq8VMYO+Zj3b+6Nlf9x0zTRzsiaOMXq/XarUMw8TExDS0TPI5W4Z1fvkHc/H/KoTQlvXvZR0J7NevufLWI5Lo/j3iZh+/eu4qR0QyAV0fM1lYWKjVanmej4qK8vLycndzysAENAAAAACA2xgMBq1Wa7Vaw8LCfH193d0c96P+Q5fvb57HET5ny1PD37ru7vY0QMWZtFgsISEhfn5+7m4OADGZTFqt1mg0hoaGIpPk1jjZzMPGSUsh0SQ279E2odTtPVSpUlJiNZk9ooRIaWazWavVFtfLapi1iahf7+XfJuZxhL/501NT15YPIRuYGOtFzp7+7ZKlT2MpIYRwWUf+vGGTJiZFimP2mdS3TJbUJhJtJjEBDQAAACBePM/zfJnfQhHhASXUjNVqTU9PLygocEXJyHKxceJi7WTSue8hCWp8VxAhhNf+5SOas9QGwqUlI+s0kxgn64uSTGo0mujoaE/JZMWFu2ycPOEx46RqwLvHB5R9iLu+dcthi6xVh1YedKlpSW0iV9TLclEm7S68tplkNY1baAghfOY/9kLoNfS5FyecenHhg5NSR/Vp5Wf8d/+29X/IBsybMyVCNJGtd5l0RW0iJ2YSE9AAAAAAImWxWAoLC3Nycko/GBgY6K72gLPUQcnIcrFx1vmD1WotKioqn0l/jVMWDm5UByUjy8WG45xzeZnVajUYDBgn6yVX1yaq00z6+ztl4fWI6cqOeaNn/VgY+9CLk+JEMyVZjeJMyuVyF9UmKhcbm83mlN23xWIxGo3lM1n75VZJEt7h0ZGtdy09/Nn7Jz8jhBDq3XLiE/3iRVypxCMzqdPp0tLSXFcvq1xsrFarzWar2aIwAQ0AAAAgUpRSlmUb0g/aNAh1UzLSRbGhlDIMg0zWM3VTMrJcbJx1kTLDMMhk/VOSyYiICG9vbxe9C8ZJdzFf37d89rMLvz1njh+5avPS/hoPuGWhpDaRS+vA1J9xktcffOvR/h9qW0xYtO2hHs18jRcObZzzykdDx+Ru+HbB8GDRze56YiaNRqNWqzWbzS6tl1UxkzWOJSagAQAAAERKIpEolUrUBa43TCZTenp63ZSMLBcbZ72X/UxyNbwWBtzObDZnZGTo9XrPzSTLsgqFAuNkvVFcxtRFtYnKKRcbZ9X3kEgkcrm8wjjpcRVlXYPPPfrhsw/P++qUKbLPM+vennd/Mx+xz/RZrdbMzMy8vDy3ZNIpb8eyrEwmK5/JXBcWD+cydr366b+y3q9teWlICCWE+LbuP32jV07zSZv+99m4oc81FdFcpAdmsnS9rJiYGOfWJiqnXGxYlq3x24mo0wGgjjV5xTN+r0Ik/ol2dwsAAMBjubRkJEANuLRkJEANcByXk5OTlZXl4+OTlJSETNZDtmsbpw2csPZKUL+5W5c/P7SRiIsxEEJu1ybKyMhQq9UuqpdVX1kv/nPaxDbr1Dao1Fyud9sO7WXfbj93voBv6i+SOV4PzGRubm5GRobr6mW5DsZ0AAAAAAAXKilj6qLyfACOcnXJSABH6XQ6rVbLsmxsbKzrahOBW1nPLZ8wZV1aysyt3y3qI74aDOUV18uilMbExKjVanc3x8NQldqLcrm5+RwJL+lqXpefayMylVouktlnT8tk3dTLch1MQAMAAAAAuERxyUir1RoWFoYSASAGRqMxLS3NYrG4tGQkgHAmk0mr1RqNxuI6MO5uDriMcf+77/5uajv/s4Vin+kzm81arbZu6mXVV9Lkbv1C163a+OnGMYvGhEsIIYTL++Wjr361evfv3UYsXzF5TiaLaxPpdLrAwMDAwEAPzSQmoAEAAAAAnKwuS0YCCFG6ZGRQUJBLS0YCCFGSSY1GEx0djUzWb7bUw79ncDKfQ69PfbhsT1Ofbk+/NSlFDJNTJbWJ/Pz8kpKSUC+r5hTt5r107w9Pbh0/6OKGQV1a+BrPH/5py4lsTa8XlwwJEMkhkWdlsh7Uy/LgpgMAAAAAiA1KRoLYeHTJSKivSmoTJSQkyOVydzcHXM7635X/rLz+7PefnS33FyZYMurNSSluaVVpxZmUy+WoTeQMTFi/Vw592fy19zdu3fnFLoM0KLbZg3MW/m9y5xjRTEOKP5PF9bIkEklcXJxSqXR3c2pLND0PAAAAAODhSkpGooxp7dGwqT8VTXV3Kzyep5eMhPrHYDCkpaXZbLaIiAhvb293N8ezedA4KR/4SY7lE3e3wr7ielkWiyU0NBS1iRxFg0f/9O9oe39hgtuOXr569PK6bpFQYs6k0WjUarUmk6k+ZRIT0AAAAAAAtYWSkSA2JSUjkUkQCavVmp6eXlBQgNpEIBIldWCQSRCJ0rWJYmJi6lNtIkxAAwAAAADUHEpGgtjUp5KRUD+U1Cby8fFJSkpCJsHtijOZmZmpUqlQLwtEorgOjFKprJf1ssQ07vPpO15amDVm+ZSU4qN2Pnf3Sw9/cNJS8gQ2YsSSlROTWMLdPLlp7YZfTlzVecW06j1m8oiWGkoIqfRxAAAAAAAXQMlIEJt6VjIS6gGdTqfValmWRW0iEImSelnR0dFqtdrdzQG4Uy+rHtcmEs0ENG+88fP6raeL2nMlD3GZ6Zk0acizw1Nug5MrxgAAIABJREFUTftTZUQ4Q4jt6uZFr2209Zj81JiArAOff/ra6+xbi4ZFsZU97qY1AgAAAID6CyUjQWyKS0aazeaQkBBkEsTAZDKlp6cbDIbiOjDubg4AMZvNGRkZer0etYlAJErqZQUGBgYGBtbjTIphAprP2rfs5U8P3ygw8ySw1OOWzIxcn8SO3To3LzOHbP57587LkSPemdY/iiWkWWBe6nM7vjszaFqTM/Yfb1HfrloHAAAAADeyWq2ZmZl5eXkoGQkiUY9LRoKHstls2dnZOTk5Go0mKioKmQS3Q70sEBuO43JycrKyshpIvSwxrB71a3P/zOh7+YLfVr32y52HuayMTD64aTBnyM0plGgCvKWUEEJs186c04d2bBtePFqw0W1bB2/666zWorb/ONciBvs6AAAAAKi9kjKmarUaJSNBDHiez83NzcjIUKlU9bJkJHii4tpECoUiISFBLpe7uzkAJD8/Pz09XSaToV4WiEQDrE0khgloIvWLTPAjfO4FZenLR7gsbZY1a9/iKZ9ezrcRiXdsl7FPPjawkTQ7M5sPCPK/PavM+Af589mZWdZKHucIJqABAAAAoLZKSkbGxMSgZCSIQUnJyMjIyPpaMhI8S3FtIqvVGhYW5uvr6+7mANypl4XaRCASJpNJq9UajcaGVsNNFBPQdvG67FyL0ithyIxXukWQjJM7V634ZNEnQe8+YjZZqVJZMldNlUoFNZvM1koe528v8OWXX/7uu+9Klu/j45OdnY1bJkXFaDQajUZ3twIAnCA7O9vdTWhw8vLy3N0EuMVgMHAcV/3zwHOgZCSITcMpGQmewmq1pqenFxQUoDYRiERJbaKAgICgoCDUgQG3K10vKzo6uqFlUrwT0FTT76UN/W7/L6r9A08MPzH96/0nJ3WXs3y+wcgTBSWEEN5gMPJSbxkrs/94yQLDw8OTk5NL/qvVaiUSCfaLIsHzvM1mo5SiEhNA/VDvK1iJis1m43meZVns1EQC+a9PUDISxKahlYwE8SupTeTt7Y3aRCAGPM/fzMnJzMxEbSIQD9Qm8pzjFSYwIlxuydWZ/YMC6eWcXI74sYQQwuXl5NGAlABJgP3HS75QmDp16tSpU0uW169fPz8/P5yri4TFYsnPz5fL5V5eXu5uS4Oid3cDoN5qUDcTuZ1OpzOZTN7e3piGEAmZTNbQrmior1AyEsSmAZaMBJFDJkFs9IWF6RlZPCFRUVGYXgAxKCwq0qZn8oREREQ05HpZ4j1TLTq8cuZ667jFM7r6Fv/44I2LV82alCi/mOBk9bYTJ7MeiAulhHDpJ/9O926aEiGLTrH7OC5TAQAAgHpF75nlVrw17m6BAwzJydq5cy3h4SFt2+Ibterd29rdLaiRdT+6uwUOMFlt2ny90WILDQ9HJqtns7i7BTUi8aTrNE0xMemzZxc1bx6cnIzaRNUzeualP28+5e4WOMCs9sto3l0fHB189rD/2CeQyWpEJbm7BTVi8KSPksVqy8grKCg0BPp6B0VENfBMincCWtm8YzPL4o/f9LeO7hjB5pz54YutWSkTByVLZNzAgdFzvl3xZfiU7v6ZP6/efC1h+JPNZIRtYf9xAAAAAABhbH5+mdOm5Q4bFrhuXeDq1Qx+nQLczcbxmbqi3CKjRqWI9vdhMPsM7sapVNmTJmVPmqTZvDly1ixWp3N3i6Ch41hJduP22UntfW6cT/x+tcRsIA17pg/cjuP4HJ0+K0/no1YmRYZKWAaZFO8ENPVq9+iCWX7rvvl88fYC1j8yqd0jC8b3CWcIYeJHzp1l+XDdyjmbjaqIVoNnTx0WwxJCJJU8DgAAAABQDV4iuTlmTOb06arjxxsNGyZLS3N3iwBInsGUXlColEoaBfnJJDi3AXejNG/IkPRnn1WkpiaMHStPTXV3gwCILiwhrVUfWVF+/M9fKPKz3N0cAKIzGLU5+SzLxIYGquS4LvYWEU1AU82ABRsHlH5EGtph3OwO4yo+lQ1qN/7FduMFPw4AAAAAUDl9hw7aOXMIw0TNnOn122/ubg4AKTRZtAWFPM9H+Hp5K3D6Cu5naNZMO2eO1d8/bNEi3x89qYIN1FdGv5C0lr0sXn4hp3/1u3qWEN7dLYKGzmSxam/mGc2WYD8ff2+1u5sjLiKagAYAAAAAqGPmqKiMp5/Wd+gQvGqV/5dfUo5zd4ugobPYuIyCwgKjOdBLGeSlavD37IL7WYOCMh9/PG/gwMB164JWr6Ymk7tbBA2dTabITO6cG9ss4NKJoEObGavZ3S2Chs7GcZl5ulx9ocZLHR0cwGDnXQEmoAEAAACgIeIUiuwpU7InT/bZsydxyBBJbq67WwQNHcfzOXpDlt7go5AlhWgkDOPuFkFDV1KbyOu33xLvu0+q1bq7RdDQ8ZTJjW2WkdJVdVPbaM86WVG+u1sEQPL0Rem5BQqZJCEsWC7FRKt92C4AAAAA0MBQmt+3b/pzz8lu3IgfN05x/ry7GwRAdEaztqCQpTQ2wEclk7q7OQBE37Gjdu5cxmSKmT5d9eef7m4OACkMjta27M1TJurobq+My+5uDgAxmC1p2bk2jo8I9PNWKtzdHFHDBDQAAAAANCCG5GTtnDmWyMiQ5cv9duwgPEpGgpuZrDZtvt5osQV7q/zVOH0F9zPHxGhnzSpq2RK1iUAkLErvjGbddGHxwWcP+1/8i/LIJLiZxWrLyCsoKDQE+noH+XpR1NyoDiagAQAAAKBBsPn5ZU6bljtsWMCGDUGPPcYUFbm7RdDQ2Tg+U1eUW2TUqBTR/j4oGQluxymV2ZMnZ0+a5Pfdd0mDB7N5ee5uETR0HCvJbtw+O6m9z43ziT+skZiw7wY343n+pq4wI7fAR61MigyVsKiXJQgmoAEAAACgnuNZNnfYsIwZM1QnTzYaPlx244a7WwRA8gym9PxChVSSEOQnl7Dubg40eJTmDRmS/swz8osX48eOVaSmurtBAEQXlpDWqo/EWBh34GvlTZQgB/fTGYzanHyWZWJDA1Vymbub40kwAQ0AAAAA9Vlhhw7aOXN4lo2aM8fr0CF3NweAFJos2oJCjuMj/Ly8FTh9BfczpKRo58yxhIaGvv223/bt7m4OADH6BWtb9TGrfUNO/+p39SwhqJcFbmayWNNz8w0mc7Cfj7+32t3N8Ty4UBwAAACgYeNyj372wpCuzTQh0WFt+o9buveK0d1NsqeAkLmExBOiJCSJkEWEmG7/yUZIe0KovX+SgG4731ym2bSp0bBhmH0WJ70uf96fl1ruO+v9/T9ND1196r+i7DLzDPz1rKzJh8+Hf39avvtszK9XnrxalCPGiQi+4OzmuZMGxDeKV0Y3Sxo0fdGe66YKT7LYuOu5uqs3C3wUssRgDWafPUXRhe2vTuiTHBWkVPsGJnYZ8cLXp/UiSuFvhIwhxFrhcZ6QNYT0IsSHkCRC3iTEUvYJBYTMlktilFLNpbS+sxZsHDhIidlnT8HlHl03d0jnpprgyLBW94x78yex7btt2afaL1hH59v5J1lx/MjtGs68IWfNj/t7vf+Nz6Kvkz49+OalIqNMoW3Z+1KvsYrcjMQf1vhdPYPZZ48g8nGyItv5d9r7+1NvO/8krV4+UmpItXFcRm7BxbRMmUSSFBmK2eeawRXQAAAAAA0Yn/39c4OHrb4W2uGesY9EGv/eseHV+w+c+fjI6mHhYrpQQU9IP0KOEjKAkPsJ+Y2QFwk5TcjnhDCEUEL6EZJQ6vk8y5piQ45dS7/p69fm3sEBubluazpUyazLHvKb9gAv7xeuGSTl/8nO++Bv/S+FsQeT1T6EEEJyMtN6Hb35n0w1IiookbEez8h7/9TlQ8a4g41VKje3vQz9sWX9Ri07ShoNuG/y/aqM377b+eL4I6c/3PH5fWHFnySeJzeLDBkFRT4KWVKIRsKI6QMGVbL8++GInjN+KAjrPHLKyGjLxZ83b3pz4r5D13758bmWcnc3jhCekJWEHCCk4o+yLSRkPiHtCXmSkCOEzCHkMiHvEVJca1zHMr0Z/i9pVM+WCWNOHPpde/5/hJy5Pa6CqPHZ388cNOyT/0I73jP2kSjjye0bXhl94MzqI2tEtO+mcr9+KXEJ5XLJF/3xb2aGtyqoOIWWnIWf/zBfK2nfLO7JRMuRs5fmfJn/57IvF6uLGv34qaww3w3thhoR+ThpF/Vu3G/E8IRy393Z0v/Y9XtGeETQ7Y9Snr4oPbdAIZMkhAfLpZhErTlsOwAAAIAGi8//aeHUNVeaPLX1l1c7+lJC+CeHTOs18pvFK54YsritiA4UVxBylJBlhMwghBDCETKLkHcImULI3YQwhCws9WRdz55pc+dkbph137rc/13akeieJoMQ3K7UrANWxXOdE5ZoGEII4QPePpw680rmF3FxjykI4c1rL+Rekvms7Rb9oIISQkiS5vmDl966nLU1Pmas1L2NL8V2fsXsd4+y3Zbt/HRGEyUhhPs/e/cd30T5BgD8uVx2M9t078leskEBQfZQBBUEVIYMUZShMhUFFVF/CIKoDFkiKqtM2ciQjbJ3W6A0HUmTNDu58fujgG2p2Ja0d6HP9+M/XpPLE+6597178t77jn/5vedf/nr63CGdZj0jB6vLoy+wkwQRF6SSi/kTNyoD1pz68fSdptjBaw8s6hEqAABm8u5xHbotmDV1zcBNr4ZxuHCk8169+BeA0Af+ehNgNkBbgN8BxAAMwCCAxQBDARoD2Jo3+Mh48a/s2rNiiHcP74YH2lXEY6xl98cjlmTUfHvj/hkt1QQAO6bn8LZ9f/30m7d41HcLlNEzn48uvo3NOLWnyfXgqV1rJBAAwN78+9TsLGjbufPvLdTe4Jg70YIJQ2es+2zmhGHxcTgxvh/hcTv5EILwrjMXdS2+jclY1q/JriZTv3gtQQBOt1efb6ZoJjxQrQ6QcRPlY4Q3v44hhBBCCKEqxuanLl6Xqe4+ZUJzdeHNARHcc/K8BZ++3kzm/Y/3ViEaYANAFMDIe1sEAFMAFACri7/SVatW+vLlWdOmBX856asfzyYyznFVHSwqD9Z7xU6DJKCT+t5dCSHuEiIRMu5LdhYAgHYcLGCVOm0f6b27V1L2XLBIQLsvOHj0YC+dtmPDBTqqz5iRNe/eoAoCW04Z01GRtW3lAVuG0XLHbNMFyBKDNVh99j/U2QNHzGT9weO7ht5NU4Gu/fjhrUTWg3tPPjjLSpVhAXoDNAWYW9rYZwBIBXAAjAconOdFADABgAVYHRp9c/78jDEt96ZRUfazYy7+DfdeUGq7iniHzU9dtC5T3X3Kuy3+6bunzF/wGb/67gcxBWnv7MlJaN18XOHJxNpTz+c6AmLfbh2V27TbrZa9tDbd9NpqNufvX/SlJjXiK762k+XF3Pnlnel/Joz7ckxNYabBlJ6dp5BJkyNDsPrsE3z5cQwhhBBCCFU1z6l9Rx3iph2eVv0zNoWMbT9iVHsOg3oQDXAHIBGgaOlOCRANcBqABiABaLU6d9QoU9++2rVrY0eNTHU4fwfYd6/ygniKECYHCKDA8aed7aAkAABY6pjJQwukKXICAICQDa8b1U8hl/7zHtZKMSwhCRbxaEAVrc+8QwsS46OLpCghT0wOJ34/9ud5Yct6KYEqAcGjgFE5eO2gTa7XtnFikfGYhEwuI4ByezgskhEAcwHMACzAGIDMB15wHEAM0KLIlpoSodbDHH71u7F5xxMn/ZjDsA9vVxFPeU7uO/JA3x3XfsQb/Oq7S2LdqbtP/x5Qc1/LwLtdM5V/LIcW1Wod3GMoZF1N3rFU6HaoYoKD2Oun9C4mSo7jJf0GX9vJ8mGNqdNn/h48dOMrcRmZ2Uq5NDkyVCTEttBnsACNEEIIIcRTLMvSNO31FhvQ5MPxk0xOepqNCInT3Fg1ceCCjYfTneq4ui07vTbt/b71FDwqlgkA1ABZAFSRgrIHIBeAAaBI0tK7d86YMfKzZ5OefVZ8544DYBJAn+KVl+qmRNr4CsMwPs1JsleNyFcsmTOPpl2PVjUUMVfyzCvzBV1rRwwpHGxESrpF35080kVR+R7vuVzjhDt0RHjQi3wajSRQadQCJutONgXRhSlqdrozLqfnMQyY7CHqACyjQKXlZOntpA//xeVd550q+Yx25sYNR7zihs0bSkt/TxWpAQAALIDqgT8xABkAQQDKwv8nCEvHjndeigobvsywaGSo6Tbx0Ha1mhSgS6QNy/rmuQqWZRmGqfS+O15zY+X7A+dvPJzuUMfVa9n5tWkTX+BV312C4/bZSRfYPn3qtrj3b2GRSy7TAk1c3ToHf1XnZxVuFKoU0QL2lslOQ3UsQFdpTlaPdrLsHEfnvL+e7vRF/yTGGRGmk0twDANAaTlZ4bTEAjRCCCGEEE9RFOV0Oi2WYovw6KQ+u35jbQVWlrVsfbfTj96kzj1GdBTpj29bN3fkrhP6/RvHNODNHYMQoD3AQoDVAK/d2zgPIA9AHpR8Y9HnIpEoevJkxaFDhX9aAnATYP29hbaqpxJp46ubWJqmXS5XyZx8hB0KZQHDo+TbrthWXHesAAAApUb3Zqik5AKDrHvOkWuTLSwAaANDt9VTR/Dp6AprtWkfvmDhr9+uHr7opTDIMtto28XUlbvzGVbucvNorhBOlUgbhvHNqDiKotxud8mc1Kp9svPSuDM2T3nxvZ32uKFTX4vnbYGMBbADKAAEAM7atfWTJnnDw8M+HxtEM3mm2yyA6CHtKkA1SdpKaidLz0m5z4pZd/vuLRM6LfUmdekxopNYf3zruq9H7Dqh35/6Nn/67mJY65K9V2+G1V9fU0IAuJVB+gZP23M3eRnQ5P0RkB90/4WEWKQAyPRQ1SQJS3iwnfRJWlIU5fF4sJ18CLf7+hfTlt1KGbGsd1SiJoDAh5buKZE2NE1XuPvGAjRCCCGEEE8JBAKRSCSVlribpEp/dfmxFEWxTEFOwPCftyzoHEICAPP+oHGdeiz9cuq6fpsGhPDn6nsiQCrA6wDbAZIBjgKcIEkdyzibDFNv2RKxciVxb4CGHWAOQC+AWtxGzLUH0sY3BAKBUCj03c6ZQ1cyutzw1I+LSo1X1RUz1wz5E8/n9TpCr2kd9bykyAsJ0fO1YuKc3hvmgsW3c3ucILY1DW7Gn1sZScuJ03qkvrHp9We6/dK5RU1Z/rndv58gQkJJuwOf3r2nRNr46vbe1zn5MJ7MvXPfHzfzt0uehL7frf+yi5Y/bWQpWABCqtS/M9rau7du+XLdkiXgdkORCaNLaVcBQgEcHAZdtSovJ0mSfCAnfTYPwT9995qtC7qEkgDATBw09pkeS76YurbfpoGhPMxLe8bFObfIXs+npEik+tqtTAn1tWlnI/88LWBZorTfOxgf/Rjgd6o2JyuFf7WTAMCwrMFiu71zztJTkl6LRrXU8vg5Ai48mJMCQQV/U+DPVRtCCCGEECqGJEmJRKJQKIpttZl9tX9CJpMRhLjViGkdQ+4WyQSBHccNbblyyoHdRx0DegX46pMeWRTAQYCpAL8DbCaIejXbLp7aYPYr8/T7Zwa7rUVvFTYA3AZYVL2HPwNAibTx1U1s6TlZUYzL/HG6UxwavaGOJhQAgGwUFrqWpOodN01LD+pVU1bkXkVQQ6eqAQDRgS8rMxpcyJ2Wpdke48sHiB8FywpkXWYvnRezcEnqgXXL/pBFPNF9+t5htjGdZtxUBlTzVLyv8nJSLBaXzEna19N9sKYT348bNuXnc+6oDmOXz5nyUl0Vvw8sKZCybE6PWZ4oNql3b3FWFgDQADYAxb3msVi7CvAEwF6AMQA3q037WaU56Sjwyc7h7tS6hLjVyGmdQov03cNarph8YPcxx0Ae9d13sa4Nx9JuKxPmdHziepN2MmNW0s4fxXYLQwoUBOQXH+zMerw2AIVYWE2SsIQSaSMQCHySliRJikQibCcfZLY5sk0Wqch6bv22rPA+I7rr+B5xlSuRNiRJVjgnsQCNEEIIIVRNkaGREULiWlSUrkgZTxAaHSmE4xaLgwVeVc7iAFYBWNu100+aRBqNuqlvjaPZeNpa9HKWAVgCEAfQhqMgUblQNud5hqgbFBBcZKMyUNFMkL+pwFUAMoXD9ms+FRukeeqfGZ+J2GBlXbBfLvDQPp3BssKsLo++wE4SROve73Z8afL97Z5Dk25RZHxCDN5x+T369tqR3V5ZlhHcadLGue/2Sio5Qwzf2Jo3149tFzx49pldX2jWZtyf+qFwQdcaReZ3jgNYVeSNHoBbAPFYJuA3MjSilL47LDpSBMfNZr713QDAWDJ+uEFF9n0zpX79yBPblNnphdsFCkWMkD1lthWwEHQvZtpqv8MQNbQB+PCIn/G3dtLp9urzzRTNhAdqlMYty/fa44a/1IZPy0s8fvhwzYYQQgghhLgQUK9JDdJ+7ertIk8G05lpGV5CHRHBq2Er+wEWRsVfXLbszrRpIQsWJA4YcD3NmA3QpvjlbAbAEYCePl3uCVUegiQVACYPVfTRdJaiTSyIhQIJANgt485kTsn2lHiBFUBGcj9Bo5uib+YXZJqtQTLTrd2bV+9LLzJ3gffc/j+zBfFtWkbgHZefoy7NfWXI8qw64zee2Pwhz6sqnpiY2199dft//wvcfPUZJ+uxZBws8tdrAAaAJveazf0Ai4tPuHEO4MF2FfFOYd99vXjffTstw0OoIyN51XcDgFemOOqwHKMjutaga+5adr/6DAAgDGwRRnoy9Qf/GYnLXss0GIiAJhEyTEK/4k/tJEUzWUZzenaeQiZNjgxVB0gyNm844onu2aMBXj1WKjypEUIIIYSqKzK5T98GglOLPlx/++7dH6VP/WLpCSa0Z89mkoe/twrRauWRWOGblrDNRy+l9Oql2bTJy7LTASRF1s4qtAfAC9CJiyBRBYhUyk5SuJRpWOu89wQ2S++/YTzIku1DAuQAInVAWyF77Fb+cfree1hqe4b5Mgjb+XA5zvKjGTbH6riRZxaTZEqINihAcumXD0aM+nDFzbuBetN/nb7yhqTZwNfq4lhSP+f6Y968o+7G762Y2SGEz3fPpDjvjTeur1tHuN3JPXoE/bThWQAZwLcAhc07C7AQAABeuveOiwAjAFbc+18vwPTS2lXEO2RKnxcaCk7+8OG6+313VursJSeYsJ69eNR3MwJhXkqzax2fPXQyjZIrn6VOEwxd7BVEQK86ITJn5rd/F9zNUnf2wr/zQRf3UjifTzb0AD9pJ1mWNRbYrt3JoRkmOTI0RKMkCADWsGfX396g1p0a+mylUFQqvB5CCCGEEKq2yJpDZ479rfesYe0vb3yuUxKZvn/D+tPmmH4/fNRRyXVsAAAgEJh79MieMKHXuumr5u398LsjFwFCAXYCnAf4GiC5+Mv3AEgBmnETKyo/MmBKHc2O06aBB1xrIpT1RcxVY8EGE6UNifg8UkgAgFj9YVL+rst5XQ+5+oXKw4E6l2fZaKGjIqOm6Di7xzU73dkWu1QkTAzWSO6uMRg58N1Xv33hh3e6P3+kT8tQy6Wd2/eeh6e+/vLVZHyM3M/R148czWHEqsOzRgwrnnOE6ql3vnqtDvd31ARBEUB1nWFvEpwwYID06tXCzXEAEwBmAPQA6A5wCmAVwOsAje+9byDAtwDvABx5aLuK+IesOWzm2F+fmzW03eWNve/23adMMf0W86XvBrCGJ+obtifdzrjdC05f9Epjg5qV0hgScQ2fmHBmx4ydu3sYkroHMafOXF5lUb7er05jbDn9ih+0kwA2p1ufbxYIBLGhQXJJkVqz7eiekx5pq1Y8+vXmMcWHNEAIIYQQQhxRNJ+xcWPkzM8Wblkz53dWm9B08KwJ04e35sPYI3vTpvqJE1mJJHLyZOWhQ/sApgFsAzADNALYCNCj+OvdAIcAkgBU3MSLKiI8LPJwS/kn1/M3Zhm20URwgHxQrahp8YrYu0+RE3UT4w5Jcz/OsKzPsJlZQZhCPrxu8NTYgHAuHjN3eim9xU7RTLg6QC0rdquqaj1t78a4aZ8t37byB7MovNHT4zdOGtUjFodT+T3qVsYtirVd/H3FxRJ/EYQIX/jitTqcRHWfs1atrFHNPeOXC86nxm09ImaLLucGHwAEA3wD8B5AJMBMgAlFFhhUAez9r3YV8ZSixYxNqZEzPl24+ec521ltQtPBn787fcSTfOi73cpAfYOnXergkIt/Bmacc9+4dMgNSeGBpc8NItZ9MKBT8J7T31w4956HjAyLnNm/8YQkCc/mEUH/geftpIei9EaLw+0J0SgDlQEl1tBznzpwyCpIaliPb9PXPH6wAI0QQgghVK2Rumajv94w+muu4yjCGxqa8/bb1nbtdIsX61auJLxeAAgB+P6h75IAZFZNfMiXiBBt4NymgXP/9QWCupFhv0aGVWFIpaAYJtfqMDvcOoUsWCkv7S6VDGn22vcbXqvqyFAlk3RbbPQu5jqKUtAaTe7IkabevYPWrDkkkgky/nzwNQKA0QCj/30n/9muIt4idc1Hz00d/e9NZ9WjRdLc2q1MCfW1aWdjjm0ReN0AIElokflhi4e8SyAPHt2z8+ieVRUlqgS8bScZljVYbAaLVaOQpwSHkoJSfqKRtPsy0/Jl1cdWDWEBGiGEEEII8QUjkRgHDMgbPly1d29yz55Co5HriFB1x7JsvsOVa3UqJKLkEK2I5MEIQ1S9sSSZ379/7ujR8lOnknr3FmdlcR0RqvYIwhxTO7t+O6k5N3H3SokV+27EPbPNkW2ySESihPBgqRjXF+QeFqARQgghhBAvWNu100+aRObnxw0fLj97lutwEAKb26O32AUEERuokovx1glxz968uX7iRJYkoydMUBw+zHU4CIFdF61v2J4hhZEntiuz07gOByFwuj36fIuXpsO0ao1CznU46C68ikIIIYQQQhxzx8fr33/flZwcNneuZvNmKD6NKUJVz0PTeovd4fGGKOWSXaqSAAAgAElEQVSBcmmJKSMRqnresLCcMWOsbduGLFwY+PPPBE1zHRGq7rxSRU69NgURSbprJ4MvHyMYzEnEMYpmcs0FZptDp1YGq5XYdfMKFqARQgghhBBnaJUq9403TH37ateujZkwQWCzcR0Rqu4YljXYnAabUyuXRoUoSp0yEqGqxEilhiFDDIMHq3btSu7RQ2gycR0Rqu4YgdCY9ERezeYq/Y2UHUuELjvXEaHqjmXZfKs9x1QQIJUkR4aKhCTXEaGSsACNEEIIIYS4IBCYe/TInjBBeuVK4osvStLwuV3EPbPTnW2xS4Rkgk4tFeG9EuKetV27rEmTxFlZCQMHSq9c4TochMAanqhv2J50O+MOrZPn4xTkiHs2p1ufbyYIIjY0KEAq4TocVDq8qEIIIYQQQlXN3qSJfuJEViqNnDJFefAg1+EgBE4vpbfYvTQdpg7QyPD2FXHPVauWfuJET1RUKM5NhPjBrdDqG7R3aYJDLv4ZmHEOcxJxzkNReqPF4faEaJSBygCcL4vPsACNEEIIIYSqjjckJOeddwo6dNAtXx68eDHh8XAdEaruKIbJtTrMDrdOIQtWqvHmFXGOVqtzR40y9e4dtGZN7KhRAoeD64hQdUeLJIaazY2JjbTp52KObxF43VxHhKo7hmUNFpvBYtUo5CnBoThfFv9V3wI0y7Jmsxl/HuEJlmUBwO12UxTFdSwIIR8wm81ch1CN0DQNAFarFTs1nnA6nQzDcB0FHzESiXHAgLzXX1ft25fSrZvQaOQ6IlTdsSyb73DlFDgCJKLkEK2IxNtXxDGWJE29e+eMGSM/ezbp+efFd+5wHRGq9gjCHFM7u15bqSUvce8qSQH23Yh7Frsz22QRC4UJ4cFSsYjrcFCZVN8CNEEQSqUS79V5gqIoq9UqFovlcjnXsVQruNATqixKpZLrEKoRu93u8XgCAgJIElfb4AWSJAU4CuMB1nbt9BMnkmZz3MiR8jNnuA4HIbC5PXqLnSAgNlAVIMHbV8Q9e7Nm+okTWZEoevJkxaFDXIeDEDgDw7MaPE2LZZGndij1N7gOByFwuj36fIuXpkM1Ko0Cy0f+pPoWoAGAJEksQPNE4UgxgiCweoLQ4wHP5apU2JcJBAL8Z+cJPBAluL1efb7Z9cEHId9+G7h+PeDwcMQ1jy5M332gw2QNUcoD5VK8I0Cc83qpnLw865w5uiVLdCtXEl4v1xGh6o6i6WyjueCpF3TXTgZfPkYwNNcRoeqOpulcg9FkMuvUSp1KIRBg3+1nqnUBGiGEEELI/4ilXEdQVjRN5xpNpoICrUoV06yxoPlSWL6U66BQJZj/M9cRlBXDgsELBg+rEREpsYn4c9Fji/SbIe0MwxgMBoPBoFKpkps1E7ZqBUuWcB0UqgSk39ReWJbNtxTkGPOVAQHJYBUlJUFSEtdBoUowsT/XEZQVKxDk12yW2/Bpec7NpJbtxCK/OZtQUXjYEEIIIYSQ75kLrNl5BqlEkhgTJRGLgcIBfYhjZi9ku1mJABJkhJQEwOoz4prVas3KyhIKhfHx8TKZjOtwEAKr3aHPM5KkIC4yXC6VQn4a1xGh6s4WHq9v1pVgmJg9qwNybkKbZ7iOCFUQFqARQgghhJAvOV3urNxcmmYiw0KUAQFch4MQOGnQu1kvA2ESQuM3Q2PR48zlcun1erfbHRYWptFouA4HIXB7PNmGfIfTFRKkDdKouQ4HIfCoAnOeeMYWFh9y9o/AS8cIluU6IvRIsACNEEIIIYR8g6Lp7DxDgc2u02qCA7U4tS7iHM1Croc1eUEnJoLFgBmJOEfTdG5urslk0mq1sbGxuGgt4hxNMwaz2Wgu0KqUUaEhJIk5iTjGCEWGuq0NdZ9UZVxI3vCN0O3gOiLkA1iARgghhBBCj4pl2XyLJceQr1IEpMTHCnFyA8Q1FiDfA7keVk5CcgAhwtoz4hrLsiaTKScnRy6XJyUlicViriNCCMxWW3aeUSoRJ0ZHSsT4hAjiGkFYYmplN+0stpoSti6SmnK4Dgj5DBagEUIIIYTQI7Ha7fpcA0kK4iIj5DK/WSMRPcZsFKt3AwEQI4MAEmvPiHt2u12v17MsGxUVpVQquQ4HIXC63Po8I0XT4cFBaqWC63AQAmdguL55V69CE3p6jybtLOCcG48XLEAjhBBCCKEKcns82XlGh8sZEhQYhNOYIh7wMJDjARsFIWIiUAQ4DQzinNfrzcnJsVqtOp1Op9Ph3ESIcxRNZ+cZC+wOnVYdrNVgTiLO0RJ5boO2pqRGQVdOBO9eJfB6uI4I+R4WoBFCCCGEULnRNG0wmY1mi1alig4PxWlMEecYFgxeMHhYjYhICSBw3DPiHMMwRqMxLy9PpVIlJycLhXj3jTjGsmy+pSA336SQy5Njo0SYk4hrLCHIr9Ust+HT8pybSanfiu1mriNClQWbG4QQQgghVD7mAmt2nkEqkSTGRElwGlPEAxYvm+0GsQAS5IQUfw1BPGC1WvV6PUmScXFxcrmc63AQApvDqc8zCASC2IgwuRTny0Lcs4cn6Jt1YQlB9B+/Ke5c5zocVLmwAI0QQgghhMrK6XLr8/Ioig4PCcYpIxEfOGlW7wYvC6ESQoMLaCEecLvder3e5XKFhYVpcG4ixANujyfbkO9wukKCtIFqFc65gTjnDVDnNGpvja4RcmZ/4KXjBMtwHRGqdFiARgghhBBC/42i6ew8Q4HNrtNqggO1ePuKOEezkOthTV4IEhPBIhBgSiKu0TSdm5trMpm0Wm1MTAzOTYQ4xzCMwWwxmCxalTIqNIQkMScRxxhSZKjX2lC3tSrjYvL6eUK3g+uIUBXB1gchhBBCqDrzZu753+BOjSKCtRJNeGzz599adMJYfBgKy7JGs/lq+k2WZZPjYkKCArmvPjs29Q9VEwGqYv8FvrDMhAum+y/3nwvH9lt6iXrwL4zlxC+f9+z+jLZ2i/D2gwYsOJTuBqMHrtpZDwNJcggV86L67Li+6eNXO9SKCZYp1Lrk1n0m/3LehglZjZjN5mvXrnk8nqSkpPDwcKw+oyrC5m54o1lMu1mnH2g9zVbb1YzbdoczISoiPDiIk+qz49bhj6eOrdWpl6xFN13P0X3m7T3vKNowsra0/VMmjm3Qo7eyzUu1X502Zv0lA46F5T06/0qz/60jvizlP+GSc8fuH0HWc+LcmZ4rtmnnbgpfun/AsZwLYTWuPTfaHhafsG1J1KENvKg+M6YTyyf1bFVbGxIV3rDzgC92Z7i4DukxhSOgEUIIIYSqLda4Y9zTfZbcCmra59WxyZK8U5t/+fatLofv/H5oetPCKUutdrs+10CSgrjICLmML1NG0lnpGW5B6BNdnk6U/bNVWD9exIMyJKoQNv+P+Uv3Huj0UsnKA2v6/cPXev+UFda4zcuDwl0Xdq/58o29F75Y+3mnBnJCQXISbCm8V7/v0+7tHQXhrfoO6RvtvbF//bovX9375+39OyY0kHAdHKpkdrtdr9ezLBsZGalUKrkOB1UrTOaasW8su5CX0NFbZKvT5dbnGSmaDg8O4nC+LG/Gpj5D5+2w61o9061vOH3jxIF1yz/d+3fe/u9eaiAGAPBcX9dz2HcH6KhOHTt3V7svH9u/8JPx+2/NOvROfRVXQaMyIMSqTjWjE0t02Kzz+HVjjkIefPdazP37ngO9zzjCIsJebii3m7J/PfTnXmnnffJ98elngeXHD7Ss4ffx3XsvvhXWovPLr0e7zmxa89GLBy4sOba0dwT+huhrWIBGCCGEEKqu6LRln61M0/Za9udPgyJJAIDJA95t3emrBV9tHPNzH4U3O8/ocDlDggID1WruRz0XQd9Kz2ACOry39Keesv9+NeI1xpl/58LZo6sWzPsljw0t+VfWcmDuiNWZNYcv2v/+EzIWctxDGr3/4jtb528Z8UzrBrwpP7Pm1I+n7zTFDv7twKIeoQIAYCbvHteh27ezpv4ycNMrYTw6eZBPeb3enJycgoICnU4XHBzMq3YSVQd0+vIREzblsMT9WhlF07lGk9lq02nVwVoNlznJ2lK//3FnQdjgr75Z1EYrAABm4O4vx3b7ZdXU3ztu6hVIgGPbstUH7LETliz4vL4UAIB6fs7IUeN/WflT/9mjQvFs4i+BInxmt/Di29iMs382SQ+c2iE+gQAAsKRfGHHGXrPpk3s6RrsbtDMlxrYb++KwPV8sD33mM770iqxl98cjlmTUfHvj/hkt1QQAO6bn8LZ9f/30m7d6ftYY66U+hiV9hBBCCKHqynbi4N8eZfsBfSLvFfICGj/XMUrguHL8TN6NW5likSglLjZIw+kdbClYU0aGiYhJjsMl5/wea9zQu0XXpq99NPeEqZSnrllz6qrtmar2k0c1cnvhuoMlCO3rEz5eMLV/M6n3wZdzhjp74IiZrD94fNfQu/dXAl378cNbiawH9550cxsbqhwMw+Tl5V27dg0AUlJSQkJCeNZOomrAe3X+yCkH4vv3qyeEu/NlWa5m3PJSVHJsVAjnqzXQNw6csZEp3cY/qb3XMKrbv9qzldB58PhlNwAw+Vdu2SGwfqda956vEkZ2aRUj9GZeyqS5ihpVDGO99c5BQ0KzRuN0hUfbnfr37UxpxNsvd8p57i2PUpu0ec2gGnUWtEtoJuTNHCtsfuqidZnq7lPebaEuPFeI4J5T5i/47PVmMj5dYzwusKKPEEIIIVRdCRsMn7ewX0rTIjNrUNn5dpbQqqSexJgoiVjMXXAPQWek3aJFNRK1N//YcOS83iGPbti+fdPYAKz++B9C3X7ub8lmFtj83WOGL8ss8WfvuX0nneIGrWMEYKfYBDkhFQDEtBoxuBUn0f4rrx20yfXaNE4sMiabkMllBFBuD29utZHPWK1WvV5PkmRcXJxcLuc6HFQ9uc/MGTnt73rT94ylR/36q53KvJ2pExJxkeFyKT/my6JcoI6q1zglsci4R0IilRFAeSkGAATa5Gg5XLny502qQ5IQAIAxHjurp0XxKRG8ecAFlYk79eCF3+UJ+xqr71440qZdelrUoH+dJq2jD21Q3LkGAKAOHfHEA086cchzct8Rh7hph6dV/1xAknHtR7zRnsOgHmNYgEYIIYQQ4imGYbxer8tVbDEUqQ8fYAuo1e2VWoUf5SowZd1JO7BxzqdrjWE9Px3ZPErC3yfl3BnpWTRjmdiqmd7oZQEACHFYm4lLl05vG4xF6EIl0ob10WSLpefko+xRqK3RQAsAbO5l1QMp58i5fdEG2giVbcus6ct3Hr7pVMfUbPl032lvda/Hq98b5F3nnexafBOTmbrhiFfcsHlDfpSCuFd5OUlRVMmcrLQCnNvt1uv1LpcrJCQkMDCwkj4FVY0qzUlft1iOE7OHzLrS/NM/RiVRM70sUA6VSpUYpOLRSHxp83k/Ny++ic3ce+AIJWxYL0kKABDQa/Tbr1yaPXPU2OvPPtlQ5bpyZOfK0+KuY0cPCefNt6haD+akT9KSYRiapn3ZdxfnuHNl0hW2T/eUFiIAAG+AWh8lv+w9EqwwMJ+8/sKJ24cttFqtbpkQP61FTD3ejG1gctLTbERIvObGyvcHzt94ON2hjqvXsvNr0ya+UE9RTTPwQSXShmGYCuckFqARQgghhHiKpmm3222z2YpulKp8v5oQ5bn8UYfms85SAAJtq6nbfniZ10uv0Jk3bnpZLx3/6vJd73SIA/2pzV+PmbRi5sDRsX+uGRLN59CrTom08RWapj0eT8mcrIwPYiHXwxoMVicLjn2f9PnNm9T+mRHtRPrTe9d9P3nX6bz9KwfzeHE/d8bmKS++t9MeO3Tqq/GYkYVKpI2vin2l52QlFKBpms7NzTWZTFqtNiYmRiDAA+v3Ki8nvV5vyZxU+nSkvPXQByO+vvXUl9/3Ccq4dZYkAERKtUbNn+JzabwZfyx6cc4Je3j3qb3CC88fYVij4T3rbltwasXSiysAAAhl3b5vPh1bbR8rKJE2DOObR2hKz0mf7BoAWPuSQ+k3g2uuT5awpCivXmtD3dYBBz6laNZ67OfODiYpIXJEAqHP0q87fnJXlmt/35QG/KhEsrYCK8tatkzotNSb1KXHiE5i/fGt674eseuEfn/q2w3w12MAKC0nK5yW/DjsCCGEEELoASRJisXigICAyvsIlmXzLZZcA9N54jd1CuwZf21dvPyTHs8Lt214t5nvC90+Igh57pOfG0lrtG1eeI+a8NRrX28msuqO3j1v5cVXJ9fFB3cBoJLSRiAQlJKTdl9+BMtCvpfN8YCchEQRDcAU5MmG//DLgvY6EgCYUYOmDeix+vupm3tu6qvjYbHFk7l37sRxM3+75Inv+92GL7toeRgjN0qkja/GaZIkKRKJKrWdBACz2ZydnS2VShMTEyUS/v70gcqlanPSN9VtAADWvGPKG9/ktZ8xv12Q2xkeFaISEgC8bmo8Oafnfr1g5q6bnsi23815o0vhjAes49C373VZllv/pfdTB7Ssq3JdO7514herew2zrPnxvef52MBXuhJp46sfukiSFAqFldRO2m9fm3NH0KtbfFRMjWvNugpd9vgdy0UXLtDAFtiFw59rsyBBSgIAW3vQ7n09zlyeejlmU12fPxJQESxFUSxTkBMwfM3WBV1CSQBgJg4a+0yPJV9MXdtv00BcBxOgtJyscFpiARohhBBCiKcKi30ymazYVo/rX15ebjaHQ59rEAiI2MikWkl1AQAGj3y5ds8GYz+ftmbA9mF8HQZNaGu37VS72CZBZPdeLcfu2v/3BRvUVXMUF6+USBvfFlZK5qTvsCykOUHIQrSMUJBAy6UyIMTNBk5rp7v7u4JA03FUv5a/zj7wx1+Ovh0rt+hYXqzpxA/jhk35+Zw7qsM7y+dMeamuCu9e/1FJOSkQCCo1J51OZ1ZWFk3TkZGRSqWykj4FcaLyclIoFJbMSbfDJzsHYLO3TBq61PrM7InD6gUHKhVA+2rPlYO1nli7YNg3u895QjoMnDTn9fZ1702gxOTu+Xj1DXGb9zdM6BhKAICyUfvX1srN9d7cNu2X3r1Gp1TDctWDOemTtCw9J33DveH0rduqGjPeGJkVpAk7vUeTdhZYlhaSMgBxVOK0eOnd7psQd2yW2PL8mQMZRkfdSD5034RMLiMIcauR0zqF3rvGCOw4bljLFZMP7D7mGNiLD0FyrkTaCASCCuckT28rEEIIIYRQ5fF4vTfv6NOOb9yzc/cdiJDL7j9nSMZ27FSXdF2+cMO/VqAnlBqNEFiKon03yAxVJS8LbgCaAo0QkuSEggQAIINDI4SEPDxcV+SuRRASESkCd4HVwatjTd9eO7xN27fWmltM2vj32V2f98Pqs7/zer2ZmZnp6elKpTI5ORmrz4hzFE1n5eaePvJXLpW7bVyboOBQQhpABDR474SXvv51C0WAsO6UYxTXURbF5K79eEzbWfvN9Qdu/O3HXe90qFtk+n4q48Z5D1m3Sf2iqzcoGzZqJmZuXE0v4FULj/6F15Wz8BYd8ey7T9n0KRsXaG6cAZYFADJAFiEg5Ep50YHsAoU8UgBut5cnv5mQoRERQkIeFVXsGiMsOlIEbrOZX9cYj4Vq+JMSQgghhFD1xTCMwWQ2mMwalTLZffCZt1fX/KLD/jdj7197swUWK0vI5DLeFs+ov+f1fjtVO2zpskH/hE1nXLvuEYQnxSt5Gzf6FwwLBi/kOVgAEIogSFzkSXJ5zSZJgm3p6beZtkn3DjZ951aGh1CHh/KpwEtdmvfKkBVZdcZt3PpphxAc5OPnWJbNz8/PyclRqVQpKSlCId41I46xLJtvKcgx5gfIpI26DJ0s0f/zIzFrOrJiyT5Xk1dfbxetaxXJo/aHvvTTJ0M2G+q88unWt554sGEk5HIFsCaLlYHQfy5CbAUmBsQymYRHLTwqBUsITMkNT16+fpIKGSn8I+a4pdifxZomQcQ2k/U2G55071DSBbYMmlArZKqqD7dUAfWa1CC3Xb96m+nyzzXG7bQMD6GOjOTTNcZjgkeNE0IIIYQQqlTmAuvV9Jt2hzMhOjIiJFjapH1bNXXsx8XH78/hS+du/+6Xy2xou/a1eVtxESYmam+eWv35F9vy7o1O8dz+7fOlf7EJL/RpLOI0NlReVgqu2Vmrl42XEaVMrEsm9OlZR3Bm9Ydbs7yFW6jc1PlrTrC6np35tAah64958466G7+3YiZWn/2e1Wq9du2a2WyOi4uLiorC6jPinM3hvH4r01RgjY0Ii40ID2/z+vQPP5hx/79poztHCojAliOmffDRW89E8acJ8pyZt/qiu3b/FW+WUn0GAFFKs06h7KVNv6zNvjdsmynYvzz1IKVo/1S9arsOoV+wh8Xd6DnCWLvWla0XKKm0q9JS8hWEsk9NjUB/48MrjrvdN+NMPZp2gpX2TA7kS/dNpvR5oaHg5A8frrt97xojK3X2khNMWM9ezfgS5GMEe1OEEEIIocef0+XW5+V5vVRYsE6juvsgORHU68P3W+2a/L+urS/269kknM05t3f9xtPmqBeXTHmax7d+ys5TP+y46+2VfVtde6HvU/GCvLN7Nm4576n39i+T8X7Bf7gY0LvBw7ChEkIjArb0lQwFNQdOGLvp9VnvvHR5W5dO8YL0wzvWn7XE9P78o7Y8WiWTvn7kaA4jVh6eNWJY8TILoWrzzlev1sGbLr/gdruzs7OdTmdISEhgYCDX4SAEHq83x2iyORwhgdpAtcpXs1RXDfrWhaNGVhxwbtaM2SUbxif6ftUrXihpMGVC5x2Tfh/Y/+aajk3qq9xXTxzccN6kfXLM551x/Vae8spVOU90sEbX0J07qPt77eEMWhqla1ZKJ0fUbFB/7KWDs7buvXw1qpOWSL+VuV7viand7KN4/gwVIGsOmzn21+dmDW13eWPvTklk+v4N60+ZYvot/qgjzrnke3gthBBCCCH0OKNoOteYby6w6rSa4EBt8dtXSd13NhyK+Pzjbzes/26v2SsNq9Fi+JzxU19/Mpw/Q6hKIUwZvPJI1PefzFuzffk3v3qkkXXaTFj03sR+9TR4w+oPaBZyPazJC1oRxMqI/8i1gEYzVi6O/GrBwp2b5uxhtXENBk8bMf2VJrxKUepWxi2KtV36fcWlEn8RhAhf+OLVOpxEhcqOpmmDwWA0GrVabXR0tEDAp/RC1RLDMAazxWCyaJSKlLgY0g9zktLrb9GsLe34irQSfyFCyHZf9IoHIMKfHnf4+xqfLN26ceeGbS5hcHTNQWPem/Zyk1isVPEPQwqNtZrn1W+junU5eeN8odPmzso+5IGkUE3pU2qIg2b0fSry8MWF12/OuQFabeDg9jWnNwwO59WlmqLFjE2pkTM+Xbj55znbWW1C08Gfvzt9BM8vg/0VntYIIYQQQo8nlmXzLZYcQ36ATJYcFyMq9UFyQlH3pRm/vjSjyqN7RNK4jm8v6vg212Gg8mFZMHnZHA/ISUiSE+IiN3hEyIu7r75Y6rvIwIajP1k0+pMqCrICJN0WGz2LuY4CVZDZbM7OzpZKpYmJiRIJPkWBuGex2rIN+WKRMCEqQioR/8eryaR3D5rfrZLAykXy1HvGU+/916sEIQ16zp3bc25VRIQqzhpdQ9+8K+m0x+1aKc/LLNwoiWmUOb7RQ95FyoNGd3xqdMcqCbGiSF3z0XNTR2MKVj4sQCOEEEIIPYZsDoc+10AQEBsRHiCXcR0OQmCnQe9mWRaipKAU8moEFKqmnE5nVlYWTdPh4eFqtZrrcBAqnC/L6KWoUF2gRsmjiYZQteVW6/TNuro0wWGn92jSzgLL/vd7ECoNFqARQgghhB4rHq9Xn2twuJwhQYGBarV/TRmJHkteBnI8rJUCnQh0EsxIxD2KorKzswsKCnQ6XXBwMLaTiHM0w+QaTaYCq06r1mnUOA8M4hwtluY2fNqU0lh79VTM/l8FXjfXESH/xqcCNJu9+YOZef3mDqlD3t3C5J9Zt2zN/r9vWhWxDdv3G9ynQeFM9OXdjhBCCCFUDTAMYzCZDSazRqVMCYsjSbx9RRxjWDB4weBhVUJIDiBw3DPiHMuy+fn5OTk5SqUyOTlZJOLPcliommJZNt9SkJtvkkulSTGRYsxJxDmCMCfUz27aWZaXmZT6rdiaz3VA6HHAmwI067qzb+XG845mzP1N9M31n36ylm47eEy/oLwDq378ZBb51ae9o8nybufwWyGEEEIIVRGL1ZadZxCLRAnRkVKcxhTxgJUCvRtIgo2XEzL8NQTxgNVq1ev1JEnGxcXJ5XKuw0EIbA6nPs8AANFhoQqcLwvxgD00Vt+8G0sKIw9uUN65xnU46PHBhwI0m7f3fx/+eOROgYcF3T+bPWe3bEmP6vP1yC7RJEBdnfn6hM1bL3QfWfNC+bbX/685+xFCCCGE/JnT5dbn5Xm9VKguSKNSch0OQuBmQO9iXQyESQiNCIc9I+653e7s7GyHwxESEhIYGIhzbiDOebzeHKPJ5nCEBGoD1SrMScQ5r1yZ88QzBTG1dBf/DD53iKApriNCjxU+FKAJzRMvjY95li3487tP9t/fSt++cMkW1qJxROEIZjKmcaOQdX9d1HsDyredqR+L4y0QQggh9FiiaSbXmG8qKNBpNTqtBqeMRJyjWcj1sCYvaEUQIycwIxHnaJo2GAxGo1Gr1UZFRZEkPiGLOMYwjMFsMZgsqgB5cmy0EHMScY0hhcZazfPqtVHdvpyyYZ7QaeM6IvQY4kMBGkSaqEQNsKZrsiK/+TGGXAMbFBx476pVEBgcyBpy86hybmfgbgF6165dly9f/mf/DGO32/FnRp5gGAYAvF6v3W7nOhaEkA/guVyVKIoCAKfTicVHnnA6nWzlLxHOsmy+xZJrNMml0qTYaJwyEvGB2QvZblZGQpKcEGODhHjAbDZnZ2dLpdLExEQJzk2EeMBitWUb8sUiUUJUhFSCj2sj7gtE4YgAACAASURBVFmja+ibdSXdjrjdK+V5mVyHgx5bvChAl4r2uClCJrtfkyZkMinhcXuocm6/f/936NChrVu33t+/SqVyOp1YgOYVmqadTifXUSCEfADP5arnduPK1HxRBQVom8OhzzUQBMSEhwXglJGIB+w06F0sC0SkFJS41CDiAafTqdfrKYoKDw9Xq9Vch4NQ4XxZRi9FheoCNUoF1+EgBG61Tt+0i0sbGnJmf+C101D54ydQdcbfAjQplpCsxeliQUoAALBOp4sVKcXl3X5/hy+++OJTTz11/39nzZqlVCqxAM0TNE07HA6RSCSVSrmOpVpxcR0AemwplTgLbdVxOp0URcnlcnysmCdIkqy8CwyPx5Ojz7Y5HCFBgYFqNV7JIM55vd4cF2ulQCcCnQQIwJxEHKMoKjc312w263S64OBgbCcR52iazs0zmgqsQRpVMM6XhXiApuncZl1NKY21V0/FHPhN4MGBLKjS8bcALQgK1hHpRhMDGhIAgDEbzURQnSBhObffb9rr1KlTp06d+/ufPXu2RCLByxGe8Hq9AECSJD4Zh9DjAc/lquTxeCiKEovFQiF/u/VqhabpyrjAYBjGYDAYDAaVSpWcnOLzw22z2Vwul0ajqaxEElfKb8xer9disUilUoXCz0aTmUwmmqZ1Ot1/v5SvGIYxGo15eXkqlSY5LMznmWO3251Op1qtFvnVDDMURZnNZolE4ne/xZrNZoqigoKC/PcWiWXZ/Pz83NxchUKRnJzs88xxOBwOh0OlUonF/jRzAk3TJpNJLBarVCquYykfi8Xi9XoDAwP9t2LLsqzJZMrJyZHL5UlJST7PHKfTabfblUplZV17N2pfGXtlWdZoNIpEIr97OqGgoMDj8Wi1Wr8e9nF3bqKmHRLDwyUNGsILQ324c5fLZbPZFAqF3w0uNBgMQqFQo9FwHUj5WK1Wt9tdiRfwvsPf+MiYOrUCUv8+k9c/PowAYLLPnM1W1q4TKS7ndj9uFRBCCCGEAADAYrFkZ2eLxeKEhAS/u6BHjyWr1arX60mSjIuLk8vlXIeDENhsNr1eLxAIYmNjMScRH9jtdr1ez7JsdHS03/1Kih5LTqczKyuLpunIyEi/+5UU+Tv+FqBBXL9bt5iJv32zOmJIm8DcfUvW3058/q26YiDLuR0hhBBCyG95PJ60tDSv1xsaGup3gzLQY4miqIyMDJfLFRISEhgYyHU4CAFN0zdv3nQ4HIU56b8juNFjg2GYzMxMq9WKOYl4ojAnCwoKcG4ixBVfFKCZW4d+PXiTLsMryejWfdvElfUzhQl9J73n/X75/InrXfLIhj3eH9E7lqzAdoQQQgghv+RyuRYsWFA1E3wzDMOyrEAg8K97EpZlGYYhCMLvHtAu/Af3u2d4XS7X6tWrf/755yqIvPDgYk5WmSrOSV+tV+xyuVatWpWamoo5+RCFc0NhTj6c0Wj0yX7cbvfatWt37tyJOfkQmJNlkZOT45P9uN3ubdu2HTp0qFLXKSmEOVnFqvgCPi8vr8LvJXywSrt77YuaF34rw2JmwpoT/zz3WVN+jLru1KnTjh07/O6UeFz57wSOfq3mR5lch+BPLscs5ToEvzL4A64jqEb8aOavasLhcPTv3z81NfXRd+V0Ot1ud9VcChdeE/rjpZGfRl7FYRME4ZOHbd1ut9PpxJx8OD+NHHPyP/npkQW/jbzqw/bJNNmYk2Xhp5FXfdhKpfLRP87j8TgcjqrMScCDW1WqPmyFQlGxXPLFnark+RWnF1jbjPlD0f71t17r0jhOSeVlnN3/0/wf/hD2/t/Cd5qq7/5DCNRx9fDWGCGEEEKobGQymUwm4zoKhP4hkUhwmVnEK5iTiG8wJxHfiMVi/1o6FT2WfFIPtu+ePWNPwMDfji59NvRuFfzJDs++PKD96y36zt4w9Pw3T+MaEAghhBBCCCGEEEIIIVTd+GIEvufk9l3GmL4juoUW25sgpOuIF+PvpK4/7vXBhyCEEEIIIYQQQgghhBDyL74oQLN2m51lGebBPzAMwxRYCh78C0IIIYQQQgghhBBCCKHHnS8K0KJaDWoLbq5fvD2v2HqGrGHn4rVpRFKNJJz3GSGEEEIIIYQQQgghhKofX9SGBQmvvPfy3L7LX37KMu69IR0bJerAmHZm94+zv1p/U9N96qCapA8+BCGEEEIIIYQQQgghhJB/8cngZEL37ILtS4SDxi6bOXTDjPtbpXHdPlm5bHCML0ZZI4QQQgghhBBCCCGEEPIzvpodQ177lUUn+0w9umvP8ct3LJQkKK7+kx3bNwgV+2j/CCGEEEIIIYQQQgghhPyML6dnJgJiWz43pKUP9+j/an6UyXUI/uTkeCnXISCEEEIIIYQQQgghhHzGdwVo1nZ5y5IV20+n5dIt3/9xtPbILnutZxoEi3z2AQghhBBCCCGEEEIIIYT8iY8K0FT6T691en31dScLQGilrzGetHnP9/89btD3mxcNSMJ5OBBCCCGEEEIIIYQQQqj68ckCgUzad0NHrjE1GvfLX2k/Pi8FAJB1nrbojdr6VSNe++YK7YvPQAghhBBCCCGEEEIIIeRffFGApi+sWnKIbfvRT7NfbBihIAEAgNA0GDhv3eyOguMrfj5P+eBDEEIIIYQQQgghhBBCCPkXXxSgqRtXbkByu7bRJXYmiGjVOgkyrmfgEGiEEEIIIYQQQgghhBCqfnxRgCbUGhXk5xoeqDN7c/R5rEKpIHzwIQghhBBCCCGEEEIIIYT8iy8K0OInOj6tubP688XX3EU3O88vnLVGr3qy/RMiH3wIQgghhBBCCCGEEEIIIf8i9MVO1D2mfdxxx+gxLVvsfSn+CuVWbps/c8f+n1Zsuyps+9UHz2lxBDRCCCGEEEIIIYQQQghVPz4pQIMwZeTafcqpb09b9N1GO8PCwglHSWVC+zE/fvXxoDo4/hkhhBBCCCGEEEIIIYSqI18UoGmH2eIik16es/vlz/JuXE7LdZKq8MQacVosPSOEEEIIIYQQQgghhFD15YsCtHPL8NhBOZ9c3TcmVhqc1DA4yQf7RAghhBBCCCGEEEIIIeTnfLEIobx5h1ayi0dOWFgf7AwhhBBCCCGEEEIIIYTQ48EXBWhB7LClKwekf/zq7J03Cmgf7BAhhBBCCCGEEEIIIYSQ//PFFBzeP2YO+d8ZgevvyV2Sp0jVOq1CVKSuLe3x3fmF3SU++ByEEEIIIYQQQgghhBBCfsQXI6BBKFUoFEE1nuzWvXvXDk82faJhUfXjND75EIQQQgihasizc3gYSZQgICXK4ITGXV+fteWaw5efxmavGxgb9fLaPJxZ7fHhOjGlga7NVxc8PtwnpmWFMNkHls75+re/bVwHwgM+T0vMSfSIMCcR3/AoJ9m8I6vmrziUzfgqlCK7xtR9/PxL6hIsW02PcqdOnXbs2EEQRKV+Ss2PMit1/4+Zk+M1CoWC6yiqEczPcrkcs5TrEPzK4A+4jqAasVqtyrVzuI7Cr1Ryfjocjv79+6empvpmd56dw2O6LsoVasIjNOJ7Gyl7XrbBTrEAAk3LD7fv+KCFsshb3Bk75n/+9artJ64bIDi5fsueo6e936dmwH9/FmvY+GrDgenj/to/Lpn0TfhFOa6nzpnx9aqdp28WCENqtn5u+KQpw1oG//cHeTL3fjf7m9Xbj125k+8WB8U3fLrPyPfGv1RfXewyji24uG7u7O9+3XM6zeCRh9Vo0f218VNGtQv3xfN+j6iiX9xxfes3s7/5ecfxa9kOUhtbr82zQ8e/+2rzB9/5H0eczV8/qM7gzIkn9ryd4qPjWva0dG9+JezZleZ/veMQNfn0zNFJtR4SF0/TsvxvpNMXP9tsxNaCtvNv7B4dxfkQnQp+cU/mvu9mzVm1/ejlLAsl0cU1aPPskPETBjUJKv6F/vt89HValrupLPP59SB+5mQZD00ZW1QuVPhk/I82sKytENc5+Si9GD9zsqzJ9ggnYyWr3O7bD9rJe5ib37SvOS7rrUMXZzcvLSErfvLyM3V91tNxprKa0/u7/48MLz11K16AfiVYc3ro9r9mtRTd3UC7HW5GKJWJOb+aKhMsQPMQFqCrGOZnuWABunywAF2FsABdbv5YgDbW/fDkqekNityUuLNP/jRlyFs/nneKGk0/cfyD+oV/Y00HPuj23KfHzBAQlpIQ6Mq8fjPfTWif+mT37xOfkD/8o9xH32/UdkXT3y4v6+XzSgRr+fOjrt1nHLFAQGhKos51++pNk1eY0H/F3hX9Yh92Qez8+6seHd/fZ2CIgLCUlBBGfz0tx06BvOawn/Z891zE3etO5s6GkZ0GLb7oALE6OjlGZrxxPcfOkOHd5+9dO6Iml3PBVfSLs6Y/pnTu9fmJAlasjkyIUXuy028aHIww5vnvd/88OFlU5IVlOOLevz9s0vy7WivP//xisE8ObdnT0r1lcOTzq0pdrJxlaJoVP/nVxT/GJvz7DQQv07ICb/Remdelxdi9Zkb8NPcF6Ip+ce+V759v9+bWbJoICEtJCReaMq7fNLlAnDho1R8/9o28953KeD76Ni3L1VSW+fwqFR9zsoyHpowtKgcqfDKWoQ0seyvEYU4+Wi/Gx5wsY7I92slYmSq5++Z/O1n0K+19p3WXb67GTThcSgG64icv8DN1fdvTcaAym1Moc4aXlroV72JcNpvDXWTJQfeGQUGqOu//6a3wHhFCCCGEUNkQkrCmQ75b9W4DEes5t37DxcKLMjbntzde+vSYPaHfor8yMy+dOZ9+5/L6N+pLzIc+Hr3g8sPXimZz1s5efC3m5eGdK2EcnOPPmcM+PVoQ+PTMgzczL505l37n/KpXkoj0NW+9/dOdhzzQ6To+Y9DkfUZh8oDFf93JvHT67yv63IvrxrfSui4vef3N1frCggKT8cOQwYsveWJ6fXHgluHm+TOX9XlX1o9vqc7ZOva1/53n8uq0ol/c/efMYV+ctGnbfbDzevbtS2fP38jOPLV4QCLcXj/2nRX/vLOMR1xUf/CwVtaNs3+4SFXq1y0lLSU9fjR4vA/y5GweFk9Kar0xc2j8Q+5IeJmWFXij++xXQ6bsM1fCw8sVUcEvztxZMfa9rTmClFeWn9PfuXT61Ll0/Y3dH7QL9N5Y9fYH2633XlbW87FK0rLUprKs51ep+JiTZTw0ZWxRuVDhk7EsbWDZWyHOcvLRejE+5mRZk+2RTsZKVbndtx+0kwCM+caRHb8s/HhkpyY9v7nk/Zf2ocInL/AzdX3d01W9Sm1Oy37Olpa6/jFaGSGEEEIIPUBU+5l2kSTQ6dczKAAA78mvp6/NEaS8+eOiofXVAgAAadxzX309JEbgPLX614sPq0AzGWu+316Q2OelZr4ftcGaNn+9+DIle2ra4omtgkgAAFnyy/PnvRpFGLbNWfrvcbkPLll20SNIHLnohyF3vxDIk3vPXvPpMwrWuG3JutsMAFCnf5i31yKIGbpo1fgnQwvHdsgSn/ti7f96at0n5n61g7MZdyv8xamzW7ZlUILEwZ9NfSZaCgAAAm2DwXMmPSOFgv1b9t+7ASrzERfEPN/vScHfSxcfcVfe172rZFqWhjVsfXfUkjv13v1xZlvVQ247eZmW5X+j4/gngz8+Juv8So8I7h8pr/AXZ3O3/brPSgT3mz1/UG1l4VETR7Sf+tWoWkIme8fWE4VzPZbjfKyytCyRk2U9v0rFx5ws46EpY4vKgQqfjI/S65XaCnGUk4/Wi/ExJ8uabI90MlamSu6+/aCdBADH9nfbd+n3xoff705z/NuvUxU/eYGfqev7nq6KVXZzWvZztpTUrb4FaJZl3ZWP62/pZ2iaroKDgu7j+oCjxxnX2V290PTDx7WikqrgoFTdGhuUlwIAlmEAALwnf1l7lRI2HjKiZdG52qRtPz+RlnF90+ikh01Pe2PtmmPeqK49GhWZ3MH4YzcpIao58fj9OiKdtWlkHbmAVDefuM9Y5i/p2J+62wKSJ19+sehYV2X7l3tFkN4LW7Ze/5ccZm6fOWdgBCEderQoNnuIIKLt07WELHX9choNwOadPJ5GCTTtejxVbNpCIrxXnyfFbN7vm4+Uc/0e9+29899+vnXNCK1cIpFrIms99cK7i4/llb80U9EvDsAwDAAhEouKFmcJsVQqAGAo+m4o5TjigvAuPZqSN9euOVwF/X+xtCwFm79t4pvL9XXGLZzc7KHzwvAyLcv9RuuBD4bMPqPp/fW3r8Y9Qv2Z87Skbly67mWFNZ6oX2wuSDI6LpoEtsBSwAKU83ysurQsnpNlO79KxcucLNuhKWOLWg6c5+Qj9Hr/1gpxkpOP1ovxMifLnGyPcDKWhvucLNM38ot2EkDWdsqGLVu2bNmyZdMPQ2qWPq9xxf+heJq6ldDTlQn3qVvW5rTs5+yDqcuDybG54/V6K3sOaFQuDMN4vTiJC0KPAzyXq1K1XU+4wio7Pymqcmc5KMJ+dNOubBrIuKR4EoDJPHrsFk3GtH4yvvg9tyAgOOY/liBksnZu/4tS9W3b6CHzLTL6LWM69//hsrjpexu3fdouqKxXUdT1MxdsLJnc+AldsbeIGjRtICIyr5y96IYapdYhpbWffeudVhFd65a4ZKVz9XkMECq1kgBg3S4PC0CQgpIBiaUSEpj8SxezmI5xZR124T43r+cz43bnMkJ1VHKtBlJ3bvq1w2u/PLx1x/WdR2Y9WYa1HO+r+BcXNnj22eQ5X15Z/unS/ster6skAMCTtXPG/3Y4iMCefTuoAaCcR1wQ+eRTycThHdtOe9u3rNRZNYun5YNYy55p7yy/k/jmisnNZQ/dEz/TsnxvZPN3vDd03uXgfr980z/q8pEyBvcAPqSlqMWscwUzgJTIi51MBSePXqAIUYP6heWJ8p2PVZSWJXKybOdXqfiZk2U7NGVsUcuKDzlZ4V7vIa0QFzn5SL0YP3OyrMn2CCfjg/iQk2X7Rv7QTgIAGdG4SwQAADDXL31WatJU/B+Kr6lbGT3df+JD6pa1OS3POftA6lbfAjRBEAqFovIL0OZK3v9jRSQS4SKEVQvzE1UWPJerktXK2QOKfqqy81MgEFT6BQbtyLt5/sCK6WPnX6MIadP+L9YRAnjSrqZRQMYmhmft+vLjz5f9fjItn1ZE1W37/IiJ773S+P/s3XdgE+UbB/D37rJXmzTp3ou99xZkgyB7VZZAcSAiIshQVBRQkK0C+hMQBZRV9pJRNmXKhgIFSjOatGmTZt/d749KLaWFtDS9S/t8/tKQXJ70vvfe3ZvLc34vOg62pJy46ODUbFCnxAlBSrNnYpdBP97gNp26fffX7p8DIISoJ4+eUIgIDivSfgATh4TKMdrw+JGOQsUdpuOh3acu7P7cw2T6psUbH5FEVOeutTgIoYDq1RT4cf3Jo5fs3ZoX+hlnzpF9p2w0wrIys4pffnHy9s7/4lAmET9m496l/aOECCHkUB+a+UavBZdW/3xkduueArc/d9k/OEKCll8lrTMNfnfV+IZRCxs3jPN1PrmacuUJFdXr2/X/G/7vLXBcpVrjnGoN64ioradPP6JaxHjkV5DFxvI59gsLPv75gWrgpultXnZOxc5YluaFtC5p0rjVD0KGb1vcNxBz3XK/vGexI5YETyTi5f8nnZN2+Va6QX33bNIPi9alC+p9NHdsNQIhhPDSbY8ejmUJmXRr+yoWOzPp3qpxd0R1DysyWbox8D8vHIUYyGQpt5pnsTOTboet7Bvjc1iRSfc+kVeMk255hT8US6PrkT3dS7Aium4Pp6XZZotGt+pOQAMAAAAAeA3XP1/U537x/OMYP7zX979OqsVBCNG5OTk0ojO3jWl55IiakIVEx4TnpN0/u/nbs7u2/L3m8JpB4SX9Gpl8cO2WBQmjY0s42SO1ez/qMnDFdW6zaUm757RTlG5+3WU2WWiEiaXiIq/DxGIxhvR55hKbCz6Hzrn8ywcJH27PxCMSvp3aWoAQQsJ2oxLi1iy8szxxUtOtC/rFiBBCLt2pZWPfWZdBIkTYbHa3l09lu/zb9ugdOfyzvlFPT4l4Qa8l9IxbdOG2LjOPRgL3P/wrfXCub2hstL/wUrbhzumDd/Jfxg2OqB6tEj1dWinXOD8qLpxw3vrnlhPFlE+7RXdiWQT14JdpS64SzeZ/9qbqZX9JlsbS/RdSTza+/+7vGVFjdy3sqXyVL6XYE8unHIent+23wUwjhDBh9ZFrts7t8PTvX8rtsZxj6W4m3di+isPSTBb2glVTjOJGVLewI5Nl2+u9bBRiIJOvsBfzgkz+q6SwlXFjfA47MunmJ/KOcdKdRZX9D+UF0S2/Pd0LsSO6pRhOS7HNFonuq3x9Qudc2Lho4VOLd94hn30k35Jdd6A1JQAAAADAq8B4vsGRhURFxdZo1GHI9PUpV7e9Uyv/PM5ps5E0cl79+6xqzG9XdVmPb169nZGdnjy/a6Dz3u/j31lT8v2lyCcP00lcFeRf3Aw1qd0/ueuA5f/kIXGTEePaFDoHcJ39JJ6DvQCv6bxbJEJP28SUcABNudfHnNSf/98H7Wo2G7fuBh0/dNXelX0Dn54HtPxs7ezWCtvVHwdU8w+Iq9+gZqhfaOvJh+UdWocQCBMI+W4fuuOh/b/ftnPbogFhBUfJrpzUvzcdelC4Ro9/cDrr4KT2nads1VZ7e8W+y2lZ5lz17RN/fPoaduLbAW0GrL6b3+WllGucCAjyx+m89Efu91B8CXdi+SzT399+ezQvcNCnY+Nf3g2ZrbF084Xkg/8lfrBFH/feqnmd5a/2mwiWxLIQbqPxK3/9ZeXiORP71ROnrhna5LVZR7P+XW7ptsdyjqVbmXRv+yoOWzNZyItWzbPlljiiuoMdmSzTXu+loxATmSz7XswLMvmisJV9Y3wOOzLp7idi/zjpprInxAuiW357uhdiR3TdHU5Lt80Wie6rXAFNZR1fMfX4s489/4hgQMT4nm4cYQIAAAAAgBIQ1SfuuTC73guP3Dh8PoEhjNds1sblw572/OQEtJ6yZu7JaqN2HPrlzwejJhf/400qz2yhsSChsJjjVfLe2s9/wGSRUcqHDw5/8cmfb24c/PTMEQ9oMSRxvK7kW6QQEQ3kGCIkEgFCFkuehUaywu9AW/LyaISJJUWv03iuhswzqz794LO15/WkOK7nzLnfTe1bTVL4NdJmM/afa7hs7qL1e8/dvXlbGFSr55SJsz8O/bnx38dxma9Pqa65oIzXdv3+18GzV27evf/gQdpjndlJ0wih/y478vQHd15Y+OEPN+yBg9ftXdXfP/858a2GfJ0Uz2nV6qs906Zv7vvnYD+stGtcKBJiiDKbzBRC5XJw7k4sC6Merf/2t0dYjenvd/Fx48yMpbF074WuOz+MmbLXVOvj7XPau/NhX4r5WBaGh7cdOqItQghNnDrx5z5NE3fNS5zf89r8ZlyESrk9lm8s3cmkm9tXcS9laSYLe/Gq+bfUl42o7mE+k2XY67kzClV8JlHZ92Jsz+SLw/YKG2Pxfw3GM+n+J2L5OOnuosqeELZHF5Xrnu5lmI+um8NpabfZZ6Nb9sxN27ZrhDtfdxFBjTx6mxMAAAAAAIAQIuR+cgzZ4zt3jX3mCA9TtetQl7vj5J3rt10ohlfcSzEuj1vS7RlpGpO3/mzn9rfvj204ctuWqdN3d/qlZ/6xJR7Z54sVfV5amCskPJRAN9XpGSQKLFyaVZ2RTWP8kDD/Fxym01kn5w0Z9PnBDFrVdMzybz8f2zak2M8gjO72yepunzzzyrUPdBQmiolzv40knXP6mzffnH0sk5ZGNG7dsmWfLm/FxNWqr0h+t/f8mwXP8vAHpx4dO5Lqwvy6JvT0f+Y8QVh/2KB6cy+dP374gnNwZ15p17jT6UII4/F4nr4HSglc//zy4zELr/nbo190x6H/sDSWhFsvzDl94KQR8XwOftwpuaDo3DQthVwXF/ZutZ7HqT7+t19GuNchkhWxRJTL4SIRzuVxnm3xGDUssce0PWvTzp3XUs1C//0397fHCo+lu9tXca9laSZLs2rcHVFfgh2ZLP1ez61RiKmhskx7MZZm8t/yXxK2V9kYn383NmSydJ+IxeOku9zbIRaLpdH10J7uRVgRXTeHU05pt9lno1v2CeiGXXuU+bUAAAAAAKCccarVqsbFNK7nD+YpikII8fgldg7ElQFKnDJmGYu5sgIPTvg16bNWCqz5gi/XH3nv4G8fzU5ou6yDrBSFxdStKcauPbj0j5EufFdu57VL15w0p1bdWiXegAZZLnzTs/usM/bI3gvWr5rYUlXslT+kJdtgchJiuZ+k8JSC9WxyigPxW7Zo6Pb8Cnlj+YQvjxn8e6/Yt3Z8nYJrR8hrF8ty0lfWD05TFEUjxBcJi35cjC8UYE9XaGnXOGXMMlIYR+mv8MgtCF/KcXbd7zdc/LaD+rl5Xx6WxrIUL6RMDy+deVh0ATkPLp55gLiuXlY3f0zNjli6Lsys23L+gyYLbpwock0pRywRYijXasn/QKXbHis+lu5uX8VhZybdXjVujqhuYEcmS7/Xc2sUYmKoLPtejJ2ZRMitsL3KxlgUOzLp9idi+zjprldICDuj66E93YuwI7puDqel3WaLRJdt+QUAAAAAAGWCBXbp0ZhHpu7aftle+HHq0b7dl52YsGGzOiVd8cWJjo/m0NmPH+c+PyOGS4OCZBhCiIh+e9GMFiIyddWHc89YEHK/IZ3kte7tJMh6fPNOTaHl289t3fmQ5MR17VZiszby1vL3vz5jVvb84e+/Pip5rsSy9934oMCw3qsL9/uk1ZtXbs+kJe0G9Qp2+4jXevXiDSeSdRozuk7hXy5aHz/UlqUTXxk/OBFap7YfTmmO7L/0zJpEtObwgStOjFurfk0OKvUaJ9MfppNEWHysyN0/R7lynN60NY3iNevTK9TN9cHWWLr1QvmInTa6CMeRLmvQZAAAIABJREFU98MIxGu//DFJ046UT2u4OfvHkljG1qslwpxX/z6qeXZ9uG6fOKUlcd/qNYIJhEq7PVZ8LN3dvorDzky6vWrcHFHdwI5Mlnqv594oxMRQWfa9GDsz6WbYXmVjLIodmXT7E7F9nHRbmRPC0uh6aE/3IuyIrpvDaWm32SLRLY+2LwAAAAAAgHl41IhpQxe9uWbB0OGBv/3wbjM/HCHL3S3TE2YcseCRiR/09S/pYgpM2ahJDHH45j83XahNyb9L5tacsHTKhlZfXFrywfeDT8ysx3GvIR3ClH0nDp+9e8W+2R+ub/vbWzE8hGjD8dmTVqZSss4Tx9UvOCB1ph3bcjKd4kS0GdA6DEeuK7+vO28lan385fCoFx20SjoOfTPwz7VHv3p3WfPfJjT0xZFLe2zusMk7s7k1p3z21n8zDfnLJ4mwVv3bRha3RJ5/oAKjtWf2Hs/q3jH/pjfW+3sWTnhnrZpCPJfj3+tC3OzEV+YPLmyf+Hbt3765umT42PhNS0fW88URQraH+74e8cneHMx/8LsD8+9UU6o1Tmlv3MikJW2bun0+X65c1w7+/YTk1O3Uwe2fpbI0lu6/0E1eEktM3n1k36Dtaw/MGvt9rTUTm6s4CCE67972GaO+u+zixCW83UGMECrF9ogQM7F0d/sqBjsz6e6qcXdE9ZpMlnav594oxMhQWaqt5hnszKS7YXN/Y/SWTLr7iVg/Trqr7DtEdka3/Pd03hJdN4fT0u1Ai0YXo2k3f/pV2XTu3Hn//v0Y5tkmOtW/SPfo8iuZ85N9JRIJ01VUIZDPUrkV/j+mS/Aqoz5juoIqxGQySTcvYroKr+LhfFosliFDhiQlJZXP4hwHxoV3W22o/fl5d+4YQ2cdnvJ6r+8vWxDfNyIunK9PTdXmUbiq3Vc7dkxrLi35uMd+5P24TqtC5l4/MSXu6cURtOHXHiGjD0ZOPXltXtOnb513YkrTDgtv8tssPP/3pGpunwvR2UemtH/j+3+sooim7eqr8m6dPHk7G4X0WX1s08jogqXkru8d8NYOu2jQX1kb+/FpzcoukeMPOjgCsaC4N+LUmX7i+Ke1CIQQ9WTzyLZD1993EbKQanH+ZPrN21obJ6Tnkv1/Fr6je/7ybYLe63Xbh0mLq9NxZX77tp+eMhF+1Vo0q+Zje3Lrn6v3nTUTunP/2phChrUZPHbq3Ond3b+wpUwfHCGEbNd+HNT9w52PnRjfNzQ20tf2JDUt00Jivk2nbN4z9/WCG7y4v8ZNW4eGD9jR8uf7u0aV+E2E20oXS4QQefe71rU+SQma8Hfq0nZu3yCGjbEsxQuLch6dENNxubbt8nuH3is0veA9saR1u997beBPN61I4BdTPUbJNaffuv3EROIBHebu2j6l8dPDeDe3R4TKM5alyqS729fzWJpJd1ZNKUZU78lkacZAN0chhjJZiq2mCDZmshRhc3Nj9KJMuvmJ2D9OFkKlLmhdc8q5yCknb3zbrOjryrZDROyMLir3PZ0XRdfN4bQUO9Ci0YUWHAAAAAAAlQam6PBd8tkNMwe3iuBlpd5Kd6oa9Jyw9OCFfZ++aPYZIcRv3qdnMHXl4GHtS65NELeauXhMFJF34qsP/5fmdnNGhMnbf5d8cu2UPrXx1GN7D10xhXQY+/2Bsy88OSGfPHpCIkS7bObiWRxPf52Ih/T/38lDS97p0SiYenzzbra0bp/Jq5IvbXvJefvzePU+2fX3ygndagnV5w7tP37bEd1nzu5LJ3/9Yf6U18J4mrN7jt+3lOrqjbJ8cIQQEtR+Z+vFk2umD2kbK8q9f/22lg5q9MZ7i/ddOjbvmYN7t9e49cyBZJOobd+uKibuYUTrDh+87ML49RrXKc0FXGyM5au9sGzYEkvMv8eKM2c2zB7xerw49/6Vi9fSydAWAz7+6dilvf+dk6PSbI9MxdLd7et5LM2kO6umFCPqy7Elk6UYA90chZjKZNn3YmzMZCnCVvaNsQjWZNLNT8T+cdJdZd542Rhd5Ik93UuwJrpuDqfub7PPRReugIYroFkEroCuYJDPUoEroEsHroCuQHAFdKl51xXQFcZ5dlqd1svCl9/Zl+j+rbu9UN7GfuFbBz/+cwD7Wil6kuXg+GrdN7f6486GAQp2nsIWD2JZqXllLCGTlRpkksUgk96TSTdBdCu156NbmVcyAAAAAABwF7fJOxNfw5PX/JHq/kVwXojMeKwNiY1y++7klQOdvffXLdrYtyf18rbTV4hlJealsYRMVmKQSTaDTDJdS/mD6FZixUUXJqABAAAAAABCCI8YMXt89KWfliXnMV2Kp9gv/DQiYa1y4tsN2HcjH08i761ZvAN/87NJTflMl1JqEMtKy2tjCZmstCCT7AWZ9LJMugmiW2kVG12YgAYAAAAAAAghhEQtP/1+JLb+q1/vVdJLUYiApom/Ht38dgzx8udWHnT23m8W32rz5byBgV55/RTEslLy6lhCJislyCSbQSaZrsVTILqVUgnRrVpz8AAAAAAAoGSYosu3W9f8dTcnl0bySni2wwlt2IbpGiqeU89t8822LkOivfXkB2JZGXl3LCGTlRFkks0gk5UWRLcyKiG6cBNCuAkhi8BNCCsY5LNU4CaEpQM3IaxAcBPCUoObEAIAAAAAAABARYEWHAAAAAAAAAAAAAAAAAA8AiagAQAAAAAAAAAAAAAAAHgETEADAAAAAAAAAAAAAAAA8AiYgAYAAAAAAAAAAAAAAADgETABDQAAAAAAAAAAAAAAAMAjYAIaAAAAAAAAAAAAAAAAgEfABDQAAAAAAAAAAAAAAAAAj4AJaAAAAAAAAAAAAAAAAAAewWG6AAAAAAAAULyVK1du2rSpYt6LpmmEEIZhFfN25chLK6/IsimKkkqlO3fufPVFrVu3bs2aNa++HHd46ZpFXlt5BWeSw+EcOnTo1Re1ZcuWFStWvPpy3OGlaxZ5beUVnEmapg8ePMjj8V5xUXv27FmwYEG5VPVSXrpmkddWXvGZTEpK8vX1fcVFHTt27IsvviiXql4q/0+EYOVWlIrP5Pr168PCwsrwcpiABgAAAABgKbvdPmnSpDfeeKMC3stsNttsNl9fXw7Hm44PnU5nTk6OQCCQSCRM11I62dnZJEkqlUrPvQVJknq93mAwyOXy4cOHl8sy7XZ7YmLioEGDymVpL5aXl2e1Wn18fLhcbgW8XXlxuVxGo5HP50ulUqZrKR2j0ehyufz8/Dx3HktRlF6v1+v1Mpls1KhR5bJMu92ekJAwevToclnai1ksFovFIpPJXn2OsiKRJJmdnc3j8WQyGdO1lE5OTo7T6VQoFDjuqZ9uUxRlMBgyMzNlMtm4cePKJfxOp7Nv377vv//+qy/qpaxWa15enlQq5fP5FfB25YWmaYPBwOVyfXx8mK6ldHJzcx0Oh1wuJwjCQ29B03RWVpZOp5NIJB9++GF5ZbJLly5Tp0599UW9lM1mM5vNEolEIBBUwNuVI71ez+FwXn26v4KZTCa73e7RA3iaprOzs7VarUgkmjVrVpnD700nGAAAAAAAAAB3GI1GjUYjEAhiYmK8a2ICVFY5OTkajYbH40VHR3vdxASolEwmk1qtJggiMjJSJBIxXQ4AyGw2q9VqHMcjIiJEIpHXXY0LKp+8vDy1Wk3TdFhYmEQieZVMwgQ0AAAAAAAAlYfValWr1S6XKygoyOsuLgOVUn4mnU5nQECA111cBiolu92uVqttNpu/v79CoWC6HACQw+FQq9UWiyU/kzD1DBjndDq1Wq3JZCqvTMIENAAAAAAAQBKJxLNdLEinJ5bKxZFS7uO55SPCU80f5HJ5uS/T5XLpdDqj0ahUKlUqVcWdvlKUJ5YqFgrFQqHnlo8886N+Dofj0c4qnuOJqWGSJHU6XXZ2tp+fn0ql8lwjhaI8kxmRQCDKv3bbqzJJEISXZtITX6EVZFIul4eHh1dcJj1DKBQK88dJD/FM1DGElPnz/h7alJCntiZP9LEp6E3k6+sbHx/vueYeRTntnliqgMAEPlLPLd9DaxYhDx9PIk8dUkql0nJv+VW4X1ZcXFx5Nfdg8wQ0nb33szE/Xvlv5RMh/eYvHxFPICrrypY1G49efmiSRNTvMHhUv3pyDCFU4uMAAAAAAABUXoVbRsbFxXlX02RQKRVuGRkbG+tdTZNBZQW9iQDb5GeSz+dDbyLAEiaTKSMjg8PhREVFle/3W2yegKZ0Gh0W/8ZHfWv9e7SCCUOCcYTIh1u/+Xoz2W7UB4P9MpPX//r1PGLhN33CiJIeZ/ZTgFKQ/PU90yV4lVGfMV0BAAAAAJhXpGUk0+UAULRlJNPlAPBvJimKCgkJ8bobhIJKqaA3UWBgIPQmAmxgs9nUarXD4fBQvyw2T0A7ddpsWVzzNi3rPDOH7Phn164Hof0Wj+8aRiBUW2lM/Xjn7us9xle/XvzjdeHLdgAAAAAAUAlBy0jANuXeMhKAV5Sfydzc3IruTQRACRjrlwVACQr3JoqIiPBQbyIWT0BTmVod7V/Tn7JmG/I4cj8pF0MIIfLx9ZvmwOaNgvNnpYnwRg38t1y6oXaKi3+cqhvh3V2dAAAAAAAAeFZBez65XB4aGlpxLSMBKIGHWkYCUGb5vYm0Wq1MJouPj4dMAsYVZFIsFkO/LMAGFdkvi8VDMJWpznRlHp47+tcHOSTiSCNbDZ3wTvdYrl6np/1UiqezyrhCpaD1ukxXCY9TCCagAQAAAABA5QEtIwHb5LeM5PF4kEnAEiaTSa1WEwQRGRkJvYkAG+T3y8IwLCIiQiwWM10OAP/1ywoNDa2A3kTsnYCmTfpsp1AS88bEL9qEIO2VXT8t+/mbn1VLxzrsLkwoFD79kQImFAowh93hKuFx+ukCP//88927dxcsXyaT6fV6+LED8F56vZ7pEgAo0avns/UKW7lUUkXcCme6Aq/i6fHTarVSnrurO6jaoGUkYBtPt4wEoLTsdrtarbbZbPl9YJguBwDolwVYp6BfllKpVCqVFZNJ9k5AY/LOn23s/PT/wpoOeb/v5fc2Hbsysi2foHOsNhoJMIQQoq1WG82V8ghe8Y8XLDA4OLhGjRoF/6tWqzkcDmz5wHvBj8gAm0E+AZt5Op+Qf+AJ0DISsE3FtIwEwH0kSer1eoPBIJfLw8PDIZOAcQW9iXx9fePj46FfFmAcg/2yvOcECVeGBPOd2SaHQqXEHhiyKeRLIIQQZTQYMb9afhy/4h8v2OckJiYmJiYWLK9z586+vr6eP3Y3e3j5oOoqj2tMIJ/AUyCfgM08fY0ej8eDk15QjqBlJGCbimwZCYCb8nsTCQSCmJgYPp/PdDkAoJycHI1GA72JAHsU9CaKiooSCoUV/O7snYC2nF4++TfXsLkTW/vk33zwyb2HDnmtMN8I/xripMtXModEBWIIUZor/2ikNWuF8MJrFfs4fMEEAAAAAAC8FLSMBGxT0DIyLCxMIpEwXQ4AyGq1ZmRkkCQZEhJSAW1MAXipgn5Z0JsIsERBbyIGe7ixdwJaWKd5befc1d8pXAObhxCG6/t/355Za0SPGhwe1b17+LS/lv0RPLqtQnfkl62PY/pOqM1DRN3iHwcAAAAAAMDbQMtIwDaMtIwE4AVcLpdGo8nNzYXeRIAlCnoT5Y+T8JM4wLjC/bKY7U3E3o0BkzQe99UnnaVX1s+dPmPur8nmumO/mtYtGEeIE93/00+6Cc8sn/bh9J/OS3tOndongkAlPw4AAAAAACoby90dXw5/vUaYSij2Uca16jd90zUz/fKXeQOKonQ6XWpqKpfLjY+P9/Pzq6qzKrZT8wcMXnrJxXQdID+Td+/eRQjFxcVV4Zk+yCRb0DRtMBju3LlD03RcXJy/v39VzaSXqoSbUkEmHQ5HbGysv79/FZt9dqYfWjiqc/1gpS/fJyiiaZ8Jq1MM3nBP7kp8PIkQMhqNd+/ezc9kUFAQs5lk7xXQCCFuYLNhU5sNe/4fCFXjhJmNE9x+HAAAAAAAVCLO2yv7vTZxf25Qy/6j+4c77x3ZuuW7EYdPPj564ON6Xt75M7+NKZ/Ph5aRdObu5Ut3JPd+xxtOYCszZltGsgpkkiUKMhkZGSkSiZguB5Ra5duU8vtlIYSqam8i2rBvUvt+vzxSNuk38qM4vu7Cjk0/vN/l5JP9J2Y3YfMmWomPJwv6ZbGnNxGrJ6ABAAAAAAAoijYmfTn7QHbEqM3Jq3sG4Aghavqhj17vvmLezI0JO0YEeulVcAUtIxlsz8cOpFWfdv384fVzZ23SUAFMV1OV2Ww2tVptt9shk5BJlrDb7RqNJr83kZ+fH9PlgNKqhJuSw+HQarVms7lK98si76+Z+9t9Re81p35/K/9GbNMTprTstHD5wu0fbBiqYOvfpJIeT7K2XxZMQAMAAAAAAK/i+if5tJGoO3Fyt4B/f0mIKztMHtdy1UfHD5+3j+jpdZcNF24ZWYWbG/yL1q3pEzluvz3//6rU75dZpHDLyIiIiCr2Q/KiIJNsQJKkXq83GAxyuTw0NJQgoNum96lkmxJFUXq9Xq/Xy2SyuLg4DqcKT6+Zzx2/7JD2Htov5OmGKW70ZufQRStuX08jkYKtf5lKdzxJUZTBYMjMzGRnJtlVDQAAAAAAAC/hzEPyuDrtGsUUmn/AhCIhhlx2h3f9npem6aysLJ1OJxKJ4uLiuFwu0xUxD1P0WnKstpFCtGHbB30XpjNdTxWU3wdGKBTGxsbyeHBTd8gk8/IzKRAIYmJi+Hwv/2F8FVaZNqWcnByNRsPj8aBfFkIIceqPW/bT4Pimhf4QLpPJQuNBKgWLv2moRMeTyBt6E8EENAAAAAAAS1EU5XK57HZ74Qfh3BuJui290O3Zh6j07dtOO3n1m9X3orPA/JaRGIaFh4eLxeLyXXiR2JSX4jNZvvPmHFW1JiqEEK2+LGPxeWul5NGWkZBJUAb5vYlcLldQUJCPj0/5LrxIbGi6fO48RlEUSZKw7y5GpdiUCvplBQQElHtvIg9lkqbpYjJZjqtAXKP78BoIIYQoW252lv7x1f3LPt5oCO6zcGA4i9d0ZTmetNvtarXaZrPl94Ep94UX/l+apsscS5iABgAAAABgKZIkbTabyWQq/CCcxD7HnrZzxsBPDuRFvj1zZBSLT3T+UwEtI4vEprxOYvPPYItmsrzPdkDFq4CWkUViQ1Hlc3kZSZIOhwMyWfm4XC6NRpObm+u53kSeGyeLySTsu71fQW8iPz8/lUrlid5Ez4+T5RJLl8vldDqLZtLHAzemI+8s6tJk+gUnQri81aw9P/QL9orDsn953/Fk4X5Z4eHhFZBJkiTLvPuGCWgAAAAAAJbCcZzL5QqFQqYLYS9H+uElUz+a89dNR3T/n7Yu6Cpne/fkwi0j4+PjPdfG1EOxgUxWPhXWMrJIbMprPhHHcQ6HA5msTAp6E0kkEo/2JvJQJgmCgExWMoX7ZXm0N5HnxkmCICoik3hI329+i3ykvnd+x89r5/TsQ+zZ/klTicff9tV53fEkqqjeREVig+N4mae5YQIaAAAAAIClCILg8/nl3pyhkqCzU1Z+NGbGhqv20NcnrV00Y1BtGdvPFiqyZWSR2JTjxAqPxyuayXK6lBVUvIpsGQmZBO7I702E43hERISXZjL/izrYd1caBb2JwsLCJBLPTqYWiQ2O4+USS4Igismk0wNtkTBptfZvVkMIjRg3tGbPepPmz9qYsHcMuy+D9sLjyfxMUhTliX5ZRZRjJmECGgAAAAAAeBvy8ebx3YevSVN1/nT7kim9Ytl4r5XCPNoyEoAyKGgZGRgYCJkEbGC32zUajcVi8VxvIgBKpaA3EWTyxRz3j/x5ShvRbmCbsIKpZiKic+faRPKt6/dIxOIJaG87nszPpEd7E3kOTEADAAAAAADv4rq5ZPjotRm1Jm/f/c3r/uw9rUGoQlpGAlAqFdAyEoBSKehNJJfLQ0NDPdebCAA3Fe6X5dHeRJVE6p8fjfm9+nctjk6IKNij0Lm5JhoTigQsniL1puPJwv2y4uPjvTGT3lcxAAAAAACo0mzHli49Y280e90cVp8tVFjLSADcVzEtIwFwX34m+Xx+BfQmAsAdJpMpIyOjYvplVQ7cRu3b+azd8evP50Z/1Ty/YQOp2/vjxlt0wJj2tdg77eglx5OoYvtleQ57kwAAAAAAAMDzyNTTZ7QUT3ZyXuKYZ88XMFmbDxeOZMWpTkW2jATAHQWZrICWkQC4I783kcvlCgoK8vHxYbocAJDNZlOr1Q6HA/pllQrm1/vzqS0PTl/YreX1wb0aB9Haq39v3X7RGDrwlxkd2Dtb6hXHkwX9svL7wDBdzithw98TAAAAAAAAd7kepT1y0eYb+9bdKPIvuD9nwHcjazFSVQGHw6HVas1mM7SMBCzh1S0jQaXkcrl0Op3RaIRMApYo3C8rIiICehOVEr/2pO0nQuZ/uWLr1h8PG53CwGrNxi36eOa41kEs/kOy/HiSJEm9Xm8wGCpNvyyYgAYAAAAAAN6E3/1ng/NnpqsoBrSMLF9YUOIhSyLTVXi3StAyklUgk68uvzeRVqsVi8VxcXFcLpfpigADWLUp0TSdnZ2t1WqhX9YrwSS1B33156CvmK6jFFh7PIkqab8sOAQBAAAAAADgVUHLSMA2laNlJKhMzGazWq3GMAwyCVgC+mUBtrFarRkZGSRJVr5+WTABDQAAAAAAQNnZbLaMjAyn0wktIwFLVKaWkaBycDgcarXaYrFAbyLAEvm9iUwmk1KpVCqVkEnAOJfLpdFoKnG/LJiABgAAAAAAoCwKt4xUqVSVoD0f8HYFmaw0LSOBtyvoTeTr6xsfH08QBNMVgaoO+mUBtinoTSSVSitxbyLY0gAAAAAAACgdaBkJWKhStowEXi0/k3w+H3oTAZbI75fF4XCioqKEQiHT5QBQhfplwQQ0AAAAAAAApQAtIwHbVOKWkcBLWa1WtVrtdDoDAwOhNxFgA5vNplar7XY7ZBKwhN1u12g0+b2J/Pz8mC7H42ACGgAAAAAAALcUtIyENqaAJSp9y0jgdQr6wEAmAUsU7k0UEREBvYkA40iS1Ov1BoNBLpeHhoZWkd5EMAENAAAAAADAS0DLSMA2BS0jZTJZfHw8ZBIwLj+TOp1OJBJV4jamwItAvyzAQlW2XxYcpgAAAAAAAPAi0DISsE3VaRkJvIXZbFar1RiGhYeHi8VipssB4L9+WaGhodCbCLBBfm8il8sVFBTk4+PDdDkVDSagAQAAAAAAKF5+y0iHwxEQEAAtIwEbVLWWkYD9HA6HVqs1m83QmwiwhNPp1GZmmkwmpVKpVCohk4BxLhepUWureL8smIAGAAAAAACgKJIkdXpDtjEHWkYClqiaLSMBmxX0JvL19Y2Pj4dMAsZRFGXIysqEflmANWiazso26vQGiURSxXsTwdYIAAAAAOBVNA+YrqBM3uvPdAXuonE8u0Fb7ev9Ren3Yt8YCC0jX27+O0xXUCaN2zJdgdswzCiQa2RBApctplaDKtUysozuXWa6gjIxG5muoBRyML6GkPAQGR1XUyAQMF0O61lyma6gTHo3ZbqCUjDVaqzu9zZhyonc+ovo551Ml8N6Rh3TFZTJiR1MV1AKZpFcrYrFaSoiM1XUNYHpchgGE9AAAAAAAAD8Ky+qhrrbMJrDDd22Snr3H9Svqp8tAMZZuSK1T4gLI4Jy0n1sOYjfnOmKQFVnxThqQurEiADS7EvZEMw+A6bZ/UPUfUbZgsIDd//he/4YommmKwJVnZ0r1KhiLQKpf9YjhTG9KnbceA5MQAMAAAAAAICcMoW2Y39TfH3lid3K0/sx0sV0RaCqcxFcjTQoV+CjzMtUmbUYTKkAppEYrsPF2bjAj7KqXEYcQSYBw0ihWNd1UHaLjvLTh8LXLsRtVqYrAlUdhRN6eZheHirP0YRqbhAUyXRFbAET0AAAAAAAoEqjOFx9m576Vt1lN1Lilk3j5HnnD6VBJUIjLEus1EoCpA5zXOYtLulkuiJQ1dEIZeEiHSEWUY5Yp4GHKKYrAlUehhsbt9X0Hi5Muxv77Uc8vYbpggBARlmARhnNt+dFP7oocFiYLoddYAIaAAAAAABUXaZqDdTdE4i83Kg184Tp95guBwBkEsjUshCCIiOzH4gceUyXAwAyY1w1IUUIC3PlSGgH0+UAgPJiaqr7jqa5/JDfl0tvXmS6HACQVSBVq2JdBDdIl+pjzmS6HDaCCWgAAAAAAFAV2VXB6m7DbKqQwL83+145CS0jAePsBF/jE2LhCv3NOkVeJrSMBIxzYISWkJgxnj+Zp6AskEnAOKePQttzWG6dZsqjO1SHtmEu+IEIYJiLw9P5RRol/kpjuir7EUbBD0SKV3UnoGmaNhqNGAb7UOCtjEZvuk02qGogn4DNPJ1Pq9VKwaEnu5FCse61PtmNX5OfPxq+aRlutzFdEajqKAzXS/z1YpXckhWanUbQMIYAhlEI0xMiPS6SUfY4l54D7Z4B0yguz9Cme2anvrJrKfFfv8cx5TBdEajqaAzL8gnR+kWIrTlxj85znXA8+SJVdwIawzCpVOr5CWizh5cPqi6pVPrKy4B8Ak+BfAI2K498vghBEDiOe/QtQNlhuLFeS02XwcLH92JXTOdl6ZguCABkFCo0siCByxZjuMuH01fAAjkYX0NIeIiKdmULaLgjK2CeqVZjdd/RRJ4pcuUcUdodpssBAJlFcrUqBqOoyIxrIit8HfJyVXcCGiFEEARcAQ28F0EQTJcAQIkgn4DNPJ1PyD9r5UVWV3dPoDnckK2rpHf/YbocAJCVK1L7hLhwTlBOuo8NTl8B82wYNwMXO3FOAGn2peDrEMA8u3+Ius8oW3CE/75NijOHEfxABDDNwROpldEWgcw/65HCmA6zim6q0hPQAAAAAACgKnBK5dpOA0zVGiiP71Ke3o+RcEEfYJgYoj6BAAAgAElEQVSL4OokgUahrzIvU2XWYTClAphGIlxHiLNxgR9lVTlzcOi5AZhGCsW6roOyW3SUnz4UvvZ73GZhuiJQ1VEYoVeE6eWhviZd/MMUgoQW5KUAE9AAAAAAAFWQ/dSySUsF760fW6vEw0Fav23KWxPvdN++dUJDFhwz5uZmzb2p25RpU1N4mI9sZLXgyYE8fjFPpE7dTltKBK6PFXEQojhcQ/POmW3ekN2+GLdsKsecW+GFg5eh7SkXLn555sEJvUMgU3Ro2ODr1mGRHIQQIjMvt1h6LoUs5kWEX72Tk5o1Y7LbDZl+ce+sDcn772YaSF5gWFyvHn1md4/x++9SKDr3wem56/dtupyudgnCYuqMHDxgclMlD2FZYqVOGiixm+Iyb3NJB4OfARTLknZ0wfLfN5y+k5bjFPvHtus+9It3u9QWPX+Vm+PUyplLBW+vH1GNBWMkQghZHp1csGrzhnP30nJdYlVUu079vhjTvlDltPn+sbmrknZdS7ufywuLiu/Ye+hnb9bww1E2LtDiEhHtjHVm8VBxmxxgGyo75bdvv1yZdCI1VxBcq8OwKV9P6BgpYLqq5+Sac+fez96U7VBTWJhUPDJSOVnJfWbfTZMpasOXj00nLJSAz+8Q5Pd1hDiSwI2N22p6vSXIeBjz/VS+5jFT9QM32E8tnbhUMGH9uKKHlJb7+xcs+HnD8Rtp2U5xYPV2vd/+4qNetcWsuWKYNm37adnExw22f9WtYeGfL9KWlL/3frn38gm1VeAX3OG1rl/3qhnJRUZZgMYvmu+wRD+6JHDkMVa212LJjhIAAAAAAFQc2nB4+c8Hk7smlHzVJZW+7bN3N9zOjGzHhqs7zFnqzifVKUjQLUQ1iOM8lWGcedp8rUm19aHcIjOQtD13+b2c5CAVhZCpWgN192FEninyt+9E6feYKR28GG3bt3Nnn7OmwIjwoc0kNnXaxoP7kjWvnx0UHYwhjC/vXCcmpkhMacu5mxqtj1jF5DksbUhZ2/7zI49kMf269ojj5l44deqHpV+fzJxxYmSMCCGEkPnmts7Tt6Wg4G7tOg0SGE+dPDfz81uXZ3771Zt1OTQdkXVfBKevrOR8sLnfkPn7zaqW3d7sH+S6d/bwltWzDl/QHl07oh7vmWfSWcnL1x1N7tifJZevO9N29Ht76f48ZcuO3fsHkfdSkres/ebw5cyjPw3Kr9yRuuWNMT8lk6GdO3Xp4WO/dfboj19PPvx44fqPW4tpFEblSij4OsRL0Pp9k3v0+flRYPMuQ8eG2a7s2PjFwOTrv5z9X59gNt2Ewpxj6HxJn4J43QJ8BxGuUzrTzCvWa7XD1wdwnpZJ7rv9qM8TV6CPeGgo12YybbyXfoxu+NeSmX5iSciGH6Q3LjD6CcDL0Ya/l686kNztrSIjoTP1t35vzNpvCmjZa0j/UOe9E3u3LJ94+FzG0S3vFBlLGUKnH9/07qGMzMCazxzo0uZ9qxf32Z8VWL320K5y2/0rG//46djj8X99N0zB4wca7vvmapmq2NvBBDQAAAAAQNVBWrOeXL98cv2ShZt0dMALnvfwz8RZB7Q0xoozWdq27IomBZN93zZ6ogxHCFHVTZ8cv7f4mmZ0YFjHf49naavDcT3btP5WxiYb7S9UPHxrIhkQ5n9km+JiMrSMZK2cu+cSz+VWb9PjaJdAHwwhut4bm7f1v3J+WevIuaE4LouYMzDi2VfQaSn7Gt/xn9mzZjSDE9CUbs3vx+9LG69ZPuEtJY4QQsPaTJkwZ+H2Xdv7fTBUiiHqybIVO1Pw2t9/P2liBA8hZBve6YNPvvnfqv2D24b2ITNZcwEYeBZtSlr6w4GcoFEr1qzuoMARQtTYQ1+P7b7+l5m7eu7om3+BO2XNzrh+9dz6H3/YlPmigbRC0eaklb8eyA0ctXDZ6rZyHCFEJRxaMKn7pvUz93Xa0UuBIcueNX8k50V8/MuK+XUFCCEnOWDO+MSvNv52aGiDySobZNJ70DmHvkz8Ja36xO1Hv2rhgyFEf/DGuHb9//xm2YQ35jZizSQP7Vh225CCib9vHDxRjCOEqCifTy6mL75rGK0M6EgghFCOITPxibN6eNjROKEPQk6f6Jaae4lnsjYeurD4dhLmYsM34KAkpDUr/fqlk+sXf7dJRxUdCencpO8WHMgJHfXr9tVdlDhCiJp4aOaA7r8sm7m1/47BjH6DjBBCiNSeSvzfFS0qcqBL51zemXjAUP3N948mxPhgyEV0b/XTvHEH9m683GVxwBOMguPJsmPFOQUAAAAAAKgAtH5znwavNRk2Y8m5rBcdQTvvLZ88Lzm8z+CarLihImk2bstBoWEB42X/HrviPOmMajKJ1fiH/t/PQdsNffZcb3Ly0RKDi0IYWXMUX6+JXzZNceEozD6zF21LOnsvXRA547VAn/yTUUz4Rse2K7rXasotfq1ROXc/PKCObtv6o0BGT2SsqcfvuaQNWvdTPi1DEP1mIz/cnnFdQyGEyCcXt90nQzv0Gh/BozBcJw28H/3mpOEtJdr9u04/YfzEG5SIvJN8yUTUeHNyO8XT4ca3w5h+LTmW46ev2RFCCNGGHX3a9G4y5uslF7JZNLiQ95KvmIn47pNby59W7tNhxBstOdbj527ZEUJU1u1HeUhRt3MNAYUwHSG+K6jTvlUEx/ng0SMzZNKb0FlJq7ek+/SYMaX505FT9caM5Svmjm0qZNGMLWkxbzPRoYGK8eKnkeSKZkRKJHbzH/9uOmRSuimdI5kRJZQRHEPbHnenrejYe+iy2ui1s3/C7DPL0fo/+9Rt02TItCVnDcWMhK4bySm5RK3Bkzs+3U3iig7vJbTk5h1Pvmyv2FKLQWqXr9ie7N90cESR+ee8pH0X0sV1Z/SNluGYwTf0TmSH18Z+svTtFq9Z78Hs8ytizZdjAAAAAADAwzDfTkuSqhkpRGft/2D06vTin+W48uPUWVerz94+jvw46U9rxZZYHNLqeEKjGDGfW+hBqUQYhnIuZtvJQCGBEMbzXfKa+HFsHUM17jef/KG7sSaQcsClFmxH6o48dPHCwtoXaghKyEMTW4YW/3zalrQ/ZZ+41pHWfgz/fpeIHDdhzODQmEINV0mT1U5jcpUURwiRev0TEo8JUuYJFTpZIN9pi9anchS+YZj54h0t2TSMFd/tgOc5bcgnok6TmjGF1hAmEAgx5HI48+ceMN92SzbEGilEZx/+4N3fShhIK5zLhnxC6zSKjyk08GF8gRBDLqeLQgjh8rgwEbp9+8gjPLSanIeoaEfquctPSG5UfDDk0as4zh85beE1eb297L8vDojIDonvdmCwqOeRducThMUIuc/su0W8MGS+mOsklXyCsh0xUjwfcZN6je/2GUVY8yJXfS16cPsdVXH3dwAsg/l2XrKzupFGtGHfByNXFh0JXRbkG1WnZd1nxlKhUIj+G0uZ47qyff2s+yGzv+5I/nj+z8LT4a60I7fsvLgaTZWKVFUMhuiIJ9fESPhu15aMFVuJwAQ0AAAAAECVwVFUq69ACNHa67ISLnizXFoxevG9ZrO2TYxHiyq0uBLhXI4PQhlWpwvxCqYdHTaHDtGU1UkiIYFQXmQtontCOJfXdPNnq2k602pASMpk0cANlDn3vh35K3j3Lp5KOHn/pMHlo/BrUa3GrPaxdYqbf7A8vPzpVbrfoHrNucX8a4UShHTvHIIQQoi2WcxZRsPV8/s+PmwObtN5YACGEMLFYhlOPTRLMqSBobkaX2sWQshiyNJRFKXNJhFMQLOVsNXSpFbPPkSlHzx82sWtX7/6v983EPJqdeQIITrzlow9X3MJmi3d0OzZh+j0w8mnXZz6dWIFCCEk7vz+R31vzvv2nQ/v9W7VVGq+ffrAbxd53Sa9NzoILoD2JpT2wX0z5h/le++3qQnLt598YPGJrNOiy8hZ0wbUkbBoVeIcwgfRGTaXC3H/23fbXTpEUzYXifiYw5FKYorGg8+K0lcN7HXOYPMR8lv4+c6KltWBIZL9OH7VGvihkg4phR2WHi7yjQiVvnvvaRe3fqNazN4s03J3/+jN2mbDp0wMK3qgSxn196yYX3S1M2d3rVq379wTm09ASItGrWb1b1xHyKKNy0vBBDQAAAAAAEtRFOVwOKzWZy5CFnr0Lc3nPpu06lHL2ZuHR3JQmkffyn0cmbSDUPvjI+0fMVEjRRhCCLksS+8YM2kkclEOqVzXaUBujUbKU/tUx3chs5rpelmhSGxomi6XxZIk6XQ6yyuTtN1hQijnxsnO56jY6pGJ8YT6UdqW40cOPs47OqpevSJnKnTuL4duPgxqsLWmgEVngZR60SefTr9DIoTJa/fb82HTYAy5CK6uXocGAbs27VqT0lVQ2x9DCCFr2tK/UjJpJLLby2dleBsPZZKiqHLM5HMcaX8vGzjvdF5In5l9Q9gz2+wGZ9qx1QMXpeQF9ZjZK4hGuJoQZ4d2GNF7b/Kysxt/ubIRIYQwae3+77ePEDFdK1M8l0mXy+W5fTdtzjXRdM6ujzv/zxnbtWdiZ5763O4tixMPpqiPJk2sx+zcXiEciagD3/CjJuuP8OCR+cM2aV/60JRJIxFJuYRifeNQw5kj5rO/jjuQF6uUJIby1TnmLQ/VB3NdRxso6nnV9lZens9kucTS05l0gyNt39yBs4/lhQ2ZOSScyXVrTf1s+aFHtQZs7qLioMzC/0JhhJYv0COUm7xk3HZ7bKN6ifUI9e1/tmxfd/B2ztHPO9Zj/MtvJhSJDUVRZc4kTEADAAAAALAUSZIOhyMvL6/wgx48YaBz9s+ZuizrtZ//GBBFIER67p1KiZBOq+WbdD577JHbe0NlcbjzTEZ2CuIGYGSef4PU96cqb1+MX/IJx5yDEKqaU3vPKxKb8pL/pUh5ZZKmKBdN55q54xJ6rqgmIhBCdMO3diT1PHdp5j9xOxqKCk80592/uiiN6DWweg1WzUpgir5j3o/UGu/dOf/z/q09ZxEbvh8dogwQO4K/GdX8+LxT4yao97WrHUcYz5w+l4J8AnCbhaiil/YViU35finiiXHSoTm3ZP6COXvvO8I6/fTj5K4+LPri48Uc2otLFq+Yc/ChI6Tdj4vebeorvINLRJRRu3TM4DXauoOmJg1rUVtmu3tu97Tv/ug1Jmfjr5/0VXrNpytHFZpJUbn1DaJdLhdN5WrF4zbuXtE1gEAIUdPemtSx5y/fzdw8eEdCAFvWJS6aFitNum4ae+7R3gBxHOY6k2lKQZwAzJGnqpM6fZb45PcESZmM1nH1IlYoOQRCiPZ76/ajnumGmRrZjmAOWz5IBSoSG6qcmg6TJOlyuSruePJZjoyTS774fE7SXUdEz5/Wfd7Vl7kVS1v2//b7MlPNn2e1iMIRKvTXzZGoNKoY4vpZgqbMBmLctE9XNJIRCCG6+1urFvQ8sG/m8aY7OpT068HK7PlMljmWMAENAAAAAMBSBEHw+XyJRPLMo0aTZ96NNh6Zn/iHrc/yL4YFs2qGDyGEQsMij3OFM28b9qVpdxK8hsGhuzoETvwtJSOkQeT6Bb6PU5kukHWKxqacEATB4/HKa+EYlyPEEC+y9qx40b+TspigU9uaLc6fTr6jtTSMEhc8lbZuO333sSx2dQ02Xf6MEMIE1eo3qYYQ6vL6m9ELmi3b8eXR4Xs6PpA68lC7cceFwTM3HN+3d89OnqJhq6GHe9s+mLDhoYhlH6GiFIkNhpXPn6H4TGa/2kLp3JQNC8Ys3HvVEfD6qDmL3utSm02dDV6ENqVsXjFm2aGrDv/XEz79ZlxXuUxqwLBQV65Ys23sH6m8tlO3fdwpAEMISRt0GLlZZKzz/p5Zm/r0ei++Ck4NeC6TXC63aCYpR7ksHCGECUVCDOO1HD+rc8C/Iyeu6PTRmBbrpicfOmtJ6CV+8esrUGhg0HEOf2Zazr4nWTsJTkOVam9TxYRdt57EdAza/LPi9HERQjy5fJYf5+kugOgU4dsiQ5dssFqCpez5IBWmSGxwvHyOx4rPpMnzd/mgc1LWfj5mzvar9qDXxy9ZNLl3bSmDYyltvJSUeNDR58OBwwp/5YZxn4TW9xUIAgwPpNnZIoTxarab1VD2NJPiTn3atvh7a/Ll+5YO9SGTOI6XOZZVcC8DAAAAAOAdcBzncrkCQcX8npbS3biZ4dRuSmy+KbHw46uah60iosedPDatGZNHjlhkYOD6wECEkN0vUN1tmCljs/bXC3GPNsm4VfInkS9TJDblNbFSvpkkJJJgHLvrIyl8JohLpSEEOmezW2gkfvo4lXP/l7uuyOZxbdmxth0Z1/+8nhNRr0Ubfwwh5ODw1dJg1PH1miuuPbp2StC2BkIIIU5k0zfXN33zv1ddWfOIJKJCVFXzHMxzmeRwOOU5TpKazbPeG74lQ9Vm9PZZo3pFsKajwUtRus1fTR2+Q61qkbBl6rAmkX4mnO9D5ikpK4ZoR9q9aw6iduO6qkJ/eGn9Bk15u3bceZBLxyu8ZI69HFVoJi3lNgFNBAQHc7C7oaHKQrNAeGBYCBedMxoLj5wsgEUq/dYr/RBCLh+Fpucwg/2oJulO3O3VfnkYzuMEY+gun/PMLoDPDcHQORdlQagKTvY9n8lyiSWO4wRBFM2kh65nKEA+2Tw5YfiGx6r2E7bPfbdXVMX2/CgGrXuYnkHmbFo4Y9PCwo/v7ddiLxHc6eSS3s3kvsEEuqtUPJNJuSKEg87lWVm2cVWQIrHBcbzMmayaBz8AAAAAAKAIXNFkwPQP2/zXeIM2nt604Yit3ogRLcP8GjPZ/ZR2HH2Um8qXDIpUWNr0NDTrKL9wJPPH/TrEHenHYd3V2sB9PL/GKmyP3viYDo99ejpD5uSkkZiPj6TQL13ptOv3TpOSd2uq2DH/jFDG6Y8WnKg+Pu5w34Asib9erPK1GuPSH1ppTMjnYQgh2nD00JVUWbWhzUKeNtglr168qcEDhtdRQGhZjLy5dsborbpaby/e/XEzf29aVeTN378evVNfa/g3az9sgzgiRNnjnAbO0x+ZYyKRBNHZOSYKBRR8LNqcm00hnlDIr3qzKl5MXKdxNWJP6p3HVNfYp+uSfHw/zYH5hISwqEcA7TqqMadyRUMCRLZWXbTdBklvX7TN36NDxEgZwhFCBL+xGNtjcTym0X+7AJsjjUI+Ao6MwcpBOXDdXPnB6I3aWu+u2T2rNTvGUkxRrcX0ATXyD3StfFmeEF3dvvm0LWpE57gwn5gQHCFBaONQfE+G9jFd+79M6jPTnMjHz5dFG5d3ggloAAAAAACAEMKUzYbOblboATLtu+MbjxobJ378EaPXPiOE0I1H6RNMYekfrxxJPIlZ+QWedmVcqpXvFzLSe7qygmLgvv3qKefsv/b51eg1dSVchBCVl3TkRgotGlnTn1/wNNr69x29UxTbmTU3gePG12onPrZj/8mtw6c34dqj9XcFDu3O7Sdu0T5jGoTlby43Dq6fkFrd9cPH4wNxhJAz4/jsPWp+zWEjY6poD2jvYD+/dM0/9trvrpvsXbPPCDmuLP3jhr3m2C8ndebjZDBpFFLOwv/OjW/aOeCvn3Zs2txn6uBADkIIUblH1yYdd0m6tqlTZe9D6JWI+H4D6s/5bNXnW/qsGRDGRQi5MpK+/SWFChzZqyn/pS+vOPQNtW5CXuCTqSsTfG2Rq77h3jj77n0L39d/ZH4fBozfL1AwJ9X4uU66JoDLRQjRrqQHxhTEGakSsumDgNKzn1m66qK9/sfrZrBk9hkhhClrtp5dE5mFvmpVLMKwIO2JH49tOWOKShzcs1n+nhkL6Nc6fM76Y5+fbLCmtYKLECKNSZuPp9A+I5tHQSZfEdMnEwAAAAAAALyQNax6qykxMTN3zBvR/0EgFuC0HlDnXkPSxfVVcTD/7N2w6k2bT7qyZ96fW29di+msxB6k3t/6xBZev8MX8YVu2OXQ/P2YFEQGNmXNzK3Nr83bY07tX7p13JBHQ5qHByHj1Yvntt/NC31t/IwGPIQQwvwSEl7/Yfq+Dz/6+nT76gHmxwdOXbmGai/+oEMcW07FQTHIh/+c0dM8yaV5Mx4+u6IwWZOEhf1iWHv+bHl0M9lAcyTX1332qeCZe8hisob9F/aK4vDrzfi4y/5P9yUMebixU+O6MvudlOPbrmXLW38wv4schlKvQlQfM2fSn2/Oe/u1W9v7dI4lHhzdtvVCdvjgn7/oJGW6tv/Y/cPbfRAf/c3+bxJH3ZfbA1y2A5l515B4cXXfgn139VDVJE36vGsPb2mlnUXYgyzT1lwyPCjoCz8YKL0bef/8mUyKJz0376P7RcfSFmMXDqnGyFjq4Aq1yiizSO5veKgwpmNU7nNPwat36TPp+PJ5i7+9dbph52D8wT8Xt6bmhbcd+UUD72nHxFas3YECAAAAAICqziWTazoOyK3RKOjUnuOtr3x2TbsnzW7EuQ38g7bX9O9ZBVvxVT78wK9G9Qg5dP7HG3cW3UJyP/9RPRrObh4UVGjd2tMzTtix2BAlG379SuIcnSQgW6RoOPDLE8LVc5LObt1xyUjyAsPixr3bc2bP6gWVy+oOOfxtwKy1h/bs3WskFA0a9dk+skfPQLY0EQHFcmU8eUTS5tST64re2RT3Jzp/1y+GkapejESYjpBoMw0ZJG25d2LjvSL/jvkTr33XKwohLKj9RydXVvv6f7u3H9i2x8ZRhVV/64NPZg1tHAGzAl5H0vyrHUkhX33z484Ni/bS8ugmo+ZPmZ3YOogd07akUKzv2MfQupvizMHkJtdn39TteeI04pwGCr/tMYqewkJDOSH8qkFoyH39j7rcRXokFwpGxfvNDhMFsWC0B6/Clf74kYs23z6y7naRf8H9OW98N6RaBddDYbheEa6Xh8lMmXFp5ziks8SnCqO/+vz9kA27fzx7btF5Wh4YOWpU19nd4iCTrw52NQAAAAAAVQ4WMOzQw2EveRIROWX3nSkVUs/zaIKT1aSDtn1f6b1rccs/5eZkIV/FytaKl74QEygPvamsgApBeSHEAe/17vFe7xKfwI9pnf516wqsqHg0wrLESp00UGQ3x2be4pFO//YD/2w/sORX4P41O66c37HiSgSvjP/abMPt2W4+GVP1P3StvyfLeXkJRpyvIaRCylGz5aTsCx+87Pm4f703lix5Y0lF1AY8i1A2e29J0ntsW5cYZmzcTvPGWwLNo5jF0/jqx0goWtkw8gWvIHjC96qHvVe9oioE5Q0LSDiUnlDkQX6nhQbtwmKfX/FyJCqNMprnskc/viiw5/33D7hqyrwlzx/oErLo9xInvJf43D+AVwMT0AAAAAAAgF1M1Rqouw0jrHmR6xeKHt9luhwAkJknUctCEIbCstMkdhPT5QCA8jCempDQGBbiypHSDqbLAQBZw2PVfd92iaVBW372uXKa6XIAQFa+RK2KdXKFAYb7vrlapsup6mACGgAAAAAAsIXdL1DTbZglJNr/WJLi7EGMppmuCFR1Dg5fKw0y8yT+Zq0iLxN+gwsY50S4lpCYcL6SzFNSVgzBOAkY5pLJdV0HGRu2Vh7dofp7O+aEb0QAw0iCq1NEZMsC/XIyVBlXcYp8+WuAh8EENAAAAAAAYB4pEOnb9DQ06yi/kBz61w+E3cp0RaCqozBcL/HXi1UyW05c5k0OnL4CplEIGXBRJi6W0fY4p4GDKKYrAlUdTRBZrbrqug2S3L4SN/9Dbrae6YpAVUcjLFsWqFVGiWy5sQ/P81w2pisC/4IJaAAAAAAAwCgMM9Zrpek0SJCZHrPqS74unemCAEA5Ah+NLJhHOqL1dwVw+gpYwITz1YSEoKlIMltEu5guBwBkjq+r7jsadzojVs8V3b/JdDkAoDyRXK2KpREK096S5GUxXQ54BkxAAwAAAAAAxlhDotXdE1wiSdCedT7XU5guBwBk5QrVshAnwQswaXytcPoKmGfHCDUutWEcf9KsoOwIem4ApjlUQeo3R1oi4v0PbFYc34vRcDE+YJiTw9f6RZkkfv6GhwrjE+hNxEIwAQ0AAAAAABjgksk1HQfk1mysPLlXdXwX5nIyXRGo6kico5MEZIsUfhaDKus+DlMqgGkkwnSEJBsXyilrOJkLmQSMo3h8fYfe+va95Wf+Dv1tCWGzMF0RqOooDNcrwvXyMJkpMy7tHIeE40mWggloAAAAAABQoWicyGr6uq5DX0nqtbhln3JzDExXBKo6GqEssUonDRTZzbGZt3hw+gqYhxlxvoaQCmhnjCuLDz03AOMwzNi4naZnAl/7OHrRNIHmMdMFAYBMYr8MVSzPZY9+fElgNzNdDngRmIAGAAAAAAAVxxxdS909AXc5I37/XvTwDtPlAIDy+FK1LJhGWFh2msRuYrocAFAexlUTUgqhEFeOlHYwXQ4AyBoWo+77ttNXEbhrvW/KUabLAQDZBFK1KsbBEQYY7vvmapkuB7wcTEADAAAAAICKYPcL1HQdagmN8T+WpDh7EKOhPR9gmJPgaqVBJr7M36xV5GViTNcDgBPhWkKSi/OVlEVFWqCNKWCcSybXdR1kbNhaeXSH6u/tmBO+EQEMIwmuThGR7RMkz1FHGK7iFMl0RcAtMAENAAAAAAA8i6Jpffs++lbd5BeSQzf/SNitTFcEqjqK4OilgXqxSmbLicu8yYHTV8A0ikYGXJSJi2S0I95l4EC7Z8A0mqaz2vbQdhskvncz7ttJ3KxMpisCVR1N09myIK0ySmTLjX2YwnPamK4IlAJMQAMAAAAAeBV5ANMVlI7RZNZkGvg9hkUHBQkaNEJjJjFdEShvHy1iuoLSMeVZMnR6Hp8fHRQkEAiYLgd4wLXTTFdQOiaxn9o/lhDIIkUcEUeEkC/TFYHyxuUzXUHpmPMsal0mNigxQqkQ16qJevVjuiJQ3tJuMF1B6eQRfDXXhw6KD+NjEh8lClAyXREoHZiABgAAAAAAHmG12b3rwNYAACAASURBVNWZBhdJBqn8fJT+TJcDALLZHerM/7N3l/FNXW0AwM+VaC1J3UtpixR3dx+D4e5DNmTAcBsTNmDDeZENt+EuwweUYWMUl5aWuqVN2rjce98PRSppm7ZJc9s+/x9fSHJvzsl5eu7Jc849SdcbDO4uEhHEJGABHUeQ5Bqk5dm7pb+T1Khj6+IAgPQGQ1JqmlqjdXOWSOyFGAa7EwEbM2BECsdRgfNdjAoXBxFEZDlVsRLQdMbjY7sO/h0eo7D3r9dh8Jh+dcUQmQAAAAAAZc1IUanpMrlC6SJ2chWL4OsrsDmKolMzZLIshbPI0d/LHcdxW5cIVHYUTkolfukiL3Fmsl/yS5w2IgQJaGBLNE1LZXJphkzk6BBSJYAgcGQ02LpQoFKjESblOEhJe0dKE6xLIRkabhApvypSApqKOf7zsqNU2zHTBjun3dy3c9lyYtXPfXwJW5cLAAAAAKDSYBgmIzMrJT3DTiAI9vfhkBVptAnKJYZhZFmKFGmGUMAP8vPmcji2LhGo9DBM7uCW7FKVr1NWjX3E06tsXSAAUKZCkZwq5XI5gX4+fF452zAEVEgKgp/EEREMVUUnFdDw65flXgX6SqB/cvZstE+/tZO6+RII1XKRR846c+75Z5PqcG1dMgAAAACASkGp1iSlSTEMC/D2FMLWuoAFVBptUpqUYRhfT3d7ocDWxQEAafiOia5VKZz0TnntoEq3dXEAQBqtNik1zWAwuru6iBwdbF0cAJAW5yRxRDqM8DBmiYxqWxcHWEbFSUBTcc9fKj2aNfTKXvFM+DWs73bs0Yskuo4/3F8HAAAAAGBVeoMhKS1drdW6ScQSJ0fYcwPYnMFoTJFmKNRqF5HIRewEMQlszkjykp2rZNm7uMjjXTNiMYa2dYlAZUdRdGp6uiwzy0UidpWIoZ8ENkdheCrpICPtxEaVv1GBQz9ZgVScBDQtTZUyzq6SD9lmXOIqYaSpaTR6n4C+fPnyq1evPr2eplUqFfSwoPxSqeBmPcBeEJ+AzawdnxqNhmEYq74Fq9A0LZVnSmWZIgf7kAA/ArbWBbb2MSYd7YTB/r4kAVvyARtjMDzDySvF2d9RmR4Sc580wr3kwMYYhsmQZ6amZwgF/KAAP9ibCLAAJicFyRwnAaUP0qZwGcrW5QEWVnES0JReZ8QEAsGHhDImEPAxvU7/8ftfWFjYuXPnPr7e0dFRo9FYOwEdNhluPi0GKfra1kUoVzSaUp4A4rNYID6LB+KzbEF8Fk+p47Oo01eiBLRcoUxOS+dxOYE+Xnwe7HsGbE+hUiemSkmSqOLjKYBtTAELKOyck1yDCNoYkPBUqM2ydXEAQEqVOik1DcMwPy9PO9ibCLCACuclcZwYDPPWyRxora2LA6yi4iSgCS6PYDI1WgbxMYQQYjQaLcNx+PRFaODAga1bt/743+XLlzs4OMAKaJagKEqtVnM4HD7sFwlYSalUIoTs7e1tXRAATNBoNEajUSgUErDKjx0IgqgMAwyNVpeUlm4wGj1cnUUO0D0C29Pq9Elp6Tq9HmISsISOI0h2C1LzHNwyYp0zE1ClmZsErKU3GFLS0pVqtZuzRCKCvYmA7RkwIoXjqCAELoYsF6MKQ9BPVlgVJwGNO7u6YNHpMhqJCIQQouXpcsw51PnjXaChoaGhoaEfX79y5UoejwcdLksYDAaEEEEQPFioAlhJqVRiGAbxCdhJr9cbjUYul0uSFeeyXq5RFFWxBxgUTaemy2RZChexk6tYVLErC8oFiqJTM2SyLIXY0cHfywPHISaBjVE4KZX4pYu8xJnJPkkvCBruJQc2RtO0VCaXZsgc7e2CA/xJElYtABujEZZO2qWRDo60NlibTMJ2zxVdxfmmSviF1rA7Ff44bUgVDwwhOvnxk2SHmqHe0K0CAAAAAFgEwzAZmVmpGTIhnx/s78OBOQ9gawzDyLIUKdIMoYAf5OcN25gC28MwuYNbsksgX6+uGveIp4NfxQC2l6lQJKdKuVxOoJ8PH5bUABZQEPwkjohgqAB9upCGbfErhQr0KzHcOj16+L07suHA/bdxkXf2bTweV7Vnj1qwFyEAAAAAgHmY1BNfN/Frt/w/o4knlWpNZGy8LEvh5+nu7+UB2WdQFgqNSZVG+zYuIV2e6ePh5u/lAdlnYHmM4sTmn/0WXPgvzwpmRv3gyrHPv10sHjrLc+rqYcdevDMghJCG7xDlUy9V4u+ZGhkQ/9h22WfdPxunDN72Iu/fjebSkGohmHdwrn9Vxu+Swz3v5Y4h/sqqMV3qebmIeE6e/k36TP3jQbqp9aMarTYqNi45Veru6lLF19bZZ/XpIe6OmNAh1z9x/10yiMDyyBh/78iYryZ4te/Fa93ff8SSqcdf5QlCRhGxY92y9kOGOrYbFDJh1a8P0g0I6TDyHdc5gSNyMWRV1Ultl33W/bN5xuCdL/ONLxhlxMWFU0fXbd3KoU6Hmn2nTvvziRQWZ1tCRfrmQAb2nz/HsHX3xnnHtULvej3nTuzjD+ufAQAAAADMQscfnPH1rudpgZ0NuZ/QGwwp6TKlWu0mEUucHGHPDVBWCoxJg9GYIs1QqNUuIpGLGLYxBVbCxN869PWVxDSPmrkikFH+9cfaPhczPKrXGtpNrI16fPDAlpux40/+PEDg6OIij3fNiMVsei85k3594/YrN7sOzVMIKjn2nRZ3r9u+fUCO393h1KzCgb+g8oVJ/2tG+37bY10a9xs9M5iX+vD0oU1Tut5OuBi2tLHww4soik5NT5dlZjmLRa4SMY7bfvUhlRj9Tou7N+jWvmqOXz7k1IUILIeY9H82tZ91IVZUrV+v/sEc+cOb1zetmHs7dUXYpOrvg1D35qdpc5e+4jfp3H5qC9W9q9fnzXjxfPX22W3dJEaVn06G27afzLixcee1m10G5SmE/s2ezweuumn069Lzi89EmldhFzcvHPN39NawBY0cbVPSiqMiJaARIlwbDV/UaLitiwEAAAAAUN5Q0bsnzjqdwmA5v6HSNC2VZ0plmSIH+5AAP4IFX19B5VFQTKbLs9JkMkc7u2B/XxJ+fBVYDZXyz8Qdj1MQlrvjYzLDz0y8lF79iyl/D6/qhCEGdW635bcxVy/tiOi/1vVfjkFro/IihChNRsLz8H/2bVhzKJVxz/90XMw7Rthx2pr93eCH38szKmrXL3ujJL13/bN/RPaeowuGz27RedXGVSen/TlUgjEMkyHPTE3PEAr4QQF+7Lk7hIqJekfbdZy7c//ngqJfDdiMTtq143KUY4tduxaOcMMRQmhcp9mj56w6dOTk0EVDHTGEmJizO1e+xNp+s/KvIb5chGWMbDFq2Pf71xye2GhoKG7qtqayKrpGlvD88d19/1t/KC1/P6k6v3nbTWXgrMN/rmggQAgh44g1wwZ+u3fL/rG/f+UBw+BSgY8PAAAAAKDSM7zZOGnhzSpDBtf+tDohU6GMiIlXqTWBPl5ebi6QfQZlylRMKlTqyNiELJUqwNvTx8MNss/AiqiUjf87edOtyWD/PPln1am/Hsbb1VnYN9AJQ0qhONK/fdMpi9aMb90p66lNs8+IkR7r07Bj4xGL193PMLWwkJHFxssw72A/tqQjQQkp798K1zu0H9rv4y9e2TX8oosPrn79/B2lUmvexsRlyDN9PT38vb3Yk31GiJHFxMgwv+AA9hQJlJT61a3XRofGHfu5feghBSFfNHfFtXHPE2mEEKJTT116pha1+ra3rwHnRfJc090/m9vLD0VfPPHCpv1k+ok+zbo3HvP9un9lJvpJKu11tAK5NOxS+8McCenXrW0V0hDzMga24SitirUCGgAAAAAAFJvu8ZpJi8NrL706g/rq8GE10ml1UbJ0g9Ho7iIROdjbunigEsobkwa94V2KVKvTe7g6Q0wC6zM+PrlvcZT30mWdqM3/HtblfObd9Vc6bnCNlk7CGLcgNd/BLSNWYiRDujSxWWE/wESd1p2oJmcQk3Fx2tjt8Xmfp9/FJFBk1aqiuBvnHj5L1gi9Qzu0qecvhN0Pyhuy3oQNWwaHNMmxjt2oUKgZ3INjSI1N1Lo5SyQiFu5NRL2LiqE41aqKY26cuPMsSS30rdehQ2N/O7aVE5iBCJowd/pg/+o5gpBWqLQMLnF1xBFCyPD2foSRW7eun5M4hhS4GJWuBoVf3RrO6PLDV5l0LWdbLWrARB3WHQmW04jJuDJt4q68/SThEhxgj148+yfK0LEaByGE6LR7/yVQnOAQH1iHUVqQgAYAAAAAqNTUD1aOXf666c83vqmBViGEKG1iYlI1Z0dXsYgNW0aCSih/TMbHJ1QVO/h5euA4pCqA1akjLo49mtJ05OxvfNGa3E/RcmmUBnMOCLj56OrW3bP/TdA4uXs3b9hycf9GtQW2Dk5SUq2eBCHEpL5wNNF5697FJFN01ryu3ZMyjAxCCGFct2bzNq5Z2tLZ1kUHxWFXo8fIGgghhGhtlixDGvfkrw3T/0x37TTncx882N2fJNl5d4juXVQiRWfOa944Kd3wPgI92szbsXNpO1eIwHJG4Nejpx9CCCFGq1JkyNKe3jkx62KWV4evBnpgCCFjekqEDnPyCbHHkK82mWRohBDp7uGL07EJqRSyWQIaEeJqdcQIISb1lal+0r7XrEUjny76acToyAEd64m0r2+c2nuf233hvLHeMCQuLUhAAwAAAACwFEVROp1OqVTmfNCeY9ERsCJsycS1sW1WHfmyaqb8sVTHIIby8fV2F8AdsuVbnrBhGMYipy3LmDw6PkipePI+Jn28PYUQk+Wb9WJSr9fnjcnSnFETuWTjldjQAUe7upIoLc+TMoJIQyjr9taJp3VBDetMrEskvX5y7OSey68z//6uU102BymV9DbOwBipKkPWX57UOgClPPzrj2k/HPlp4nz/i1sqZ26lTGOSZ4XgoN6s6dp4wUMDQrhTo29Obx/X0JnFu3tT8W9jDIyBqjJ6z+XpHQNQ0sMza6bN2/PT8K/97xwa61sZIzC/PGFD07RFwpKiKIPBYMl+8iM6bs3XXy94aUQIE9cbeX5+ay8cKQh+PIUrGMxRYPTVyz6mHTGBwB5j4jVay/ylWQfp1XRC//rnf7uzZ9PjPQghhDnUHTWlS6CwqAMrqjxhQ1FUiWOyUiegN27caOsigPdomtbpdARBcLlcW5cFABM0Gg2GYXw+i4d0oBLT6/UURfF4PFisyhIGg8FSp6Jp2mAwaLW5Nsuz51huDMzILy78eoO0y8ZDA6iE+AxKKeJgiLTjsGjLSFBCecLGUmiaNhqNZRCT/zs8gEqITzMqnLJjkgsxWe7lCRtLJftMx2SJT8eoL+7dv0FRc9vi5lVwhHLs+anhOyS5Bul04RhDK6X4hHnz/tfQkUAIMT1G/P5bz0t/LbrV5HQHR/Yu5MRdvli0uT4/qG1DHyFCCPm3HvrDGSyl1uyb6w+9GTWzOjsXzVqV9WKSoqi8MWmFBLTW4Np4+tpVsUkZkTf3/bm+7yDx+ZNzmrB2jyLc7Ytlf9YXVG/b1F+IEEKBrUevO4OSak2+sn7Pi1ELa1XCCMyvTGPSIqfGXPtOnR+QlP72xT/bzuz9bCa5Y+OkanyOi0HLZRDDmBgS0zSLN1NmlGGrJnTbmlRn5M+nxrWt5aSNuH103ve/9xosO3jkx75ulfGrVv6YLHELVt4E9PTp0600LgclkJ6e/uTJEz8/v9q1a9u6LACYcPHiRYIgOnXqZOuCAGDCo0ePEhMTW7Vq5eTkZOuygPdq1aplkfOQJCkUCkUiUa5HKb1FTo4QI7+0aMJOVdc1C1sQaRInscTeg1sZh9YVU56wsdRmoCRJCgQCK8ekuuuahc2wNEd7J1dHdx7EZEWRJ2wsNWlKkiSfz88bkyXEyB+dmnhZ32f6wGEuOf5kMELqHhLt5OYij/fLkNojjFuz7eIGju/zZZhd5z5tml89fjM8St2hnp0lymEVmFPNlu1q5noI9+7SpfmCG38/fa1E1SvhGMJ6Mcnj8fLGJENZ5OTZKIpKTc+QZWbV7vhFB4kYx+ePrdez7owViw8Ov/ClF0t7TUxcs13XvBHYs1fzGZf+Dn+mRLUqYQTmlz8mLXL5JkmSy+VaqJ/MDRNUa9SyGkLU5593CV7cfuWBNed7X+nNx3kce5zJyL3YmdFolAxmL+SzdqKOTjn/w87X3A7LTiz53B1DCDnV7zb5qH167dHHFu8Z1mtWzUqYQs0TNgRBECX9CehK+Om916NHD1sXAXzy8OHDrVu3hoSE9O3b19ZlAcCE9evXC4VCiE/ATuHh4Y8fP541a1aNGjVsXRZgYRiG4ThOkrkHbBZK9tG08eX9R4mG5NgpTc/kemZtM/u1RND02+HLmlbeoWK5lzdsLMTaMfnq/qNEQxLEZIVUpjFZQkxqTHwilXlo1cJDq3I+frFnm4uEV7fb63q6OTl5ESjCRZIzQY2LJd4kuq/SqBlUvn5QDXNwEpGIMVIUg1C5KrlFlGlMGiyTgGYYJuXxuT1Xo6q06du7nh/3wx1L/l261CJuvnr+lkJsTUCbgjmIKnME5pcnbCw1eWzRfhIhhPTx4YefyPwbtGvtgSGEyUlBMunk3LJlLfy/6DevGaY27uzhx2UeJqRkMejjHvNUWmoCjVfzcmPtanfj21fPdESt5g1z7kru0LBpE+6R0y/fZDE1JZUvSi0YkzCCAwAAAACodDIVymRpOq9Wv7mzO2Eff62Ikd3Zs/26ttGo8e18XVpUyh1Bgc0oVOqkNClZq++c2R3xj992ICZBmcIk1ZovGFAjO1OoJ/lKIRF++sRdbeCoLkG+TlW9cYT4Po188POJKXFMraCPWRVp2jsDcnIWsXgDDmR8uq3PvIvikWt2DfL5+JdExURF6nHPQD8HFpccfKRSa5JS0/RPD/268FSNX3v3a/xpWw8mK0vBYAIWry01hq/rM+2U+Mudu0b6f4rA6IhIPe4ZVAUisJyJ/3vmD1eqT695YahvMseJQri3QSaQpaoYTMDnYgghblCzEPLQs0e3NJ2/eL9NFx3x7LUUuQ2rKWbtxRwT2tljtEyWSeeYyGEUmTIKcYV2PIjS0oEENAAAAABAJaLV6RNTpQaj0d3FWdRnZoM+OZ6jIn+9uvNvWfOJi5fAOlNQZnR6Q1KaVKvTuzmLQ/p82whiEtgM5lKz1dKaSM8VJrkEqvmObtK722+dvKcImDi4Z9PsqTrMvV8rv5/23fjudv1drSQchBAlP3X01gPGaXSzKjzbFr9QZECAOP7JgXWbBnZc1jN7/bYh4cj6g4+Q38xedWCTdZYzGI0paVKFSu3mLBF3/7yd07HTO7fdH/tjs+w9X6jUC5sPvmLcv2wfytqekgwMEsc8PLBi5cDuG3tmry/Vxx5ZueMREzizf0OIwPKFU6N+G/uLp89cOz3424600tWgwOiMM0f/fsWIv2wcQCKEcNdenUIXrLq/6VzCZwO8OQgxqiebz0ahgIGDqrM2SBGnRusuHru3HN15dPDPg71IhBCi5X///ucto0O3Dg0q7e8QWgp7Gx4AAAAAAFgQRdGpGTJZlsJZ5OgqFsGvVgKb+xiTYkcHP08PHIfFRcDGaIyQSnylYh+RIjUk5gFhSMkXlHj1rn1m3Nq4fO3KV3cadPHCo5/8dzxS5ddm9Pf12f1r1Q7tF81pc3n+0f5dowf0alKFyHhy48LZl4bak7YuaAC/A89eNE1LZXJphszR3i44wJ8kCYR6fze3xeUFq7q3eD64VyNPJuXp1eMn/5P7DNy+sAOLU2SOXRct7Xx52t7+zSMG9G9dhUh7cuXk2Wf62tMPL2jC5rkbkBeDsAznLiO+vHRp7d6vB70e3DbEk8l4ej/s5CulT5fZCxtntyYW0HPMrHNzf1y3qOe7Lp/5UQ/PndqX5Dn+t74N2ZyG5DdauKT3xaknh3/29uBnLes4ad/cuXIiXCpuv2jF584wRiklNrc8qERq1ap16tQpOzv2/mgHqOQOHDgAmRrAWtOnT584caKrq6utCwLYi2EYWZYiRZohFPCD/Lw/bhkJgA3JFcrktHQ+j1vV15vHhZgEtid3dE92DuTpVYGxj/h6VYGvEwT++N0U7z/Pbb53f82/jNgjYMyYbku7B3uyPTlBhAzbeMdr77LfT144uOOwnuddvdmstVPm9asuYnvJKy+FSpWYnEqSZBVfbwH/4wwHr9aMk2HeK3743/Hjm6/JDQKPak0nrJm1aEIrT1Z/XyFDxuy747N12fo/L+zecFjP9w5tM+uPufOG1IYILEcUBD+JIyIYuvOQH/4R7/nh8K3jR/6TG7keATUmfDtwUb/an4JQUG3Jul9c/7drw5VDc9Qc75BGP60eN6sZm3cqQgjhnl2+v32g9rJNR0+e3X9ew3ENqDVi3k+Lx7Twh+xpqcFHCFiBx+N5e3vbuhQAFMjLy8vWRQCgQBKJxNZFAKym0miT0qQMw/h6utsLBYW9lAiafUs+u6wKBiotjVaXmCalKNrb3dXBrtD1ehCToExoePZJbsEGkueRHiXKSvn0BO46e/m6/BFIOAZOnjh18sQyLGJxYG5DrkQPMfUML6D9l3+0/7KsCwSKT6vTJaWm6fUGd1cXkaND3qcx+1qDfjw86EdbFK00+AGdv/mj8ze2LgYoCR1GJnNFaozjZlQ4G1UIEbW6jjncdUwhh+BONSYvWDF5QZmVsRgwt4FXXg809Qzu1nDguu0D15V1iSo+SEADAAAAAFRMBqMxRZqhUKvdJGKJk6OlfksdgBLLjsksldpF7OQqFkFMApszktxU5wC5vZuLPN5VFovRtK1LBCo7iqJS0zNkmVliJ0d/by+4CxPYHIUwKccxnbQTG1U+hnQCMbYuESiXIAENAAAAAFDR0DQtlWdKZZmOdsJgf1+SIGxdIlDZMQyTkZmVkp7haGcXEgAxCWyPwbAMJ+8UZ387TWZw7L8cg9bWJQKVHcMwssysFKlUKBAEBfjBflmABTA5KUgmnfiMoaoujUcbbF0eUI7BZBpgATrj8ZHV8yePHDry6/mrjz6WwXwaYB8m+cziKTueU7YuB6jEqMg9k/v0Hv3bbXnOTpJ6vXNi/7mnknM+pv7nt2G9e/WZeiAKIraSUqjUETHxKrU20MfLx8MNMn3A5rJjUq5QBnh7QkwCNlAKxZG+DWWO7v4Jz/wTn0H2GdicSq15GxOXLpP7eHj4e3tB9hnYnAbnRvFcUkkHT4M8QCeF7DMoJUhAA5ujYo7/vOxonM/n0+ZO/dwr5vCy5SfjIGcCWIXRJlzfe/KZ2gA3ZQJbYzLCtu96kFXYPB2j+PfmQ7VAyI0PC4MMdKWj1emj45MSU6XuLpIqPp58HtfWJQKVnU5viElMTkhJcxE7VfX1Fn76ES0AbEPPEcR51ozzqCHJSq4a+9BOm2nrEoHKzmA0xiclxyYmOTnYBwX4Odjb2bpEoLIzYkQ8VxzNc7GndcHaVCdKY+sSgYoAtuAAtqZ/cvZstE+/tZO6+RII1XKRR846c+75Z5PqwHdmwAZM2rXV3+28k5ClZ5CLrQsDAO5Ruzp964+9rWt+3dDe9M6pTNaDm48MNQeMdT39x+2wiGHB1WGhYeVAUXRqhkyWpRA7Ovh7eeA4bK0LbIyiaKlcni7PEjs6+Hq4Q0wCm6MxQirxlYp9RIrUkJgHBAWr+YCN0TSdLpOnZcgc7e2CA/xJEgZtwMYYhDJI+1SOoz2lDdamcBhYzQIsBlZAAxuj4p6/VHo0aOiVfbEl/BrWd8t6+SIJVpoCdsBEDQZ9+93yVd/1D4EJO2B7mH2dYRPaMdd+3/9EbXoVNCO7e/MJVaNVu3YtGtin/nPrFXy7rviyt9Z98y5WbzAE+Xl7ujpDpg/YnFyhjIiJ02h1VX0hJgErZNq7RgQ0VvGdAmMfeaW8gewzsDmFShX5LjZLqQrw8fbx9IDsM7A5BcGP4LvLSaG/Tuqrz4DsM7AsSKgAG6OlqVLG2VXyYS4El7hKGGlqGo38YXoEsAFH5FNVhBhZhAC+OwM2wBwajvyy1Yxft/7ZavW40Hy3sjPSOzefMTW/bOIsFDavb3fjzs0Xo0Lrwh0lFZhKo01KkzIM4+Ph5mAntHVxAEAarS4xVUrRtKers5ODva2LAwDS8OyTXIMMHL57erQoK8XWxQEA6fT6pNQ0rVbn4eYqcnSwdXEAQDqMTOY6qTGum1EhMSrhiy+wBkjxARuj9DojJhB8zO1hAgEf0+v08EOEAABgEubUdPSYZqoLWw690uV9jkm5ffMVHtq6qQRDgtrN6wsz7t56lu9VoGIwGI3xyamxSclO9vZBfj6QfQY2Z6So+OTU6IQkB3thsL8PZJ+BzVEEJ8k1KNqnnr1GHvzuPmSfgc1RFJWUmvY2Jo7H5YYEBkD2GdgcjbBUjuNbvhuXNoZok50h+wysBhLQwMYILo9gtBrth4Qzo9FoGQ4HlusBAEBBMHGrMaMbys9uORqpz/UEnRB2KwIFhHhkxcXGxkrFVQK58ns3H2ttVE5gLTRNp2bIImLiEULB/r6uEhGGwZcFYEsMw6TLM9+8i2UQCvb3cZOIISaBbTEYli7yeRPQVM/hB8U8cEt/hzOwwx+wMXmWIuJdjN5gCArw83RzxXHIxgAbk5PCN3wPNc4N1KZ6GjIJBOsAgRXBFhzAxnBnVxcsOl1GIxGBEEK0PF2OOYc6w9UYAAAKhLm0Gzfi1oxtm080Gf3pUTouLCzKaKAOLpx68NNLH9x6pG7SHBbHVhgKhSIpMZEg8Co+ngIez9bFAeBTTAZ4ewr5+XYGAqDMKZXKJN+GCMN8k57bq2W2Lg4ASKVSJSUmMgzj7e7uYG9n6+IAgDQaTRLP1Yjhnga5E6WxdXFApQAJaGBjhF9oDbtT4Y/ThlTxwBCikx8/SXaoGeoNP8EAAACFwNw6TRgWNmPXltM1je8foqJu8tnFWgAAIABJREFU3orhNJiy/bsukvdLD9X31kz85cHNh8pmre1hNWK5p9PpkpKStFqth4eHSCSy+PmVSqVWqxWJRCRZnsaHBoMhMzOTz+fb25ezDR9kMhlFUS4uLrYuSMnpdLrk5GS1Wu3m5iaRSCy+6lmlUmk0GicnJw6HY9kzW5XRaJTL5Twez8GhnN1cL5fLjUajs7Nz+V3ArtfrU1JSlEqlW0CQRCLBsCaWPb9arVar1Y6Ojlxuebpfk6IomUzG5XIdHR1tXZbiyczMNBgMEomk/C4WNhgMKSkpWVlZLi4urq6uFv/j0mg0KpXKwcGBZ6U5aY5VTsswTHp6OofDcXJyssb5rScrK0uv14vFYoIorxkLo9GYmpoql8tdPHysEZNarVapVNrb2/PL25y0VColSdIaY2yrUigUOp2uXAzgy2s/DioObp0ePfzeHdlw4P7buMg7+zYej6vas0et8jSkAwAAW8A9uk4YEhR//7+07JuKqciw24nCRp2aiz8NI4X1O7SQqB/d+lcBN9SVaxRFJSUlvX37lsfjhYSElLuRMah4KIpKSUl5+/Ytl8sNCQkp1ylLUDHQNJ2amhoZGYlhWHBwMMQksDmaptPS0iIiIhBCISEhbm5uEJPAtrLz/hERERRFBQcHQ0yCMsb2BDmoBMjA/vPnGLbu3jjvuFboXa/n3Il9/MvrbCIAAJQhwueziQPDZu+JRAghw6ubYSlOzSc0csg5kOSGdmjjeen8zfuZbTuJYIRZPslksvDwcD6f7+7uzuVylUqlld5IpVJptVocx9m/gCIng8GgUCgMBgNNl7MNXhUKBUVR5WsdZTa5XB4eHs7j8dzd3Xk8nkqlstIbqdVqjUaDYVi5WwGtUCj0ej3DlLO5P4VCYTQaORxO2aQkLPj5ZGVlhYeHczgcDw8PHo+nVqstdeY8NBpN9snL118uRVEKhaJ8lTlbdvdOkmTZrIC24HVEqVQ+fvwYx3EPDw+BQGC9mNRqtSqVimEYa62Atg6GYRQKRZn1NhaU3b0TBFE2K6AtGJMqlSo8PBzDME9PT4FAoNFoNBqr7Lyh0+mUSiXDMHq9vuhXs4lCoSiz3saClEqlTqcrswE8RVElPhYrdwMjAAAAAIBKYvv27RcvXuRwOGUwGqZpmmEYHMfL17dBhmFomsYwrNx9YcgewZfZPbwODg6bNm0q/XkOHDhw8uRJkiTLoOQQk2WsjGOSw+Hs2LGj9Oc5efLkgQMHICYLR1FUeYzJ7A+8LPc62LlzZ+mTOBcvXty+fTvEZOHKdUyW5Qe+efPm0m8yduvWrQ0bNpRNTGZfBMtpTKIyvAhaStnH5OrVq11dXUtwICSgAQAAAAAAAAAAAAAAAFhFOZtuAgAAAAAAAAAAAAAAAFBeQAIaAAAAAAAAAAAAAAAAgFVAAhoAAAAAAAAAAAAAAACAVUACGgAAAAAAAAAAAAAAAIBVQAIaAAAAAAAAAAAAAAAAgFVAAhoAAAAAAAAAAAAAAACAVUACGgAAAAAAAAAAAAAAAIBVQAIaAAAAAAAAAAAAAAAAgFVAAhoAAAAAAAAAAAAAAACAVUACGgAAAAAAAAAAAAAAAIBVQAIaAAAAAAAAAAAAAAAAgFVAAhoAAAAAAAAAAAAAAACAVUACGgAAAAAAAAAAAAAAAIBVQAIaAAAAAAAAAAAAAAAAgFVAAhoAAAAAAAAAAAAAAACAVUACGgAAAAAAAAAAAAAAAIBVQAIaAAAAAAAAAAAAAAAAgFVAAhoAAAAAAAAAAAAAAACAVUACGgAAAAAAAAAAAAAAAIBVQAIaAAAAAAAAAAAAAAAAgFVAAhoAAAAAAAAAAAAAAACAVUACukjUmxVNuRiv5aq3tIn/mk93eoQTTvhOuW6wRilLinryfT0Oxu+yNZkpq7dkko8N9/cZejStzN6xuOjkmzvWrD0SrrR1QcoP7YOFdV3arHqut3VBAAAAAAAAAAAAAACrQAIalC1GemrONyf9Zn7fxxWzwunVkaeWjWpfw9NJaOcc0LDX9K130qhinoKK3vFlv/Ez526+Lc89x2C4Mc2fxEzgNv7lZXHfxdJKXnHdu4urvupeP8DFwd4lsH6HYUuOvVLlePbMSDFuqtK5685v9O133SJ+mLz5ja0/CAAAqHj0lyZ4EHn7X5zgObgGNuw+fvnZCHVBRzJpd/Zt3BOWXMScuZkvy30M66eTQcFK0uJ5WT0sSwLCkrVMLO+w+PIFiMkSgZU3BSt1YJRJTBa3Bdkdk1YctwCEoJ8ExVPyC0RBl3gGFMH4enkTDuK2+C2SMvFf82lPDXfEcJ/J1/TWKGVJ0Rn/ndixbeeFV+qyeT/tnTk1uB4jT8lpy5+blt/+rrkIRxhu51G9Tq0AMRdDGCdw6J/vjOafRP9qXQcRjhDitt8Yl6uJaemOHnwMw3AyL0HTX14W4y0sruQVpzNuLGomxjEMt/esXic0QMLDEMLFrX95qHr/Cu2Z0c6cfDUmSZIkCRxDGK/V6rfZH5P+0ZI6XLdBh1Kt0LQAAFCp6S6Od8cRxhV5BXzi42pHZs/k4qLm39/JMnUg9W59Wz4ZPPuuodDzm/mynOi0EyO87VqtemOdy58q4uRPI9tV93AUCCX+DT7/Zss/qea8kS7u2rrJnzcOdHXgcwVOXjXaDJ6364E0z3hN//dUP8LUUJnT6OcXtryaM0yJK86oIs4uH9+1rp9YyOU5uIe0GDB7+91CjixBi+dnrbDUxV1dN/WLpkGeIgFP4ORVs+2wxX8+Nm/cyM6wNPfAYjZiGSpxxT8xRv3xmQued3RNpx8b5uHYdu1rC1XTSjFpVsdSALbG5Ccmm0Z7eoSosJVCNu8ti13xktWo9F2ltS/fTEF/XAVjeUxab9xiZSWquNkDktL0QnlYJSZLN7Jia0yad2ApBi1WZrVrN2Nei5u+xEMCukgVOwFdtujkfX0kZNDMMK0VTq4Km1WDg+Eu7ZfdlhoZhmHUb/aPDOZiuEvv3fFmNpb28S8t7LM733x/ZoYH86uTmKDXXpnly14qJa44nXxosAeOcYOGbHsspxiGYTTRJ76uI8AwQbOVRaTU6fQLE6uSvJoz/s780L1S0evbCXgNf3rGmoEAAABUDNnfFsg634Xn6mBpbdL97WNrCTGEcet//zhf50tnXJ1Wg4MRRXxDM/NlubBxOln/aktPDxJDGG7nWb1+g1oBEj6GIYxXdeSRnBfDijedTGf8Pb+xI44QxnXyqV47NNBVSGAI4/j12/HG5JizJC1uglXCUv3otw4uxIdWrBviYUdiCGHC6uNPJBQ5lmNjWJp5YLEbscxYeXmHZZcvWCMmzexYCsDKmMypgKYxfwGKDZSo4iWpkSW6SutevpnC/rgKwO6YtOK4xZpKfPk2b0BSul4oL2vEZOlGVqyMSTMPLNWgxZrYsTTT1CUeEtBFYlMC2qBRacvyu5FBpzVYsCOgota25pPV5t6zwlCazjjYX4Rhwrbrco4esi6M9yUQp94PT8352FT3FjcQEK7dRvb0IvL/mSkO9bfDiKBZd9g1g1Dyiuvvz6tBYmS1mbeUOR7VXJvsTyBOve+fFPKR0WlnxgaQ/PqL7qlyPErFb+ksIAKn37TG/AIAAFReBXxbYBiGYfTh39XjIETWXfr4fbdNySL/+evgpu8ndgoUYgihAr6hmfkyU9g4nUzFb+vuiGHcaiP3PM/KHrroEq5+184ZR7jX2LOfVvNUuOlkbdjMIBLDndstuRyrYRiGYaiM8O3DgjgY5tRjW44jS9HiJlkhLDX35tfiYhgvZNj29zPjjOrN8W9bSHCEu/TZm1jomJSNYWnugWY3Ypmz9vIOyy5fsHxMmt2xmMTOmMyh0KYxxcQClDJniYp/YmpJjSW7Sqtcvj8pfguyMyatP26xqhJX3KwBSRG9ULFb0hoxWZqRFTtj0rwDSzVosSq2LM00cYmv9AlobezVDdP6tKjmKRJwuQInr+qt+s/6425qjs+3RAlo1ZtTy0a1r+nlJOA7elRvO/Lnc9Hyk/kT0HTms0NLR3So5S0W8gQirxptBs3b9SAtZ+KPitvYnosJBx6KvvJDrxAnEsNwrqNX7e4z979QMbTi+Z9zv2joLxby+CLfBr3nH4vQFLd2z39qyEG8zluS6BxvN+iILOLIjA4BDgSG4Vx7j+rtx/x2LSH3JFnW8yPfj+xQy0ck4HCFEv/63SeuuRpfaG7W+GZlMy4RMP1Wzk9AuqM7D5HV5t77eHZjwqmJNQUY7thk7jWp2X+1yuNDRBjG77I1KdchuuuTfQnEabL8VZEZ6Kwb34byCM/++6OuTvHNn4B+/0l1/SPFIj1J0U1jphJXXP/Pt0EE4jRdkee+R0qZGvMuJlZa8KYsdPrZcf4Er+6Cu3leQ71b14ZL+Hx9FTLQAABgQYV9W2D0t6YHEAhzHH7qfd+rONCHn/NuuAK+oZn5MhPYOJ1MJ/3ehY/hbiNP5coIGR4uCiUR7v3VVd2HhyradLLh/rzqJCKCc1eITt3eXYBhwi/2yT8+VvIWN83yYam9NMETR0TQNzdyTm8zVOyWLvYYxmu3IaaQYRIbw9LcA81vxDJm/eUdll2+YPGYNL9jMYWVMZlDUU2T/01NLkApW5aoeI6zmaqRRbtKq1y+Pyh2C7I2Jq0+brGmUlTcnAFJUb3Q2+KuTrRGTJZiZMXKmDTzwFINWqyJRUsz81/iK/ePEOqerv+8UZdp608+SCa9atStFSjSRN0++tuE9h0XhKmKPrwATObtpZ2b9lm4+/rLVFri70nEh+1d2Kv5gO2Rxlyvo5PPTmnVdPDSvdcjtJKQ2jXcqXdhh5ePadl0+L63uV+JDE9WftFn6V/p7o07dW7uT6Y+u7B6ZNdRi7/t1mrY+jtav8bNa7sZE/47tXxIryX/aEtfOzr1/LTuQ9feVrg37NilbU2nrNfXd87u0XXhp8MUtxe3bzbwu71/R+ldQ+rW8uenP/lr68xurSedLnjneDrx0oVHRseWbetzCnnrpLPTug75/RW38ZxT539p72zuDxUaIx8/VzJElYYNXHIdwqnbuC4HM75+8kJX6PFMxsU549a/ch28YcMQH5N/FcboiGgj4Rbklnjy15ljB/bo3LX3sKk/7b6dUPiJTbJg4JW44nT83XuxFOHXslWV3Nv34Haufv5+vs6CAt6Ryby6ePruhKpfrV/QNM9rcO9WrYOxpIvn/zMUrxYAAABKzGgwIoQY+sOvwgjaLjxx9uzZs2fPnv59bHWyoMPMfFl+1NujB+8ZfLr3zHE5Z9J39uBjnOrz7n8cwFCJpyeFCnHCqem86+lm/6qM+u9TVzIRr9XQgVVyXIwdOgzt5UUYnp89F1nAT90a376MNDBktQZ17HI+TPgG+BKIycrM+lACKjYiWs+QVasFFqPKBdPFXdv4Td+W1b3EQh5PKPKu0XrA7G330or/Cz0lrThCNE0jhHG4nJzDAIzL5+MI0UbqU1FK3OIlUoKwpOMeP5XSuFvHns2EOR/Hvdq2r0EyxshXUQX/0jErw9LsA81uRPOwICw/UNxcMnblY1GftZtGBZjcLhLhnt16NiZijh68XYIRdbGUICbN7lhMYWdMflR00+TBZJyfN2V3UujMzQuaCIt+eW4sislPCqhRGXaVJbx8Zyt2C7I4Jq09bjGFBTFp1oCkqF5IZ9mf7StRTJZiZMXOmDTvwFINWkxhQUx+UET3Yn6Lm7jEFyeVXtEoTwyTYBi32pdHoj6s5NQlXp7dUIDhklFnPqwlLu4KaMXVKVVJDONXG7H9UYaRYRjGkHZ/Qx8/EkMIfVoBTSf9OcANR7h7l2U3krIfotIfbOjjR2KYY4cNH85OxW1sz0UII7x7rftXRjMMwxiTjo/yJxBCGKfq0F0vsrdP0Lza2FWMI6LKjDB9sWpnYgU0QgjjVR93KPL9ceo3f/TxwBHuPOrs+9sCYza052O4pMMvd9Oz508o+b0fWztiWGErwxXHBjth3Oa5X5BrBTSVdG5KbSGGOzWdf938tc/ZVTs3xhlHvI6bEvIcp7s8yRNH3NZrowuZgKJTToz0I4iAMafTaIbRXzexApqKXtuaizCenZDMlejFHOqMPxxVvLlX85rGPCWuuO7KJC8ccTv8L+rdpV/Hdgz1chLw7V2DmvWfs/Pfwn7RQPtgUV0u4Tn0qMnd+pTHBjti3BarirtBDQAAgIIVtlxFeXNGCIkQWXtJ/iepiF+bc4peImTmyz68OnZjex4uHnYi5/ZNee9nohLPfF1LiOFOTeYV64JuCP+uDonIGvMf5C4KnbGrJx/DnIYeL2jhnVGnUilV2jw1kJ//0pfAuE2Wf9yQTnt2lAQjfCefenR85YwxA7p36tJr6JQfd4XFl2D5pfbJus5uBIYwjpNvzQaNG4T6i7kYQpig9txcm1uZoeQVZzS3Z9fgYIR3361P39+cy+gSLn7bUIjhzr12mbzTsngtXhCLhyUVd275zOnf/nYxKU+hdTemBRCIrLng3wLLy86wNPvAEjRigdgRltmvS/9rUhCH8Bl2NIk2Obp+/zYPF4aSRNVv/yn1AjjLd5XmdiwmsDMmP7zOvKbJeYT88tdBJBky/UYxo4hhVUzmPKToGlmgq7TW5bv4LciwPCY/lNEa45b82BGT5g1IiuiF0or7rdsKMVnykRU7Y9LMA0szaMmPHTGZ/boiu5fitHjeS3xlXgFNy4xubT7r/fWPS/pW+bCSk+vZbnjPYIJWpaapSjSbxEhPbtgTRXHqzf3zj7H1xARCCJEujafs+mNcrt+JpCL3rT+dhlz7r9s7v41H9oQPLmk0eeeW0T541s1N2//LuQgas+/249apDbN/vJfw6DmmlzeBcOd+yzeOrJE9F8avNmpsJyFGp6dK6dLXjqgyYfP6gVXfHycIHvXt0ACCViYnKRiEEKLevoowMGTdfiMaS7IrhTs1nrxi1ZKFc3uHYAWcmYp+9kqNBIFB3qaDjkq5ML3rwP895zSdd+r8snZmr33OZlQq1AzC7Bzs8hyH2dnZYYhRKdUFL81OODjl6/2JVcZvWdXTpaC3NUa/iTIixkBW/3LHnXcyrV6d+urK/8bWd1Q92TZ60PJwvflltWjglbjiTFZmJoOYtBNftug+Z+eteNyzqp+D5t29oyvHtmo66lCs6XkxOnr7vHVPiaYzl3zhauqj4lUJ9iMMr568giXQAABgXZQ6Ler+saUDhm2MMGL8+kMGhlp7TWs29YOw//Rk9fq1C7pRBtHJ57/pOmjzC06TuSfP/1ysCzqdEJtAI8LL1yv3ggvMzttHjDGauNjUAlaCEFyh0E7IIxFCTOa7R/fCrpzcuWxMpxE74vl1p/4yvtr789FJkVFKhk7dNaRxvzlrdh65cOXS6QMbF49uXaPJhCPRRtPnLoDqworvr6QRIV8efp0U+/zh/YfP3iW/uzS7IV/7/I9t17VFn8AiFUf8Fj+e2jOxrvrkpAZVqrfo0rNH+/pVQ7qtfuHRa+WZnSMLGHRZTWnCEvfpMXfVmt++7eKRq9BU/KG1B2Mpwr9Lt4JPxs6wNPtACzYiS8ISIcSknpox4Y9o75Gb1vb1KOzjJqs1qC2k4+7ciS3+Oi8zlKqrNLNjMYWdMYkQKkbTfKJ7+NusbdGuA39e0Nqu6Ffnxp6YzKk0NSqtUl++S9CCCLE6JssYO2LSzAFJEb2Qs0Wu8qWKyVKMrNgZk2YeWJpBSz7siEmEzOpeitXieS/xlTkBjfv0X33izIk1A3w/fgrGzMirh65EF2+tfC76B9fDlAyn2egxdXk5H3dsP2pAjq0OGPk/N8L1mLj78M/dct1t59RxWC8vwvg2LCw+R1gQ/g3q50iN4mJnMYbI0BZNnT49yHV2dsDQx2RjaWqHu3Xu1SLnjQS4k8gRRwi9Pz0RWD2Yhxlu/Tx64d5bkTIDQghh4uZfLv3xhzmfBxYwFKMSYuIp3NXTzdTzVMrFb7sN2PhEhewaj5rQWvKpWsZ7c0JIrBDcJstfUQgx72teQJ9EUwVVm4reMXHaMWnw5N+XdxEX3KNhXt3nr163+XjYjU2jm/mLeByBa7WOX2/7a8cQb1z9cN2q84oCD83LvKaxdsUNWi3FIMPTq/dcv9z7NDUj7uXT14my+JsrunkY3u6f9NWuOBP9kuLqypV/qzwGzR8fYrqZCXdPN5xRxceaf28MAAAAsxiffF+P8+kqQNq5VW3a//sLcUauX6/VO2eUUf6ZvdPJH+mvLWjTvHXnPmMX7XqoDhm94/gvHT6OKyrcdDJCCHFEPkGBbgJkSH9z5/K5C3+Hx6sQKfavHugqLN7HXxLWDUsmM3zb2G5fnUzD/YeunNuKX9DrWBqWxTjQUo3ImrA0a3nHexZevmClmCysYzGBpTGJitc0Hw4pYgFK4QezJSZzFao0NSo+y8ZkCVoQIcTmmCxrLInJ4g9IitkLFVpsC8ZkyUdWLI3JkrepuYOWfFgSk1ZZmpnnEl8231bYi5Y/O7v/yOV7j19GREVHv4tLVRoYBiHEK/JI05isxEQFjUtq1PTM81fEqVmnJgdFfXjflPhEI0MEVAvK+05k1epVCZSYGJdIoYCP5yAIPF/7Y9zcW8XlV9La4S7uroVNTeD+4zasvzdw5oGry0deWUHYeVRv2KxF646fDRj4WV3XgkKKVinVDOYpEJgoM/V293ebMMeAKi4x0de+n3P4i4ODP0y34O7Nh0ycVMgkDeFfX4whwt6ej5BarVIzyDHnOzBqlYpBmJ193r+/bMY3m76cfUEROuvkT+2dCvs0OdV6Tq6W71HM7fOvBwUcXP3u9o3Hhi9aFbK5dR5FN42VK45IHo/AEMZtuvjgxmEfNnQi3VvN3vXL7WpjTl/Zfjh6zLdVc4UBHbtv5d5YrMaCKV0L/KwEQgGGaKVCSSNk5nZkAAAAzIFxRZ5eIu6n/2MkX+JXr+u4+XOH1HYsg6/QCCFzppNXbHqiQg6d8k0n12z5a0TBc+Ccxr88uTPPr8TTyTlP1XDS1p2dlPKkF7eO7j+1a2jj10+PnvmhnQRD76eTqxEBHYb3qpX9297Z08keugYD9z9ct+r8N3u/cCj6LRB6P53cP9dDpqeTrVtxJuPyjPa9N7zk1R/3v5+nfNYkSKJLeHJ99/ezf105oPXzzTdPjA+26mDfamFJSf/d/cPMxVvDEg2CakN/P7G1sIV+bA1LMw+0YCOyJCw/LO+Yur/Q5R3vZS9fiIiPTWeQV+m7MivFZGEdiwlsjcniNU229wtQRhS4AKVQLInJXEpXo+KzZEyWpAXfH8nSmCx7LInJ4g9ITPVCV35oZyq9UhRLxmTJR1ZsjcmSHFisQUs+LIlJM7uX4rV4nkt8ZU5AM5l3fv7ii6U30hgH/0atWrTo03VE1eDQepKbX/de8bKkJ8XxgjK3PKEgRxI5OygwE82afQaKLuVNKqWqHY6bKlkOgtBxex/3WXDt1Mm/rt26fefevZPbbp7Y9svCupN2n93Q2+QUFsbhchAyGEwtbmAYTNxqyZmT46LGNxh94tjcBec6b++ZPcWFB/T5/n99iqyu0dvPh0Avk+ITKeSRM6o1SYkyBuN5+7qZbBjFnUu35YjrdHlW55sfS5P1LoVGxv9W9W65j0tWn7R3+6iAAvPxZEBQAImiZBkysxvMvKaxcsURIXYWY0gX0qVbUK5eAHNt26EO5/TtN89fG1FVbo5njE+2b76h5jYbN7aQn5E0GIwIYVwut6xSIQAAUFkQ1b85/3BpXRuP3Ng5nZwL7tdm6Kg2CCH0zdxvtvVpMvHs8okrej5b0ZRTAaeTDQ9XTd/0QucxeM+F3/u/v6kupOWQZadCyJYtfzw/b8HRvocHF3PRULFYIyyptLu/z5+2ZPe/UsouuOeiX36d27eafaF1YGlYmnmgpRvR5mFp9vKODyy7fMFKXWVhHYsJ7IzJYjcNMm8BSpHnsHVMWrxGxWO5mCxJC37Azpi0FRbEZPEHJKZ6oVsTX3TxKX6/acl+suQjK5bGZHEPLP6gxSSbx6S1lmbmvsRX4gQ09WLj1B9upLv1/t9fuyd9muehnv1Xis4Rc/DxEeN0xquXyXQnv5yZPzo+Otb4aYMMd29PEguPeROlRzVybXlDRUdEUYjw9PYo1QDMKrXLjZTU6DKmRpcx8xFi1IkPz66fNeXXG1sm/9Sn6+ZOJm43wF3cXXBaniE38ReDew3feWpJSwnW7Lcf9l2ffHnvzKXD22zo4FiMwlStU9MOexb96ImcaZDjbgHDs0fPDAwZWie0wI2FEKIVMY/uxuR9NDP6v7vRiGPspWEQI3926fLzLIeanbrWzj0ZRGfK5DTCXQtfM56TZZumxBUnq4VW42DJxvwzAjRNI4S4vDwL5fX39ux/YeS1GdSv4HQ8ouUZchojXdwklXl3HwAAqLjYOZ2MaKPeSCGcwyVzPU9WGTbxs3nnd7+7/28K3dSn4EtTeZ1OpmNvXI80Ys7dhvfMtaUbEtQbNqjuL4/+vXXtoWFwF66pY9mJybi9fMig7y4nMq5Nvty48rvxbbzNKD1Lw5Iw60CLNiIrwrLYyztYu3yhFB0LO2OyBCtvzFqAUhhWxGSuc5S2RrZUmrVT7IxJW2BdTOaWe0BSVC+UkKBCPsXImpShokdWLI1J867d74tZokFL/tqyISattTQz9yWeNf1A2dM8/e+FATl2/nJsrrsMNHExKaW4QYTToF1LR8xwZ9eup7n2PtE/PfDnw09/Wpi4eZs6HCb9wv5z0lw7sCj+3n8yjiIDWrcuJMtnBuvULhv1bFWX4CpBHVc8/rDDOCb0ajTwh8X9PHBaGv1OYXJPGTIwJJBkZHFxWfmfxh08PR0xhBAROG7NwuZCKvL36b/cVSNk/lbI9u16tLVHmltHzyTnOL/u/vEzMRQZ3K17ATdYiUedyfdbnbl+61P/YH4NAmFFUrs/AAAgAElEQVRkxN5JQwd98eXWV7l3VTe+PnX6mRF3bd2+jrlDGDObxsoVR5hH188acanIsyfDdTkfp2P/OhduwAQNmtbOVSP9nUPH39Hcpn16FfIFHlHxMfEU4RsSJCz4NQAAAMovM6aTnX2G/vZDJxETt3fm0utZxTp79qwqFf3oiTzXYOH9rGpIQbOqxoeL6tjxHdqseZu3WKSdvQBDjEatYRBi5M8uHjl05K+nsrxDkdJMJz+Ki7p7bv+W35bO/mpYjya+JVj1UvKKMzRNMwjxhIK8V3uMJ+BjHyaVyw31w5979lh4WerT+7cbz27/PtncL3LsDEszD7RkI7IjLBFC75d3fHLvRbKeQXRm9H9379699yxRk+OMrF2+YGbHYhJLYxKhYjXNxwUoLQpdgFIYFsVktlLXyPaK1YKfsDgmyxY7YtLMAUmRvZDp7G0ZKs3IiqUxaf6BJR205MWOmEQImdO9FLfF81ziy2u/awFcNw8JxijuXriV8eGj00Sd/2nQpN1JNEJGfcn+lDHnXpNHBBKGR8uHTtrzLItGCCFG+erPycNXPDLk2IaFCB4+5TNnlHp42qhVd9KyE4+0/NGWcRO2x9AOraaMb1S6xenWqd37svsFusli397437LdL5Tvz05nPt37x4UUmvSvW1tk8u8Ec2nYuCphfPnkZaE/hcqpOXX97Po8w7N101Y/1n+40aAQE/rWF2MIYS59vxkZgGf9tXT6vrfZuX8m/dbSGVsjaceO30yo9/HjNLy7cXD//gOHwkz9yF6B7DuNHRpI6B/8NGzG8UjV+zpnvTgwZchP9/XCJtNndP6Qcc0+//6DN98VUE8zm8bqFcerjJo31Id+9tvQkRvvpWc/po44NnPQwutqPGDEtL65luEYn12+mkCRoZ07FPZb7HTKixdpjH2DJjUr8b0VAABQkbFzOpkIqhsqxAxPr/6dnLtYxtdh/6RQuKh6DS8CVcDpZMKndi1nnE6+fvFRrtlkxCRfu/TYgHFC65WjKzL1auOUZXeVLj03XT0ys4VrMW4FZGdYmnmgJRuRHWFp5vKOj1i7fMHMjsUkdsZkcZvGzAUohWFHTFqyRjZV7BbMgZ0xaQPsiEkzByRF9kIurmb+cIW1lGZkxdaYNPPAkg9a8mJHTFppaWaeS3z5GZRaHLfVhKnN9s3/Z1P3kKvNm1Zz0ia8evI0ylBzeP/GRw4+uPHzoNFpc39Z0MOruOe1a/fDznn3P//53s5RdfZ941fNl0x6E5VhcOk0c3zmhm2JH16Gew3duO3W66F/nJ/Tyn9V9dr+nNTXL2PkesQLHLRp21dBpeyirVU7hBBCjp/Nnd/6/JwbR8bXufBd9ZoBjlR69Ks3KSqGX/OrNd82KaCHIWt1au+54vd7d99RrYMLqR6vwax1Uw53WPXvimn/G3B1RjWzbjRACNm3/3H79LDPVx8ZXff+prb1XFWvbt9+LUPeff7YNDbHbiiasNVjRpzWCQcd+aKVr/k/NunQftm+759+tvjmxv4193gHBXkJ1bEv36SoGX7I8G37v6318S8p+/xafu99n7UJMHU9MLdpzLvDohQVxySf/bZr+qNeqw9Pa35qiX+wH08aGZmionHXtj8eWNk51608VPTVqxFGwrNlq0IHD6oH/4QbhS06t7Izp+AAAADKnezp5Gsvn7w0otYFJ2s5Naeun/1ny+8frZu2enDYorqkefvWZc+qLj33v7+WTt/XZu+Iqtwcs6pd8syqHrsdT5P+rQe08sUxcY/RfT1P7r60ePzq0F3fNHMlEUKM6u3JhWN+DTeSwcPHdbBD6P108qH/Pfhp2IyQw8v7BtkhhOisFwfnDPnpvl7YNPd08rHb8RTh27J/mwBTo+Xs6eSUuxduZfTolP3bOJqo86umfrU7iUbcPNPJVqs4ErSfOK7W3p+frhs5PuTQ+tF1RThCSBvz17JRcy5kYm6Dvx7oW26SLMbH+/f8qyFCZ/0wskoxv6CwMyzNPdD8RiwvYVk875cvtGHf8gVzOxaTx7I0Jovn/QKUOgUvQClvMVl0jSquihGTRSsvMWnegKTIXqhhoK032TJ/ZJUPW2PSvAPNH7SUl5g0U/FaPN8lPm+Ou1KhMx78PrVHXR8nHpfv5F2ny/hfL0SpKdn1Je397Lk8ly4bIowMY3y9vAkHcVv8FkkxTL7/FkD5+viPI9vV9HTi8+xcqjYfvPRkpDJ6bWsu7jP5mj5HAWRP/lwyrF1NL5GAy3f0qNZq4NxdD9KMOU5ExW1sz0Vk3aWPczxqfLy0Lol4nbck0Z8e1F2Z5IljDsNOfpi3MK92z39qyPl0KpNvxzDGpz/U4yBe1z9SPrwhrXhxZOmIDrV9xUIOyRE6+9frPPr7Q0/kNFMI9ZWvfAlB5y0Jn15FS3d05yGy2tx7hpwNI7/0VSCJ4eJuW6ML+5jzoTPD98zp1zTQxY4nEHnX7jJhzbUEQ+6XZO7txUcIEw46mm+C571c8zy5n0m4sWlm/5bVPEUCrkDsU7vjqO8PPc1T5+zzI37vfVkFF9OcpimWElecznp2cNGQViHujnyenXNAo8+nbrgWm++ToRO3dOZjmPDz3emFtbD60kRvwr77tsRCwwAAAEDx6C6Od8cRWee7cEPRL86Bivi1OQcRwbPvFnqcmS/7QHttsi/BabbyTY5LlcmrufLWrJocDLNvs/pVccpNZ1z7tq4dhuF2Ac16fPF52+oSEsNIn7473+Y8S76LGp1y9qsaQgxhGN8lqF7TZo1DfRxIDGGEe8eVDxSfzp55d1lbZxxDGMfRp0aDJg2rewhxDGGCkBH7c75B0VdzXfjyFo4Ywkjn6q179O7ZoVGQCw93qj9ySBMBhnH92oz88VxC8cYwJas4o3m6qZcvF0MYzhP7hdavU9VNSGAI4aImc69ITV6Qi9niBbB0WNJJWzrzEMJIvr1JouY/Pyt4eMTSsDT3QDMbsRyFZV4Fj66ZrGNDRLhdjx0ppR4+WqGrNLNjMYW1MZlHIU1jfLOyGQcRflP/1ps68tP5y01MmlGjHCzQVVr58s0wTKEtmEc5iEkLjFvKT0yaOSApRS9ksvZW6CfNHFmZwNqYLPrAYgxayk9M5mO6eylOi+e9xFfuBDQoY/q7c6uRws5b4ov151P+KP/sKxlwWGXrYpQ11aWJPqTzoMOFJqkBAAAUF7sS0OydTqYznxxcOrpTHX83Rz5X4ORZo/XAWVvDEvPlGSredLIx7cHuBUPbhXqLBFyevWvVJr0mr70UrSnobdiZgDb8u6DQFbD5lkfkxtqwNOtAxrxGLF9hmUvBOTILLl+wTldpbseSD4tjMqeCm8acBSjlKybNXFLzQYVLQJeDmCyTBDSbYtKcAUkpeiETrBST5lUkPxbHZBEHFmPQUr5iMpfSLc1kTFziMYYp6LcTALA4OmZz11ozlEuehM1mzz5QFkdF/Nq2n2ztfz+XciPv8oWRHRsWMuTR2FvhK5qav7UJAACAcsdwb17tVhv8Nr75a2KFvolZdbCf3/HBcYcHsG1nWmAKhGX5pL48qVqPoy0PvPlzgKQkv7bEZhCTgG0gJgHbQExWaPkv8RW5kQH74P6jlk4KfLRlw02VrYtiLbqHW0YN3+3yzbj6lSn7jBD1dtfa0/gXS2Y0gewzAABUbJzGX33TDr+560AkVfSLyy8qMS7FO6iKrXdXBGaCsCyPGNmFncdSgsbN6FXhss8IYhKwD8QkYBuIyQrM1CUeEtCgbAlbzF89Gtv34863FbSLIdybTNz599FxVSvuCm8TGNmFn9e+av3D8oEeFfD7AwAAgFxgOhmwEIRl+VPRly9ATAK2gZgEbAMxWWGZvMTDFhygzDFZT04fifDt27eBGJKVFYQ+4uL++3Zdh7TygjktAACoDJiMv75qMuTN9H8vT6mQM67G+P/uZPk1r+lSub4slHcQluUKIzs7rt6YpAX3zk4MrIjNhRCCmATsAzEJ2AZisiIq4BIPCWgAAAAAAFBMMJ0MWAjCshypJMsXICYB20BMAraBmKx4CrjEQwIaAAAAAAAAAAAAAAAAgFVU6AlnAAAAAAAAAAAAAAAAALYDCWgAAAAAAAAAAAAAAAAAVgEJaAAAAAAAAP7P3n2HR1FtAQC/s7237Kb3RglVOoIaegkIgqGDIIICigpYaCKigvQiwqOIUgTpQZDQCYHQexMIhLQt2d53Z2fm/RHEkEIC7GR2k/v7/L73mJ3cPTtz9+7MmTtnIAiCIAiCIAgiBUxAQxAEQRAEQRAEQRAEQRAEQaSACWgIgiAIgiAIgiAIgiAIgiCIFDABDUEQBEEQBEEQBEEQBEEQBJECJqAhCIIgCIIgCIIgCIIgCIIgUjCoDoAy48ePN5vNVEfxAjAMAwDQ6XSqA/F1BEHgOI4gCI0Gr69Uwu+2FUEQKIoOGjSoT58+VMdSTdLS0rZv307e158gCIIgyOgAOI4Xt4wgiNcbxzCMpMEQbupS4KYu6YU2tUKhWLRokddjgCAIgiAIgiAI8ju1NwF9//799evXk3G6ThKj0QgAkEgkVAfi6zAMM5vNLBaLz+dTHYuvc7vdNpuNy+VyOByqY6kciqIFBQVHjhyx2+1Ux1J9tFpt27Zt27dvT6PRxGKx19tHUdTtdpPxZXE4HE6nk8/ns1gsrzduNpsFAgEZGUaDwUCn00UikddbRlEURVEej+f1lu12u8vlEggETCbT642bTCahUOj1TU0QhNFoJGlTu91uj8dD3qYWCoUMRiWHTw6HY9KkSV55U7PZbLFYvNJUpUi9mEEev7uY+lTxBq+euQU4jgMAIiIiXr0p2CerAsMw2CcrfS8cx6Oiol69KavVajKZXr2dqigecGCfrDbV2ScJgvB4PFFRUa++c+12u8Fg8EpUlYJ9sppVf5+MiIh49bdzOBx6vd4rUVUK9slqVp0HS8V9Mjw8vNKzoXLV3gQ0ACAsLMyPvhIcDgdBEJlMRnUgvg7DMB6Px2azhUIh1bH4OpfLZbFY+Hw+l8ulOpZKWK3WvLy82NjY8PBwP/raeoVYLA4ODqbT6VKp1OuNu93u4oSa11u22+12u10oFLLZbK83zufzRSIRGQcHbDabwWCQcanP7Xa73W6BQOD1lm02m8PhEIlEZOT6eTyeWCwmIwHN4XBI2tQul8vj8ZBxWaV4U4vF4kpz/V68TrZhw4YjR46Qcf2prOJ8EJ1O969hliAIDMNoNJrfnTBgGEYQxMsdwb/oG6EoqtPpjh079uqtbdu2bc+ePdVzROrXfRJBEL+7c7Ga+6RSqczMzHz11tLS0jZu3CiXy1+9qUrBPlnNqrlP5ubmnjp16tUPqA4fPrxy5crAwECvxPZ8ftonAQAej8d/+2Q1bHAcx1EUzcvLO3DgwKufBp4+fXrevHnBwcFeie35ivukPx6YwT75fMV9sqCgYOvWrS83p6FWJ6AhCPILer1epVKFhobCOwAgCKqFPvjgg169elXDG1mtVqfTKZFIquFU34tQFDWZTBwOh4wLPKQyGAwYhpGaNXM4HEqlEkXRoKCgd99911vNDh8+fMCAAd5q7TmqftXHp3g8HqPR6I+TIYxGo8fjCQgIIO8k1uVyKZVKp9MZHBzsxT757rvvjho1ylutPUfx9XWSLvqSB8Mwg8HAYrHIuPGIVCaTCUVRmUxGXibL5XKpVCq73R4YGDhs2DBvdf5evXpNmDDBK009n8PhsNlsJM35IA9BEDqdjslkVs8ldi8ym81ut1sqlZKXpnS73Wq12mq1BgYGjh071ludv1OnTl9++aVXmno+p9NptVoFAoFf3GZdklarJWl+DKksFovL5SL1AB5FUbVabTab5XL5lClTXrrz+9MJBgRBtQ1BECqVymQyxcTE+P40bQiCIAjyERiGaTQag8Egl8vlcrnfzUKCap6nfVIqlUZGRsI+CVEOwzCtVqvT6aRSaXh4uN9Ne4RqHhzHtVqtVqsViUQJCQn+NSEAqpFwHNfpdEVFRSKRKDEx8RX7JOzQEAT5KAzDcnNzMQyLi4vzr6lPEARB5MJxMloV8HiC4trZ5LQPMJSMVpkAyMVCAABAXWS0D5hkzSkjo7ASAIAgCL1er9FoeDxefHx8Nc3TvHaCjFb5APABAAVktA0AACA0joxWGQDIAQBOB3AayWgfKLxQy7tc5E37MhqNKpWKy+VWX58kZ8DhsZk8tpi89oFZR0ardADkdAAwDzCQ8ySVqydJaRYA8ibHGjkSFT+II5LExcVV09xhcn6kuAwal9QfwfSNZLSKFI+TpHLYyGiVvJsITMJAVVACSxIQGxtbTXOHL6ST0SoHAHKj55O1E570yUKSmgfgn8tktCoEgKT7rSz8AGVgPF0ojY6O9srzdWACGoIgX+R0OnNzc7lcblRUFJwjA0EQBEFVYbValUolgiCRkZHwacyQL7DZbEqlkiCIsLAwv6tJAtVIDiZXKQjxIPQQq1LcqAnV4UAQcHCEyqBElMUN0mRLmjanOhwIAi4WTymPc7IFgbocWROv9UmYgIYgyOdYLJb8/HyZTBYUFER1LM9FqPbNnFM0cOmopPJu2cP113Zu2Hri6mOLIKpJh4Ej+zWWIs9bDkEQBEEvq2TJSJlM5ndPo4JqnuKSkRaLpbgODOyTEOU8NKaGrzCyxXKHTmHXIgQ5t/tAUJVhdKZGHmOQhAYY8hV5V2k4RnVEUG2H0RiagGiDOERqUkaq7tBwjxcbhwnoChQ8oDqC0gKK/6dAT20Y5SDpBrSXRS++dcIOgIHqUMp6eIPqCJ7BBsAHn1Wh48rUwtDw8HBff0wK4Sw4vnHPTXvL8o9dsce7fvh+B/bmyE8GBhRlbPr1+7n0hT/0jaBXtLyao4cgCIJqCFgyEvI1JUtGwj4J+QICIHquTMMPFLitCYYHTB87gYVqIQIgBkmIOjCe5zDFPzzLQp1URwTVeghiFAaq5HEclzUu9xLb7f2STfBoAIIgX0EgSAE/xMYS+PwjB4miY4u++TWrwOwmKipf5r7+11+Pwvst+bBbBB2ABnLjg8n79t/q+WHdW+Uvb+RPz1KvFEEQhYWFSqUyJiYmPDyc6nAgCIJqLJPJpFKpWCxW9ZWMhKDnslgsSqWSTqd7q2QkBL0iK5OvFIbQCCLK9JiHklMFG4JehI0vUwYlEggSUXhLYCWl8jsEvRAbV6xUxOMILUx9V2gja9orTEBDEOQTPDTGY2E4AkCc8SGD6+Pl2BDJawMmRb5NmM+s+v5EuWtgebfuWINbNwstntlMj2zWNHDnldtKlF/+crxRVM0odG02mxcsWLBhw4a8vLziJfXq1Rs/fvyYMWPgkyQhCIK8yOFwKJVKFEWDgoLIe3YcBFWdy+VSKpVOp7O4DgzV4UAQcNPZSkGQncELtBfJHDpYBQaiHMrkqBVxFoE8UPtQps9HAEF1RFBthzJY6oBYs0AuN+Yr9Lmk1iaCCWgIgqjnZHAeCyP4HkeYtdAvyrExJeFxEkAY7nMrOJLFtRotEaCQ/ZtVpskUMkKrKfJUsBwHTxLQubm5c+fOfdoOl8tNSkoCAOA4bjKZvP5BcBwnCMJbLT948CA1NfXhw4clF965c2fChAmbNm3asmWLt05HMQwzm80kVZPEMMz3N3VJGIYBAOx2u8PhIKNxP93UHo83C5Y9bRkAYLPZKt0gDoejeGUIIgOGYRqNxmAwBAQEKBQK+KheiHJP+6RUKo2MjIR9EqIcjtC0PLmWGyB1GsLN+XR/OL+AajYcoWnl0dqAKJFZk5CdxcDcVEcE1XYEQtOLQ9UBUSKrLvHxeYaH9D4JE9AQBFHMxBIVCEMV9iKFo+bcf4S5XR6Ey32an0a4XA7idrk9FSx/eu3bZrOdP3/+aTtNmjQpTi8SBIGiZJWr80qmTK/Xv/POO7m5ueW+evbs2SFDhuzatctbhSDJSC8W8/1NXS7yNgjc1KVUZYOQ97mgWo4gCL1er9FoeDxefHw8i1WjyjdBfspoNKpUKg6HExcXx2b74ONFoFrHyJGo+EFsjzPW8JCDuagOB4KARagoDEpkoc7YnAscp5XqcCAIWPgBSkU8HUOjC27wnObqeVOYgIYgiEpF3IAirjzCUiB0W6iOxZvoLDadMDmcBOAgAABAOBxOgilkVbT86R/GxcXt3bv36T/37t1bXA6bTqeT8VRGFEXdbjefz3/1pmbPnl1R9rlYVlbW3r17R48e/ervZTabBQIBGROsDAYDeZsaRVEyqmE6HA6n0ykQCMgocmIymYRCodc3NUEQRqORpE3tdrs9Hg95m1ooFFZ6HYXNZsMJgJDX2Ww2pVJJEERERIRAIKA6HAh60idxHA8LCxMKhVSHA0HAweAqBSEonRFsU0ucRqrDgSDg5AiVwYluJjdIky0xKakOB4KAi8lVBcY7WIJAXY7MogJE9dWBgQloCIKoQSC0AkGoncGJM+ewPTVtbgItQCFHHukMOJDQAQAAN+qMSEBSAKOC5U8zVSwWKyws7Gk7HA7naRqLTqd7PU4MwxAEefWWXS7Xb7/9Vulqq1evHjt27Cu+FwCgOGaSEnxe2SBleWtTl1VcDoJGo5HUOBmbmiAIQNqmptFo5G0NULVNTca7Q7UZiqJqtdpisRSX1iWpKg4EVV1xnzSbzXK5XKFQwD4JUc5DY2r4CiNbLHfoFCatX9T0g2o2jM7UyGMM0jCpoSAq9xoNJ+ueQgiqIozG0MoidZJQqUkVobxT/X0SJqAhCKIASmPkiiJogIg1PmIQGNXheB89Mqkef+/Va0WDYoIRAHDVtesqYf2kMFYFy/09WXXt2jWzufI7d65evWq1WuHEPQiCoCrCcVyr1Wq1WpFIlJCQ4K0qRhD00nAc1+l0RUVFIpEoMTER9kmIcgRA9FyZmqfge+wJhmwmLK0LUY0AiEESolbE8Zzm+OwsFuqkOiKo1kMQozBQJY/juKxxuVfYbhslUcD7QyEIqm52BjdbEsv1uKKNj2tW9tmTfWTD+m3n1DgArEY9ekTmbF++5Xx23oOsTSt25cWl9GjAqnC5n9NqtVVZjSCIKq4JQRAVnGfmvTtw2RU/maKD5h9ZOLJLk1C5hC0OiWrZ9+M1F3Q1a8abxWK5f/++zWaLjY0NDw+vwZk+e27m7KkT63VK4bbsJu/5Ub+lR2/an9wQij3a0rJ5MtKknP8YvVef85WDCNeZZR8O/N+tst8d+8P02ePerdcwiRueKG/eu993e2/aqu9eV6+zWCwPHjwwm83R0dE1u0+WZb+fNnt4x3oRCi5fLE94vd/UbTetvrwrXWeWjB646mbZPkkYr6+fMSb59SaiiAaJPSfOP6nygacWYPmX0kZ+Pik0ZRi7+/tRY+d9vO+B7t+ti+XubdllINKhnP8YwzefoPEfSOMMHHGUOTfKlFubss9++CNImHevmBX5xV+Xnxm6sfyrB0dOmxk6YBy738Soics/PvhI51PfLcKye/W8yBnpz4ZNWPOvTFuyvPH4acL3vqk/be0nRx5rCQAAsPGl2bEtdQFREcrbUXnXanT22ZN/bvvIj8aEJvdmt+8fNWzmx7vuluqEhOX++qXfJw8aLHprQOKYhfMv6HxgwAH2xxmzvxxX760u3KbJ8q6j+y06/PSoozRCv/ubYZFDfr3sK8cbAAAACMvuX36InPp36agI+4UjO3tNmiEdPDnk40VDdt7OQQEAwMERZYc30ciiwtT/RBdcpyr7DOAMaAiCqpmJLS4QhATZNQEOPdWxeJ2n4MJfaY+wNv1bBQFGbP+vv0BX/7biq11OXliTlC/H9o2iA1Dhcv8mk8m8viYEQdWMKNq/Yllaxtsf+fgJLAAAAEJ38LPkfuty5S36vfd5AltzKW3bygldTxekZ85q4f3639XO6XQqlUq32x0UFCSRSKgOh1xozt5+I5em2+RtO/fsH+LJPp+xc8P3x64WnVg9sDELIILoLl07xJU6xcK050/eUAcqFL5R+IHQHV3xv0MZ3YeV+u6gDzb26zUj3RLUtveg/uFodubfO1dMPHa+8MTOjxr726Vnl8ulVCqdTmdxHRiqw6lu6D+r+701Md0c0rb/qP6RaPbxXTvnjzh2Ou/EocmNffKxi4T28IpV6Rk9R5Qez53X5vTvP+s6r2Xfvh93tpzbu+urgRcfbfzr505S6r5MhO78r8nTj+aK4/t175XAMl86fXrlku9OF83IHBXPAwDhh3dJbltmEDCcO3NXHRTvFkfInEUyh843BoNq448/gkT+yc3jDhUUhTQokYIkdJf+SJ6TkSuK6de5awLTcunsuZUrF5zWTs4cGuMbH4TIz9wx7piyKLheycypO+9kr5l7M3BFlzYtewrdd69f/WXNiuPqj7dP6U4I5HJdjlyfV9PrwBC6MyuTJ/+dK6nTr3f/BKbxUsbxlfO+PK2Zl/lh3Sf7znVvzidfzrrLadk5+eO2tnNHj3/12e1HPy3+ua2Iwi8s+mhXv+GL0q3ytl179Q/xZJ8/sXP9t8euqE+sG1rmpxnP379g3K7soojWvpA3/xeRf2rbuCOFRcH1n4mKsB5cs6Rvuj64boPB3aTOh9e2blmVkfvBnh/e5YrkcmO+Qp9LeZ+ECWgIgqqPhqfQcWRRljw+dZfdvAiRdv9uR/cSCzhvfL3jjaf/oiuaD53efGiZP6touT9r3Lgxn8+32SrZrQ0aNCDjoXMQBL0azKHNuXXx2KYfZ2xT4UFUR1Ml2MMNP258KHt7w5nNw4qLGE0dOqVt54UrFu755I/BMj9ORGAYptFoDAZDQEBAVFRUzX+aJWHdu2r9IXPwyEU/r3lTSgMA4MOPzJ/YY+vG6Qe7pPWW0RRt53zfttTf5Oz6uvmZ+tO/7B1L8ebBHPr8W1dOb1oyf5umzHeHMO+dv+CQKXzkr3vWdJXTAAD4xCPT3+2xbvn0Xf3TBvpI8rxyGIZptVqdTieVSq7AJK8AACAASURBVCMjI2t+nyyLMO6dPeuQIWrkjow1KUE0AAA+9cjnHXv8PHf61qFpI4J9aVdiDl3erSuZmxbNLadPAvzxlh9+uoq8+d3Ogx/FswDAx701LPmjtTNXv//mV828/yTjqsHVGzaefChssWHlp8MUNAAAGPbGlI++Xbgrbc+7nw0WIrSAZnO+bvbMXyDIlUMLO11sPHFySkfTA3otLK3rhz+CmCpz7JoraoA8M4LgRRu2nX4oaLph4dhhchoAAAxoM+Xz+Qv3Hdzz9oeDhdR/EEx9duyG66XDBq4Dew5nOIMmf/v5vEQWAAAflPz9Dwu+OXh694huU9RZjNowEx9Xblh/+KGo7YYN04YF0gAA4P1OU977YuG27XsGTx8sQgAgHv/16093kDcn/nRwUAQLAHxw82HDf1y7bPf7LUc0oyoTSVj3rlxzyBQ8ctn/1rwlowEA8JFH5o7vseW36Qe6p/UJKNnnsPy/xs7NUBOIT/3sYeozY9dfK9MnCdPVfWMP6er2mXBiaJwYAQTo8taq+SOPpq+/33+J/ALTN5655VNbEoKgGgtHaLmiCBNbHGt6VDOyz1BJXC53yJAhla42ZsyYaggGgqAXQmg29I1MbNHzw6WZRX4zV8d6/tRVtzB5cL+nJfT5zfp0CafZ/7mV41M3Sb4AgiD0ev29e/fcbnd8fHxQUFCtyPRh2RlXrfQ6PSe1lz75tDRxhxG92zIcp87dLfdsCVcf+nTZtdiRn32eQPFMGkL7Z99G7VsM+mrpufJufPfczrhgpicNnNRJ/u9Hk3UYP7Qt03Yq46pPnAhWgdFovH//vsPhiIuLCwkJqRV9sizP9YwsI73RyEndg/7dlfIOk8a0ZVpOHbvoU7uSKNrat0GbFqlTlp4tr0/iBXt3nbUH9Jw0PL54nh8tsPvkIfHE/X3brlE3vc/x4NQDj/C19v0U//YuTlyfFgE0V+EtZTkfwsQW/YPe/fqXG3GDRswKKqqN2Wfghz+CHtWK5TsygtoMjH52DHE8OpWNCRu37id/uvej+7wmo7lUt9Q+UIYDU69YlZYR2GJg5LNh4+Z/lE4giusSywIAWISKB4m9WrWLZqAPlNdv1IrsMwDAfvfUPx5hi479Av/dONzEPm0UNGferUIcAABwzd5DN+2SdpPejngy4AS0ndwrgsjJ2HaXuq8tdj/jioVet9ek9rJ/x3NJh1F92jLsp87efmY89zxeMWNFRli3gYm+dLcypl7x856MwJYDo0rln217D17K5zea9k6sGAEWfsD96A6tJkxfPLp9J/MNH8k+A5iAhiCoGrjpzGxxNA6QWONDdi35Sa59vv3229DQ0Oes0KJFi7Fjx1ZbPBAEVREi67305JmzZ85k7ZvSgqoZcC+K0WTM8lWrxrXk/LfIY7HYCZpUIfPLg1ubzZadna3T6SIiIqKiolgsfyvQ8NI8TiCOaNisTlyJ/YZwOFwEeNxoOcknwrR32dqDsj5Lh8ZRvo0QSZel+/aePbg3a/NH5Xx3PHYgiWnYtlFciVNXhMvlggo+mo9xOBzZ2dkajSYsLCw6OprN9slKE9UDtQFpQsM3mz27K3lcBHhcbp/alYi029ID+88e3p+1dXw5fdJ96/xNlNWkdev/Shsw6rdpHkDkXbpGXfVgevSYiWNW9U0oMZ5jFoebQAQK4TPjuYPBeSiJUfE5lxYuyxB3Wt4vhPJBgDJ+9iPoubZ7w4zs8FmfdG1Sap/RI8aMG74qJbbEB8EtDjeB8BTUT3/2XEv7Y8aj0FkfdSgdNk2YEMwBltwMHfdRVLOCoDqBmkuF5/IwhjRR4YPbnxz0+DFffroqte4z+87mJGhChYgGAABo9vn7Hla9hq25//1N/ab1A4D60l0TZQOOxwnEkQ2b13tmPGcXH3V4SkSFXvv1+xl34md9N6SJD/36ea7t2TTjYdis8Z1K90lPzvG7LlZCvdfFvMehDfOD6gQYCxI8jI+7tuob6UMjJSzBAUEQuexMXq4wQuwyBdtUlB9HQOQJDg4+cOBAz549CwoKyr7atGnTvXv31qKUCgT5EYaiTgsFAIBQXhX5y3kTv16P4fUAAADgTrNBr827kb588lZdaN+FqZH+8hmeQFFUrVZbLBa5XC6XyxGklv1Uclot29bq2UVE/rGMLA+jSaOSCakn7Fc3f30I7/fjwNZlX6t+jIA6TQMAAIT6Vjn1LLkdlh3r8OwiPH//31keZpNmSb4QfkU8Ho9KpTKbzXK5XKFQ1Lo+WRav+7JL3Z9dhOfv2Z2Fspq0auJbu/K/Pnmz7HiOq3NznEhAZFjJzB4jLDKCjufm5GMgmJrRkxPeo1s4AAAAwmm36o26G+cPTD5iCX1jROq/1U0wGl3DUxg4UrlDxz+36O2jWL/pvVv7UFao2vnVj6D93v5R25StRk6bGAkWl3qNE9qjY/H8FcJpt+lN+huXj0w+aQltOzA1kOKRx/7g8KhdmlZDP5sYXiZswOk5ZMC7uZt//HblnW7NWtNU966c3XiH0X1Y31F+U13plXEje6REAgAAIJw2i95QdCNr9+R0c2iHj4q/ubhOleMCASHPXEpgBAVH0PDcAg0GAigacNos29nm2UV4/tETWR5Gk8aJT8dz+40No1Y9bjV57cS4snufMvb76aN2qFsNnzIxonRUuFGb7UAComMzrhxd/duUiwUOcVBYm2avz+jfvCHXh/okTEBDEEQiPUei4geHWJVSl4nqWCAvwzAsJyfHZDIFBwcXz31u3LjxlStXZs+evWnTJqPRWLxaSEjIuHHjJk2axOVyn9seBEHlwDDM5XKVKrDOh9+mp7B7i7u2mHoJBYAmfX3GgZX9Qn3u1LtCOI5rtVqtVisSiRISEhgMLx+Wl+o2BOGd25kxDHO73aX7pFeaBgAANOfE/1IXnreFpkx/O6T0zsQL1/381+PEobs6iH3odKqq3DkHf0ydddIWMWj6IN9LEQEA/q0Do1arRSJRYmKif/dJDnnXvF05+6alfnHIFv3+9PdifHNXlouwWW0ETSAUlIwZ4QsECJFvs1Nf7wAvXDzpi6n/YAAg0obvHvi8dSgCCIDouTINP5CH2hIM2UxP3vL1Rx7H9d3VzjvzY0nqkziOoyhauk+ySMi9+P6PoOPezKXpuQ0H7egeyACaClfDVYunfzv1PgYAIq3/9oEJzUKpHeUd2TN/OZZbv9+OzgoGKHrmJQQxioJV8Y0G9Lx+bNXF7ZuubQcAAEQY/9aElsGv/uDEUt0Gx3GvdEsMw8rpk6/eLgAAz1s8btzUOx4AEGmT4Qe+bl/cCQm7w0bQBHzeMwMOlytAiHyHk/oB5wk05/jK1PnnbKG9p/f999tjuzpz+ubclp/vSI1ggDxq4/uP48HMFUdyk97d0bVMnwTAQKdrATCf/mVsmiu+WaOxjenKf67v3PP74X9MJ77p1PjVbnD0Yp+ECWgIgkhBAKDhB+nZ4ihzLh+1Ux0O5E06ne6HH37YuHFjUdGTH7/ExMRPPvlkzJgxCoVi+fLlixYtunbtWmFhYUxMTFJSUi0tGQlB3lB8EutwOEouhAno/9DC3vlhY3SuMvti2trf5qT0pR/Y80VLAdVRVYHFYiksLGQwGDExMSRdnyvVbbyl/D7pjZbd6stLFy+fc+ixO+ytVUvHdyszqdh2cfviK8zeP6TU87dfFXfh6aXffjNn7313VMqq37/pJvHF/LnFYlEqlXQ6PTo6msd79SxKOUp1Gy8m+zweT+k+SU4C2p1/bOmXn8/Zfscd23/VrgXdpL64KytEEAQByo0Yx30gHYTI3hkzMVptyL57Ye3BHSnTaDvnDwlVBCMARJoeF59N2K7uX3yD2XtqB28NAiT1SQzDyumTLKFXGn+Gj/8IEvb0Db8tNzdY+227GBoAzym7gEjfeW9MtMaYff/q2iNpKbORA9/0aEnV/QWEPX3zH8vN9dZObVUqbBtPqgxOJIAjd+7IYTu0jboNSUtJasB337+R9dWGw71n2bbOHvTOqw0L5I2TGIaR8dsNEMU7H38drdRl3z6zdt/GlM9pBxYNaMkDxbFXMOD4RO0it/ri0gWL5xzMcYd3XLVi4pOjDsKSvuiH5YY2a1enxNAB8JGa6oQ9fePm5Zb6a2e0KdUnHRyhUhHvcl1FCNyqpY356qufm4noAACix7D/LUg5dHD6qZZpHcq5TavqSnUbHMdfeg/CBDQEQd6H0eh5wnAPQo83PWJi1D3VBCLBtWvXUlJS8vPzSy68d+/ehAkTtm/fvnv3bqlUymQy69evHx0dLRQKYfYZgl4Fg8HgcrlisZjqQHwVIqyT3KcOAGDEmMH1Uxp/Nm/G1qF/j/a5GWAlOZ1OpVLpcrmCg4MlEgl5b1Sq23irkAKdTudwOKX7ZDm1l14EYbmwfcXoZYdvoIEdh01bPKZDA36ZaAnj7j+O5Ck6rnnrlc6jqhthuvDbN6Pn7LnhCun44dLFk95uQH1h09JcLpdKpbLb7YGBgQEBAeS9Ualu460jBAaDwWazSR8nCcOF1Z+PnvbHDVd4x89+WzxtQAO/6omgeLIzjdA/O9mZsFmtBCLg86j/MAi3TtOWdQAA3Tq/Gzu32bI9006N2t3DKHfonsRGmHfvPp0X0HZNW699i0gaJyvokyQk3Xz6R5AwXt4x9pC776QhQ+SVbViEU6fRa3UAAJ3eGhy5pPHqAzNOtP27m4SKD0IYr+4bexTt+0n/IQElw6ZrQpNyJXK5Nkd2/4/xe3NZzQbvfq9FEAIA4DVt1X0H19rwh6wZB9v3HhTxKlm2suOkV7olg8FgsVikjJMIt07z1+sAAHqlDI6d2njhHzPSO/3dNwDh8gQ0Qv/sZGfC4bASiIDHoXjAISwXti0eveTQDXdgxxHfLP6wcwNBcUSEMfPnsTucfedNHkJRUaLyEMYre8cedvf9NPWZrxJC1wYlPhIHyo35kXqtACCs+m/OeE30pLo1wu/c9402R3dlXH1o79DkVS42lOo2dDr9pX++YQIagiAvc9NZj0WRbI8z1ppHI3zi8ibkLYWFhd27d1cqleW+evLkydTU1PT0dJh0hiBvQRCETqczmc/eO+cbM0co5H54/M8z6qg3U9tHPB1t6FFdujSgZ9y9lY0BHzn3Lg3DMI1GYzAYpFJpVFQU2UNl6W7jJTQarZw++SpwzY7ZU4bvVSraDtvz1eDeEeUXdsVVx9edcUQP7PyGHxV+xQp2TBo6/I88RfLHe34c1zvG5+5dwDBMq9XqdDqpVBoeHk6n0yv/m1dAUp8sf5z07gQILG/Hhz2Gb8hRdPl6z9IpveNJmSFONlpQZCQbv/Q4z0yAp4k1TFlQgNHqRIeRu+8r5i68+edNU1STtu0DEQAAjtC0vEB3p051VtzMu5UlSa7zNN2Ca7LWXXBGv93ei4NAqW7jrQQ0giA0Gq10n0RdXmkc+M2PIKF5lF/oMW6bN3nbvJLL01v3SaeHdj29sn9TzZ0/75ijGrZs/1/pZFrUa0kN6P/czdVggJoEtCa3oBAzbVs8c9szdXYP937zMD2k8+lFPcUFBTfdtAZJcSULPgvrJLRknkl7rDQTEbJX6EfV2idfgTv/6p/XDVGvvdU+uMS+a928Ae363exCDAQwA4IjWcSlAvUzA06RpgCn1QkNpGrAAQAATL1j1qfDdxcqXh+xZ9qw3pElZ9oTmnsPCj3abZN6bZtU8m82t260mR415PS+8a0oCJ3QPM4vxEzbFk7btrDk8vSUN9Lpod1OL00JFItD6eC+XFYyQU2TysIY4LzNYSdA2cv6VVe2T750t4QJaAiCvMnKEuQJw2ROY5BNA4AP3M0HedX06dMryj4XO3LkyObNm4cNG1ZtIUEQVBs9+PPz0Zvrzm9z4uOop2enhNlsIRAu5dNqykMQhMFgUKvVPB4vPj4ePpG1BOzOpjmj0rRJw3/cP7FZYIXJBiLn2PEsNGhcch1SUpik8NxZ/cmoreqkcRv2z2hX8UejjNFoVKlUHA4nLi6OzfajvH7189xZOnzUb4VJk/bs/6GjD+7KqmI3bN2Que1ixin7gD5PpsNh9y9e0SLhQ5oqKPtYBWc+n5dRd1ziiX4KC1uk4gezcHeMKt9FIFw2vcR4TuRkZmWh8nHtYv1nECCNf/wIIrJ6r08dUP+/GgaELetoxnF3zIjudSNECWE0AJQXPl+SVXd0/Ine/z2SjrA7LATgspkUfRBElth6ar+6xWG7WTwrj3E1bddZZ8yITnERotgwGkA4bAFCGCx2HMhKhG0z4IDFYbN9ZgeQK//E57OP1P20/omBQf9tBJvNQiBcDgsBALDiWycytt28csrRuc+Ta3b4/Zv/aEHgkPpS6sZR7M7GWaP2FCWNXLD/sxZlxnNE1iRl6octS3Rac9aePced9UcMaB4hbRxGzc5FZHXaTH233pM+yeBYeYyr+3addcSO6BIfIY4LowHACW8eTjtQqM4jGsQ/Tfdri3JQIA6Q+M7tOjABDUGQ1xQ/cjDUqpTARw7WRBaLZcuWLZWutnr1apiAhiCIVMxmyW+Kf0v7de35Ud+1Lk6jYJq/f9l6lwganZzka0e3NptNqVQSBBEeHi4UklAD1K+5ri7bfMtVf9Tvnzwn+wwAYTiaeQ+VduxSz9d2b8VcZ5f977KryeTfp/lc9tnhcCiVSo/HExISAiv8VM55ctmys65ms36f48/ZZwAALbR3n5ZTvzq68o+HPUfHMgEgLGd++eM2SJgw4BWfUfUKmHUavCk4nvb3id2Dv2ggYAbZNBL74307T9wlxKNfK1HKgDAdPfcQFb/eJdF/BgHS+MmPICJPenNWUokFuGb+tVMnLPFjB/cpnkZKJNR7k5+Zdvjk+S7vtC6eh4qb/95//i4hHt04jKIPgsjrtZ1VD7hYPGVQopMtCFZnrsnYfc4aNTa1x5PZr1H1ugScWHXi2I6OQwbKiz+J7URa5ikPt9trsX55f8SLY9Zr+iY/PS3twPm3R7Yuvr0HN/y948RdQjq6RTQDAEBT9O6UNHXh+ZX7C3q+G8YEgLBd/+WvhyA6dUBd6jqp6/Ky32+4ksb8/mnZ7DMAAJE36zOrWYkFWN78rLQTpsZjJ4yhYu7zv1HVbzerPnCzeEp5nJ0jDNSeXXdq9zl69NiBKU+iQoL6tYucs+nkN6ebbmgnYwIAMOPeHacuEOL3Wsf4zhVmnxmdIAjyZwSCFPJDLEx+jOkx10PKU48gyl28eNHlqvzmwbNnz3o8nmqIB4KgWgsJePubL9senrqwe9tbA3s3DyHUN47u2nPZGJ66bloHHzr1Q1FUrVZbLBa5XC6Xy711I21NguXeOqsjWPwbc7+d9+yZICJq9u7Ct2OenKvYbxy96ea81ril/8wdxx5ePFuEs4Tn537+sPRHa/PBwkF1KDkN83g8KpXKbDbL5XKFQgH7ZFVgD7LOqnGW6PTcsaNL78r2ny58z3fyfZWiRQ+eOvmP/t/NGJxyb1DPOPTStnWb8qI+2DymGXWTinFJ63EjT6av2P3+0MKBbSNDccONy2f33LOFJ4+f9lqJtInjn6N3UU7Dei3h/Gf/+RGsFCJs+k1qwuFfD3b/vGBg65gQwnTj2qU9D+zh7d+f1piy4R6jMzTyWIM0TGooiCy8SUOLSq/Bip/2Xov0JeeHfqHe2qZuI4H73s3rux9YpE37zXvd98r8kwMRt/1mZIPDK/7s/l7OwDfrhBD6G+cz99y1hneZMq1F8TcXiU4ZOXn/l98tnZ6S06VnJHZp/95NypAPFrzTjLpBE3t846yOYAmuzZ35fan8s6j5oIV9Y31zPMcRulYWoZWGS02qcNVtukddppvR6nbt+9mpFXOX/HQ367UuobRH1y/vemCLfOO9b5tS9TTPcvjm5oUgyJ9gNEauMIxAaPGmRwwcZh5rLK1WW5XVMAzT6/UCge88gds7CII4fPjw/v37Hz16xGKx6tev379//0aNGlEdFwTVTuwGn+3JDJs3++ddu345ZkS5wXVajVk8efqYdiG+MT8Rx3GdTldUVCQSiRISEhgMeMhdPo9KmYsR1ofnfn9Y6hUkkJE8/+2Y4n+4bl7JtNHi68X7zm2klfLk5+V6COs/x3//p9QrtEBGr/mD6lRzPARB6PV6jUYjEAgSEhJIKsdcI3lyc3I9hPX2wd9vl3qFFsh4d/57SeX+lY/iNZ25fZti9tzle5d9YWGFNeww54/pkzu8SsXal0cARM+VafiBscMXnRSv+HFn1u7dF40YKzgycczHvaf3qhdSIizX3ZuZNlp8YrQfDQJk8vUfwSpjNOjzSWbA/tn7Lu3af8foYQaHx40Z021698QQSnY0ghhFwaqgBI7TEvfoPNtlq2i9kBYDTs+M/H5P1p4zGQfcdEVw5LAhg2b0qBtFZW3jasZsMGR2pmLr7D9P7dp+xehhBUfXGzMpdXq/hv91Qm6dmUt/VPy8YfmRbV/YmWGJzecsen9yayq/xB6lMhcjrNlZv2eXeoUWyOg0v28sJVE9n1EUpJLHsl222NzLHLe9wvW4sd99MyHsj/2/nDu/+CIhDY4eObLbrO4J1HyVKgCPhiEIeiVOBidXFMFF7WGWQhos+lyjBQQEVGU1Op0ulUpR1KsP/6HavXv3hgwZcvHixadLdu7c+d133w0dOvSXX36pedl2qHZCQsYesY+lOooqQwQNBnz354DvqI6jHBaLRalU0un06OhoHs+fJqNVP3b7L3VXvqx8tVaf5l/+tBrieTlI0NAj+UNLLWR3XqhTLyx3/epntVqVSiWNRouKioJ98kWxe6zVoWupjuLFIEHDjyiHl/sSTdZ8/JId45dUc0Sl2VgCpSCYACDCnCdwW6OSB/yZPOA567Nfez//6PvVFp4f8OEfwQrRAqcsWDWl1EKE3eCNd/584x1KIirJxpMog+oQNFpY4W2htcS0G5piyvcLS4cNaIF1Xl/65etLqzNEX4NwG3Qd+WfXkc9ZhSauN37qvPFTqy2mSrDfnKa7Oe0F/oAeMeWPjDJ7v5o4OEKlIh5lsIO1DyVm9X8v0BRT5i4tGxVdFDt+7MfjffhYHiagIQh6eRaWIF8YHuDQBdrL3JoE1TjNmzdns9mVVuFo2bIlk8msGQno69evHzt27NatW5s3b3Y4yqkts2nTpn/++efEiRPwfB6CIACAy+VSKpVOpzM4OFgikVAdDgQBl8ulUqnsdntgYKBMJoM1NyDKueksNT/IyuIH2opkDh3skRDlUAZbHRhvFirk+lyFNgchcKojgmo7D4OlCYg2CgLlxnyFIRfBa0ifhAloCIJeUhE3oIgrD7cUiNwWqmOBqoNIJBowYMDvv//+/NXGjBlTPfGQ6v79+x9++OGxY8cqXfPChQuTJ09euXJlNUQFQZDPwjBMo9EYDAapVBoZGUmj+dld0FDNg+O4VqvVarVSqTQ8PJxOr0V3hkO+CUcQLU+h5cpFLlOC7j6DwKiOCKrtcISmk0UUBUSLrNrE7DMMj5vqiKDajkAQvThMHRDFd5gSci8yUSfVEXkTTEBDEPTCCIRWIAixMXmx5lwOfORgbfLDDz+kp6er1eqKVkhOTh42bFh1hkSGK1eudOrUSa/XV3H9NWvWTJ06NTw8nNSoIAjyWUajUaVScbnc+Ph4Fst/HpMH1VzFfZLNZsfGxnI4PvQAIqjWsrCFhfwQFo7GGh9yPDUqpQL5KYtQoQxKpGPu6LyrPIeJ6nAgCFh5UqUiDsHxqIKbfGcN7JMwAQ1B0Ivx0JmPBeEIIOKMDxk4nLlQu4SFhR04cKBXr16FhYVlX23Xrt327dv9fY6VzWZ7++23q559BgB4PJ59+/Z99NFH5EUFQZBvstlsSqWSIIiwsDChUEh1OBAEHA6HUqn0eDwhISFisZjqcCAIOBncQkEwSmcF2dQSp5HqcCAIuFg8ZVCikyMILHooMykBAZ9jBFHMzeIp5bF2jihQnysz5tfU2kQwAQ1B0AtwMriPReECtzXUpkLgT3Wt9Nprr125cmXOnDmbNm0yGAzFC2NjYz/++ONx48bVgKl/a9asycvLe9G/un//PhnBQBDks1AUVavVZrNZLpcrFApYWheinMfj0Wg0RqMR9knIR2A0uoanMHCkAU69wvSYBkvrQlTDaAytPFonDZcaCyMLb9IwD9URQbUdjtC1sgitNFxi0SQ+vkDHasKDlCoCE9AQBFWViS0qEIQq7EUKh47qWCAqBQYGLlu2bNGiRffv3zebzUFBQdHR0VQH5TU7d+6kOgQIgnwajuM6na6oqEgkEiUmJjIY8HAaohhBEHq9Xq1W8/n8hIQEJpNJdURQbUcAYOBI1fxAnscRr3/AwmtySgXyDwhiFAWrguI5TmtczgW2y0Z1QBAEjKIgVUAs222Pzb3Ccdf8PgmPmCEIqhINT6HlyCIsBUL4yEEIAAAAg8GoV68e1VF4GUEQ9+7de4k/TEhI8Howz2E2mwUCAXzKGQRVP4vFolQq6XR6dHQ0j8ejOhwIAlarValUIggC+yTkI2wsvlIQQgAQYSkUwBMHyAc4uOLCoASMzgwrvCO0aqkOB4KAgy1QBiagDHaw7qHEXOEDlmoYmICGIKgSOELLF4Y56ew4Uw4bc1EdDgSRCMMwj+eF78VjMBgpKSlkxFPKwYMHly9ffuLECbvdTqfTmzVrNnLkyIEDB1bDW0MQ5HK5lEql0+kMDAyUyWRUhwNBwO12K5VKu91e3CdhzQ2IciiNqeYHWtjCQFuRzKGDPRKinIfJVinizUKFXJ+r0OYgsA4MRDWMztTIogyiYLkxX2HIRfBa1CdhAhqCoOdBaYxcUSQd98QZH9EJ+MhBqIZjMBjBwcHlPmLxOT744IOIiAiSQirmcrk++OCDjRs3Pl2CYdj58+fPnz//v//977fffhOJRKQGAEG1GYZhGo3GYDBIpdLIyEh48wFE3gDEqQAAIABJREFUORzHtVqtVquVSCSJiYn+/vhfqAbAEUTLU2i5cpHLlKB/wMBhaV2IYgRC00vD1PJYkVWbmH2G4XFTHRFU2xEIoheHaQKieQ5jQu5FJuqkOqLqBhPQEARVyM7k5QrDRW5riFWJAPjIQahW6Ny582+//Vb19Vu0aLFgwQLy4ik2evToTZs2lfvSlStXUlNTMzMzAwICyA4Dgmoho9GoUqk4HE5cXBybzaY6HAh60ifZbHZsbCyHw6E6HAgCFrawkB/MwLEY0yMu6qA6HAgCFp5UGdaYjnmi867yHCaqw4EgYCXoyohmCCAiC2/wa2ufhAloCILKZ+BIlPyQYLta5tBTHUvtheM4hmEAAIIgUNT7z2/xeDw4jpPRMo7jAAAMw8honCAIj8dD0r3G48eP37JlSxXDHjJkyPLly5lMZqXrYxj20pv6wIEDFWWfi929e/f777+fN2/eSzT+fMUdz+vzPQmCAKT16lfZ1M9X3KurUqQFRdHiz0gWp5XExsnz+btUR/BiHEGRhW/0xSLiw8LChEIh1eH4tsi6VEfwUhx+9lVyeHCl3YMi9uDgYIlEQnU4vs3jn0+9yzpAdQQvxsniKaXRbml0kJAn4bIACKM6Ih/mp3fPtOlBdQQvxuXBVBaH3Y0GBsgCJGLQsDHVEfmwFl2pjuClYH42vLvdqLqoyGqzB0YGyKQSBGlGdUSUgQloCIJKIwDQ8IP0bEmUOZeP1vyHsfqy4kxr8f9xOr1/k05xgpuMlovz5m63u/j/eBeO4y4XWeXI4+Lifvzxx8mTJz9/tXbt2s2fPz8pKQkAUJUNiOM4juMvt6mXLl1a6Tpr1qyZOnWq16dnEgThcrlIyvW/9AaptFmSWi7+Mrrd7kpz0C6Xi9wENEQylC9Wt+1pjm0gv3JS0aE7LK0LUc6DExonZnR55ByGIjYR9kmIchiNoRGHGQSBUqsmKiqCBvskRDUMJ7Q2p87mlPLY4QoJXSSmOiKotsNxXKs3aHV6iViUGBcD62XBBLSPcJ35edIyzrhN79d/ukuwB6vbdFpwobyTXHrM6NPHv2zFAAAA+6PDCxb9+sfpuzlGlB+c+GbKyG8n9mzAr8FHAK4zK79cxhm7aVS9Z7svYb67/8clv2/LeqBEeRH12743/tNJyaHFyRgse02bLosr2JijTh+Z3KqmfhUI0+5FcyY+ar1nab/Xyhnu0DNbli9jv7OpX/TTDYAjtDxhGEpnxRkfsnC0shYgctHp9OKUIo1GI2P+ndvtdrlcZLRst9s9Hg+XyyXjjnWj0cjn88kow+pyuWg02qRJk7Kysnbu3PmcNTMzM+l0etU3ndvtdrvdAoHgRUPCMOz06dOVrma1Wu/evduuXbsXbf/5DAaDQCAgYwa0y+V6oQ1YdS6Xy+Px8Pl8r7dss9kcDgePx2Mymc9fk06nwzLBfoqg0/UNXle36ip6dCtx448MuwWM+pzqoKBajQBA78TUDpTPoCWI2UwaAmCmD6IUARCDQK4Wh/PctnjldZbHBZB6VAcF1XZGh1tltnOY9Di5iM2AZ60Q9Uxmi0qjYTFZsdGRHFjDDQDgHwlo7MHvn0zZaXv9iyWTXpc8Pd7C/vl13LS7PVbMfTv46TL7mQUfzMuwRw5cuGRwrD8NOoTu+Iq1RzK6DS75/EtEGN+ld0pcqbmDmPr8oUvq4BAFDQAA0Owt/d75Nt0S2DYltX8Ymn0mfecvk45dVJ7Y+kFjVjV+gGpE6E6uWH80o+vAUs8KtV5Z2WXYLxdATPeUwQN4RWcOHpo++tLNpVs2pQTRAEAE8V169SizMTXnD19WBz3ZmDURkX903bj9uUVhTcq9TYUwXlqx82JGuy5PN6abznosimBhaIzxEZ3AK20BgmokDMNOnTpV6Wo//fTT9u3byQ7GYDC43VV6aopSqSQ7GAiq2SwxScr2b9Ndjuh9a3jKHKrDgSBgRXGlHUUAiBKw+Mwae8AK+REbR6SURhIILVz3UOispWVMIZ/iQD1Ks92D4SEinphbQ5MgkF9xOJ1KlQb1oEEKhUQMHxT/H39IQAMAACD0mes2vNFwYktRhZf8CcvFjEt2Lo+Vn5n5cEBsgj9koDGHvuDWtTObli/eVkQEPfsaLajjnGUdn12G52wZ0/xEk+nfDYqlAUCY9y5afMgUNnLNn2s6y2kAAHzCkW8G99iwcvqePmmpipo1OwJz6AtvXc/atGJZ2W0FsOzlM9dcoLdZtH35xEQOAAD/uN8Xg8cu+WH1qA4zO/EALSh5zpLkZ/8Gz/njo+YnGk//NjW2hh7PY8pjY1ecVwOkzOfDHaaiW3dvbNq8bZsef7oxrUx+nihc4jSF2NQAEM9tAYJqssuXL2s0mkpXO3jwIEEQZN8HLRQKEQSpSj0HsRjeaQhBL8klUaja93HIQwPPp8tunwOwggpENTdOqO0eK4oFcpkyNg3W3IAoh9JZakm4hSuRm5VyiwqB4yRENQ9OqMx2s9MtF3AUAi4cJSHKYRim0eoMRlOATKoIkMEbIkvxlwQ0LbhhXfzUmo3t649rJih/ZCHMFzKuoPXfHaVIW3M68/6QhLo+n4EmtDv7tpyW/mRmW+VdE1fu+XTu+dhxf35elwkAANjdjIsWev1RkzrIn/wxTdrho0FtN805lXndldqxJj0Vm9Dt7tt6ZkXbCss5tvs2Fj7kgw8Tn3xomrTFtI/eXPvp4S3nvuiUXM6WwJVpn/50MfajLU82Zs3jKVgxf3NGyBsD5Zl/PlsslzCe6Ju6Ov3JlOYn3yc9R6LiB4faVBKnsdIWIKia2Wy2jIyMwsJCNpvdsGHDqKgoUt8uLy+vKqtZrVa9Xh8QEEBqMGw2u0GDBjdu3Hj+anQ6vWnTpqRGAkE1Esbmapt11DV8XXr7XET6Rprb+9XDIeiF4ATQOj1ap0fCZiRKOHSYU4GohiOIVhSqFYWI7PqEwusMvPKH8UIQqQgC6O1OjdUhYDMTFGImHab5IIoRBKE3GDVaHY/LjY+JZrFqaJbp1fhLAhoRNBoyMHjRvP9tbrd4TGNeOQdihOFsxnWs3si33grI/+PkmVN3h9ZN8vVdjkg6Ld1dx4gDQp/+yfvr8p+/NmHY++Oig/Ihxz+o++TGEtQOJNENWzeMK5FqRzhcLgI8bhQvvxV/hYg7LN2RaMQBYTj8yQe/ltpWmKqwAKfFRYWV2OWIMC4uAjl2+XoulpxY+mIEYdg7b+nBgEHHR9epoXfpoNe2rZpxL3LWst7YgtLpY0TYfOmySCMBCNO5T2bsywdAJQixs4Qx5lwuaq9KCxBUbWw226xZs37++WeHw/F0Yd26dRctWtS9e3eS3pTDqer1Oy6XS1IMJY0YMaLShyJ269ZNoVBUQzAQVHMgiLFOM9XrvThaZdz2JWy9muqAIAiY3JjK7mHRkFgRiwNTKpAPsHClSlkUHUOj1Xd5bivV4UAQsLhQpclGp9GipEIey18yWlBNZrXZVOoiAhARYSECEp5DU2P4z9cVETYbPrrdZ/NX/9Fu0ftJZXIDhDYr4yZRf3TLAB6vTVP+yayM2yOSnimDXFhYaDI9U6bK4/FUdDtbNW0XhqxOYxkAgNDcFlV2hGm/sOrrfXi/n8e0fpru4L61LP2tZ9fC8w+mZ3mYTV6rX5OmPwNQclvdKbutaEKxmIYXKjUeEPZ0p7vVKg2O4/kaDJROQNsvrvn6L6zf8vdbV0fuiAL2u7tHbSxo9eH3E6PB4rIv00V16ooAAITukRABGCvQxuDGmx4xMbSqLZDM46lwYgWO41WpRQDVDDqdrnPnzleuXCm1/O7duz169Jg/f36ladmXk5SUVJXVYmNjeTweGQGUMn78+PXr19++fbuiFfh8/o8//lgNkUBQjeEIiihs3xfj8kNO7hI/uEZ1OBAEHB5cafegOBHEY0hYPn8jJ1QLuJhcpTTSyeAGG/MlNi3V4UAQcHkwldluRz2BAq6Mx4a1iSDKud2ouqjIarMHygNkUgnsk8/nPwloABBxq/dGtv506aptry8YUffZyAn16Yy7tKQPW8kQgDRs05SXcfbUzVGNXyvxqMnVq1fv37//6T9FIpHRaKyof8hJ+QSvAM9dN3/r4/rjdnWVVtyj3TmH5qd+d8oWnjp9QEStmjLBqNOmQ9C6X3at3zJyyXthdAAAsN1ZtvpwEU7wnI7S2Uo8b92CPx/XH7ury3M2pj+z35k5Ly23yagdvUMY4HkPJXPRGQ4EAQCPMT1ilszqVrkFkhiNxopecjqdbPgM2dqBIIjU1NSy2eenpkyZkpiY2Lt3b6+/dVRUVJs2bbKysp6/2sCBA73+1uXicDj79u3r0qVLdnZ22Vf5fP66devq1KlTPcFAkL/z8MWqtj3NsQ3kV04qLh1FMHgvOUQxjAAaB2pwYXIOQ86h0+DpK0Q1jMbQiMMMgkCpVROpfUDDscr/BoLIhBOE1ubUWp1SHjtcIqDT4DgJUQzHca3eoNXpRUJBQmw0g+FPyVWq+Nc2QqTtRr6X+dnKVTte/+mZ0368IPPUfRDdP9icl2sBQBoTy8o4l3Ft9Gst/5sHnJSU5HL9V0fg4sWLbHbFF818rOCALevXxRdYvZcNqFfBfAi38szSOXPm7Hvgjuyxav20buJaNiKzW3z1ZZe9nx/8oPegv1PaJjCLzh5KvwDkQXSbnV66k9vO/rb4Iqv3kncr2pj+jbCl/2/VclPTtfOSY2gAVFyKxcIU5InkDADobi2NCH6JFsjznBQznU6HtfxribS0tGPHjj1/nc8++6xnz550uve/zHPnzu3UqROKohWtEBwc/Jz51w6Hw+VySSQSb8UTGxt7/vz5mTNnrl+//mk1EhqN1q1bt9mzZ5NdFBuCagaCTtc3eF3dqqsw95+EzT8xrRVe7ISg6kEAoHdiGoeHx0DiRWwWrPcMUQ5BjLwAlTSS67LGK6+zPD52VgzVSkaHW2W2c5j0OLmIzaiR5/CQn7FYbYUqFYvJio2O5MDpcVXmXwloABD5W+8PO/XZ2l92t3zvv6V4XmbmQw+KbZ328db/Vr1w6oq9ZZund0enpqampqY+fblLly5CobDCBLTZl+oAErrdv6blBaWs6SIpr/q16cLGOaN/TLvhDuk4ZuHiiSkNhLXw4JUW/vbcU6KE6St2H9z66z5O8Gtdvzj2nu2T3gsfC58tGU7od2/YlxfYc03n8jam3yOM5zeP3e/qO23UkMDnfT4dV6bmKsIMRlbpchZVbYFUQqGwopfYbDYZ2UbIB/3++++VrvPw4cPTp0+/8cYbXn/3N954Y/HixRMmTCj3VbFYvHv3bqlUWmq5TqdbsGDBtm3bHj16BAAQCATdu3f/8ssvmzVr9uohyWSyFStWzJs3LysrS6VSSSSS5s2bBwcH22y2kgWyIQgqlyUmSdn+bbrLEb1vLU/5iOpwIAhYUUxp9wAAIgRMARNeXIeoZ2MLlbIoAqGFabOFTlPlfwBBJHOgHqXZ7sHwEBFPzK2hD2+C/IrT5SpUqlEPGqRQSMQiqsPxM/53rIMEdhozpG7hzlVpj/+9ZRJ7mHHqMfO1CRv2pv1r67Rkke1SxiVrTagVixccWHfCFt2rzxtl6zpjhTumpL457YCx2Ud7jv59eHqvWpl9LsaMTv5w08507T/X7NfSM39KbWjKz8XoMdFhJS+z4IV/rztpj07pXc7GrAkIzcPHhR7Dtm8/pCcPQJIHIB0//eIOhuWnte40gDFs8zkMEAhSIAzTcuUx5scil/MlWoCg6vGc4hslXb58maQAxo8f/9dff8XFxZVa3qFDh3PnzrVu3brU8jNnztSvX3/u3LnF2WcAgNVq3b59e6tWrebMmeOtqPh8fqdOnYYOHZqSkhIcHFz5H0BQVeCGC7993attfWlgeEiTrkPmH8kp+/vgA6wG1bQjFxpvOS789WT9PVc+uWPSPnugZzdpZh+7UG/jMe7aI/It5/qdU91EgUuieNxrdH7HAQHXMmP/XAKzzz7MdWbJ6IGrbpatikIYr6+fMSb59SaiiAaJPSfOP6mq8P4UarjOrJgwcO3t0pE7Dg2qk4iEJTzzX8wHa/V4nhXNs3pkbEa8iAWzz36G0Owe1zLyrbmXfbx+D2HevfybyMn7Lj979G4vvDJ7wbx6wyZw+3wkHzWn36/nbjoIlM7MD4jNVSSKbbp45Q3qss+uM0vHDFxdziBQ5RVqEfv9tNnDO9aLUHD5YnnC6/2mbrvp09mPF9u5HpwoNNkf6SwCNjMhUOJb2Wd/GQSgqqniVwnDMKVa8zAnl8/nJcTG+EL22d8GAb+bAQ0AALTgrmMGZU5ad9lBrwcAANiDzNOFvOaD2pQo6Mtr2qGt7OTJUxct7d4S+XlGFs85eCALDRvXtQGz9EvYnbWTRv2pTvpwzf6v2wbW5mNXXHViV8YDabPBHeP+nfPuuZF5XkWLHN4ypMSGwXMO/p2Fho7rmlRmY9YMiCwpeeqwRv8dZxLWrINHjrviR/RuECGpG0xn5IjCCQSJMz5k4J7yBqdKWgirzd0Mql5Wa5WetG6xWMiLoWfPnl27dj116tSFCxeMRmNISEhycnKDBg3Krnn79u3u3bubzeayL2EYNmPGDBaLNW7cOPJChaCXR2gPTurZd21ucOuugz+IcF5L2/ptasatdefW9w31pTHfrX/cK+1eBs7rEhfWk4PdzVf9knHhhKlZZmtp8RkAaszrt/duOspuGxveX4BnF6p3Xr1x1B796++ft35wLjx9E93tk2l16F+E9vCKVekZPUeUrv7lvDanf/9Z13kt+/b9uLPl3N5dXw28+GjjXz938pWHeRC64yvWHcnoOrhU5JgqN8dJC2qcnBz9ZOIDAQgXUo/pQBE2LUHMYsAypv4Hz9/62bgNt4piO/vYVZBSiPwTm8al5xeFNCgZJ5p/vN8Xm9Ptkrbt3ugfiGVfu7Rz55qj9zy/rvukBWZIUF5nYFR+LEJ3ZMXq9IwewysqAVjpCrUH+s/qfm9NTDeHtO0/qn8kmn181875I46dzjtxaHJjn6wHUPWdixHAZHdqrA4Bm5mgEDPpvnQsAoD/DAJQlVTlq0QQhMFoUhdpeVxufEw0i+UTySS/GwSAfyagAaCH9xybmjnl9wcAAIDezchUi9uMaf7M1F9WUoc3Qg4dyDhverOTf5daIHRHj99EZb26NCrTy13nlq294mr06e9f1u7sMwAAELd3zv34ZnPPgV8+jKADANDHe2b9kcNu9sV79UuUayD0R0/cRqU9uzT0iSGDBIi8UadZjUoswJXzLx09Yak7duSAxmzOY2EEz2MPsxTSQEVXxp7XQitY+gKqRiEhIUVFRZWuFhoaSmoYDAYjOTk5OTn5+at9+OGH5Wafn5o5c2ZKSkr9+vW9Gh0EvTrCdGT22HU5dSfuOfFdGzECAPFJrzFv9v/zh+Uf9/qxme8cKHoOXH2YgfIn9241L4gOAAAtIhf/dXbSrezNDZt9xEcA8Oy99OCQmzOyS6v/s3efgVEUbQCAZ2+vt1xP7wUQQu9FlBKQTugdEUFFQRAQgSAKIoiAAT5BBBGkShGkSBMQRDooTSCFFMiV3OV63fb9iGJIQhLgLnuXzPMLdud23+zNzu2+OzvzbTSbgSCmpNSuF/ZP2HVi/UJOv3BzQF8M1nSE05B/+/rvW5Yv3qkjg0uvJXO3LfriT6Tjgj1H3k5gA0C+88qoV99eP++bNzrOakbzBR3hLHp0+88/tqxasVNHlYkcEPm5ORS/8+QVW7tzAQBmD6Fx4GwUCeUzuX6XUoGqhHiwaeL0n7UU4uffH6E5O3HdNS14Mk7KsX/rvmM2xetzZn/bSswAwModmfLtp2/u3Pntj636vcKkr50knIaHt6+f3fLVF+U1AlUpUMtQpv2fzj9mjH5995lvewUzAADk7BPTOvf43+K5O0b+PCbEn37ynu3LVRF4lt7MQZBoqYjP9p+LkP8ESiMAVUkVTiW7w6HW6ChARYaHCgUCuiP+VyA1Av/xx1O6NDRh9P92jy61LHrAFz8OKP53yJvrf3qzzKeYdcau+Wms76PzOdvVX697uK1atCzz0gnx4NqFQpIturJ45odPNn+IuNW4ZUOSAuHb9RJG6MgpQ78even9gWPO92kRbLl/7PiZW6DNV58NSSyZM7Vf+/VPD7dl87IHs8azc8TZQWFKR6HSaaA7FiiAeTyevXv3HjlyJD8/n8fj1a9ff9iwYY0bN/bFvrp06XLjxo2KyyAI0rlzZ1/s/Zn8+eefZ8+erbiM2+3esGHDsmXLqrJBjUazdevWP/74w2QySaXS9u3bjxgxQqlUeiNYCHoSVbT/2z0Pg3oum9H6nwmMEWXvOav/1yRTxcP86EKR8twz44AXkqL893edwe8eKfhQ4/jbAoAAANJ6RoOj8pgPotju4Ej1y/1xrqCf4eYm5MG5e5nucGXNHHmrRqAKd/RvOP3oP1OdlbmjJx/t33vBIU/9YHRC8eUbQ/Xa9BEJP644sPOvD5o1pzMDTen39G8x56in+H9lcxGUMe+hEQlPjGI5cVLtwDGSCuYzJWz4PD9gYfdXvzXnTOywoeE//uigO5gK4OrV6bvOhLQZKr/4Y8lJBIn8M3870NiUD1qIMRZXLYl2sXm9BnRpt/vbP67ccr/SmK52ktLv7N9wxtNPpcoL1Dr4jTPnTWjDKR+8FvzP4WAoOn0woe26aWdPXnGP6eU/P3nP+uUSHqeUzwnhc546WRe9AqURgKqowlPJNry7ubDQarOrFHKZVOJfdTJwGoGS/Oa+AnoK91/nf7chCcn1yo4kgj/KzyMo2/3fNt8vtYahQnsuHZJUTSH6B3HrD05uj0xbtuPwjk0mVnCTDpP2TX+9V+QTmWb3Xxd+tyEJDeoG+rAszwzhFgrDWtgeidw+HKwAqvHOnz8/cuTI7Ozsx0sOHTr0xRdfjBo1as2aNQJvPxCeNGnS6tWrPR5PBWVSU1NjYmK8u9/ncOrUqaoUO3PmTFWKrVixIi0tzW63P16yZ8+eefPmLVmy5O23337OECHoaTxXTp13sFt0frXETyMa02niO51oDKocCDtRzAR68x8msrOMAQAAlPui1kmgoiQhAAAAkgAcfoOoEH6nQQ+Smiiu/6a8dhLYNDwE4AQJX9b2Z4i0e/rheiYSUIbDk0eteVhqtef2pVsYu1Xr1o8nFgfMl9o0ly//8epfBrJ5CI25KETSJf2nOiYKUEVHJ4/bUDpyQObkPiKY8XLOgx/3XFEbParo5M4dG0tqXzeImsL914q30v5Mnv/rVOJtf8494X/t3ZiWFTH/i9eIlaUS0G4gCm7QMF4gj84SqqQ2XZQhE8E9PATgGE5jO4lIuqUfqmciAVV0ePLotWVOpcoL1DqYHUgTkzs2iy/xPAvh8XkIwN0ev/rJq8qXu+Jg3VyHx1hw6IvJ32u5QrmA668364HSCEBV9pRTiYsAzGLIyH6gEgkT42KYTP9LnAZOI1CS/x3HWglRDTuRPazcVZz2nzzM+6T8VZ2XGPKX+DIuf4SohpzIGFLeGlTVbNg328o/jMU47eY9fDDPR4H5JwoNH/bDb32ZvGjrAw7uLrUWkXc9caxrJZtghM74etsMXwUIBYyzZ8+mpKS4XOWMoPrDDz9kZ2efOHGCy/Xmo9a4uLjFixdPmzbtaQVCQ0PT09O9uMfnptVqq1JMp9NVWmb27Nmff/552eVWq/Wdd97R6/VpaWnPHB8EPR2pfZBtQ1SxkqwfPhy5et+5B46gmOQ23camzRqULPSrG0Bmn5b1RutvLzx0JbOOqjGHuJdf8IOa8VqbOuNECACAYgd/vCBV16obmncvcdtSltUIAJX/QHueZDQOFvlnNxDoH0x5nSZyAAClvSUu2wFam5fjQuRR4SXH2mOGR0WiZF7OQwLQmYAGTFmdxjIAAKW7UzZyinLfytYQpPmzvr11xuKJNxC2qvWs1Svmt5P71dkFVYXj8hfjFt9rtei3KfXACrqDqYDj/sFxO9Stxs2dElUmTm6jT7/rpJFGUR5HvOYWB3MCQOX/cfU8jjauG0VnO1myESj33Ki0QG3Df23l1deeXEQ+3PfTeYzduBVtPdnLV9l3Z8JESHhcHSYjJObuBgbQ+lUn0ycFSiMAPYPyTqW7O3f9gbHqNYirEx0p8OrtrTcFUCNQAkxAQ1CNhTGYeeJIBqDiTA+YFFH5ByDoKWw22+DBg8vNPhc7d+5cWlra0qVLvbvfqVOn4jg+e/ZsHC89yXRSUtL+/fvDw8O9u8fnExQUVJViYnElcyUfP3683OzzY/PmzXv11Vfbt2//DMFBAY4gCJfLVWqyTZH33uCnbBYrRZkPTk/5Dkvo3mtiClt96dCeryYev6w+vX9KI3+6gGUK5RPqSA5fMmy+btoMAABApIp5N0bAB8AWmah+uT8Dx6MPbuAXFL+lQebkZAy+YLCLwufW4dfOF7ZLVRuK8s7E6DiOu93u0nXSK5suD2W32SmGUCQs+SUiAqEQoR7aHX4717sdJ9XWvDv5GIVzEoavPPlWhxigvXrk28mf7lo48aPoo2vH1cppnX1UJwmCKKdOeneoE+vv8yZ+lffyst1vJjBBpje37F3O+/O+OpLXcPjuHsFM8MTTcTtHpJZGkwgj3JAtcpoAAADgORd3D95wyx788tyuytpYI31ZJz0eT+k6yffdb6o758CcwTOP2WPemDs2NlC+SieGqy0OjCBDxHwJj01p/Xt4oupqBEpVG5IkvVItCYLAMKx0nRT57tc7ILnclstbZkyac9IZNWrhtPb+2xe/HD5sBEpVG4IgyOd9txAmoCGoZnIweXniSLHHFmpTI0+dchCCquSbb77RaDQVl1m9evVHH30kk8m8u+sZM2b07Nlz+fLlR44cKSgo4HA4ycnJqampkydP5vP5lX++WrRo0aIqxZo2bVpxgQULFlTKggyAAAAgAElEQVS6kQULFhw9erRKYUE1AkmSxfm+kgtFfK+9w0/hOE6RFq1gwo5D/+sejAIAyFmjpnbptWHp3N1Dfx4Z7DeX3vjvl690/9PVsH6D/Q2VDThExqNHs85l9znEWJX++csvRasun5DdOItQFADAYy9Kv3B3YZbNIw5Z261ud3+dCtzXSlUbb6Eoqpw66bu8AUVRFCi3HpKkP17eYCSldeJWD6niqsbNW9OFl9CxWQQfAACiOwz/9ACibTDjzMqd98dMq+vfuRafKFVtvJXsI0myOAddcqGI7b2LBMp0dM47q/Qp638eHYsC4LedOijH0Y0bV5mT13/SIZYBwL/5ARxlPZRHWvhShUWjtKgRigQAePR/p2/YtvCs2hPaYm3a0O7+9cpL9anWOumbBLTn4cn0D6ct3PW3J27g2r1fdpcGwFeJk5TO6jQ53QohVynkBUDE1dgIVGudhAnofxEE8ejm/pXz5q47koXFDlz708qAOJWK+boRKFsnn7tawgQ0BNVAZk7QI2FosEMndxbRHQtUE/z888+VlnG5XEePHh02rKJhcJ7PSy+9tH79egAASZIMBgMAYDKZvDvcxwvq2LFjTExMTk5OxcVGjhxZwVq9Xn/u3LlK93Xy5Emr1QqvF2sPFovF5/OlUukTS932pxR/ZgiPz0MQdtu30lKC/0mHMWRdp41vs3n2mRMXHSP7+Mls36Rd/elNGzu6/k/twoIBAIDVKKnemuTgDisuLt9zfeyVrRxP8Ssa2OU798ZfVN8kuJ0bJq9oGtqgFo+3W6raeGvyHCaTyePxStdJS6FXNl4WIhAKGVTRk52dKbvNRiFCAd/f7g4LnbjZRYjZjMQgNpPBkbd/pf4T6xnhKSltZv92+uY9G6hbpXdnapZS1ab4N/3FMZlMLpdbuk6WGXrueVGmY3MnbnT037hiRIQ/dy2lTFd3TTzq6T995AjlP2cGBQBgCPJDG0Z7jEkFN5gEBgAAlOPy4W3jN124ick6939zxbCWDfzuTKo+1VongbfHZaWMl7+ZNn7O9pvuiM5TN62YM6RBIAxQYrC7jFangM1MVAaxUH8+px6r1kagVLVBUdQrP99MJpPD4ZSpkxCgKMpozP119fR5Kw7ewwLpVAKgmhqBsnUSRZ/zGTpMQENQTaPjKw1cWZQlX4h5LUMB1XIlJx6sQFZWlk/D8NZdgdexWKz09PS+fftWUGb48OFt2rSpoEBOTk5V3mbCcTw3N7dBgwbPHCUUsBgMxnNf51UKDQ4LYyIZERGKEqcXIyQynAUumUwOCgj84wocN9luEUiDMKkSAIAgpjrNNG17cdR7W6/849CfB+2hYRwAAOXafebq6LtOZWTsvnaxfYJqYQfTJ/io2iAI4tM6WQojOCqKQ17NzbdQ4PHAyYT60SOCUScm3H++YwIA3IPZcTJOzOaiTz1tEFGQhAkonCAoUH6/7hqtWutk6bG7nhupu3mzAFPvHBm/84nnyF+1Fn6FJrx/7s/PWvnFLTWly8kvwE07F0/bubjk8j3Dmu5Bw7qfWzuoFQoAWbR71fLRxwuVTXvte6tHn7Ba/IwOAODLOokgSOmNE15NQBP5u9/qMfr7HGXKR/vSZ/RJ8Jf3AitAAIC77CaHO1omFLBZdIdTddXaCFRrnaz17A6H+tGfv6SN+3DPowA6lf5RXY1AqWrzIk9E/OLXEoIgryARxkNRuBvlxJkfcAgP3eFANUcVM79+myCuBn369ElPT58yZUq5a1NSUr7++uuKt1D1K8LafJwh7xMkN6+DHs68n092T/i3ZhH52TkeJCg83H/6fyBMVAgoowu3qyILX+6PCYNC/jgYdO2QhQRsFsoBAADq75s3xt1z12/U5FArucpvIodeFCe5dTJr55UzZx1D+v3TIZ/IuHJdj0SMaOIXo9a6CKrAhrsBYDDRGBH7cT4Pv7m+/6yj0tErvh/yX5c5Ijc708MIjYsSwSoaMBiyNqNnf9T5v3fuKeP5zRtOuZqPefOVSEVbvxnNG5HV6zB7aH0CAILBtHKDCIbj9r49v7tjx/SoFxmUGM4AAJB/71s37rixfuqUQ6+/BNvJQIb/nT563KaC+h/sO7Sos8pfKuFTeQiywORyAcBgsuIUYo4fzzRYnkBpBKBngGG4trDQarMU7Zw5Z29hoJxKJQRYI1AMJqAhqIbwoKxcUSSLxONM2Sjl7Te8oNotKSkpLy+v0mJ16tSphmD81uTJkxs1ajRr1qwLFy48XhgcHDxz5szJkyeTJOnxVPRYKDY2lslklp1usRQOhxMTE+OVgCEIAADQpAGDGi+ct+7jPf2/HxTJAgDgBfu/2HCZDBnbp6X/DJ7Mkiu6iHLX5RLftHlzdN455bWTCOY49Vf+WZLVPUrKBwAQRStvmN3KhM0tYfa5ZmGE9enXcvasX7/ent1zfBwLAMr6x5rtd0Diu0Ma0dyBjqCAzokZ3aQERXhlng4yY2KkD29sS/96cOfPeikQAADAHu1aueM6iJrWp2EA9f2r9RBFuzfmtyuxgMhc+uvG08Y2E9Pm+Uff52KIon7HtGRULw4ziIKltsJg49VlZ/eesyZOHNG/VfEzbs/dlfuz3In9N4+B2ecA5/pt5coL7mbzNy/098QTSVF6u0tvcwUxGHwAGEy2t8aDqkaB0ghAVUKSpL7IqDcUiUXCxLDc9zZcDYhTqbTAaQRKgqcLBNUEDhY/TxQZ5DaH2DUB95MO+b/U1NQTJ05UXEYkEqWkpFRPPH6rY8eO58+fz8nJuXXrlsfjiYyMbNq0aXHX5oqzzwAAiUTSqVOnY8eOVVyse/fu/jP7IlQjoHXHL5z6Y7/Fb7xyd1//lAT0wemf9l41Rg1d/0lXfxlqnGKgRc36Dnkp7JdZB2aldv89TtKQQ94v0P6k9Uij6i5JYCMAEGbTBSfFZhsXn7E/eR2OiEOjl9URwkvegMWIGT57+vaBC9KG97o/rGc8dnXnhi350W9undCMviQuRQGjG9c6cT6TkSBms7DyBt0QvTp35svHP9o9sNuDQX1axqJFN3775eDfWPJb38xuWtvHPYC8D0FMfLlGGsX1OOI1tzmYE5ClJ0ojCjIvmCg2//7ilZrS7WSDlGVdw2E7GSiIzPMXtCRbfG7xxPGlv8oO7y8bW99Pvkqz06OxOtgoI04u5iBseJcK0c5qs6u1WpSBxkZH8rhc4taGgDiVygqURqAU/4wKgqBnYORK1YLgUJtG6jbRHQtUM73++utffvllxSNBz5w5E86MVywmJub5OinPnz+/4gQ0i8WaP3/+80UFQU8lbL3g5/3hCxatObB9xS+UNK7F60tmzJ/YPtQ/+lPYIhPVHfojBNb8TP7FnnU/u/5oX1beYZyhFItHtW6QliyPZgAAAG5z5pHAZtRvNpbaAKJCQpbWEdIQOuQt/Cbzdu1Ufrp41f6VM63s8OROC7fPnd5JRlcuw46TajtOASpSyBayGKB4qrdyoEkjVp8P++Gzdft+2fHdjx5OeN3W0796d9aAuhKYhoG8yskRFkiiCAYz3JAtcj71dgAv1OcRlC3v5ubSb7UhKrTF0q7hPg4T8ho8LycPp2x3jmy+U2oNQ8UctHRs/XI/VZ2cGK62ODCCDBbxJTw2eGo7CUHVxO32qLU6l9sVolJJgsTFC/3/VHqaAI0cJqAhKIBRAOgEwUWcoGhLngBz0B0OVGNxudy9e/e+8sorJlP5dzW9evX66KOPbDbb2rVr9+7dm52dTVFUVFRU//7933vvvQBNTDscjnXr1u3ZsyczM5MkyZiYmL59+77zzjsSicRHe2zTps3y5cunTZv2tAIrV65s3Lixj/YO1WaootWk9P2T0umO40keiVLdvo8jJEZ1+bjsxlmEogTBkendI8sNkxPVwDARTs4Z2JDg0SfUo8tdxZA1n/TV7klfVXNEpWEkpXXiVg+p4KIKHvNxGhlRDTvxYFh5n+DEvDr+21fHV1+IUDVAE2acNc2gO4piOJOtCYqw8KUKi0ZpUSMlR+FjBM9Yvq5knJwW4wwHx1V7jM8ACR51omDUixSoJTg91huw9XRHUT6CpHQ2p9HhVgi5CgGX8e+AGzXqy/WnRgCqFEEQOr3BaDJLJUFREWElx8vy51OpYgEaOUxAQ1CgIhA0XxyBI2i86QGbxOgOp5Yhi/7a8/2O03/mWoXRjTsNfX1AI+kT3Zmwi8tHLjrtfPJZPyMs9Yv/jVEemzd+zV//fWFo+IAlq8ck+fuUxI0aNTp//vyYMWMuXbpUcjmbzZ4yZcqiRYsuXrw4cOBAtVr9eJVOp7ty5cqqVat27drVvn37ag/5hVy5ciU1NTU/P//xEp1Od+nSpRUrVuzYsaNz584+2u/UqVNDQkLef/99nU5XcnloaOjq1atTU1N9tF8I8iski61v8qq+ySuS+9eSti5BnTa6I4JqO5Ki9C5C7yLEbEZiEJvJgH2YIZpRCFIkDNYGhYtc5sSCmyw4/ThEN4oCRQ6Xzubks5gJCjGb6e93N1BtYDJbNLpCHpebEBvDZsP5F2gGE9AQFJA8KDtXHMUmPHHWXEaZId4gHyNy9y76bDfR8fXJQ+WFZ7Zs/GwxumxR/8gSV1nMxN4fzGqNP05AU9a/dn93PSE5lEEWaHRIUu9pqfX/GQAS4YWH+ceL7pWpW7fuhQsXTp06deTIkYcPH3I4nIYNGw4YMCAqKurq1atdu3Z1OMrphq/RaFJSUn777bcWLVpUf8zP59atW506dbJarWVX6fX6nj17Hj9+vEOHDj7a+7Bhw3r16rV///4//vhDr9crlcr27dv36dNHIBD4aI8Q5EcQxFSnmaZtL06RNm73Sq5BXflHIMjHrBipdmAoALFiNq+80Z4hqJpZeVK1NAol8ZjCe3w3fEQH0c/mxtQWBwAgUiIUcmCaD6Kf3eFQa3QUoMJDg0VCOBSbX4AJaAgKPDa2MF8ULnOZgu06OKAWDTw3Dh58EDHgq7e6R6IANFCYMqcfOHS751sN/5tTCJEltmyT+O//KNu1rzc5X3l7bFMR4tZpjeLE1h3aJgdirwAEQTp16tSpU6eSCwmCGD16dLnZ52JOp3P06NE3b95kMgPgR4eiqLFjx5abfS7mdrtHjx599+5dDofjoxhEItHIkSNHjhzpo+1DkH9yKiPUL/fHRNKQPw5K7l6hOxwIAi6CUjswN06GCFgSdiD+bkM1jZvJ1ciiHSyBylIgs8K5xyH6eQhSa3XY3JhKyJPxOQgCayVEMwzDtYWFVptdIZMq5DJYJ/1HYHS7gyDosSKuJE8UEWrTBNu1MPtMCyL/9t+2kKbNworvRNGoZk1Ulr/vqMmnfcB1e8eG6/XGjmgsQABZqNVRqlAV6TTq9FasRnyBhw4dunOn9PQHpdy9e/fAgQPVE88LOnPmzNWrVysuk5OTs2vXruqJB4JqA4IrUHfo9yD1HWH+/aQtn8PsM0Q7ggJqB5Zt8XBRJEnChdlniHYEA9VKIrNCG7AxV1LBX3KYfYboRlKUzubMLDQjAElUBskFXJjpg+hFkmSh3pCR/QAAkBgXo1TIYZ30KwHQGQ2CoGIUghQIQq0sQaw5l4c76Q6n9iL1Oj0lV8r+fYDHkClllF5XSILo8p7pEbk/b/xNPmBZKzECACAL1YV44cnPx218YCYAUxTTbvh7b/dI4P/7y/jo0aNVq1aV/HydOnUAACRJVtAn9/n/FpJ88S0fPHiwisW6dOnyIjt6jCRJm83mo+uJX3/9tSrFDh482Ldv36pv1iuHulw4jgMAnE6n2+32+sZ9eqgJgvBdrSbJpz4Sem7Fh9rhcJScvaRcTqfTFwHUSBQDLUpup2vVjV+QnbhtKctqpDsiCAImD6Fx4DwUSRCz2XDMDcgPmAQKjSSSizvjNXc4cOJxyA+YnR6N1cFGGXFyMZcFH9FB9LPa7GqtFmWgMVERfB6P7nCgcsAENAQFBoKB5okiCIQRb85hwSkHaUV43DjC4/H+vSNFeDwu4nF7yu3NTJnPbT9ge3lWZxUCAACUVW/EeML43lM+6RAOtH8dXLtq/aL1ypXvtRQWb85isZw4ceLxxxs3bhwfHw8AoCjKF+nFf/4i4oWGES85U18F8vLyvPgneDy+mmzn0aNHVSmWn5//HH/OCx7qCmCYr5oF3x1qf67VFajKofbd31XD2CIS1R36ISQRdXCDoCCb7nAgCNhxUm3HKQDCBUwRTKlAfsDJFqhl0TiDGWrMDXIU0R0OBAEnhqstDowgg0V8CY9d+QcgyMfcbo9aq3O53SqFXCaV0B0O9FQwAQ1BAcCFcvKConiYM9qax4DDbtANZXNQyux0UYBbnFR2Ol0US1Tu5Rf58Pj+a8ouy+r9O+OgNGXejpR/10a2HPZu6p+Tdv7215st2xU/pY2Pj9+/f//jz+/fv5/H4wEAUBQVi8Ve/1swDPN4PC84u11QUFAVi0ml0hfZ0WMWi0UoFFbaC/U5GI1GPp9flZJisfiZ/hwMwzAMq+LGn4nT6XS5XEKhkMXy/pQvZrNZJBJ5/VBTFGUymXxUqz0eD47jvjvUIpGo0tHMORyOL+pnTeIJUmjb9LBFJKouH5fdOItQ8KcNohlGUlonbvWQCi6q4DFht2eIdjiTrQmKsPBlCotaaVEjFHyxBqIZQVI6m9PocMsFXKWQy4CDG0B0IwhCpzcYTWapJCgqIgxefvs5mICGIH9nZQsfiiLkToPKUUh3LBAAADDkSgXywGAkgQQFAADSZDAh8vrycn7uiKxTp/Ljus2IeNpPIUMRHsbBjFYXBYp7VLPZ7PDw8MfruVzu499RFPV+VyyCIBAEecEtN2rUaOfOnZUWa9y4sbf+hOKYfXSF0aBBg6oUe9Y/58UPtdVqvXnzptVqValUDRs2fLyp4vExGAyGL2qIjw41RVGPN+7dLQMAGAyG744GqNqh9sXeawySxdY3eVXf5BXJ/WtJW5egThvdEUG1HUlRBhdR6MLFbDQxiM1kwJQKRDMKIEWiYJ0kXOg0J6pvsnD4Vg1EM4qiihxunc3JZzETFGI2E17nQPQzmS0aXSGXw4mPieZwYGf8AACfD0CQXyvkyfOF4eHWRzD77D/QqPr1BOo//yos7rBHav66oRG9VD+87IUYfvf0GW1ih7bBj+9lHedXv/3OV7+b/+3rRzzKyvVIIyNFgXy3O3jw4Eo7hDKZzMGDB1dPPC+oT58+HA6n4jIoig4dOrR64gEAPHjwYPjw4Uqlsl27dt27d2/atGlISMj8+fMdDjgKJBRQEMSc0Chj+Ex7eHzc7pVhp3bB7DNEOytGZlo8FoyMEbEjBCyYfYZoZ+OKM0MbmASKaN39SH0mzD5DtLN78CyDtcjhjpQIo2UimH2GaGd3ODKzc3R6fXhocExUBMw+BwqYgIYgP0UhyENReBFPFmvJFXu8P08X9PzYDXv0iMrZtWrbpaz8zPNbVu/Nj+/VowEbADzrxPff7byo/ecVSSL3+p+m0JfqSf+7m+Ult26Anf126Q+nb9zPuH1+X/qX+wrrp/asF9Bvo8THx0+aNKniMm+//XZSUlL1xPOCQkNDp02bVnGZMWPGNGrUqHriOX36dNOmTbdv315yWGG9Xv/JJ5906NBBq9VWTxgQ9IKcbk926iRN+77BF4/E/vQ116CmOyKotnPjRI7V88jmUfGY8WI2nwlviyCauT2eXFWdfHmCzFYYp7nFd8Prf4hmGIY/NNnzjFYpj52gEAs53h/tDYKeCYZhDwvUufmPxGJRYlysSCikOyLoGQR00gOCaiwcZeUKIxBAxZuymaSvptKCnhczbuBHM7FvNq2etdfFD2/c68OJ/aNRAAD+6PLBnx8QbQa2CgYAUIU3b2h4SfUiSvQSQITNJyyYKdn045bPf7agsoik5m8uGNk5LOBvepcuXZqRkXH48OFy13br1u3LL7+s5pBexIIFC+7du7d3795y13bs2HH16tXVE0lGRka/fv3MZnO5a69du9a/f/9ffvmleoKB/AgeSFPREiSpM9uMNoc88SWlkMtIrOR5FRSQsm/RHcEzIABDxxQaUb6UBaIECAPgwIPTHRTkbRzvzwTgOyRJ6vV6vV4vDYuJUMhRtD7dET0jEo5PXQVoIGVvH9dJsVicGB1b6cuOUEAiAul6kqKoIqNJW6gXi4RJ8YFZJwO0qfTeOw8B+J1BUE3nYnJzRZFCzBZm18B5mfwUqmw+cm7zkaWWcl/+aPfLj/+HhPT7Yk+/Mh9lhbQa8WGrET4OsJqxWKyff/558eLFS5YssVr/67AjFApnzpz50UcfBdYlAoqiu3btWrZs2aJFi0wm0+PlfD5/2rRpaWlpbHY1vec1c+bMp2Wfi50/f37Lli1Dhgypnngg6JlQFFVkc+jMNj6HlRCqYFPweSpEO8SEcjVMEZfE4z16jlBJdzwQBEwmk0aj4XA4cXFxXBYc3ACin9VqLSgoYLPZcXFxXC6X7nAgCFhtdrVWizLQmKgIPo9HdzjQcwqkjAAE1QZmjviRMEzpKFQ6DXTHAkHPAEXROXPmvP/++8ePH8/OzvZ4PKGhob1795bJZHSH9jwYDMaMGTPefffdEydOZGZmEgQRGxubkpIiEomqLYbCwsIDBw5UWuyHH36ACWjID9ndHrXRQlFUpEIi5HIAAACDCWiITnYGW80UUYARjplFJBxXF6Kf0+lUq9U4joeGhgYFBQEQYB0SoZrH5XKp1WqPxxMcHCyRSOgOB4KA2+1Ra3Uut1ulkMuksE4GNpiAhiA/ouMr9VxZpPWRCA76DAUmgUDQr18/AIDD4XA4HAKBgO6IXgiPx+vduzdde79y5QpBVJ6wu3r1alWKQVC18eCE1mS1udyqIKFMyEcQOKsbRDMMMLRMkQXlKgi7ErcjAL5eBtEMx3GdTmcymRQKhVKphO0kRDuCIHQ6ndFolMvl0dHRDEbAjxAIBTqCIPRFRkORUSoJiooIg3WyBoAJaAjyCyTCeCgKd6GceHMOh4C9ciCopsFxfPfu3ceOHcvJyWEwGElJSQMGDOjRo0cF95xGo7GKW7bZbFKp1HvBQtBzIilKb7HrLTYxn5sYqmSi8FYBohkJgAEVFKICMelO8hQyqcAcfhGqQSiKKioq0mq1AoEgMTGRxQqkcYGhGomiKKPRqNVq+Xx+QkJCtQ00B0EVMJktGl0hl8OJj4nmcGCdrCFgAhqC6IcxmHniKJQi4k0PUDhEJgTVOLdu3Ro0aNDdu3cfLzl37tzGjRvbtWu3c+fO8PDwcj+lUqmqsnEOhyMWi70TKAS9AKvTXVBkZrPQuBA5F6ZUID9gZXDVTBEKyBjMyKfgyAYQ/Ww2m1qtRhAkJiaGzw+kaRKhmsput6vVaoqiIiMjhUIh3eFAEHC6XAVqLUES4aHBIlgnaxaYgIYgmjlY/DxRhNhjC7Wp4TuhEFTz3L59u3379uXOJXju3Lm2bdtevHgxJCSk7NpWrVpxOBy3u5JXItq1awdf3YXo5cLwgiIzRhDBEpFEAGeGgejnRlA1U+xCmCrcJiNdAF5fQXTzeDxqtdrhcKhUKplMBn+4IdphGKbVaq1Wq0KhUCgUsE5CtMNxQqPTWaw2hVymlMN2sgaCr0ZCEJ1MnKAccZTKqQ+zFcDsMwTVPARBDBkypNzsc7G8vLzx48eXu0okEo0ePbrSXUyYMOH544OgF0OQpNpoydboBRx2YqgSZp8h2hEA0TJFWWwFhyKSMIOMdMLsM0QvkiR1Ol1mZiaLxUpKSpLL5TCrAtGruE5mZGQAABITE+Eo5BDtKIoyFBnvZ2VTFJUYF6tSwHayZoI9oCGIHhQAOkFwEUcSbckXYHa6w4EgelgsluPHj+fm5qIompiY2KlTJy6XS3dQzyAjI+PMmTN6vV4ikbRt2zY5OblUgZ9++un27dsVb+TQoUPXr19v0qRJ2VWfffbZsWPHcnNzn/bZQYMG9erVy+l0PkfwEPQiKIoy2p1ak5XPYSWEKthMeEkJ0Q4xoVwNU8Ql8XiPgUPhdMcDQcBkMmk0Gg6HExcXF1hXOFBNZbVaCwoKmExmbGwsjwcfG0P0s9rsaq0WZaAxURF8WCdrNHi3AEE0IBFGvigcQ9nxpmw2CQclrHaeXz/q/Bnn86Pz25capZTS75nU77uY9P0zm8HW0cdcLtfHH3+8atWqkslTmUyWlpY2ZcoU/3/ofefOnffee+/kyZMlF7Zq1WrVqlUtWrR4vOTAgQNV2dqBAwfKTUArlcqjR4/26tUrMzOz7NrU1NTvv/+eomDnPqi62d0etdFCUVSkQiLkcugOB4KAk8EqQMUEgoRjZhEJJ3OG6Od0OtVqNYZhISEhEomE7nAgCLhcLrVa7Xa7YZ2E/ITb7dHoCh1Op0ohl8vghOo1H0yxQFB186DsXFEkm8JiTQ9QOBt7tSJMefcfWUnguXH9ylXujdu3pU8moCn3vVNnLp2zPiIATED7lN1u79at27lz50otLyoqmjp16qVLl7Zs2cJg0D9I1J07dx48eMBms+vWrRsZGfl4+ZkzZ3r16mW1WkuVv3jx4ssvv7xjx46+ffsWL8nJyanKjrKzs5+2qk6dOtevX1+xYsWmTZuysrIAAAwGo3Xr1lOmTBk0aBCCIHY7fIUCqj4YQWhNVqvTrQoSyoR8/39WBNV4OIJqUKEF5SoIuxKzwwHNINoRBKHT6YxGo0KhgIMbQP7gcZ2USqXR0dH+cI0N1XIEQeiLjIYio1QSFBEWgqIo3RFB1QE2PRBUrewsfrYkVojZo835MPtc3SjTT281adCgQYOm0466LPsnNWlQSnKzAf+7w0xuUg9mn33szTffLJt9fmz79u0LFy6sznhKoShq/fr18fHx9evX79WrV0pKSlRUVNu2bYv7O6vV6tTU1LLZ52Iul2v48OH37t0r/i+zauMSsFisCtYKhcK0tLTMzEyDwZCdnWL8J0AAACAASURBVG21Ws+dOzd48GB4Twt5CWW7u2/O670bJSeJIpNf6jJy8vdX9WV+oEiK0pltGQWFAIDEUKVcJKCvBrr/SJ8w9JtbTx9hodICkH9x5J37NG1ave79eG17Kfq8N2DVqVuOknlkypJ58qOZ78Z16sV7eWDS+MWLzmndAFAAMaCC+yw5ACDJU6jCbfRln91/rJk6dOPfZaocZcs4Oue9sY06tBc17PRS6nuTt98oe3JBNQZFUQaD4f79+x6PJzExUaVS0f5L7cj4+dPRnetFKnmCIEViuwGzd96yBcRDGuzhiWWvpzQOU0g4QaHRLfu/9+1lAzx3nh1FUUVFRcV1MiEhITQ0FGafId+pYoNjMlsysnOcTld8bHRosIr27DNsJ6sNzLJAUPUp4ko0gpAwu0biMtEdS62ECNu/v3b9AALgV9dO3sR+a/m4hqXaQITBVTXt9loifATrS1euXNm+fXvFZZYsWTJx4sTg4ODqCakkDMOGDh36448/llp+/vz5zp07L1myJC8vz2AwVLAFh8Mxd+7cXbt2AQDq1KlTapiOctWtW7cqsclkMplMVpWSEFR1njtrer82/wwel5I6tKfMeffk/jXv9z2dtev3BW3E/5axOt0FRWYmyogNlvPYFT0vqQaU4cTqb46e6TH6adfYlRaA/AqWe2DA+FVH7Yq2XV4bGEJkXTm7Z/PnJ//Snf56SCM2AADYbm5Jee+HyyDqta59h/AMf5w6O3fazeuL1i54LY4FyBjcyKd7NDOq6LfVG0+eSRlSqsp57m/uPXjZGTwqpVe/nhLn3d+Prpnz+ukH3/w+u7m4/C1BAcxms6nVagRBoqKiBAIB3eEAAAB275sBr0w5agltO3DcwCgs69TePUvHnDyXf/rY9EZ+PXgSZTgy9dUBG/IULQaMnZbI0V39eefX73Y79+jo7/Nb8OkOLoDY7Xa1Wk1RVEREhEgkojscqIarSoPjdLnUGh1O4KHBqiCxX9RJ2E5WJ5iAhqDqQFFA4ybNfFWsJY+HOegOp9biJKaMTQQAYAkPf3rIGTrujTY0p1Fqp23btlVaxuFw7Nu3b+LEidUQTylpaWlls8+Pffjhh0KhsNKNHDhwwGq1ikSigQMHrlmzpuLCTCazf//+zxwoBHmH7fBX6WdsSdN/ObakJR8AAOZOXNG38wffLt369u63wxguDFcbzR6cCJaIJAJ6Z4YhnIaHt6+f3fLVFzt1ZHmPpyotAPkfyrb/m++PWUJeX5r+7ctSBgCAHHFi2Qc9ftw292jXn3vLEDJ31dLtlxlNl6//ZEocBwDgHN9zytuzvkvfMazD+6lsB6BzzA3SaXx0+68LW/63cmchVabK2Q+vWX/GFjf9x+1LmvIAAAAftWLE4A9+WLt13Lq3Q2AnxJrD4/FotVqbzaZSqWQyGe29nv9BmfZ/Ov+YMfr13We+7RXMAACQs09M69zjf4vn7hj585gQ/4iyPET295//kC3r+/0fW0eFowAAMHvkjLZdl61etm/y9uEy/w3cf2AYptVqrVarQqFQKBT+UiehGqyyBofACY1OZ7HaFHKZUg7byRcWmO0kTEA/Re7fdEcQONr1oTsCf0cEBeUtW0YEBcV37cRixtIdDgQAq+PHRzrSHUTtdfPmzaoUu3Hjhq8jKevu3bvr16+vuIzNZqt0O263++7duy1atOjUqVOXLl1OnDhRQeHx48fHxcU9W6AQ5C2E9l6mBSj7pDT+t7cEK7Z7l8QPL2TfycLUPLfR7pAK+NFKGYPuWwVKv7N/wxlHPcX/Kyd5V2kByB8R2Wdu2NCkgR+0l/7znTGCOo3u1Xbv12cv33P3bsPKO//TfSIiddhbcRwCIHqm0KDsPO319j/OPn7w8ujUdnR2T6IMP/Vv+/FTqxxReO+BFShSUpL/fXLDjOreMfbDq7l/55IAJqBrBJIk9Xq9Xq+XSCRJSUm0v0j+BPzGmfMmtOGUD14L/vfkUnT6YELbddPOnrziHtOLS294FbBdOvunR9R3+IDwf4+noFm/lIgV/7t3O4cAMpjBqAhJkgaDobCwUCwWJyYmVnEsOAh6URU1OJfVvdub9QahgJ8YF8ti+VOdhO1k9fLTsCCoxnBHR+etXs29fz/63XcZeg3d4UAl4NZH9+8/suKlu04x5InNE/z1qWFN4HBU6SUAWubW27lzJ0EQXtnU4/i3bt3avn37jIyMcou1bdt2+fLlXtkjBD0PVJkYJwI3r/+R4elcnw0AAKT2wsU8glUniFPkwTkJIUo20y9SKoikW/qheiYSUEWHJ49e+/DZC0D+CHcBcURy06T4EvlYhMPhIQD3YCQAhE77iGTER4TYUZ6OKeKSeDxWhEaGRSJnrt0pINrF0lg7EUmn9F2JJhJQRScmT/y+dJVDFYkxQnDn1h/ZWOc6LAAAIAsvXntEsBKTImD2uSYwm80ajYbNZsfFxXG5/pemwOxAmpjcsVl8iZME4fF5CMDdHr8eoYjZeMKqtUOTWpY4prjV6qAYoUoZPHcqYrVa1Wo1iqIxMTF8vt++hQ/VRE9pcNgI8BQ9KjJb4iLD+Tx6X6QrD2wnqxdMQEOQD9nat8//4gvZrl3B6emA9OsWrLZx3Vo3qt+UPVmucl7c5Q7aZfpxoF8P+RTYwsPDq1IsMjLS15GUde3aNW9t6nH8KpXq/PnzEyZM2Lt3b8kCTCZzwoQJX375Jc8Pr8agWkTcZ96S0X9OXti/b+aIHo2lztvHt287z3r5w5mTk6Uqnj+lVJjyOk3kAABKe0tc7jPCSgtAfojbcuW2lk8uoh6e+v08zmycnMAFgBSKxAiZq8fUqCACswSRLgCAo1CnowhSrScAnQlogErrNJQCACjdXXE5t3vCPtPnjr45d+GosZmDOjeWuO79tv+HS+zX5swaF+6/N4dQVTidTrVajWFYcHCwRCKhO5yn4L+28uprTy4iH+776TzGbtyqsT817mUI6vUYXQ8AAADpshiL9Pk3j66avsMQ1n/Z4Ch47pTP7Xar1WqXyxUSEuK/dRKqwco0OG636/rG7RcwVsPWrerFRKF0v0hXPthOVi+YgIYgXzGMHKmdNCli3jzx8eN0xwI9iXy4adq0PfmKTu9NGdIilF+qiUajW8KhoX2pW7duxRP0VVqsGoIpxWw2e2U7CQkJ8fHxj/8rl8u3b99+48aNX3/9NTs7m8lkJiUl9evXLzo62iu7g2owHMftdrvRaCy5UOrVlBsz4uUJI1od/vT05uWXNwMAACJsPH7msJYqHnwQF9hKVRuK8s5YyRiGORyO0nXSK5sGAAAs58z6wV9dtof2nNs7lERQTZ2XmwTv3Hlg46VBc+qHMgAAwJG5cvPvhSTgu9x+Pks9M6zVhIFNDn95fvPXfxWfXKJGY95Niau1/RJ9VCdxHHc6naXrpNR7tbIEgiB0Op3RaJTL5UqlksHw3/v8Mtw5B+YMnnnMHvPG3LGxgRE3cX9Ftxazr2IAMKTt0g5/PSDM23GXqjaklzoM4TjucrmquU5KpdKoqKiAqpNQOUpVG4IgvNJU4jjudrtL10lx5RPbPAeSJPVF2r92p81cdMYZPW7+O439NPtcDthOlqNUtcFx/LmbSpiAhiDvo9jsgnnzbG3axL7xBu/OHbrDgcrA/vzjsjvy9Q37Vqb45FcXqtCwYcPmzZtXUFBQQZk2bdq0a9eu2kJ6TKlUemU7M2bMKLuwbt26zZs398r2odqDoiiKokqPDIN67zqesv6+YGD39Ef1xiz7amjrpiGU9c99cz76qm9P646jK1PhMLWBzFsDCpVVTp30Bo/uevpXXy88kesJ77hm2VstpML7qEDEbLpoUsez805PGDP5SNemiUzDhd/OXgbSYIbT4R+DwzwVZft92YTu36gbjl60/42ODYJcGed2z/pkXZ+hxh27FqSqauPJVaraeCsBXX476W0URRUVFel0Oj6fn5CQwGazfbo77/I8PJn+4bSFu/72xA1cu/fL7tIASQYxwlMX/RCTp8668vP6TQt79UcP75vZ0qvX7j6qNtVTJwEAJpNJo9HweLyAq5PQ0wR8nTRb8m8c2LZs0deHMz1xA9fuXRYoDQ5sJ5+mbLV57p9vmICGIC8jpNK8FSsoJjN+yBCmXk93OFB53GazixGf/FKt7YJELz6fv2nTpp49e3o8nnILSCSSjRs3endyZBzHjxw5cvLkSbVaLRaLmzVrlpqaqlAoShVr167d6dOnK91a9+7djxw58rS1PXv2HD9+/AsGDEHFWCyWUCgsXVctBm9tn1TvmbfmNvrK56s/7NlQHsRjs0DMrN1B+uQBW9LWvdlnXiN4pRi4SlUbbzWqLBZLIBCUrpO5L7ZRynZ5z//Gr/71pkfVecSshRNekwaJTYCKwU180gO6zTwrjJ773bEj+3Yd4Cibvjrx5BDn5DHrcgU8f747JLWHP914j93ps5/m9Q5GAABBTbpP2i00JI/dk7Z5RJ/pL9XCk6tUtfFWV00Wi8Xn88v+pnuRzWZTq9UAgMjISKEwoHovUMbL30wbP2f7TXdE56mbVswZ0iCAhihCRHVe7VcHADBmwvCXejWauiRtx8hfxnuze5/v6iSPx/NpnbTb7Wq1mqKo8PBwkUjkux1B1axUtUFR1Cs/3ywWi8vllq6TBPbiW37M6XKp1RnXt3768fIDdzwB1eDAdrJCpaoNk8l87hl3a+OzdwjyHVedOpk7djC12pg33oDZZ//FS6gTRd05f9ns5+/u1lxdunTZt29fua8ixsTEnDp1qk6dOl7c3blz5xo0aNC7d+8VK1bs2LFj3bp1EydOjIuLW7FiRamSw4YNq3TOluTk5H379k2aNKnctcOHD9+1axd8/xEKCG4Mz7p09ZYbrd/x5RahCh77n+GHRK07tGQTWbfuWGAjCVUDUrd7weSOS34zNRyx68fv108fIA4KkhOOOI+eTxY/p2TGtBuxZcMm/blfHCc3/57WM9miziPQ2MgQf87h4ll3b7nRBm2aKUvcxoqatWrJJrP+vg9PrkDh8Xjy8/Pz8/NlMllCQkKAZZ+J/N0TXu743m5T64/2/Xnj+JKhAZFV8WSf2rJlx9n8kq94o9EpKQ1Q193bWT7vwOn3MAx7+PBhbm6uWCxOSEiA2WeIdjiOF2i0D7IvnZo3ZNQnR6xtAqnBge1kdYJ3yBDkNZaUlOxNm2Q7d0Z++CHD7aY7HOjpWC0/XDs9+si7A2fvvmnwwHtAWrz22muZmZmffPJJs2bNZDJZcHBwhw4d0tPT79y507hxYy/u6MiRI507d753716p5Varddq0aZMnTy65MDg4+NNPP61ga1wu99tvv+VwOKtXr75w4cLrr78eFxcXFBQUHR09bNiwkydPbt26FU4qCPk/giTVRkuWVs8RiyQIZbW5Sl7AUmajkQRsgZATAFfgUKAj/t72+biDhvqjPvtl9aR68eFsikjyFMoJ+z+1jyw8ffDQ+rO5jv8+gt+89JcGCX+5idKf72QQvkCIkEaj+YmTy2o2EoDNF8CTy/+RJKnT6TIzMxEESUxMlMvl3n03y/fwv9NHj9tUUP+DfZcPfNwnIXBe/Mv8cdr4CXP2PZFZoSwWK4Xw+NzA+g68iyTJwsLCjIwMAEBSUpJKpQq0OgnVNBRFGYqM97MeYJibODxv6k5toDU4sJ2sVv582QZBgQNBCseNe/jJJ5EffaT87ju6o4Eq4zm1/JNTHoHl1OJBDZUCsSIktKTYCQfh44NqIZPJ5s2bd+XKFYPBoNFozpw5M3nyZO9mb7Va7dChQ91PfyC0atWq7du3l1zyxhtvLFmypNwXi4KCgvbu3duqVavi/7Zq1eq7777LysoymUw5OTnbtm179dVXvRg8BPmIye7MUBd6cDwhRBnVpkdKGPX31lW7H/77GiZZdHrld2exoE7dWgfOZTgUsDx/rdx2x/3SqPlTu/GZ7HjMEIpbUFDy0TB159CaifPWbi745yYLe3h8/k/5nEY9x9bx6zGgWfU6pIRQf+/euLsA/2cRaTq9bvtZXNSpU1N4cvk5s9mckZFht9vj4uIiIiKYTH/ubf8Urt9WrrzgbjZz88LOgTXkOKvZqx2D8Isb11+y/7uI0P2yZsddKviVV+sH4DfhHVarNTMz02KxxMTEBGqdhGoWm92e+SDHaDLHREVEKzO+Xn0x8Boc2E5WL78NDIICBsXhPPrkE0fDhvGjRnEyM+kOB6oChCsJDomRhsQ0LW8tO0kWUD8/UAWWLl1qNpsrLpOWljZ06NCSXUhmzpzZtWvXzz///PDhw3a7HQAQHBw8ePDgWbNmhYWF+TZiCPIlu8ujNlooQIXLJCIeBwAAmG3nLB56dNy2ke3v7ejfqaHEef/swZ+uFEpTliwZoPTbDhRQjWHLv3umiGKKbm/5eBaXKvnOKCJuMnBZnxgmQzXyzd5fv7vn/fEfnO/WMNiafey3y7dA069m9Ur08x9rbvM58/oefW/fyJ5ZO3q2axjkun/+xE9/6qWvzl3SWw5PLr/lcrkKCgowDAsODpZIJHSH8/yIzPMXtCRbfG7xxPFPniuIuMP7y8b6b4YCkff9+MO2x2cve63t7aF9modS2pu/7t13zRQxeMOcTrXx2Y3b7Var1S6XS6VSyWQyusOBIODxYGqtzuF0qhRymVSCIAhxKyAbHNhOVjO/PZ4QFBgwlSpv5UqG2x03YgTTaKQ7HKhqWG2n7/xpOt1RVAVFUSRJFv8Dx/FKyz8rgiB8tOXisAmC8MXGi2OuyjjLe/bsqbRMVlbWtWvXGjVqVHLjycnJ27ZtK379lsViyeXy4rXP/ecQBEGSZA0+1M+6WeDLWu3rQ13pG6++2PsLwnBCa7ZanW6FWKAQCUr8CYzQXsvPHWjy2fLN+/auO+xkK+OajPpkVdrbr0az6AwYqvFwBNUxhTp9UQFBObJ+35FVaj2iQl9Z2icGACBu+ubJtaFpaw8c3rfHxFQ0aT1q39uDeoX5fwVlhKZ8cm5b8mdf7953cOthJ0sZ02DUrIVpr7eNhndgfokgCJ1OZzQa5XK5UqkM9Okc8LycPJyy3Tmy+U6pNQwVc9DSsfVpiapqOA2m7vs9fMmn/9u7d81JE8YLqdNqworpcye0Dw3s7+SZPa6TUqk0Kioq0OskVAOQJKkvMuoNRZIgcVJY7ON3RgO0wQnQsAEAAdpOwssfCHp+joYN89LTxadPh372GeJ/6QaoBiAIwuPxAAAoiiruiutdJEn6bssAALfbjWHenF758cadTmelxTweT25ublU2ePPmzYSEhMcbL3lAiqd2efFDVPwswReHmiAIAIDb7S6uKt5FUZTD4fDRCIM+OiDFdc93W3a5XJUeEKfTWVzYH5AkZbDZC802MZ+bGKpkomUvS1FVq7HpO8em0xDd80CCR50oGPUiBSB6UQAUoQIdUygk3fVbTzFefreyTzBUDft883Wf6gjuuSCqwSfuDS5vDUPVbHD6hsGBcnLVWhRFGY1GrVbL5/MTEhLYbDbdEXkBp8d6A7ae7iieFyJsMGTBj0MW0B0HnUwmk0aj4XK58fHxHA6H7nAgCJjMFo2ukMNmx8VEcZ+skwHa4ARo2P8IwHYSJqAh6DmZX3vt0ccfK9etg4M+ByrKdvfghs2/XMvWEW0+3DhJev64vV6XRkq/6lLFZDK5XC4AgMFgBAUFeX37Ho/H7Xb7Yvpsh8PhcDj4fL4vrphNJpNIJKq0G4jL5ariBjkcTvHh1ev1KIr66FB7PB6hUOj1LdvtdqfTyefzfXHDbDQaxWKxL3pAGwwGHx1qt9uN47hAIPD6losPtUAgYLEqaSdYLJafdFOyOt1qowVlIDEqGZ9TE1IqUKCzMdhqppgBQDRm5JPef2wGQc/Kbrer1WqKoiIjI33xMw1Bz8rpdBYUFBAEER4e7ourdAh6Vk6XS63RYTgWolJKgsR0hwMFKpiAhqBnhyC6t982DB8eNWWK8OJFuqOBngv+YOvYlDe3ZTopABApdyzpyV6ZOuxIzKhvDnw7IgFmaWoELpcbFhb26NGjSkvGx8dXQzwQVJ3cGK42WlwYpgoSyYT+OxgcVHt4EKaaKXIgLBVhlxF2OAgyRDsMw7RardVqLR5a10ev+0BQ1RXXSYvFolAolEolrJMQ7XAc1+kNJrNFIZcp5bCdhF6IX3TPgaAAQvL5eenpph494kaNgtnngEVmr33jrR3GJtN2Xs/emMoFAABet7Rv33lJvWXi2FX3iMo+DwWKPn0qf2U7LCysefPm1RAMBFUPgiTVRkuWVs9hMZPCVDD7DNGOBIiOKcxky1mATML0cph9huhWPMdDRkYGACAxMVEul8OsCkSv4pfDiutkUlKSSqWCdRKiF0VRhiLj/awHGIYnxsWqFLCdhF4UTEBD0DPwRERkbd1Kstnxw4ZxHjygOxzoeRG3t2z4ner4ydYvBjcOExZPnYBIGo1cueeLroxLm7ffggN61xQzZ84sHsOkAmlpaX4yWgIEvTiT3ZmhLnRjeHywIlQqZsBbBYhuJpR3n620I6w4jyEMM6OUvwyPDtVaVqs1IyPDbrfHxcVFREQwmfCdYIhmxXXSZDLFxMTAOgn5A5vdnpmdYzSZoyPDoyPDWSxYJyEvgNUIgqrK0bRp3ooV4pMnQxcuRAjYRzaQ4Vn3skBiasfIUllHRljbdgngy8wcAjSCrWONEBMTs2HDhhEjRjytwODBgydOnFidIUGQj9hdHrXRTFJUuEwi4sHZiiD6ORGWminGEEYIYZUQlc8cC0G+5nK51Gq1x+MJDg6WSCR0hwNBwO12azQap9NZPA4M3eFAEPB4MG1hoc3uUCnkMqkE9nqGvAimWCCoSowDB6pnzAj9/HPpvn10xwK9MCRIIgZFOj0BAPrECkyrLqSEIiH8na1Bhg8fLhAIJkyYoNPpSi5nMplTp05dtGgRvK6CAh2GE1qz1eJwKcRCpVgIazREOxxBdUyhicFVEHYlbkcoiu6IoNqOIAidTmc0GqVSaXR0NHzzCaIdQRB6vd5gMEil0sjISFgnIdqRJKkvMuoNRZIgcVJ8LIqilX8Ggp4FTEBDUCUoBkM3ZUpR//7RkyYJrlyhOxzIG9hNu74q+WbbkvWT27wT9d9i5601i3eoxV07NWXRFxvkA3379u3cufO2bdtOnjypVqvFYnHz5s1HjBiRkJBAd2gQ9EIoiiqyObQmq5jPTQpTMVF4+wrRjAKgCBVoUYGAwhI9ehYF3xiDaEZRlNFo1Gq1fD4/ISGBzYYzTUP0M5lMGo2Gy+XGx8dzOPClJYh+ZotVo9OxWey4mCgurJOQb8AENARVhBCL85ctw2Wy+KFD2QUFdIcDeUtQr7RPux6dNLlN65NDYu/hbtHh1QuPnt66+fB9Zsdl8/pJYf/BGkcoFE6YMGHChAl0BwJBXmN1utVGC8pAYlQyPgemVCD62RhsNVOMUFQ0ZhRQGN3hQBCw2+1qtZqiqMjISKFQSHc4EAScTmdBQQFBEKGhoUFBQXSHA0HA6XKpNToMx4KVSkmQmO5woJoMJqAh6Kk80dG5q1ax8/Pjxoxh2Gx0hwN5EzPprd2nRHOnpH27dp+dpMCa6RdQUVynyRuXfTqqPuz/DEGQX3NjuNpocWGYKkgkE/LpDgeCgAdhqpkiB8JSEXYZYYePcSHaYRim1WqtVqtCoVAoFHC4LYh2OI5rNBqLxaJQKJRKJayTEO0IgtDpDUaTWSGXKWRSOA4M5GswAQ1B5bO1bZu/dKls9+7g9HRAwhnbayBB/RErTgz/vDDrbrbOiYpD4+vESGHqGYIgv/bPkJF6vVTIj1JKGfD2FaIbSZJ6vV7PlktIVxKmRyl4yQTR7J86qdeLxeLExEQmE97wQjSjKKqoqEir1YpEosTERBYL3nFANCuukzqdjs/jJcTGsNmwTkLVAf4eQ1A5igYO1MyYEbZggeTgQbpjgXwK4SoTGivhQMAQBAWA/4aMTEjwxZCRNpvN5XJJJJLAytdgGGY2m7lcbsC9X280GgmCUCgUdAfy/Mxms0ajYbPZcQmJXC7X69u32+1OpzMoKCiw8jU4jptMJg6HIxKJ6I7l2ZhMJhzH5XJ54PbNtFqtarUaRdHY2Fgej+f17TscDofDIRaLfTWWNOqTqk4QhNFoZLPZYrFv3q/32VxlZrMZwzCZTBa4fTMf18mYmBg+3/svLTmdTrvdLhKJAmssaYqiDAYDi8UKuHFILBaLx+ORSqWBO0efzWZTq9UAAB+NTeRyuWw2m1Ao9MWFgU/p9XomkymRSHy1A99UGavV6na7A+IC3t/jg6BqRrFYBWlp1nbtYt94g3frFt3hQL5Dmu6fOXn+nsaGU6XWMBO6j+8WH6hXFBAE1UCPh4wMDw8PuJQWVCM5nU61Wo1hWHBwsA9v1SCoytxut1qtdrlcISEhsE5C/sDtdms0GofDoVKpZDJZ4D7XgWoMj8ej1WptNhuskxAtnjcBTWSf+P54Fl6VPcR3HdslDqZyoEBASCR5y5cTQmH8iBEsjYbucCDfITK/G/jq2/sfekonnwEAgDto11iYgPZ3GIbl5eU5nc7w8HC5XE53OBDkKyRJXrp0yWAwBAUFCYXCvLw83+3L5XJhGMbn8wOrUw9BEA6Hg8ViBVxHG7vdTpJkwD1RIEny+vXrTqdTJBKJxeL8/Hzf7cvtdns8ngCtk0wm0xc9cH2quE4KhcLqyUoQBOGV7ZAkefPmze3btxfXyYcPH3pls+UqrpM8Hs//O5qVRJKk/f/s3WVcFGsXAPAz20uDgLSkhd2Nid0ooth6rWte69qdr93djY3d2F2oqAgiIN2wOfF+4KqAxLLB7uL5//iguzPPnmf2TJ2ZfSYrSx9zUiQSURRVYjkpkUjU0g5N0yEhIUeOHDEyMjIxMYmOjlZLs/mSyWRSqVQgEOjXL0UYhsnMzGSzSkteAAAAIABJREFU2Zq4K1yjxGIxSZKGhoYlc1e+SCRSSzsMw3z58uXw4cOGhoampqYazUm5XC6RSPQuJwEgIyODxWIZGhpqO5Diyc7JEjtYSk9PV3peZXec5Ivtf488ocj2WdDrhD8WoJEekHh4fNuwQfj2bblRo1hSqbbDQZokf7p92fnvZl7TV83pWd1amOfggWXqqJlfVSK1iIiImDlz5vnz57N3fgRB1K1bd8qUKT4+PtoODSH18/DwSExMjIqK+v79u6Y/i6IomqY5HI5+3RHDMAxJkiwWS79qlABAkiTDMCV2etaxY0e1tOPq6hoZGRkVFVUC596YkyWshHOyXbt2amnH0dExJCSkZHKSpmmKothstt6NCCGXywmC0K+6OZR4TrZu3Vot36ydnZ2ZmVlkZGQJbAQwJ0tYCe+YmjRpopYBf6ysrKytrTEnC4c5qYi6desqfd1IxSVLCGxqtOnu06NdXUfDAnKLXbaqnl32QH+ijKZNo1asKHPggPWWLcDkd1csKk3o2OhYVo2pGxf5e+rZqeGfjaKoq1ev9unTJ+d1V4Zhnjx50qtXL39//927d+vdlXaECtexY0d11Q0RUos2bdq0adNG21Eg9IuXl5eXl5e2o0Dol/r169evX1/bUSD0S40aNWrUqKHtKNCfTtkCNL/j2qBTTQMCTp68cGnrrIsHytXv0KNXr1492tdzKqgSjZCuSvL3jxszxmHmTJObN7UdCyoRbEdnR/Ynfbsv6Y8VGxu7atWqM2fOhIWF0TRd0GQHDx40NjbevHlzScaGEEIIIYQQQgihwildLBba1e0+dvmh26Gxkc/PbhjXTPB6z9TejVzKOjfsNXHVsftfMwusESCkOxgeL2rx4sRBg1yGDMHq8x+EU2PouOZfN/6780OWtkNBRQgMDKxQocL//ve/0NDQQqrP2bZs2fLkyZOSCQwhhBBCCCGEEEKKUH1wE4FNzc6janYetViW8PbGmYCAgJMHZ/itmyq0r9O2h08vn54dG7ma4G2GSBeR1tYRa9cSJOnm68tJStJ2OKgksV2HrJ52sO7oWu6bGtTxsBTkuhbHa/jP3kkNcCAHHXDr1q2ePXvKZDLFZ9m2bVu9evU0FxJCCCGEEEIIIYSKRY2ja/OsqrYfXrX98Pny5A+3zwYEnDx5bE6/DdNM/M/E7e/CV9/nIKQOkooVI9avN3rwwG7xYkIu13Y4qISJH8zuPet+FgOy8DePYvL8FERg2h9/wqEDpFLp0KFDi1V9BoB79+5pKB6EEEIIIYQQQggpQROPd+Sa2Dg5OjrY21kavo+XSCXFKx4gpHlpbdtGz59vtX271e7d2o4FaYPs4aGDH1jVx184t7y9I14f01Fnz54NDw8v7lwJCQmaCAYhhBBCCCGEEELKUWcBmkz9FHT2xPETJ05ffxMv45ap1LzbjIm9enVrieUdpDsIImHw4MThwx2nTTO+c0fb0SAtkcZ+T2LXnjyhLVafddiNGzeUmMvS0lLtkSCEEEIIIYQQQkhpaihAU2mhd88dP378xKnrr+OknDKVWnSdvr13r24tPS1xDFWkU2ihMGrpUomHh2u/fvywMG2Hg7SHY17GlHkfGS0DZ4G2Y0EFiY2NVWKuxo0bqz0ShBBCCCGEEEIIKY1V9CQFoNK/3Dm0bEzXWg425VsMnHf8i1WHqdsvvfke8+7KrnnD2mL1WSFU1NNTg8eOsfP24bfsW27wgrFnPiX9GHyWigio59WFaJzPH6fP3sfUb40xqaeXj3UaeezF72/puQcAfQDI314XASwAqAQgBLAE6AkQnHuCKIDBAHYAfAAnDn+Q/6wkoYGbn1/O6vNTgM4A5gC2AP0Avmq4L1pDpzzd92/nxp7mZR1ta7brt/L6V0nOt5n0dyf+7dfS1dFWWNa9fJu/llyJlGor1BIgbDN9SUfRjtETjodk4HDPusrY2FiJuYYPH672SBBCCCGEEEIIIaQ0Ze+Alp4b7NTtYBrwbaq3Gby4V69uratZ8wAAID0pKdeUBN/YwoinYpilE5P0aFuLaVe+mZbv2am7Bzft+d07m/83837C4nvDyxsAEIZO3q2auuWpJtPJT+6+j7O0tCLythZ1bevowIgE+9ql7IF6DMBGgCCAPHVCOUBPgCsAjQB8AL4AnAS4CXAboDoAACQBtAD4BtATwNm6zAOB+NCOecG76Hs0ZfCjkcsA3QFsAPoCSACOAgQBPAawK8kelgAm8fI/nbrv+mZTv23f4Q6S1+ePLvANerfz8e7udiwAgMwny727rXgK5dv3HO5rEPfg/NlZvg+Cd1892MNO+YtUukwWtHdfJI8dvN238m6jMmWMcm8JBZ13hGzvhINzaFutWrUOHTpUrFmGDh3aqFEjDcWDEEIIIYQQQgghJSg9BIdMImUYAEnsq/NbXp3fMqPACQW9TqQe9ynJUg4Te37OooQ+64Z4skvwU4uPjt2790aYSYO9O6f1t2YBAAxuOWXov6tOnDzjO72vCcGyrLdoTr3c8zBfzy2o86jCrIntXHPXBanvV0esfRjHEKWpXCgGeAdwEOAYQNnf3j0LcBVgMMCOH3fyXwfoADAL4BwAAbAXIAxgL0DnDh2+z537z/9mLft2bRUNZwD6AgBAGsAIgIoAtwFMAQCgM4APwAaApSXUxZLBpF1fOGL314rjz9xe0MCUAGDGdR7R3Of40g1jOy+tzQEqZMPkNU/ZzVdfPTS+khAA6Gn9p3byWTtr1ZC2q1obajt8TSAEZjaO1Swcq+X7Lq+8RZErEp38+uTeo7dfRWQYlavRss/gntXN81wUYlIuzRm25fWvC0Js+57LNw4sz1ZgXgQA0Lt375kzZ0okkqInBQAAHx+fTZs2aTQkhBBCCCGEEEIIFZeyBWi2q/fwkWUUudWWW9u1JOvAjCT61oEzwaJ6uv+zetHHu59IY68WPa1/1LoEHt3qW60JiHoXQ4NJPkuNjr81Yes7V//lk9xyf3Fk1Male4PsWvSxunO8tIybwAB0B7hS8ARBAGyAf3KMI9MSoBHAXQApgADgLoAxQTSdMCGmR49yY8caPnnSDWANwLsf058FiAJY9aP6DACdATYBWGuqT1rCJJ/deTLKtOOqyfVNs+uchFXnGRs21Qy1FsoBONSXS6ffkg5DJo2sJMyeg2XReOaktjuHnj98b1HrtkItxq4p3EaTj52erPz8VMSpJYsDKK/B4/qUSQg6uGfxMvaqJd0dc621dHxsPFG+86Qenv/9BIQQ2tuxFJsXAQA4ODhMmzZt/vz5RU5ZpUqVadOm9evXjyCwlI8QQgghhBBCCOkWZQvQnFrD1m8ZVtRUpCg1XcIxUsOTDhXBJNxcPXfPw+h0GQOWJfORKuG4/TV5bB+nCjmegUZliKQMy8LKJL/bL5n0s1sPXDbvcMvXJfeQJvLXR9bP/uQ8b3MPalnpKUATAOsAUgEYgHEAUflNUxXALfcsQgDyx2Adw/n81mPmyJpWduvThxcdDQAZAAyA1Y/pbwHwAFrkaIENMEITndEu2bNbD0W8uq1amPyqzbGdW44Y1TL739T3yGiK7ebqlGPcdsLYo4IjcfHFi3CqbWUsjeYlexMYGO7Qc+3Ido5sgCqWqaGTz19413FktZyrpjw+LsXEo0HTRlXZxZ4X/WfOnDnh4eH79+/P992OHTtOnz7dxcXF3t6+hANDCCGEEEIIIYSQgjQ6YIP82dy61vZDzpVQSZQwq+X7z9xlq+b6lC+hkrdqBI4dOrTuU8WcBYwkK/17dNiVk5snX0u3a96pd9l8buITvQ349ybdc3iPBoLcr78/PmRvVP2/xo534ZSye/8qANQHqA9gkt+76wGeA+Qc3CUK4CFADQABgMzRsfyxY509LNz696ejo78DXAGYDGAH0BsAAGiAMABrgC8A7QFMABwBegO8LYmelSg6Ljwsk7B2NvtyYHr7+hVNrJ0c63XoPfv420wmewKWiZkpi/oeFZPzMY+ymKh4moqO/F7qHmmZA5MZcn7djNED+/j4r3sqJ0ODLr1OUOR3HVTkuw+ZNrVq22VXltlOtWtap394H5Prdxd0Qlw8Y21rTYtT4hMz5Exx5kU/sFisvXv37tixI0+J2cbGZuvWrefPn2/SpAlWnxFCCCGEEEIIIV2mF5VaRXHNHNzMgEn5LMyvEHv8+PEXL178/C9N0xkZGQX9XttYQyHmi45aM27cjBAKgDCv1vfi1Mb5PPeNjt21/XKEe+9TzUxyRSx6N2fJ6W81/wrobseB7yUWsg76CtAbIAtgFoC4Vq3ItWtNL160XbECaHoFQPYg5eYAF388YJAByABIA/AGcAcYARADcBLgWo7HGJYOTGZ6BsOkXZjsvUfu3q7TCG9ezOMLJ9eOvPYk9vbZcdUFwKncoqXdui1H1h8etW+QEwcAIOvN+rXnE2jGQCRmimpfEzIyMgp6SyqV8vnqGFSeDD80yHv44VAxA0CYCwbRsrD1PfwuO/ffdn5HP/dCb0emE+MTmTJWPweKZllYWTCJ8Qk0lPu17tIJMQlkws2lQ/aEp1HAMXZu3HfsqA7u3KLmjY6O3rBhQ86Pq1ChAvzYZKmh43n6QtMaapmiKAAQi8UymUzFpnx9fXv16vXixYvQ0FAAcHNzq1q1Kp/Pz8zMVEOgv9G7RU2SJACIxWKpVP3Xe2mazszM1NDYJhRFaW5R07T6L+tkL2qRSMRiFXH9XiwWayIAhBBCCCGEENJHpaoAXbh3795dv379539NTEykUqlOFKAJyx6jpzrHJn/58GjnhSOdprIvrvSpl3vc3ayXZ9e84XaZ27ZSznNeJvPK5vUb0mrvXN3GhfVj4Ik/jwxgHcAiABnAVoB6Pj4RU6bYLVlidvZs9gQ9AJwBvgDsBOgEcBGgHgADQAKkA/wFsAkg+3bU/gCdcjzGsHRgSIpk6PQ4w7+OBG5qV5YNAPS0/pPadNq1claA7zn/soSg8fT5Xc8OPz28ufelHs09uLGPAs8+hbJl2ZkijnY2EYXU0SiKUkdZhw7bOnTk0ZSak45tGiNa6DkJAIRtZ+8Y/e3vLSMGVatz558KhQw8QsmkJCEU/rzSRQiFAkImleUs1jMZiSlyoZFb5/Hzm9pD3OvArRt2LtlptX54UfOmp6fn3FLVqFHDzc0NABiG0UR58b8eUZq6050kyeyaneqqVq1atWrVn/9Vva5dEJqm9XFRy+WK3L6vDM0taj3NakUWteb6hRBCCCGEEEJ65w8qQI8YMaJPnz4//zt+/HgzMzOdeGIVIaxQu2EFAOjYvq/L3Oprj8++2uJS1zK/Ss1M2umA25GWzXY0Mc4RLpP6eN+I89Luc0f2s9aBXmjJU4BhAG8BWgGsZrMtp06Nb9PGZfhw4Zs3P6epAFABAAD6AlQHmA1w6ceA0TyA2T+qzwDQBqAhQBCACMCw5DujGYRQKCQIXqMRs73L/tdTlkWbicMa7p8RdP2xyL+LIbAcem29a1Jp1srDl/dtPC+wq9Vl8c0RmeOaz4kwNtRKbpmZmRX0lkAg4KheFqfeHdx1j/Fac2hFb2d5QPZiIcyq+68/KQr1/Hv/keDx86oX/CFsHp/NpIklDAgIAABGLJYwXONcd00T5t5zjnr/+J9jPb+/e7wac+zO60HNipjXxcXlwIEDP/977do1oVAIACwWy8Qk39FoVCKXy+VyuYGBgdpblkgkEonEwMCAx1P/8NYZGRmGhoYkSR46dOjUqVOhoaEURbm6unbp0mXQoEGqdCc1NZXNZhsbq/8qpOYWdfa9z4aGhlwut+ipiyk9Pd3IyKjIG36Li2GYtLQ0DS1qmUxGUVT2iqNe2YvayMioyK0Qj8dT+0JDCCGEEEIIIT31BxWg7ezs7Ozscr7C4XC0WICWRb8+/ia1XK1mTX+N+MwqV79WFdbbkLAYCn4VoOm4e7seS5x7tmiWa+ABJj40/DuZfGz2wGOzc75+qkGzU2zHHvcPDapf2h8eFwAwAMAK4AxAR1PTb6tWZZmZufXrx42JkQEcBygH0DTH9OUAqgCEAFAAXAA7gM+Q64GVLAB7gCelqwDNLmtnxyE+OzhY5iiGsGwc7bnwJC1NxIAhAQA857ZTDrad8nMCWdDkbyTHxb2cVrYRhRR3WCyWGlZb8svHL+DRw8sxT4GIZdeosTv8L/QrBYUUoFllrCyJ8KQUGszYAAB0alIqUcazTGHVJpalvR1fnpIhsyhiXoFAUKlSpZ/zPXz4MLuMRRCEGirvv6FpmiRJTbScHTabzdZE4wRBhISE+Pj4fP78+eeL4eHhN27cWLly5YkTJxo0aKBK4xpa1BRF6eOi5nA4mihAg8YWNUVRDMNod1Fr4tMRQgghhBBCSE/h7TnaE3V30pJ1M+8k5BxNgMkSZTCEUMDLeafz1zt3H8qtOjd1z31vG2FRtfWMQb6zfv4N7NDKisUyqTh4gO/M7tXsS/td0R8AhgB4AjwFaFuuXNjBg5y0NFd/f25MTPYEkwBm5h6YJHvcZ+GP4TXqAGQBROaYgAL4CmBawGMP9ZVhtToV2FmhnyNzLAsqKuyrjDC1tzMhAOjo24f27rwUIvr1vvztrXuxLNdmjexL5zaCMDUzgeT4xN9+oi+Pi0lgjIyNCl192E6elQxjXr1OyB43g459/SbWuLKnfc4rPqKHG0eNXnsv7efDB6O/RMjMHR3NyhU9LypSaGhoixYtclaff4qKimrZsuWzZ89KPiqEEEIIIYQQQgj9Ttk7dOj44KC3cUWMr0i9jxAr2f4fgFuxupfhtXOBl590GdBAAAAAdOqlU3dCGPNhdXLcdsqk3ngUKjfz8q6Y58siLKu3m5fzYXn095VPr9zOqDxiWL9Sf+8zAKwHkALsBzBo0iRsxQqLEyfKrlsHP0YH5gJ4AZwDeALw807ISwAhAMN+5H1PgEUAcwH2AmQX988CPAUYBKCOh9zpDLZHT58ai+Zun3uq214fRy4AkDFnV+x6Spcd1LkeHwCAeX94+thXjcn7x0c6swFAHn5k3p7P/PqLB1UrpTfx8Wq1aWG27fDyneMajnb69bI4eMuyozEmbVrWKnwkA161Dh2cpp/YcNhuSDOL+Fu7TkW69RhbhQdAfrl+8E5SpY696ltXbVBFvnTHSguydwN7dtK7K4fOJHgO7FiJw6MLmBcpimGYUaNGJScnFzSBWCzu169fcHCwJoakQAghhBBCCCGEULEoW12SBy1o3+uERIEpBUp+QqlHmDaYO6DytS0n2w+N6NO0vC2kvH16/8zHTIfWk2bWzlH/FL2/8V4uqO5ZDwspOVAAjwB4APPd3KRmZga9e/OiorLfMgFYBcABmAtwDaA9QB8AW4C3AGcAHABm/mikIsBEgGUAIQDeAOEApwCcAOZrq1eawq44bOHEE92XDW0Rcrq7twc7/PbpU89TnPrsmN/GGACA5eD/79DN3TZP8O74sFeTsmnBVwOvB0PztesGe5TaKxmmnWYvaHNlzLiGDW76unwkpcYXNy66cvvQ/oufOF6r5nQzL+IHBBxXn3+nyrft2zj9lMTAvkanaSO6l2MDABn9NPBcONXQp35Zozp/LZxqtu/4waXn0tkWDuXrDF/o38qOBcAqYF59RdP0gwcPgoKCkpKSTE1NGzZs2Lx585+VX7lcfufOnUePHqWlpVlaWnp5eTVs2FDFQVSCgoKKvMH506dPp0+f7t27tyofhBBCCCGEEEIIIdUpW4DmVO49a54nqciUnpVL9h5Kwrz9woD2JfqRSuJW8Zt7z+r4goD7p069TiV5NuUq/jWx56xunrY5Rj2QfnhzT8Ryr+BqUtqH1CgWEuAbQCbAsS9f4MuXnG9ZA6wEAIAqAPcAFgCcAkgFsAH4C2AWgG2OiRcC2ANsAVgDYA4wGGBe7glKCaMGC8+esV+0dMv5I2suM+audQcvnzLvr8Y/M82kyYKbF1xmL9x1ce+mVK5dzVbTzswe28m5VN0Ingen/MiAW8azxs/esfVMFs3AlsmP2MauLcftWbWgv6cCV3vYVnX8Z9Xxz/OqoNm/Ac1+/IdrU7/ftPr9FJ1XLz18+HDUqFGvX7/O+aKbm9v69eubN29+5cqVmTNnRkRE5Hy3Vq1aW7durVu3rtIfeunSJUUmu3jxIhagEUIIIYQQQgghrSOyHwT0B/L29r5y5UqBN+I9OF+y4eizxl1K/jMpc/Nva9YwHI7ThAmcxMSSD0BJmanajkBPGJoW9M6uXbsMDAz8/PzU9EmMJOFLSFi8mG1i61bB2Vznfmiwe/dugUDg7e3NZrPNzc3V3r5MJpNKpcbGxkrMGxgY6OPjI5VK833X19f32LFj+b4lEAjOnDnTtm1bJT4UAPr27XvkyJEiJ2vRosXNmzeL23hiYiKHwzEzM1MqtMLIZDKZTGZkZKT2lrOyssRisYmJCY+n/rFcUlJSTE1NNfEQwqSkJA0taqlUSpKkoaH6HyWbvahNTU2LHN1FJBL5+fmdPXtW7TEghBBCCCGEkN7R7APGSFFqcnKmTKOfgf48kvLlQ48e5cTFOQ8dqk/VZ6SLCIGVe436jRrWqaKD1WddFhER4efnV1D1GQAKqj4DgEQi8fX1jY6OVu6jBQKFhnZScDKE9IDs6l82bCIPFptvbOVau/3wZYGfRQXNySQ8PLhx/71YuqAJlMfEnvQv59A3IEEnb2RQsOMaXD6lH6alUujYoN1r1p54lantQEojzEmlYE5qEOZksf3R++WSWBmVz0kN0u2c/KMpn5OSpzOrWzZb9S5PNVijBWj5s7l1re2HnCuwQIFQsaV7e4cdOGB+9qzjtGmsgotfCBWNyQw5v27G6IF9fPzXPZWToUGXXifItR2Uvli8eHFmpvKHR2lpaUuWLFFuXk9PT0Umq1KlinLtI6SjCJ6ZnfMv9mW4kqTwF5d3/tu1XusFjzLym4X+dvTf4RMXnYso6ERO+vXKqlHtazpbGhtZutZs2W/OyZAshYJhEs9OHX/GadL87laaGCFMFHp28cAWlWxNDQzLONfuMmHbw4QiHnydW5EdL9ZkJUjZjotCLyz/q12NchaGfIGJTYXGvafufvz7nLKoW+v/7lLPzdpEyDcws6/s5ffvvmdJqnVejWkpPT/AnJX3rDgHXt2lHwpfGjqelgBAhe8e1nP4pGlb7qfm7r38zrhyHOV6rXnF7nixvkom/X3AwkGtqzpaGAqNrFxqd/57w+0YRYZ5LIj6N5WKrV/50uOcBJU6rmGa3VSCCjvHfKk9J1VZa3Q8JwvreOnaTv4u35WxqM3p/G1ByoRbjJyURd1cP657Aw87cwOBgZm9Z3P/OUffpP1eKVZ+CehqTio0oyaOrNREwzuIohJDUOefue0+Lxiz5VOuT9XsHdAIqRNBJAwZEjV/vsP06dabN2s7GqTnyPBD/WvW6jph6Zb9x05dfBlHy56v71HTpdrAQ6H4q42iUBQVEBCgYiMnTpygaWV2zz179ixyAAQA8PX1VaJxhHQXu+L4i5/Df4qMz8j8/mTXkCoGTOqjxaPXvPnt3JNJub16ywNpQbeTMClBs5vX6jBl29VQmZWrs3Hah9uHF/Zu1H7Zi6LvfpE+XjnjGNVzylB39T9DlUl7MK913R6zDgRFgp2Hq0l6cOC6UV4NBhyNUPS4uYiOF3OyEqNsx5mUOzOa1+4yfcfVD2mGThXcreioxwErhzWt47vnc46LqvKP23rW9Z6wKfB5HMe+UhU3c0n43WPLBjepPzggWoUzJXWmJcFmc/LHZhFAsAQCfqHnprqdlgAg/7hp2JRLifksbiY97Es8TRCsfPqu2nN7VaVcxxX+Kuno0yMa1us9Z//NT5nGLuUdOAmvL2wa36Z2920hSt9kot5NpYLrVwH0OSdV6rgmaXhTqdrOMX/qzUnV1hrdzsnCV8ZStp3Mo6CVsYjNKcFR6nlriuak+NWq9jW9J2w4+zQGbCpWdBSmfQo6tLBvwwYjznzPEapKS0Anc1KxGTV0ZKUGGt5BKJQYhEXnyX85P1wy52TOO9uxAI30A8PnRy1ZktKrl1v//ia3bmk7HKTv6LCtQ0ceTak56djLsD09BAAAwrazd4yuHHNwxKANH7V9EV3XxcbGpqSkqNhIQkJCQkKCEjM6OzsPHTq08Gn69u1bu3ZtpeJCSG8QfJu6Q7YenFKdy8jenjr9/r8tF5365eGVY1sWjPSu03nDB3kB9VUm7sRo3yWPs1z77HgZFfXhdXB4dMip0dX4qfcWjNkUUsRpfFzAip2fnfr+1dZU/ad8ogeLhi15lG7RYtHdiKgPr9+GRwcfHOBOhB8dO/5Q4YfzinVc0clKnLIdlz5YNGzls0zz5nOuhsZGfngT/CU26vnOfm4QeWrihP0/5qSj90+ceiGOVX7Avrcx0R9ePH8bHvPl+pzmFvIvB8fPuZTvHXjKUT4t+Z32JMrkv5PFnR/mwuZXGr1oqEshJy46mpa/SN+sGjLz1u83EQEAUOGfw0gQdN6XkLf3okfTK6r/nFxhynVc0a+S/rp9yOCdH2ROXVYGfUuMCH4dEpPw8dQ/DU3jLkwctDpYXSunKptKxdavAuhzTqrUcY3S7KayiJ2jRE2dUCEni1hrirg4oKM5qdh+uZRtJ3MrcGUsanNar5V6znfyzUnJk4X9Z9xK4nj02/kyOurDi1cfY+Lfn/ynkbkkZNfwvw/H/PimVFkCupmTCs1YckdWxabhHYSiicGtNnhYo4wzK7a//3WVDQvQSA+Q1tZhe/fK7Oxc+/Xjh4ZqOxyk/6h3B3fdY7zmH1rRu4adUfYRC2FW3X/9yRVtWE/2HwlW5beff4BChn4umXbmz5/fpk2bgt6tV6/etm3blA0KIf3Crdy6uT0bqPDQr/9tuESXprRs12f03G3Xw0QFFnDkz9bOC4hjlf97z46h1UxZAAAC526r1g5xYomfHz7+vrAKNP01rfNcAAAgAElEQVT16LZL6W49fevx1doVAAAm5fzanSGksOnsndMblWEDAAg9+m5cP9CBSLy4ZnehcSnUcYUnK2FKd5x8E3jxK8lyG7x0VmvH7JHvWebVB6/5t7UA0m8H3s4+AWLiLx6/lUFY9VmxsX9l4+xzPJ5dy1mrRlXi0LFXLjxV809/lEzL/DCJF6aM2hVddcqeRV4mhZyd6mpa/iB6snjwgsfCtgM62eVTJ5GEfY6kWPbl3dX/8FRVqKPjOVrL+1WSL7avv5nGchq64+A/TcpmLxahW7eVAas7m0ufrluVqc4qp3I5qdj6VQB9zkmVOq5JGt5UFrVzTFLn8LhK5WRRa82VQofH09WcVGwHUYq3k4XvIPL70J+b01bOavwu8+Sk9O6uve9lLLeRO7YP+W9tAAOP7iuOLmltxCRd3HUykgZQcQnoZE4qNmNJH1kpTtM5qWBiAADLqUefJqxXu3c+/HnOjwVopOtE1aqFHj0qDAlxGTqUk5ys7XBQqUB++fgFPJp7OebZBLLsGjV2h6+hX/EW6ELZ2tryeDwVGyEIQiJR8lYSHo8XGBg4a9YsAwODPK9PmDDh9u3bRkZGKoaHkN4g5SQAMD9HtBF6zTwdGBgYGBh4bvuQivn/NFP+7FjAJ5JTe8iIhjlP5ARey5+GfQ09N6awn0FSXwKOPpY7tO9U89dQOEzSng4Cgltx+pOfl++o7+dGehqw2Kb1p99KUrjiKLp99noa8Jv07Z3zXlfjln272LHl7wIvhBaydVak44pPphhp5M2N43s0rmhnbsDnG5jZV2raa8rOxwnFr5sp33GapgEILo+bszhL8AQCFgBNUtmhkF8+hMoZToVa1XKduLMdnR3ZwKSnpau9FK9MWuaDSb44/e99MZ6TtsyoZ1DYhDqbltkyguYMWfHarPvazQOd81m5qG+fw2UMx62Cq4oJmU0H0vJ3v3+VTMKzJ2Eky6x5p6bGOackbLv0bMJjEi5nitWal0rlpELrV/70OydV6Hh+dCAnFetRETvHsup9vnXxc7LIteb8w0KKXjqbkwqtjKV3O1nEyvi7nJvTogclLJacOUlHvn6bSLOsW3VqkGv/y7LzalGJw5ChIWEUgGpLQDdzUrEZ1X5kpS85qWhiAACwbNt1qsuOCDh6/0cFWi2rL0Kakta+ffTcuVbbt1vt3q3tWFApQpiamUByfCIFkHubKo+LSWCMjI20OpCY7hMKhS1atLhy5YoqjTAM07Fjx8ePH1tYWCgxO4fDWbhw4aRJky5fvvzx40eGYVxdXTt06GBlZaVKVAjpm6xH567FUsB2dnf5b3PGtqvdzg4AAOjQD0vz3ZrRUY8ef6PYTo2buOTeBrIMrZyKuLWI/n710kvSxMerZiFnPXRM4Li2fttDeHWnnrm4pHkZRbepZOjrd5kM26N2Lctcs3Cr163OJaI+vnkvhQoF1SEV6HgxJlOA9O36zq0nXY+nOaYOHpWqC6Tx4Z/vB/zv/oUroVcfLmtSnHu0lO84p3rXrh5r/vdx35LdfnuHVzEmAED2/erC1VdEhEVnn1am2e00WPY2fSGw+Qa5rrumP3v0jiS41aupWojPS6m0/B2TdmP2hH3Rbn/vn1FfWOiUupuWAMAkX5k6dH2IVZ9jG/wcQh7m9wnhn8NJtrW79fczK5edfxoSmca1Ll/Xu8/gPo3ti3tTmE6k5W/y+yoZqUTGABBsVt5vgifgs4FOlkpJMFRXdUW5nFRs/cqXfuekCh3/nU7kpGI9UmXnWGzK5GSRa82H99/pNs7532Oouzmp0A6ilG4ni95B/DaHwnvGYsuTk4LKXcdOaGTXvkqeQwQqPiaBBsLE1JgA1ZaAbuakgjOq98hKn3JSscTIxrJv0tSDuH/l4gt5y4ZcUL4ATccHB72NK6J0Tr2PECvZPkIEET9qVFLfvk7jxxs9fqztaFDpwqvVpoXZtsPLd45rONrp18vi4C3LjsaYtGlZS81Xk0uh6dOnq1iABoDQ0NA5c+Zs3LhR6RbMzc39/PxUDAMhvUSJEiKCg/bPm7jxM0kI6vr19lT8mI4M+xRGArucm+33a/9bsHzv5WdhyZSRQxWvHiOmTx1Qu0xhv48TPb33QsapXLNqgac9dOzF8W19t7zn1pt25sJixU8VAICO/hZNA9vOMc8P/ghDewdzgkmK/BZPQwGn1iUu69Ly+dcT2OWHHb203sdFCAAgi7k+q3OX/73csfPWvCadinGrnAodFzRaeHZ/Rp/R20fWcllVp5aHmTz67dPX0bRLlxUHdw+w/28eNs/A4L/frTBpX1+FRCXFfH58dvOa/VGC6pOWDq+grtEzVUnL30if/2/yznCr3sdmNC3q1EuH05KJPzvxrx3h9gNOr+1hQ5Ah+X1ATGhYJkNn7fWru1lE/nfP1NVzhzetWD1s15nNvVyKsRB1JC3zyPerZJWtWMGCdTfx/u2X0vYNchSQ0m5dfiBhgKBICkDlAzLVclKx9Ss/+p2TKnT8NzqSkwr1SJWdo+JUyMki15rkhOQCv3odzklFPqBUbicVWRnzKMaeUXH556RDh2mrOvw+bdSxtUe/UWwX73aeHFBtCehmTio6ozqPrPQpJ1mKJcZ/OBVqVTWgTz18+I1u6MZSvgAtD1rQvtcJRX48rd4fqqA/A21gELV0qcTNzbV/f354uLbDQaWPaafZC9pcGTOuYYObvi4fSanxxY2Lrtw+tP/iJ47XqjndzPEO6KI0b9586tSpK1asKGgCR0fHyMjIItvZtWvX8uXLDQ11azg3hHQR+WZ+De78318n+E5dVu+ZWJyiCpOelsYAk3B6WKNbt2LYJvaubk5pX8MeB6x4HHjyxt6be32dCjpspsKDQ0QgdHUvoABBxV2a1Lb3pnfc+tPPXljkZVG8rSmZmSFigDA0NswzH2FoaEhAYlam7gzbTKeQ1s06dnUeMKeHy48zJ55tc/9OHmuef4xPyGJAoHjnVeo418zB3dVa+DIl6dPDa5+yZ+PalavoamWQXwSymzOa9TySyQAAIaw4aO+ppS2L+TXlilx9aZkHHb5r+rq37PrL53SzKio+3U1LOvro36MPfXcZHriqk2VBH0uGfwojgQFOxb92b5reraYdPz3swYkVU2bsfblzkK+Tx71ZNRQd9Up30jJnUAV8lUKvwf4ee1d92jhiYr1T/+vpZgAAZPyDDcNH7f9OAbBpRqnVXc05Wcz16wc9z0lQuuO/f57O5KQCPSpq53jA16nA5gsLW305WdRaI5FIC1oCupuTin1AKdxOKroy5pylGHvGQsNWLieZtFe7xvlPOJPAKue/YloTAYBKS0BHc1KJGVU9stLnnATIPzF+4Lt4OLHlIW9C5ODGV74Azance9Y8T0We08XxrIzjfKDikDk4fNuwgRMX5+bnx87Q5uNDUSnGKT8y4JbxrPGzd2w9k0UzsGXyI7axa8txe1Yt6O+J9z8rZNmyZaampvPnz5fJco03x2azx4wZM2fOHBsbG5IsYj8hkUgePHhQyBMFEUL/IXhmtnZmv86vCIIjsHCq0Xbov9P8qhb2dLbfySUSigH52xuPq/914OpyP09TFgAZd2/1oN4zLh8aOap5o/ND846R/x8qOiKKYlnZWudXoabirvzTbvnmN1lg3HrgX01zHHyTj6dWbrzyc8E/nePWXfrm4XSnHwWnArpDU7ozQj/LwWf1aZ9cL5FpoTeOXQ/PGaPGO84kX5vYouuGD/yaQzct+btjPXcLafSbW/vmT1m5olfTd1uCTg/3yHMczq09ctue1pmpMe/vBhw6u7dv3Y9vA84vaK5kEVqNaZlbxo0VK25n2fT/d3j5om8i0tW0pMJ3jxh3MtFj7KFl3oVc2ibs2v+7ugLbuaV/lyrZY4BZVWg1eudlG2mt3oeer1t1cfyBbsYFzp2LjqRlLgV/lcJGc/bNe9xxzr0tvSrst3Jxt+MmhoV+z+BXbdOEvnE3jkUolUDqzMnir18/6HlOKt/x3+hITirWo6J2jqu7X7BS4hko6szJItYagZBfUHu6mpMKKn3bSQVXxlyKtWcsTPFzkkp8tm/BpNnb7n2XCyv03X56Ww+b/yZT/qvX1Zws/oyqHlnpcU4WnBj/YZe1tWYxn6O+JTFgRyhdgGZX9pk516fo6RAqHlHNmt/WrjW5edN20SJCh84zUelCiVLTJGz3vmuu912a8CUkLF7MNrF1q+BsjqXnYiAIYsaMGb6+vjt37rx7925sbKylpWWDBg2GDBlSrVq1+Pj4IqvP2WJjY3/++/v374GBgSEhITRNu7q6durUydXVVWM9QEivsCuOv/h8XnV1XNXn8PlsAghe/dlHN/b7MUgdp2yTKXuX3q8w+Nz1XcfDB//jlm8Fms7KFDGErVCYz4Ep9WXf3M2EibOLZUT4zflTj3c72ufHUSirbEO/ESPjC36SCrtcTXMC2EZGAgCRKEvEQK4TIEaUlcUAYWiU93YO7aJTgwMPnbj2+PWHz2Hh4V8j4zPlDAMAv34XremOy5+vmrD5vdSmz/5L232ss6cp39hv8dnynMaNF16cPiOgx/E+uX+yynJq1ndgMwCA8dPG7+xeb0TgshHLOwUvr6/UHlCNaZkT/e3gigPfiEoz/m5rqsBXrptpSX7aPGzKpQzPyWcWtSi0F9wKncZU+O1VwrrzaF/no6u/3r/zWt6tieJfj/bTMlc0hX6VxvVnXnlSa8PSNQcvPfn84aPQ1rPTlPHzJjvsrHPjLovFVur3+mrMSSXWrx/0OydV6Hi+tJ+TCvaoqJ1jQrLUyqa44w2reztZ6FpjYmZa0GqjmzmpsNK2nVR4B5Ez6OLtGQtTrJykEh5t/3fcnH3PEilDj06zlq6c1qPCrwcmqfDV62hOKjGjOo6s9C8nC0+Mn4QGQgLozIxMGoCNDyFEuiSlZ8+YqVNtly0zP31a27GgUk0c+Fe5/nGLP90aV05g5V7Dyl3bAekxNze3pUuX/v66gYEBh8NRpAZtZmYGAFKpdNq0aZs3b5bL5T/fmjhxYv/+/detW2dqWqzn3SCECsU2L2NOgLS8dzv3XAeChJVXy2rcc/c/vftIglu+t3kRXB4XIOd6+gvDEOZN5pw/MzRseK1Bp09Om3Ghza5O2TUKlnP3+Zu6FxkYae/kwIYPMVHfKbDJGZo45nsKQ/DtHa11ZABoACbt4ZJu3ebdSWCMy9Vp0qhR97b93Tw8a1gEje66/MPPqTTccfrbnVuhJFGmnX8n61zH/MIa/XyrL3357O7N5/I+3jyalJEUsLg8Tq5mOC79RnScfnHf1yfP4qC+Q7H6r1Hkm11b7oh4DYYOKezBRL/oZlpmPLx6PxV4ptcmtwn6GU361zgayBerujY+yONUHHlg18CCR0XlOLs7cyAsJTml4NPNvL3VhbTM1UaRX6XQtf3UHe2n5uxE8r7weJow4PG0fFuAoutXfvPqdU46qdDx33urCzmp6FdZ1M5RIhbnLAdpTcFrjZtHgQN062ZOqkxft5NK7CCKu2dUCyb5/jI/37nXvjNW9YZtXDF3eDP7PGs+W/mvXkdzUsEeKXBkRdd3UCzt9S8ni06Mn+RyEoDg8XgEgPJDcCCkVgyLFT9+fHL37uXGjDF89kzb4aDSzqB+q0bCWQ+fpo0th8M9awiLxapevfrz588Ln4wgiMqVK0skkrZt2wYFBeV5l6bpffv2PX/+/M6dOxYWFhoLFqE/DKeCZwUuEUv+fsxP0zQA8PgFnmCzLMtasujU5NR8zvRYdv57zs5pbEE0+N+Cg7fGXDswaZ5/sw0tTYoRmFu1yoZEcPjLN6lMzod3y4NfBssZjmc1TzU/8V151PuNYxfcSbLuuunyvpG/fq9KBb9QZq+ibMcZmqYZAL6BMO/vVwm+UED8+ELJ57OqNVoeXvd/7+/lubOdY2gkJCBdLNKpx4bLHu8/9J7kN/PtqeAjq3Q4LemMiJePIvK+mhb+4lE4cMkuYgaY1OCr196lG1du3bZq7mMSOi0llQaWVVkrRQs3upGWORT+VVKilKQMOdvQvIxRznKK+HHQUxnwG+V7V1xJUnD9ypd+56QKHc9LN3JS0R4VtXMkCK1fAy1irWlYq8DrAjqck0UrpdvJolfGHIq9Z1QD0fMlnTrMfiR17vq/g9vHN7LKb6gMFZaAjuakYjMqcmSl6LjnepeTiiTGzxZTk1NpgmNpbcECAND6NhQhoI2Mvm3YkNGkiVufPlh9RiWBVW7Y7gP9whcMXHH1SzqO9KIpvr6+RU7DMEz16tUbNWr0e/X5p+Dg4MGDB6s1NIT+bIRN2451eFRo4JlX0pyv098uX3glJ4S16lct6O4ajmt5Vw6TEhmZ/vthNcvY1taEAAC269A1MxsaUKHbJyx9JAIAIB9PLc8hCsGrtyyEAjBq3sHLCMR3A87H5mhf+uTU+QiK49GuvYqDHqqR+O2L93IwaTNsSK7REsWREXF5BuzTZMfZDlWrlGHRsbeuvMz1TQITe/PqaznB9axRmQPAdq/uaUDI3964HZv7ayM/3nsQR7HMKlayU3WBqJHs4bFTX2le/e5dFLx1SEfT0nzgeQmTh+zW345s4LXYGEkxjOzpv5XYQHA+HxjZ17fbsG0huX8zRH48ey6YZFk1bVFN0bvddCMtfyniqxRdGl3e1sax647IHNUHJiZg25kExsjL10TbN0opuH7lS69zUpWO56UbOaloj4raORoaaf0iaBFrTRe7gn9SoZM5qaDSt51UcGX8pfh7RpVRIRv/Xvwo07LT5hsnJhVcZFT+q9fVnFRoRkWOrBRNej3LSQUT4z9UVEQUxXYs724AAHgHNNI6mZNTxMaNvMhI14EDWZmZ2g4H/RnkdxYNWf2aJXk1o53HTIGppbkRN8euXNBpa/CWjjrwAzt95+/vf/jw4VevXhU+WVZW1suXLwuf5ty5cw8ePGjUqJH6okPoT8ZyGTi975pue//Xd4DNgc2j65dhAYg+n5zhP/OWiOU8YlwP64LuuSAsa9d1Y9/88OYDCU0LPtvjVh67fsqRxvNfrhu3us+9WdU5io1bB4Rlj/ED5l3YdHnehIPNDvR34wEwSXfnTdwWSpt4j/+rxs/jVvnXOyfvR9Gcck17NSngeYkqyW6fYjs29mnmnN/RMs/axoJg4h5dupvcoXX2Y2bEYRdXjR21L4YGHin77/45BQfsU7rjwhYjhlY5sOTtugHDyx9bP6i6GQsAJBGXFw+ceimNsO4zurcjCwDMOwzqYXtm39XZw1d77h3fwIoDAEzWlzMzB698RXI8/Ie2NFTjwlMRGXztRjTFqdamZYE/Jc9Lv9PSqPWQvq7HNj1d1G9i+ePLergbAgCd/v7oVL9FT2QG9SdMbGOQq33dT8sfivoqjVr37WZzfN/thaM3NDgwtpYZC8i4O0v7/XM+hVt5ypz+2j9NVXD9yo9+56TiHdeXnFS0R0XsHMtq/2kxRaw1hdQm9TsnS+92UkFK7BlVRb4+tP+ZmO05ecEAl8I2xwovgXzm1M2cVGhGQvEjq1KWk4omRjY67v37BMaoWb0fly3z1rj/GG3atKFpusC375/DP0X/AJT+y2jU6P39+7ETJzIslirt6M1fZir+KfRXsJ07dx4+fFjV9V92b1mPTgXqseyeTNVPUJddu3YdOnQoISEhOTlZE+1LpdL09HRNtJyVlZWQkPDly5dKlSopuj8r1Pjx4382npKSQlGUJsJOSEhISUnRRMtSqTQjI0MTLWdmZiYkJEilUk00npycrIlFTdO05ha1RCLJzMzURMvZi1omK3oDkZWV1aVLF7V9sPTK8LIs4FSb+0perPmozysbcoHtMeVRPvPRSTf+qWFIAEHwzZ2rVK9gY8gmgGBbNV/yML3gwyOGYSQ3xziyuQ1WfCJzNJa4uz0fOBWmPc7xSZl3J1fmEoRRs9UhxYmbTr75T3VDgmAZOjfo0K2zV0ULDkFwHHrs+ZKzlbQDXQQAhIFvwG+3axTRccUmy24fBF0PFrSFlL5a1siEAIJTpmLTDl07tazjbslnmdYc4FdPSBA8p2YDFl6ILta6o2zHxW83d3HkEUCw+OZOnjWruVkbsAkAllm9adcTf36VdFzgqEoGBBCEwNK9Rv0GdT0djDkEEOyyrVY8VWrTpJG0ZBiG/LSiARfYTmNvF2dXrAdpyTBMnpuJfrWe9mixVxkWAQTXxKFSrXq1K9oYsAgghOX7H8r5AXqUlgyj0FdJRZ3o78olgOCYOHjWrlWxrJAAgmvfeXOwuDhR/kcTOanY+pUf/c5JRTuuRzmp6FdZ2M6xOHFm914DOan8WqMHOVlIx0vpdjKnAlZGhlF2z5gfhXOSjtnahg9AcARG+TJruCT4RyYptgTyobM5qdCMih5Zla6cLE5iMAyTftLPjGXYYXfcf1tZHIIDaU2yj8+3NWtsly0ru2YNKD6UGEKq4zaedvJ8gU5Oa6z1+xtKC3t7+4cPH06aNMnIyEjFpj58+FD0RAghRREWLVcGPT4yq0/jcrzk0JAouVXNTmPXX3t++d8GxoUOOcdv0L2THf362s24Isa2M2w8a+0wF3bWvYUTdn9VfC9PmLdYGXR/35TuVVihdy5df51h33L46quPjw1y1f79kDnxqk8NvLFtbHtPYcyT61fufpS5dl904eX9PZuXT2nuyIt9fPFumEjR0f8AQPmOC6qMOvXi/t4Zfs3cDdLD3n2MY2xrdx6z9vLLO8talfn5VRLWHTc9enRk3sBW5Q3Tw16/CI6iHBr2mrz1zstLU+qoun1WJyb+5rVXJMGvXqdqcb5w/U5LwqT+jGtvbm2a1LOeLRXz4dX7OI5biwHzjz55sq9v8T5AZ9ISFPsqWfY+u+9fXzeqY207OvLD5xTjat3/2R708vQoT0FxotQgxdav/Oh3TqrQ8Tx0JicV7VFhO8fixKkxyq81+p2TpXM7qSAl94wqoaK/RVMADCnJzJ9I9nN4CKWXgM7mpEIzqu/ISp9ysjiJASB+dDUow6BZj3ZW/21lCYYpVk9KD29v7ytXrhBEATvQB+dLNhx91rhLcedg2OyYadPSW7UqN368MDhYE0HpqMxUbUegJwxNC3pn165dBgYGfn5+qn2ANC0+VfL7xo8g2Fy+0MDIkK8rw4zu3r1bIBB4e3uz2Wxzc3O1ty+TyaRSqbGx+g+pRSKRSCQyNjbm8/kAcOrUqZ49e6rSYPPmzW/dupX979TUVBMTExZL/ddQExMTORyOmZmZ2luWyWQymUz1QvzvsrKyxGKxiYkJj6fYE+mLIyUlxdTUVO2LmmGYpKQkDS1qqVRKkqShofqHFMhe1KamplxuERepRCKRn5/f2bNn1R6DTpA/nl61yQanjZ8ujyixX4JqQ9bRnk6n+kQe72VQ9LRI6zAtka7BnES6BnMS6RrMyVJNdG1khQ4BjQ9/OtIre2gRfAghKnGUmdnXHTtENWq49ev3Z1Wfke6Qnh9eziYfZctaWZgZC4Umdp7N+87c/yIJH1CoLu/fv1exBWdnZ3UEghBSGbfuqPHNWUF7D4eW6m0k9T0yzt7dRf3XdZBGYFoiXYM5iXQN5iTSNZiTpRiTcmnPyTj3oRO7WPy87RcL0KhESTw8vhw9yklKch0wgBsbq+1w0J+KW2/s1nmdHTkEz7pa236jJk2bNnnMwI61bPhsywb9J0wc0auRVczlFYOatJx5P0vbsZYSmSo/YrRjx45qiQQhpDJWuYHzRrq+3LohqNRuIqXPtw7032c5fmhN3Rr4AxUM0xLpGsxJpGswJ5GuwZwstagve9eeY3WbM7Ee/9eLWIBGJSejadPwffvMzp1znDqVJZFoOxz0B2PZGH09e0PcYsXDz68uH9y8atmylRv3Bj7//GRVnYh78Q2m7wi4/eHTtX8qft607IS2Yy0l7OzsVJnd09Oze/fu6goGIaQqg0b/rh5EHFy450spvWOFXbbeiD23A4a66cqATEgBmJZI12BOIl2DOYl0DeZkqcSkXFqyNqTpgmW9bXKOevxn1eCRFiX5+8eNGeMwa5bJjRvajgX98eRPDux7Z93v+rhaJjk3iEbVRs/pu6HFgq3/dF9Y09Jr8simG+c+BBikrTABgGEYmqaz/0GSpNrbpyhKQy1nh01RVHbjLVq0ULopY2PjgwcP5owz+9+aGAMaNLmoaZougUWtXhpa1NnPn9DfRV3gAyR+0MSn6xjCou2KU3tPfE5LZ8C8OA+k0hMch1pNtR0DKjZMS6RrMCeRrsGcRLoGc7I0kidymy453dbPNXfZHQvQSOMYHi967tys+vVdhgwRfvig7XAQAqBTklIYAyPD34pqhIGRIR0ZEUVBTQ5hYGRAZGn5x0AURclkMgBgGCZLA8HQNK25lgFAKpXK5XIAcHJyatWq1Y1Crz+xWKzsuXJyd3ffu3evi4tLziBpmhaLxWqP+Wfjmlgg2dcSNNEyRVEAIJVKs1NFvRiGEYlERdZblaOhBZKdRZprWSKRFLlAxGLx78lc2hAm1boOrabtKBDKBdMS6RrMSaRrMCeRrsGcLH14Hm0He/z+MhagkWaRVlYR69YRJOnm68tJStJ2OAgBAAC3Sq1q7MMndt2aWLNNmV+FJCYlaNfxD+yqgypzAej4y4GPKdcRWgwTADgcjkAgAAAWi2Vqaqr29mUymVQqNTY2VnvLIpFIJBIZGBjw+f8N+7Rjx4769esnJCQUNMvOnTtNTExOnjz58eNHkiQ9PDw6d+7ct29fLpebZ8rU1FRjY2NN3AGdmJjIZrM1tKhlMpmRkZHaW87KyhKLxQYGBjye+h9tkZKSYmJiook7oJOSkjS0qKVSKUmShoaGam85e1EbGhr+npN5cLlcDd2hjxBCCCGEEEJ6BwvQSIMkFStGrF9v9PCh3aJFhFyu7XAQ+oHlPHjB37var+5aJ2TAEJ+mle2MIDPmwzk4OeAAACAASURBVL2Tu/ffjK8ydfsw56+H/vKbsv+ZqNkGf23HWnq4uLjcuHGjW7duYWFhed7i8/kbNmwYPHgwAPTs2VMb0SGEEEIIIYQQQkgjsACNNCXN2zt6wQKr7dutdu/WdiwI5UGYeC2/fsVm0vjle+be3MZkv8Y2rdRj+eXNk5oY008+vEgo13vlytUj3bQcaelStWrV4ODgrVu3Hj16NDg4WC6XOzo6dujQYdKkSS4uLtqODiGEEEIIIYQQQuqHBWikAQSRMHhw4vDhjtOmGd+5o+1oEMoXy7rpPwdfjF0f+uplSHQaJbB0rla7qr0hS5bw7iNVZ9GzsEXajrB0EgqFEydOnDhxorYDQQghhBBCCCGEUEnAAjRSM1oojFqyRFK+vGu/fvzffmiPkI7hWbjXa+UOAFTq5zsBi+cfOXrqZnjLwynHffjaDg0hhBBCCCGEEEJI/2EBGqmTvGzZb+vXs9PS3Pz82Onp2g4HoSIxosjHgcePHD1y4tKLGAkDBEto17CqPT48DCGEEEIIIYQQQkgdsACN1EZUo8a3tWtNbt2yXbyYIElth4NQYWTxr6+ePHr0yLFzD75mUAwQHLPyrfv69e3Xt4eXhylb2+EhhBBCCCGEEEIIlQ5YgEbqkdqhw/e5c8uuXVvmyBFtx4JQgajUT3fOHDty9Ojpmx+S5AwQHFO3Jt6mn268a7b91fFeAm3HhxBCCCGEEEIIIVS6YAEaqYphseLHj0/u0aPcuHGGjx9rOxyECrSxV50lgdkDbfCtPL2H9ujZo0eXVtUtI5Y3qvIOCELb8SGE0G+Cg4M/ffpUMp9FURRN0xwOh9CrDSLDMCRJslgsNlvPfr5CkiTDMFwutwQ+Sy6Xs1isXr16qd5USEjI+/fvVW9HEZiTJawkc5IkSYqi/Pz8VG8qNDT0zZs3qrejCJqmKYpis9kslj6N15adkwRBcDh6dvqfnZMlsxEgSVIqlfbr10/1LzciIuL58+dqiapImJMlrCR3TNk52bt3bz5f1ccTRUdHPy6pWo2e5iQAyOVyzMkiP0sikXTv3t3IyEiJ2fVsySJdQxOsyHXrZM7Orv7+/IgIbYeDUGGCAp/HyIyr9Fuwas7AluXNf2z+KK0GhRBChbl58+aXL1/c3d1L4LNkMhlFUXw+X79OGGialkqlbDabx+NpO5bikUgkDMMIhUKNfgpN0yKRSCKR3Lt3Ty0F6Lt37758+bJSpUqqN1UkuVxOkiTmZImRSqU0TWs6JxmGycrKkkgkt27dUksB+smTJ7dv365atarqTRUpOyd5PJ5+XV1gGEYikbBYLNXLWCUsOycFAoFGCysMw4hEIrFYfPPmzT59+qi+wXn16tX58+dr1aqllvAKR5KkXC7Xu5wEALFYjDlZEIZhxGKxSCQKCgrq3Lmz6kvpw4cPJ0+ebNCggVrCK1x2TnK5XL2r5OppTpbYAbxIJBKJRA8ePGjRogUWoFFJk7G4EUJrHifS1c+PnZmp7XAQKkIZCx7xPSP48DT/N9d7+vn59enSxMVYn85oEUJ/pNatW3fu3LkEPigzM1MikZiZmenXCYNcLk9LSxMIBModCmtRSkoKRVGWlpYaap9hmJSUlLi4OAMDA1tb244dO6qrZS8vL19fX3W1VoisrCyxWGxqaloy9+SqC0mSqampfD7f2NhY27EUT2pqKkmSZcqU0VxhJTU1NTY2ViAQ2NraPnjwQF3NNmjQYMiQIepqrRDZp98mJib6dXWBoqiUlBQej2diYqLtWIonLS1NLpdbWFhorrCSlpYWGxvL4/FsbW2fPn2qrmZr1679999/q6u1QojF4qysLGNjY/2qmjEMk5SUxOVyTU1NtR1L8aSnp8tkMnNzc81V/DMyMmJiYthstp2d3bt379S1Qa5WrdrYsWPV0lThJBJJZmamkZGRQKBnA1wmJiZyOBwzMzNtB1I8GRkZUqlUowfwP3PS1tZ21KhRSm+Q9ekEo0Tp1amXVmSxeJECK1NSZNvVG7p6azscPSEw1HYEf7QtX6NHXz1x+PCRo+cubZtxYdssA4d6nXr79a4TJ9V2aAghhJA6ZWVlxcTEMAzj6Oiod6V5VCqJxeLv379TFGVvb693pXlUKonF4piYGLlcXrZsWb0rOaFSSSqVxsTESCQSGxsbzEmkC6RSaWxsrEgksra2trCwUPFyCJZZkTKSOYaxXHM7WYoZmQVgre1wEFIM17Jqx1FLO45akhXx4NzRw4ePBFw7serRcQAAjujYuhNO/p3r2gn0aZhJhNCfKTNFE60aARgJ2CDJ0ETjmsMFsBSwAeQaWiwwWFNX2c0106zcxDyulU9G+eqW5VwtLS1LaPRkmtZEq4ZCoWH2cBCaaV9DOCyWpYUFgMbC1titoBqqd5AkGRsbm56ebmlpaWVlpdc5aSAQGGTf06dXOckmCM3mpMaY/rxWodbIKYqKT0hISU0t0Zx8fVsTrQoBNDtojodGBhIhACwNeAAAonRNtA8AwNfIgjExFIKhEIAGSt05mZiUkppmbm7u5ORUQgNPUXJNtCrgsgXmppprH7I0lTOWPAKAgvQkDbWvod23MQHGGjiAp2g6MS0zKT3T3MLCwcFBLbf846/PUfEwADE883ieWTlpghmZpe1wEFIGYViusd+0TedfRUW/vbh1hr+XqwkTGjCtd4NydpXbDl908FkCo+0QEUIIoWKiubz45t0+/70MADw2zii5qgpCBcj+lf2nT58YhvHw8LC2tsacRNrFMExScvKn0FCZTObu6oo5iXRBalr657CvMpnc3cXZ1tZWvx57gEql1EzR5+g4sUzuZmdta2urrgFn8A5oVAwUwYrkW5LAcpPEcWlS2+EgpCpuGc/2Ixa3H7FIFPno/NHDh4+cuHJt5+ygtIq9jvvo0yhqCCGE/nQZFWrEtPdnZ6a57F8hjPqi7XAQ+jVkpLOzs4GBgbbDQQgys7JiYmMJgnBycDA0xKERkfZliUQxsfEMMPa2ZY1xvCykA8RSeUxyKknRthZmpoZq/hkBFqCRoqQE55vAik/JXGUJLMAbRFFpQhg4NvSd0tB3yprkDzdOBsQ441VnhBBCekJi4xTTrp/UwsrmxkmzNw+AwYM0pGXqHTISIdXJZLK4+PjMrCxrKysLc3PMSaR1cjkZl5CQkZllaWFuWQa3k0j7SIqOT01PzRRZmhpbmRprIiWxAI0UkskWRvItLMissrI0wOozKrU4FpXaDp+t7SgQQgghBVBCw3ivrim1m5s/v13uyBqWVKLtiNCfjqKoxMTEpKQkc3NzdQ0ZiZAqaJpOTEpKTEoyMTb2cHPjcLAAgrSMpumk5JSEpGQTYyMPV2fMSaR1DMMkZ2TFp2YYCfke9mW5HE3tuzHXUdGSuMZxXFM7abIZJdJ2LAghhBBCfzyClVqtYay3rzDqi/vmmbyUBG0HhBCkpqbGxsYKBAI3Nzc+H8cyQ9qXlp4eGxfH43JdnZ0F2U+PREirMjKzYuLi2Cy2s5ODgVCzz49ESBGZYmlMciqLxSpXtowBn6fRz8ICNCoMA8R3vkUmi+8iiRfSMm2HgxBCCCH0p8tyrhjTri/D5dmf3mEc+lbb4SAEYrE4JiaGJElbW1tTU1Nth4MQiMXimLg4uVxe1traDHMS6QCpVBYTFy+RSq0ty1iYm2k7HIRARpIxSWkiqczazNjC2LAExoHBAjQqEEWwv/HLMEC4SeI4DKXtcBBCCCGE/mhyE/O4Vj4Z5WtY3rtg+egqQeEToZGWkSQZGxubnp5uaWlpZWWFw5giraMoKj4hISU1tYyFhZWlJYuFj3ZBWkZRVHxiUkpqmrmZqdP/2bvv+CaLPgDg9zzZaZJmd6YjXUDLRvYelVnZsteLgAsQkI0gooiIyFKmIiJ7lD1llFGmsndLW9pmNLPZyTPeP8osU214nrT3/fiHJE+e/nK53N3zyz13keGwTkKUI0jSYLUbrDaJMChSIWG8rToJE9DQi7lRVi5bzie8EV4T3HIQgiAIgiCIQgSTZazXpqhJJ9HtvxIWT2I6iqmOCKroSJI0mUx6vV4gECQkJLBYLKojgio6kiRNZrO+qIjP48Wr1Wy2f+8lh6A3YbEWa/VFXA4nLiaa4+f1DSDoTVjsTq3ZymGx1GEKLvut9t0wAQ29QDGTn8+SyjGb0melOhYIgiAIgqAKzZZUQ9OuH8NeHLP2e35+FtXhQBCw2+0ajQZF0ejoaD6fT3U4EAQcTqdGqyVJUhUZKQgKojocCCqpk3qCJCLCQoQCAdXhQBBwebwak9WH46GSYLGAgr4bJqCh0oqYwiKWKNJrFOEuqmOBIAiCIAiquDzyMM27vd0hkaF/bhVfOQ1IeFMaRDGPx6PVap1Op1KplEqlcM0NiHI+n0+n19vsdqVCIZVIYJ2EKOfzYbqiomKbXS6TKmSwnYSoh+GE3lJssTvlwUJFsJCqKglXn4GeIBEknyMzswRxHj3MPkMQBEFQuYff+bGuVIoIX/Afs8b0s3RdYTiwwi62miZl3lTv/IuXfinx2P1vtF7PsweQXucvV7JaHLwsSr+UeOz+XL3XBwDODdK07ZM1/EuOUZu4ZIr48qkKmX12n57To9fCv2n2kb5WgIb9GgRB6PX6rKwsNpudmJgok8kqZFYlQD/cAA0bvDpygiD0RUV3s7IAAAlxcbJy/YuIM+/kzMmjKrfuyKvbVt7hw24L/rzmfNgp4PfX1a3TAqnxgv+YacvO0m0vJ8J8/rdJnRpWkSgjw2q823fu4Rw31SG9GefdnTMHtKqsUvCCguUJjbpN3njNXrpfJgiiyGC8m30fAJAYF6uUV6x28k2KiH5I+630KYM7Va+aKFRVrdK638jVFw0E1UG9zpuPhEmSNBbb7+RrfRieEBGiFFOWfQZwBjT0GIYyctlyhCTVbh2TpP0XDoKoRZgub1294dilXJsgukbLXoO7VZeUbshJV86RtavTT97UuNiymOpteg/qXFPOBKR53xdDf77se3wcI6LbnMUDExlv9w1AEAQBAAAiTErt1jWu1JU9rj2394wuPEJB14kKARS23VSYeqLwPOC1i1S+z/SdLjBPPWW7Vq/S2kj2wzBxx6yTd2aY0boq6adh+Nl808STjlt9B477ZCBP+yBu2QyOoZDat0AhsmjP4oU7M977MLAGpgEa9qtZLBatVsvhcNRqNZfLpTocygTohxugYYNXRm6z2ws1GjabrY6JKfd10pezo9vgBQcc8oZtOnQPw7LOZWxd/fWRS0XHlvWqzgaIICb13ZZxpRLNuOHc8as6pUJBq/wnadg/tkOXlXmh9d/t84HKfXnnhi97ZlxfdfaXLuF06ruf57u9rFvzUQeKwxp2H9I9ypd1dNvWuQOPnHpw7OC46pyHx9jsDo1Ox0AZMVGRfB6P0ngp8CZFREPeGz93ajcjA1Ondu3VQeq6dWTHz6PfO5a1+eRXDURUx/YKbzgStrs8GpMFQZDoEFkQl/qPASagIQAAcKPsXI5ciLvDvCZa9VAQREt47rZvvt6CNxs8spesKGPtr19/y5j3TRfV0zlk0np6yfTF16I69/+8ThiZc+SP32dNL545b0gyS6/VI4mdxnRNfrgJBcKLoPmAC4Kg8gsNazdrRbtnHyNyVveqc6jO1LmD1HRtnAImbNK16G/NeUT0Q/P4USIUAEBUlo/PuPvjFc2Q0OjWTAAAyM0p+M4MmlVL2p/AZQNga1G575ZTa07aB4WvbJJ1heL4KYO7DDnXLxxZO3vaRi0RQnU0byxAw34Nl8ul0WgwDAsLCwsODqY6HKoE6IcboGGDV0fudrs1Op3X6w1RKsUVoU6S9h1LfzlYHDr4hyUrmklQAAAx4PDcUe03/D51f+rONCmqaDjr64alXpOzbVKd01WmTkijUZ8ISOvhmcNX5VQalX7sqwbBCADkyE7DmnXf9M2iTzvNrk3j3BRp2TFzxkFz9OAtGSs6hqAAAGLy4TGt2i/5duqGfjsHhno9Xo1O7/Z4lHKZVCKmOlwqvK6I6Jplsu/9cUGGPXHcvoNz6vIBAGDq8PnvtRq7Yu4fH275kMYX6a8dCXsxTGO0Oj1epVgoFQbRZCY+jb/k0NtiZfILWBKFr1iB2aiOBYICgffK7t33I7v9OKKtigFAitxyb9yuPdc7jKj2ZF9j0px54CxWf+T4AU2ECADJlUKd90elH7raL7mqXmcWJdRv0rAqnPMMQRANEQUbR884rR6zf0xyIO3VTs+wcbt1uxVEqsNGiB5ew6Bs4ZSk4JXnLOsMqtahKCA9Ox7YnBzZ2FguIhTnt+5RXKn6qJy0fQe27jqf3ERKi6uFt4/Ur+4SM+zAw5VK6Hv5V0qAhv0KGIbp9XqLxSKXyxUKBU0uXykRoB9ugIYNXh45juP6oiKzxSKTSqNVKhQNpDf17+FZGZfsjKSeY5tIHvUlwS0HpjXcsvjE2VuetIbPT/8mdAdHL7ysHrx4TAKdEj6kaceKrfnBHeZ9Xj+4pDlBFJ2mLF5S856S56N1bgq7kpFpYVQbNbZdyKOPQN5y7LCGy8ec+PPsg/aN7CazRBwcFRleUerk815RREcueAZ2pOlNCrju9r1ioEhLrfFoRz5WbNvWCRPOZN/MxgGNE9DPezwSHl2FpbfYDFabWMBPVIQw6FQnafwlh94KPSvYyBREeQwCwvP6oyEIAgB/cP2mPbR+7fCSDDIjqnZN5da/b2iIatGPW3fS5uNE13mnkuDhtRpDERbC9LqcGFGk05PKKkrCZTY6mBKZkFVxr+YgCKIf0rhjxqz9iv8d/TiFRnnc16Jr2LjLU0CCuCA266kHhUKuClj+MnnwUB6DcJ2zkmyFOKFp+7tNO4pu/524cHKcg5QBz0Wzj5CyaXTR8BYh0rQFx1MsBCCN20d2nZdPdTxvKEDDfiGSJE0mk06nCwoKSkhIYLFYr39NuRagH26Ahg1eFDlJkiaLRafX83m8eLWazaZVY+9nmBsEq6rWTop7qktAuFweAjCv7wXLqpDWHQtX7pd2Ptovjl7F5L1wNNPJfqdVC9GT6x9GTMvhH7WkMKg34nMASULVZrXjnppAhPD4TAR4TQUOlzsuJprDoVdhv20vKSIeAjCPl76L/zAUCWohuPr36bveViUzGAjd2XN5OLtyYnRAzRZ7NBLeNTgut0DHZjLVYQoum3Z9N0xAV1wEguSzZW6EqXbrOGQA7kgBQRQhDHoDKVNIH40BUalCShr0RQR4koBGoztN+f7JS3B9xpErIP79JB5RqCnCio7MHvLrfSsOmMKYRn0+/bB9PP/RMKygoGDRokVP/7mkpCQAAEEQNlvZ36NAEESZn/ny5ctnz561WCwikahx48YpKSllePISBEHY7XY/TcUKoKIugWEYAMDlcnk8Zf87ol+LGsdx/xU1QZT9WLekqJ1O52unt7hcLn8E8BY4z8yftA3v9svI+vzXH0wftA0bZTGDASh0+TDw5MLU6/LpAUk4vTjgIW5PFoEE1/uISE6IWTuPn58FAEB4bBUC8hxeHFTQBDRgKpLeUQAASM0lUQAVQYCG/Ry73a7RaBAEiYmJ4fNp9qWiSoB+uAEaNigdOYm5s+/fZ5KkKjJSEBREdXBvHbfewo31nn2IzD+SkYkxa1RLeH5iqfPSH5MOEt1m96pPs0mnhO5+th1Rxoqzfp/Qb3H6qfvO4JiqDd4dNG1ij6oCek/J4bdbePGZ5Q5cbufFlevO+VjVmzRJiooMrK+XXzxXRAAQ+enbM33sGvVq0KwmPk2U9sWcAZdGzury3r2+7WtIXLf/3PD7aU67Wd8MUQXSp+o8M3/iNvzdeX1VbmuIWCQW0LTvhgnoCsqHMHI5ciZJxLn1DBCQF8kQRBXc68EQHo/3aJyE8HhcxOvxvmSLX4/23Naly7ZlqfvNfDcU2K6YfTxBXKdRXzaJALrLu5cuWvnNSsXCT+s+HHYVFxcfPnz48Ytr1KgRFxcHACBJ0h/pxYfvCC+b7bEvXrw4ceLES5cuPf1g3bp1v/vuu+Tk5DL5E495vd6yPeFjBEHQv6if5/P5Xn/Qv+K/og6IWv28NynqMnxfGIY5nU6LxfL0g2I/Dd+I+6u++i236thtHWX0vhB8Fo3DZopELXnan3O16+LjBpX80og5F94xF5GAjxNuWWhR4xjLoUKh6WL8yg2Pt4BGmAwBIPMx4j/uHF+q2pBk2exEj2GYy+UqXSdFdN6qB3pTXq9Xo9E4nU6lUimVSsv810f/1Um32w3rZLnkw3APCXB7kUhUN1wm83edLKsfj19cJ8vk1AAA4Ms5trznvHOO8I5T3wsrnSQjClct2Z2b2G9by2C69YmkvdhGktbd41J/8cW37Tg8la05t2frj8MPndcc2zGqOo2TlE/DMFyrz7+586vxc064ov83fVhK2eYpS1UbHMfLpKnEcdzj8ZSuk0L//Zzjydk1pef4g46Y/00dFEvnVC4zsumwvvX2zjy25ofzawAAABHW/vCTjgk0zeC+CI5lz/9idW7isFWdwpKkwjKfOPR8nfzXTSVMQFdETpSTx5GLcBfcchCC/gUGm8MgrS43CbgIAACQLpebZAlfcNeVT3d+09Ll6ddA1c4T5vV8R8kCgJP6xYbUR8+r6vb+pOuljzcev/xB3UYlOyXHxsb+/vvvj89w6NAhHo8HAEBRVOSHSymfz+fz+cpkftPOnTv79OnzfN7t3LlzHTp02LJlS+vWrf/7Xylhs9mCgoL8sciaxWJhMBhCobDMz1yGRV1KydznoKAgf9wiXVxcLBAIyryoSZK0Wq1+Kmqv14vjOM8Pm4+XFLVAIGAyXzN8YrPZZVVoJEkSBFEy+foJpl/uCnSc+Hl+Jidt5YDKAXXTIa3DZggnVpXsOGf64MitfZGiBNR3ptB0HrBCENwR0Tx7xMfyHZM4OAF0fwFF6YvA/5p+fjRnv8y9uE5CAY4gCIPBYDAYxGJxYmIig+GXr1OpalNWCWhYJ8slgiAMRmNRThEAgBkcrpDL/XHd6r92kiRJf5zcq/trwfxFsw7meiOaL13wcVtR6VJxXNg8/29W2jcdK9Mv50diGEYSxbqgYRv2LGkbwgAAEBP7f9a646q5U7f02tkvhOapCZIkTWZL/rXdm3+cs2j3Xa+6+9Jt37eVlHHUfqqTBEH4qU4+z5t/ZMGEMbM23/RTEZUl0nbyq+5tFxRUG7Zkx8epKWLX3eO/Txw/P629acOBhV1D6fctehZJkiabI/fAvGXn2Z2Wf9hIJnwL7WRJ+/bvTgUT0BWOmSnQsMRhPrMEc1AdCwQFJFSmkCP3jWYCiBkAAEBYjBZElix7toMinbc2fTVrS1FitwmLu9YJecmiYKg8IpzjM9vcJCiZUc3lcitXrvz4+czMzJI0FoIgr815/QslF2z//cy3b9/u37//y2Z9OhyOXr16Xb16VaVS/cc/VKKkNPy0y4f/ihrHcX+cuaQcGAyGP07up6IuGbX4qahLpopQW9Rl+NdZLFZQUJBMJnvmUYflJYf/B2TR9qWbH4R1W9E+oHa+o33YkarYEyze1JuG/fe1uxjsWhFRO9qpxqw4pZGGxy2fEZRzQ4AA07OTnUkMtwNEwET/4zsqVW3KauYgk8nk8/ml62QZZRIhSlgsFq1Wy+Fw1Go1l+vHWYilqk1ZdS5MJpPH48E6WZ7Y7PZCjYbJZMZGSjkIAIi/fmB8q3Wy4L+dlLSd37x46MJDV33KVv2nzB/WMiXouVadtGxff/iBotWK5s9lpmkA4fF5CMJuOGJaasjDTxSVthkztMGayRmHzzr7pdF5dRWb3aHR3r2+8Zsv5u287o1s9dlv86e8n+KHYi5VbRgMRpl03ywWi8vllq6TRFnno0nz+WVjhk5Zf9XjxyIqQ4Rm68yfr7PbLt7+bc8QBAAgqdlpwhZBUdVua6ct/yDti+p0TpjaXW6NyYoA099b9mjCu4/opPBTWZeqNkwm81//Sk3n8oTKGAmAni02MfjR3qIgHG45CEH/EiMquXLQjkuXi3rHhiIAENrLV7TCKskRzzTD7qu//7C5uNHk70fUEj/VFTgzF4/9Hes7e1Tjkrvi8IKsXK8kWeWXHyvfounTpzudzlccYLVaZ86cuWLFircWEgSVGwiC+GkZ7qcRD9JX/emIGfZ+07KfO+5HgRA2EhMatjY0DADgilAXtuvrvrlKj4H4gvQgPgflsqMY5EWHpxgIH4/ucbe3gARJQez/mHHxU7VBHnnmUZjsC0wul0uj0fh8vtDQULG47FYIeAlYJ6HXcrvdGp3O4/GEhoSIg4NJjX83dvNfnSzjkxP6LTM/H7BDo2jYP31inzQV58VHaY+uOu2K6dWm6YufpxgjJDycidyNjJQ/ledHQ1URLHDOYnGS4PmMOh14PF6tvshpzz4ze8TH6/MUqZPSF3yeFu+vFRr8OuTz73gSf7BlRPsBq3P8XURlCLtz7ZqHmdKkwdO5W2H9JnXZv+28dqOYrE7P2Q1eDNOZi+0uj1IsFFt2fnDU6deRcBlWG5iArigIBH3AlvoQZpxbxyb9tTImBFUI7Grt20dN3LxoXfiQplL90VXbHsR1/TSFDQCWdXjtcWPlDj3qSW8cP2kIq5+A37t44fHrUGlcjar1U3yzV8yVYj3rRzCM1w/8kV6UPLBD5YBuix0Ox44dO1572ObNm3/66Sd/LBMBQdB/RuTs2p7pVX3UsXpAfUVpHzbpPZZnvccW9EgMs7XuUVypljxzr3nFIR3gDJSzUQAAGlQ/GNlotJ3A5J0f9gTkXaPDANh9pSy63/kJBTIcx/V6vdlslsvlCoXiLfzKBUGvhuO4vqjIbLFIxOJolcpPN7oFJvzm2llDdhqSB8zeM6q28qUFQ+YcOZrpC/moRRJN+8SgqnWSGHvv3XlAtI1/9C7wB9k5XiQ4IoKGM2VxHDeYzEaTWSIOsu2d53FzqAAAIABJREFUNmqDNnls+p5vWr38I6jIsJsLBgz5rTCwiggJEggQwmyyEODJnoOk1WwmADtIwKFfnSRI0mC1G4ptIj4vIULJZCDZv9N7JPysgE56QG/KizJz2XI2ias9epSEWw5C0H/EVHefNN637LfFE7e5+RE1Ok4Y3iWaAQDACs7v3nkfb9C9LlpQ6MByDyz86sCTVyHcJhP/+LzBsK/Gi3/btHb2zmKGNDKxzgdf9WsVHiBd9Evcu3fP7Xa/9jCr1ZqXl1eypyIEQfRCGv48dMkn655aw79zzcpYIIR9Pe/ByOKYBxNmfWC7nLhoIqnN+l+WmyOLHFRydwzCTlMJJl+y/JTr7hDHZQFA+mw/57qAMPR9Mf2ue6BygSRJk8mk1+v5fH5CQgL8YRiiHEmSZotFp9fzebx4tZrNpm+TTg3PpYV/XPdUGbJm5CuyzwCQ5j9P3vFJWqXSdmYLI7Fbjxqzvlg+fWuX1T1ULAAAVrjju1XnidBBaXXpNmnbYi3W6ou4HE5cbDSHODFz0VlP7RlrZgVMavVtcx9fuPBMwBURK6V1avjPS/9YtGXgkl6RLAAAIEzHFv5ywhfc9t36dJvCbXW4tGYrm8lUhyq4bBYAAJB6+o+En0bXtgkqO3YG9wFbJsUdIV4rAPBmNAgqCwxFnX5T6/Qr9Si36aQtTUv+t9PsbZ1e8trQen0n1Ovrz+jeslcvvvHvjoQg6K2yn/nzgpfbsCHtrv9ejfZh2yrVbdAsKW7cljl9OuWEM0N8roOF1mtA+GMtZcKj9HJMdOS4nNtfXbnbsVjeQUhezNWvdXI+aBhSO3Cu36AAYrfbNRoNgiBRUVFBQXRecBWqKBwOh0anI0kyMiJCKBBQHQ4d4XnXzxhJdtDVb7+c82zPgIhq95j3XuzDnI7z6p/XvNxa1evSNxPFqDR01mebOn/7v+a30rukxjPuH9u+7aI5qtfKL9uU/a7U/5rL7dZo9RiOhYUog0VCAAB+LfOMjmCLTn07fGjpj6DJ6HmDkmFaDb8XmEXEazjl214Hhqzr1/j2hi4tq4ldd07s3n6hSJI6Z043fy2p/C+4PF6NyerD8RCxSCx4KjFO+5FwKTStBlBZMTGDtCxJuM8shlsOQhDkH5GRkW9yGIIgb3gkBEFvmedixkkbGl+jKg1vgH0FOoftkYVq2/ZxhUbFHN12snH0tGu6vfc9FpRdMyQ8PTmk49PrXDKDvmiSqLhasChfMx5DI8SiWY0ix4Uw6feeoMDm9Xp1Op3dblcqlVKpFK65AVHO5/Pp9Hqb3S6XyeQyGayTL4NpNXk4ac8+uya71DOIktli7nuxJf/wXPv7pAONrxxPwz7xCUH9r3buiPjqm593rZ+/j5So3xk85/MZwxuH0eM3VwzDtXp9sc0ul0kVsiftJJaXk4eR9hv719wo9QpUyewxd1DyW4+UdgK2iNCwjj+c2lXz6x/WpG9bvtfFVqhr9v9y0bQPW0TT4+4gnCD0FpvZ5pCJBAqxEH22naTzSPiFYAK63CIB0LDExQx+rEfPI7xUhwNBULmlUqmqVKly40bp4UYpdevWlUgkbyckCIL+EU7z7/Ot31MdxT9Gz7BxLt/QuIOxbivJXxmqLT+jHheQypc1lb/iJShb8HHtpI9rv7UYAwYSNvywczjVUfxjdAubIAiDwWAwGMRicWJi4r/evB4C9Ptw3xDdwiYIwmgyFRkMIqEwIS6OyXxpUoJukVOC02SC8e8Jrz+s3uj8v0a/hXj+I4a83scLdny8gOo4nkWSpMls0RuMgiB+gjqWxXqmTnLarzT6VlIVW0AI5CJiKOsNWrBxEM2qJCBJ0mRz6C02PocdH6Fkv6idpOdI+BVgArp8whE0jy3DETTOo2eRGNXhQBBUzo0fP37QoEGvPeatxAJBEEQRBLVUa6Bt05Ory49b+RVHX0B1QBAErFarVqtls9lqtZrL5VIdDgQBm92u0WoZDEZMVBSfT7dFVqGKyO5waHR6FEGjVRF8Ho/qcCAIONwejclKkqRKIRXwAmR9jTcAE9DlkBtl5XEUPMIT7TagcNFnCIL8b8CAAbt27dq6devLDhg4cGDXrl3fZkgQBEFvkysiVtO2L8YXhO1dG3zjPNXhQBBwuVwajcbn84WEhIjFYqrDgSDg8Xg0Wq3b4wkNCREHB1MdDgQBj8er1Rc5XS6lXCaViOE6MBDlvBimMxfbXR6lWCgVBpWzOgkT0OWNjcHN58hkPrvSZ6U6FgiCKgoEQf7444/g4OBffvnl+Wc/+eST+fPnv/2oIAiC3gJMKNG27l5cqZY884Di5B4E81EdEVTR4Tiu1+vNZrNMJlMoFChKj9VVoQoMx3F9UZHZYpGIxVEqFayTEOUIgjCYzAajSSIOjgwPhWsTQZQjCNJQbDcU20R8XkKEklke6yRMQJcrRpZQxxRFekwi3EV1LBAEVSwcDmfVqlVDhgxZuXLl6dOn9Xq9QqFo3LjxRx99VKdOHaqjgyAIKnskyjC901LXoosw61rCkimsYhPVEUEVHUmSJpNJr9fz+fz4+Hg2m011RBAELFarVqfjcbnxajWskxAdWKzFWn0Rh81Wx0RxOeVnfQMocNlc7kKjhc1kqkMVXDY9NkD0A5iALidIgBSwJQ4GN9aj5xFw6g0EQdRo1KhRo0aNAABOp9PpdAqFQg4c1UEQVB7Zkmpo3u3NcLti1s3n592lOhwIAna7XaPRAABUKpVAIKA6HAgCDodDo9ORJBkRHi6EdRKiAZfbrdHqMRwLC1EGi4RUhwNBwO31FRotPhwPEYvEgnK+LD5MQJcHGMLIZcsQBMS5dUwSpzocCIIgCIKgcssjDdG27eOMUCszdkrPHUZIuN8GRDGv16vT6ex2u1KplEql5WzJSCgQ+Xw+nV5fbLPJZTKFXA7rJEQ5DMP0BqPFWiyXSRUy2E5C1MMJQm+xmW0OmUigEAvRClAnYQI64LlRdi5HJsA94R4zArcchCAIgiAI8g+CzTU0bGto2FbyV0bk1qUMD1zxDKIYQRAGg8FgMIhEooSEBCYTXtxBFCMIwmgyFRkMIqEwMT4e1kmIciRJmswWXZEhiM9PUMeyWLBOQhQjSdJsd+rMxXwOOz5Cya4w7SRc/p9aWP65LYM/Gh7esjOnac/oATM+3X7bSDz1vPtU7xYdkHrtn/mvyYzVxQ8TzVYGL5ujkPrsEV5t5m+zem3Mwih5H2+V5/Tij3utvPGCd0pYzq+f1Sm1sSS+eliTnn0XZuR4nn4ay89YPrjHu+FJVTjqWtGpQz/9/dIzpV2uOe/umDmgZWWVnBckkic07DZ5wzX7C3+ucJ+e836vhZcqQEWCIAiCoDeGIJbqje6MnOOMSoxb+VXY/nUw+wxRzmq13r171+FwqNXqyMhImOmDKGez2+9lZxfbbDFRUZEREbBOQpSzOxz37ueYLdaYqMhoVQTMPkOUc7g9WZoiY7FdpZBGh8gqTvYZlLcZ0ITp8tbVG45dyrUJomu07DW4W3UJnSexk8bTS1t8vi9PnNStU7cEtvVixtGf5lw+pf/25PCkkqVf8CJNjhcJqVyvReRTi6gy42JZCACgiCk0sINVHqMQd5Hmc4s3nslo1qHcJ1RJ45HFKw9ltO1b+p2Spv1Te3dZUxhap0WfQeHuq/s3zBmacXP+2SUdwtGS181oMXhDnrRGt14fJLCNFw/s/Gliv1OatSfH1yjnC+0A4Lu9rFvzkQeKwxt2H9I9ypd1dPvWuQOPnMo/dnBc9WeX5yWL9ixetDPjveHlviJBEARB0BtyRcRq2vbFgoRhe9cG3zhPdTgQBNxud2Fhoc/nCwkJEYvFVIcDQcDj8Wi0WrfHo1QopBIJ1eFAEPB6fRqd3ulyKeUyqUQM19yAKOfDcJ2l2OZ0K8VCqTCoAtbJ8pSAxnO3ffP1FrzZ4JG9ZEUZa3/9+lvGvG+6qBhUx/UyhGb1r4eyRQ1X/zqpvxIFAIAhrT4fPGHexi3pvSf3ESEAAFyjzSF4rQZP/KPZM/sFEwDJ48jcCEvt1hCm/As3Lq1dvWajkQih5I28JbjLVHD90um1C+dt1JPPvVPSemze8N8fVBqx5tiUOsEIAOQHnUa/1337gkXD286uwQB43uoft2aLU1fvXdQ/jAEAAJ91/bx973mrlqcPW9JHXK6/+aRlx8zpB83Rg7ecWNExBAUAEFMOj2nZfsnsqRv67RwYigAAAO4y5F6/cGTt7C82ast3RYIgCIKgN4XhhL7TIEtKPXnmAcXJPQgG93mGKIbjuF6nM5vNMplMoVCgKLyfFaIYjuP6oiKzxSIRi6NUKlgnIcoRBGmwFhusNnGwKDE8lsGgbUoIqigIkjQUOww2u4jPS4hQMitqnSxHCWjvld2770d2+3FEWxUDgBS55d64XXuudxhRjf3611LCefvEbUzYvGU35aNOmpfQub58/qYH1wsJIGIAQJoLtWZEmRD+TO30IYw8jhwFpNqtY5j3tUtbcMBb8kx5zqKShi1d6kx+9E6fG9aQlh2/7coXtZk3snZwSTEgsk5jZy+pdl/J9QLAA45LJ675hO26dAt7VJj8ap2bh83/Jet6HgHE5fr7j13JyLQwqo0e2y7kYcGh8pZjhzdc/tmJI+c9AztxASD1v3WJHX7g4YolcNQIQRBEb4LAnFyGB1L2tmTJSL3BKGjaPkEmYVWuBIaMojooGtPnUh3Bv7JoCtUR/AMkgprV1XTVW/Dlyvj4eDabrtc4NFFsoDqCf+WjzlRH8E8gqCWlnrZVd64yLC4ujsPhvP4lFVl4HNUR/CsWPdUR/DMWL651YhwUUavVXC6X6nAgPzi7n+oI/hkbV1QoimDiWKzXxDO5QT7VAf1TjcusYyo/CWj8wfWb9tD6tR8maxlRtWsqt/59Q0NUi6ZpOo0RN2z8qF7RSU81ioTN6SFRmUJUEjKRk6/Dmao4ke74kevXijz80LgG9asBsUKEu8O8JgQAIKq/YFmMhQSk5dTI8VsDria/OUTcZkF6koUApOnAyP+tLP1OfZeOnnexazVtIXyShWdENRn+vyYP/8FMHjZ7dq/46k+VNmazu0kkRFG+pz8DAHwOIEmo2qx23FNpdoTH5yEA83hLltpApJ0WHE+xEIA0bB/Z7YdyXJEgCIIg6LXsDodGp0cRNFoVwWfQdCAJVSiOkBhN7TYkgqoydwg+mUV1OBAEXOGxham9cC4/Yvdq4cxlVIcDQcCFERon5iPIUD5TzGYAmH2GqOZm8TSiCA+DHWrTil0mwAuiOiKKlZ8ENGHQG0iZQvroIgGVKqSkQV9EgIcJaJPJ5HI9s10MjuMvW3XlbUyI5UW17xgFAACAdDtsJnPR1TPp4w4Uh7cY0bNkUQTgzck34qRj4oARGgtGAgAAwlK8M/qrKXNqsh7GzQhOqhIMACANWaLyfX3ElCbVkAIASN0N0XMfGqHPy7YjyqjgrI0z+63YdyrHFRxduUHLXtNGp1UVIAAAwI9v/358ybFum9Vk1Fw9+su47abwDtN6RpbvggOA327hxXbPPkTkp2/L9LFr1Kv5sFtmKpLqKAAApOYSHSoSjuMve4ogCJJ84faJEARBEPRfvWDJSK/n9S+DIL/x8UW6as1sEQnKayekdy4iJNynA6KYTyjWNe9anFRTfvagInMfgsHNyyGKYQSpd+MWDybnMhU8ZnmfXwYFABxl6AWh5iCZxGGMNt9HiZfmNyqU8pOAxr0eDOHxeI9aG4TH4yJej/dxpmrBggV79ux5fLxIJDKbzS9LQMv9GmspRP78jz+efBMDAJFU77d3UuPwhxOgDVkajMSI2LRJB/vWDmJ7Tx7fOPf7bfMmfF1pzfQhobBdfYK022yAtB6YnrrWF986dXgLlubi4a0/jzv0l/7Y+g+e2WcPz57fs8PkyxgAqKTu6L3ftQ+nQb717fLk7Jrcc/xBR8z/pg6Kpee7N5vNL3vK7XbD+/sgCIKgMkcQhMFkNhhNcMlIiCYIBstQpb6hcn1R3q2E3UuZHifVEUEVHclgmmo10zVNE925nLh0KtNupToiqKIjATC5cZ3LF8REE4I5LBQmSSCKkQCY+VKdMIzvdcbrb7FxL9UR0Uj5SUAz2BwGaXW5ScBFAACAdLncJEv4ZHG05ORkj+fJHJYLFy5wOBxa7DuJyLt+MiFGa8q6kbly1x8dxzL2/tCzLg8ARNz502k1Oaom1cKNLKmXwerRflhzX17KNxcX7s4ZODQWXhg9RuIYRhLFRfxhq9Ytaa1gAACIUf0nd+v4++Kp6Z13vq948jGjYV2nLIwp0GVdOrRyw4KOA9G9az6sW2HuhPDmH1kw4bNZm2961T2WbpvXVkKD+v8ir0gxMxgMuLcJBEEQVLYs1mKtvojDZqtjorjwZ06IBmwRCYW1U9nOYvWhNVyzjupwIAjYEqpr2rzPcDtiNi7k52dRHQ4EAbuP0Dh9CADRAnYQC14hQtRzsAWa4AgSIJGWPKHHRnU4tFN+EtCoTCFH7hvNjzaUIyxGCyJLlj1uh3r27NmzZ8/Hx6empgqFQnokoHlJdRolAQA6duijnlp93oZpB1rt6yxDEWGVOu/EI8xcjpxFYmqXlgHIiCYNG7AuHLt13w5ig6kOnD4QLo+HIOx6A6e1VDzMy6PiNh/3a7D+64xjF53vt32SYUaCkhq/mwQAeL9vn8RB1af9NG171339Qsp/f0Wazy8bM3TKuqseVavPfps/pVfK80uZ0IZQKHzZUxwOB85KgyAIgsqKy+3WaPU+zBeqVIiDRVSHA0HALQnR1E71CsQhl4+Jc64BuPIYRDWPNETb5n1XiEqZsVN6+RSA68BAVPMSpM6J2X24kseSclBaZHWgis3HYOmEYTaOSG7XyZ0GBPbdL1J+EtCMqOTKQTsuXS7qHRuKAEBoL1/RCqskR9A2U+XNv7TpiiW6VrMmTxbTQKPr105Br9zKKsSBDAXAgbIfcBXBmDPUay45CAkSiBmAxHGcBAA2s48wFKHhDORueLj8qUQyGhIRwQLnioudJGDlnt503hDdsGOTiMdHMKJbNE1hnL11KwcH5T0BjedtGdF+wOocReqk9AXj0+L5VAcEQRAEQRTDMExvMFqsxXKZVCGTwstXiHI4m6ev2tgcV1OS9Xf08Y2oD963C1EM5/AMjdobazeXXDqlSl+Belyvfw0E+RNBAoMbM7gxMYeZKOYyYNcNUY0AiDFIXiQIEXmKE4puMQm4LP5LlZ8ENGBXa98+auLmRevChzSV6o+u2vYgruunKezXv5Aq+cfHfPVnpdGVj73/JPtJOpw2EuFx2QgA+nu7es4+Fdp10roOwY/bVbyw4J4PCVOFCWFT+7SgKnUS0L1ZWQ+IlvGPShMvyM3xIcFhoSIEgJzdYz7bVmlGrWNDn+w5SNpsNhLweNzyXpbYzQUDhvxWmDx2x55vWinLea4dgiAIgl6DJEmT2aIrMgTx+QnqWBarHI2HocBEIqhZXU1XvTnfUBi/dznbbqE6IqjCQ1BLSj1tq+5cfX7cr7M5hkKqA4IgYPXiWifGRhG1iM1lwMtaiHo2rkgjimQQvhhTNt8Ht2p4jfL0pWWqu08a3453ZvHE0ZOXXhB2nDChSzRt5z8DwKpco1kQfnbHvnOPf0gmLPs2H71FSpq/E1PElhhjk8ILr25ZtXqv+dHsfZ9+8697/ybDe7RJYlEUNk0x1N3eq4pe+n36rgJfySOYbseCP84Tik7tanEAYFVv2EyIn12//tzjNgE37Pt15y1S0bxJYjm/7nQfX7jwjKf2hDWzYPYZgiAIqujsDse9+zlmizVaFRGtioDZZ4hyjpDorHb/M1auH5m5KzpjE8w+Q5RzhcVkDRivb9whbP+6mHXzYfYZopwLI7KLvVonFsJnxsLsM0QDHiYnR6ouEEUqbdo4w12YfX4T5WvMzVDU6Te1Tj+qw3gzSHDD6YOTDy3e3G5wTq+mSWHAfPXcyfRb9sjUzwc2VjlQNJ6VNGP4O0fnHOzeP79Hm2qxqOXK2ZO772FV+06fnALzz6UwKg2Y9Fn6wG8/6Xxrd4dUNXr/5N5tlyxR3eZ/2UIAAEAkqdNH1jn09fJ27e/0erd6GFl09cS+9CvWyPfmTWnMozp4/8LvZZ7REWzRyW+H33m2o0ZETT6bNyi5fLUCEARBEPRiXq9Po9M7XS6lXCaViOGaGxDlfHyhrlpzW0SC/MZp+e3zCIFTHRFU0WFCsbZ51+KkmvKzBxWZ+xAM3ksOUQwngd7lM3twOZcp5zJQ2HdDVMNRhl4Qag6SSRzGKEsuCvvuNwZTTxRipfT58qRi48xNJ7dtuWTB2KExlf83tteAvi0jgDfSXYQCMrHz5MyQnV+vO7Jv19ZNXk5EfLVx03tPbKsWw1b3eYLaX61fEzH3x5/3b5t/iJTE1hz85cczBtULe5hzZaeMWHUybMnMVfu2rT5l8XFD42sOmzV8av+6YeX911Ms734eRtpv7F9zo9QzqJLZc+6gZEqigt4QSZIEQZT8D+aHawAcx/105pKwcRz3x8lLYkZRv3x7/VfUBEHAon58WhDIRf3axKU//jr0XxAEYTCZDUaTOFiUGB4LN7OFKEcwWIYq9Q2V64vybiXsXsr0wJlTEMVIBtNUq5muaZrw/o2E5dNZxSaqI4IqOhIAkxvXuzA+E4kXcdhwvWeIcghi4Uq0onCe1xGvv8XG4VYN/wxMQFMK4aWkDtqUOqjkX3YG9wFbJsUdIV4rACXLbrBjGnRf0aD7688kb3/4RHs/hkobSEifwzl9XvgUQ1br42/XfPzty17JT+n8+abOn/svNnritF9l9K16w4ORsGGHHcP8Gg/0j+A47vV6AQAkSTocjjI/P0EQ/jszAMDj8fh8Pn+c3OXy1zY4BEH4o0BKfkvwx5lxHAcAeDyekqpStkiSdDqdfpoo6qcCKal7/juz2+1+bYG4XK6SgyG/ct7d+f1XC9YfvZJj8gaFpzTrMfLLyT1TBKU/HWuxTavXs1lsdUwUl8OhJNRnOHf2ju23wfbs9uicd3/N3jxIUsGvrj2nF322kPvx2g9efnsWadj+ef9Rd9qnb/u0FqXXMbjxRoMVl8+/6IvOkFY+NaxGPRQAQOTfvz3tdPYBrcOIM0Jl8rRaKTNqyNiRCZraqQy3I/bIOp6h4G2HDv0bZPGN7bPnLNt44rbGy1dVbT5ozOSxbSJp0KCUZrcaZ1/T7jY6s72oKjiodWzkF3ECOfKaAziJ1TVt3me4HTEbF/Hz71EXPvRantMLRy3kfrp2WOl20pl94PvvV64/cSPH7AsKrdTsvf99OSYtJYg+3Yrn9OKxC7kfrR1a5ZnIXQd71/hkg/3ZPpHdfOm5n1uycQCASsASsMr7lLHy4g0HZlTD8//aN219xoG7RUacHapKSOvQZUb7ONmTMMni+5mz1+7feClfg3FVcVUH9eoxtq4cYwdpgiNJBImw5Ao9NgrCPr9z2tojB27rjBgnNCop7b2eMzolyl745SAt2+fOGHW/YfrinrXoNOkCJqDpwsQM0rIk4V6TGIczICAIeojJZHK5XAAAiqLBwcFlfn6v1+vxeIRCYZmf2el0Op1OPp/P8UO6x2KxCIVCf8yANhgMDAbDT0Xt9XoFAkGZn9nhcLhcLj6fz2aX/b67ZrNZJBL5Ywa00Wj0U1F7PB4Mw4KCgsr8zCVFHRQUxGK9ZiEsFovlpxn60GO+28u6NR91oDisYfch3aN8WUe3bZ078MipB8cOjqv+qNVxud0ard6H+UIUCnGwiNJ4n8AL7+e40ZBabVvEPbUIGKt6LItuV2hvG2k8snjloYy2/V7+6w2Rv/2Lj9bfLoppVva/bf5DCCc4tUp0XKlYSde5O0U6IV+BAACAMetii8338vjybtWjEhjui3dyf9p/5Khk9trOjWKuHBPnXAMk+aJzQ7RjvzAvtdu88yC+XZch7/N1p3fvmtrnzLXlu9d2CadVW++1ajodzskgealRyg5s/JbW+PP568dslU/WFIleesCNQxFT1nRspz65R3rhCALrJL2Rxj8XLz+Y0a5/qbbHd+/3bp2mHbCFNEzr3T3Sl3Vy39bFo46cKzy29cPqZT88/DdI49HFqw5nvNunVOS4Ni/HjYZUb9EihlvyCEGSbqQSz4tLhUwpB4XrZQWKNxmY0QBpPP9bi+lH80Rx3dp2SGAVXzx9+qeFX58qmnJyUBwfAACA/eb21Mnbz4Pwds3avM+1nD51bur02+e+Wjaro1rpKFLYdVS0k6TxzIoWkw7mBSd069AlgWW9eDLjp3lfnCqaeXJoIv+5g/MPLf9oT25ReE3KB0ulwAQ09UiAFLIldgY31qPnEXAOPwRBEARB0CuRlh0zZxw0Rw/ekrGiYwgKACAmHx7Tqv2Sb6du6LdzYCiB43qD0WyxymVSuVRCq98D8NzsHCKo1YRf/+hUzneheGO4y1Rw/dKptQvmbdSTIa84LnfT8GkHdSRCh48TFUTMSot49jEy59LxOlmyqW3i1QgApG31qexsnmr14Eb9hQjO5uo/7Tll6nert2+4HnmtBhOO+QMHfmfR+AXnGU1/2Lt6VCUeAIAY13d8514/Tl8w5N05rZ+79KcOvvdGfoaPP6511TlyFAAAiLD5R6+OvZv/R1KVD/mlD8A5PEP9dxKXL/pu74ZzrBPvMN0Uhw+9Cu4y5V//+9TaH+du1BOl20myeMfc7w9aIwf/mr7iXTkKACBGHZ7ao/2qRVO3dd/ZS0FpBrekhT+9dtH8F7bw+IPcHJLfauT8P9pyCZI0uHGDGxex0VAek4nC1HPgeN3AjC6fJaFf/ceJbGGd1Ys/7V/STvZt8vmns+al707vNrKPEAFEwaIlu86jKT/88NmoaDYBkKKhnSd+NvX3Rb9/WK1XCpuiRfYI7erfjmSL6q1e8Xl/BQoAAIOaf/7B1HmKPxRSAAAgAElEQVRbtqf3HN9H9Ezp4oWHhy88Q5PBUik0DKliwRFGDlfhQVlxbh3MPkMQBEEQBL0ediUj08KoNnhsu5CHY1lU3nLssIYs24kj5zUm852s+16vLz42RimX0Sr7DABpzs01I1EJMXBD6YdIw5YuNZu/03fKgnOmV61c48taPPbbjKguvarQ6W7SpxC2nNHHitQN3hmjRAEAwGs8oSWEMTHdRKglturdjiO80loDwvio594Ng4fqYKF/AM/ev/0aHtl91IhKD380QqUNpoxOFRTuWXfKXwuC/Ruk77YNB1xhqvRRo4dy24bxmIT7Zsn6Bo8PkDEsVRvcHfGVK6JWby6H6cu9baLTG4GeQxo2danW5J3eExecNb6gncRuZJwvZiT3Gtta/qhPlLb8uF9DluNExiVqmxvSsLVL7Vbv9J/2khaeNOflm5GIhCiW1YvftXodGKEWsSKDWDD7HGBeNTC7QKM+z3XvRBYmrNm426PvCuCqO9eWoZ7C61oCAIAX/LU9G49smTYimm3jiu4pK9lDm3zds5ZAd3TjJerWKnDdPXEXE9Zu3k3xOOyEznXlqLvguubZLxZWsHjObxnhzXvF0Wr0+xCcAU0lN8rK4yh4uCfCa0IBvN0JgiAIgiDoDfgcQJJQtVntuKdSkQiPz0aA11hgtFjVkeFBfBrNS3wKnpOdi7OS4iS5x7dnXtM4+aoaLVu+E02jZTrfNkTcZsGOJAsBSNOBkUNW5L/4KO/lnydMu1ppRvowfNyOTXTMlXl2HL28n59wtK744f3uqGRY23pd4qvnt+2CMJgRZ3YJC+/cdHhJRKjgUhsq9M/ghfkFOBoXq3rqVyNEGJ+gQvb/9XcO3qYyXX4SQVgJAgYwO04Xk61K9qwnfWcNbhzlJ5a0MCUHWHx7mo9TVQkOO7A++Gbm6lzbkwMgukLEqQt2VbKQgDTuHzloWel2EnMCcWzVhtWe7RN5PAAwr4/aLSkQcesF25MsZEkLv+q5Fp7IyS3AmWohM3tX+kWtxSuLqtqyaY1oenbg0Cu8ZGDGQwDm8dJoXxRGzLBPh/aKjHuqH8ZtLg+JSBRCFACAGwwFOBobGVEgVXuZXKVdK3WZsbAQFXLurzs6vK6KmgafETts7Me9VInPhO30kKhUIXo60ey7vH7RtNsxM37qjM/J2ES/21pgApoyNgY3nyOX+WxKn5XqWCAIgiAIggIHv93Ci+2efsDr9fy9ev0ZH6tag3pVYqMZ9F0y0pOTXYgT1okN3tEYfSQAACDs0KYTf/l1RnNq75KmDlOaVEMKACB110UvKQLn30uG/JhVb9r2UYlg/lsN7k05H9yYdJPs9l7l+o+SlL7gyGrD+tkiEyXXTwqunDLbbaezb4+77gmvVLtncAX9qAMUKhIHo0RhgRYDqser6Xq1hXoCJx5ocECbBDRgpFVXDzDfm3X0+j21tAYHv60p+l2PtqsZMyQIAAAwgbTO6IFpP/6xePxoYxSjBstX6gCIvpiypJoy8LJ2ktdy4ZGWzz5E5O/Zl4mxatROpvgHr8ctvP6G6LkZmTjpuZSlxQnr913TdGbsYZ+orD9x8fwZjWSwoQwkzw3MACDy07dn+tg16tWg0a+u3Ij2qSXLZ5Fup91kMV69sH/cEXt4k9SeIQgAgBQKglAizyZgYp4YSy5K4AAAr9GkJwhCZ8YBRQlorqp9O9XDsB02k8Vw9ezucYdt4c2GloRdwnlzy5A1BfU+/G5UDE0HSzABTY0iprCIJYr0GEU4HadwQBAEQRBEBz6fz263G43Gpx+UyWRUxUNDBEEYTLrLW6Z9PivDFT14xkc1aJx9BgDPz8r1kT48dtCaQ6NbxQDNxV3zR05cM6vfR9GZG4eoyvJ+yVLVhiyjPXN8Pp/D4ShdJ8vk1C9jP/fFZ8vzGs7YMiCGCXL8+qf+JdK+KuNerjJ5WxIHAYBgMI2JdYqSG4vybyfsXsp0aWav3TdZQwCASFRV97aLCqdxDfUrP9VJDMOcTmfpOll2SQJmlWYtwxb/vHHJuuErB6mYAADguLpw4Z4iguQ7XbS6iZXJDx4WK9x7xbrmhm0NAAAAoSz8k0g+D2UYazfXN00TZJ8dE7rjdF7emmvg6QMq7HzTUtWGIMpmpiaGYS6X6622k8/w5uyf3XPGcYeq99TeUXS8Dx8AkgRmD6Zz5GTl+0iME9dn4Z8jmsQA3cX9K0bO3Dxr+KToA0uHRNAzdv8qVW1wHC+TphLDMLfbXbpOiv23P7MnZ9eUnuMPOmL+N3VQLB0/SEIzf/ykyXdwABBJSre9o+uGo4iFK9HW6dBAuWvtzsVH2nw8KIQBAACunIWbzxeRgO/xUN/gEwXzR4+efAsHAJFU673384ZPdsJ1Xv9i9va8mh9s6RzGBJoy/Julqg2GYf+6qYQJ6LeNRJACttSJsuM8eg5Bt00pIQiCIAiCAoa12Pbgys4/vv/mp733vOruS7f90FZC79wequz89fqavErN6pXcYaxuMmjBLqBJ+fjwwjU3Bk5Joc1UStogrQdmTVhkar5yXY9YBgA41fG8iCP31vwHjLS0uMoIsEUkaGqnMtyOmKPr+MZCAABAeF1bNIwpdmUV5q+8crXjJmRvzyp12a87KUQfnAYTp3fcMWLnB6077OvcLIGlO7N313mgDGHYnUxaXU3jJ6/caHvTUy0hfkclSQqbuKvVTfyrIO140PyVi9sGY9Gb5v+1e2e75w/407ehdXxXuCtqueAtPLXgy+mzdtz1RndcumZ6WzEd+0QHRmicGEmSKmHYoOk/t+DGN6sdyQcAgOgmfWbuQnQpn2cs3Hhn4JhKsE8MRN78IwsmjJm1+aZX3X3ptu9pOjBDpF2HfhKjs2TdubDywLYOX3BXLBmZEoRGFPu+HlT3yHdnPxj55b5mKQkMy5nMc+dBcAjqdjJoUB8RWdcPx8VoTVk3z67cu6HjBHTvd93q8gAg7Qd+XrLIWnvl961jUQBotOjJM2jVZZZ/GMrIZcsRklS7dUySrpUCgiAIgiB6YLFYAoEATnl+nsvt1mju/rX2yxnzd9/wRrb67Lf5U95PedkKDvSBSKo0f7fKMw+hER3TGnx28Nila3aQElx2f6pUtUHKaGI4i8UKCgoqXSe1xWVy8ueQlqNzhq9zd1n8Zd9wOs6gAgAA4N5+IfeBIPqn2uG59dq4xUrl1Qxp9mXwZM4aKylGlQQAqJbQR3G0+sHr067H7qvJo+378R8/1Ukmk8nn80vXSYu+TE4OAAAAjey25ISo8tR5G/av+WkXL7xWxy+PfGAf2XpmrpBGaycTTsPM2w52RPz22ooQAAAAydXrzG9dqc3Mo4uWbhqmvMlwaEsdUFOl2sLyVT2mn3Y3LK1aUAVMDZSqNmW1aS2TyeTxeKXrZJGfdzAjred/mz50VvpVT1irEQvmj30vRUif6vlEgcPn9hJKHlPKYSAIp0qj5qX7xNTUBpOPH7t62w4qlWGfGChKVRsGg1EmTSWTyeRyuaXrJF7WEyJJ8/llY4ZOWX/VQ/uBGcJNqvFOEgC+dm1bVvq+zbyti3Z1PNwaZ5CksMWIE0GRU9ef2L9v7y62tFajPkfec4/8dH0un0v9m0F4SbXqJwEA2rftE/tl9QVbph1qvi9NWnx2zfDdni7ThvVVln2MpaoNk8n8101lBexlKONG2bkcuQB3hXstCNxyEIIgCIIg6J/DcVxvMJqNtzJnj/h0wwNF6qT0BZ+nxQfwHeSIUCxmAhLDcRIA6i9uaIXQ37hZ6NNtHF5/4/CnH19eX7WcoR526vjEelRfzRDWvJX3scj2PcM7dedk/R11ajvq8wAAvGbdpnx3dHRUkyeX30i0OjwF0d8qsuGgIiagAxkrps1na9t89vjf3hMT8zBGbFwU1RXwCazYcY1AUpQiBQAEi2Oon2qonyo5t6Qhiu+6cdymUAieOuAxoSK4LqrbaXYWgyApZbFD/xlesGVsvwHrHyhafJo++6O0WNpNaCdI0gsA5vEBABKC2Uz0pb0dIgyGfWJAwh9sGdF+wOocOg/MvIXXN123Rldv0ESJkAhi4st1gpCI+vWqon9n375KtCpZ058ZU7fz2rqdn7zq8uo8nBEboaCqwfcWXNl01RJds0mTJys+o9F1a6ag125la3Eg0WflFGKmjdOHbJz+9OvS6zdPZ0R2PrV2YD0azN4GMAH91lgZ/AK2ROErVmA2qmOBIAiCIAgKPCRJmswWvcHI57GxPV98tlGXPDZ9zzetlIGTycMuLegycodk6K+rB0Q/jhq/f/eeFw2Lj6XlZDVqodJ3ekwe3eTJwhukJXPj+qPu6gMHNlTJ6lC/QCgCrhiMmXh4/5Z1kvb/wik2PHnKnDtm9/1KreXH3gl6HCbp8doA4LEY8KMOJEThsY1/3pPW6/Nu4qOEiu/qsVNaNHZAAxrNzEeYDAEAZi9uqtrA0KIrx6BRr57NyfvbQgA2E+U8OQAjAOdJnfRiZvLhAVDAwm4uGzlkgy75o9V7pjWmYZ9o8xEFxTgOAIPNighiPU5CYVdXdpl4QDJg/ur3I5/0ibnZ97xomDoK9okBBbu5YMCQ3wrpPjArzBzz/clKIxJ29Y7TiSIYBBZjvs/WFdpJhMdhIwAA0njs8OV7oqQ+9SIeNfj41b9uatGQAVWllL2tgpNjZh+t9EmlYz2eFC3pdNpIhMdlIwCRprSaPLDGU4Mle+a+A0c9CQPfq6YSV46gzVcJJqDfBj0r2MgURHkMAsJDdSwQBEEQBEGBx+F0arR6EpCqiDAB48yHS856as9YM4vGFzkvwlTHS3IvrpvzXc92izsqEAAA8OZt/u6Xv0n1mO61WVSHRz+IvF6fGfWeegDPmXtiwzFLneHjxlA+99mhjNLUrL370DYsqEr3gk2cZ+NhhYU042TvvHzvXI3q9Us+WtK972LuLZI3NEZMdezQP0Le2DD108sNsON/jIhmAAB89zfNWJPFqfvloKo0+iRZEnFLoWalLnhNpQ5Djm4TX80EJHb0pvYEyWwbIeIDgEjEqXzN0uzCLXHxvfgIAACQ2LGnDoAClefMwuV/eWqMWzOFdtlnN05qnD4vTobwUB4ApRaTYMbESPKvrFvwU89WX3eUIwAA4CvYvHDD3yBqTFo12CcGEvfxhQvP0H9gxkpMbiI4vuvQX/sHNGtj10pdZoBbdu04fYsMHlqzZJNZcOPQ2k/vVcJ+GjciFAUA+ApPzNir4VTpOyiOslnErKRqzYIO79x94Fyn/vW5AAAACMu+bRm3SPHQ2lFMgMirvzuj+lMvIDRzLxw8Vlx5+P/60GTucwkadZnlEoEg+WyZG2Gq3ToOiVEdDgRBEARBUIDx+TBdUZHN7lDKZVKJGEEQ/FrmGR3BFp36dvjQZy9zEFGT0fMGJdN3gCt6d+qMNodG/t69wd0e3ZvEMoquHE7ffc1bdfSmyXXhBMSA4eMJddWbF6uS5H8vvXbFy1Vx6j5X5xCeanqje4eO3Gz3q7VXojSMdF/NeZCu8UYm158SQ6fLQei10Ih+4wf91G3Z6HZdMrs3CLHeOLj3yDXQ9McfBibQ5pPEBMH6pv161ztwcMKu8b3TMlTB1djEHb1pu8EnCY+dE8VCAACM4Cm1FAdO6fvtc22IetEBUGDCsy+cKSLYwnPfjsku3Sc2+GBe7yRK+kScBHqXz+whJBw0WsBGvC/KSgpbTB3f9NCkLd3fvd8jrW4sw3Tl+L7dN31VRyybXAtu1RpI8HsBMDDDEYYhMm3AB2cO/7h2RK/rvRqow4Dl6l/n0u86IpuPmFKTDQAAiKxfv1Y/Td4/eszXmS0qhdgfHDx9+RpI+XFkywTqEutIcL3p/ascWrq93Qd5vZokhJGWqxdOp9+2R7YaPaV2II0e6VANyi0fwsjjKBgkHufWM2i7DyUEQRAEQRAtEQRhMJkNRpNIKEhQxzCZDweuWF5OHkbab+xfc6PUK1Als8fcQclvPdI3x0wcvDYzctnXC9fv+23RJi83IrnpuBUTJvauKobpn0BAMJjGxDpFyY1E+XcSdy/Fbx476QHxoRLRC45FU+o1Oym4PvPCg20XtRacESqTD0utPLWWMgx+1oFG1OiLIztjpn2zeu+aZRZWWM0W49KnfNQxmhYJMhJlmGo31zVNC3pwt+Ep/EyL2K9v6NLztHsxRCEU9K8RNy1J/HjFn7BI9alWglccAAUiLP9BHkbabx9dc7vUM6iS2Wlu76S3HA9JArMH07kwPhONF7HZDASAl22BxUjsuzgz/Pevl6fv2/DLJi8nolL9cT9+MrFbJdgnBha6D8wQxMKVaEVhXMzdtsNnpzgbZ+44t23nVQvODlUlDPuo49SOlR53zaJqvY98FzLtt8N79+2zMKQ1a3dJH9ShYyi1M/JZKb2mnlRsnrk1c9u2yxaMExqVNGxUl6mdk8MCqvWGCWh/caKcPI5chLvCvCbYeEIQBEEQBP0jNrujUKtls9jqmCgu55n5HZz2K42+lVQF9p9xY9qMWtFmFNVh0A4S0vdwbt/XHPR/9u47MGqyDQD4m+T26vXaXvceTNl7o4LIkCHKFBEREAUXKPCJeysyxIkgKCogS0QUQUBAEAXZyGyBlt7otXft9WbG+/1RCqXttdeR5q48v/96TXJPkidvkufevKGSZv98fnaDxFORPTbd0L4/5XEm7VmjsFxDCImSOuTM7eB7DlHLFq3XtWjtewIQLCh9p0c+3/yI0GGUV5zUzNB/FMEwies+UmZfRAjpwyMX94pc7HMOoroJQEAjIsfvzBlf7kNpvwX5pgWCxFORg+EMDgYjHK+SqMQ3a2OEfszOrDGVzSFN6jt5Wd/JDRYh4EMgX5i5JIpcdQxLimILs9XuIoRQy76j1vUd5XsOUt/87s/fvbvBIvQLIWt590Pr7n7Ir4nJ6NmfrxfqYqkKUIDmhVWkMoi10bQ1lHEIHQsAAAAAQDBxezwGo9lLeyMjIrQhlXUtBaBhedQ6Q7t+7tBI/cm9uszjCPvozAdAQ/HqIg13P+CMTdXv36o7vIuAnARCozlscjF2Lxcuo8LlIuiEBwTHUGKjOrpIFhLuyIsoNkE7KTgoQNczjJBZoi2gFInePCULrxwEAAAAAPAXy7JmS77VVhimC00MiyXJoHqwEDRGrFhqadE9P719aOaxhAObSRou74HAOLHU0qW/pUt/7em/Mz5/iXLahY4I3O44jC1u1uJmNRIyPUQiIqH4DASGCaJAEW5SRaq9xel5Z8UsLXREACEoQNcvjiCzJTqaEKW6TRLMCh0OAAAAAEBwwBhbbYWmPItCLk9LTpJIhB1rDwCECMKW1NLY9i6ZzZz621fSQovQAYHbHkEUNmlnvPsBiTUvZeU7srxrQgcEALLTnMFJUwglayRyCkrPQHh2mcagiaU4NsmapfDCmAQBBArQ9cZLiq5IwiWYTfGYSQyvHAQAAAAA8IvD6TQYzRjh+NholVIpdDgAIFdYTG67fqxUHntoq/raRaHDAQC5ohIN/UfTIbrIPZu1Jw8KHQ4AyM1ig5P2MFyUUqyVUEKHAwDyUFJjSKxTLNcXm3WOPPg9JNBAAbp+FFOybEmYjnVEegt9vuIVAAAAAACUQdOMKS/PXuwI14WGh+kIAm4WgMAYhdrYqk9RfJPws4cizhwkWEboiMDtjpWrzD0GW1t3Dz/0W8TBXwkGniUHAmMxMrtoq4cLlZKJKhkMuQEExxKURR2ZrwgLdRbEWS9T0CU0IEEBuh4UiJRGcWgMbdXCKwcBAAAAAPzAcZylwGrJL9CoVekpSSIRXJQCgWGSKkhvZ7qjlybnfMbWz0SuYqEjArc7TFIF7fuYe92nyL6QvuwVcWG+0BEBgGxe1uhk5BSRppFIYMwNEABscp1REy1j3Kn5F6S0W+hwgE9wrV8nGCGjJLSQkid7zHLOK3Q4AAAAAABBwF7syDUaRZQoOTFeLpMJHQ4AyB6bbmjXj/K6k/asVVhyhA4HAFSc1NTQbzTBsQnrliqzLwgdDgDIwXAGB4MRilWK1GIYcwMIzyVWGEJiGYKKLswJcRcKHQ6oBhSga48lyKuSMJYgU91mMYan8wAAAAAAquH2eAxGs8fridLrtSEaocMBAHnUOmP7fk5djP70/rDzhxGGwfSAwLyhelPf4cWJTfX7t+oO7yIgJ4HQaA6bXIzdy4XLqHC5CLo9A8ExlNisirLJteGOvIhiMwFjbgQDKEDXkpsQX5VFyDlPottCwqDPAAAAAABVYlnWbMm32gpDtSGJ8bEkSQodEbjdsWKppUX3/PT2oZnH4v7cTNEeoSMCtztOLLV06W/pco/m7L/pn88XOWEcGCAwDuN8N5vnZjQSKj1EIoLxnoHQMCIKlOFmdZTKY0/POydmYSiCoAEF6Nqwk7IcWZiOcUR6bULHAgAAAAAQ0DDGVqvVZDIp5PK05CSJRCx0RAAgm4cxDp4mK8xL/W2ltDBP6HAAQIVOt3HKqxJbXsqqd2RmGAcGCM/uYQx2L0UQSWqJQgQ/GwPhFTschogMEuPEgkyFF97BFmSgAF1j+WK1SaSJ8xRoWJfQsQAABMIVHN+wcs2eY1fsqsQ2d45+5P7WoRW6A/iaxp95AQCgsXA4HAaDAWMcFxenVquFDqfm5FAu9wPHCh1BDbgYzuBkGA5Hx8eHNM1AnbsLHRHggSiYjlyXx2soKKRZNrJpc61GjfoPFjqiGuKC9uH3hnwW579/Gu676sxDSQyKCDcljQpRaqVQNWqkiGAayNvr9RqMRqfLpddH6tRKgkgTOqKa89zuJUT4FasGMCJyJDqLSJ3syYPqMwC3MfbKxrfeXJ8dN2TmCzOGxFxZ9+Y7m7PL33r7msafeQEAoDGgaTonJ+fq1ashISFpaWlBWX0GjQuDUY6DzrJ7VWIyXSsNUcqFjgjc7liOMxQUZhktSpk0PTZSq4F2EgiMJUiDQn8pJFHK0hmFl6H6DATHcZw5L+9iZqZEIslISwvTqAgC+m8FJWhN/MUQ1BVJGEGgVLdJhKFcBMBtzHti69asuPsXTRsQTyHUMtx2cdZPP58eNK2VpPppmp6ufl4AAAhyHMfl5+fn5eVpNJr09HSRCC44gcAwQgVu1uxiVGIyPUQqhmFMgdAwxgV2h9lmV0glabF6CbSTQHiETao2KiJkjCe18IoUhtYFAcBWWGg0maQSSUpSkkwmEzocUCdwnvOLm5RckYYpOW+spwBeQwzAbY7NPv1fcVSX9jElzyxRCe3b6jccPWPgWiWS1U1DK6ufFwAAgprdbjcYDBRFJSUlKRQKocMBABXTnMFJkwSRqBbDMKYgEDjcHkNBIcY4PkKnkkuFDgcA5BDJDUo9JsjYYqOahqF1gfBcLpfBZKJpOioyUhsSInQ4oB5AAbp6hZT8mkQXQRdFMHahYwEACI+zmC04LEJXegdL6iJ02GLO49DNIrKvaZjq5jUajStWrLjxXQ6HIy0tDSHEcVxxcf2/CZ3jOJZl+VgywzAIIbfbTdN0vS+c4ziHw8HTs1dBt6lLtrDb7fZ667+jCq+bmqcNwrIsxpi/rHa5XB6Pp+opXS4Xvi1/rvZ4PAaDwe12R0VFabVaocMBAHlYzuhknQyrl4t1UhIe2gWC8zKMyVpU7PLotWqdWgk5CQRHkyKTPLxIogp3WyPc0N8OCI9hGHNenq2wMDwsLCI8HNrJRgMK0NXIE6ktkpB4T74aBn0GACCEEGK9HoaQy+WlJ0JCLpcRXo8X+zENU928Vqt148aNN5bTpk2bpKQkhBDG2O1287VGLF/DCtE0zUcBGiFUbQWw1jiOC8ZNzUf1uQR/m5rXrC4pFvPBn03tdrtvtwI0y7Jms9lqtYaGhiYkJJAN+VonACrDYWRxMxY3Eyql4lRSCm5fgdA4DluKii1Fdo1Cnh6rF1HB9Pov0ChxiMiXafPkOo3XkVGYJQqq18mCRgljXGC1msxmpUKRnpoqFgfT62RBtaAA7ROHiByJzk1JUtwmKcdLAQUAEIwoiZTChS43RjICIYSwy+XGYrXEn2mqnTc5Ofmbb7658eeOHTvkcjlCiCRJjUZT7+tSUiDm4xl5t9vtdrsVCoVEUv/DW9vtdqVSyUeFy2azURTFx6vS+NvUJR1ylUolH5doRUVFKpWq3jc1xriwsJCnTe31elmWLTlw6lfJplapVNWOaCyRSG6rCqzNZjMajXK5PC0tjY9DHoCasnlZo5ORkkSKWiKDMTdAALC73Ln5NolIlBIVIZNASQUIzy5RGRQRFMcm2a8pGL46BADgv2KHw2A0EgSRGB+vVCqFDgfUPyhAV44mqKvScBLhFJdJhDihwwEABBAyLCKcyMq3ckhLIYQQZ8u3EWEtwkg/phFVN69MJmvWrNmN5Rw8eLCkjEUQBB9v8eI4jmEYPpZcEjZFUXwsvGRr8FTg429TsywLm7pESe9gnjZ1yRAcwm7q2+edew6Hw2AwYIxjY2P5+DkBgJpyMZzByTAcjlaIQiTQwxQIz+2lc/NtNMtGajVaFQyLD4TnISUGRYRbJNW78nWeIoRur2e2QADyer0Go9HpcukjInShoTDmRmMFPQIq4XQ6L8ki5Ryd5DZD9RkAUA6V0KKZ0nDseF7JxRpnPH7CqG7eIpbyYxqJH/MCAEDgo2k6JyfnypUrGo0mLS0Nqs9AcAxGuU4my+5Vicl0rRSqz0BwLMcZCgozDXlKmTQ9NhKqz0BwLEGaFBGXQhKkHJ1ReFnnKYTqMxAWx3HmvLyLmZlisTgjLS1Mp4PqcyN2u/TQ8V9hYeG1a9ciY+LCwsKEjuUW+fn5BEHodDqhAwl0LMtarVapVAo3w9XyeDwlQxnw8ax6YyZpNXBgwpwfPvouZlIvnXn38o3ZqSNmtJQgxFzaufqP/GaDHugc6Wsayte8AAAQHDiOy8/Pz8vL02g0GRkZt093bxCwMEIFbi2USzcAACAASURBVNbkopUiMj1EKibh3hUIDGNsLXaarEUKqSQtVi+BdhIIj7BJ1UZFhIzxpBZlS1m+3vABgP9shYVGk0kqkaQkJclkMqHDAbyDc+FNGGOz2VxQUJCYmAgjzgAAfBOljJz7PP35qqVzNroVsW0GvzB1eCKFEGKu/bN1SxbbdWTnSJ/T+PocAACCgN1uNxgMFEUlJSXxMaY5ADVVTHMGJ00glKSWKGC4ZxAAHG6PoaAQYxwfoVPJpUKHAwByiWS5Cj1LkLHFRjXtEDocAJDL5TKYTDRNR0VGakNChA4HNBAoQF/HcVx2drbX601JSZFK4UIBAFAlKqLD+Bc7jC/3qazX3PW9qpnG9+cAABDAPB6PwWBwu916vR6exwL88BxY+twS2fTVk5vfcovi+m1MmyfXFN/6nLikz7Ijn/cTM06G08vFOikp7EO77PlFXbu89k9lry2nUmf8efjVznDXFbT837k0w5psRXanW69V69TKAHiQnM7ZuWT+e99s//dyPi2PatLlvsfmvfJox7Bg+qXGfeDdh5bI562e2fb2PobYnMM/zV+9e/t5Uz4jjUpoct99D7wyOP3mrnT/NWb4B2uct7aT4vbLN8/vHxlRJFGFu60R7gICCzjghufAR88skT2x+rEWPncltmya/dBT5wdu3jij3e29v4NcVYcty7LmvDyrzRYeFhYRHg7n7przHFg8Y4ls5uqpLX1EV+0Eggm0eITh9XqvXLkiFotTUlIoCvoiAgAAAABcx7Ks2Wy2Wq2hoaEJCQk8vf8TAJy/e+nynXvvGVvuBSys8eplNxnZum/fpOvP52KEPERTscsrlokyVBJK8CofQoS6Sf/7R6Qyt37KGv/e9pcpJjYCDppg5s/O5ThsKSq2FNk1Cnl6rF4UEHeUOP/XZ/rev/xqeMf7Jz6bLjUf2bL2kyfv+fPa9v2vdAyWB1hw3s9Ll2zZO/Tx2/u9TDj/0Jd95+24GpJ+/8Bh6eLCI/v3ffLhy3/mvbr/0fSSXclaTJe9RGSTjn3jbo7s55E0p8KSEHJkFF4WcYyPhTcQnL9r6Zc79g4Y73tXcjmbXpr+/bm8pN6V1QNB0PB12GKMC6xWc16eQi5PT00Vi8XCxFdGMJ67cf7OpZ9v3ztwgq9DqdoJBAQFaORwOLKzs0NCQqKiogLgZ2oAAAAAgEBhs9mMRqNMJktNTYVHxAA/WFfBtdPHDqz+aOFaM46s+O/sK5ex4q6ZC78dIEMI2bys0clISSJaKZJRgXJ3SEbf+8aye2/9jLu8cnSHHR1efH9iSqCECWqj2p1rd7lz820ikkyOipBLhC+pXMdmrnz7m0zd0JUHvn2o5HXX88bP7tZvwdIFm2d+P1YX4Le9rMty+fThXavfnr/WyFVsFm4vnGnl17sz1Z1Xfv7cQyUlsYf7zJ46f8GGzZsfmDVWQyCEWKPxMie766Fnvu0pQQjZJSqDIoLCXLQjV+FxCRp9SQv/5+rFCypt4W9Od2Xd1Pm/mTAB7WXQquqwLXY4DEYjQRAJcXGBM+BtUJ27WVd+zumj+1Yvem+tudJWsdoJhHe7F6ALCgqMRmN0dHRoaKjQsQAAAAAABAqXy5Wbm8uybGxsLLzXF/AHWzYM7/i/7d6Svyre7WHr1RwrEZueIHYxnMHJ0ByOUoi0kkDoYVoV7trap185kPLsr8+2gFcNNzY3du70dCLLaPEyTKRWo1UFWK/i4r/3HfOqh469P7b0YFG2H9Y/buHH505fZpEuoOsA2LxyeNKU7dffkxdYRSABuM7vu8Coe/a+/0aHTFnasE7hCzfknDZwSEMhhK0Gk5WISI+mPKTEqNQ7KaneXRDmtiEk4JgbCCGELeuHt5/ru4UvRV9a+tw7exOGj47+cZ2wBXNQW74OW6/XazKbix0OfUSELjQ0wDt9Buy5G1vWDm81u4pDqdoJAkFAn3j4ZjKZrFYrvHIQAAAAAOAGmqZNJlNRUVF4eHhERESA3yqAYEdo7168qYkNI1ywfeak5Tnl/89dvnKNFaXqpJfXbfjHYPXqk+64q1cbbWDdGFaA83985Y1fIx7d/UTLAI8U1Nj1nTtp/dj4HGNeqEqZGBlGBmA7KWoz5aPPRmd0kt38iLHbnZiMjtAFaG3iBkJ33+I/Wto4hPM3zRyxoEKzcJuhUqY8M310QnqZXcnanR5M6iI0JbuSu3wtjxXFhUcya/7+91quLVIXeXeHtDCZ8GlJaPst/rGJjStp4Zf52JXe45++MP9k01c2T2FnQQE6WFU8bDmOM+fnW/LztSEhGWlpQTDabQCfuwntPYt/bmbjEC7YNnPCZxUPpWonCAS3bwGaZdlFixapVKpgGcrQ7XYTBAFPv1YLY+zxeCiKCoRBhQIcy7I0TYtEIpEoaJqCs2fP3nvvvdVP14js3Lnz7NmzPB3+HMexLMvHwcIwDMMwYrGYj0sNr9crFov5KIq53W6SJCWS+r/k4HtTSyQSPk5nHo9HIpEE16ZmWRZjzEez5v+mZpj6HGkRY4xvfWsQfxVhjHFBQYHJZNJoNBkZGUF0dgAVYX5eNoVLlf2wThkp0jVpo0MIYfMZTYVjCyPPyUwjyxW+NXSw2cpghBAiJPouc5YufKV7mPDFFR+cfy2cu5G9f8XMLgHWKVZYQZOTVXIcXPj8Bqbf+6NbipiYSL0kYNtJZbOBE5ohhBDi3EXWAkv2ye0fzVqTHzN8wYMJAX//K4po0jECIYQNxyo2C/WIv5ysuPDa56QsbuC9cSULdjvsBYX5Jw9tnbXTHtPr0QcjS5bKnDYWsNj9xvgJZltpOxnWcs6Lz7zSLkTgdvJGC286rfERivPox5MWXeo8f9NTGWhhgwYXiHjKyUoXXs+5cethi72Oi5cuKcXilKQkmUxW7dyBIKDP3aKwJm3DEELYdKryQ6naCWqrHnMyUM+X/Hv++edJUuD3ZdfImjVrpFLp8OHDhQ4k0Nlstq1bt8bHx3fv3l3oWAJdZmbmgQMH2rRp07JlS6Fj8VenTp0yMjKEjqLh9O3bNyEh4dtvv1WpVEOHDq335WOMOY7jo0Z8/PjxkydP9ujRIykpqd4XzrIsHw04xvjbb78NDQ0dNGhQ/S4Z8bmpjxw5kpmZ2adPn7i4uHpfOMMwFEXV+6amaXrt2rXh4eEDBgyo3yUjPjf133//nZmZedddd0VHR1c78V133VUvX0rTtMPhyM/PL/theHh4vSy8HLvdbjAYKIpKSkpSKALw0hvUTLm0qa/7B4ZhnE5n+Zysl0VXUExzBvuV/7JpzEjTxi7ZNa1nEjId+XXZzNd+eGPq3MTtn02KDcg6Gpe1/PVVV+54buPgwC2RC6Jc2nBc/bwhiWEYl8tVPidlvHS1czjPvTt/ZXbTad89mJKkDo6SCmLPL7yn47wjNEJkaPf52z65PyYgjxtBNGhO1n253LWFzzw77xyLEBF6x+hts7rGkMglkhlk7CkTgxkmbeBzu0a3SUIFR/ZtnvnJzjde/iTxyzmTIgO7HSr++6Vnvrja7ZX1E5JE6LLQ0QivXNqU9Kuo+2Jpmna73eVzUqer+5Ircrm9LoxYl1Wv1+tDQvj4Cl7AuduHcmnDMAzLsrVb1O1bgL7nnnuEDqFmXn31Va1We/fddwsdSKDLysp655139Ho9bKtqbdu27dSpU71794ZtFbCSk5OTk5NffPHFmJiY4NpNmZmZp06dGjduXBCFzbLs3Llz09PTgyhmhNB///136tSpSZMm9erVS+hY/OV0OufPn9+yZcvg2tTHjh07derU9OnTO3Xq1GBfShAESZJ890T2eDxGo9Hlcun1eh0/dyOg4fGUNpXnpLeev8XLYZOTKaZZvTxy0kuf3i1P690+ToEQQok9x772E2FqOXvvkrXnH362aQA+0OvY9+nCg9L7vpzQLACDE1S5tKmvXzd9tJP13IuQZliTrci8e8mqf6VDlz3eIViqzwghMnbEW98kXTVcOrzly1VvDB5Obdv8fCeV0FEFBv7aSYIg6n/hRNiIac8mmayX/jv05S9rB88VrVwyLUWtCnddeXTKnH6S2N4t9AqEEIrqOXjqT0R+y/ePLvnl6sMTEwO3KcKF29944aOCPl9+90AyhVAti1qNCk85WdJ3h+/rSZZlzXl5BTkFFEIiTYw2iKrPcO72reK5u9an79u3AA0AAAAAEOBEIpFCodBqtTwtn2VZi8WSn58fGhoaHx8fLOOSAX+US5v6KvaJRCK5XF4+J52Well4iTwXU+hmtFJRhlZGEbKwHn1a3PJ/MrZ//67z/thz8lwxahpwd7c4b9NnP2RH379soA66UJXDX07KZLLyOVlsrZeFI4Q4DluKii1Fdo3ceXLDttzo+6cMCqr+cYS6Sd9hTRBCD08Z23xw62fenb9m/C+ToRs0QhVysr5OgpXnZN0R8ibtujRBCN87YGDGWz0XrH9/+wO/DbBIOUbftu2t7SQR271L14VH95y/UowSA66dvA7bdr879Tv38KWvjoN8LFUuberrSUSKoqRSafmcrKcu/6hkDDer1ZyXp5DL0xLDJQRCRFDtUzh3+1YxJ2vdVAZVTgAAAAAAgHpis9kuXLjgcrlSU1Ojo6Oh+gwExyDEeGkHzaVoJDEKEeXjLpBQh2hFCDMsy+NQmbXEZW9e/rsjacSoXnKhQwH1we5yX8w1212upMjwGNfulbuCZud6M3evXr1mX3bZAhOV2L9/S8p99vQl6GkaRLy5J1dv37fPdL29s0tUF0JSVL16tiQ9l/87RnKVv3aCUCq1FMJsILaTpTjzmf9yadPaqV2o6BQiOoWIu/P5fxk284su8Smi7u8cqs8XagAeOZzOS1lZBVZrfFxcYkKCRBx8/Vzh3N0wgi8zAAAAAABAXbhcrtzcXJZlo6OjQ4LqAUnQWLkYLtfOeBEiRVSS5ub7SZmTXw6fsz10wsKVo+Ju/ELCXsm86CWjUxLUAddPibv806aD3vjpg1vDu7CDnYdmDAU2t5eOCg3RqhQIcZnBtXMvrnt28rdN3++6Z0bijWMHFxXZMSFXyALu0AFVyNn/7Dt7mj7RZPuDsWal3knJ9O4CjfGaAxNymYRAiDn/4/AP/wod+szKe/U328nc3IsMER0XFXjt5A2kruMD857uefPnEGw7uPb73e7WDz/cLT6sQ2AO8g/K8nq9JrO52OHQR0ToQkOD6BVrt4JzdwOBAnTQ2Ldvn9AhBIfk5OTDhw8LHUVwGDhw4MCBA4WOAlTvr7/+EjqEGpsyZcqUKVOEjqJmKIoKxtZjxowZM2bMEDqKmlEoFMG4qWfNmjVr1iyho6grhmGMRmNRUVF4eHhERETQ3iqAxoPFyOyirR42TETIKzwCL0pKCs058d3iTx68683B4QRCCNHXfliy5ihKePa+VgF3o4gtv+84RoeN7N9GUv3EIFCxHGe22a3FjlCVMkEfRpa0k8G2c8Xt+/YOWbXlqy//nvR6FyVCCCHW/Muna87iyMl9W0AVIIiIm97RS/n7ll/2bR7/Qh+2KK7YQLEFP23adxZrJ7dPECGEYqNDjRe++3r9g10eHxxa0k7m/fDNb0dx1LN3pgVcO3kTEd557Cudy3zAXn5/35o9tg5TZz3bGXI0sHEcZ8nPt+Tna9Tq9NRUvkeX5lewNe/BK5izBAAAAAAA+AdjXFBQYDKZ1Gp1enq6WBzA96Tg9oARKnCzZhejEBFpGqmYrmzIDXXfF5/vtWPu+pH3ZD1wX6dkquDEH79s/Y++Y9rn89oF3o1i8V+/H/bKunXrJBU6ElBbtmKn0Vokl4jTYvSSsiWVYNu5RNjQl1/otmPegnu7nR59X4dobDr5+8bN/9riHlz+vzsVQkcHaqAwot/Dj+39bdGa6aMuju6REo1tJw8f3Hy+OO7Omf9rJ0UIIWX7Fye327Fg18jJuQ/c2SKZKjzxz8Gtl5g7Rs+d1xzO9aD+2YuLcw0GiUSSkpQkkwXPG1l9CbbmPXhBARoAAAAAoJGz2+0Gg4GiqKSkJIUCSg9AeMU0a3AyCKF4lVglJhFCPsYppTLGLT0Y882bX2z+Zc2KdV5pbNMusxY9Oef+ptrA677vObJ3v51Ma3OHJvBiA9VyuD2GgkKMcWyYVq0oX1IJwp0rbfnM5v2x77728caNn+6y0fKoJp2nLJz14pQe0TCyQZBwiWQGhZ4hqF4j5x9QrXptw8GNm47aGGlUQsaUmcNfHNq8dFdSGYNnH9Rve3PtH79s27KOlsSmtJw174E5/ZICsJ0EQc3tducajTRNR+r12sYyhlsQNu/BCgrQAAAAAACNlsfjMRqNTqdTr9frdDoYcwMIzsthk5Mppjm9XKSTkjdyktCP2Zk1prI5pEl9Jy/rO7khg6wdaZ8Pcgo/EDoKUGM0w5psRUUOV3iIOiJEVWk7GZQ7l1C1HPX6ulGvCx1H7RHRU3c6pwodhQAYUmSWh9kk6nC3NcJtJTAXctf4dXeN9z2HOKnT0GWdhjZciDVERI7beWVcNRNRSbN/Pj+7QeIBNcWyrDkvz2qzhel0EeHhVby5OugO2+Bq3onIh3bmPlSXCQQEBehgwBUc37ByzZ5jV+yqxDZ3jn7k/tahcPdYJWz86aU38kYvntSCEjqUAMBe/Hrm7A2O7s8veq77zR/B2XNfTf/f2YFL3xkadeMz54EPHnt3rzNh9IJFY1Ng0zUsPw5z7Lq8a/XKzfv/M7gkYUmt+42ZOKxtuAhh6y8vTf70OH1jOir2/neXPpzB5x70p1HyNY2ADVpwbWR/Y/YdWwBvavrQh+Pf2uO6tbsjGTPivY8fjvhNoE1dourTRwBmdZVYlrVYLPn5+aGhoXFxcRQFDTsQGIexxc1a3KxGQqaHSERkQBwp4HbGcTjfXpxns2uU8oy4KBEFfYOBwDAiCmRaszxMRTvTC6+IObr6eQDgE8bYarOZzGaFXJ6WkiKRBN74VyBIQAE68LFXNr715nq29yMzR4fl7V391ZvvUAveGh4Pd5G+YPe13d9sPuXsxAkdSSDBBfuXr+x1x1OdfD9Xgu2H9x5xyhWSnP37M0elpEOKNSA/DnNceODjl5eeShj20OwO0fjyrm+/eePlotcWTGohNhvNRMaQZ0e0uH4tQMhjY3i9ffKnUfI1jYANWnBtZL9jRpyP2AJ6U4vShzw3pwtzowCN7cfXrziadkc0yeUKs6lLwqj69BGAWV0Vm81mNBplMllqaqpUCmPaAeEVelmjk5FQRIpGLIMyHwgAdpfbkF9IUURSVLhCCiUVILxiscKg0JMIJxZfU9AuocMBADmcToPRiDGOj4tTKZVChwOCGxSgA573xNatWXH3L5o2IJ5CqGW47eKsn34+PWhaK7hIqgjn7frw5a8OXivyYhQudDABhYy6oym3b9k3PZtPb6+qvASNi/7Ze5Ru/sCkiC3L/tx/YVx6U6GrJ7cRPw5zbD24/RDTZebzE3qqCYRaNI1yZj21ecfJ8S3uMJusmvQuPbvd0UB7zJ9Gydc0TU8L1qAF10b2O2aE6MpjE/Dc4cdXE7r0Tl3TS//Cxf9+ssrV5/GJ7dSER5hN7c/pIwCz2geXy2UwGBiGiY6ODmksw/OBoOZiOIOToTkcqRBpJXB5AYTnoRlDgc3tpfVajU4NJRUgPC8lMSginCKZ3lWgc1vh8RAgOJqmTWazvbhYHxGhCw2FMdxA3UHvg0DHZp/+rziqXfuYkqt1KqF9W33Rf2cM0Lu3MoS23ajnXn5nwcsjM+C3lVsQqlbjpvTBu7749oSz8nf8YOtfe0+wzXr06dOtncp8YN9ZeNqr4fhzmGM7LU3s0LFp6e8HVER0pMjrcjJcnsmM9dF6zmU1W+y0j1c4NXC0vqahhWvQgmsj+x8z8hGbgOeOGn+1+/Sa5UebTRzXRkn4Wh3+VX/6CMCsrohhmNzc3KysLJVKlZ6eDtVnIDgWI4OTzrJ7lWIyPUQK1WcgOJbjDAWFlwxmqVicERcF1WcgOI4gzfKwi5oEMcdkFF4Og+ozEBrHcea8vAuXLiGE0lNTw+ANIqCeQJUu0HEWswWHRehKfyogdRE6bDHncSgRfj2oSKyNS9UibL0ghxayHELdfsLkHs+8//n3PT58tEX5F3sjbDm49xRuPrlTmELRta3yj4N7zzzcojV0s28Y/hzmZOKQ/5V5NQJr3rvrBEob1UTO5RrymLxdb0/6KquQRSJ1UvexMx4fmKbg7RDwJ1pf0zDCNWjBtZH9jxlxeZXGJg7sTV0Ge2XLV3+E3b+gs4bwvTp8b2rkx+kjALO6LIxxQUGB2WwuKT2LxeIG/HIAKoExsnoYk4tRiMg0jVRCwZUZEJ6t2Gm0FskkotRovVQMN8JAeDapxigPl7LelKKrMtYrdDgAIHtxca7BIBKJkhMT5XK50OGARgVqmIGO9XoYQi6/cUNMyOUywuvxNly3MNBYECGdJz7SxfHLZ2vPesr/D5v+3HuWbNGzs45A8ju6tlUU/LXvVIWpAE9qeJh7jH9/9/rcLy6kjJ1yTxSyW6y0XJU65NWVP/zwzdI5A1XHvnzry3+K+Wsi/InW1zSMcA1acG1k/2PGPmILlk2NC//8/qfiXqPu0hNVrU4gnPICMKtvKC4uvnjxos1mS0xMjI+Ph+ozEJyD4S7ZvfkeNl4lSVRLoPoMBOdwey7mms02e2y4NikyHKrPQHAukSxTE2+Sh0e5LMn2HKg+A8G53e6sK1dyDYZIvT41ORmqz6Dewak30FESKYULXW6MZCV35y6XG4vV0DMV1AIR2uORifuf+eSz9d3fG132H9y1/fsuoKSRUUXZV+0IhSanSPYe2nt8crtOFbpKg/pAH/pw/Ft7XBghQnXni6ue8Pswp03/rPvsi82n0B3DXljwYEe9GCFp/5fW9C/9f3ynMU+OOPbE2j+OP9apO0+XDP40Sr6mEbBB8/+rA2Ej+x8zEVp5bBN7BcGmRojL2fHjvxF3L2hW+sZBH6vD96b2RwBmNULI6/UaDAan06nX63XwgCQIADSHTS7G7uX0cpFOSkFKAsHRDGuyFRU5XOEh6ogQFbSTQHAMKTLLw2wSdbjbGuG2EhgG1wQCY1nWnJdntdlCtdrE+HiShI6qgBdQgA50ZFhEOJGVb+WQlkIIIc6WbyPCWoRBkwBqgwjv8+hD+5758tNNnSbe/JTL3r8/k6HZNf+bsebmpP/sO+rs1FXR8EHeBsTtpn3x9SSMESIIiUJMXvHnMMfOs+tef2N9Xsb9Lywd0SHSR3mLDI+NkdJWuxsjngai8adR8jWNSLgGzb+2NFA2ck1irjw2ry7ANzVCCCH20u7d2Sn3zI7zFVZDbWp/BFpWcxxnsVgsFktoaGhcXBxFwdC6QGAcxhY3a3GzGgmZHiIRkUIftOC2hzEusDtM1iKNUp4RFyWi4P4JCAwjokCmNcl1SsadXnRFzMJLd4DAMMZWm81kNivk8rSUFIkEejoCHsFpONBRCS2aKQ3HjueVPMzLGY+fMKqbt4iFG01QO4T+7injmuZu+GzLFeb6R2zm3n1XxO2eXPnjllJr/tdX4ziy90hAPPjeGIkVISFarVarDQlRiP07zN0nv/nwh6Lucz+YP7psYdR5cOnj0xftL7zx7rlrl654Q+Pj1bzd+PsTra9pJMI1aMG1kf2P2Vds2sTA3tQIIYSYs3v2mtJ7dou8sSGF2tT+CKisttls58+fdzgcKSkp0dHRUH0GgrPT3IVCr4PhUjSSOKUYqs9AcHaX+8I1s83hSooKjwsPheozEFyxWHExJMEqUSfacxPt16D6DATncDovZWXlFxTExcYmJiRA9RnwDXpABzxJq4EDE+b88NF3MZN66cy7l2/MTh0xoyU0DaDWyKh7pozZ/9zyf11UM4QQYi/u/zNX0WFM19Cbd4uKtnd20/3xx77D9h59NHATyTufhzlzaefqP/KbDXqgs+7MH/st0V3S2YtHDt+Yj9SltrmjS0v67WXv65gHu8RS+ae3f7s5r8XDg5rx2Lj7EW2kr2ko4Rq04NrIfses9xWbhAvkTR1JIoTYK0eP2aK7NSvT9MiF2tQ+BVxWu1wug8FA03RUVJRWq+XpWwDwn9vtNhgMXhcdqRBpJfBbCBCex+MxGAxul1Ov1ejUSqHDAaB0vCxVtN5VoHNb4d4KCI6maZPJZLfbw8PCwsPCYGwi0DCgAB34RCkj5z5Pf75q6ZyNbkVsm8EvTB2eCJf3oC6ouEFTH9w/++uLCCFEn9273xTSdUqHW7oYSlrc2Sv6t217/y7sfbcWzke883WYM9f+2boli+06shN5LdfBXNm+5PXtN+ciZD3nfDu765TXn9euWrf67S1FlC4uo8Njr4+/K4bXbj7VRts50uc0AjZowbWR/Yy5c6Sqg4/YyADe1J0jEUI47+QJozyjWVyZqAifqyOUAMpqhmHMZrPNZgsPD4+IiODjVqG4uNjtdmu1WpEomK4PaZouLCyUyWQqlUroWGrGarWyLBseHi50ILXEsqzZbLZaraGhoYmJiXwMGelwOFwuV0hISHC9WpNhGJvNJpVK1Wq10LHUjM1mYxgmLGiLESzLWiyW/Pz80NDQhIQEPnLS6XQ6nU6NRhNcXQVZlrVarRKJRKPRCB1LzRQWFtI0rdPpgnRQ2hvjZWm12ozmLfl4YsnlcjkcDrVaLZVK633h/MEY5+fni8XikJAQoWOpmaKiIq/XGxoaGqTPn93ISY1Gk56ezscln9vtLi4uVqlUMhk/L5RShfKyWIQsFotIJOKxhwc/kdvtdo/HExQX8ATG8Ig9AAAAAEAgWrJkSVJSUvfu3U0mk1KpjImJ4a8SBwXoBtbABeh+/frt2LGj7stZtmyZWq3u37+/yWRSKBTR0dH8VeKgAN3AGrgAXV85+d1337nd7hEjRhiNRplMFh0dzV8lDgrQDayBC9ADBw788ccf697g/Pjj4t/yygAAIABJREFUj9nZ2Q899JDRaJRIJNHR0XxV4qAA3eAauAA9cuTI5cuX130r7dy588iRI9OnTzcYDBRFxcTEyOV8veGb9wI0b3gvQPOjgQvQDz/88Ntvvx0TE1OLeYPpBgMAAAAA4LZC0/SWLVuOHz+uVCr5rsF5vV6WZaVSaXB1NOM4zuPxUBQVXPUghJDb7cYY83cHyBOapn/99dfz588rlUq+tzlN0wzDQE42GI/Hw3Fcg+Wk1+utl+UwDLN79+6cnJwGy0mJRBJcnR8xxm63myTJ4KpRotKclMlkDfOjSHFxcb0sh2GYAwcO5OfnK5VKvrc5wzA0TQddTiKEXC4X5GS1rFZrvSyHZdnDhw9/+OGHDZaTYrE4uDo0oKDNyQa+gDeZTLWeF3pAAwAAAAAEqCNHjpw7d65hupCwLMtxnEgkCq6n7zHGDMOQJBl0994Mw2CMG6xvr1QqHTRoUN2Xc/z48VOnTjXMvTfkZANr4JykKGro0KF1X87p06ePHj0ql8sbIE84jmNZlqKo4PpRpCQnCYIIunpQSU42ZCMwbNiwuu/cCxcuHDp0CHKyCsGbkw1/Yho8eHDdf1q7fPny/v37ISerRtM05KQ/BgwYoFAoajEjFKABAAAAAAAAAAAAAAAA8CLIfpEAAAAAAAAAAAAAAAAAECygAA0AAAAAAAAAAAAAAACAF1CABgAAAAAAAAAAAAAAAMALKEADAAAAAAAAAAAAAAAA4AUUoAEAAAAAAAAAAAAAAADwAgrQtwPuyuJeUlI5eoOnwr/oPTMSROIWL/7LCBBXXbiyfls8c0S3JjGhCqlMHZHSfuCU97ddcgkdFgCgMTs6v6WYin9yN33rx96LX49KkpDqds/+ZuaEiQwAAAAAAAAAAAhUUIAGwYcz/PJMzzb3PvPZXltcjxETJj7Yr21o3h/LXxjS4e5XDxZhocMDANxOmMtrHh3w2A+WZjN++OWD/no4qwIAAAAAAAAAALcQCR0AADVEn/34oXFLToTd/8nGL6a20RIlnzK5v84adP+SNye92f/ou11lwoYIALhNsDkbpw2Y+J0h4/F12xcOiITqMwAAAAAAAAAAUB7cLYPaYr0epn57G7M0Xe3T6zj/x1df3+1oMev7VdNuVJ8RQqKYAe8sfiyZO79y2S4nP19da7wuHAAgFM7w84wB47+6mvrY99uXDIqq+fm02rYBGg8AAAAAAAAAAMEPCtCgDC5zYQ+ppMv7F9ibH11a0F0q6fbBxZIqSPH3I+TS7m9tXf5Iu0iVXCJRRrYcNO+nq7T74rpn7m6qV8k10U37TFl+wnFzoZ6sbW8/clfLWK1cIlVFpHQc+tyq4zfHySj+foRc2mPBX7+/PiRdJ5eKZbqE1vfMWHWyuPIIcf7WVVss8jtnzugkL/8/Wbenv1yx7J2hsd7SpXP5/yx7+r72STqlTKlLan/f08v+yb9ZzfHjq53nNrw0unt6pEoqVYandn3wpc2X3Df+6br00xsTejeL0shVEcntBs/8ZL+RrY+FV78XqgkMAMA/zvzbcwNHfX4pcdJ32z++L4Yq868qGz3PprFqaec3d2x+vl+yVi4Vy7QJ7YfOXn3S/wmq/QoAAAAAAAAAACCQwBAcoMaY0wsmPBXSceLLC5Kdf3/z8bp3Rt+7/w7bRfKex14YRJ35YemqLx9/KLr9kVfbiBDCpvWP9hr9vS2l36gp9yfInVcObl63cNLfRvWp1SPCSvsvs1e+mvRADtlr0ivT49kzm79Y9fGj93Fxpz6+S1nhu+nD+w65RS369NQTFf6HREl9J0y68Rcu3PPCnYMWnJI0Hzhy+lit9fi2DR9N7bP7/M973+sT4s9Xc7nfPdxnwkZP8/tGzxwXwWTv++H7Nx48bt95dGEvBfKeWTqsz1M7vU0GPDB1pJ6+vH/Tsifv/vng13+sejCOrNvCqx0/pMrAAAD84/L3zB88cvEJxX3Lf/10WFzZ6rM/jR578ZMJY0x0+sBHnmkiyflzy48LHt532PzH9mfvkPgzgV/tKgAAAAAAAAAAECgwaPzYy4t6SqpIAlHz/x2hMcaYvfRhd4m483vnmZvzXvygm0Tc9f0LLMYYY/t3w2WIjB61JrfkbzZrUU8JQSi7v3fKgzHGmMtbPTyEkPb/wshhjHHh9yOUZOjwb0xc6fJyPrlTRsVO/71k8pIFEvKO8w/Zr0/h2PNUGiVqOvcfuuKacJYVA6VINuzbompXmj7+ShsxGTHw4zPO0gWfXjIgjJS0fe0E7c9Xc4bP+0nJ8LEbbNf/6z3+ds+oyPYv/kVj9upn/dVUxKDPzntKIys8MK+9nIqa+FNRnRdezV6oal4AAJ/+fbGFiIwZ+9qcblpSIpUQVPxDG2+0biWqa/TcG8eoCERGDfvyvOv6BKbfnmolJTWDV+Ry/kxQfbsKAAAAAAAAAAAEEOgBfdsgRBmDHh+YRt36KZez+6sNp2u2JDJ80CPDoku6+ZIxLZrriL/bPDKxeUmJm9A2bxFP/Ux7aYwQgVTDvrqah+UhN7scezwcwgzNlA1Nfuf0mR1V1/9StGnfTIzPeL2VPU7OcSWDUFTbyY89t2XLaS5l5v8mNysdq0PRfOq8hxbu+HjL1gvz7mhGVfvVIqmUwsVn/vgj854hKUoCiVvN2WuYgxBCOPfn9X+4UmbOfzS9tLBPaLrMmNJjwfTftx+hB/cR12HhqNohX6uYFwDAN2xY8/J7mq7zd3yS8EG/x76b8dTgLt8+GH1jPCu/Gj1R88defjj9+tMOpP7ul+cOWTVu26Yd1okTdNVOQPj1FQAAAAAAAAAAQICAAvTtQ9J24vsL75fe+iG9Z8amTTUsQBMyuezm4OEkSSFCpVHfKAmTVJmRxUmZRlN0dOuybQdOnMu8fPXyhdOnLlk8ROQtCyR1SYkhRJkl+hyanNBERioINjcnl0UZVIV/M9cO7zyWF9K8d9dk6vKly4y4Z5uWZbt+S+5o20LM/nXxCouuF6Cr+GoifOQrb6w/Oe+jYenLIpt36tqla4++A0cM7ZGkJJjLF7IY5tL7XcTvlw9QkZfPIiSuw8J9rXu9zAsAqCtMqLvM27L15Z6hOPmDnzo8su6pmUO6rx0be/349qvRU7Ru37TM6ZfQtO/UlNqceeEyi3TVTiDy6ysAAAAAAAAAAIAAAS8hBNXAGNf+zVbYumde94wOo17+4YwrvOWdo59esPHgFw9oyhdKqyg5lyPp0K2jlDn1+x5jJf2EmROfThwyZNSiI1xJ4KhCT2mSJBHmOPbWT3xRtn/mp3OXj2z57MXRbRXXdn02Z3zvps2GfXrag0iKRKKWU7/6aWs5P22Y3VVUx4VX5ta9ULN5AQD1iYwa++b8nqEEQmT8+KUfDtebNz7zxDdXrzdJfjZ65RongqRIAnEs588Efn8FAAAAAAAAAAAQCKAHNKgAc2WKIIwhx8Ch6Notibu6+pWFh2Ujvzv2/aio67VY18ZPuNpXtInIIeP6z9n5y+KFB8Z+0EN1y/88//6w6RyruLtfdyVCXGJqkog+c+w0Pa6ruHQK+vTxM7QoMSWxYufpSoIvuHDkYmFoevvBj7Ud/BhCyHvt56f7Dfv89aX7J72SkSLG52Sp/QfdHFwb205t3/GfWKXx56CqYuGPfpyMUFV7oap5P72rqsG+AQD1gCSJ0mIvGTtmycItB8atnzX9q94/PppE+dnoOU8ePccMbXWjsbAfO3yWEXVMiacQYquZoP7bVQAAAAAAAAAAgE/QAxqUJRaLEZt1/FTh9VIGm/PDR+uuslXP5BtXYLYwpC41Naw00byXN/2w31WHCInoUa/M6iT9b/HoMR/+ZbkZmTd766wpS/7D8WNmPhBFIEQ1HTKkKXnp67dXnHdfn8R9bvlbqzLJZkOGNPWnAM0cXTisa9cRC/4t7VcsiWqaHkYhhqaJiHuG95Jf/ea1T0+XLhwX7H7pwfvGzPk5T+xrgX4uvNq9UOW8AIAGRcaMWrx4VLT1l+enLbvE+tvoMaeXvf5tprfkD86y5823Nlvl3Yf2jyCqn4CHdhUAAAAAAAAAAOAR9IAGZZDRPfo0F/+xbtq90pPjOobk/7vpy2+OOlWi2j7aLWo2YEDKuws/mjCam9wvkTCd2b12zVGsVSPzwbVf7Uwad1eGqvqFlCdt+8KaFZkDH1kxq0fapz369b4jRurIPrbrt7+uujQd53z93oCSYZdFrZ9Z+MTGIYund+2yfdTAO0JsJ7at3XLS3eLZRc+09ivtJV3HjWu64oN3B/Y490C/VtES27nf1/1wgGo199FeElIx8f1X1vR9/tnubbYOubdrmtzw59rvf8+OG//97G7S6hddzcIlVe+Fquat+eYEANQNETVy0Uc/7X/g27lTP73z18nVNXpihBCSxUgPTOvadcvIfk3EOfs3bdifI+36+nsTE278JlzFBGT17SqMxgEAAAAAAAAAIJBg0Pixlxf1lBCKUevdFf7l3f1kPCVq/r8j9PUPPJc2zhnaPjlCISIQIdJ3f+HHZeNDJV3fv8BijDG2fzdcRiXM2OMtXYDn98djSdnIda7SD+hjL7cSSfouzS6ZwXVu3ewh7ZMjVOrIJp0HP/n5P/lFB17rFS2XaPt/cpmtZIEYF60eKqNSn/uzzEcVcIWnN7wx6Z62iWEqqViqjkjpMGja+z9fdJZbcfPBT2cMbBMXIpPItPFtBz/1xSELe+O/1X+198ovbz3Uq0mkSiISK8KSOtz39Od/5ZUugLOfXjvvgc7JOoVUpU9p0+/RD3bmeOtp4dXshaoDAwDw5d8XW4jIuCd2lW+dOPOPExMoQtP7wzPeaho998YxKlI/eeulbS8NbRWjlkrVMa0GPr3iXyt3fVnVTlB9uwoAAAAAAAAAAAQQAtfhDXOgEcMeq6GAjIgO8WtECcAP2AsANDaeTWPDR/4+elv2snsqf2Sh2gkAAAAAAAAAAICgAkNwgMoR0tCYWr56ENQb2AsAAAAAAAAAAAAAIKjBSwgBAAAAAAAAAAAAAAAA8AIK0AAAAEBDIaPaDRjcr1WEz7NvtROA25D3tylRFFEOSUnVESnt733sna0XnHX8Apx3cPXSr/cbuZrMY9wwPjFu7Pq8gBzKrQZrxBn3rli46IdjxfxHFVjquuK8p2VtBHZagkrU5wEIOQkCTYPkZE0Pokadk7W5nrm9QDvJF8i9W7n/+V/r8F4LTnvLfS70INQAAAAAAMA3z/bHIklESLQxSTfFRShFBEIIIVLb9dWDRbfMkP374hnDOqdFa+VSeUhM897j5n9/3Mb5Wj57eUlvmSh99l+0rykq4PI2PRSr7LHgPFOH9fLNcWHzGxP6NI3SyBW6xHZDnvrsgLlGX+T/GjGZywaFk+jmy5OFVasV9+6ZkUBVdvEv7vDWGV+z133F+UrLGmZvWTynpS+1Tlf/ZqzDBuFZXY9TXEUeevfMSDh9+nTNlsZTTnqydy1+YkjHlAi1TCIPiWnWa/Sclf9Y/DtuGmFO1qrBaSg1XnH3loe0RBUllFtWiit05l+rWUB8n75xzRvzRpiTZdTieoZnfOakd8+MhJfnz69ZQLzkZN2ahQC9pOT/WppntT9Hu7N+/WDagDaJYSplWHKbvmPnr/+vuMJE1W4fLn/DuChN70XnbvlWKEADAAAAAASwkrsFUauXj91yVcu5DX8vn9RSQSBC0vbV46X/cx794M5wikAEqYxu2rZ1RpRSRCBEKJo+tulaZXenXMHvM5uJCaomF83ug883k0RN+JGPKhhn+/PlrloSEaQyqmmrlkmhEgIR4pSx31/2987E/zXynl18p5ZEKCAK0LVdcc6yYqCMIAhSVJ6889v/VT5vfaw4L2lZ0+y9BZ9p6Uut09XPGeu0QfhU9+MUV5WHnGXFQFktC9D1m5Pes58NjhKVTtWuZZJORhCIkKZO+CGn+j3QCHOyNg1Ow6jVirt/mhgmrrAqIpFIJKJIAhHSHh9eKtnPbM7Gx5ofPnSoZkHxe/rGtWjMG2FOlpm+FtczfOI5JznLioGyl156qWZB8ZGTdWsWAvKSsiGupflU+3M0V/DHi11CSYIgVdFNW7VI0kkJhMjQnm8fcZSZys8T6NGXWkn0o9aay+xaKEADAAAAAAQwH3cLGGOMvcdebiNGSNT6leMMxhi7Ds1tKSEIaca45cdtJdeAjvMbn+umIxEZPvyb3BvXgKz14oFf13zy6tS7UxQEQqgGF82ccfVwnSjt2f3u+li7chz7ZzUTE2R43zf/tDAYY+w8/+2EdAlBhg9dVXW9p8Zr5D7+djdVSZefAChA13rF6X/mNhUR8vu+sfr7VfWz4jykpd/ZWxle09KXWu81/2as0wbhVe2P05uqykP6n7lNRafPXK1ZVPWfk2zOl/dqCELSZMLXp4tKPvJc+/3lPmEkImMmbS2q8DW3aIw5WYsGp4HUR07exOX/MjVVJG3+zJ5CDmOM2axP+4cQxN/HztdsObycvm+qcWPeKHOyLtczvOI3J68fjC+99m3NlsNHTtalWQjIS8qGuJbmVa1zjzOuHR1FEpK0MV9eX3NX1qbpreQEIe/y3o3fEvzfPllL+sil7d84dXOjQAEaAAAAACCAVXW3gL37nk6iEKEZ/6MbY+z+bUo0iai0p/4o21EBs1c/668iCGmfj66UXnfavxsuK/uYpP8XzWzmop4yUZMXDnnruF6V4ArWjNQShKL34ktlLpCLfnksnkLiNq+drKrjRg3XyHFofjs5FTFgwuAYSvgCdB1W3L52pJKg0mYd9HN/1NeK139a+p+9leAzLX2p9V7zc8Y6bRA+1eU4LVV1HtrXjlQSpy8YaxZXveckZ/iiv4wg9RN+vKXUTB95sYUIkbGP/+6pKpzGmJM1b3AaSH3kZJml5f00KUkka/vioevpQf8zt5kIUYlZthr28ebl9F2q5o1548zJOlzP8InnnMTXD8aXF/5as7j4yMk6NAsBeUnZENfSfKp97nn/ntNMRIiaPLuv7JAbrl1PJFJI3ObVEyVz1qCxYnM+6yenUp7ee+P3BXjLEQAAAABA0GJoBiGEOQ4hxGUfP2nhSP1dg7soyk5DxvTu20yEmYtnM9nrH8l7/2/T1q1bt27duuWLSU1F/n8fe2n9mkN03L2D24pvfIbzvxooI8RN5/zN3Jgsd8u0FgqSCuk8Z3e+32+Vce75cWchkvYY+2BymUtU9Z1j74uh6NNbf77I+p63Rmtk3/vSpPeOa4cv+uThpErHLfSPJ3vX0qdGdG8aE6qQShXa2GY9H5j95aG8mr+BpvYrzl69kOXFotQmKX7txHpa8WrVIi1rkL0V8ZqWvtR6r/k3Y502SGUCIF1LVZOHJVlNiCU1Dq0KtchJ5tJ/F2ksatKulbLsVFR8UjyFcFFhUVU51BhzssYNTnUCKCdvwgXb5jy5ytDi2U/ndSpJD5x3+O9MhtT20arrtdms5em7RC0a88aZk3W4nqlMkOQkKj0YSV14jUOrQq1ysg7NQkBeUjbEtXRlhM89+vDa9ecZUftJU7uWPenJer/7T+bli1ueSKMQqlljRUYPGNyRurJ+zZ+e65/Uy6kDAAAAAAA0PMdfW3YYWUQlpSVTCCFZ86Eznu4Wc2/Lchd4rNmQxyFCE6IufbUNFdN+QAxCCCHu4n9vV/XCm1txub/9cpTRjOxd5mah4kSGrTPvGfPFWUnH5zdve6tPmL+LZy4eP12MqfT27cJvmUXcumNrMZFz7sQZD2qi8DGz/2uEC7Y//+iSsxGj1340Ju7sQT+Dq8BzcsmQu5/daeZEIXHpzVrLPOasC3+u/+DPn7df/O3gOz2U1S/hhjqsOJN1IYuh9Gn63M3vv/PTP2ezC8X6jI79Rz8yunustNy09bTi1atdWvqfvRXwmpa+1Hqv+TtjHTZIRYGRrgghf/KwJKspaT3eqNYqJ8Vd3jlZ9DqipIpb+mwVHf7rNEOIW7eqqtzQOHOyRg1OdQIoJ8vAhb/Pf3rVtdQnv57XWV76mcftxQgRFFHXPVRWrU/fqJaNeSPNydpfz1QUPDmJSg9GZVhNoqpGLXOy9s1CgF5S8n8tXVEg5B6X89ehqyyV0L1H8q0/apHKiIQyEdSksSJje/RMJ/7cvu1f+s6uYoQQDMEBAAAAABDAKn1eknGYLx1a//K98WICEbKOb52q4pk/Jvvr4XoSUalP73VV/C974f2uYr8fG7RvGB1CSLp+cLHss76cZcW9UiRq8sIhGmPW8POTdygIMqTz3N2Wmg1S6/n5kTASSe/65Fq5+Tw7pkWTSNJzUZY/Yw5UvUacadOEBIpKemRLHoexd/eT8bUbiaJ40zgdQUiaTP4h01kaZu6O2e3lBKl7+KdKNnQVar/ibNainhJESJUK0S33GYS61WPrMm99xVA9rXhpaPymZc0m4zUtfan1Xqtbnvu53coJjHTF2K88vJ7VZ86cqVFc/OYkZ8v69699OzateGNihzCSULZ57vf8qhKpceZkDRqcagVOTpbl/ufF1hIqeuz6sm/Nws5fJkeRSNTkqr2GO4qfnKxlY944c/IWNbueqSCYcrL0YHz19ddqFBcPOVmHZiEYLilvqM9r6QoCIvc8O6fFkEhy58eZl397f9JdLWJC5DJVRFqXkc9/ddhS7bbytX2KN4zWEJJuC67vZBiCAwAAAAAg4DEnXm0jJm4QKfWpnUe++ks2I0m478OvnmnhoyseLjz25aQBj2/OIxPHvvdCD1nlU/mNzTp11onkKWmxlV9CsqZfnr7nwY9PizvP+XHbmzXtPMUU250YEUq1stx8hFKpJBB2FDvr+jgwd23Nk9O/zU1+7LMFg8Pr0lmFszL6XoOGTn/9pRHJpV2SJNF9xg9OpziHOc9Ro0Brv+JM1vlMBmFa1HTyioOXrW6v03x258eT2mocJ76cOOqdY94b8dbXipf7fl7T0t/s5Tctfan1Xqv97q714Rwg6epnHl7PakzUtEttydz85KR317xeXXv2Gz7pxZVHnBkTV2x8+05dFYnUSHPS7wanegGTk7cElbV8zuKTVOdnXxoWUXZJ8t6PjE8XsefNl6/UJKwb4dVrTta2MW+kOVmPgionSw9GlqzVEBz1mZO1bxaC55Kynq+lKwiM3MNFhYUY4bxNk7vd+/xX+3LI6NQEtevyofXvTerR+eG1V32PGlPV9pEmpydQ9NkTZ2mEEEJQgAYAAAAACHiERBuTVEZyclqz9neOmbf6n5ObHm9R2cUwazm8Ymbv5p2nfH0GZ4z94pfPR0TV+YaSvXYlhyUjovWVDTnJmrY/N+CBpSccSNnx4Sk9y1RnmEPPZ4iIKkg6vXOWRQhfvyb2ESfH1mzM24oRZq2YOnODJf2JL97pH1q3jUHGjfxw00+bFj4Qf+Nimim8+PvanVllY+R9xYmYe+d+uPjTjfv/+GRil0StVCyPaHLX9C9/XTEmlnQeWbxgm72+V7zc9/OVljXKXp7T0pda77XazFi3wzlA0tXPPLye1fHJSf6vYZm5+clJcftpn3+1/PNFbzx1f2vlxZVjO/aZv6fAd1Ggkeaknw2OPwIkJ29h//299/Y4okbNfSyj3H6Td3tp1Ss9dJzT7PcKllGfOVn7xryR5mQ9Cq6cvH4wjpn8aI1WsnTueszJ2jcLQXFJyce1dAWBkXu0281iRJ/8/VDE5G9Omguy/zt5Lteas/fdAVH0pW+nPb4yu5LxqKvdPlRktJ7EjpyrJaN3wxjQAAAAAAABj2r61LYjr7T278qNzfvri7kzX1p12MIq0we/+Pb7L4xooqqPK2bOUezERLRcXsnC2EurXv6E0CQlh1/J2vXq8+uGrRldehVKRnYdM3Wa2febVKjEtqEEolQqGUJOp8OJkabsN2Cnw4ERoVSV785RI8z5TybP/sXeYtbmN/qG1MvWsJ3a+u0POw4d/+9CZlbW5WxzMY0xQuhmv03eV1zcZPATTSp8SuiHTB+VtObDy3/+cZwe1oOo7xUvEz8PaVnz7OU3LT0/TYga+o3tRq1R0u2DM/ueSyVrvddqOmM9Hc6Cp6vfB2DlWe0vnppKMqHX2Id7IYTQUy889eXwTlO3vjP13cGn3u1c+dCljTQn/WpwqhjMtRzBc/LWaK6ufu+bq0SzeU/eU0l+qjv/b/vfhbZaNaD1l5N1OYs10pysZ8GTk4HTTta+WQj0S0rerqUrJXzuiaRSikCEpPP8NUvHlb7jQBTZY/bKt/9s8siWncvXZT3yXOrNLsx+bh+5Qk4grvj/7N13XBPnGwDw9+6yIYGEhL0hgIIDB27rHmjdu247tLVa21rrrFpra5d1dfy0dVatG7d171U3LhBwICEQSCAhIePufn+gCAgSIOECPN8//Hw83rz33N2Ty+XJe+9pdRRCBBSgAQAAAABqETr7/HfDh351NI2Wxby78vuv3mvvw7FZ5xibw0bIbDaXtmIaE7edt2/PhOT3mozdvXPGrANd/+xdcMckHth/war+5fZu8fH3JdB9RWoaiTyLXqMaFGlqGuP6+LlX5d497cV/z2sQx+Xo513PFAad+1hJIcv1n/q22cRhRUzc+OeYQKvWQedcXNyv3/zTmbQwoFnb1q37dx8VIo9sLDnzYd8l9wtbMbbhrMDQQBZKVmerKYT0Vmz4ybVj7PqtwMq0rFz22jktfdsMGUm/umOVJa8vxBBCRGWPWkVeaKO3s0Okq03fgDZQ/r6lLCYLiXA2h1UsJlbQOx/0+vLg+sdX/lNSLXxLjbcW52Rpip1wrOMQOVmsj9t//nZaz2k5YXxZz0PjB7vwS/+LrZSbk1V5E9WxnKyEGpiT9leFz6DyTwuOfElp12vp19fmELlHiN3EGDKGdesRWuyCEJO91akhe+/5hLsPLSikYDdUYP+YzRaEMA6HgyEEI6ABAAAAAGoP/bXFvWPnXjIG9v1x0/+mtpaVdl88WiFwAAAgAElEQVRjFeBSDylOabI1pXydwL1Hro2b10aCtfxx4aaTHx3d+On8ke1XdBJZ3zsrpGF9Jyw+5cZtDV304d3m+BvxZpoV2TCy6t/+Ke2TG5dem8YzJ+X6pRTEtvQxWDnRHnlv5ccLT2e59111eP3EBoVDTMj465UZHFPZDac18f8evZsrrN+le4PiN2NTOWoNhXCZh+zl14xyNtzWk2kWZ2VaVjZ77ZyW0R/8seGDUpZXNl2tf6Gt3s6Oka4IIWvegIVZPaBHAxufv4qyYt9ars1p2HpJSvMf750rOugLIcRycuZjKNegL/OEUStzsiInnPI4UE4WMF3e8Pc9C7f90IGlVW9JvTpLayakMjfCbuMfrX6/V/JTrFbmpC3VqJwsfDP27t6gtPHDNmJFTlbltOC4l5R2vpYuyUFyjxUeGc7G0i2v/yJAURRCiMN9ORq7IvuH0mRrKIwldZfgCMEc0AAAAAAAtQX5YOXkby7ppL1/Pb79U3tcMbOCw4JZtPrZs9zXv+LiQi8vEYYQIoInLJ3dSkA++t8n317SI2T9vHXOHWLfckaGszv2pRfp33hl174nJEveo2fJORArRjxmX37Jp3abTk72IxCn48pnJE2brs6sZ+UaDHeu3zMjUdd3xzcoeoOj4dkTZWUm7KvkhmOsxI0TRwzt9+4fDyzF/mB5GLc33oLL2nVsyLZuw+05vMrKtKx89to5LctS6XS18oW2ezs7Rrpa+QYszGq10X4/i1i1b4nQRpECzHzn+Kn04pFYHp67oCRx14h63mUdlVqZk1aecKziGDn5iuniP7seU5wW/fuUOqRdf+jDMC9Pv8TMCjxmsYKsysmqfIrVypy0pRqVk4Vvxv9UVt91UGFW5WRVTguOeklp92vpkhwk9zDP7r2acchH+/fcNBZdTj09fOCmGeM3adGAjVBF9w+Z+iSVJPzCQgUIIRgBDQAAAABQS1hu/b3hPwMR+fnC0UH2ucTDpE2bhxAn7t++b0Htyq40sOt/vHz6ljYLbiyb8vOwc3Masaybtw5h0gFTR88/sOrw/E82td84KoSDEJ11dv60Px5Rom5T329cuFHmx6d3nk+lWAHtBrf1s8NwioL+ScKvzaD2gaXtSo67pwSjlZcOnc2O7VLwbBxD8sGfPp60XkEhjsX0YviIlRP2VXrDnbuMHxH8z6qri96ZFrbtuwGhTgghKvfe1i+GL7piErT4ZFpXgU33S6VYmZZVyF47p2XZq61kulr3Qut3SE1JVyu9zOrM50ppsKe1r6oQ6/YtJo4dO8Brz/p/5773c+S6qS1lLIQQnZe0Z/a4H25aWPKREzo5lfnaWpmT1p9walpOWuKPHn9Oshp27eRTaqI6dxnRz3Pbeu3zx8g9rOz9XwU1/uO77NXaNSetV8ty8uWb8fSOQ+0m9argvrCOlTlZhesQB72ktPmbscbkHh405ssRS/ut+3HEaM+Nv37Ywg1HSJ+4c9bI2Sf1eOAHUwa4Y6iiJytKee9eJu3cPqb+i7Ylf0IDAAAAAACOw3jkPQ8csRp+ddP85oaU4veuXIQwFs+5VK6tFsdbXnsVmfhDKzYi5NMvldN9gfwTH/kR7JbfJxTpiVL91ZOLWOEzLhfpQnf28/psDHNu//MDqzp+2Vf2ic8aOWEY7hTYMrbf229FSFgYxvIdsDapaC85G/vwEMIEQ3e8NhqsYltUbOxYyf4Rr++m3DJeaLz5XWsRhjCWW0S72L69OzULlXJxl+jRw2P4GMbxbz/66wPPyTJeW6pKbjiVc+mbt9xwDGFskW+9JjFNIzwFOIYwftiov5PesP1lbLj1bJ2Wlcvel+ydlmVuXGXTtfwXVmCH1Jx0fU3peViQ1Xfv3q1ISHY5VVLK/ZPqCTCEYTxpaOMWLZtH+gpZGMIIj87fX9W+cSW1MCdp6084NSwnLQnft2Qjwv/jU6ayuidTt48KvnL5ckVCsvvHN03TFTmZ186cLOpNn/61LicL3ozz5s2tSEj2OU9W8jqEdsxLSttfS9ek3KOyjn/W2AlDGMYVB0Y1Cvd0IjCEEbIOiy/mUgUtKrZ/cncOd8WdYv9SFryahik4AAAAAABqA/L50+ckQrQlX1c6vekN98laiduyf29v6tbRE8pybo93ajPnl3eDiLxzX3/y12PrbxHFxB1/OHN+/fT+Ufij04eO3dL6dHrv538v/zM22LFu2+M0+mL/8T8+7hnJV1w5duTsQ1Nw/0UHbpxf++uS6R38OOmXD55N1ldoAoFKbjgmajHr6O2Tqz4dGONFKu7fvKdkhXQcvWDrlSvrRzjGLrMyLauWvfZOy7JUOl3Lf6FN386Okq7W9i5qMevo7UBPiQ36Ko31+xZz77Xq0qUt88d0DnPKTb51PT6V9G01+PPfT984NL2Z8xtXUgtzEtnyhONIOUlnnDh604JxGzVrUGZb3GfQX+cjAtwrElIF1IqP77LYNydtp4blZMGbcVyv1hUJqQIqcJ6s/GnBES8pq+XNWILj5B4m6fTDmctb5gxrE8DJfvQg1SyL7v3x8qPXDs9sKSy406Fi+8dw6d8zWkH7AT1kL+6TwGjavg8dAQAAAAAAtYf58pcN2q7wX5lw+IPSb1auJfK2DvTfNezZtsEOMIsFKFddScuyQLo6HshJyElHAzkJOelo6kpO1tHc0x+dGB67o83mhC2DC6YWgYcQAgAAAAAA67GbT5raAT+zbvMjm48BcSRk2jOlT2gQh+k4gHXqSFqWBdLVAUFOQk46GshJyElHU0dysm7mHq0+tHanMnTCtD6SwnnioQANAAAAAACshweMmT8x+MbvK87kMR2KvRiv/T5m5Hrp1AnRDjGLBbBCHUjLskC6OijISchJRwM5CTnpaOpATtbV3COT1v2yF+83b1oM99XCOl2Avr2gMRvjdfsj3RazkBj3jnLBCb/JJwueUUlWsHMr25dYi22RCUtacDBum5+Sqj7VU/mo5KVtuRi33S/lTOJTIqqK7thKq7YVlcqoSU97nqbMMdl7Rcxu5pvQ6TtHBviO2JFp/8DozIubVm44l15O3letWf7V2Y2k7X+6a/dDCgAA1UDQeubPY7FNX69NqqUjVgiPmA/WntoxIYRgOhJgvVqflmWBdHVYkJOQk44GchJy0tHU+pysm7lHqw8t/uVBu4XfDfHEiiyu0wVoAF4xPb9x8vjJq0/0TAeCEEKm87Oa+fn6t/n6P1v/0uBQm/kGtCrui6l7/D9d0F+Gld+6aqinW2e+N23R3idvrixXsRmv2Wdf9Uhc+NFvCbX0kxUAULdgku7f71r3jldOrqP9fmkbLN8m7epL69ZQlVqgtqdlWSBdHRfkJHA0kJPA0dT2nKybuWdWsdst3v3ne8HFy+51bTcU49dn/v98NV5tXexQ4cIr2HlF29dZ9tpRdNa+6T0nnWmw+NalmfUIO66IWTVlM42Xf5j1Dzlw+4RQu/9OSKtP/fzbBSMdaO9mmOTtz98PbLF43s4RW4bYv6wOAAB2hoka9p3QkOkoACgG0hI4GshJ4GggJ4GjgZysfTjy7uPkry+u0wVocXS/cdF26hurYOcVbV9nVduOYvSIYDw+D3vxr53X5IiJRyt3fL8m0X/s6u72K4tTmqTLl/+7efnkrvUbjyeb6TIK3TZtxm447t3WP0z//n/3BsyOrNPnXgAAAAAAAAAAANQdUAQpi8VkRGwuC8YploW2mCw4hw2TuLxJZbOIVa9xJBfLjGwot+4dSmpz851FTjbPVmbeBdTjrX8cyg2ZOrTodPXFVT0w/aHpnUbszq/eZrj/gGFtZ3z015qLny9tV+bGAQAAAAAAAAAAANQidbp8eO+bZpxXj1+jUld14uJOw3ZoHu34tHOQRMDnsLhCr3qdxv90Ms1S/JX6xL2Lx3aK9HEV8F286nUY8+3Bx/nFJ6whi3SuP/K+D4GxI2dfK9GN4ehE34I/mMniwVi5FsvVmfXYGL/f39pii03/vu9JENLxh4o+78z47MTKqQPaRHiLBVyuwNWnXrvB09dczqzA8wap5KVtubh4dFzaxV9GNfMW8bgsjrMspMWA6X/9l1VkXtuKRIUQonJurvusT9NANye+szSo6dsfrzqjKHvm49J2FKW+uWnWsHYRXi58votXRLthszbeUJfYsDdtvm7LAD7uPem4EZn/m1WfhXE7rHhKlbYiOvfutgWjOzfwlTjxBGKf+m8Nm7n+P1XRKX2tzyJae2/HwjGdG/iJBRyuk1tgk9iJv5x4/mLDMVF0szBevaaNBKUfiSfL2nNx0cg4oylp5+fdI9ycA6ecNNliMyvyLqCyrq75pHe0v1ggcPVr3PvzLfdz73wdzSF8Pzzx6hC/cTPLOMRJO7ZeNvv27B3NrsyOtRL/rdm79+/fv3///r3/Gx9RZp3fts0Q7tWjd3PiyY6t542ViBkAAAAAAAAAAACgBqLrsLuLmrIRt+vvCoqmaZp8trIjB+N1HDcqlI1x3UJjunTv2NhHgCGE8aK+OKt7+SpKc+6r1mIcIYSxhD7h4T7OBIYRnl3fbinAcN+PTphomqZpS9HODccm+RGIFTnnmrno+vMOveuFY5zmi+9bire3ei3mK19GsBCv76bcYhtmPPKeB467jTtofLkk//ayru4EhjC2i1/9Js2bRAaIORhCGL/BjFdbZnn4XQwbcVr/+IgsdX+RST+34WCCJh1buuIIw/nuoRFBEi6GIYRx5WO2P335KuuiIpN+bsNB7IaDRjRxxjBc4CGvFyjmYBhCGNuv35qHptKjKrmjaMvTHePCeRjCCJFfVNPoCC9nAkMYN3zC7ueFm1HO5htvrJv5+cSuAQQiPNuN/+zzL389p6ZeWxGp2PdhAycMIYzrFtK4WZNwDz6OIYwTPGzjo8Ljam0W5Z6b3VSIIQwXuMsbNWtSz9uZwBDGDhofl1GwOtODvb/uTyiWL0WOxONf2nEw4fDft44L4nBl9dr0GL7sP7MtNtPa+GkyLe69CB6GMJzvHta4caiUi+GSmH6d/AncZ9Lxl4lX7maWtnFPV3bk4uJ3duuKLbU2sIojE39oxUaEfPqlMna3TZuZr82OZBEhn10wlfpnAAAAAAAAAAAAgFoGCtDFS28IIYwbMeGfR/qCJvqE1f09cYS7jdlvKFiiPT45hIVhvPBRf97IttA0TZszr6zo78/CEEJlFKDp/JMfBxCI1WDujSJFKd2B8Z44xu+w4jH5Wl3VyrVYW4DW7X5HgmGc8He3J+tftkk7Or0pH8MlY/a92DLrCtAIIYTLOi04lppP0zRN6VMOzGwrwREu7bs+laxAVK96c+/6zak0I03TNJWXvH9GGwmOMGGHZYmW0qIqWTBN+V9PMY7xIsZsvK8tWKK+sbKfD4ERfu8dyrF+86m03zpzEbvZ4nsWupQjSFOKLYPdcYR7dPvmtKJg75NZV1f092dhmKjTipe7zLosIp+s6MjDcEmnby9lFayO1Fz+up0Iw8re+8WOxONf2nEwtruXX/RHe1JeHj9bbKaV7wJKuW2YJ45xI8ZtTsijaJqmTamHp7cQYQihVwXoym2mducwF4zTqkQDKwOrjOotQNO6ncNEGKf1T48qHzEAAAAAAAAAAABAzVGnp+AoFRH0/m/Lh4TwC/7Hl4/5bEQgQenSFVoaIUSr9qzYkEyyG8/Ysnp8YzGBEEIsafPJ61ZP8C/j8WQIIcRtPWRAAGG5H7fnbuFsAboT2/Zn0M6dxwz2L3kUKrmWMlFqi3v7Xn0//HregKAXG4Y4Xh1G9pYTVF5GZh79xleXhLv1+WnT3M4+XIQQwviBsYv++bm3BGUdWrkxgSzvxa/3Jhu4bNPMt7w4CCGECYJ6Lf7n594STHvuj7U3y59ZwXJj9S9H1XjYR2t+GxnhjCGEEO7aeNLKOR15VNrhA9fNCNlm88lHm5bvzUSyQcs2zmzvWTA1BC5p9tHa38f64rlnfv3zerFg35xFiEx6kGimWY0GjmouKTiguEvzj5b8NG/2jL5hmJWHgzZnC4es/KlvIK/g/7Y8yuXETyX/vXy3EguYsHL5cLkAQwghtk/3xas/b8wuOitzpTaTTIl/oEf84FCf0k5O5QRWE3CD5P6E+cHtB0wHAgAAAAAAAAAAAFAdoABdAu7etU/rohPv4i6uIhwhhGiEEDJdPXlOR7Nbjh3XqNgjxEQdxwwOekNtmNNiyMBgwnI/Lu7+ixpt7rFtB1RIEjumr/trT1Kr7FrK3CjfQT/v3rd76WC/wuNtyXl0/J9jKRUvGCPMpfvoAV5FY8a9B03oJcbMd06dU1W0DIhLYkf3KbYHcJ9BE3qJccuj8xfSypugmkw5cSLRwpIPGNaCX2Qx7jN264NHD0/PacZCyCabT2sunL5pwsQ9R75dLFjMpfM7fbwJS9K5c6lFgi0nixARHCHnYuazi8fO3nj2kdqMEEKYuNW7879e+MXbwdYeYdy9U89mrxLEhke5nPjp7DPHrpkwjx4D2joXacSq37dv/aLBV2ozyedPUklc5uVe2t/L27GWy1+EsbA34MR896ASSW9LhIeXO07npT5lNgwAAAAAAAAAAACA6lH207LqKFzqISu7Kk/npqVpKVxSr75XiUbs+g3rs1Fyma9kNxs8UL70u7t74u7PbhBFoJxj2w5lI89xY3qKX6s/V34tb0Bp4vf/vf3o5Vv3E5NTUh4/y9CZaRohxC33lSWwAiPkvBLLeBGRIQR9/fmTNBJ5VCiniKCI0JIh8CIiQwh0XZmmpNBro8OLIZ89fkYiIiQ8pMRKeW7+wW5FF1Rx8yllapqFJgLDXwuWFRIRQqC0tGdpJAp8GeybswghPGDCiuWXh3y6+fh3o48tIZw8I5q2bN2uc6/BQ3o1klm9/whPH88SVVobHeVy4idTHz8z04R/sH/xWImAkAAWuvOqm8psJpWn09OYF5//2vui/MAQ7tFq+AcTM8r+4YIIiH79DVfN+AI+hiidtvyWAAAAAAAAAAAAADUfFKBLwnHsDQUqHC+r/MUV8PE3VbZY0UMGRfy4KH5P3MOZUfW0/247rMYCPh7dycmmaylUbCQynXNxcb9+809n0sKAZm1bt+7ffVSIPLKx5MyHfZfct6a34koJACdwhBBJljO41Mrx0QW9sdjscluSFhIhjCDeOGjYFptfEHlpqVFwsEiKKr7wTVmEEOJHTth4q/+sE3F7Dp84e/7i5ct71pzZvebb2Y0mrt+/om+ps0+8rvgesuVRLid+0mJBqJTd8dqrKrGZGJvDRshsNlcmMDyw/4JV/d/QwBGYzRaEMA6H6TgAADXDiRMnLl26VD3rIkmSoigWi4WV8yHmWGiatlgsOI6XczngeCwWC03TbCuud6rOaDRyOJzZs2dXvatz586dOXOm6v1YA3KymlVzTiKEFixYUPWurly5cuzYsar3Yw2KokiSJAii7O9rDspsNmMYxmLVsK//1ZmTJpPJYrHMnz+/6nvp1q1bBw4csElU5YKcrGbV+cFUkJMzZ850ciqtbFQR9+/f3717t02iKhfkZDWrzpw0m81ms3natGlubm7lt35NDduzTMOEvr5inMp+cD+d6lJscC6VmvLU8sb6KqvhkMGRS766vScuYYbnrX+OaPCID0e3Lm1oalXWghBCyJidnUejwmHK5L2VHy88neXed9Xh9RMbiF7mJBl/vTLpaXny4FE+iip2BjQl3EsmEe7p4/mGM0yJqF4EkfLgkRFFFJ1VAZke3ksiMbZfoE95F+2El68ngbKeJD8hUYMijenc+INx17IlTfrENnChbLD5uIePFwu7+SQh2YTqFZ3tA5EpickkIrxeG4xcPpakXrdx9bqNm4kQrU+7tn/555N/OP37R4v6d/+tS8kx5uWz7VF+I9zD2xNHD5+lPCVRaJHNJlOfpL7+E0QFNxOXekhxSpOtKW/+lZqK0mRrKIwldWc6EABAzRAfH08QRNOmTathXfn5+WazWSAQ1KyqGUmSer2ezWbzeBX/9GRUXl4eRVFCodCuazEajWq1mqbp9evX26QAff/+fYvF0rp166p3VS6j0WgymWpoTrJYLD6fX35rR1KQk87Oznb9EmsymdRqNUVRf/31l006fPTokU6n69Spk016e7OCnOTz+TWrQkFRVF5eXk3MSb1eT5KkvXPSbDZnZ2eTJLl27VqatsGjZR4/fpydnd2jR4+qd1Uuk8lkNBp5PF71lOlthaZpnU5HEIRAICi/tSMxGAwWi8XJycmu1VWz2azRaEwm05YtWyyW8p+NVa7nz5+npaX169ev6l2Vy2w25+fn17icRAhptVocx6te7q9mBTlp74sli8WiVqtNJtPOnTvz8/Mr10lN+uB0BOwmHdqIVu+6uG7dnQ/mNXo1htF0Z/OWa6WP2SxE1B80uOGiObd277nsc/VYDjt6xshGpe//Cq6F1ml1NBK+/EymNScOnjcUKfUa7ly/Z0airu+Of1WXRAgZnj1RVmI6XFpzeOOe9L7veBZ2Rafv+nOfimJFtW9bpABdXlQFqOxDG/dl9Br6amZlWrHzz71ZNKdVl/Zu5V1mEGHt23kTt+7u3H77ywbRhTuKVsXNGTFmL91/89u9Gthk8zFxq/YN2QevHvr7gCp2kPRVN9pTf+95RrJC2rULtP7zh4z/qWf/lcn+E3cemVGQApjAu9mQhXNPbjz7uyrlsZZGvApfYdn2KL8R7tW+Q332qTuH91zQd+pQeMVAJsbF3Sny4Vi5zWQFhwWz6DPPnuXSSFrRvWC5/EX9Nj8klr3B7Obf3r74ZQSTX2LJ1CepJOEXFspgDACAmqV+/fpdunSphhXpdLr8/HxXV9eaVVgxm805OTk8Hs/Z2bn81o5ErVaTJCmVSu3Uv9lsViqVubm5zZs3l8lkGzZssFXP4eHh1ZOTeXl5BoPBxcWlZn2JtVgsGo2Gy+Xa+9cFm9NoNBaLxc3NzU7FPovFkpGRodFomjVrZtucDA0NrZ6c1Ov1er1eJBJxatTdbCRJqtVqDocjEomYjqVicnJyzGazRCKxU7GPJMmMjAy1Wt24cWMPD4+tW7faqufAwMDqyUmDwZCXlycUCrncCk+uySCaprOysthstouLC9OxVExubq7JZBKLxXYq9pEkqVKpsrKyCnJy3759turZz8+venIyPz9fp9M5OzvXuJEBKpWKxWK5uroyHUjFaLVao9Fovwt4iqJUKpVKpWrYsKGHh8eJEycqfZFQw4bEMw5z6/PRqGDCfOO7ERM3xOdSCCFE6x5s+Wjkkhvm0uamKIoIHzQ4mmO5uW7yD//m8tqMGR5WxinL6rXgMk8Zjkzn/1h6JvvFgNG8++smTtuiLDp8lOPuKcFo7aVDZ7Nf/p5rSD64aOjE9QoKIYupnMJ5SVTWnk9HfXsmveBlxmf/fjXskz0q5Npl8rgGLOujetlb5s5PxvxwPqOgcJn/9PCcoZ/EZSHPAZ+MDCk/OzltJ34UI7Dc+Wns1B1JBoQQQrT27p8fzdmvxWS9h3d1qeDm08Z8Y6m/eRPykZN7uaGMbVPG/HQxs6DASWlu/D7h/T+fUMK2k99rVoG3OuEf7K5+mnR61Tfr7+lerI7KubNx9SElxQpo1MC1Mu9mm2ymtRsQ+e5nb8volDWTP9312IgQQsiSfvKrd7//r+BBgy9aVWozMWnT5iGE5f7t+5X4obdgDug3eH8A03NAU8p79zJp5yYx9RkNAwAAQG1W8MU+MTERIRQWFubu7l6zprAAtU9BTiYkJJjNZrlcDjkJGEfTdHZ2dkJCgslkCg0N9fLyqnHTBYDaR6PRJCYmGgyGkJAQyEngCHJychITE/Py8oKDg729vav4u0tNGuHiGJw6LFz75ZW3F19eO6bhpqn+4X4sRUJytlna5dP3clasSXvjawn5wCHN5l29cDMeE749ZtAbHrBn5Vpw/4Hv9/72/K6bP3YN39cqJpSbef/arWSNILJBwIN43ctWnLbvf9xy08wLv/YMO96qRbhL/vMHt+8km+uPHNR8+9arpxcPHZs549tZsd7W7QBWSMeOxLk5HXy/9QoLds5KfJRpoBAnePivv40PwCsQFUIIIcxZHumeemRGO59F3mGBgsxHSSoDhZwaTv5z6UB3a65KifpT1y672G3Snt+H1PsnMCpcZlEkPHiqsbCDRiz/rr8bZv3mCyUSDkbeXTX67bv1m45d/nXP4ivCvUesXHP24YjVB79oG/BTRIMAdsbD+080JsQNHvrrmkmhFXobinrNmNnu4Bent7/X8NBXEfUDRWRWyoMEZR7Nqz9p6WcxlRrjY5vNtBLu/c6vay8lDP71j0Ghf3tFhLlpkx6kWhp+8nHXVcuOc3lcrAqbyYrq0tFryf8uX3pMtpNX8OxWA+aAzrt64aZF0Lpr2xp2Xw8AwLEYdOW3qThnAjk78ZA5H1Xwp2lrnYuzR69shOw1hLhAbradOhbbp1uts1ThLidIc2D9RtV3a/OFvfbo1Qkh+35eSjzt0SvL3jl556KdOrbToC+dk0ThEYbRVEC9htV3a3Nulj16FSAk4GAoX4sqef9xecxGe/RKICTFEDKbUJZdPj7Qx4Ps0i1CdhocmxcQrug2jCZYfk1a1Li7Z0rg8/k1bmYVhBCGYfa7Aciu7HQbgcFgSEtLI0nSy8urxo0KL4HH49W4sc8FamhOCoVCe9xxZTAYFAqF2Wz28PCw1ahw+EWlwjDXdl8fv7Lj69Ed6klpZWJyjmuToV/turh7cv3y73nBgwcMacnBEC7pNbrvGwusVq4F9x254eSWmQOa+ZCPzx86cPRqcp5n94W7Nr1fbPQwp9EX+4//8XHPSL7iyrEjZx+agvsvOnDj/Npfl0zv4MdJv3zwbLLe6gGxmHvsijOnfvuoWwiuSHyiE/g37fvJH6cvbRgeWFgstC4qhBDCXLosvXhp0+yhLb0tqYlPDQilQUMAACAASURBVMKQ1kNn/33x7LKeHtYOiuCET9h25dRvn/SNFmsTrt9M0kka9/nk91OX1g/1Jyqy+cLes5YMi/Y0PTx28OQ9VSkzbePefX8/f2nzvBHtg/C0OzceZvOC2gyZsfbc5U0jQyr6Qw6nwaf7z/8zf1TH+mJ9yo3L/93P5Mo7j1mw9fKFlbFWFd5L69M2m2klzCN2+alT//t0YNsA6ulDBS963MoT/85szEIIcxY6Y1XZTG7L/r29qVtHTyhtMAGbozFc+veMVtB+QA8ZjPoBAABgY0aO4LFvw+ceYdKsJyFPr9W4iTVB7WPiCJ74NXrmEyXRPA9JuVLjJtYEtY9ZKE59e/zTgZNc7lwKXb2gplefQS1gsVhSU1NTUlKEQqFcLq/p1WdQC5AkqVAoUlJSnJ2d5XK5DeckwWwyyz5wBGRexlMlKQvwcrbTDLdU8tL29T690vSHe+c+D7X2pwu7RwUYYNFlZuSY2S4esqKH1XJjbuOYb5J6rkvbO7pKo7rMl79s0HaF/8qEwx/41K7fyPRHJ4bH7mizOWHLYAlUoAEA1li+fHlQUNDbb79dbKl9RkDbnX1GQNud3UZA2xCJs1RuAVmuPuIchUdWCk5aEEJo4MdF23Tt2vXo0aNVX9fq1atFItHQoUOLLbXPCGi7s88IaLuz2whoG6JwQuUWoJL4u+YqPTKTCIsJIYQGTy3axlY5uXnz5vz8/PHjxxdbap8R0HZnnxHQdme3EdA2RLE5qpbdVS27ix5c9zy+naXXIoTQ5gtF28TGxsbFxVV90vm4uLhnz55Nnjy5iv2A2q1gHhilUikUCj09PUtNvEGDBv35559Vr0ofO3bs2rVrM2bMqGI/oHYryMmMjAyBQODl5VXq0w7GjBnz7bffentbOYVCMTAFR+1BOLkHBTMdxGscMypQJbR6+9jQCYddxu9PWtOzcHSV+d7e/Qkku1n71lW9K4ndfNLUDqumrdv86N3pZU2UXhPR6kNrdypDJ0zrA9VnAAAANoJhGpFHuiyUZ9SFPL3GNeYxHRAAKEfonu4h55gMwY//4xlr5g9moHbRyhspug0j8nKDNv/Mf57MdDgAIK1Wq1AoCIIIDAyEO5aAI9DpdAqFAiHk5+dnp7tDoAANAKggTNrznVi3w7v+/mxiC9HCwU19+Yanl7ct/PD7W6S0/4cjgqtcM8YDxsyfuKLz7yvOfLiiY625V5NMWvfLXrzf6mkxNekJ1QAAAByXgS9Kk4WSBNsn/b5QVzPHe4LaxcATKjzDzWyeR0aSa46C6XAAQPkefopuw4yuMs9Tu13jLyG4/xswzWg0pqen6/V6d3d3iUQCT2QFjDOZTEqlUqfT2TsnoQANAKgozHPYyo03no9cuun9thvff7mQ7dF+5qbfRnjbYtYMQeuZP4/dPfzrtZ+0nxxSKwZB0+pDi3950G7h+iGecIkBAACgiiwsbrosONdZJlU/k2U9wWiK6YhAXUcS7AxpkNrVW5r9VKp6jENOAqaRPEFGuz7q6HbiG2cD/lmBm+z04EgArEWSpEqlysrKEovFvr6+BFErvueCmoyiKJVKpVKpRCKRXC5nsexbIoYCNLAaJu0w9adflO7t4PlpAPfs8cPZhLFHd+8/fy9Ni5xkQY3ax8a2CxbaKjcwSffvd63bnpiTSyNxbUg4s4rdbvHu7sOrPj4cAABAXUZjeLart9ItSKhXy1Musy01c8ZYUIvQGJYt9s2QBQv0mtDkSxwzlPkA0zBcE9UivfNgflpy6P++4mhUTAcEANJoNOnp6TweLyQkhMuFW2IB83JyctLT0zkcTnBwMI/Hq4Y1QgEaWA0TRQ+eHM10FMBhsCSRPSdE9rRX95ioYd8JDe3Ve7XjyLuPkzMdBAAAgJpN6yxVuIcSpCXw+W2BIYfpcABAOoFY4RmG0bT/s1tOeg3T4QCA8gLCFV2H0iy2z76/hEnxTIcDADIYDAqFwmKxeHl5Vf1xggBUXUFOms1mDw8PV1fXalsvFKABAAAAAABwaEY2P91DrueJ3LMeu2mewzSmgHEmjkDpHqITiN1VKZLsZ7XhfjVQw5mFYmWH/tqwRtLzB6VXj2OkhemIQF1nsVgyMjI0Go1UKpXJZDDdM2AcSZIZGRlqtdrNzU0mk+G4LSZQtRoUoAEAAAAAAHBQJM5SuQVkufqIcxS+aXcJimQ6IlDXUTihcgtQuQWIcjPkSRdZpJnpiEBdR7HYWc06ZbbtJXp4U/77XFZeLtMRgbqOpuns7OyMjAxnZ2e5XM5ms5mOCNR1NE2r1WqlUikQCEJDQzkcTvXHAAVoAAAAAAAAHJHGxTNdFsIz5oU8vcY15jEdDgAoR+ie7iHnmA3BKVd5Rh3T4QCAtPJGim7DiDxt4OalgrQUpsMBAOl0OoVCgeN4QECAQCBgOhwAUF5enkKhoGnaz8/P2dmZqTCgAA0AAAAAUIfp9w4PGrlVW3xKB273tcnbxzrWU2DJ1OuH5m45cyQxM4vkePrJ+/TqPz82xO1VjHRuysVvNx3+52aqwsLzC2kwdtjgz2KkDvSgH1q7+49VU5813rOwRxMCIYTI50dbfbrvamljmgnvntt2zYlis72UCS7azGqOtHqRqVfj5m44fuRhRpaF4xkQ0afv0Pl9wtxw6xswRv/k9I+rtmy5lPg4x+zkHvpWj2ELJnWNEhQmpSX1wpa5/9t/5G5aloXrGdSwz9AJ8wdHOkLkL9Da3f/7dWpq4z3zuzd59ZxkWpd689sd5/Ynpifnsfx8/Lp07Dqvc4ATX6jwCDNz+B4ZSa45CgajZgKtexD37ZI/9//3MFnD9Qtv1GXktHmjm0od51CWZLyw7OPlvCmbPogq4wt/uQ2qlS4n69v49P1Z+mQT7ufi1CXId16IsxQrp4FQ6qnoOjRf5uN5ardr/CWYmwgwzmQyKRQKvV7v7u4ukUhgzg3AOLPZrFQqtVqtI+SkI3zcAAAAAAAAZpBpKY/zcY8mPTqG8F8tZTcKYjvUtyY66+r6jl+dfCoKGdijl5yde+3ChV+Xf3M+c/a5sSEFg4t093d3m7X7KvLu+VbXoTzNhfNX5nz1IP7Lrza9JXGMGhGdem77h8fTMj3rFU5YgPE9u7VpElK8AE0j7cUrjzK9G/rps+WaJxhFVXuo1YnOuvRHxxn/PnUJG9i7v5ytuXb2zK8/zjmfuejce2ECqxowxpyyc+DIH4/opK179B3kZUm6fGLnn1+duKE89deoRhyEEJ115seOH+15Ko4cOGCUnJN97cSRXxd8eF7567kpkY4xIo5OPbfjwxOKojmJEDI9O/32vLgzlKxbq5heQtOD2zd/W73yWO4362Y2DVCnyp7dxOvePDCme7+93XP+GUtwtwHDekkMD07E/fZJ31NJ28993UrEdGylorOOrfzjyJnY0WWdPsptUJ1MOYq3jz0+Q/O7+bv34pAP0rN+u3r3lLbeuWiRqOwGx9wmr5sx1u/GWf/d/8ONBoa3AdR5FEWpVCqVSiUWi319fQmCKP81ANhTYU6KRCK5XM5iMV/+ZT4CAAAAAADAFPJJ8mPKqfOMtX+/zS+/NVOojHV/n00WNlu38uNRBWMO32k3/eNFP+3Zv2fglBFCDFHPV6zadxWP+vnnaVMDOAghakSHL2Z8/8uaveNbjO3CYzh8hBCpvPjBX7eUCCtaDcclDRZNaVD4XxrDsl29b5xe+u8NzuzRAc2z68C95FT6unUnkkUt1635YpQ7jhBC4zpNnzDrp+279gydMUKEld+AKbQ2buUf/+Z4jVuxZnVHCY4QosYf+3Zi7N9r5xyI3dvfDSOfr/v9QLJLh3XbFo/yxBFC6MPY6YMn/bRx454x345wYf4HHlJ56YN1t0vkJELGg3uOnsn3+HzBp0vCODTCsicN+2H2jO93b73cRRgjMjIULLN0B39ZdkYX9vmhf5fECBBCaM4HS/t2/mz1D39P2jHJ2zF+4XqBNGSl3r1xdtMv3/+TQXlUpkH1Iw/eSz1jFnzepcGSgtM75bX05J3PElP/Dq8/SfBaAwzX1ItdsmvrkhMnLy9/FpOfznD4ACCk0WjS09O5XG5wcDCP5wDXHKDO02q1aWlpHA7HoXLSoT4vAQAAAABAdaLVT56oMX95oGM/Hsfw6GySRRjddmDhHe+84H5N3XBj2t10CiFEPr++O5n07dRnYsCLZ6rgoojZQ6OdM69uvm1iKupXSOXK3+LOeDQfFlDmtbdOIH4U2DzbeHPZL1dD+/ae7m2pzgAZo084m2ARNusw0L3wyMr7tZDh+al3FZRVDZhCJp65oSUi+nzW/uUQe9y104QBrVn6s5fuGRFC+viz983CVj0Her6MnF+/X1sP3PD4bqoDjDollSt/33vGvfkw/+I5SeU+VOQjUUi3YE6ekyQpuEW2rNngBh4sc0piqp6hWJlGKh8+ykWyVt0avxy5zg7q0UXOMiXfT3asweC06p/+DVo3HzZj2aWsUpOs3AYMoM0PtSTiCbsV3qyC83p48VlU/n0dXaJBnn/Yo/FzMtsPHyh2ZpkTEp/WtalggMMxGAzJyclKpdLT0zMoKMhxKn2gzsrPz09JSUlLS/Pw8HC0nIQR0AAAAAAAdRb5OPkJyQ4PET85vftivEIv8GvcqVPzACfmh2cWQwS+//G7w3xDilxEk1qDkcbEMiGOECJVquckHuIlLVJHx4S+3n7YtesJSjLGj9FbYS234jbPTfaev6gz+du1ba8NITWy+ekecj1P5K66ffq75UdFbU/29mHg2eSMYAW///nkYf7hxY6s3kjjEpkIt6oBUyz5yMW/QfN6IUVyC+Py+BiymMwUQogV/v682cOCIotFnpdP41IZ88OfLbf2bpmb4j1/YSfyj2vbiv5Ggwvlnjz0OPWwOdzbx9NdlSzJil9/J4NkeYXJ6urQJUImDxaiOzcuJJo6R3IQQohSXr7ylOTUCwtwrLvsMdfuyw7U01CIzj44ZfTvqRVvwACMLXcmkDrvQi7d2RVDCCHafFmVT+KCsIJPohcN8g83Ge3Vpbn08r+yC3vWP1S/agAAEywWS0ZGhkajkUqlMpkMpnsGjCNJMiMjQ61Wi8XigIAAHHe4T+26W4BOSEggScf6yboQTdMURWEY5oAZ4/goikIIwa6rBIqiaJrGcRw+PiuBJEmY6qsS4HRXFXC6q7RqON1xOJyQkBA7dW5TxsfJaSSV82Wr5oosM40QQhjHs/2Xf62d30HmQB8GPJ/Ybj4IIYTofL0uW5N157/Dn5/QebfrNsQDQwjhTk4uOJWWqbEgWWHp1pSVnUFRlFJNIiYL0PpH/47fqWwx6rOpvmhp8T9ROKGS+KvEfuIchW/aXeO9HbMu0AM/6dLSgZ6caGc8v9hYP4QQQnR+njZbo7pzae/nR3O9O7xbcGTLb8AUXuvlu1sXX0SlHjt50cJu3CiMhxDiB8X2DypYnq/Lzc5W3jm39fP9Gu9unw5hetIG/aOj43dltBg5rZScxAQtP/qwT+qKZdM+U3YIi3bKf3jzysb7rJ6j+o93pFNC9RL1mbdk9M0pi/r3ffRObGOx4eHxrRsvcHsuWjzez8E+gllu4dFuCCFaGV/6/DTlNmAA0adR8Gj1o0Un7z4KljTmkg8VmRsz8J7RgeOdEEKIYvFaje3XZ93+Zd/+qNxMROP6Eg0AqGY0TWdnZyuVSicnJ7lczmY79j1koA6gaVqtViuVSoFAEBoayuE46DCGuluAnjx5cmhoKNNRlI6maYvFgmGYI0wTXuNARabSSJKkKIrFYkEBuhLMZjNcfFRCwekOx3Eo31cCnO4qzWKx0DRtv9MdRVEKhSIuLq7qXZnNZp1Op1Kpii6UOtnuZjoyNemJmTaTQWM3HP2kcyBSXNu3dMqXGxaN/DDg4j8OV1tBCFGKpV/MnJVAIoSJowYe/CTGG0MIIVZgVCfp/t+O7d/cb8pYDwIhhAyPl2+/mkkjgdFIMxiwIWnequNPIwft6CZjocyif9G4eKbLQrjGvOAn13imPESr/txy4Ulgt10xthnUVyJtaNo2u8FsNufl5ZXMyar3Sz1fOmXKrAckQpi44YiDX7QpWaQttwHDTI9PrBry/aU8n75zBvgUC418unTcO7PiLQjh4qbvHVzQmeHIDUnzfjvxtP7AHV1L5qRWKEvzCOMYgz9pf+DCxnsbd93biBBCmDC0w+QYz6o/OLFE2lA2esCm2WzW6/Ulc5Jjy9M7y7f9+++0OLjw1Iafr25ACCFM2HTS5N5yx3iYZI3HEri8HyQ8eDtnwz3tBoQQQkI378m+AgFCWnkjRbehRJ5iyonzF84lbbyFNhZvUEX2y0mDwVAyJ6U2OFMCxul0OoVCgWFYQECAk5PtfwMpkTYkSdrk49tsNufn50NO1kp5eXkKhYKmaT8/P2dnZ5v3XyJtLBZLpcfy1un65qpVqxyz0EaSpFqt5nA4IpFjPlfZoRkMBoQQn+/AT1JyVFqt1mg0isViKAVWQnZ2tkQiYTqKmqfgdMflcoVCIdOx1Dxwuqu03Nxck8lkv9OdXq8fPny4TboquD/Ajj9I4+79vtkSzY94q0WAACGEgtuNXbYPKaI+OrZ8w70xs6Mc7vMAkwx4d3KgUpOU8N+aI7t6z8UPft0nho8Qp96X42Pivr/83pQFh96KkhOaSxevXEUuHni+nsEPNVp/ZNPmFdp6a2a3DMIRelnZMPKEyV5hFhbbS5ngon1RAcyLP7n0AavPlNb1bFSdtFPa2CsnMbcBH04PTM9Oun95zYEtvb/AD/4wKIZfkQbMMaVfXfbDz4sOp5h8u/z+67QeJUaW4u4DPlsUmKZKij+9Ztfq3pOIg7+PiWGqcknrj/y9ZUVuvTWzWhTNSRNPmOITZmLzPZTx8X/M6RWnbtjjnbjekVFOpsQ7F79cd7TP/LytC4cPEFfpq1OJtLHVF7EyctJ2t7rS2nNfD+qx7HnD91fFfdQtytWQeHrjl18s7RObvfXI8gGejvVLSA1Enrt9r8d9Y0N5aFyEOIpDJaYrv7z+vM9J1vJl33WI8Hc/vePextVv33utwXHz1i6hA6p2ErDfeRIGk9U+JpNJoVDo9Xp3d3eJRGKnUpKd0qbgtj/IyVrGbDYrlUqtViuVSqVSafXkZMH5rZJd2SIeAAAAAABgeywWSyAQuLq6Fltq0NlsBZi4fofu9Ystwn1692k17d9TN+N1KMrFZmuyEYwX3rh5OEKoe+cRAUsarYqbe7LdoVgxjjDfjhPPOvnO2XL28KGD+ziSJm1GnOibP+XjLU8EPIaGG9Cam3s/OGbqP3XIO9IXIVAYQoQkzS86IveZLPsJVjjajtbuPvTfM3HT1c1tNqdpibSx1dcSFovF5/NL5mTVYfzwpq3CEUK9eo4Imt/ol+1z/+14qK8bbn0DRtDaq1t/enfpkTsm985jFyyd1C3K+bX9jAnCW3YMRwgNGDgidEqjb9bO3R97aAgjEyrTmpv7Pjhu7j9l0DtuL3MSIURIngc0DctNDVDdRJlnFh58zmk6YvfY5h4YQkgQ3aLnDr6uweKLcw+36zPcryrfHu2Xkzwer2RO5mbZpHOEEKXYufC3u5weK3d/VzDvizj67Rk7nDMbDNw093/v9ZnXCL5RVwWlVy18mMfxCd3dVOaBEEKoYWjYr8392i+7snTn9fHSNSz144UPijWI9vPbwTY3OJUxN9GrT0MnG+akre4qKz0nQY1FUZRKpVKpVK6urmFhYXYdrVUibQiCsMmpkiAILpcLOVlrFOakSCSSy+V2/Wnh9Zys9KkSPi4BAAAAAMArmNDVlYVoC0nSCDnGrWKmtLvb7uYENGrVzr0wIDygWcMo4v6Dx+kkEhc8ri4wpt+mmH6vXnVr3VOSCPKRMXS9S2c8eZ5G5vzz85x/fi66fPvwJtsJr87nf+nb4uV3WEp148+bxsAezds76Kx99mJ6fmvb7ZyAJu3aeRQ5si2io/A7D5IVJHKzlNeAyQI0mb7jq6mjd6XJ2o7bM2d0H/9ic+OYnl7ddiM7IKZrO6/CGPGAtq2i8GsPEp+RiJkCdMbT52lkzj9L5/1TbO7nHcOb7CC8Op3/uU90Wlq8CY+KDCk64bMwXB7DvrD3iSKX9pM4xjmhOlkS4uONrKh2rYrtk5btYjjr98bfy6Ub1cF9YkOW3Lx4CotyF8kQQhiuiWqR3nkQ79n2Visu7r++R/eWzLlog5eEMpcYXLlXrc9FTnAHIrCrnJyc9PR0DocTHBzM49luDjQAKkur1SoUCoIggoKCata9sFCABgAAAACooyw3l/WfEid+d+260QGF5TAyJfGRCfcKDRI6TlUl7eKnP56LmCg/1f9V2Y7WG7Q0xudyMIQQnXXq2K1HovARLXxezm1A3rl+Px33GN1AwlCNEpOEt5w1KIJEyMTm6QQSROfci9tzxhgwpluYnyi4yDzB9OPL1y9aJB/G+Ne5hwmknv108cmIjyNODXF/dWTz9Foa4/O4GEJ0eQ2YQ97fMG/87ozI8T8d+DTG/fUke3r001kHI2Y0PDX6VQWa1ukYjRyThLWcNTCCRMjM5mmd3BDS3tuz64zRf0zXFzmJ8bjOGK3W6ikkKfJey1NTiMPjMrvHmYI5OTtjlDpbQ6FX8+LTOWo1hThOznVzn9gQxiKcEVKbLHneERldh5J8J5/9653vHM2hEIeFc4s0oBD31f43WdT0iwYA2InBYFAoFGaz2cPDA8YOA0eQn5+vUCiMRqOnp2dNzEmYsgoAAAAAoI5iBYeKn1zbvOT7g5kvH3Fjerr9+79u0MGDBzV1nGIoOyzyLSfy8uETV/JfLqJyDsVdeEC7dIh+MSfAvaObPljy94b0F5NamNPOzj+o4NbvNDaEqTmgMWm9NrNGD373s5ljZ3y1cMTbK3tExkowTBj8wdBeC3rX8y2sW9Ha4zeemUXyboyFyhh2RKO3nMjL+w8XObKaQ7vOPKBdOzTzZ1nRgDHGa8s33DFGjd0wrbTqM0LsqOZvOZOXd+6+Yni5iMw+tPnIA+TWoVUIQ5Fj0nqtZ48c8MG06WO+XDB/RJ+V3eq9yMkhsQt6RfhiiB1Qr5sbun/qxA7VyzmU6bxTe8+dtfA7NQmum8/cY0d16eZN3/97xY5U84tFVPap5X+dNbt06t6ybu4TG2KLXbs4ofsK3h+dpgiT78rXLBAmXj91P/0szerkIxIgxBa7dhOg+8lpO/QvP6doS9EGANgcSZIKhSIlJcXZ2TksLKwmVvpALVOQk8nJyTwer+bmpKOOgKbT981blDls2fjI0i7EqexbO9dtPXXzidY5oHGnYeMGNip4IEZZywEAAAAAwOtE3efM73p0ysZBrRIHD2oXRGTePrZnf7ypwSfbZsU40MAyTNTsq+HhR9fs7/lx6rBWIV5Ic+f6lT2Jeb4dJs6O5iCEEOY2cmTnX2cd/uTTby52jPDQPfv3wq14FPXLlE5yhoZbUDihkvirxH6uWmXY4yuExVRm0/zk448svHohMY56YW4/mEvLr0bXP/rbrp4Tng5rJ/dCmjtXz+95qPPtMm12U641DZhCPrlzSUVznG5+N/dpiRQTNRvx04AQlutbX33Q6OhPG3sOThrWub4XnX3n4vE9d7W+sfNnt2TmJm4Kw1XSQJVbgCg3Q550kUWaEE2VbMQJnT22+ZFfroz8Qrm1VURDZ1NC/O3dj7Ti6IFL2jjQTRHVit969nfDjozfPLLtw639OzV0NSSc3b/7v0xxtyVLBsrq6D6xEZpgZTfvPzQm9NDMfV8O6HrOT9iQQyVkZO9WmcXeQUv82RhCiHCZ3UR25HzGyEOGrf4upTQAwHZoms7Ozs7IyBAIBKGhoRxOHZsYCzgkjUaTnp7O5/Nrek465HUunf/85MY98fqY166IEEIIkU92Lf5mB/nWuCnD3DLPbFr7zXfET4v7+xFlLa/m6AEAAAAAagpW2LhNF33/+Gb5lkPrV2wz8Xwi23++esaXwxu4OtbXenbUoM/PSeMWxl3ZtTdeQ3I8/eTvf9h7Tu8Ir5dxihoOP/G9x9z1xw4eOqQhJNFN++8Z26u3JzPDuDUununSEK4pL/jpNZ4x782NjY8Szumx0GBfkWPt8+rBjho+75xs28IdF3btuqWxcDwDwt+fNnBOv8iX81aU24AZFkXaU5LWJV3YkFTiL7g70fWHASEIcaLGLT3nsXbhpuO7Nl/RWLieQQ3enz16zrBoRiLXCmVpHmEsizHoyXW+IafshphX86Hn5/l/s+fingtnDpoImaf/qHeGz42NCKi736pwr94/n98X/c3PG/bs+t9BA0cWHD1qwYq5kzoGOM59IjWQVt5I0XUokZ/X/N/HlzsEfXNPuedp+kELJhM6j2ocMjfctXBmKC/f4POdnd/QAACb0Ol0CoUCwzB/f38nJyemwwEA5eXlKRQKmqZ9fHyEQiHT4VSVoxWg6cwTP3+19uLzXBONpKU3Md3evz/Fd+AvE3v4EQhFSTWPPt934G6viRF3S1/esAb/PgAAAAAAYGe8wK5TV3edynQY5cF4UR2Hbus4tOwWuHv9Ln8s6VJ9IZXGwBMq3OVmNs9TleSak17sb7hs+rdLp7/2Em6DIanbh1RXgI4H40V1Hb2t6+jKN2AC9625WffmltMI40f1+nBbrw+rJaIy5fOECo8wI5vvmZnkmqMo9jdcNv2bn17LSdw9vM2yGW2WVVuINQDh3mLssn/G1pR9gnmMOpY2qioN7Moo8UjvOlTvHeh+7oDbfycRTQmkHsvae5S9ezH3choAUCUmk0mpVOp0Ond3d4lEgmF18Qdh4FDMZrNSqdRqtVKpVCqV1o6cdLQCNObaZOhn/n3p3Au/f3Oq1Bbks7v3dZ4tm3oX/AZP+DeNdt95457C7FT6cqoh/DIKAAAAAADsiyTYGW6BahcvqfqZLPsJRpV+Kx8A1YYkh0nT/gAAIABJREFU2BnSILXYR6x+HvDsFk5ZmI4I1HUkl69qE5vVtIP45nnfPasJo6H81wBgTxRFqVQqlUolEonkcjmL5WglMlDnUBSVlZWVmZlZ+3LS4baE7eob4opodSK/jPo+pcpQ0W6ywscy4xKZhFZlZFrKWE6hFwVog8FgNpuLdkXTNHJIhYE5bISOD3ZdpdE0DXuvcmC/VQKc7qoOdl2l2e90BwelrqExLNvVJ0MaLNBr5I+vsM355b8GAHuiEaZ29VLKQgT5uaFJlzhmKPMBpmG4JqpFeqeBvMznIeu+5WamMR0QACgnJyc9PZ3D4QQHB/N4zMzOD0BRWq1WoVAQBBEYGCgQ1LbHrDpcAbpcpMlowfj8wvo0xufzMJPRZCljeeFXwO++++7AgQOF/YhEoqysLEcex24ymbKyspiOoqbKyytnvkVQFo1Gw3QINRW8YSvNaDQajUamo6ip4HRXafY73RkMBgpGv9YZOoFY4S7HaMo/9ZbTm6bWBaCa5AnECs8wGsN90+4J8+DiBDDP4BWo6D7cwnfyOrLF5cE1psMBABkMBoVCYTabPTw8XF1dmQ4HAGQ0GhUKRX5+vqenZ23NyZpXgCY4XILOMeTTiIchhBBtMOTTbCGnrOWFLwwJCYmJiSn8b0JCApvNdswCNE3TFosFw7DaNNi+2hR858dxmHmlwkiSpCiKzYbHqVSG2WyGXVc5ZrMZx3GCqLvPNqo0ON1VmsVioWmaxWLZ6TLAYoH73OsEE4evlIboBK7uWY8l6lRHvKYEdYyZxVW6h2qFUqnqsTT7GUbDL2GAYRaha3qHAbnh0dLL/8ouHsLg8xEwjSTJjIwMtVrt5uYmk8ngQhowrjAnxWKxv79/Lc7JmlffxN1kUiwlS00hVwIhhChNlgZzi3RjlbG88NCNHj169OhXTy/p1q2bi4uLYxagSZJUq9VsNlskEjEdS81jMBgQQnw+n+lAah6tVms0Gp2dnaEUWAnZ2dkuLi5MR1HzFJ7uasFTfasfnO4qLTc312QyCYVCO53u2Gx2Lb52BAghCidUEn+V2M9Vqwx7fIWwmJiOCNR1FIZnSfwypYEirUqedJEFOQmYRuNEdtMOGe37OKfck6/+ip2TzXREoK6jaTo7OzsjI0MgEISGhnI4nPJfA4CdaTSa9PR0Ho8XEhLC5XKZDse+al4BmvCPrOcUd/NW5vAgTwwhKv3W7XRh/UgfThnLoZAGAAAAAABsJUcoS3eXc0yG4KfXeUYd0+EAgLRCmcIjjLCYAp/eEBhymQ4HAKSVN1J0GUIYDQH/rBCkPmI6HABQXl6eQqGgadrPz8/Z2ZnpcAB4lZM+Pj51ZDBWTSlAW5KObTqdVa/X4BYenIaxsf5fbl+x2Xt8e0nGyT93PQsZ8HEUBxFlLAcAAAAAAKDKDFxnhUeYmc3zUCW75qQzHQ4AyMgRKDzD8zlOnplJrjkKpsMBABklHuldh+q9A93PHZD8dwKDp/ICpplMJqVSqdPp3N3dJRKJY94ED+oUs9msVCpzc3OlUqlMJqs7OVljCtDPr+7fm0K2GtTCA7GCB838wvzH+pVf7soX+DTuPeOD/gEEQmUuBwAAAAAAoPJIgp3hFqh28XLTPJel3sIpkumIQF1HEqwMabBa7CNWP/dPvYNTMLUuYBjF4apadFO17Ca+ed53z2rCaGA6IlDXURSlUqlUKpVIJJLL5fCELcA4iqKysrIyMzNFIlFYWFhdy0kH3VpM3PPrHT2LLOC1n7mjfeH/CFmzkXOajXztZWUtBwAAAAAAoOJoDMt29cmQBgv0mtCUKxxLPtMRgToPwzQiz3QPOd+QE5p8iWOCMh9gGoZpolqmdxrIy0wLXvctLzON6YAAQFqtNi0tjcPhBAcH83g8psMBAGm1WoVCQRBEYGCgQCBgOhwGOGgBGgAAAAAAAGbpOM6KgFCEIb+0eOc8eIIWYF4ejSuCYmgM90m7K9RlMR0OAMhgtihGz7AIhF5Htrg8uMZ0OACg/Pz8tLQ0s9ns4eHh6urKdDgAIKPRqFAo8vPzC+aBYTocxkABGgAAAACgRuHUzGdkN2zLdAQVYCIpZZ5JZ7K4u4klIiFWL5LpiBxb6z5MR1ApFMV0BBVgNpuVGRm5Wq3URyyTiLEGjZiOyLGJ3JiOoPazWCwZGRkajU7aqLlMIsZatmY6Isf28D+mI6iUpbOZjqACSJ4go3k3df0YtzsXZMPfx3EckWamg6oggl196zr6d/Wty4aeJDAdQQWQBFvlUy/LM0SckeLfqS+O40xHxCQoQAMAAAAAAPACRdMqg1mlN4m4LLnEieUiYjoiUNdRFJWVnZ2pUomEwrDQUBYGT3UDDKNpOjs7OyMjw9nZWS6Xs1FN+i0H1Eo0hqvrxyhb9hQon4Zu+ZGTm43emch0UKBuwzCNNCDdvyFPnxNy5zjXkIvw/kzHxDAoQAMAAAAAAIAQQjlGc7rOyCHwYFcBj1WnR6kAB6HV6RTp6QRBBPr7v5gyssYN6AO1i06nUygUGIYFBAS8yEmzkemgQJ2W5xuqaNePxgm/Y1ucnzxgOhwAkMFZkhYYTRJsn+SrQrWC6XAcBRSgAQAAAABAXWewkAqd0UzRHk5cV1413gALQBmMRqMiPT3faHSXySRiMdPhAIBMJpNCodDr9QXTmGIYxnREoK4zO7sqW8VqA+u7X/lXcvscRsNgfMAwC4ef7t8gV+wjVSTI0h5gFMl0RA4ECtAAAAAAAKDuImk6I8+kzje78TkyARuHkgpgGkmSGZmZao1G7Orq7+dXx6eMBI6AoiiVSqVSqVxdXcPCwgiCYDoiUNdRLLaqSSdVk46ipNvyTd+xDLr/s3ff8U2U/wPAn7vLTpomadK907SMIiAbZEtFQGSp7KWCoKAggjLULyLCV5EhIv7gK0MQREVAZYlMkVFWgcrogM6MZjb75u+Pk1jbUoZtLy3P++XLF71cLp9cnlufe+7zcB0R9KhjENQaqTXGNpfbSlMv7eMRPq4jCjowAQ1BEARBEAQ9ihiGsfkIoxuX8LEUpUSAwTQfxD27w2EwGkVCoTYpSShsmCOOQo2L3W43GAxCoTA5OVkkEnEdDgQBZ1Lz0m6DeR5n0o9rxMZCrsOBIOBURusTW2Eknnj9hMRp4TqcIAUT0BAEQRAEQdAjx01QepefYZg4uVgmgL35IO55vd5Sg4GiqJjo6BCZjOtwIAh4vV69Xk8QRGRkpEKh4DocCAI+TYy+22Bcroo4tVdx4zxg4KCsEMf8ohBDYiuPTBleci3MkAvbZA1gAhqCIAiCIAh6hBA0Y3T7nX4yXCpQifiwjCnEOYIgjCZTudOpDgvTqNWwTUKcI0nSZDLZ7Xa1Wq3RaGCbhDhHiSSmdhm29I7Kq6cTflqH4nDoS4hjFMY3xzS1RGqVpluxOacxOETwvcAENARBEARBEPRIoBnG7CXMHlwu5OlUUh4KUyoQxxiGsdpsRpNJHhKSmpLC48GrM4hjDMNYrVaj0SiVSnU6HZ8PB2WFOMYgqK1Ze2PHpyXGwpStHwvKYX0DiGsIYlcnGOJbiDzl2quHhR4H1wE1DPAUB4IgCIIgCGr8nDhZ6vQJMDRZIRHxYLlniHtOl0tvMGAYlhgfL5FIuA4HgoDL5dLr9QiCJCQkSKVSrsOBIOCOTdF3HcRgvNhD20IKrnMdDgQBr0ylT2xN8gRRty6GWou5DqchgQloCIIgCIIgqDHzkbTe5cdpOkIqVIhgbz6Ie36/32A0en2+cI1GpVRyHQ4EARzHjUajy+UKDw9XqVSw5gbEOUIWauzU35nYTH3+N3XWcYSiuI4IetSRArEhvkW5Mkatv6kpvY7QsE0+GNj7A4IgCIIg6JHmydmzcGzvpnEasTRUresydO63V13BPIKK/4/Ppgxfl01Wnk4WH1s7YeiT0bo0YWLLhD4Tp22+ZKIYvcufb/eIeKhOKQ2K7LNnz4gIOSIJ+cd/ymEbbcG8zqEH4vtj6XPDV12s0kQBAICiKKPJlHfrlkAgSE1JCY7sM1F8aNmEjFbRaoUwNCqh/eBp6zItNNdBQfWFpmmTyZSbm4thWGpqalhYWBBkn2GbrMxTcHThW5Oadu0pfuwJ9ZPjhy47cNXDPNAMXHHZDPMOZbb85kjIhmPNdl2cfs1h/mdcHodp4eHMpl8fFq8/pP7mzNAzhss0v+zxnjkj5wAAdFuWaC4cCYbsc0M7WaoHVPGFnye8NTt60AThM5MTpn4y7Zc8yz9WCVN+6493Png3eehE8bNTU2d+sfismfvS3fi1EdMWIi//878p2za6K8zDeDN/P/DMByuUry2NWrBh1N7cWyRqidLltHyKQTFd1oHw4myYfX4IsAc0BEEQBEF/IwiipKTE5/OFhYVpNBquw4HqHHHjy6E9Xj9QHtV52MRh8UTekZ0/fDzu8MmiowdntRRyHVx1GMtvq9f9evzp0XSlyYff7TluW6Gq1dARk3UC8/n9u9fMGfFb3v92zmydopQIsGDpdUGV3rrtQyMe79tTK/57Kr9lEp/zjA9UO5iyX1av2nP82SlV02V2h8NgNIqEQm1SklAYJBsYY9k/o+fQ/xWq2w0dP1MnNJ3f8+2a1546WXLg9/fbwbIgjZ7D4TAYDAKBIDk5WSQScR0OC7bJyohb3w8d9fEBl7pz30HDosi8M7/9sP7dwxeMRzeMbSm4rxm4glsLntlz8zgtydDG9BdR14sNXxzPPOpo83tHpZz9avaiobuvHyCEnZNjh8novFLjD1lXDjGdtw5p2Wv3lxJjAZfRV9DgTpbqHmPJ3NTzvSOFcu3Qvv11/PLzf/yxZtWHJ8vm/T5ey26nrms/Zsz9MRNEP929zwsi+x8nz85/7/rVt9/b0l3F4TkZZbfdJpCIxNSemgrpUF5UUuAvxrP/m02Dj9kjtbqRPUJ9hde37dp+2L1w5/uJLa//LnGauYi6kYAJaAiCIAiCAADAZDKtW7fu119/zczMZKf0799/1KhRzzzzDIoGS/IOqmWMfffC9w/aEiZ8f3zdgAgUAEDPPTSzd7/Pl8zfPnrPuMhgyolSXmtx9qWTW1Z+8q2Jjqj8YsHG5d/nK57auP/zMVGYm6D0E/tHPjfuq62bLszo1AQLou9BFeTfpqW952zY+oz43nNDDQnlNd/OPnd4y0cLvjVUbqJer7fUYKAoKioyMlQu5ybAalH5Gz/6Ol/17MY/to6JwQAAYO7otzr3WbZ62a7p20aqgmjbgWqX1+vV6/UEQURERCgUCq7DqQC2yUoY5+7Vaw86oias/mpdTxUKAKBfPLR4Ur+tX83/pf+ewWHIPWfgLHRy76X844R01sAOSyMwAABoF7/859NvZudtbdFmihQBgNx9PvcgLpqQ0WFdgoBQRuif6NVn038mf7/hy/9e75/Kae68ooZ0slRfaNPGrSfyQ9puXD1tjBoFAIBRXd+atmjZrp93DZ0+MgQBdMlnn/+UiaZ/+umM1xMEAAB6ZI/Zc/67Yv2eiR3GP8nd3S7KbLvNCHr3G7q1dfXpUEf24cnHbU2eGn10SLxILDMkJLX+72tv7Fuzp52/U+Kj+FPXIng9CUEQBEEQuHjx4vDhw1esWGEwGFJTU5s0aaLVajMzM8eMGTNz5kyfz8d1gFDdIC8fP2XHHpvw5tMRf50Uoupeb07qzHeeOHyO+8ckK2DM3w1u1b3dyLkrz1ireQ7bfenEFSKk65CBEUix01fo8IYqWo1/Mhr15WcXBtUzkoytoMCGxOsSg6AYCFSrGNPGwfGp7fq/svL3sopNlCTJ4pKSWwUFITKZTqsNruwzAMB19sQlPKTnyKFspg8AIG0zKCMW9dzIvh1U2w5UayiK0uv1t27dkslkOp0uuLLPALbJKqic4xecWJNn3+x2p98oquj14tDOPM+JU9n++5mBKwx+w0ECsTJDc+enRCV946Q8ynOtHAAAAO08biCxsNg3dKHGroPyhs8Q2r1jZLLOiP9EsSOITkIazslS/fHmnsgjQ1o/MVR9J6koSh7UJgz1l2YbaAAAVXLhx3wqttfAVxL+upGAypvMe6G1rCzzm8s4V1EDAGxmuw0odOq75EIZz+6jV4slaXMHJPnjmuc91kfgxyZ16/v5cy3b86strAU9ANgDGoIgCIIedQUFBTNmzMjPz09ISAhMFAgEYWFhcrl88+bNQqFw6dKlHEYI1RXCDZS6Ft3baLG/pyFiiRgBpB8PqnqbiCJj5Z4mdhow1v3TJ/xf5UHHec1fXrKkX2zzIqtHIeTpVFIe6j/v8jJIhEYRVP0tqNv5BRQ/TassOPbjqat6jySuVa9e7RKksE9Ng4eoBq48lm6nAWP5cfqQZcUAMAxjsdmMJhObeubzg/KuA6/VpM/WDk9tX6E7Gul0ehg0SsPlQ9JQnWAYxmq1mkwmiUSSkpIiEARND9OKYJushPQCRUKL9k3/caQWicQIIHGCvp8ZuIIIdHIeMDv+sNO92d+O8Z8xeiksJFUGAACApoBI0qx5W2bM67ixIOWbjwUOC0MzYgSQFB1EJyEN52Sp/mCJk6a9NDxWW2E7pZxeP4MoNSEoAIAym0soVBulrnDkQ0Jio+OQ8xduGqn2cViVRdYL+naZncLUWqn92PnCq3ZCoorq1Sw2IVBHhSo5kkfw0zrGdern8ZVrrx4WehxAmTC5d0JNS4XuD0xAQxAEQdCjbvny5devX4+Nja36Ep/Pj42N/fzzzwcOHNilS5f6jw2iaZr659g7tXnKLnl61fmnK31g8a4fTxGCVh1aBUk10L/wVGmtVAAAxpgtr5KtdfKSdBnRTRAQHSJEvOWmwrwrR76atdMWPeC952ODKmHhv51fStGOtzu101sIBgAAEEFkt7e/2vB+D03tJqGpuhmyiWGYatokxtGFZFDhadLaaQAAjP6SHAUM4c3NyxNhWGJ8vEQSxHVrpU37jW0KAACA9pXbrOaiKwc+m7XdEj142fPxtbztwDbJLZfLpdfrAQBxcXEymYzrcO6uUbRJhmFq7dgt6rLqx0onYHTxr4dPkfxWLdNE9zMDZ3gD2zcda85e9Mu53LTwVkLqRlHp13r06U5pE0MQAIA7ocP075dMw3iRh7aFFFwDAADAFN8ynqLRVhEhQXQSUo8nSw2jTQIARDH9MmLYZfs8LqvdcuXc/lmHXdFdM56PQAAAqFQaitKlZXYSaAJ3unCL1UTTtNFGAa4S0ORtUznF+N7+YI3eRbMjJgpCk95+acj7TaQIAG7C96cfCdOmer6aM2XX2ZNlRKgmslOLxxf0b9EiiFpkvarUbBjm4cfehAloCIIgCHqkmUymkydP1jDeoEAgUCgUO3fuhAno+kcQhMfjsdlsFSeqlaF19oH+2z/Ne372QXfii/PHJwVV4vZu/BStd/l8JB0pFSpEfEDlfjSs79wsEgBU2WHG3o/7RwfV16CK8woIhqCSxm/+9Y3eiUB//qfl09/evGj01IRT306Mq81YKzWbf3PBUBFJkl6vt3KbVKtrZeGNgx8nfQyg3GaVqlOkUokgDaR7O3Vz+VPt5p4nAECVXRbsXTO01redSs2GrqUOjiRJ+nw+2CZrgOO40Wh0uVzh4eEqlQq2yYB6bZO1smgAAMBvH179/H9Pu2MGzR8aU90quecM9YcnC5uUpth71rL5on0zAACAkPDE1xKlfGlocef+5cnp6ovHNOcPIX9luOjbt3OeP21xh8TMT5ME1dH7n+rwZKlSs6EoqlYO3yRJ+v3+OmmTtH757Hfm3qQAQJTpQ/e+0T4aAQAAXmJ6L/XPXxz6+ZtB08ezFcC9t1d9l1nGAInfXztnJA8TbXmehWIoOumJYb8+lZIIys9f/GP6dxcXfflT3MLx/Vo2t9jMXoZxH/pwSDmV0qLJ5BaYPu/GDwd2/ZrvPPpG55ZB+SBTXavaJh/6NglMQEMQBEHQI+3SpUs5OTkpKSk1zCOVSi9dulRvIUEBKIryeDyhsD5GWMeLD6+cM3PRd9fw5GFrd37SVxnsGQqKYfRu3OYjlCJ+vFyCsvGiUUMWrE4sNuZdOrh+24oBY7C9W6a2l3Ic6t/Q8EEfbmstbtK9Q4IEAACSu45f+RPQp796aNXmP8fNS6/FDkF11GwQBKm3NtngUBRltljMhWYEAF5odJiqQQ2XhsYMWfx1YqE+79ye9ZsWDRiM7d01u32tdpOt1GxqKw2KoiiGYbBNVoumabPZbDab5XK5Tqfj8RrU5T9sk1XghsyVH3+yaN8tPPbJtWtm9q3yQNA9Z6hf5O+Z5/pe8j3WPH33Y5p0IZVTUjLnj/yBB1SfbP1wiPNa6tcf8TzOvyJ3W1eevr4oz4XLI9c+1aRvsG7QdX2y1ODaJEBUQ156LdFoz7t5bv2BnQMWoHs/GNheDICg6dsT2+/+75mXp/9nX/d0HWY/fepsJgiNQH0eDp9QQaSDhr3Qmq/prlVIAABA1bVr/z2IM31z3ic3tU+2EaRcvwFoptzBnzT1pc8fk2EAAKb7mK3/G3D8xPzMx/Z0ljWkw3otqdomH7pZNqgjEARBEARBtc3hcNzzUWUej1deXk7TNIoGcX+UxgjDMJFIFBIS8o+pFFHLH8PYMr+c+dK8bVf8sb1nbFo+74V0ji9Z740myVyrW87DUpQSAVahWSLStCf6pgEAho8emTa25bzVC3YO2TcmMlgaLqJs1uOpZv+YhMYMGNhpxsGjl666QHotdm6v1Gxq6yKWzT5XbpMQAHaHw2A0ioRCbbxaiACANLQSEEhIWs9BaQCAcZNGNhvQcsbSBdtH73upNruc1lGbZLMqsE1W5XA4DAaDQCBITk4WiRrg0+MNuU0KBIJabpNMeeb2ZS99uv8KHtF7/MLlU59Kr5QKu+cM9Y526xdecQkSmv/YJToCAAD4Kb0GLu2X/8zMn7/4YMnU5u472Sgi888bL53RX6FEvR9rsfzxqPSgLE5ePydLlZoNiqK10iwxDOPz+XWyn0REaa3apQEAnuo9MmFpy893LzjSdV8/JQqQ2J6vnJDGzt92Yv++vT8JVI93GXn4Wd/0adsKJCLOmiYibtZEV/E0zBUa4R05rNU3S86e+1nZJknAADECBLoOC1rIsDtv6fN0u04nDxy/WuTp3DR4ujTUm0rNBsOwh74ehAloCIIgCHqkhYaG3vNBKpIk5XI5zD43TlTR96/0G7vxtibjnV0r3xqYEsTFagEAALhJ2gsATZHRIaIwwV+nsvjtkzvOmhO6PNP176eNsYQe3dOx09evF1AgaBLQ1UFCFAoeYEiKYgAI9sw/VA2v16s3GkmSjIqMDJXLGX1DusLC84/s+MOY0P35rnEVtp2MjHTs+PXsPAoEVw0b6D55vV69Xk8QREREhEKh4DqcBwPbZDUow/fvThu7s1TzxMRdC8YNjK9yO+GeM3CBtLuuUkh6tFIDgF8Zru/6rC8sOuH35Z1Rak9hTnnzaBUAgPF9f/z82OteTVzSri5JA0OD9dZdQztZqmt4afaObEdCy05dwwMnLmhC28fSsWvXbxsooEQBAICX2H7QlvaD/n5X1sZCCkuK0QTDYRIXh+gTWnpkYeG3N0ejDOMvpxiAhcqjUSRHJVdXOB9DQ0NjMHDW6/MwAA4a/W8Ew+8OQRAENTylpaW3bt2iaTo6Olqr1XIdTgOA4/j169fNZrNCoUhNTa04/g9JkteuXTObzTKZTKfTPei1YllZWV5ens1mKyoqcrvdHo8nPj4+LS1Np9Mplcp7vr1Vq1Y6nc7n89XwXJ7b7W7VqtUDRQU1EOS1lWMnbipt/uauXxb3Dg/uy3qCpo1uvNxJYADwhKIQQYXz2Fs/zXzjhyb/aXP05b/HHGRcTieDiMXcdbSpgry0cvD03cqXNmwcmxCIk7qVk4ujUSlJIcETKHR/SJI0lZXZHQ51WJhGrW4wpXUryt0x86WtTT7udHTa322SKS93MoiYw05q0MOiKMpkMtlstrCwMI1G0yDvHMM2WRl1bfOCiT+amk9c/sub7as7Ut9zBm4gPEwGGCuJlXQd5EzvqLx6On7/14g9x8YAAR8TAgAAc+3K5Yk3/M1btv6lQ1h48P66DelkqZ6Unpr5ye9NXtEdHaz5ezv1eJ0MIhYKEAAAYzl6KCtXnjayQ8ydbD115cI1AxoxtoWKq1VIFp4avOWaosdzHz/f0RqdqjAXpl7aD4qu5JJIVLgyBAFAGNk2CtlrtBQxIOVOg6Ss1tskEqqUB/3zgcHu0U1AMwzjcrmC8zSRLTNPkqTL5eI6loaHJEkEQepo9NjGjSRJAIDH4wnO7SLIsbsUrqOoJ6dPn163bt3PP//MPhRGUVSPHj3Gjx/ft2/fB208j8juzul0btiw4ZdffsnKysIwjKKoZs2adevWbfLkyaGhoVu3bv3xxx/Pnz/P4/EoimrSpEmnTp2mTJkSHx9f82Ipirp69er69evPnz9/7dq1SqOUoCialJSUkZExZcqUpKSkGpYjkUjat2///fffx8TEVDsDjuN2u/3pp59uND9TXe/uvF5vbQ34Vud8x1atOu1v8/7mRUF9QUUzjMWLl3lwuZCvCxVUfTaX36pL95Ade77ZenbUnI7shQ5l3vfV7uuM5qWuqcFzvstLTlEWnP9m6X+ff3r1AA0CAAB44Xf//eoikzxzWJtHcmybhophGKvNZiork0mlOq2Wz2+ovx6/Tc/uoZv2bFh/duIHHdlHiynTvi+2X2ciXurZPHi2HeieGIaxWq0mk0kikaSkpAiq2VM2DLBNVuY/v2rTZX/6lM0z75JcvucMHOGrNd0VBRsK+LsozaTty4U2I2CII1lFJ2h+33ilBABAWVdddvg1KZvbB3P2ucGcLNUnfmrz7tJje/YfPvv0Cx3ZDve0Y9/uP64zoS+1jmO30z9/3TIttwm5ZtYrkSgAgCg98f5evbDZqPFazvq58zRhUmu5+lVaAAAgAElEQVTJtoP5PYb0H3XlN5G3HJCO7b+cv8ioZraL4QMAUPXQ9tGLdp5971yzje1C+QAA2rn7l3OZjGx869hgrUzeYDyKO3AWgiBCoTA4E200Tfv9fhRF4WAaDw2uuofAjmcqEAgaZF8JruE4/oi0uvXr17/11ltKpVJ753qbJMns7OyJEye+/vrrCxYseKD28yjs7kpLS6dPn37ixAmNRpOamsoed5xO5+bNm0+fPi2Tyc6cOaNWq1NTU9lV5/F4duzYcenSpQ8//LBTp041LPmHH35YtmxZQUGBw+FgM6oBCILQNJ2fn7958+asrKz//Oc/3bt3r2FRb7755tWrV/Pz88PDwyu9RBBESUnJ1KlTa15Cw0KSJE3Tdbe7a0A3QancU6eNtEB+csnkl/65LhB51zeWjQ+KS30nTupdfgxBEkMlEj7GeKo5eUOUT733ettfF335dN+bw/u2jGLKrhzfu+uyI3bQ8nldxfUf813Jn5r/fp9fp389rFPOc8O6JmFllw/t+vkq3uKNHXPbN9rdYOPjcrv1BgOKoglxcRJJw34QGwl79r05nX+du+zpztnDB7aNYoxXftu564I99vn/zevVsL/aI8Xtduv1eoZh4uLiKj5i1RDBNlkJVXD5tJkRyC4umV9Q+UjdbtSyIVrkXjNwcih3Ryfruw0an7zy8Lv7Zkw6/Zs27DEhfbPU+KMRV8Y3WZoiQACgHPbTXkYgsC057q4ceVTCsjRZMJyEgAZyslTPEHnb90ak/br+56enFQ/vpI0C9isXzu7Kccf2eGVeawEAACBho0f3XjN3/xszPzzVs0mEq+jgH1lXQfqK6b10HCUbvFKlvvnLE6YVHVm859UxF4+2S0hC3Zf/vPZzMdUiY/jcZDYtjjTp3mfG2S1L1q+7fq55RiRy69qfO2974zsO/k86PE/7tx7BLeVvfD4/OBPQ7IUriqINtzMFh9gsDFx1D4FNxPB4vHsORwZV61Fodbt37549e3Z8fHzF620+n69Wq0NCQj777LOIiIhp06bd/wIb/e7O5/PNmjXrzJkzSUlJFY84UqlUIpFcunQJx/G0tLSK+XeJRCKRSIqLi+fNm7dp06bk5ORql3z69OlPP/20rKzM5XLhOI4gSMUutwzDsB/n8Xhu3rz57rvvbtiwIS0t7W5xJicnr1ixYtasWVlZWWFhYRKJBEVRgiDKy8utVuuLL764cOHCxvQb1fXuLmhPMKoiC28Xkozrz/2b/6z0ChrOe+7j8c05iSrAT9F6l89H0uESgUpcc28+QfqUDb9HrV74v307N/xuJ0SRuscnfThl/tj2UcF1U5WXOmHLqdgvP1y1bd+mz3bgopjm3Watm/P2iBaKhtFkHnU4jusNBo/XG67RqJTKhrKl10iYPmPX7zFLF36+c+cXh+2EODKtw6Tls+ZPeiLIth2oegRBGI1Gp9MZHh6uUqlgm2x8yNKSQopx5f6xObfSK2g4r8/HQ7TMvWaor0j/QkhDjZ37lyenqy8e0xaDUwOafnixZFde4V4S1cjlYzqmL2gRxlZXIV3eQhq4bObNtkrLQMKRyI/TguVWSpCfLHGEnz5s1u/q3Qt3n92556qdEkTG6SZNHTB/QJOoOzsh+WMjDv83YsGmQ3v37bNjqtZtBu8a339AJAcXFKRAbIptZg+LV+tvZiT1OjNN/OGvl/edPLWD4MfEJs6a0O3tjhF/n4aJ4j54Y3TM7mNfXMpafhkow2MnvND1/Z4JUY1g58q1RzoBDUEQBN0/t9u9atWq8PDwant7CYXC6OjorVu3Pvvss/esHfHo2L59+6+//pqcnFz1gtDhcPh8PgRBLBZLdHR0pVfDwsJyc3NXrFixatWqqoulafrjjz/W6/U4jrMLqVrwgWEYFEUZhnE6nfn5+cuWLfu///u/GkJt3br1tm3b1q9ff/DgwczMTHZi//79R48ePWDAAPhgRGMl7LfeQqznOopqUAxjcuM2H6EU8ePlErTCBoREjDpUOKqa9yDS9MFzdgyeU29BPixRYp/X1/V5neswoAdD07TZYjFbLEqFIjYmpobbV0jU5EOeyfUZ27+FyNJf+GDHCx9wHQf0YGiaNpvNZrNZLpfrdDoerxFd2sM2WYGwx3uWa+/VNMc9Z6gvDIZZ07sYOzwlv5Wd+vVHPI8TABAeEbeyb9zK6uYXxqdbJqfXc5APIWhPljiGiNJ7vrCj5wt3nwMNb/bkl0ufrL+QqmAQ1BqpNcY2l5abdZcP8v1uAJDE9M7r0jvX8C4sJO7V0aNfHV1fUT4yGtFRCoIgCKpLx44dO3fuXEpKyt1mkEqlubm5+/btmzy5QV1416WffvpJpVJVm711OBwYhqEoWl5eHhkZWXUetVp96tQpk8lUtSzG5cuXDxw4kJSUlJOTU8Ons1lpHMf5fP6FCxdKSkruVuWZFR4ePnfu3Lfeequ4uNjn82k0GrVafV/fE4Jqld1HGNx+EQ/TKiVCDN78gLhndzgMRqNQIEhOTBSJRFyHA0HA6XSWlpYKBILk5GTYJqFg4Exqru86CPO5E/f8n8RQwHU4EARcoeH6xNYITSVc/13qNHMdDgQT0BAEQdD9yc7OlkgkNT/aKZVKs7Oz6y2kIOdyuQoKCqRSabWver1eFEVRFPV6vX6/XyyuXKZWKBTevHnzzz//rJqAzs7OFolEBEHgOF5zDGznaBzHc3Nzr169WnMCmsXn82setBCC6o6boPQuH80wMSGiEAE8TYW45/V69UYjQRCRERGK0FCuw4Eg4PP52EegIiIiFAoF1+FAEPArNPqug3zq6PCzB1R/ngENZRxmqPHCRTJjfAuXPDy85E+VPhcBsE0GBXhmD0EQBN0Xl8t1z4K5GIY5nc76iSf4uVyua9eu6XS6qi/RNB0o04wgyN3GrLvb+mR/C5qm2T+r1t+oiGEYiqLgTwMFOYKijR683E+qJQKNRADr7EGcI0nSVFZmdzjUYWEatbpRlNaFGjaKokwmk81mCwsLS0hIgNWxIM5RQrG5TW9Liy7KP8/EH/gaxX1cRwQ96miUZ45OM0enKsyFqVn7McLPdUTQ32ACGoIgCLovKpWKHeSzBiRJqlSq+okn+CkUiubNm3s8nqplGdm+zyRJsj2U71a3kSCIsLCwqtOVSiVJkoH7AdXWgA5AEITP53s8nmoXBUGcoxnG4sXLPLhcyE9VSXkoTPNBHGMYxmqzGU0mqUSi02ob0xCsUAPFMIzNZjMajRKJJCUlRSCoeVBWCKp7CGJPa2Po8ozIrNd+t0JoNXIdEAQhDlWMIbGlwOdKvnpY5HFwHQ9UGUxAQxAEQfelbdu2brebpukaetw4nc42bdrUZ1ScYBjm+vXreXl5Xq83IiKiTZs21dbZKCwsDA0NvXXrlkqlkkgklfqPS6VSq9VK07RQKPR4PCRJSiQSdt0yDOP1esvLy6Ojo0mSJAiiUvqjbdu2Pp8PwzCRSOTz1dTZhE1M83i8tLS01q1b18KXh6Ba5cRJvcuPIUhiqETCv8czFhBUD1xut95gQBAkIS7ubjWUIKg+ud1uvV7PMExcXJxMJuM6HAgC3oj40q6DKLE05rdvQ27/yXU4EAS8UqU+sRUhlEYUXVWU3eY6HKh6MAENQRAE3ZcOHTr06dMnMzMzIiKi2hlsNlurVq369+9fz4HVsxMnTqxcuXL//v0CgQBBEIIg0tPTBw8ePHXq1ECq4vTp08uXL//ll18QBHG73VarVSwWKxQKjUYTSEMLBAKSJBmGQVG0sLCQYRiJRKJSqTAMs1gsLpeLYRiRSNS/f//27du/+OKLw4cPD6T+k5OTx44du3PnTpVKVVpaerdQEQShaVoikXi93r59+8JKkVBQ8VO03uXzkXS4RKASw958EPdwHNcbDB6vN1yjUSmVsOYGxDmCIIxGo9PpVKvValgHBgoCpDTU0Ll/eXK6+uIxzfnfEOoeD0dCUF2jeEJTbFObJkmtv6kuvY7S1Rc2hIIBTEBDEARB94XH482fP//VV181Go1V62w4nU6j0fjZZ5+FNuoxmjZv3jx16tSwsLCUlJRA3Qyr1frRRx9lZmauXbtWpVJ9++23L774okqlYucpKiqyWCwkSRoMBrfbnZCQwOPxTCZTSUkJAABBEIFAwGaWCYIoKioCAPD5fAzDJBJJUlISiqIFBQVTpky5ePHikiVLAvnrOXPmZGdn5+XlyWQyl8tVtQoHm31GEEQkErVv33769On1uqYg6O4omjF7CYsXV4r48XIJLLkBcY6mabPFYrZYFKGhqTEx9xzwAILqGk3TZrPZbDbL5XKdTne3Ul0QVG8YDLOmdzF2eCqk8IZu63/5LjvXEUGPOgZBrZFaU2xzSbk55fIBgd/DdUTQPcAjGQRBEHS/Hn/88aVLl86fP//atWtKpVIkEgEA/H6/w+FISEhYtGhRv379uI6xDh09enTq1KmxsbGVHoCVyWQSieTIkSOzZ8+eOHHiiy++GBMTExISwr4aExODIEhZWRmPx3M6nYWFhTKZrLi4GEEQpVLJ5/PZl1AUZQcVZBiGIIjQ0NC4uDg2CaJQKKRS6bp162JjY19//XV2sYmJicuWLXvnnXfOnTtXtRAHm49ma3Q88cQTy5cvV6vV9bGOIOhe7D7C4PaLeJhWKRFicAQtiHuO8nKD0Sjg85MTE9njGgRxy+l06vV6DMOSkpLEYjHX4UAQcCY113d9FvN7E39aJ9Hf5jocCAIuebg+sRVAkLibp2QOWIK8YYAJaAiCIOgBdOvW7fvvv9+wYcNvv/1mtVoBAEql8vnnn58wYUJycjLX0dUhmqZXrFihVqurLb+IomhMTMy3336bk5OjUqkC2Wf2pdjYWLlcbrPZPB6P3W73+/1SqVSj0SiVSgRBFAqF1Wp1u90+n48dnJCm6cjIyIpDDPH5/KioqG3btg0bNiwmJoadmJ6evnXr1u+++27fvn1Xr14tKyvz+/1skW4Mw0JCQtq1a/fcc8+NGDFCIpHU9fqBoHvyknSp00sxTEyIKEQAT0Eh7nm9Xr3RSBBERHi4olE/vgM1FD6fT6/X+/3+yMhIWDgLCgZ+hcbQ9VlPRHx45iHV5RPI3Ue9hqD6gYtkxvgWLnl4eMmfKn0uAmCbbDDg2T8EQRD0YMLDw+fMmTNnzpzy8nKSJKuW42iULl++fOjQIZ1Od7cZeDyeVCo9depUs2bNqr4ql8vlcjnDMIWFhQ6Ho0WLFoFKjjKZTCaTWSyWoqIioVAIACAIory8vNLgV1KpNCcn58CBAxMnTqy42Ndee+21117zeDwej0cqlRoMBrFYzOPxZDIZ7MoHBQmSpAwmU3m5Ry0RaCQCWHID4hxFUSaTyWazqcPCNLC0LhQEAm1SqVQmJCTUMOAzBNUPigFmhm95YabyzzOxB7ZgeE2jXkNQPaAR1CwLN0eky63Fukv7eaSf64igBwMT0BAEQdBDksvlXIdQf27evCkUCmsuDMq+WkOhRgRBMAxDEKRqssPv9weuNlEUrVRSgyWRSG7evFntkiUSCdvNOSkpqcbvATUKGJ/rCO4XwzBWq9VoNMrl8tS0NFjGtNGiaa4juF8Mw1htNlNZmUQsTklJqfisSYPBwNRkY2O329n7xw21TTacoxKXdI9zHcEDsDscBqNRJBJqY1XCZk3AsHFcR/TgYLO8p8ee4DqCB+DwEwaXX4ChyTExoqZNQJcnuY4IemDwMgCCIAiC7s3r9dZWdySmuqcX2QEDK/5ZdR4MwzweOLwG1GAEypgmJibCOjBQMHC53XqDAUGQ+NhYqVQKYCdTiGtut1uv1zMMU3H0CAjiEFubiCTJqMjIULkcELDjM8QxL0npXX6CYiKkQoWID4RCriOCHhJMQEMQBEHQvWk0GoIgap6n2sxyVdU+683j8QJvZxiGz6+m1waO4xqN5n4+AoK45ff7DQaDx+MJDw8PCwvjOhwIAjiOG00ml9sdrtGolEpYcwPiHEEQRqPR6XSq1Wo1rAMDBQGSJA1GY7nTCWsTQUGCYhiTG7f5iDCxQBPKR2GbbOBgAhqCoEdFSUnJqVOnTCaTQCBISUnp2LEjrJALAKBp+urVq1lZWXa7PTQ0tFWrVunp6cFZedBisZw8ebK0tBRF0fj4+M6dOz9oDRC73X7y5Mni4mKDweByudRqdWRkZHp6euvWrSt+ZRzHz549m5WVdf36db/fn5iYqFAoPB6PQqEoKSnh8XjszAKBQCaTYRhGEITFYvH5fC6XSywW22w2uVzucrkIgmAYJjAbu3CSJAEABEFUSjFLpdJAr2eKoqp2F6Vp2uVydejQ4QFXGwTVK4qizGazxWJRKpWxsbE1V62BoHpA07TZYjFbLPKQEJ1WC+vAQJyjadpisZSVlcnlcp1OB9skxLlAbSKZVKrTaqvtBgFB9YlhGKuPMHlwCQ9LUUoEWDBenEIPCh7tIAhq/KxW69KlSw8fPpyXlycQCGia9vl87dq1mzJlyrBhw7iOjktZWVlLliz56aefRCIRj8cjSdLn8w0cOPDtt99+7LHHuI7ub16vd+XKlT/++OONGzfYYfp8Pl+LFi3GjBnz0ksv3U+GC8fxtWvXbt++/erVqwRB+P1+AACPx2MrLWZkZLz11ludOnUCAOzZs+ezzz47ceIETdMkSSIIwuaF2R7KFEUBABAEYXPQ7D0Mn8/HTmc/qLy8nA2J7TnCMIxIJFIqleHh4W63W6vV6nS6Q4cOxcbGVoxQJpOFhIS43W4URcVisVKprPQVzGZzz549e/bs+e/WJQTVIbaMqUgk0mq1QviAJBQEHOXlBqNRwOcnJybCu85QMIC1iaBgw9YmQlE0IS4OtkkoGLgJSu/yMwwTFyKWCWBXhsYDJqAhCGrk9Hr9yy+/fObMmYiIiOTkZHYiwzAFBQUTJkzIy8ubM2cOtxFy5fDhw/Pnzy8sLNTpdIEcLkVRx48fv3379qJFi3r16sVthCyXy/XKK6/s3bs3MjIyJSUlML2srGz27NnZ2dmffvppzb2HcBx/7bXXduzYoVAo2CSySCRiM8s+n0+hUGRmZs6YMeOdd94pLCycO3cuhmEkSfJ4PKFQiOM4m0emKIphmMDTiBRFCQQCr9fLpqcRBGE7O7Npa4qiEARhP4WdWa/XO51OmqZnz56dkZExbty469evR0ZGBhaIIEh0dHR+fr7f74+Li6uUVTebzTExMe+//z7skwIFJ6/Xq9frSZKMiooKDQ3lOhwI+quMKUEQEeHhCtgmoSDg9/v1er3P54uMjFQoFFyHA0HA7/cbjEaP1wtrE0FBgqAZo9vv9JPhUoFKxIdtspGBCWgIghozmqZnzZqVmZkZHx9f8QCGIIhCoRCJRIsWLdLpdEOGDOEwSE4UFha+++67BoMhMjKy4nQMwyIjIw0Gw7vvvpuSkhIfH89VhAELFy7ct29fYmJipcIgISEhYrF48+bNWq329ddfr2EJn3zyyXfffRcbG1tYWIjjeCCHi6KoUCi02+1CodBqtb799tuFhYWhoaFsnRYAAI7jbNKZYZiK2WcAAIIgbIWNwBSBQMBmt1EUZef3+XxsJ1D2vW63u3///hMmTEAQ5Isvvpg1a9bx48cVCoVYLEYQBMdxh8Oh0+kQBCkqKmKz5AAAn8/ncDhatmz54Ycftm7duvbWKwTVDpIkDQZDeXm5Wq3WaDTwUgHiHEVRprIym90eplJp1OrgLCoFPVIoijKZTDabTalUxsfHwzYJcS5Qm0ipUMTGxMB6WRDnaIYxewmzB5cLeTqVlIfC88lGCCagIQhqzPbv3//TTz9ptdpqcyIikSg8PHzt2rUDBgxgE46Pji+//DInJycuLq7aV1UqVU5Oztq1axcvXlzPgVVy9erVNWvWJCcnV3u1xuPxoqKitm/fPmLEiPDw8GqXUFhYuGvXrujoaIfD4fV6q/7QAoHA4XCwX5nP55eXl/P5fARBSJKkaTpQRgPcySOzIwTSNB0oxwHuFOUIdJcOvIthGB6Px+PxpFKpVCotLS3Nz8/XarWpqak7duz44YcfDh48mJ+fT5JkZGTkE088MWrUKIlEsm3btiNHjhQWFgIA4uLievToMXLkSNirFAo2DMNYrVaTySSTyXQ6HeyeD3EuUMZUIhanJCc/akd2KDjB2kRQsLE7HAajUSgQwNpEUJBw4mSp0yfA0GSFRMSDt+gaLZiAhiCoMTt48GBoaGgNd/UVCsWpU6fOnTvXuXPn+gyMW36//9ixYyqVqoZ5VCrV8ePH/X4/txdLBw8elEqlNSQRpFLpjRs3Dh8+PHz48GpnOHToUH5+fmJiYnFxcbUtAUEQv99vsVgIggAAkCTJfuVAWeeK3ZzBneQyiqIVE9AMw5AkWbGXdKAoR2pqauC9t27d+vXXX7VaLQBAJBKNGjVq1KhRVUOaPHny5MmT775WIIh7gTKmCQkJsGQkFAzcHo/eYGAYJi42ViaVch0OBAG3263X6xmGiYmJCQkJ4TocCPqrNhFJklGRkaEPOJQ3BNUFH0nrXX6cpiOkQoUIdmVo5GACGoKgxiw/P18sFtcwA1uoNzc395FKQJeWll68eDEtLa2GecRi8cWLF0tKSgKFszmRl5dX8y8IABCLxXl5eTUvgaIokiTv9tAriqJer5ftwhxIUlequVER27W50kS2GHRFbGr7/kOFoAbB7/cbDAaPxxMeHq5SqWDNDYhzOI4bTSaX2w3LmEJBgiAIo9EIaxNBwYMkSVNZmd3hUIeFadRq2CYhzlEMY3LjNh8RJhYkSEQobJOPAJiAhiCoMQuURKgBW363fuIJEuz3rXnNsK/6fL56iuku7vMXrJTnrbqEihWZq1UpfVw1vxyYXimeGvLUDxoqBAU5mqbNZrPZbFYqlbGxsbBkJMS5QBlTeUiITquteUBaCKoHNE1bLJaysjK5XJ6amgrbJMQ5tjaR0WSSSiQ6rRbWy4I4xzCMzUcY3biEj6UoJQIM1tx4VATfL01bs7779J1Xx44cO/WdT7/PslVOARBnPn3h2YGVDHpl402Kse1bMLTi1MFTNt2kOPkSEAQFiYiIiHsml3EcrzQQX6MXERHRrFmzmtcMjuPNmjXjfM1ERkb+y1+QXQKGYWKxuIa0MjuEILiTer5bTjlQ4rliqY1K/6io0pXnI9jYoEbDbrffvHnT4/EkJydHRUXB7DNUL3x/LH1u+KqLZHWvOV2unLw8t8eTnJgYGxMDM33/hidnz8KxvZvGacTSULWuy9C53151VX/EhGrgdDpzc3PLy8sTExNjY2Nhm6wNNe0EIABAzavI5Xbn5ufb7PaEuLiE+Pjgyj4zph+nto/vseQC/HUbPP8fn00Zvi67yi9JFh9bO2Hok9G6NGFiy4Q+E6dtvlTkp/LsXouXiJOLE0LFQZB9JooPLZuQ0SparRCGRiW0HzxtXaal8nOtUO0ItoMiVbBz8YffU90nTB8eVnZ8y4YPl2DLFg+Oq3CNw9M98+bbHcnAGRHjzPr+q4spLaJQutRgQlKfmTmk+V+1QhFxTDTnrRmCIC516dLl559/DgsLu9sMHo8nNTW1Y8eO9RmVxWI5cuRIXl6e2+2OjIzs2LFj69atH/pROJIkN27cuG/fvrKyspCQkJYtW7766qsxMTHVzkwQxB9//HHhwgUcx4uLizUajUwmq7YwhcPhaN26dc11ou9Gr9evXbv23LlzTqdTKpVGRkbGx8cDANhEMIqiISEhzZs37969+z1HPuncufOqVatomq4YJE3TLpfL6/USBIHjuMvlysrKWrJkCQDA5/MVFhZ6PB61Wp2QkNCiRYvHH3/c5XIZjUaSJHEcR1EURVEej0fTdKDXM0mSPp+PYRgURdnpKIpiGEaSJJtrrpS5ZoMhyb/PshiGwTCMoqiKvyPDMBVrPlIU5XK5nnjiiYdYpRDEIa/Xq9frSZKMioqCg2FC9Ykp+2X1qj3Hn51S6UrQ5/OVGgwEQUSEhytgm/zXiBtfDu3x+oHyqM7DJg6LJ/KO7Pzh43GHTxYdPTirJRwz7/74/X69Xu/z+djaRFyH03jcbScABdxtFeE4rjcYPF5vsNYmoou3z5i6MbssuQ/BdSjQv8RYflu97tfjT4+mK00+/G7PcdsKVa2GjpisE5jP7d+9Zs7w3/K+2j+nTZxEGBwtkrHsn9Fz6P8K1e2Gjp+pE5rO7/l2zWtPnSw58Pv77eAIJ7UuyBLQ+OWff74VO3TFK33jMADS1fbcWT/9kt3/lcf+Hn4KUenad9Ld+YtxXVizydtjyvjHQxC/yWiT6zp27dwC9smBIIg1bNiwrVu3FhUVVXsxQNO00WgcMWKEWq2un3homl63bt3mzZv//PNPsVjMFh32eDzDhg177733kpKSHnSBu3fvfu2114qLi1EUZfOk+/btW7NmzejRo1evXl1p5tOnTy9evPjo0aMSiYSiKIfDUV5eLpPJwsPDKyWV/H6/zWYbP378Q3zHGTNmbNy40eFwsGe6bJKXzfmyo/xJpVKJROLz+dq2bfvqq69269athqU9+eSTPXr0uHDhQkREBDvF4XCYTCa3280unE0Nf/XVVwzDsIljmqbZVSGRSFAUjY6OJgiipKSEfTtFURRFsZEExg8EALhcrsCH+nw+Ho/HBhzo8hzIQbO56YopaTb7zCa1AzlohmF4PF4gbACA0Wjs378/TEBDDQhJkiaTyW63wzKmUP2ivObb2ecOb/lowbcGOqLiCxRlKiuz2e1hKpVGrb5bZX/oATD23QvfP2hLmPD98XUDIlAAAD330Mze/T5fMn/76D3jIuFmXzOKokwmk81mUyqV8fHxsE3WkrvuBKA77rqKArWJFKGhqTExwfnEEnVr0+RZe4wMAjeYhozyWouzL53csvKTb01VtlOqYOPy7/MVT23c//moSNTsJczj+sWNGP9/32z+fUankUGS3DJSv1QAACAASURBVKXyN370db7q2Y1/bB0TgwEAwNzRb3Xus2z1sl3Tt41UwQNgLQuu7Z0qyr7miny8TTS7j8Ti27QOL7/2p/6uNzx92dv/d7Hp+FGtpAigy4wmJjwqnPbaTGYnAR8agyAIAJVK9e6775pMJqvVWuklkiSLiop69uz5xhtv1E8wNE3Pnz9/9uzZZrNZq9VGR0ezXYNTUlIOHDgwYcKEGzduPNACN23aNGbMGL1eLxaLRSKRUCgUiURisdjj8axZs6Z///4VZz548OAbb7yRlZWVkpISGxubkJAQFRWFIIjX683Pz7dYLIE5PR5PYWHhW2+91atXrwf9jkOHDl2xYoXb7WbT62yfYgRBaJrGcZzH44lEIp/Ph+N4UlJSQUHBuHHjNm7cWMMC+Xz+hx9+GBcXZzKZGIaxWCz5+fl+v59dJriTDqYoiv2ToigURdlV4ff7cRy/ceMGWwa6Yt0MVqWxBBEEwTCMnYckSYIgBAJBIMcN7lTe4PP5DMPgOK5UKtmkM4IgAoGAjZZNVbNviYmJYR91pGnaYDCkpKR88MEH8NIUahDYzS0nJ4eiKJ1OFx4eDrPPUL1hTBsHx6e26//Kyt/LAlcBbBnTm7m5OI6nJCdHhIfD3WntIC8fP2XHHpvw5tMRf61QVN3rzUmd+c4Th8/BUQtqZrfbc3Jy/H6/VquNioqCbbK2VLsTgCq62yqyOxw3c3PdbndyYmJ00NbLIm6ufmXe8aQRw1sEWYdI6EEw5u8Gt+rebuTclWes1Wyn7ksnrhAhXYc8FcbkWN1OP5EU1X5M72jUm5ddGDSVcl1nT1zCQ3qOHBpzZ0uRthmUEYt6bmTfDpogG5Hg2uBps8nMhGlUd47cqEqjYsymMhokVHcwpwr2bDgWNnRZBzkCAKDL9GVk2eGPJm645aAALySxy8hpU/qlSO5cLrEPa1d8/92KgXIuEFjQRhj84Kp7aJVSco1Ar169du/evWjRoqysLLlczqYUvV5veXn5iBEjPvroI5lMVitf+Z4L+eabb1avXp2YmMgmKwN4PF5MTExubu5bb721Y8eOGgbKq6igoGDGjBler7fq/Hw+H8OwvXv3Lly4cMGCBQCAwsLC999/32w2azSawGyRkZEoitpsNrZsBUVRfD7f5XIlJCS89957r7/++oOulmXLlu3cuVMoFGIYRhBExb7A7AwEQWAYJhAIXC5XaWlpfHw8n89/7733WrZs+eSTT95tsc2bN1+zZs3cuXNPnDjhdrt5PB5FUWz5CzZfzH5QIB9N0zSbO8YwjB3xj53I/v9unxJIrrGVNwAAFEWxXZvZHDSCIGxKnSAImqaVSqVEIsFxnM/nsyl19rKTjQRBEKVSyefzHQ6H3+93OBzdu3dfunRpSkpKrW9fjWyDrU91t7tr6D+Ky+XS6/UIgiQkJEgkQdJHBXqEIKqBK4+l22nAWH6cPmRZMQBuj8diMDAMExcbK5NKuQ6wcSHcQKlr0b2NtkKeChFLxAgg/TjM/d2N1+stLS2lKComJqZiuS2oVlTdCUCVVF1FXq+32GgkCCIyIiK4axP5s5a/suBSi/d/m0FN2bHDw3U40MNCFBkr9zSx04Cx7p8+4f8qb6e85uMXL+kVnWZ2+qKlQoWID4DP6fIySIRGETT36nitJn22dnhq+wpFIUmn08OgUX+nJaHaE1wJaAr3k4hYLL6TM0bEYhGC+/FqL+MYx8ltP7m6vd07HAEAAMZpthFimfaZ1//TNQYYs35e+9n6xes1q6a1l7GLW7JkyS+//BJ4u1wut1gswdydB8fxin0SoQfCPp4PPQS73c51CLWvZcuW//vf/37++efMzEyTySQSiRITE3v37t2pUye2l1+tfErNy8Fx/Msvv1Sr1SiKVqwdHBAWFnbs2LGvv/568ODB9/NxM2bMsNvtIpGo2lQXgiA8Hm/16tWvvPIKiqKrV6/OycmJiYmp9NFhYWEymczhcNjtdpqmW7Vq1aJFi379+iUnJ9tstvsJo6Lly5fzeLxACphNyFYKj00N83g8i8WiVCrFYrFSqfzyyy9bt25dw5JjY2PXrVv3wgsvXLx4EcMwj8fDlrxAEITt3Vzxvh2CICRJsknwiiukUjyV+jWz/6ZpmsfjCYVCmqbZAtBRUVFSqTQkJITH40mlUqfTSVGUWCyWy+XR0dFdunTp2bPnl19+uXfvXqPRyCamO3Xq1KZNm6ysLL1ezzAMO1tGRoZAIKiLvTrc3T20utvdeb3eGu52PBCGYQJFYwLqbhAhHMf1er3H42HLmAbzaRJ0T5WaTW1haw1VbpO128mOp0lrpwEAMPpLISig3OaioqKYIC1j2vBJnl51/ul/TqKLd/14ihC06tDqHgM1PKA6apP1vJ8kCMJoNJaXl8PaRHWowk5AXpdZoDrqoMbWhavP/STtsd4uKIgKC9Oo1UHeJj2Z/5245EaHxcdebwqWcx1MEKrXNvkvF8pTpbVSAQAYY7b8n42OYhgTHZ+aEdVBxI+Q8nGXvdSgv3Lkq1k7bdED3ns+Nmhyu9Km/cY2BQAAQPvKbVZz0ZUDn83abokevOz5+KAJkmtV2+RDN8vgSkBjAiHGOLw+BojYpLLX62P4IYLq5qWLf919QfPksqZ3RhxUZry7PePOq3HtR7w25NKr3x7Lerl9FzEAAACtVtu+ffvA+2/evMk+K113X+ehMQzDJj7g0MkPIdALkutAGh62iEFwDY5ce8LCwsaNGzdu3Lg6Wj5BEDWvuvPnz1+6dEmr1d5tt4MgSGho6MmTJ59//vn7+cQzZ84E6kVUi8fjlZWVHT58OCMj49SpUwqFotqZRSKRSCRSKBQikejjjz+uYcDGmv3++++lpaUikSjQJbna2djewWw62OVySSSS0NDQvXv3ms3mqKioGpbvcDg8Hk9iYqLX6y0sLGT7fZMkyWacKyWg2RgCGUB2YmB0wcDEu0XIdiFnU9iLFy8eOHBgzd99zpw5c+bMqTRxzJgxNb/r34O7u4fGthz2HkYdLb8WF+X1eh0OR8WJdVG2nqZps9lsNpsVCkVqamqQPrQLPYhKzaa2LmIpivL5fJXbZB2MukbTdJnF6WEAACBFq5XAs+J64r/907znZx90J744f3xS7R5gKjWb2rpRR5Ik+7BRxYl1sZ9kGMZqtRqNRrlcnpqaCq/UGoE62k9W3ybrYD/JMIzF7vYwgKGJFK1WGvzXcc7f3528orDbsu9fTuGBXK6jCUZV95O10izZwdgrt8l/v9zq2H2E3uWX8LEUpUSAoYDKXT6s79wsEgBU2WHG3o/7RwfhtQt1c/lT7eaeJwBAlV0W7F0zNBiD5EilZlPxKvtBBddREw3TqJFbFhsNFBgAANB2ix0Jax5WzU9P5R05UpT81Ft3vXeCqmOihYTN6WMA26N67NixY8eODbyekZERGhoanAloiqJsNhufz5fL5VzH0vB4vV4AgFgs5jqQhsfpdPr9fplMBvMOD8FqtYbW+LCbxWIRCoU1X6uIxeLS0tKal8MiSbK8vLzmX4otvpyTk9OrV6+LFy+mpKTUML9EIrl+/brdbk9OTr7np1crJyenai9jUOVUvuJQfmwvaTbba7VamzRpUsPy8/Lybt682aRJE6fTec8kcrUvsbnvmr9FpcEGaZrOy8u7n1+EE3B399DKy8txHA8JCamj3R2fz6+tGwPsNlLXv7LdbjcYDEKhMDk5WSSq3S6PEGfqqNnUT5t0ulylej3m9osRgEnVMNNXP/DiwyvnzFz03TU8edjanZ/0VdbyhVKlZlNbF2LsQMd13iadTr1ej2FYYmIirE3UaNRRm2Qf1KvrNulyu/UGAyj3ihCAySIaQC8ixn5g3tTPzBnr94xNwgCAJXarU3f7SQzDKrdJVy0/RukmqEKXjwEgVi4KEdw5cKNRQxasTiw25l06uH7bigFjsL1bprYPtmJaaMyQxV8nFurzzu1Zv2nRgMHY3l2z28u4jio4VGo2KIo+9GVOcJ3MYfHNm0p3X8oqG5EUiQBAG7IuG0KaNY+penVIXj963Kgb3DkisDl6Tq1+82ty1EevPxGKAAAAVZJXgCubx4UEY4YZgqBHTg2dggPYfrv3szT2ruP9nJEEblHez6f/m26b9xn5Q3901YrS9aMWu7JC0EPAMEwoFErrrOit1+vV6/UEQURGRioUijr6FIgTlZpNLSZWBAJB5TZZS11ZAQA+n09vNOI4HhEeHipTwx5I9YSxZX4586V52674Y3vP2LR83gvp8tq/iKrXNll7/H6/wWDwer1sbaI6+hSIE3XUJtkbdXW3n8Rx3GgyudzucI1GKQ5rIF2HGPvB+ZM3eAZvWD4qeCowBJ9KzYbtUfTvF4thWDVt0mX+90tmMQBQOF5U7o0S89US4T8iRqRpT/RNAwAMHz0ybWzLeasX7Byyb0xkcDUCJCSt56A0AMC4SSObDWg5Y+mC7aP3vQS7QQNQq20yyNan4LF+/eJvf/fZN2fzinJPbVm9s0g7oF+6AAAy79DGr749Y/xrp00VXLxkj2rWtMJteXGLjunEiXUff3308s2c7FO7Vn6yq6z5kP5NgyvFDkHQoyomJoYdEK8Gfr8/Njb2fpYmEAhkMtk9c74MwzRt2jQsLKxVq1Y1fzo7sN59fnq1mjdvHigIVfGYVOn4FPiTYRi2pwZJkhRF3fOjY2JiAqMLBp76qeHgV+1Ld6uXXXGGivWgURRt2rRpzYFBUANFkmRpaemtW7dkMllqairMPkOcoyhKbzDk374tEgp1Wm1wD6LVuFBF30/q1n3a9/aO7+y6dPnXpcPrIvvcEFEUZTQa8/LyBAJBamoqzD5DnKNp2lRWlpufj2FYakpKWEMarYE2XblSSui/Ha3FRFJEJEWkLWdnElTuio4yKS993hnY5aNhohmmzEuwY0mmKKWaO9ln/PbJLTt2nyipeN8FS+jRPR3zX79eECTd3/H8I1u2bD9R9M8gMzLSMd/17LwgCbIxCbb0LC952DuziS83rX57p08S02rAnMmDEzAAAFmS+fOeW1SnYR0iAABM2ZXLBnFq09iKgzXL2k76YLZi044tH+0px1SxqW1f/mB0b3jHAoKg4NChQ4cWLVqYzeYahkp3OBzdunW7zwW2bdt23759fD6fHQ8qkPnFMIx9KIYgCJVKNXjwYD6f37lz5y1bttTQOchutz/zzDPR0dE1f+iFCxe+++6706dP2+12oVDYrFmzoUOH9unTRyAQZGRkaDQau93OltRgxwasuoRAjQ62R7Ner3c6nZGRkT/88AOfzy8tLXW5XDKZrGXLliqV6uLFiwUFBUVFRV6vV61Wx8fHl5SUyOVydvngLmMgsBMxDGOLPoM7hTXYYguBQhwVq21UFKjJQJKkSqXq06dPzesEghqcQBlTqVSq0+kawEO7UGPHMIzNbjeaTBKxOCU5WSCodgAYqI6Q11aOnbiptPmbu35Z3DscXjzdwdYmEolEWq2WHXkCgrjlKC83GI0CPj85MbEB1stCVZ3Gzn2n999JPcZ2avP/jvjajnu5R5y6cwzc+TRATpzUu/wozogAwAQCHlrh6u/WTzPf+KHJf9ocffnvHu+My+lkELFYFCy3TXJ3zHxpa5OPOx2dlvB3kOXlTgYRS4ImyEYk2BLQAGCatqPntx1daaqo2zvf/52VQSIH/feHQVXeyo/sMGpOh1F1HCAEQdBDkEqlI0eOnDdvnkQiqbbsrNlsbt269XPPPXefC1y8ePGxY8c8Hk+l0sYEQfB4PAzDSJIcOXIkexk/ceLEL774gs3tVl2Uz+ezWq2TJk2q4eMsFsu8efM2bNjA5o5RFGUY5uzZs1u2bOnWrdtHH33Url278ePHf/LJJ2wGnMfjsSnmSnleNtVFEASGYQaDAUVRkiTLysrmzZvHMIxUKlUoFDiOr1y5kqIokUhEURSby6ZpWiAQ+P1+q9UK7qPMNP3/7N13fBPl/wDwW9k7TbonHZSyQRQq/hAQEb6IAk4ERAFFRRTFLeCCryg4AL8uFEFRZAjiYDgQZIqCrFI6obRN2jRNmn3798cjMaZpKaWlLX7ef/iql7vnnrs8XC6f++TzCAJFUShOjRZSFIUmgG7oGFH6czBOzfP8LbfcEh0d3chpAaDD8Xg8FosFx/GUlJTW+8U6AE3n9XotVVWiKCYmJGgifUiB1hXYuWTJfrrvC6tegejzX1BtIo7j4uLi2u08EOBfxe/3W6qqWJaNiY7usL8OwU1XT3nh6pAFfNHrP634xTHg/jlzr2p/cSnQOJoXLJ5AgBNiVTKdTlr/y62k19WDNGs3f776t7ue6o/K5vM1Wz7+Ol80T70mq5284ZK+gwfpVm5esfy3e1/uj26K+eot767JF2OmDu7aTjp5OYFTCgAAl8i0adP+/PPPDRs2xMfHh6YtiKJos9kSEhLmz5/f9KlHzWZzXFwcmvovrOQFz/Mcx/Xs2fPNN99EC7t06fLee+9Nnz69fplXj8dTWVn53HPPDRkypKF91dbWTp48+aeffuJ5XiKRBPMlRVHkOG7Pnj3Tp09funTpq6++unv37v3796N1ULQ3NAYtkUhwHGcYBoV6JRIJy7Iajcbj8aCXPB4PihqLokgQhNfrpSgKnStBEGiabihtub7gDIccxwmCgPKysXORZdR5mUwW7AzKm5ZKpegEMgzTt2/fRYsWNfHtAKD9YximqqrK4/GgMqYd50e74LLFsmxVdbXb4zFFRZmiomBMtgm+aN/+KkGq3fPq/VP/GX/Gtdc8unjyv+sbOMdxVqvV5XKZTCaz2QxjErQ5nuerbTaH0xllNJpNppaa4hiAZuNFsdrLOAKsQS5J1ioJHBPrIqyGG4bPe+SKH155f8QNBXfc0DNOtB3b9f2mo3WJN7/53DXtZQZ1POqmeU/l/vDs4hG5J+4YfUWcWHXsp682HXIm3vbRc0NgstmW96+6owAAgLYklUqXLl0aFxf3xhtvKJVKpVJJEATDMG63e+DAgS+99FLfvn2b3tqcOXPq6uoSExOtVivHcaG1lVHg9aqrrqKovy/yEyZM0Gg0b7zxxtGjRzUaDcpQ9ng8nTt3nj179pQpUxrZ18svv/zLL78wDIPis8HlwSByQUHBc889t3Hjxl9++eX222//4Ycf/H4/Cj2jjGM0Wy7HcRzHoYkLUE0MvV5fXV0tlUrR/bRUKq2trSUIQiqVohY4jqMoCm2LdkoQRCNZzKEEQVAoFCaTyel0BgIBVNM5GL+WyWQxMTEej8fpdKJAOUVRHMcxDEMQxMiRI7/44guY5h5cHgRBqKmpqamp0ev1WVlZEX+EAcClJAiCvbbWVlOj1Wgy09NDP63AJcaVnS7jRE/e1lV5Ya8Q0dStr0/u2ia9uvSCtYk0Gg3UJgLtgSiKtQ5Htc0GtYlA++EMsFYvLafIdINSRjb+OETa7YEVu+OWvfTRlq9W7Hay8tjMPvfNf+D5SVfGtaPHKLJuszbtTlj40jtfffXuz05WEdv5qvvenP38fQPbUycvH3C3BwAAl45cLn/ppZfGjx+/bdu2wsJCn88XGxs7YMCA4cOHX9Bt5cGDB9esWZORkUFRVFRUlNVq9Xg8KLaLQq5yuXz16tUPPfRQjx49glvddNNN//d//7dly5ZDhw7Z7XadTte9e/cRI0Y0Xvr55MmTH3zwAYrPRkwFoijK5/MdOnRozZo106dP37hx4/79+5csWZKXl+f1eqVSqcFgSEtLI0nS7/eXlpYeOXJEr9crFAqtVmu1WoNFq7Fz5ZtRYnUwsxvFoNHRYSFFnOunQgeX4+ckJSWhaPhbb73122+/1dXVaTSaHj16jB07tqys7NSpUx6PR6FQVFRUVFZWOp1OpVLZpUuX6dOnDxo0qOlvBwDtWV1dndVqlUqlnTp16oAlI8FlyO3xWKxWkiRTk5Mbf86Hx93/o+/+S9axfyfZyOV2dnlb96KNud1ui8VCkmRqaio8e25X/rUXAY/Xa7FaMQxLSkxUN1ovqwOfIjLjiV+dT7R1L0ATeVne4gmIGJagkWuk/wgk4jF3/VgWqRQuruo25qm1Y566RF1sHlzd7faX197+clv3418BAtAAAHCpZWdnZ2dnX0wLO3fuVKvVKGWMoqjExMT66yiVyp07d4YGoDEMMxgM48ePHz9+fNP3tWvXLolE4na7GwpdobrJJEnu3Llz+vTpGIb179+/f//+EVceP358TU0NmkdeEASfzxeajInKRgdnDkT/RUUzmvgz2GDatVwuZximtLS0rq6ua9eu77zzTtMPGYDLAypjyrJsTExMWO0dANoETdMWqzVA07ExMR22jCm4rNA0bbVafT4f1CYC7QTDMFXV1R6vN9psNhoMMCZBm2N5ocrHuGjOpJSalVIYkaDZIAANAAAdT0VFxXknZJfL5eXl5S2yr9Ak5YhQSY2m7C605yzL+v3+0ANBSc0oghzcY+jfTYdKkeA4Xl5e3rXrv+UXxAAgPM9XV1c7HA6TyWSCkpGgHQiWMTXo9clJSTAmQZsL1iYyGAyJiYlQmwi0OUEQauz2GrsdahOBdkIQRbufsfkYrUySZVRRBASfwUWBixoAAHQ8TcmGQBHYS7Mv7Fzq8XlXC63CfGlA5gj4V0FlTKurq5VKZUZGBpSMBO2Bs67OWlWlkMuhjCloJ5xOp9Vqlcvl6enp532iD8AlUOdyWauqpFJpp9RUqJcF2gM3w1k8NInjqTqlUgKP6EALgAA0AAB0PMnJyYFAoPF1AoFAcnJyi+yL5/nG5/1DMeWUlJSmtHb69Gm1Wo1hmEQiUSgUoeU1gkWcQ0PnaAJDnueb3meU+4xSp1NTU5u+IQAdmsfjsVgsGIYlJSWhf2UAtC2v12upqhJFMSE+XgNjErQDqDYRx3FxcXE6qAMD2oFAIFBptbIsGxMdDbWJQHtA84LFEwhwQrRSalTAY2PQYloiAM389MzQ+bL/bnthYNhkwWLNhodu/jj17a+f7AuBbgDAZe3UqVO7du06ceKE2+2Oiorq06fPmDFj4uLiwlbbv3//1q1bCwoKaJo2m80DBgwYM2aMVqvFMMxqtW7cuPGPP/6w2+0ajSYnJ2f06NE5OTkYhuXn52/atGn79u1lZWWCIOj1+oyMDJfLRdN0Q2k7gUDA7Xbv3bv3559/JkkyLS1t6NChQ4YMCQ3sVldXb9q06eDBg3a7Xa1WZ2dnjxo1KqxmNIZhgwcPZllWoVBwHBf2A1WO4wRBEEWR5/m6urpt27alpaWhuc5GjRo1ZsyY+tMbDhkyZPPmzajMIkEQKpXK4XAEZxdEMxCiMDSabBD9L3opWBW6oXchGL8mSVIURYqirr322szMzEbeOAAuDwzDVFVVeTweKGMK2gmWZauqq11utykqymwywZgEbY7juOrqaqfTaTKZzGYzjEnQ5oK1iaKMRjPUywLtAC+K1V7GEWANckmyVgklN0DLupjAMO8sK6hwCxhz9PDvf8iPnjhh+GcAWqRP7dj12x53BY9BABoAcLliGGbhwoWvvvqqRqNRKpUkSXIct2nTps8+++yhhx66666/ZgR2uVzPP//8xx9/rNVqFQoFQRAMw6xdu/aTTz6ZM2eO1WpdtmxZQUGBRqOhKIrn+e3bt7/yyiuzZ8+mKGrBggWCILAsi25My8rKTpw4IQhCYWFhZmZm/Ri0z+crKioiCGLnzp0ymUwUxd27d7/zzjs333zzwoULUVh87dq1b7/99qlTp9RqtUQiQXtcsGDB448//uyzz4a22alTp0cffXTJkiUcx6HMYgzDUH9QWjRKfxYEwWaz2e12giAKCwt37NjxySefPPzww5MmTQrt26233vrFF1+cOHEiJiYGwzCTyeTxeHie53me47hgBBm1GSzWgdKfUUiaJElBEARBIEkyNC06+E0SBaBZliVJctasWfANE1zegmVMtVptZmYmlIwEbU4QBHttra2mRqvRZGVkwJgEbS5Ym0itVmdmZkokkvNvA0BrEkXR4XRWVVcrFQqoTQTaCWeAtXppOUWmG5QyEh6HgJZ3EXeEonPj9N73bqH/+t+Hen8dYSVcMfDeLnDbCQC4TAmC8PTTT69YsSI5OVmlUgWXR0VF2e326dOn+/3+qVOn+ny+6dOnb9++PT09PfRrj9lsPnPmzMiRIwmCSExMDC0WYTQaA4HAq6++ijJ5BUEIrQcnCAIK1546dSo9PT1013V1dadPn5ZKpWGhKLPZvG3btpqampUrV27btu2BBx6IjY0N2yNN00uWLLHb7W+//XZosvMzzzxTUlKyadMmhmFQ/wOBACr6HCzNgYLjKHYsl8tZlj158uSDDz4YCATuu+++YFNKpfK111576KGHSkpKoqOj5XK5yWQ6e/YsKruBDpbn+bA60cF9oTxo9F+0PuoAWgHtXSKRoOjz3Llzhw8ffqHvKQAdSF1dndVqRT87gJKRoD1wezwWq5UkydTkZKVS2dbdAeCv2kQEQaSkpMCYBO2B1+ezWK2iKCYlJqpD7uEBaCt+Tqh0+3lRTNDINVKI34HWchFjC1cPfPS95eN4jPvjvZkrpdPfuLdHWGs4IY/uM3xEJtQrBwBcptavX798+fK0tLT6abYajSYxMfHRRx/Nzc397rvvtm7dmpqaWv+3dUqlkmEYhUJR/0tRIBBgWRYVuAhLcyYIQiqVMgwjlUqLior0ej2KPQUCAYfDoVQq09PTw8plkCSZmJj4+++/P/HEE3l5eQkJCfVLxMpkspSUlE8//bR///4TJkwILler1R9++GFaWtrixYs5jkNVm4N5yti56DOGYShMzHGcVCqlaVqr1T722GMDBgzo3r17sLUePXp89NFH8+bN+/bbb1Uqld/vRxuiGDSKMof2Krgj9CrHcRqNRi6Xu1wujuNC1wnGqZOSkubNmzd58uT6bxkAlwdUxpRl2ZiYGL1eaMy7lQAAIABJREFU39bdAQCjadpitQZoOtpsNhoMbd0dADCGYSwWi8/ng9pEoJ1AtYncHg+6TsKYBG2O5YUqH+OiOZNSalZKYUSCVnUxDzdkmddPzsQwjM0o31guu+PeKQPg10wAgH8RURRXrlxpMpkkEkkwEhpKpVJpNJoPPvjgwIEDMTExESu72e12iqIYhnE4HGazOewlVEoi4t4JgiBJUqPReL3eadOmkSSJ47jdbl+1alVmZmbEO1ocx2NjYz///HOdTtfQhIEURZnN5lWrVo0fPz60w2q1esGCBVOmTHnmmWe+/vprmUzG8zyaCLF+tjLP8xRFSSQSVGnxk08+Wbx4ceg6WVlZq1ev3r9//08//fS///1PIpFoNBocx71er81mk0gkwVkERVHkOE6hUKhUKqlUKpPJrFbrlClTVCqVIAg+n08ikdhstlOnTvl8PoVCERMTc8MNN9x+++0GCH+AyxTP89XV1Q6HIyoqymw2Q8lI0OZ4nq+uqnI4nQa9PjkpCcYkaHPB2kR6vT4rKyvskTwAl54gCDU2W43drtVoMtPToTYRaHOiKNb6mSovrZVJsowqCuo9g9bXEhc+yaB5Wwe1QDsAANChFBUV7dy5s/E57nQ63U8//VRWVtbQah6PBxU19ng8oQFohmFcLhcKK6OSFPVjyiRJ+nw+tVodGxs7c+ZMDMOefPJJnU7XSD4FqjHX+F2vVqvdu3dvXl5et27dwl5KT09XKBTx8fFRUVHl5eUsywYrU4dClTFIkkRR8v379/M8H/b1jyCI3Nzcuro6r9cbzNdG8xwGq5SglnEcl8vlycnJaKHf79fr9XPnzm3kEAC4LAXLmCqVyoyMDCgZCdoDp9NptVrlMll6WlpD8+ICcCmhMSmTyaA2EWgn3G53ZWWlVCrtlJoKYxK0B26322KxkAKfqlMqJfCIDlwiLffkjXNXFBRUuDkxbDkRlXlFhhGepgAALjsWi4UkycbTamQymcvlami6G57n0cR6BEGEZTqj/0XJxcGqx2Gb4zju9/u1Wq3FYkFL0DeuRvoTOm1gQwiCoCiqsrKyfgAa7QKFvVAPGwp2B3uOYRhN03a7PTo6upHWkIjh7LCTI5VKg8cLwL+H1+u1WCyiKCYlJdWvn9MiPB5PIBDQ6/UdKzOLZdm6ujq5XN5Kp6X1OBwOnudNJlNbd6SZ0JgUBCEhIUGj0bTSLvx+v06n61izxnEc53Q6ZTJZK50WjGyts+F0OjmOi4qK6qCVAYK1iWJjY1upNpHP5/P5fFqttmM9AuR53uFwSKVSrVbbKjtotd891NXVsSxrNBo76E8rAoGAxWJhGKb16mX5/X6v16vRaFrrEaCsVSqni6Jot9slEolOp2uN9luPy+ViGMZgMHTQn1bQNG21Wv1+P6pN1Bq7CAQCHo9HrVZ3uMctNTU1FEV1uNJ2brebpukOcQPfMv0LHP9g4s2PbCgORAhpyG9d51x7C+RDAAAuO1KpNDgFX0OCk+ZFfDX4Ba9+fLmJ3/3Q53rwm7lEImk8uNzEZkVRbOiblVQqDQaXG4qMR9wq4vKwDkc8V6g2dOj/dqxIBAAXief58vJyt9sNZUxBO4HGpMvlMplMZrMZxiRoc4IgVFZWosJfMCZBeyCKosVicTgcBoMhJSWlgwbQweVEFMWqqiq73W4wGJKgXhZoCy0RgBbKVz722IazpiEPP3J7vzhl2DAmU66EQAEA4HKUlpaWnZ1N03QjWTB+vz82NtZmswmCEDG3VyKRBAIBURTD0hakUqlCoWAYBjsX6q3fuCAIMpmMpun09PRgl77//vtG+tyUr2Qsy3Ic16lTp4ivpqWlHTlyRKvVouTuiPcuwZAxCtAbjcaGshvS0tJomg4GnWUyWcQAdOgZ9vv9weMF4LJH0/T777+/Zs0aiqJaO6QiCAIqntOxYjdoplaCIDrcVylUXqn9p6uEoWl63bp1mzdvhjHZEDQmcRzvcPlxl3hMopkkLh5N019++eUPP/wgkUhgTEYEY7KJamtrW6QdhmE2bdq0e/duGJON4Diu447JS3bCKysrW6QdhmG2b99++PDhSzYmO+KNGYzJpjh9+nSzt22JSzn7596DdNI9H21acn0H++kjAO0Gy7KbN2/evn17aWmp3++Pi4vLzc298847Y2JimrgCaDqHw7FmzZpff/21vLycoqjU1NShQ4eOGzeu/q+E8vLy1q9f//vvvzscDpVK1a1btxtvvHHQoL+q3sfExHTv3n379u2xsbERd0TTdGVlpVwupygqPz9fo9HodLqwHz9qNBqPxyOKYiAQKCgoQMFWkiRFUUSBYBSQZRgG5Rqjqsro45zneblcnpqaOmTIENTa9ddfv2DBAp7naZpGN6NKpdJgMCgUCrSCx+NJTEy02Wzl5eVerzfYrFQqValUOp1Oo9HU1tbefPPNycnJO3fu/Oabb3bv3l1RUcEwjFwu79SpU0xMTG1trclk0mq1VquVIAj0lSZ4RKhBFDonSdLj8QwbNqyhj8M+ffr069fv9OnTUVFR6Gyg6Q1D71d4ng+eNJqmfT7fsGHDmvA+A3A5mDp16u23335pboXRtJ9oCtBLsLuWgorOo8tjW/flwqATfsm+57TU+bnrrrtGjx4NY7Jx6JMRxmTjWuptHTt27JAhQy5NjBJdcGBMXjKXeExi55sopYlGjBhx5ZVXwphsHIzJJmqRak6DBg3q2rUrjMnGdegxeSlPeLNjUC0x/ui6ugCR3j2nVYoDAfAvUFZW9thjj/3www96vV6hUOA4XllZuWPHjrVr1z799NOjR48+7wptfQQdyc6dO+fOnXv8+HGdTofyaktKSr766qvPP/980aJFXbp0QasJgvDWW2/NnTtXrVZrNBqKoqqrq48fP/7+++/fc8898+fPR7cCM2bMWLt2bcQSVzU1NahUsdfrVavVLpeL47iamhqj0ZiQkBD8+FepVKIoiqJI0zRBEKIo+nw+9JkdvLMJ5q2gj3OWZdGza7lcTtP02LFjk5KS0I6++OILjuPsdnuwTLPP56uqqoqPj4+OjuY4zmKxdO/evayszOfzYSHFoFmW9fv9NptNq9UyDDN16tSZM2euWLECwzCfz4c+z0RRPHv2rFqtpmm6sLAwMzMzKiqqtrY2WIgDHQh2rpIG+tvn8xUWFqJCYPXfDqlUevfdd8+YMUOlUsnlcqlUqtfrUWFo9AnKsqxWq0UJ1OgHtg8//HBOTk7LjQgA2jWDwWAwGNq6FwD8DcYkaG90Ol2HKyMLLm9qtbrDTUsALm8qlUqlUrV1L8C/HfnCCy9cbBuE//Dqj38UcqeO6aLoOE84Pv3004kTJ7bPZzIoF5IkSZhMvBk4jsNCSuK2f9XV1ffee+/BgweTk5PVarVUKkW1F/R6fW1t7cqVK1NSUubPn9/ICj179szKyrr4njAMw/O8QqHocA/9mm7v3r1PPPGExWKJj49XKBToZKIc4eLi4n379g0aNAh9r3799ddffvnl5OTkqKgoFBiVyWRqtVqn0+3Zs+f06dMjRowgSTIuLi4tLW316tUYhqFnA2hHVVVV5eXlUqm0U6dOWq1WrVbjOO5yuSiK8vv9NE3rdDocx91ud2lpKUmScrmc53mSJFmWRQ8wUaw5dCo/7FwtDhzHUbofRVF33HHHyy+/jDacOXPmmjVrUlNTWZYNBAIohI3Spevq6hiGsdvtiYmJZ86cUalUXq83tEEUMiYIIhAIXHHFFWfPnt2wYQNFUR6PRyaTURRFnkPTtMFg8Hg8dXV1cXFxDMMwDBM6t2Gwtyj/Oikp6dChQ2fOnEFnLOwdEUUxOTmZoqgtW7ZQFIVOMsMwXq8Xx3GO45RKJVrB5/OVl5ePGDHi9ddf71gz/7SeDne5az9omm7Vyx3Lshs2bLjzzjtbo3EAAAAAAAAA6FhaIgBNJvTtFvj2v//d5Ezp0zsjWkm2x5huPRCAvlx1uIjM3Llzt23blpSUVH80otINW7duLSsrS05ObmiFo0ePjh49Wqm82B8hXPYBaJ/P98ADD5w5cwZVewiF47harS4tLa2oqLjpppsOHjx47733pqSkBCtXBJEkqdVq9+7dGx8f37t3bwzDunfvnpube+rUqT///NPn83k8HpvNVl1drdPpQltAWdI0TaNcY4/H43K5LBaLTCbr3LmzVqtlWdbtdqPIMnYumEsQBCqLHExVRn+jkPE999yzdOlSFI1dvXr166+/npKSgqY4RxU8UHllFB0OBALXXnttXl5edHQ0Co5jGMbzfPDQ0C4SEhJKS0vz8vKMRmN1dXUwEzl4olBVjcTERKfTWVdXh3KxUeWp0NUwDDMYDImJiWq1Gp2xxMTEXr16hZ1PdLm75pprcnJyCgsLjx8/7vf7UVkPhmEoilKpVD6fz2azxcfHT5kyZcGCBRc/1C8bHe5y135AABoAAAAAAAAALpmWKMHB7HjjxR2MyrXj1Vt7LKTUxii1JCRMJr/xw/wPRkEcFYBIysrK3nvvvYZme8MwTKlUlpSUxMfHN7SCXq8/ceLEhg0b7rvvvtbp4+Vjy5YtBw4caGT+upiYmHXr1s2cOfOzzz7T6/X1q2ogJEmaTKbPP//87rvvRtGra6+9tkuXLsXFxcePH/d4PDt37ty7d29KSkrYhgaDQafTeb3euro6pVJ55513vvXWW5mZmSRJUhSVkJDg8/nQ1AcYhvE8jzKg0fyEgiDwPI9CZhqNRqVS0TTtdrtRHFkQhM8//9xsNqPKHiRJxsfHm81mj8fDsiwq8ezz+Y4dO2Y2m51OZzCdWSKRBGPQwbAvyoZ2Op0RJ5hCMWi/3x8TEzNw4MDRo0dbLJb169cfP34c5XETBKFUKtVqdTD4js7Y6tWrJ06c2FC877bbbhs1atTevXuLiop8Pl9sbGyXLl3Onj1bVlYmCEJiYuLAgQOjo6PP9yYDAAAAAAAAAACgfWmJADQu18fEphpiU/tEelWaZbw8kykBaAEHDhyQyWSNpLqjQgSNzxKu1Wr3798PAejzOnDggEajaeR3DxRFKZXK/fv3//77743P9qDVavft25efnx8sRiyRSHJzc3NzczEM27p1a0P1MQmC0Gg0arW6oKDA7XZrNJpgVQo0JSAaDKIoMgwTLMSBymigQsxyuTwhIQHDMJqmT5065XA4DAZDUVHRr7/+GlaJRSKRhHZDEITTp0/36NHDarUGd4rqeIRu5fF40HijabqhkUmSpNfrjYqKKi4uHjNmDEVR69atS0xMbCQ3GSVBFxQUZGdnN7SOUqm87rrrrrvuuuASlGMOAAAAAAAAAACAjqslAtCS3NlfbpzdAg0B8K9js9kar2aL8mHRD+0bIpFIqqurW7prl6Hq6urzFiuQSqVlZWUMwzT+vqDyytXV1fVnw+M4zuFwNL45juMSiaSioiK0P8HcZyxkbsCwvwmCYFk22NW8vDybzWYwGGpqalBGc+M7FUWR47hglY+I66BXg4U+GmmKJMkTJ07U1NTI5XI0L2Ijew+esUYC0AAAAAAAAAAAALj8tEQAumMSRdHj8bTbGtAYhnEc5/F42rovHQ+K4oVWtm3PUFdRid7GV2tkHZ7nJRLJxY8WFOb2+Xzt89/FxaMo6rxnm+d5qVQqCALHcY3Hc1GgNnja0SUF/UEQBIrzNmVH5333Q6GgMNoEDXJBEDwej3DOebcNFpiO+C6ji0/YXIKNdKNz584oR7spZwzViQ4bqHC5uxjolHaUy1270tqXO7/fH/roCAAAAAAAAAD+zVouAC168r/9aNWWQyXV/ICnVjxk2PeDt8t1Pc3teWokNHdWW/ciAkEQaJomCAKmlmoG9J2/o5y67OxsVO6goaEol8sFQZDJZI2MVb/f37lz54s/ZFRimKKoy3USwrS0NJ/PZzKZGlnH7/d379790KFDeXl5DdWARv9Cs7Ozs7Ky0GkXBMHtdiuVSnTqMjIydu/e3cj8ZizLchx3xRVXbNu2DT2EIAiCoqhgBBkV3Aj+HbpruVyOBoPf7+/du3d8fLxEIsnKysrJyfF6vcE+o6bCttVoNGg4eb3eiH0TRRG1j8LogiAEVwuNWYuiKJFIaJpOSEgwm804jsfHx588ebKhM4ZhWCAQ6NKlS/2BCpe7i9GxLnftCnpE1HqXu+AvFQAAAAAAAAAAtFAAmitdPfn6aZ8X+UUMww3yyQJTsmTsnVtTJ77/zYd3ZTT2S/Q2g+N440G9NsTzPAoPNVIaGDQExd06yqm7+uqrc3NzCwsLjUZjxBVkMlmw+G/EFViWdbvdo0aNuvhDZhgGwzCpVNp4HmuHU1xcvHLlyt27d1dXV9fW1tI0rdfro6Ki6h+my+Xq0aPHddddV1NTs2fPHr1eH3raWZa12+1ut5vjOJZl4+LiVq5cmZiY+Msvvxw9ehRV7cjIyJBIJMeOHauoqKipqaEoSqPRREVFhYUIa2trx40bl52dLZPJjh07hvKyUdjX7/ejPOVgEQw0FSFawvM8msawtrbW4XD4fL6hQ4dmZ2ffeOONAwYMWLt2bUxMDOokin+RJBnsQF1dXY8ePYqKinQ6ncvlCiv9jHAcp9fra2pqRFHUaDR2u50kydC0cRQo5zhOp9M5HI7//Oc/KOg8cuTIvXv3hp2xsEMeOnRobGxs2HK43F2MjnW5a1domsZa83LH83z7vMEAAAAAAAAAgEuvRRJ/hJL3pkxf4+j92JeHS1aMlWMYhimGz/nwwRzLZ/dPXnoKfhsMQEOkUumMGTNsNpvf76//qiAIlZWVw4cPd7vdDa1QUVExadKkgQMHtn5nO6Qvvvhi/PjxH3zwQUVFBY7jUVFRXq/XYrEUFxd7vd7QNWmatlqtU6ZM0ev1EyZMGDBggNVqDb7qcrmKi4urqqpomuY4TiKRiKL44osvTp48+ZtvvvF4PCzLWq3Wr7766tNPPy0rK1MqlQzD0DRdVVVVUlLidrtDm0pISJDJZLfffrvdbmdZFoURg+UvBEEIjV7xPI92yrKs0Wh0uVyFhYW1tbVSqVSr1fp8vl9//XXatGmlpaUGg+HUqVNWqzUQCKD4Ncuy1dXVJSUlZ86cueqqqxYvXpyamoomQqyfocmyrFqtpigqIyMjMzMTRagZhgmt8MDzfCAQkEgkKIP77rvvRssnTpzYv3//qqqqiO+Cw+FIS0ubMWNGc99GAAAAAAAAAAAAdFQtEYDmT3z20W5x0IurX7utV7wapRLh+p4Tlmx4bRjx26ovjjc2fRoA/3Y33njj/Pnzz5w5Y7fbQ2v4ejye06dPDxs27PPPP298hQULFrRFxzuAjRs33nfffU6nMzExUaPRyGSyxMREo9EoimIgECgvL0f1TwRBcDgcZ86ceeyxxyZNmoRhmFqtfvPNN3NycsrKygKBgMfjKS4uRnFnQRAkEkl8fLzf70dVj71eryiKDMNUVFRgGCaXy71er0QiUSqVqKQJy7IVFRVer5fjuKqqKqPRmJKSsm7dOpIkWZZtKE1SEASSJIMlmxmGQenwNpuNIAiFQpGSkqJUKhUKhclkSk9P3717d0VFBcqVRinz6A+JRBIIBJxO55gxY/r16zdnzpzo6GiZTCaXyxmGCca+GYaRy+WotVdeeWXu3Lk+ny/idIUEQdA0LZfLFy9erNfr0UKNRvPGG29kZ2ejMxZcmWVZi8USExPz4osvZmVltfx7DAAAAAAAAAAAgPatJQLQXPGpYizz2kFJYY0R8blXZ2Cni05DCjQAjZo5c+aGDRu6du1aUFBQWlp65syZwsJCg8Hw3HPPffTRRzqd7rwrtPURtEe1tbVvvvlmbGysRqMJLiQIIjk5GSUg+3y+oqKi06dPFxYWpqenr1ixYt68ecF4a1ZW1qpVq+6++26ZTFZcXIxhGMdxNE1rtdqUlBSe5x0Oh0QiQfHlysrKqqoqiqJQyBjVuzAYDGazmSRJjuP8fn9xcXFRUVFubu60adO+//57vV7vcrmCkeKIYehgHjQKKwcCAZvNJoqiwWBITU1VKpXBNVGBDo/HYzAYtFotTdM0TaMUbBzHTSZTYmLimjVrXC7XiBEj3nvvvWHDhqHgOOoby7JohsbBgwf/73//GzVqVF5eniiKwfgymmYQdUMmkxmNRqvViooYBGVnZ69atWrixIkKhaKoqOjMmTMlJSVFRUVDhw59//33hw0b1tLvMAAAAAAAAAAAADqAlqgBjev0Wqy2uobHsH9WUmSrLDZRrVFDFUQAzmf48OHDhg07evRoYWEhy7KxsbH9+vULjZyedwUQZvPmzcePH+/UqVPYchzHzWZzVFSU2+0+e/bs7NmzhwwZ0rt37/ozucXFxb3++uurV6++7777oqOjSZJUKBSo3m5lZSVFUSg6TFGUx+PBMCw4BR+O4xRF1dXVpaenR0dH+3w+lmWrqqrefvvte++9d9asWXq9vra2NrRL2LkSHGEL4+LilEolRVEMw5w+fVqlUqWlpUml4ZX1vV6vy+WSSqUejycrKysuLs7v96MQs1KpRId2+PDh77///o477ujZs+enn346d+7cvLw8VKs6KioqISEhJycHJSl7PJ7vvvsuNjZWpVLRNO33+2maRq3JZDLUoMVi+fLLL/v27Rvajfj4+MWLF1ut1kOHDtXU1Oh0um7duqWnpzfrDQQAAAAAAAAAAMDloCUC0NI+wwbr3/984fKZAx5M/nux//i7r66xaIcN6RMe1QEAREAQRK9evXr16tXsFUCogwcPNhKgJwhCp9PV1dUZjcYrr7yykXYKCwvRpIXBJSzLulyusJnfwlKYCYJwuVwcx1EUpdVqMQyjabq6uhrH8d9//12j0VRVVYVuEhZ9Rg2ipGN0FHK5nCRJiqLqR58xDPP5fGiySp/PFwgEgoHyUGq1+vfff7/jjjvQ/2ZmZmZmZkY85CNHjpw4cQIFo2UyWcQ57jQazcGDByNuHhsbO3LkyIgvAQAAAAAAAAAA4N+mJQLQmG7UnJeGbXto5oD+P9+edoqjNd8ve2XbL6tXfV9ADVo892YDZEADAC652tra+knNYSQSid1uv9B20KR8oeFjVAEjdB30KgpAoyUURdntdhQgpigqYnnlUKhBhmFCdxpaBDwUx3GoNRzHOS5y3f2mHCxit9uD3W4IRVFut5thmIgBcQAAAAAAAAAAAACkRQLQGJU1ff0OzfOPzPnwvU1eQcTenb2f1HQaMnPF4pcmdoX8ZwBAG1Cr1Sho2wie59Vq9YW2QxAEdq4uM1oS+nf9NRFBENRqNUpkFgSBIIiGoskICmqT5F+VjdAfoQ2GCq4mimJD6zTlYJGmnDpBEKRS6XlD/AAAAAAAAAAAAPiXa4lJCDEMwzBV17ve/LG4xlpweP+evQePldjsRdvfnNRdA9nPAIDWxvN8RUVFcXGxy+UKLszJyfH5fI1sJYqiz+fr2rVr443n5OR4vd7gJgzDiKKoUqlQ+FgURZSqHJYBzfO8SqUKzQ72er05OTkEQWRnZ3u9XqlUGrpJQ9nQqHwHWgFBUwuGBa/lcrkgCDzPy2SyhlKSfT5fTk5O4wcbPOSsrKywOQbDoMNpPIkbAAAAAAAAAAAAoGUyoM/B5eaMXuaMFm0TAAAaVFVVtXz58h9//PG3337DMCwnJycnJ2fSpElDhw79z3/+M2fOHL/fr1AoIm7rcDj69++fm5vb+C6uv/767Oxsq9Xq8/k8Ho/f78cwjKIolmVRmWYMwwiCwHGcZdlgRjDP8zqdLtiIy+Xq3r37ddddh2HYsGHD1q5dK56DnYs+h9bxQH/LZLJgGWu3282yLMuyJ06cwDBMoVAoFIqoqCi1Wk3TNIq80zSN43hxcbFSqTSZTEqlMtgBn8/XqVOnJpZmjo2NveKKK77++uv4+PiIK/A873A4Ro8e3ZTWAAAAAAAAAAAA8G/WUgFowVmw6+d9p6weLnwiLSrjhqnD08kW2g8AAJxz8ODBJ5988vjx40ajMTMzkyAIv9+/Y8eOr776atasWXPnzn322Wdfe+21lJSU+pUivF5vdXX1smXL5HJ543uJjo7u3r37b7/9huM4RVEymSyYBx2svIFqOrMsK4qiVCplWValUplMJtRCIBCwWq1z5swxGo1lZWXr1q1D2crBKhyhYeggHMcTEhLQ306n88yZM3K5HB2jVCoVBMHlctXW1hoMhkAgECwVLZVKeZ53Op12uz0pKQn1gWGYioqKF198MSUlpYnndtasWUePHrVYLEajMewlQRAqKirGjh07atSoJrYGAAAAAAAAAACAf60WCUDzRR/fMviBr8uZ8OAzhmGY/NZ1kyEADQBoYUVFRY8//viZM2dCg6pyuVwul+t0uiVLligUiieeeKKmpmb58uVms1mr1aJCySzLOhyO2trat956qykZwdu2bVu9erVer3c4HKh2Mwo0o/AxKtNMURQKRrMsi0otJyYmkiTJcRyKBc+ZM2fChAl1dXUzZsw4ePBg586dy8vLXS5XaNZzWEWO2NhYg8HA83xNTY3FYlGpVBkZGRzHlZWVud1uiURCURSO48EJAxUKhUqlstlsFEVRFEWS5NmzZ1HVjpqamhkzZjz88MNNP71ZWVnz589/7rnnSkpKoqKiUJheFEWPx1NdXT18+PBFixY1VGwaAAAAAAAAAAAAIKglAtDswQ9e/aZSP+jpxXPH9YxWhEUkCF1S5HqkAADQfK+99lphYWEwRziUTCZLTEycP3/+qFGjFi1a1L9//48//nj37t0oTMxx3E033TRjxozzFt/AMMzr9S5atCg6OtpoNBoMhpqamrq6OhRrFgQhOPVfIBAIFs1AhTLOnj2LYRjP89dff/0DDzwwbNgwDMOWL1++Z8+e1NRUHMdTU1NtNpvT6fR6vaGhZ4lEolQqA4GAx+MpKiriOE6j0eh0urS0NPRqampqTU2N0+n0+XxoQ0EQjEZjXFycVCovI3yaAAAgAElEQVTV6XQ2m62urg7lU5eVlQ0dOnTx4sU333zzhdZrvvbaa1euXPn2228fOHAgPz+fIAiO4/r06fPQQw9NnTo1tL4HAAAAAAAAAAAAQENaIgAtWCusRK8nl70yoSskOgMALoHTp0+vXr06I6PBivNyuVyj0Xz11Vfdu3e/7bbbbrnllvz8fKvVSlFUampqcnJyE3f0888/Hzx4MD09HcMwnU6nUqkKCgpQ9QyUXIxhGE3TcXFxaPY/hUJRVVU1cuTI8ePH4ziemJgY7CTDMJs3bzaZTGgrgiBiYmKio6P9fj/DMH6/XxRFmqb79+//3XfflZWVnT59mmVZp9N59913Z2ZmBrtEkmRMTIzZbLbb7eXl5TKZjOM4hUKB5h7UaDQajYamaVSUw2q1TpgwYcyYMc07zxkZGUuXLrXb7fn5+T6fz2Qyde3ataFJDgEAAAAAAAAAAADqa4kANJmUmkQWkBB8BgBcIocPH5bJZPUrO4dSq9WHDx9GfxMEgeYnbMaOVCpVMHfY5/MxDCOTyULXQbU4NBoNKoWhVqtPnz49ePDgsKaKior++OOPzp07hy7EcVypVCqVSr1ej2FYIBCoqqry+XzJyckoSr5ixQqFQkHWu8CinZIkSRAESZI+ny/0VZlMhjrp9/v//PPPSZMmXeiBh4qKirr66qsvpgUAAAAAAAAAAAD8a7VEBU+q15SZ155e9szyk94WaA0AAM6nrq4ORXsbQVGUw+G4+B2FBn95nq9fyALHcY7jQveLynSEreZ0OlHedON9PnnypNPpDO1AQ0fK83zEv8MaDG0NANAhMdvviyXxMAQp05g79R0x7dVvC33nb6PFidYNE1ISx6+3RZoA5HIgWHd9/OZb6/70tHVH2isYluDSCBx8rqfp/xafYNq6IwAAAAC4GC0yhRTZ6d43nur0w4N9MnoMvnHcrf901xv72ZbYCQAAnKPVakNjvhFxHKfT6S5yRzqdLjS2S5Jk/cgymocwdL8ajaZ+oFmr1aJJCxvZHc/zXbp00Wq1oVs1dKShO62fIh3szMWfBABAu4BL9fGpf0uIkgTspYe2Ln/mpiuve2m/O3RVpvznJTPH9M+MNyjlSn1C12snzF1ztC7C1Yc+vW3xAyN6p5o0alOn3kPumrshv2nJBGLN108+sin5sRfHmC+suvzF8RV9Pf/uwV3idEpVVGrf0Y++v88W+enbRW/Il348ddy0x556d49TaImeX6RmHrjoylv/8uTruicZVQq1Oa3vjTOW/mKp/5HClO9YMqOqsrw5PWvBYUl/M8lAhEe0Q0j7/fdk40fdysOyucOv9Q+8lTX7311TrzCNrya/4vF5NxS+9NC7BW16FgAAAABwcVokAO3fO+e25/d4RdpeenT/rl/+aVdedXu4cwcANMrlch09evTgwYPFxcXBIKnH4zly5Mi+ffsKCgoEoeX/JQcCgaNHj+7bt+/kyZMN5fBG1LNnT5qmWbaxp1ter7dXr14X2cNu3bq53W6v1+v3+wVBUCgUMpksLIgsCELojHxer7dnz56hK1RUVPz2228ej6d79+5eb2PBHY/Hk56erlarg0t69uzp9/sjnhyFQoHeFJ7nFQpFxAa9Xm+PHj2acKAAgHaPzH7k+8LSoLPVbk/lbx/d200pOvfPf/DNo+fiiv4/F4/off2jS78+aMFis7OTFHUFu1a/PH5A//s3VYZex0XHrjnX9hn5xPvbixhzp1RN3clfPn/5ttwRrx46f+YqfeD1Z7/kxz0xJePSFWAT6/a+cF2/sc9/uussFp/ZSes6/u3bDwzqP2nNmfN8ejRjQ/bUO1Of2FLTPm5gm3vgQsXG+wdcedvcVT8XeDRpWYmU7ch37zwyrO+Y9/PpkNXYU++P63f9o+/4mWZF91pyWOIkSUVGEjiGE3K5rNG4cmsOy2YPv0tx4K2p2Qfe1CtME1bDjTfOvi9134K5GyCzHQAAAOjAxItH//RgAqno9cj3ZYEWaO1SGTZsGMpGbIc4jrPZbOhX/OBC+Xw+n8/X1r3oSAoLC2fNmnXllVeqVCqVSqVUKkeMGLFkyZInnniif//+KpVKo9Eolcphw4YtX748EGiZf+ZWq3XevHm5ubnB9gcPHrx06VKPx9PEFiZPnhwfH9+3Ad26dVOpVH/88Ueze+jxeJYsWXLNNdegOssEQajV6ri4OJPJJJFIlOfIZDK1Wt2rV6+ePXv27du3e/fuKpVq165dqJFt27bdeuutSqVSrVar1eqEhASZTNa5c+eIfe7Vq5dWq/3iiy9Cu8Hz/NixY5OSkuqv37t3b61WK5FIVCpVt27d6q+QlZWVm5tbVVXV7JNwCaDLncvlauuOdEhwuWu2uro6m83GcVwrte/1ekePHt1izdHbpsUQGNVj3p9svdeYP+f1kmAY1fOFI5woiqL/wDPdpDguy7rroyNOHvWm4KvHc40ERpjGfFp57s5HsH55RyyBSzPuXP7Xev7SjQ/2UOC4ov9rJxs/MYL1szFGKuOx3Zfyvs+7e3YXCU6YBs/fU8OJoij6ClZPypTihOmmleV8i24YOPLfXDUK+EkHLzvbWOOXQDMPnC9993odjktSRi/61YreT1/RxsdzowhccdWCY8y51cqXj9DiuLTzJDdzgQfaGsMyIsG+5f50SpYz65e6xtZr1WHZ3OF3KQ68VTX7310TrzBNvRDxpUuuVcj6vnK8/mADAAAAQMfQEgFo1+qb5dKBb5a28Q36BYIA9OUKIjIX5McffxwwYEBsbGxOTg6Kovbs2TMhIYEkSYVCEQyV9u7dOz09XafTTZw40eFwXOROjx07dt1115lMpuzs7D59+qD2MzMzDQbDLbfcYrFYmtLIiRMnBgwYkJqaWj/w2qNHD71eP2/evGb30Gq13nrrrQaDITMzs1OnTgRByOVyuVxOUZRarVYqlVKpVKlUyuVygiA6derUt29fdOoMBsPs2bNFUeR5/pVXXlGr1SkpKT169EAd69Kli1wux3E8JSWlfjTZZDJNnDiRYZiwzhw4cOCqq65KT0+vf6Spqak4jkdHR9d/KScnR6PRrFy5stkn4dKAAPTFgMtds11GAWiR+fXRVBLDtRO+DoiiGNh+XxyBkRmP7PSGrsSXvXe9Gsdl1y49g+7WmN+e7kLhVOfHfg196uf/+aEUEpP0evFoY2eGL3nrGjnV+akD4VerViTUrrlFj+PKQW8Xh9xuurZMSyIxSa+XjjXY3wvf0HtgTh8Fab5h0qh4su0D0M09cPbgM10ojEyZvv0fV1ehcuVNRoKImfyNG/2/5YPr5TgRPenrC78It8KwjESwfXNvKiXv/fwBb4PriGLrDstmD79LceCtqdkH3tQrTNMvRHz5e8MUZKdHd3WkdCcAAAAAhGiRSQgNUTqx+mwFTA0BQMdy7NixOXPmVFVVJSQkBGs4cBxXV1dHEATDMMH56wiC0Ov1aWlp33///ZNPPnkx5TiqqqoeffTR/Pz8lJQUlUqFaiUTBKHValNTU3ft2jVr1iyGOf/lJCcnZ+HChUlJSWfPnvV6vaIoYhjGMExNTU1paemUKVOeffbZ5vWQYZhHH310586dqampWq3WYDAkJyczDMPzPEVRDMPgOE5RVCAQYBgmISHBYDCwLOtwOEpKSu66664XX3wRw7APPvhg4cKFqampKGMataxUKjMyMlQqVVlZmcViQaeR4zin01lSUjJ8+PA33ngjuHLQlVdeOW/evOjo6IqKChRtRJ202Ww1NTXjxo1LS0uzWCx+vx+9RNN0VVXVmTNnXn755YkTJzbvJAAAOgyO5TAMEwUBwzDh7JFjNQIRPXRUf2XoOkT8oMFdKJEryi/hMQzD2N+/XF/AUX3vvX+AKmQ1+aCFB0tOF21+qLESBnzx+jUH2MQRo3r/fbUS7StGynFJ9tO/BQsM85Wbp3dVEqTuqqd32C/6d/O+X77+sQ6TDRx/W1rIratmyPjR8SR74tvvihoqB3ChG7p3zb33tSP6MW/97+7Ui6jjQJ/9edkjY6/OjjcoZTKlPqHLNbc+sfyA7cI/O5t54KLt999KOEJ/7ahrNKHL8bjR4wZKRdvWb/YxGIZhXPHJIlakOvfpoYrYTvM1Z1hGOpDa75+esdLS9bF3n71S2cA6GIa18rBs7vC7FAceSVsPvyZfYS7gQkTE3TCqH3lm/Zo9oQVkAAAAANBxtEQAWjHs6QX/8X344KNr893to1oeAKApXn/99bKyMoPBELqwurqapmmJRCKVSm02m8fjCb5EkmRiYuKaNWu2bt3a7J2+++67R44ciYmJqf8SQRAJCQlbtmxZu3ZtU5q65pprPvvssylTphiNxvz8/Pz8/OLi4n79+q1evfq1116TSqXN6+H69eu3bNmSkJBAEH9dIaOiojp37qzX60mS5DjO5/NpNJpevXr16NHDbrfn5+cXFRV169ZtxYoVb7/9tlKprKysXLlyZXx8vEwmC2tcJpNlZGQYjUa/33/q1Kn8/PzCwsKsrKw33njjo48+MplMEbs0YsSIVatWjR8/XqfToSOVSqUDBw7cuHHjunXrPvzwwzFjxqhUKvSSXC4fNmzY9u3bH3nkkfpzIQIALi/e/Zt/sPIYmZqRRmIYJs+56eFHZz0+thv1z9X4aotNwHCtToNjGCaU7z9QxpPJVw9M+2eQlVCZk1OSk6IiV5XHMAzDhMrtWw5z2qsH9Q5/Wha6kuXbmcPv/CBf2u/Jr7//7+Coi70ScUVHTnhEMq1vH9M/mpL07NdTgnOnjuY1EJS6sA3F2m1PTlmSb75j6dI7E5t/i0wfW3LjFdfPXLLpoJWK79KzWye9v2TP+kX3DR767O6mzfHYzP6HHAkdYEQMw0ki/NRL5TISE2pP5lUKGIZJ+r96zOVx/PBQaovMChPUrGEZ4TDqfprz6MqK9AeWPHtVI2MSa+Vh2ezhdwkOvL52MPyaeoW5oAsRkTDwmkzcsu37QzC7PQAAANAhUedf5byYXZ+sPCslj39we87H6qgo9T/blN/4Yf4Ho8KDMACANlZUVLRhw4bMzMzQhRzHeb1eiqIwDMNxnCRJp9MZOiceRVF6vX7Tpk0jR45sxk59Pt/27dsbCrNiGEYQhNFo3Lx584QJE5rSYHJy8oIFC/x+/9mzZ30+X1xcXMTQ9gX5+uuvjUZjMPqMKJXK5ORknucZhvH7/WazeceOHSRJnj171u12x8TEyOVyo9GIVv7uu+8KCwtTU1Mjtk+SZEpKSlFR0bJly3r16hUVFZWUlHTeSHFGRsbixYt9Pl9ZWRnDMPHx8cHT2L1792XLlrnd7rNnz3Icl5SUFPZQAQBwGeJ9tjPHd616YdayQg6X97vztq4UhmGJI59aXP/qzJd/+daaMp5Mu/6GrhSGYVxJQQmHkSnpcZU/LHpp4Sdbfy+p5dWJ3QaNvf/pJyf1jWosGOk7uPsQQ+X07t5gXEywfv/I8NvfzZNc+dSm7+Zfe9HRZwzDhIqyCgEj45Pi/xmnwlUJiQZctJ8tqxawSDHUC9lQrP561n0fliZM2vjW2Ficy29uZ71bFr74o43Mmrpmy5Jb0hQYhmGM5cfnbxy96PCHy3e8MHCUvOltNffAiZjszkbi15o9vxymR/QPuQuv27F1b0DE8FpbrYClEhgpVSrPPa0VWiAx5WKGZT30H4tmLy813/bls9ecL0G7VYdls4cf0foHXk97GH5NvcJc2IWI6tynu1L4at++MmFAess+MAEAAADAJdASAWhcro9N6mFM6hHxVWmW8YLuEYTaIxs+WfPLn2fc6pReQ+64Z1xPQ9gtoujYMnfqu0f+fvxNJoxbuOzuLLIJ2wIA/nL8+HGZTIZizUGBQICm6WDeLkEQgUAgbEOVSnX8+HFRFJuRXVtUVHT06NHOnTs3so5KpSopKfF6vSpVU793KRSKrKysC+1MRD6fr7i4WKmM/INXVBpbLpefOHHi1KlTvXv3zsjIQC/V1tYGVzt+/HjjncdxXKlU2my23r17X1D3lEpldnZ2xJc0Gk1OTs4FtQYA6Ei4oy/2krxYfzkuSx79xopZkSNZGCbW/fnRzAmPbrIRKRNee2qgHMMwTHTV1YmYaNs4NXfHDgupTeiUnlx3uuTA+tcOfLvhp09+/uT25IbKT/Clx/N9mKJTRkLkuzu+astjw29754Tkqqe//u6VQcaWuQ/jPG6fiOEqjSqsPVylUuFYjdfji1xOoekbChVrZjy4ujJt2reLR5kupteCg4v+v//clDpp7ti0c9FQady1E0ZlvvnHqWqbV8TkTW++2QeuGHTPhMxPFhcsu3/WlV8tGpeuxDCMq967dNoDqyp5DCMDATp8QzGA4Rdc7KElh2UYofSjp98+Rl61cO7N5vOdsdYdls1+FyJo4QOvv3G7GH5NvMJc4IVIlpaZTLL5R/NZLB1SmwAAAIAOpyUC0JLc2V9unN0CDWEYxp/5asH89fyge2beEWXb9dmK+a+SixeMSfrH1yCh2lqNZ9342Niuf6Vs4IqEeKJp2wIA/uJ2u0ky/J9HWHFnHMd5PrzAH6qDzDBM/foS5+VyuQiCaDxyTZLkyZMnXS5X0wPQLcjj8Zw8eTIsMTwMyg13u90NrRDx3IZpvAUAAAiHS/Vx8fq/awvhOCU3JvcaPuWZp+7sro10WeVrfl/50mNz3t9dySo6j/9g4/tjY9FqbCDAixh77KcDPe/7dPvCO7vqCAzjqna/Mfm2Z7eunv7AtbnfTElqIJJXcaacJ8xx0ZGucXzVtsdvWPi/o15Mc93d910TEubjDjyZc/XrhQ1VjMUwSb//Ht33dHZDV07xrzhXA58eQr2PqgvckC/9+P6ZG2oyH1796vUXmbxAJN7yxsZb/rGIqyv66csfS0P72MQTktzsA1fkzl35woH/zN397q2dV5nTMuIlNSVFlW5Z92EDhZ9+rZIrZOFN4s2qW9WCw/Kf3D+99tov3tiJz0zLOv+tfOsOy+a/C//sRysceD3tY/g18QpzgRciMiYumhALy8vsIhYPKUYAAABAR9MSAegWxBz99tvSxHFvTb8hicSwbiZn0exvvjvxn+k9Qu+J2eoqhzaz/zW53ckL3hYA8BeDwcBxXNjCsLCpKIr1A6ksyxoMhmZEnzEMMxqNgiAIghBW4CIUx3E5OTltVURCr9d37do1WIckIlEUeZ5vpIdGo7H+uQ3DcVywZAcAAJwfmf3I93+80LNpd268bf8Hz8ycu/L3Gl6VOer5/77+1NjO6mDIhpLJSBzDpVfNWbPsruy/WqRiBj7xyX/3dL5n848frS295/HIP3IXvB6fiMcpFBHiP3zxynn/w7WpaaYzpT+/+OTam9fccS7CRsQMuPP+6dUNTxVCpvQ24Bj9zaTYmz51BrMqpbmL8n59PJ0g1Wo5hvl8Xp+I/SOoKfq8XhHDVerwFM1zzTZpQ67gf1Of2OLuOnvTK4N1LRHYEpzHv1297ocDR04WlpSWnj5b7WFFEcOwvz84m3hCmn3gGIZprnpu2299lv73zc+2/FZ48pQiruuoJx55YXbi8it++pXQ6nX13t9mfSlowWEZSij77LVPy/Auz84Y3pR3pHWH5cW8C3/1obUOPKK2H35NvMJc6IVIoVTgmOBxewQMgwQjAAAAoKNpuQC06Mn/9qNVWw6VVPMDnlrxkGHfD94u1/U0NzIVSH382RMnPbH9+/5VaYxM7ts7esPhPIvQI+Xvmw/BVlUtRudEC36H3UsZojQSvMnbAgDO6dOnT3p6emjBDQzD5HK5XC7neR4FiAVBqJ+G7PF4zlsAurKy8sSJE16v12g09urVS6vVouVZWVn9+vWrqKgILqnP7XZfccUVcvkFVCmMyOfzHT58uKamRi6XZ2dnp6SkNGUrqVTarVu3n376SaFosJCkx+Pp27dvZmbm4cOHKyoqcBxPSkqKj4/HMKy4uLigoADDMKfTaTabG8r1FgTB4/HwPL9582aTydSnT5+w4xUE4ejRoxUVFRiGJSYmdu/evZGQPQAAhBJr97x65+3zfqgUzVdOXfbavGn/lxD2LJ40RBlwjM66/oaMf9wI4uZBQ3pINu8pOHGKw9IjPsDHJVIJhrFspHnARBE3DJz7zaYpJdP6TN644alnvxv20ShUa5dIHfPiO2PO23Uu8erbJoh//6yfyszR4BiGkQnJiSR20lJeyWOxoV32WyodIi5LSIqOfIls2oZ1+7bvcWJS3Q+zh+0KHozrdJWAcYcW33T1Z1Iqe/qnH93dtIn6xLp9C26++YWdNlGTcsXA3NwxwyemZ3btZdz14E0LTwbXauoJae6BI4pOI578cMSTob2rXVlaLeDK9MwEAsMwgWM4HiMkUqrVP2LOPyxDcEc/enenT9p/yr2NTSr4t1Yelhf1LrTqgdffW7sYfk28wlzohYhlOQzDpVIppD8DAAAAHVALBaC50tWTr5/2eZFfxDDcIJ8sMCVLxt65NXXi+998eFdGk1OQhZrqGjHKHCwaTRjNRrGm2iZg/whAW2yc7ef/3ruitI7HKE3q1eMffmBkhuR82/r9/rAbU1FscsW2SyvYsXbbw/YPTt15xcXFDRw48IsvvkhKSgouJElSq9XabDapVCoIAs/zer0+dCuapp1O5y233NLQGc7Ly3v77bcPHTpUVFREkiTLsjk5OSNGjJgxY4bRaCRJ8qabbnrppZc0Gk3E4CzHcQ6H49Zbb72Yd9Dj8bz77rubNm06fvw4RVGCILAsO27cuEceeaRPnz7n3XzcuHHr16/X6/USSYSvf6Io2my2q666avTo0Xv37pVKpaIoosOUSqV//vkn2srn8+Xl5ZnNZpPJFBY79nq9ZWVlNE2/8sorBEGwLNuzZ89bbrll2rRpSqVSFMV169Z9/PHHe/bskUqlGIYxDDNw4MBp06aNGTOmGXW32zm43F08OHXNJopiK529tnxTfH8sGDVyzn469aZFn33wSK45UqIg1blrZwlu5erH61AhJmnDv3EhTDEmQnDWOiMkTxLxE1Z8PfdqI95/0Uuf7Xjoh08fe2HC/y0d0uDzxggd633/+6vuj7A8vUeOCj9eevioU+wTUqGZPX74OCtSXXt0beCR4QVsKLjPHN5/JryButJD+0sxCTfa38S3lM9b9vBLO+3RN72zdeX0v2tQ8McPNefy3ewDx3ifw+5mSZUhSh36UeY/sOsgg8lyB/SRYhjG/fF8j9yFpf0W5e1uIOO9pTRlWP6NObBqdR4n+7/bxzUt6N/aw7LZ70KrH3i4djL8mniFucALkeCsdQo4ZYq+sOmFAAAAANA+tEgAWih5b8r0NY7ej335zkO+l7s+hmGYYvicDx8sm/Hu/ZN7XLHz8c5N/JkUz9Acrvj793O4QiHHGZoJvecX3TUOVqFOv/GRF69JwKqOfPve0uULlpuXTDvftq+++up3330XbEer1drt9vYczWEYxm63t3UvOiqv19vWXegA7rnnnj/++KO4uDg6Ojq40Gg0ejwev98vimJsbKxEIglWk2AYpqKi4v7778/Kyoo4OH/99f/Zu+/Apqr2D+Dn3uzZpE26N23Ze0iZgoAiiCyRvRRBEXCAogLyKorCj42Ir6iACIKgCAgCsn1BRRRkCgVZbZI2bdJmJ3f8/ojWUlZb0ial389fcnPvuc9NT4/3Pj33OYdmz5599erV8PDw5ORk/0aLxbJ48eLDhw+///778fHxffr02bNnz88//xwdHV0qM8swTHZ29pNPPtmyZcsKd/78/PwpU6YcOnRIp9OlpqYWt/zDDz+cOXPm+eef79mz551baNmy5ZNPPrlx48a4uLhShTg4jjMYDFqt9uuvv9br9ampqf5LKCgo+PXXXwkhOp3OPxW6sLDw6tWr2dnZdrs9Li6uuJKJ1Wq9evWqSCRKSkpSqVSEEJ7njUbjzJkzDx069N577y1btmzFihURERHFjXMcd+7cuZEjRx4+fPjVV1+9L6dCezwej8cT7CiqKwx3FWa1WiupZZfLVaqkflVhzy19/p2f7LqeH+/5anTK7e7yqOiHe7QQ7/1l2+bjb7Zo8W+Oh7v6/XfHfZSs2QMNbzf9UpiakSrkD167VsST0mv10aqYGDVFCBGkPrXgjTWtXjn83xdmD/lpdmv5PdeAVj74aEflhq2HNm41jhgV8895Pb98vfUKK6z9SPfbVsst04HaEVvdI0od6Ns/oVaXpaYOSy/+MD6+HMOu6+RvZ3xE3fXp0TdUQHZdu2KqQBHeOhW+cOeO5zKeWO/ttPTP3c8Vl9HlDRs/2pzHK7s+2SuWJoQI0hrXl1PnT+7Zb3ypViVW1S1btyzmPbL+68ucuF2fXmX95iu5W1b4p1DpF15aiHS/Mo4w5RyI2OtXrrOChIy08q+VCQAAAMEXiAQ0e3rNJz/yHRd8MWdAsm+j/06E0jQeuniTM6v+86vXnZpU1tJwArFEwBe63P+s0My7XG5epLphBjWl7Tbjy27//Cuh1aDn+x4fv/7AiZEd7nJsbGxs3bp1i/9pMBiEQmHIJqAZhvEvdBbsQKof/zP/fZmkC7ikpKS5c+e+8cYbv//+u1arlUqlNE0zDCOXy51Op0gkEovFPp/PP5HZZrNZrdZnnnnm1VdfvWV95KysrNmzZ+fl5cXExJTcLpfLExISjh8/PmPGjI8//jgsLGzu3Lmvvfba3r17tVqtQqHwt+9wOCwWy6BBg2bOnOmf+VsBHMfNnDnzyJEjiYmJJfuASCSKioqyWq0ffPBBUlJS06ZN79zOf/7zH5qm165d649QJBKxLOuPMDEx8cqVK8nJycXzo+12e3Z2tlgspiiqoKBAKpVGRERoNBr/XOnCwkKe5+Pj43met1qtOTk5EokkLi7On30mhFAUpVKpFArF/v37hw0bdubMmcTExJLfgEAg8Ifx8ccfx8fHjxo1qmJfTshiGK6GvBwAACAASURBVIamafzOVgCGuwpjWZbn+TuUer9HldfyXTAnvlj9q0tQf/Jbw++Y7aJTRkwdvKD3yv8bPDz682XPPRBBE+K8sOn1oW/sc9LJYyf2jbzd7RGla96ylmDv2T/OMqT97YsEiOpNWDxlXdv//L5o4vyBP05rLCxbzdnbonR9Jw2f+d0H3898YU2Hz4fVEhPC5x+a+eJHWZy626RnmhRfrO/ygU3/u84Jk9o/0S6BLseBZeRvnxUktO3fIflWB4sjo8Mp3vTTjkMFj3bxr3fnurR93oRnVxk4Ima8f8/1LGMR3opfuLLL4N7RG1btf/u5Ja0/n9BMQxPGdGD2kJe3WkT1pswY5k9wUtpHR/aN2bxq1/Qx84dueVlSSXedZe2W/+x+aveebFbYqGvnuLIObpXcLSv6Uwj4hVeb7lfGEaZcAxFnOnMmj1d2aFUvxJYwAgAAgLLh7537m8EqUZO3TjI8z7u/ekKmHbHVzfM8zzMn32oqUg/Z7C5rS8yF1c/1e/6LS0zxv1fd8O9b8v48f2Df6Tvyzpfv2K5du3IcV9bIqhbDMMV5Kygvp9PpdDqDHUV1YrVaFy1a1L179yZNmshkspYtWz777LN79uxZvnz5Y4891rx5c7lc3rJly6eeemrPnj13+K0ZP358TExM89to2rRpWFjYqlWr/Du73e5Vq1b17dvX336LFi2GDRu2bds2f1aowrZt26ZSqZo0aXK7MOLj4wcNGlSWpliW3bZt27Bhw1q0aCGXy5s3b96nT58FCxa0bNmybt26xQ02a9YsLCxMLBbLZDK5XC6VSpVKZePGjf2f1q9fX6/XCwQCqVTavHlzvV4fFhbWqFGjW8ZWr149gUCQmJh4u+Br166dmZlpMpnu5SsKNf7hrqioKNiBVEsY7iqssLAwLy+PYe54f3EPHA5Hr169AtacZ+eYKJoIG7153HfnHTnD8q4SQiihVHlLmsx3T/1zzVz+npebKChCURJtcoPGtaMVAopQAv2D7x4puuPtkXvv+ASBqPWc8yW+Pc78aXcJEdZ+9ecSEdoPTa4noihlh/nn7hJ3mXAFe19urKAoWpHc+tHej3WsEy6kKGF8388ulmy98PNeUkIo+ZMb3eU7sDTvvucTBETcaem1G/635G+fSB9fc7tRy3P8vTZqilDCiDrtH328Z+cWaToJHdZ0+KBWMooSJ3YY/vZ32eX6P11FL5y9/tWwVBFFKKE6vn7zZnWiZBShRHGPLTvlKtm6aduzdeUUof66fKU8UVVSt+R5njk/p7WICBIn7PeWI5rK7pYV+SkE/sKrUfcr6whT9oGoaNMgDa149FNTiD6+AQAAwJ0FYtoUFaZRk4Jc803vcflMhjxeqbr1Ks+3IkisX1dhOH4iz183gzOe+MOoqlc/ruSEDOeRpc8+t/DHwn9Ka7DZF694tQkJmqS7HwsANwsLC5s4ceL27du//fbbo0ePHjhwYNmyZZ07dx47duyWLVv27Nlz4cKFQ4cOrVixonPnzrd7acBsNv/yyy8RERG3OwtN0+Hh4du3b/f/UyKRDB8+fNOmTfv27Tt//vzBgwdXr17do0ePe5zL+d1332k0mju8OhAREbFlyxb/OoF3RtN0jx49Vq9effDgwQsXLuzdu/frr79WqVSXLl2Sy/99+9PlctlstuLZjjRNu1yuoqIi/z+lUmliYmJUVNSYMWPmz5/vdDpTUlJuWVqaEOLPJN6hEoVSqTx37tzu3bvvGjwA1Exs9tVslhCecdtvzektvlmjwjvPPfjzumkD2yaJC7LOXffpm/acsHj3se9fa626442bpHWfnrHcid17TXepiqxoO23h0ykCx49vv/Dp5XsvSEJpO809+L9VU/o0oLMO7PjhhC2u85j5u35ePzL1LvMhK3xgxYgbv7Jtz0cTuteXGX75YeehP72pfWZ99/v/Plv2/pQHE8TGn7cfuuQsV4nwisZPx/X/9H8/LHq2R/NY7trZCxZVoz4v//fg7988W7/kordUZI8Pfvpp3cwRUmFlvRRYnm5JCJ+7d/dxhpI0btGwPD+fyu6WFfkpVMmFlxIy3a+sI0yZByLXT7sO2uQd+j6iD9G3VwEAAODOKD4A6+QUbh6W3n9788U/bX4ucesA7TPyDYaVPSWuUwt6dZjyW9d1WV8+cae3Km/AXFr/ytQtsscnje4Qnrvvk6XfsX3nzO6XJGAu/rDmQH7dHk88EOn8ddmLs3+JenzUgNZxgvzTO79Ydyx8xNyZj8Zytzn21mfq1q3bzp07Q7MEB8uyFotFLBar1eVYIgX8XC4XIUQmu/2CMHAbNpvN4/FotdoK1H45fPjwI488kpGRcYd93G63TCY7fPjw7TKw9+6hhx7Kzs5WKpV32OfSpUsrV67s1atXBdqfMmXK+vXrS5bMLigouHbtmn8pQv944vP5iitB+xUWFtavX3/w4MHPPvtsSkrK7RrPzs42m80KhSItLe12+xiNxlGjRr399tsVCD40+Yc7iURSXJMEyg7DXYUVFRV5vd6KDXdl4XQ6Bw0a9O2331ZG48Hn+3lqw3ZLEpee/35smWsk3E8cX/ZL/HrgtQ1PoBRtKKkp3bKGdj/n7nG1H93Ydu35dU+Eh+LDGwAAANxNQG7QwnpOf6urYNfEzNb9X1p7lvGc37501oTHmrWdvJfqMH1G7zJnnwkhwtT+r73SXfbT0qkvvL78V1XPV1/tkyQghDDZR7dt2XOqgCeUssUzb7/STXVizezX35j92UF7ozFvT+0eS9/+WACodA6H466Tl2ma5nne6XRWXhhOp7MsYVQ4hpvbv3mdMYqiSm0UCAQOh+OusXEcd/OxpfibKmfUAAABJWr57KQH6YMr12bdfhGz+xibc80Ul5ZSwbUKoLLUkG5ZM7sfb9nx2SZT2lMv9kL2GQAAoLoKzMuHwoxxG/eppk2a/vHyzQ6OJx9O/kmgSu088bN5bw2rX86pjgJ9i6HTWgwttVXa4bWNHf75hyj6gSGvPjCkrMcCQKXT6XT+aqp3eKvA5/OpVKpKndev0+nMZvOd9/H5fHq9vsLt+3y+kluEQmGp90j4m1Y283q9er1er9eXOrYUoVDIcdyd1y7zer06na78gQMABBCdNGLmuCUPLV9y8LklnRTBjqZKeY4tf+q5VbpJ3zbFQmihpgZ0y5ra/diLKxduoXt//GIrSbBDAQAAgIoK2O2Lov6QBT8Mnp138dylXJdAHVOrdrK2st6yB4DA8vl8x44dO3XqVFFRUXJycmZmZkxMTLlaqF+/fvPmzQ0Ggz+/7PF4nE4nwzACgUAmk/lLBBQVFT3yyCOVWvemVatWR48eDQsLu90OTqezTp06zZs3L97CMMzBgwd37tyZk5MTFhbWsWPHHj16lKzyXKr9hQsXlsyzKxQKiURSMgfNcZxCccOTr81ma9WqVcuWLdPT010ul1QqJbeiUCg4jrvdqf0tOxyOBx544HY7AABUEXmb1+aP/GbQ25+90OH5WjXpdTNBVKuxn+3PrKerSRddbdz33bJmdj/esuPdhefav7VqQDSmPwMAAFRfgf37OSXVpzXR37Z6KQCEoO3bty9duvTQoUMSiYSiKIZh0tLSunTpMnny5DssKliKWCzu37//jBkzRCJRbm5uQUEBRVH+LC3HcWFhYeHh4YWFhYMHD67MSyEDBw7cunWrzWYrlQL243k+Nzd34MCBGo3Gv2X79u2TJ08+f/68v/wFz/PLly+PiYl5+eWXJ06ceHPFjC5durRt2/b06dPFc6hFIpFKpcrPz/cXtmYYRqVSlSxCXVRUlJ6ePmDAgMjIyC5duqxYsSIxMfF2WfiwsLA71OU3m82dO3fu0KHD7XYAAKgqVPjDc75e+dWFwiKelKfWWnUnjG/WPtgxwG3d792yZnY/n1nU/t1vHh6UWqPS7gAAAPedwC3SwdvPbV30+nMjBvYfuuioj8k6uONE3p3eNgeAELBs2bIBAwacO3cuPT09ISEhLi4uNTXV5XKtWLFi+PDh2dnZZW/qqaeeatWq1YULFwoLCyUSiUQiEYvFYrFYIpHY7fbLly8/8cQTLVu2rLxrIYSkp6ePHj06Ozv75irPHMdlZ2e3adNmwoQJ/i3Lli17/PHH//zzT5FIJJPJpFKpTCYTi8UGg2HKlCljx45l2dJ1JCUSyfTp02NiYgoKCoo3RkVFyeVyn8/HMIxIJIqNjS3OL9vtdoPB8Pzzz/vXJHzppZdatmyZk5Nzc6Fn/54vvPBCYmJifn7+zZeWn58fFxf35ptvVt4SjgAA5UCpGz3+VL9m92OaD6ovdMv7jzj94VFD2sXezytLAgAA1AQB+n8589cXw5o2e/yF2R+uXv/19t9NnPfY4r5NUxqN+CLLG5gzAEDA7dq165VXXklMTAwPDy8521cqlSYmJh47dmzy5Mk3J2Fvx7/Onlgs5jiOZVmO43ie5ziOYRiWZcPCws6dO3fhwoXKuZR/jR079v3337969Wp2dnZRUZHb7XY6nWaz+eLFix07dvzwww+1Wi0hZP/+/S+88ALP8xKJpOS1UxTlnwm+atWqJUuW3Nx+Zmbm7Nmz4+PjL1++bLVaXS4XwzBhYWH+9QPVajXP8y6Xq6io6Nq1a2FhYR988EHxvG+9Xv/hhx9mZmZeunTJbDY7nU7/ntevX1er1YsXL37zzTfnzJmTmJhY3LjL5bJYLH/99VdycvK8efOaNm1a2V8gAAAAAAAAAEAAUXd43bvMuEtLuzR+4Y9GLyz7YLzz7fovqTYYPmt37otpY57/8EyDOccOvFw7BF+Z6tat286dOyu1HG2FsSxrsVjEYnGlLtd2v3K5XIQQf9FhuAOO4x5//PFTp04V19lgWZbneYFAUFw64+LFi6tXr3788cfL0uCcOXPmzJmTnJxcWFhotVrdbjfHcQKBQKFQaLVauVyenZ09cODABQsWVOJV/ePcuXNr16796aefCgoKxGJx7dq1H3300d69e/unD/M8361btz179kil0tsNAm63Oy0t7dChQ5GRkTd/ajab16xZc+DAgezsbIqi4uPjW7RoodPpDh48ePHiRa/XGxkZ2bp166FDh6amppY61uv1btq0aceOHVlZWf5FBTMzM4cOHVqrVi3/DgUFBWvWrNm/f//169cpioqLi+vUqdPQoUP9qfP7jH+4k0gkKpUq2LFUPxjuKqyoqMjr9Wq1WoGgUu5QnE7noEGDvv3228poHAAAAAAAoHoJRAKaPflWi+Zzwhec2j0+2bdxgPYZ+QbDyp4Swl3776P1nze8dPTYzMaht1YzEtD3K2Rkyuj3339v3759RkZG8fzfUgloQkhubm7Pnj2XLVt219Y4jnv44YevXLlSstOWXKyPEOJyuZRK5e7du6uyYzMMIxSWHoDOnDnTtGlTjuPEYvEdDqQoauXKlQMHDrxD+/5iGjRNFxQUhIeH3+GkZQ/v5sbL0lQ1hQT0vcBwV2FIQAMAAAAAAFSZQOQ1mIt/XiTpD3ZMKNUYHdumbRq5nHW5rG/wA0DVuXjxYqnqEzeTy+VZWVllaS0/P99isZRKhJX6A49MJjt9+vTly5fLH2zF3TK9m5WVRVHUna+dpmme5+96+TRN39xOGbPPd93zlo0DAAAAAAAAAFQjgUhtUGEaNSnINd+UZ/aZDHm8UqUMxUnGADWdx+O5a3KToii3213G1s6ePRvABiuVx+Mp456hEC0AAAAAAAAAQPUViAS0uFnXTprste+vuHBDTsd16sP3vjSo23VuJgrASQAgsCIjI73euywS6vV6o6Ojy9KaTqdr0KDBnRtkGIbjuDI2WKmioqJ4nr9zASJ//ZBQiBYAAAAAAAAAoPoKyMvdYT2nv9VVsGtiZuv+L609y3jOb186a8JjzdpO3kt1mD6jtxYzoAFCT6tWrerWretwOO6wT1FRUWZmZllak0qlzZo1KywsvPkjr9ebn59vNBqvXr1at27dspenqDzNmzdPTU1l2TuVB/JXxG7Tpk2VRQUAAAAAAAAAcP8JTHVRYca4jftWT2hS+P3yzad8ziMfTp7x4QHfAxM/2//tpPqY/wwQisLCwnr37m0ymfwr3d2ssLAwPT190KBBZWxw+PDhVqu1ZM0KlmWzs7NPnz59/fp1k8lktVr//PPP3r17v/POO/7F04JFoVCMHj1aIBAwDHPLHViWpSiqd+/eTZs2reLYAAAAAAAAAADuJ4GYisg6rYVuQdrgBT8Mnp138dylXJdAHVOrdrIWqWeAkDZhwoTffvtt3759cXFxpSYmW61Wo9H4f//3f2WvQZGZmTljxox33nknLi5OLpezLHvlyhWbzSaRSAghXq83MjIyPj7e4XDMmzfvzz//XL58uVwuD/xVlc348eP37du3e/dun88nEt0wWLEs6/V669WrN3fu3FLrKAIAVLF169Zt3769as7FcRzP8zRNV6+hj+d5juPuurRsCPK/iCMQCCr7RDzPMwwjl8s//fTTe29t8+bNmzZtuvd2ygJ9sopVcZ8UCARffPFFZZ8LAAAAQkEgEtCubc8kDTO9c37fxCSpPq2JPi0AbQJA5VMoFMuXL586deq6devCwsIkEglFUSzL2my2OnXqzJ8/v1evXuVqcPLkyTKZ7PPPP79y5YrH47Hb7UKhkGEYlmWjo6P9uWyZTJacnLxt27Y5c+bMnDmzUi6sDORy+dq1a8eMGfPNN9+43W6apmma5nneP/e5ZcuWX3zxRWJiYrDCAwDwy8vL69Wr18MPP1wF53I4HG63OywsLBRqJZWdz+crKiqSSqUKhSLYsZSP1WplWTYiIqLyTsHzvMViMZvNCoVi4sSJAWkzLy+va9euvXv3Dkhrd+Z0Ol0ul1qtLvWn4hDHMExhYaFEIlEqlcGOpXwKCwsZhgkPD6+8jD/P81arNS8vTyaTTZo0qZLOAgAAAKEmEA8Y8gceaiObduRo4YQklHsGqF7Cw8M/+uijgQMHfv/992fPnrXb7fHx8ZmZmU888YRery9vazRNT5gwoXv37suWLVuyZIlMJhOJRDKZTKPRyGSykrvFxsZu3759xIgRKSkpAb2gctBoNF999dWuXbsWL158+vRpu90uFovT0tJGjBgxbNiw6vWsCwD3MalUqlarq+BENE2LRCK1Wl3tEtA8z0ul0mqX7GNZlmXZyvvh2u12g8FA03S9evUC+8qRRCKpmj4pEAiEQmF1TEBzHCeRSFQqVbBjKR+O4xiGUavVlZSAdjgcBoOB5/k6deoolcrqNbEdAAAA7kUgHjDopKc//fxsvzdGzFEvePahWupKf2kLAAKIoqjOnTt37tzZZrN5PB6tVnuPr16mpaUlJCSEh4cnJCTcbh+pVHrp0qW9e/c+9dRT93Kue9etW7du3boFNwYAAIAA8nq9BoPB6XRGRkZW6mxWgDLy+Xwmk8lms6FPAgAA1EyBSED7DswaPf8E7T7++iPpb0jDdFqlqES9M2nP5ac+7CEJwHkAoLq4cuWKVCq98z5SqfTy5ctVEg4AANydUqmsdpOICSEikUin0wU7iorQarUBb5PjOLPZbDabtVptfHx8FRTzrVQKhaLaVVYhhAiFwmraJzUaTcDbLO6TarU6PT29er1gAQAAAIESkDsAoVSpVIprt3u09i0+FCdrqtnyGwBwr/yVlO+8D0VRDMNUTTwAAAD3Pf8CwhKJJDU19a5/BgaoAjabLScnRywWo08CAADUcIFIQIvavrpp66sBaAgA7hMxMTEej+fO+3g8nri4uKqJBwAA4D7mcrkMBoPP54uOjq6MSawA5eV2uw0Gg9frjYqKQp8EAACAgMyA9hTmWt38TZspSiCSyORKhaR6v/0HAOXVoUOH2bNnsyx7u5d/fT6f0+ls3759FQcGAABwP2EYJjc312q16nQ6vV6P0roQdCzL5ubmWiwWrVablJRE03gZFgAAAAKSgPZsHZP0xFfuW39IUSJldHqzB3uPnvzSkGYRSEUD1ARt2rTp1avX3r17bzfH2Wg0Dhs2rHHjxlUcGAAAwP2B5/mCggKTyaRQKNLT00UiUbAjgpqO53mLxWIymeRyeVpamlgsDnZEAAAAECoCUoKj1YTlM93TZ20zhTfs1LVt/Xg1bTeePbLzhxNM08HD2oQVXjn54/dzRm7edmb34ffaVr+FRACgvGiafvfdd0eNGnXu3LmoqKiS86AZhjEajU2bNp05c2bwAgQAAKjG7Ha7wWCgKCopKak6LtMH9x+Hw2EwGHieT0hIqI7LmQIAAEClCkQCmo5WXv52j6vTnCMbX26mLn7xz/7HoiceWZT70qHV8+KIef+r3R794L2v3ts6MgBnBICQl5SU9Mknn0ydOnXHjh0qlUoikRBC3G63zWbr27fv7Nmzo6Kigh0jAABANeP1eg0Gg9PpjIyMDA8PR80NCDqfz2cymWw2m06n0+l06JMAAABws0AkoH2/fL7qdOSQHyaWyD4TQpSNnpsxeEmnt5a/3OftprqOk8e1X/rmEUJGBuCMAFAdpKSkrFu3bs+ePfv378/JyaEoKiEh4aGHHmrfvj0eTgAAAMqF4ziz2Ww2mzUaTUZGxu1WWQCoMsV9Uq1Wp6enC4UBWV4IAAAA7kOBuEvgLPkWXq5U3LTABCVXKrhrV66zpKmQkivllMMRgNMFCM/zdrs9NLNgPM8TQhiGsdvtwY6l+mEYhqIolmWDHUj1wzAMIcTpdAb29yIzMzMzM7PkFkcoDQWB4h9Sgh1F9YPh7l6wLMvzPIa7Cqik4a6Yy+Xy922AQLFarUajUSKRpKamSqXSYIcDQGw2m8FgEAgEKSkpMpks2OEAAABASAtIDegGzRoJ1n71yb4Xm3aN+PdBjrcc/GTDWUHDkfVEhHC532/7mU0dG4DTBY5IJArNBDTHcR6Ph6ZprCdTAf5nfnx1FcCyLMuyQqEQ65VXgMfjQa+rAAx39wLDXYUxDMNxXOUNdz6frzKahZrJ5XIZDAafzxcdHa3RaIIdDgBxu90Gg8Hj8aBPAgAAQBkFpAZ08qi3nv+k+/zHW5wbPrp/+3qxSmI3nP1x06er9+Y2eOW/Tydf/uKZQVNW/+rssGRoAE4XIBRFSSSS0ExAsyzrcDhomvaXzYVy4TiOEIKvrgK8Xi8hRCwW463eCnA4HOh1FYDh7l5guKswj8dDKnO4Y1k2NG8woHphWTY3N9diseh0Or1ej04FQVfcJ7VabVJSEqYsAAAAQBkFpFAXpe74/g87o1+a9P5nb+79yP/KKSUIq9v3/e+XvdROxf1y9re8pAFz584fVysQpwMAAAAAuG/xPF9QUJCbmyuXy9PT0/GiA4QCfx0YmUyWlpYmFouDHQ4AAABUJ4FaKYKObP/ymt8mLM46/vu57EJWqktu1LxhnIL25p3+k20x69dLswJ0IgAAAACA+5bdbjcYDBRFJSYmKhSKYIcDQBwOh8Fg4Hk+Li5OpVIFOxwAAACofgK7VLE4PK3VQ2mEENZ64cDGd/6z7suv9/7Vea1lQ3+8HwwAAAAAcHter9dkMtnt9sjIyPDwcNTcgKDz+Xwmk8lms+l0Op1Ohz4JAAAAFRPYBDTvvPbztg3rvlz31Y7fDG6eULQsNrNhHIqDAQAAAADcBsdxZrPZbDar1eqMjAwsxgBBx3Fcfn5+Xl6eWq1OT08XCgP72AgAAAA1S2DuJLy5J3Zt+vLLdeu3HL5sY3lCCTUZXQYPGjxkcN+O6WG4gwYAAAAAuKXCwkKj0SgWi1NTU6VSabDDASA2m81gMAgEguTkZLlcHuxwAAAAoNq7pwQ0az1/YPP6dV9++c3es/k+nlDCsFrtuoWd33O6w3+Pb3gC988AAAAA94DneY7jGIYpuRFTEe8bLpfLYDD4fL6oqCiNRhPYxkt1m0BBn7y/eTweg8Hgdrujo6OrS58EAACA0Ffxm8WlT7R4d5u/0IZEX7/bU3379e3b66HGuivvt2lwmqA+GAAAAMA9YhjG6XRardaSG3U6XbDigUBhWTY3N9disUREROj1epoOfMW6Ut2G5/mANMswjMvlQp+8/xT3Sa1Wm5iYWAV9kuO4gJ8CAAAAQlPFE9AHtx0zeFUNhrw1b8aIzhnafxpiAxMXAAAAQI1H07RIJEJZhvsJz/MFBQW5ublyuTwtLU0sFlfSiSqp29A0LRQK0SfvM1ar1Wg0SqXSWrVqSSSVtXx8qW6DJQ0BAABqjoonoCPCxVSO7dTaV4f+8UO/QYMGDezVLkWF5QYBAAAAAkUgEEgkEqVSGexAIDAcDofBYOB5PiEhobJ/rKXaD1SyD33yPlPcJ+Pi4lQqVaWeq5L6JAAAAIS+iiegP7yc/dyur9auXffllh0fvf7dR9Pk8a16Dhg0oIXJE8D4AAAAAACqO6/XazKZ7HZ7ZGRkeHg4Um8QdD6fz2QyFRUV6XQ6vV6PPgkAAACV5x4WDBHpGvZ4dnaPZ991XDm85cu1a9dt3P3VvJ82EEKI0Ll+0VeJQx9rGSvFjQwAAAAA1Fgcx5nNZrPZrFar09PTsV4fBB3Hcfn5+Xl5eWq1OiMjA30SAAAAKlsAamZQiqS2g179YOvx69knty9/fWjHVDWftfHVAa2TYus9PGbWml/zArPkCQAAAABAdWKz2S5cuOBwOFJTU+Pj45Hpg6Cz2WxZWVlFRUXJycnokwAAAFA1AnnDIYqo333sO93HznJe+2nrl2vXrvtq5+4V0w8W1nliQ//KWsoCAAAAACDkuN3unJwcn88XFRWl0WiCHQ4A8Xg8BoPB7Xb768AEOxwAAACoQSrjL96UPCHzySmZT05ZUHB2z6aNhmQsTQgAAAAANQPLsrm5uRaLJSIiQq/X0zRuhSHIivukVqtNTExEnwQAAIAqVqmvXAnD6z48ZnplngEAAAAAIDTwPG+xWEwmk1wuT0tLE4vFwY4IgFitVqPRKJVKlegaWwAAIABJREFUa9WqJZHgvVQAAAAIAtT8AgAAAAC4Vw6Hw2Aw8DyfkJCgVCqDHQ4AcblcOTk5LMvGxcWpVKpghwMAAAA1FxLQAAAAAAAV5/P5TCaTzWbzl9alKCrYEUFNxzCM0WgsKirS6XR6vR59EgAAAIILCWgAAAAAgIrgOM5sNpvNZrVanZ6eLhTi1hqCjOf5goICk8mkVqszMjLQJwEAACAU4I4EAAAAAKDcbDZbTk6OUChMSUmRyWTBDgeA2Gw2g8EgEAiSk5PlcnmwwwEAAAD4GxLQAAAAAADl4Ha7DQaD1+uNiorSaDTBDgeAeDweo9HodDojIyMjIiKCHQ4AAADADZCABgAAAAAoE5Zlc3NzLRaLVqtNSkqiaTrYEUFNx7Ks2WzOz8/XarUJCQnokwAAABCCkIAGAAAAALgLnuctFovJZJLL5WlpaWKxONgRARCr1Wo0GqVSaa1atSQSSbDDAQAAALi10EtAcwUnNq38cv/xKzZlUpPOA0f1a6wtvWoz77q8d83KzT+eNbjEEcmNuw4a2bupTkh4y44ZT394wle8nyCu3/tLR2QIqvYCAAAAAOC+4nA4DAYDz/Px8fEqlSrY4QAQl8tlMBgYhomJiQkLCwt2OAAAAAB3EmoJaPbK1+++s5HtOGriwIi8g2s+e+c9wbx3+ySUzCHzhYc/eHPpqcTew6a0iOEv7/3i81lvFr01b3R9Ua4xl8p47KW+9f+ekULJ4mLxDhoAAAAAVJDP5zOZTDabTafT6XQ6iio9MQKgijEMYzQai4qKdDqdXq9HnwQAAIDQF2IJaO8f27b9Fd9v4bhHEgSENNBZsyZv/e50j3GN/n3Jkbcc2fkz03riK8PbqyhC6teJdv41afPuk0PrN8w1WdTprdu3aYg5zwAAAABwLziOM5vNZrNZrVanp6cLhSF22ww1D8/zBQUFJpNJpVKlp6eLRKJgRwQAAABQJqF1J81eO33WHt26eaw/gyxIbN40ctPvZwxco6Timcy8zSdJatGyjvLvv/UL9DFRQq/LyXB5plw+sl4k57LkO4TaCJUIswEAAADg/uNxBjuCCmmRHOwIysHWvI1h5ARBoSWlWw+ZTBbscELesR+CHUGFaPTBjqAcbBxl8NICiiQnp8rl8mCHAwAAAFAOoZWA5sy5Zj5CH/5PtpkO14fz5tw8jvybgKaTHnvj//49hM09uPcPkvZkbRmXY8hj8vbOHv3ZX4UsEaqS2w6e8OyjaXKkoQEAAACgbDxxSYbh493xydHrV2gO7SaP9w92RFDTeThiZGgnSyJFXLiAp5B9BgAAgOomtBLQrNfDUDKZ7J+cMSWTSSmvx8vfeneP8ZdNyz/6+mLq0Lcejia2Pyw+mbLWY5P+0z6OmE5sW75kxbsr9IsntPp7rvSbb7753XffFR+sVqvNZnMoF03zer1msznYUVRXDocj2CFUVxaLJdghVFf4ha0wj8fj8XiCHUV1heGuwipvuHO5XBzHVVLjUHlYhSq3/wjLQz21e7YlLpxJu6rnTHO4j3CEmBna7KO0Qj5eyglC98EFAAAA4E5CKwEtEEsEfKHLzRMpRQghvMvl5kUq8c17+kxHNyz/7+ZTpGHvV+cNaBkpIkTSbcaX3f75PKHVoOf7Hh+//sCJMa3a+l+bjI2NrVu3bnELBoNBKBSGbAKaYRiKogQClLMuN/8zP01j/cly4ziO4zjUuKwYhmHw1VUMwzA0TeN3tgIw3FUYy7I8z1fe7yxGg+qHpq3tuhiHPiu7cCZt8ihxriHYAQEQK0sZfbSUJrWknIS6zYQcAAAAgOogtB6Q6Ai9jvor38IRjYAQQjhrvpWKqB9x47M17zy34e1ZG/My+r26tG+LqFukpwkhhNbFxUp8FpubJ/4Z1WPHjh07dmzx5926ddNoNKGZgGZZ1mKxiEQitVod7FiqH5fLRQhBucYKsNlsHo9HpVLhLx8VUFBQoNFogh1F9VM83KlUqmDHUv1guKuwoqIir9dbecOdWCzGHwaqEUfdxoaRE3ixOG7Ze6rjPwc7HADi4iiDj2J4KkbEhQmQegYAAIBqL7QS0ILE+nUV3x4/kTcoJZoihDOe+MOoqlc/7oanQ/fJz+d/VdT29f8b10xTInvsPLL05c+ZIbMntQujCCGEzb54xautn6AKxQwzAAAAAASZT6szDRpja56p27xWt2MTxfiCHRHUdAxP5TKUlaF0Il4vZPEcAwAAAPeH0EpAE3GjRx9NnPrVkrWxozuE5+775OtrtfpOaCAmhLn4w5oD+XV7PPFA+JkDP5pjWqezWcd+LT6ODq/VpGHrBr7ZH88NZwa0jhPkn975xea8+iN61A2xKwQAAACAIONE4vxH+ub1HqI+djj9pRHCQqx/AEHGE1LAULkMraT5dCknQs0NAAAAuI+EWnpWmNr/tVd8H61aOvVrtzyuSc9Xx/ZJEhBCmOyj27b8xWb2b0Vn5ziYKzsXv73z36MoafupX0zJfObtVzSrNqyZvaVIEB6f0WLM20MfisULsAAAAADwL1vzNoYRzwuKrMmzX5FnnQ12OADEzlIGH0VTVJKYk9NIPQMAAMD9JtQS0IQI9C2GTmsxtNRWaYfXNnbw/+djs79+7DbHRj8w5NUHhlRmdAAAAABQTXliEw3Dx7sTUyM3rgrfv51wXLAjgprOy1MGH+XkqEghFy7gQnJ5GgAAAIB7FXoJaAAAAACAgGIVqtz+IywP9dTu2Za4+C3a6Qh2RFDTcYSYGdrsozRCPkPKYgFoAAAAuI8hAQ0AAAAA9y+atrbrYhz6rPTKxVqvjZVkXwl2QADEylJGHy2h+FQJK0XJQAAAALjf4X4HAAAAAAghhPC53zzXKvHB935jgh3Jv/jDeUUD85mbI+JZ5lNjUaesfPWZ/Iy/bHPtnO/GHa7bncNMzsgsS+Qn33bt2W/ey5PsyD6HJOfV/701/aW6j/SWtemp6zWh35J9p5wl6yDzRVl7X3vl+dTOPWUd+mc8/d67/zN5ghbsDZyX97318lN127ST1XtA9+DQfnN33Bg54QvPfDp7SqdHu6gbdcoYNH3u4dwijrrkoU0+OlrEpUg4ZJ8BAACgJsAtDwAAAAAQQrjrX7743MrTOWab7+47VxGe8S7N9xz03FStmWNmXbaOyfe5pZIJ4eJEn2fqFeskG1ec/DMSpv0153o+pV2j5q9p+MaO3GU5hV1NPmcVXwDcje/K1n5P/WfmHmNEq+6Thz7aTWfetnp2+4kbTnj/3sF+ck23p9+b84u73kOPv9C7RYzp0LSXXhq1Oy/oBbx9lzb0G/DyzB3XIzL7Tn6qXzd97rb/vtF+9KriyIn7zKzRY8as/N1dt/uEoQ8mGHZNffrpsXuKFAKSIWU1Aiw2CAAAADUFSnAAAAAAAGH/WjV28hYTT4XI9AQXy552+tbkOdYzJOqmT69YHXNcpGOM5vsIgZgQTicedrFohdH1lFLRTCQq6NJx/q6NVxUNP0nxjLRnEb2cRIimXLTOy3dt1okGo9pu6ODt3360cldR9Ki5iz7uoKUJIdyQH+a9/OiGtdN2dt3yWDjFXVkyd91Rutn8Ff+ZlCohhHBPdX/l2dcXLl43ut3ELrIgRm77dvEHuwpjR3246uPOETQhhHvmh1mjH/3842lbe27pp6MId2XTojknScfXPt4xKsXOUIZBbacNfGXT/NWTO42/uUsDAAAA3MdC5BEDAAAAAILHd37puDcOpgwa2DAkZifwjLvPuYKWV2yLnDfNfSaEEPbbQp9TKHlZKxATQgihhZLJGiHv9Xye1PrC/FXW5pFnT/tU9OUBroK/j6BFvZUCmmdOe2/RHAQNe+ngH3ZBRveX22n/fiyhwzoP79lG6Dp09E8PIezVI9+cZ+MfGTQuVfLP543eGNlaafpx7W9BrcPBnj/4m01Qt/fLHSP+iVzTecwTbYTOQ4dPeQghnPHbbb87w7uM75961U1bGColttOb/VP4SzvXnwqhGjcAAAAAVQAJaAAAAIAaznNiwbjpxxvOXP5iE0mwYyGEEEIJxItSNT/V0hxJkrekbvqYY35x82KZqHWJO9laCRoNoX6uPSJ889pa76x5Nlq1PFwk/fdz3sbxPKH1mP4cUhg3Ucc3bJZRq8SPkpJIZBRhvD6OEDbXlM3RSfHRohKfq5ISEyjbb2dy2KoPuJjPRcKSGraqX6tEj6Kk0uLIiffPn875RPVaxArpcCFfS8IpBIJ6LRtH8IZjpwuCXj8EAAAAoCqFxCQXAAAAALgZx3E+n8/tdpfcKL05IXtvnEfnjH7vzwfePTCpLlkQ4LYriqJry2hCCM8w6ps+5BjuMkciRAIVIYQQVq409x6cm26NG/ihed2EMB1DCP2o9u/ks5vjChjupN01uZCLVSsHiKvwKoKqVLfh+cBUHL51n6xwc9JWi9e2unETf33fj0cYYZOGaVJCOKUqjOJyTGaGRBX/6Lx5ubk8yxnMLEkJ2h8UZO0Wb2134ybu+q49RxhRk6Z1xIQYjTnn3JQ2LqaJjJORv798YUxcAs1evWpkSWQNnAdUSX0SAAAAQh8S0AAAAAAhimVZj8djt9tLbpSq5IE8h+3HGWMXXu0wb+OYNCHJCmTLlYbneAchSgFF07S1XRfjkHHSq5fSPpih5TiT18mTEjlmnl3wV8HrLkII0coV2+MkscEKusqV6jaBwrKs1+st3ScD1rzv8sEVAxYedcT0mPZYDE0Indasc+T6D7d/tXZgnZExAkIIcWYtXv1jHkfkbk8o5S+9l/csGjD7sCOu74t9Ei66BQKbg+WpsDCZiPwbJiVXKCly3ekKpcirTqlugwQ0AABAzYEENAAAAECIEggEYrFYoVDcuDlwWRveuvON55aYu63YMjxFQEgwKxqUD08I0SZfmvkaUariPpqr+u0I53MRQrhS3w1F941WJ3u5iy7vCouj5xWyPUneqmZMPb2p2wQGTdO36pMB4M39fdHCZbN+uOKN67h83rhH1BQhhIgbT32+w7czDowZMWlH12bpwvyfDhw6SrRRtMspDJVyKl7jz4vemzNr+yVvQre3l7zaQCaIEnEqEUfx5JavK3C3LGxeA5TqNhQV6Lc5AAAAIFQhAQ0AAAAQovzJPplMdsNWjzNAzfPWXdPGfubs89mCIfHVKSnLhivFl12mJs8o/vgl9tu1lM9HCOE53k6Iki6V06JqKyS1FYRoZYOlhY1znNOt0h3hdHW62ooq1W0ClewTCAQikah0n7xHvP3opg+eXrrnpDfyoSFTFzzdqYGiOFoq/uFXDymTp3266/vNX22V6Jt1Grv3SdfEEf+9opAFP3/JFx1dO+fp/9t+0hvVbuTsl8c8mqklOgFLU4RTKJQ0X+C4YbIz73TYeaKUh0DkwVBJfRIAAABCHxLQAAAAADUTl3vyZI7PsH5orfVDS25f2Fq5UJD2wv+Ov/NAiN0q8kJRQddepp7JsY+8dnLPLOkZb3EGi/Vx2TypLRYICPF6vRucfJJC0r7E0nVJSlEDynvOw7KkRiSgqw0ud+OsqcO3GvWZQzZPGdgr4eZ1MIXJbYesaTuk+N/eX5dcZQUpCdFB7p6sceO0Z4dvzI5o9/TS18b0SJbECDnxP32L1sUlSvhj13OKeBLxTzdlTcZsTlA7MTpUJm8DAAAAVIkQe6oAAAAAgCpCh2cOf/21h/4tvMFbjqz+ZJ+7xYgxDybo2sSFWJrW1ryNYfh4gcOWvHBuZ5pstZoPRal7/xPkBZfPTAmGyGiaEOL1vHTdXScmfH+EoPgieJa3ESIrPUUagos9u3b26G359YfN+u75ZrdYmI/L27/9l6ywBoPbJ/1T+5w5+csJIxU3vKk+qD2UPbvytVGbcmuNXLrixdYNpJyCvrGwhqRu67qi9b//dMjVq/ffoXMXjp8yU9FDGupC7HcLAAAAoHIhAQ0AAABQM1G6tk/NbFtiA5s1d89n+y2ZY6fPCKm5z7xcf3Xqa77UOpHffB6x8xvCcb3ChK87vMusbI9wgYgQnvN+aGGIWP6kjBBCRDJxR4F7i8X9i1bR2p/q47kdBZ5zhH5aIQilK6vxvCcWrz3jqTty9fhbZZ8JIYQ/892HE841ZL54Z1wsTQjxXd8985trksbjRtYO5jRir/vXdz894ak/4b+TH2gl5m7xZw06qlePJq+/9eOyr6/0GJokIoS3H/1w058kdfSTDdAHAQAAoGbB3Q8AAAAAhChWJvUKHOwDL4kN11MWvS1wOfzbkzXKyRbr24bCnm5pDwl/zOpa4xOMSZQ1pwghhBKI39SLdhud3S8yA9WiGMKdtHs2u7j4MPUbSkyADiHs1TM/FfBi5an3Zs29Mf9MqZv2n9crWUhHDh3z2LLnN73w9MtHHm4UZbu068DRU6TZwqk904M0i5gjxMzQpgt//J7PS1THls/467+lIm85bF7/NCGhk/tNnPz1mLdnj++Z1btHCnPsm3VrsuPHfDS0OZ7AAAAAoIbB7Q8AAAAAhB6Ksrbvang4mus/X3B0UfSfBTfMd6WFM5LD9EbHkiLnKxyJk4pnJSknK+l/sstUA13YjyLnW/mer/N9VkKixaJnYuTTwkUxQbgSuC3GaLjK8vZLv6y+VOoTKlLw4NxeyYQQdbMxe5fHTF++dfvmTVahrmnrYZuffaJnrOgWzVW+QpYy+igxRRLzrhlY3p714+qsUrvQkYKH5/ZPI4QQWYMZn36kn7tkyY5PXnGI4+q2mfXxC5Pba/A3EAAAAKhpkIAGAAAAAEIIIYK0KYesU4IdBSHEVauOYeQERqmO/XLFj7V1hBTcvA8tEI2P04y/bRtUgzDFhjBFJUYJ90zSbkr+0bv2ODqyUa+PlvWqioBuz8URg4/28VSUiNMIeNL5rfwLb931KFrTaPw7H49/pwoCBAAAAAhdSEADAAAAQKhgwnXGgWOKWrXXbVuv37KO8nqDHRHUdCwhuT7awlARIl4vZLF+IAAAAEB5IQENAAAAAMHHC4QF3R7PfWKk8o9f0yePEplNwY4IajqekAKGymVoOc2nSVgxcs8AAAAAFYIENAAAAAAEmb1BM8PICbTPm/T+a/I/TwU7HADi4CiDj+YJSRBzSpoPdjgAAAAA1RgS0AAAAAAQNJ7oeOOI8c5adSO/+Tz8+28ongt2RFDT+Xhi8tE2jooUcuFCHmsGAgAAANwjJKABAAAAIAg4idT82JPmnk9q922PXzxL4HIEOyKo6TiemFnazFBqmk+XsELkngEAAAACAQloAAAAAKhaFGVt39U4eKzk2l+p056TXr8c7IAAiI2jcryUmCKpYk6KmhsAAAAAgVNzE9A8zzscDooKxYkNPM8TQhiGcTgwFajcGIYhhHAcXuAtN/9X53K5QvP3IsT5h5RgR1H9YLi7FxjuKqyyhzuXy+Xv23BLrtTahpETGLUm5rPFYT8fCHY4AMTNUwYf7eVIlIjTCPDLCwAAABBgNTcBTQgRCoWhmWjzZxNomhYKa/QPqGL83x6+ugpgGIZlWYFAQNNY5b0i0OsqAMPdvcBwV2E+n4/juMob7gQCQWU0ex9gtBG5/UdY2zyk+26Dfss6yusNdkRQ07E8yWVoC0NFiPgkMYcbIAAAAIDKUHOfWimKkkgkoZmAZlnW4XDQNC2RSIIdS/Xjz8jgq6sAr9dLCBGLxUidVIDD4UCvqwAMd/cCw12FeTweUpnDHcuyoXmDEUQ8zxd072fqP1Jx7o/0KaNFZlOwI4KajifEwlAmHyUXkDQpK8avLAAAAEClqbkJaAAAAIBqSSIPdgTlY7fbDQYDNebF5EidvHFD8uSQYEcEgXb6l2BHUD4Olc4Q34An4gS9UikRBzscAAAAgPscEtAAAAAAUCm8Xq/BYHA6nZGRkeEKKSaGQ9D5xDJTbF1bWJTOeEGXloYuCQAAAFAFkIAGAAAAgADjOM5sNpvNZo1Gk5GRIRAIiMcZ7KCgRuNogTkqzRyVprYa0k/vFTIeQj0Y7KAAAAAAagQkoAEAAAAgkKxWq9FolEgkqampUqk02OEAEFtYdE5CA6HPk3LhsMxhCXY4AAAAADULEtAAAAAAEBgul8tgMPh8vujoaI1GE+xwAIhbHmaIb+ARK6INZzX514IdDgAAAEBNhAQ0AAAAANwrhmFyc3OtVqtOp9Pr9Sj3DEHHCsW50RkWfbI273LSxZ9plgl2RAAAAAA1FBLQAAAAAFBxPM8XFBSYTCaFQpGeni4SiYIdEdR0PKEsukRTbB25w5p2Zq8Y9ccBAAAAggoJaAAAAACoILvdbjAYKIpKSkpSKBTBDgeAOFQ6Q3wDnqbjL/+uKsoNdjgAAAAAgAQ0AAAAAJSf1+s1mUx2uz0yMjI8PBw1NyDofCKpKa6eLSxKZ7ygy71E8VywIwIAAAAAQpCABgAAAIBy4TjObDabzWaNRpORkSEQCIIdEdR0HEXnR6bmRWeoC43pp/cKGU+wIwIAAACAfyEBDQAAAABlVVhYaDQaxWJxamqqVCoNdjgAxBYWbUhoKPB5krOOyB2WYIcDAAAAAKUhAQ0AAAAAd+dyuQwGg8/ni4qK0mg0wQ6nBD73m/E9J53pu/mHqc1wb1vteE8PmrDuSzd/w0Zh7c8WDxup8Nd1Ya+f+t/0bb/tvGzJZ0XRMYm9OnWa+WBCBEU8UqUhvqFbqoo2nNXkXwtG9CXxRWe+mf3+R+sP/WnwyhMaPjjypddf7hovCXZYAAAAAEGHm3QAAAAAuBOWZXNzcy0WS0REhF6vp2k62BGVxF3/8sXnVp7OS+3qC3YoUAGspeCyj4pKqdMpSvTvVkFMisCffebz/9jWaeHRq6r4fh3apwsdx347sWzVJz9ax26a0NWtT9bmXU786yjNMkEK/1/2X+d16zfvKEnr3mf0k3LT4W1bpw3+6dR/t63pExtSvzAAAAAAVQ8JaAAAAAC4NZ7nCwoKcnNz5XJ5WlqaWCwOdkSlsX+tGjt5i4mnkOOrpti8gsu8+KHHnvyiuegWH3MFK7f8dklZb+WbA4eF04QQ0rvZxLc/Xrr7zLZnHh93Zp/Y46jigG+NPb/klUVHBR3mb185qY6MEMJNHvJK74EL31w0+uH3u8iDHR4AAABAUOFeHQAAAABuwW63Z2VlFRQUJCQkJCUlhWD2mfjOLx33xsGUQQMbYlJFNcVbzBYLpUnX32YpS8/1Q1dYVb0m/cJpQohDGZHVeFDbdtG0+5zp6E+hkn0mhL30/Ten2Pj+k8bVkfm30OGZb7zQTZnz3dr/uYIbGwAAAEDQ4WYdAAAAAG7g9XpNJpPdbo+MjAwPD6coKtgR3ZLnxIJx0483nLnnRfbZDRucwQ4HKoK/nGthBfpaSsuBo5dPWX3y8NjODRKSJP90OTrmmeF9BsYkCETS63H1ijTROtNZdU4RT4XrFSHULdmc69ksXSslocQsbkqVlp5Aff/b75fZrnVvk18HAAAAqBGQgAYAAACAv3EcZzabzWazWq1OT08XCkP3XtF5dM7o9/584N0Dk+qSBcEOBiqKuWwqYjnX1BmLDDaWJ4QQSqxJmTp24Mx6CooQIol8pEN0fmTqxehakpyLymO7fv99/5TDjtgWPQboQigBTas1YTSXk21kSELxmwJeY04ux3LXDCxBAhoAAABqtNB9qAAAAACo4ViW9Xg8DscNdQYUCkUlna6wsNBoNIrF4tTUVKlUWklnCQzbjzPGLrzaYd7GMWlCkhXsaEJRqW7D83xAmmVZ1uv1lu6TFW6OK7xoZnlWmNJh4O7u6cmk6Nhvhyau+3XWB18nvTV0dARlC4s2JDQQMN7k81sWvfrO63+xhFDajIe2j2oQG0L5ZyKs17FzzNIP13+wduyKkQlCQghxnFy8+Ls8jpc7XYH56qu/SuqTAAAAEPqQgAYAAAAIURzH+Xw+l+uGGrKVkYB2uVwGg8Hn80VFRWk0moC3H2C8decbzy0xd1uxZXiKgBA22PGEpFLdJlBu3Scr3Byl7P3kkKbiyI5pWjkhhES07/j4VlLU4LPzi47YOr7QzSdTRxr+DM+/SjjSd8CTyfm2i5fOrDi0t+cCevuLHVuFzl9JJJlT3+z57bgtY7r02NG7Y7rI9NP2rUdJZJTA7gzh1wiqWKlugwQ0AABAzYH7IQAAAIAQJRAIpFKpSqWqvFOwLJubm2uxWCIiIvR6PU2H/grVvHXXtLGfOft8tmBIfOhHGzSluk2gCnkLBAKJRBKwPknJ6tWrXe/GTdEtGjb7/PzhvDDGbc/46xjN+gghhJLUrle/NiGkfavBcSsbr9k//aemOx5Uh0wPoOP7fXBIXXfavC+/X71sqyy2Wc//7B1jn9jlrSuqUCpWHVSluk11GG0AAAAgMJCABgAAAAhRNE0LhUKJRFIZjfM8b7FYTCaTXC5PS0sTi8V3PyYkcLknT+b4DOuH1lo/tOT2ha2VCwVpL/zv+DsP4A6XkErqNpXaJwlFWcPjjXVESuEmUnhaf41n8i5uuGBPqtOofURxFpdOapjegP7r3PV8loROApoQIkru+uKari8W/9t7aOpVRpBSKxH90a+yug0AAACEPNwOAQAAANQ4DofDYDDwPJ+QkKBUKoMdTrnQ4ZnDX3/toX8Lb/CWI6s/2eduMWLMgwm6NnGhlJKEO2MuH+qz6rS285Mr22s9Cm1OfANWIIr+ebPBS8Xo5SqK8KY/Xvr49zqDE/d30xb/YHmXx0aITCwKoZnFXM7+9Xuywh8Y/HCG/O9NvpP7/2ekU4ZnxqJLAgAAQA0XegloruDEppVf7j9+xaZMatJ54Kh+jbU33Vvebp+yHAsAAABQg/l8PpPJZLPZIiMjw8PDA1WZoQpRurZPzWxbYgObNXfPZ/stmWOnz8Dc5+pFGKXTmq+v3XKoc883W6XE6EwX9dlH13+x93cS/tID8SJC+JRaHeXHthw4+kvHbq3902c5+475DpA0AAAR30lEQVQ9J87xqqfrRYXST5s/8+W0CScymQNfjEsSEEJ8f22YufqipNV/RjYMpTABAAAAgiHU7ofYK1+/+85GtuOoiQMj8g6u+eyd9wTz3u2TICjLPmU5FgAAAKCG4jjObDabzWa1Wp2eni7E2mgQbLy87vOjmuxY8svYp6c80SomlRT+cerUtmtsw+7DXq8lJIRQynpvPpa0e/3B7v8xDWwaH0NsJ0+f2nzZHf9A/zfqi4Idfgl03NBXRi7r99EL3fsc6Z8ZVXhm1/a9p0iHhfNHpONhBAAAAGq8EHvw8P6xbdtf8f0WjnskQUBIA501a/LW7073GNdIfPd96py++7EAAAAANZLNZsvJyRGLxampqVKpNNjhABBbWLQhvkFE7cyDyqXzv/3fjv3nv2KEcfGpk8d0mtomRvP31Hxhg0dG/Kjd/9buU1/vybKyouiYxGeGdpjWKTkmxObuq9vO2Lslefq7K7ev/sgqimnaafLmN57rmYQnEQD4//buPcyqst4D+Np7MzecGfYwM8htGBBGBNQSvB6PdcID8ZC3kB7QPBmaYZppmp7oZNhTallqJiePmaEmKoJIeMsstLR8NI+K1wyQi5e5MDAjA85t773OHyhBR5w9k5s9l8/nv73nt9b6PfDO+8z+rne/C4BuFkAn33j51W2Dj5w0dMdCgdiISYcMuue5V6pTB1dGO6pp36fjYwEA+pqWlpbq6uq2trZ99903Ho9nu50MiI25+PHGi7PdBelrzSusqTiwuaB4UPVrAzdvDPafdNPFk/ZYHck98Mipdx85dS822DWxQYfPuXH5nGy3AQDQ7XSvADpVX1cflpYPfD8xjg4sHxjW121KBX8PkfdUk0jjWACAviOZTNbV1TU0NJSUlFRWVkaj/iYiy5KxnPrBVZvLR5XUb6hY97/RZHu2OwIAIOO6VwCdbGtNRAoKCt7/Ql2koCA/0tbaFqZRk+jo2Pnz5z/wwAM7z1NcXFxfX9+dH7zT1tZWX1+f7S56qu3bt2e7hZ6qoaEh2y30VH5hu6y1tbW1tTXbXfRUprsuy9x019zcnEqlMnTyNIVh2NDQUFtb279//zFjxuTm2geAbItEGgcOrxk2Pr956+i//jGvpSnbDQEAsJd0rwA6lpsXC99pbgmD/EgQBEHY3NwS5hTlplPT4bFDhw4dN27czpfV1dX9+vXrtgF0IpGIRCKxmKeWdNqOz/wWeXVBKpVKpVKeSdU1iUTCP13XJBKJaDTqd7YLTHddlkwmwzDM3O9s1meD7du3V1dXh2FYUVFRWFiY3WYgCILmfeJvDz8o2S93yMYXBzS+ne12AADYq7pXXBItLS+LrNvckArisSAIglTj5sZI6YTSaBo1/To6du7cuXPnzt15nqlTp8bj8e4ZQCeTyYaGhpycnOLi4mz30vM0NzcHQVBQUJDtRnqepqam1tbWoqIidz66YMuWLb1zZ9UM2zndFRUVZbuXnsd012Vbt25ta2vL3HSXm5ubrRsD7e3ttbW1TU1NZWVlZWVl3fPvHPqURG5+zdDxW+ODy2rXlteujmT7ywEAAOx93WvZVGzEhHH7VD+/atOOfTNSNateqCkaP2FYLI2a3DSOBQDolVKpVF1d3erVq4MgqKqqKi8vlz6TXWEkunnQfn8b96kwGq165dFB1a9JnwEA+qbuFUAHuQdPnz5i/ZLr73h67Rtrnrx9wbI3Rh83/cDcIEis/d0tv1z8VG1qzzV7PBYAoDdrampas2ZNU1PTqFGjhg8fnvU9QKBpwODV4yc3DqwYufapitefyWlrznZHAABkTXf7fNJvv5nzLmm/8dYF31zW0n/Yx4/7z7mfrYwFQZB46y/3r1iXPGrmEfvusWZP7wMA9E4tLS3V1dWtra2DBw+2ERDdQWvePjUVB73bPz6o5m8D6163Dh8AgO4WQAdBrPzQ07596Gn/8G7+J+Yt/UQHNXt+HwCgd0kmk3V1dQ0NDSUlJZWVlR5HSdYlYzn1g6s2l48qqd8wfN0zsWQi2x0BANAtdL8AGgCAD9XY2FhTU1NQUDBmzJjcXBuOkX2NpRU1w8bnNzeNfu3xvOat2W4HAIBuRAANANBjbN++vbq6OgzDYcOGFRUVZbsdCJqbm6vHHpPolztk44sDGt/OdjsAAHQ7AmgAgB6gvb29tra2qamprKysrKwsEvmIN9fdtm1bS0tLPB7P1DMM8/pn4qzt7e3vvPNOfn5+YWFhJs6fOQ0NDclksqysLNuNdF0ikairq2tsbCwbNba8vDwy6YiP9vzbt29vbm4eMGBATk7OR3vmjEokEo2NjXl5eT3uFlFjY2MikSgtLf3IpxcAoI8TQAMAdGupVGrz5s2bNm0qLi6uqqrKVEAMaQvDcMuWLXV1dYWFhVVVVT0rIAYAYC/zAQYAoPtqaWlZs2ZNLBYbOXJk//4ZWUQMndLa2rpmzZpoNFpZWWlMAgDQob4bQBcWFh577LHZ7mKPUqlUEASeaN8FYRgGQeCbg11g1P0zwjA06rrGwOsy012X7YVRN2TIkI/kPMlkcsGCBdFodC/8R/fcEdVDO9/Lbcfj8Y/kPKlU6uabb164cKEx+SF6aOd7uW0L5wGg74js+DuDbmX9+vUzZ86cPHnyVVddle1e6EPmzZv3yCOPLF68ePTo0dnuhb5i7dq1s2bNmjJlypVXXpntXuhDLrnkkpUrVy5dunTkyJHZ7gUAAKCXs+IMAAAAAICMEEADAAAAAJARAmgAAAAAADKi7z6EsDsrKiqaMWPG2LFjs90Ifcthhx1WVFRUXFyc7UboQ4qLi2fMmHHAAQdkuxH6liOOOCIejxcVFWW7EQAAgN7PQwgBAAAAAMgIW3AAAAAAAJARAmgAAAAAADLCHtDdQ2rLqntuueux5zc0FVZ+fPLsOSd/rCSye0XY8NB3vnTDqvadb8SGnfzDBafvH9vLndIbdDze0quBTjHRkS1hzX3f+f6m2dedMeGDxpLpDgAAIJME0N1BcsOyKy5fmvzknK/NLt30x9sXXv6D2NVXfLZit4/Jqbqausj+x184Y0LujjciBcOGWsBOF6Qz3tKpgU4x0ZElYctbj/5q+UvvHp76wB+b7gAAADJLAN0NtL1w//3rhp/8k7OnVcSC4MCyxjXfuO+Blz9z9sG5uxS119U2FFcdecy/HORDMf+UdMZbWmMSOsNERxaEm1ZeM3/hk29tbQuDsg8uMd0BAABkmJVl2Zd84+VXtw2eOGnojsAlNmLSIYO2vvpK9W5LtVKbauvCQUMGpZob6uqb2sOsdEpvkM54S2tMQmeY6MiGSHzirIvm/+Dq+TP338MNd9MdAABAplkBnX2p+rr6sLR84Ps3A6IDyweG9XWbUkHl3+8PpDZVb0psWnnlGQvXvZMM+hWNPPrU874yfUx/21TSSemMt7TGJHSGiY6syIkPHx0PwobVBXsYRaY7AACATPPxKvuSba2JSEHBzg/HkYKC/Ehba9uui//CpvqG9oLC0cd/95YlS3614JvTC5//xRW/+Ms2CwTprHTGWzo10CkmOron0x0AAECmWQGdBe1PXXPaFY81h0EQKZz87VvPzc2Lhe80t4RBfiQIgiBsbm4Jc4p2230yUjL1O3dNff9VxeGnfHXG8+cu/sOqsw4/umBvt0/PFktjvKVTA52SzqAy0bH3me4AAAAyTQCdBTkTz/75bWeEYRBEIrn9c6Ibyssi6zY3pIJ4LAiCINW4uTFSOqH0w1anR8uGDc1rb2hqCYM9fa0YPlC0tOPxlk4NdEpXBpWJjswz3QEAAGSaT1jZkNN/wIB4PB6PDxjQPyeIjZgwbp/q51dt2vGF31TNqhdqisZPGBbb5Yh3n1zwlXN+8sQ7738nOPnW2g1tJRUVRUIZOimd8ZZODXSKiY7uyXQHAACQabHLLrss2z30ebHysranl977bHvFyJLm11bceOsz8RPPOfWgeDSx9ne3Lf9L69Dxw+MDoxseXHTfqtaSsoL2+r89vujGpWsqTzn3c2MFM3RWGuOtsN+earLdPD2XiY4salnz6H2vFP/bCYfuu2MWM90BAADsPQLo7iBaMm7iqJZVD9y5aMnDq7ZVTv/q+TPH7RMJgraXFv/glmcHHP2ZieX5Qw85fGTLqytXLF320J9eayg6ZPYF50wdkSuVofPSGG/RPdVAl5noyJ5/DKBNdwAAAHtPJAw96R0AAAAAgI+er5gCAAAAAJARAmgAAAAAADJCAA0AAAAAQEYIoAEAAAAAyAgBNAAAAAAAGSGABgAAAAAgIwTQAAAAAABkhAAaAAAAAICMEEADvdNzlx6YE6v46qPtu7/dtua2WSNzo0UTL/xtXSo7nQEAAAD0Gf2y3QDAXpNYf9eZ085aUj/uvKUP/XjqIHfgAAAAADJLAA30Eck3l5097Yt3VO//lbsfvnbavtJnAAAAgIwTwQB9Qar6gfOmnbZw4+iz7nz4p58Z3PmpL9ne/uE7dnRYAAAAAND3CKCBXi9V99uLps+6cW3lGXc8/N8nDI3t8qPWdQ9eOefYA4fFC3LzCsv3O+zEi25dtTV8/4f3nlqUd8Tljyy/ZMqoeEFeTn58xKQTL779xfQLOrwEAAAAQK9mCw6gd0ttfuzS42Ze90L/E27+zQ0nDd81fQ5rl575idl3Nu43ZdaXTx5R8O6GJ5fffe0ZT9cUvXT7jNLIjprkmp994ZTa9qrpc74+NvfNP6349dWnP/5M3R8evvCg3HQK0rkEAAAAQK8lgAZ6sVTDE5edcM2PVrXlhO8+u/LZLadXDtol9W169M7lbxefeOsT95y24+3UBYdOGXPeH36/qn3G5Pfy5dSWmuCknz9555lV+UEQpOY/cuGU46//7rcWnbJizpBIxwXpXAIAAACg17IFB9B7hdV3zb/qlfGXPvLUDccNfOuO885fUr3rPs2FJy3cuGndolN2htLJ1tZUECbaE7sU9Rt/1vzTq/J3vIgO+vf5844v3rby3kcawnQK0roEAAAAQG9lBTTQe4WRoiO/teL++ceUhKN+fN+hc+4+/2vHH7341GHv3XqL5hcXb33u/pse/PMLr72+fuP61S+/tLa+NbLvbufo/7FJB+wyU0aKJx1+QGz566vXJ4OBHRb0S+sSAAAAAL2VFdBA7xUdfOrllx5TEgmCaMVpC6757KC6ZV8/91cb31sFHTY89q2j9z901vwlrzSXHTh59gVXL3vy558r/v87M+/2TiQai0aCVDKVTkHalwAAAADolayABnqxaDTyftgbHXbKT69d8efPL/3GOQs/+eszR8ZSG2+/7Npn8mfe8fydswa/dzOuednPUuHup3j3xedeS5x48M7Jsun5Z/6a6HfYfhWxIEh2UJDmJQAAAAB6Kyuggb4iOnTWddfNGtLw0CVn37Q2GaS21NUnogNHjy59fyJsW3/vkiea/+GoxMs3fW/R6207XqTqH7v8iuUNBUefOLU80nFBmpcAAAAA6K2sgAb6jsjgmT+5/r4nPrdo3twbJv/mS9Om7ffDa6//wuzUl6ZURmpfeXTxXc+F8aKg7snFC3838vPH7p8TBEGQPzTvz2cfddSKmVPG5rz5xL33PPFm3lHfu+qLI3bevvuQgui4ji5RaDcOAAAAoDezAhroSyKDTrp6wX8Mb1r5X1++ft3h379v0UWf6v/cL+df8t0bH1pfecFDq56+7cJ/LV17+zd/9PvNO/bJiBR/+vrHl51dsWb5z675nxVr45PP/8WjD8ybWPD3M35YQf7RaVwCAAAAoNeKhKEEBOCDtN57atnM389+8I2bPp3btQIAAACAvs0KaAAAAAAAMkIADQAAAABARngIIcAeRAdPnHZc9ODyPd6p67AAAAAAoG+zBzQAAAAAABlh3R4AAAAAABkhgAYAAAAAICME0AAAAAAAZIQAGgAAAACAjBBAAwAAAACQEQJoAAAAAAAyQgANAAAAAEBGCKABAAAAAMgIATQAAAAAABkhgAYAAAAAICME0AAAAAAAZIQAGgAAAACAjBBAAwAAAACQEQJoAAAAAAAyQgANAAAAAEBGCKABAAAAAMgIATQAAAAAABkhgAYAAAAAICME0AAAAAAAZMT/AT4DuS/HFOOfAAAAAElFTkSuQmCC" width="1536"></p>
</div>
</div>
<div id="column-1" class="section level2 tabset" data-width="45">
<h2 class="tabset">Column</h2>
<div id="individual-results" class="section level3">
<h3>Individual results</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<p><a name='61'></a></p>
<div id="aikenhead-2011" class="section level4">
<h4><a href='https://doi.org/10.1111/J.1758-8111.2010.00003.X' title='Open publication'>Aikenhead
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[Effectiveness and cost-effectiveness of paediatric bariatric surgery: a systematic review]&quot;</span> The title identifies the report as a systematic review. [Yes]

P2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review to examine the effectiveness of surgical interventions to treat obese children and adolescents, and whether they are cost-effective.&quot;</span> The abstract provides structured summary including objectives. [Yes] 

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Strong evidence for successful and cost-effective obesity management strategies is still generally lacking, leading the medical profession to rely increasingly on surgical options to treat obesity in children and adolescents.&quot;</span> The introduction describes the rationale for the review. [Yes]

P4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review examines the evidence on effectiveness of surgical interventions to treat obese children and adolescents, and whether they are cost-effective.&quot;</span> The objectives state the key question on participants, interventions, and outcomes. [Yes]

P5. [NA] 

P6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Articles with an abstract in English and full text in Danish, English, French, or Norwegian language were eligible. In addition, subjects had to be ≤19 years of age. At least one postoperative weight loss measure had to be reported, with a minimum follow-up time of 1 year post surgery.&quot;</span> Eligibility criteria for studies are provided. [Yes]

P7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Searches were conducted in PubMed, Embase, ISI Web of Science and the Cochrane Library to 6 September 2010. Hand-searching of the bibliographies of articles and reviews identified was also conducted to ensure completeness of the initial electronic searches.&quot;</span> Information sources including databases and dates searched are described. [Yes] 

P8. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Appendix 1 contains details of the search terms.&quot;</span> The full search strategy for one database is provided in the appendix. [Yes]

P9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Thirty-seven articles (11 case studies, 10 retrospective reviews, 8 cohorts, 3 cost studies, 2 prospective longitudinal trials, 1 longitudinal study, 1 retrospective cohort and 1 randomized controlled trial) were identified and included in the review.&quot;</span> The process of study selection is described. [Yes]

P10. [NA]

P11. [NA] 

P12. [NA]

P13. [NA]

P14. [NA] 

P15. [NA]

P16. [NA]

P17. The search results are presented in a flow diagram. [Yes]

P18. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Appendix 3, Table A1&quot;</span> presents the characteristics of included studies. [Yes]

P19. [NA] 

P20. The results of individual studies are presented in the appendix tables. [Yes] 

P21. [NA]

P22. [NA]

P23. [NA]

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pending an improvement in the quality of available evidence, an academic approach to child and adolescent bariatric surgery is warranted, and reversible techniques are advisable compared to approaches that permanently alter the anatomy.&quot;</span> The discussion summarizes the main findings and implications. [Yes]

P25. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Potential bias results from exclusion of grey literature and inability to locate a small number of potentially relevant publications.&quot;</span> Study limitations are discussed. [Yes] 

P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The resolution of these issues requires long-term prospective studies and controlled clinical trials to establish safety and efficacy of surgical procedures.&quot;</span> Conclusions and implications for future research are provided. [Yes]

P27. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The project that led to this paper was funded by the WHO Health Evidence Network of the World Health Organization. The funder had no role in the design, analysis or interpretation of the study.&quot;</span> Sources of funding are declared. [Yes]
</pre>
<p><a name='62'></a></p>
</div>
<div id="al-hozaim-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2009.12.001' title='Open publication'>Al-Hozaim
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

[No] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic-assisted anorectal pull-through for anorectal malformations: a systematic review and the need for standardization of outcome reporting&quot;</span>
The title does not identify the report as a systematic review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic review was conducted.&quot;</span> 
The abstract mentions that a systematic review was performed.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

The evolution of surgical techniques for dealing with this complex group of malformations led to the description of the PSARP by deVries and Pena [18] in 1982. Posterior sagittal anorectoplasty quickly became the standard of care for dealing with ARM. Despite the excellent exposure of anatomy and exact placement of the distal rectum within the muscle complex, the technique is not perfect, especially in patients with “high” ARM defects [19], [20], [21' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The evolution of surgical techniques for dealing with this complex group of malformations led to the description of the PSARP by deVries and Pena [18] in 1982. Despite the excellent exposure of anatomy and exact placement of the distal rectum within the muscle complex, the technique is not perfect, especially in patients with “high” ARM defects [19], [20], [21].&quot;</span>
The introduction describes the rationale for the review.

[No] No explicit statement of review questions or PICOS provided.

[No] No mention of a review protocol.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were studies of ARMs, regardless of level of the defect, with or without associated anomalies, use of LAARP as a primary procedure or with colostomy, and studies reported after the year 2000. Exclusion criteria included studies that were not reported in English and those that did not deal with human subjects.&quot;</span>
The eligibility criteria are specified.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic search of the MEDLINE, PUBMED, and Cochrane databases (June 2000 to April 2008) was conducted. The search terms used were “laparoscopic,” “pull-through,” “anorectal malformation,” and “imperforate anus.” In addition, a manual search of 4 surgical journals from the same period was performed.&quot;</span>
The information sources are described. 

[No] The full search strategy is not presented for any database.

[Yes] <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 59.5%):

.

The studies included 124 patients—96 males (77.4%) and 28 females (22.6' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Only studies published in full were included...The studies included 124 patients—96 males (77.4%) and 28 females (22.6%).&quot;</span>
The study selection process is described.

[No] The data collection process is not described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main outcome measures were also recorded. Extracted data were tabulated in Revman (R) 4.2 Cocnrane IMS.&quot;</span>
The data items are listed.

[NA] No assessment of risk of bias in individual studies mentioned.

[NA] No meta-analysis performed so summary measures not applicable. 

[NA] No meta-analysis so synthesis methods not applicable.

[NA] No assessment of risk of bias across studies mentioned.

[NA] No additional analyses mentioned.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The initial search in the PUBMED database produced 24 articles, 11 of which met the inclusion criteria. The MEDLINE search resulted in 2 additional new studies, whereas the search of the Cochrane database did not yield any studies. The manual search of the 4 journals captured an additional 1 study from the Journal of Pediatric Surgery and 1 study from Pediatric Surgery International. Two additional articles were found in reference sections of other studies, bringing the total number of studies to 17.&quot;</span>
The study selection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The studies included 124 patients—96 males (77.4%) and 28 females (22.6%).&quot;</span> 
Study characteristics are presented.

[NA] No assessment of risk of bias within studies presented.

[NA] No meta-analysis so results of individual studies not presented.

[NA] No meta-analysis performed.

[NA] No assessment of bias across studies.

[NA] No additional analyses performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎When CEQ were compared annually, scores for LAARP were generally higher throughout the study but only statistically significant at 3 and 4 years after surgery. The study concluded that although there were no significant differences between the 2 groups with regard to muscle thickness and parameters of surgical stress observed according to technique, LAARP appeared to provide better outcomes based on CEQ scores.&quot;</span>
A summary of the evidence is provided.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our study has several limitations. First, this is a systematic review of mainly retrospective data. The quality of such review is only as good as the included studies. Second, because of the wide variation of reported outcomes, no formal meta-analysis and calculation of summary statistics could be performed. Finally, our review only included articles published in English, which may have contributed to a selection bias by omitting relevant articles published in other languages.&quot;</span>
Limitations are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conclude that there is an urgent need to increase the number of studies reporting LAARP-related outcomes. More efforts are needed by the pediatric surgery community to improve the quality of studies and standardization of reports related ARM.&quot;</span>
Conclusions and implications are discussed.

[No] No mention of sources of funding for the review.
</pre>
<p><a name='63'></a></p>
</div>
<div id="allen-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2014.10.042' title='Open publication'>Allen
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pediatric emergency department thoracotomy: A large case series and systematic review&quot;</span>

P2. [No] No structured abstract provided.

P3. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To address this issue, we reviewed our experience at a level 1 trauma center and report the largest analysis over the past 25 years.&quot;</span>

P4. [No] No explicit PICOS statement provided. 

P5. [No] No mention of a review protocol.

P6. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We reviewed patient records for the presence of vital signs (VS) and/or signs of life (SOL) in the field, time without VS in the field, presence of VS or SOL upon arrival, MOI, location of injuries, return of spontaneous circulation (ROSC), survival, and neurological function of the survivors upon discharge.&quot;</span>

P7. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For our systematic review of the published data, we obtained all case series regarding pediatric EDT and combined the data from those reports with the data from our institution (Table 1) [6], [7], [8], [9], [10], [11], [12], [13].&quot;</span>

P8. [No] No full electronic search strategy provided.

P9. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎These reports were obtained from a Medline search for all publications regarding EDT in the pediatric population for the past 40 year using the keywords “thoracotomy”, “emergency”, “trauma”, “resuscitation”, “pediatrics”, and “children”.&quot;</span> 

P10. [No] No details on data extraction process provided.

P11. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Variables extracted from each report include demographics, MOI, injury location, presence of VS and/or SOL upon arrival, ROSC, survival to discharge, and neurologic outcomes for survivors.&quot;</span>

P12. [NA] No risk of bias assessment done.

P13. [NA] No meta-analysis performed.

P14. [NA] No meta-analysis performed. 

P15. [NA] No meta-analysis performed.

P16. [NA] No meta-analysis performed.

P17. [No] No flow diagram of study selection process. 

P18. [Yes] Table 1 lists included studies and citations.

P19. [NA] No risk of bias assessment performed.

P20. [Yes] Results section reports summary data and outcomes for individual studies.

P21. [NA] No meta-analysis performed.

P22. [NA] No assessment of bias across studies.

P23. [NA] No additional analyses performed.

P24. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Overall, the mortality rates are comparable between adults and pediatric patients following EDT.&quot;</span>

P25. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There are limitations to this study. First, all of the data obtained from our institution were collected retrospectively, and thus not specifically collected for research purposes.&quot;</span>  

P26. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our review allows considerable trends to be made regarding this controversial topic.&quot;</span>

P27. [No] No mention of funding sources.
</pre>
<p><a name='64'></a></p>
</div>
<div id="allin-2015" class="section level4">
<h4><a href='https://doi.org/10.1371/JOURNAL.PONE.0116908' title='Open publication'>Allin
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the assessments for the PRISMA items:

P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Challenges of Improving the Evidence Base in Smaller Surgical Specialties, as Highlighted by a Systematic Review of Gastroschisis Management&quot;</span>
The title identifies the report as a systematic review. [Yes]

P2. Abstract: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> 
The abstract provides a structured summary. [Yes]

P3. Introduction: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Using a systematic review and meta-analysis of gastroschisis as an example, we aimed to highlight some of the key challenges in paediatric surgical research, and suggest ways in which the strength of our clinical evidence base could be improved.&quot;</span> Provides rationale for the review. [Yes] 

P4. Objectives: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study, therefore, was to perform a systematic review of the literature comparing outcomes of infants with simple gastroschisis following either OPFC or SR.&quot;</span> Provides explicit objectives. [Yes]

P5. Protocol: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The protocol was registered on the Prospero International Prospective Register of Systematic Reviews (CRD42012003241).&quot;</span> Indicates review protocol registered. [Yes]

P6. Eligibility criteria: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
Details eligibility criteria including PICOS, years, language. [Yes] 

P7. Information sources: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
Describes information sources including databases searched. [Yes]

P8. Search: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
Does not present full search strategy. [No]

P9. Study selection: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>  
Describes process for study selection. [Yes]

P10. Data collection process: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
States data extracted independently in duplicate. [Yes]

P11. Data items: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
Lists outcomes sought. Does not list full variables. [No] 

P12. Risk of bias in individual studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
Does not describe risk of bias assessment methods. [No]

P13. Summary measures: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
States that odds ratios, mean differences were calculated. [Yes]

P14. Synthesis of results: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span> [NA]

P15. Risk of bias across studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span> [NA]

P16. Additional analyses: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span> [NA]

P17. Study selection: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
Provides study flow diagram. [Yes]

P18. Study characteristics: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Presents characteristics of included studies in table. [Yes]

P19. Risk of bias within studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
Does not present risk of bias assessments. [No]

P20. Results of individual studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
Presents forest plots with effect estimates. [Yes]

P21. Synthesis of results: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span> [NA]

P22. Risk of bias across studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span> [NA] 

P23. Additional analysis: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span> [NA]

P24. Summary of evidence: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
Summarizes main findings and limitations. [Yes]

P25. Limitations: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
Discusses limitations. [Yes]

P26. Conclusions: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
Provides conclusions and implications for research. [Yes]

P27. Funding: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
Describes sources of funding. [Yes]
</pre>
<p><a name='65'></a></p>
</div>
<div id="alzahem-2011" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-010-2840-X' title='Open publication'>Alzahem
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here is the assessment of reporting quality against the 27 PRISMA items:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic versus open inguinal herniotomy in infants and children: a meta-analysis&quot;</span>

[Yes] Title identifies the report as a systematic review. 

[Yes] Structured abstract provides background, objectives, eligibility criteria, data sources, synthesis methods, results, conclusions.

[Yes] Introduction describes rationale in context of existing knowledge.  

[Yes] Objectives specify PICOS elements.

[No] Review protocol not reported.

[Yes] Eligibility criteria specify study characteristics and report characteristics. 

[Yes] Information sources describe databases searched and date last searched.

[Yes] Full search strategy presented for one database. 

[Yes] Study selection process described.

[Yes] Data extraction process described.

[Yes] Data items sought listed and defined. 

[NA] Not applicable - no assessment of risk of bias in individual studies.

[Yes] Principal summary measures stated.

[Yes] Synthesis methods described.

[NA] Not applicable - no assessment of risk of bias across studies. 

[NA] Not applicable - no additional analyses reported.

[Yes] Study selection process presented in flow diagram.

[Yes] Study characteristics presented.

[NA] Not applicable - no assessment of risk of bias within studies.

[Yes] Summary data and effect estimates presented for each study.

[Yes] Results of meta-analyses presented.

[NA] Not applicable - no assessment of bias across studies.

[NA] Not applicable - no additional analyses.

[Yes] Main findings summarized considering relevance to key groups.

[Yes] Limitations discussed at study and outcome level. 

[Yes] General interpretation of results in context of other evidence.

[Yes] Sources of funding described.
</pre>
<p><a name='66'></a></p>
</div>
<div id="apelt-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2013.05.024' title='Open publication'>Apelt
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic treatment of intussusception in children: A systematic review&quot;</span>
Title identifies the report as a systematic review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎By reviewing available data we aimed to establish whether laparoscopy should be the primary technique in the surgical reduction of intussusception.&quot;</span>  
Abstract provides background and objectives.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Idiopathic intussusception is one of the most common causes of small bowel obstruction in children.&quot;</span>
Introduction provides context.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎By reviewing available data we aimed to establish whether laparoscopy should be the primary technique in the surgical reduction of intussusception.&quot;</span>
Objectives stated. 

[No]
No mention of a review protocol.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusion criteria were non-English language articles, case reports, laparoscopic-assisted enema reduction and mixed pediatric and adult populations (age cutoff 18 years).&quot;</span>
Eligibility criteria specified.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An online database search for all English language articles on pediatric small bowel obstruction, intussusception and laparoscopy in PubMed, Medline and Ovid from January 1990 to April 2012 was performed.&quot;</span>
Information sources described. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An online database search for all English language articles on pediatric small bowel obstruction, intussusception and laparoscopy in PubMed, Medline and Ovid from January 1990 to April 2012 was performed.&quot;</span>
Search strategy provided for at least one database.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Results were confirmed by a second independent search by a different member of the team using matching search strings and databases. Likewise, the bibliographies of identified studies were examined.&quot;</span> 
Study selection process described.

[No]
No mention of data collection process. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following variables were analyzed: age, laparoscopic success rate, reason for conversion, enterotomy rate, operative time, complications, and length of stay (LOS).&quot;</span>
Variables sought are listed.

[No] 
No mention of risk of bias assessment.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎The principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
Principal summary measures stated.

[NA] 
No meta-analysis performed.

[NA]
No assessment of risk of bias across studies.

[NA]
No additional analyses mentioned.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Overall, 10 studies were identified which included a total of 276 cases of laparoscopically treated intussusception.&quot;</span> 
Study selection process described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 1 provides specific details on the selected studies.&quot;</span>
Study characteristics presented.

[No]
No presentation of risk of bias within studies.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 2. Laparoscopic outcome data for intussusception.&quot;</span>
Summary data for interventions presented.

[NA] 
No meta-analysis performed.

[NA]
No assessment of bias across studies. 

[NA]
No additional analyses mentioned.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.6%):

Conclusion

Laparoscopy is safe and effective in the treatment of pediatric intussusception' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎In conclusion, Laparoscopy is safe and effective in the treatment of pediatric intussusception.&quot;</span>
Main findings summarized.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):

ver, the main limitation of the present study includes the lack of prospective randomized controlled trials (RCT) comparing laparoscopic vs. open reduction of pediatric intussusception' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎However, the main limitation of the present study includes the lack of prospective randomized controlled trials (RCT) comparing laparoscopic vs. open reduction of pediatric intussusception.&quot;</span>
Study limitations discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We advocate for laparoscopy to be considered the primary interventional technique for intussusception in tertiary centers with advanced pediatric minimally invasive skills [26].&quot;</span>
Conclusions provided.

[No]
No mention of funding sources.
</pre>
<p><a name='67'></a></p>
</div>
<div id="aworanti-2014" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0034-1370780' title='Open publication'>Aworanti
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for the 27 PRISMA items:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Management of Recurrent Tracheoesophageal Fistulas: A Systematic Review&quot;</span> 

Title identifies it as a systematic review.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>

Abstract provides background, objectives, eligibility criteria, participants, interventions, methods, results, conclusions.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 80.6%):

ment of a recurrent tracheoesophageal fistula (RTEF) includes either open surgery (OS) or an endoscopic treatment (ET); the ideal option is unclear' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Patients with recurrent tracheoesophageal fistula (RTEF) can be managed by either open surgery (OS) or endoscopic treatment (ET); the ideal approach is unclear.&quot;</span>

States rationale that current evidence is unclear on best treatment approach.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We aim to comparatively review all published treatment options, and outcomes, for managing RTEF.&quot;</span>  

States objective to review and compare treatment options and outcomes for RTEF.

[No] No mention of review protocol.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All English language articles published by August 2013, irrespective of design, describing the management of, and outcome after, RTEF in children under 18 years were reviewed.&quot;</span>

Specifies eligibility criteria including population, interventions, outcomes, and study designs.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A Medline, Embase, and web of science searches were performed using the keywords recurrent tracheoesophageal fistula. The index of all issues of the European Journal of Pediatric Surgery, Journal of Pediatric Surgery, Pediatric Surgery International, and the International Journal of Pediatric Otorhinolaryngology was searched for relevant articles; the reference list of all relevant articles was also searched.&quot;</span> 

Describes literature search in databases and journals.

[No] Does not provide full search strategy for any database.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>

States that studies were screened for eligibility and included based on criteria.

[No] Does not describe data collection process.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The data obtained included number of patients treated, treatment modality employed, effectiveness of each treatment modality, and the outcomes after treatment. These outcomes include the successful single treatments, number of treatments required, number of treatment failures requiring conversion to an alternate treatment modality, and the incidence of postoperative complications.&quot;</span>

Lists data extracted on interventions, outcomes, and other variables.

[NA] Does not assess risk of bias in individual studies as no meta-analysis done.

[NA] Does not report summary measures as no meta-analysis done. 

[NA] Does not describe synthesis methods as no meta-analysis done.

[NA] No assessment of publication bias as no meta-analysis. 

[NA] No additional analyses described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 23 papers between 1984 and 2012 described 57 patients undergoing some form of endoscopic treatment (ET) while 21 papers between 1955 and 2013 described 108 patients that underwent an open surgical repair ([Tables 1] and [2]).&quot;</span> 

Reports numbers of studies screened and included with reasons.

[Yes] Tables 1 and 2 present characteristics of included studies.

[NA] Does not assess risk of bias in individual studies.

[Yes] Results section presents findings from individual studies.

[NA] No meta-analysis so does not present synthesis.

[NA] No assessment of bias across studies.

[NA] No additional analyses.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, based on our findings on 165 published cases, OS for the repair of recurrent TEF has a low morbidity, mortality, and re-fistulation rate particularly when an interposition tissue is placed between the trachea and esophagus.&quot;</span>

Summarizes main findings and conclusions.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main limitations of this review include the heterogeneity of the included articles, particularly as case reports would predominantly report positive outcomes.&quot;</span> 

Discusses limitations including risk of bias in included studies.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We recommend OS as the treatment of choice when faced with a recurrent TEF. Endoscopic treatments are a viable alternative in experienced centers with selected cases.&quot;</span>

Provides conclusion and implications for practice.

[No] Does not report on sources of funding.
</pre>
<p><a name='68'></a></p>
</div>
<div id="baker-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.02.021' title='Open publication'>Baker
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic review and meta-analysis of gastrostomy insertion techniques in children&quot;</span>
Title identifies the report as a systematic review and meta-analysis.

P2. [No] No structured abstract provided.

P3. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Gastrostomy tubes are inserted via multiple techniques to provide a route for enteral feeding in the pediatric population. This review compares the rate of major complications and resource utilization associated with the various insertion techniques.&quot;</span>  
Describes the rationale for the review in context of existing knowledge.

P4. [No] Objectives not explicitly stated with PICOS elements.

P5. [No] Review protocol and registration not reported. 

P6. [Yes] <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 71.2%):

All studies that compared postoperative outcomes in two or more gastrostomy placement techniques in a pediatric population were included. The prima' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎All studies that compared postoperative outcomes in two or more gastrostomy placement techniques in a pediatric population were included. The pediatric population was defined as patients 0–18 years of age.&quot;</span>
Specifies eligibility criteria including population age range.

P7. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic search of electronic databases was performed to identify all relevant studies comparing two or more gastrostomy insertion techniques in children reporting procedural-related complication rates.&quot;</span> 
Describes information sources including databases searched.

P8. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following search strategy was used in OVID and adapted as appropriate for other databases:&quot;</span>
Presents full search strategy for one database. 

P9. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Study selection: All titles and abstracts identified in the electronic database were independently screened for relevance and categorized as relevant, possibly relevant or irrelevant, based on our inclusion criteria.&quot;</span>
Describes study selection process including screening.

P10. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data extraction was conducted by 2 reviewers (LB & AB) using a predefined data extraction worksheet.&quot;</span>
States data extraction was done independently in duplicate. 

P11. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following information was extracted from each article: title, authors, number of centers involved, geographical location, patient demographics, the interventions being compared, complications assessed, markers of resource utilization, as well as the reported findings of the study.&quot;</span>
Lists variables extracted.

P12. [No] Risk of bias assessment not described.

P13. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Postoperative morbidity necessitating operative management or resulting in mortality was analyzed as dichotomous data, with odds ratios calculated.&quot;</span>
States summary measures used.

P14. [NA] No meta-analysis performed.

P15. [NA] No meta-analysis performed. 

P16. [NA] No meta-analysis performed.

P17. [No] Study selection flow diagram not provided.

P18. [Yes] Table 1 presents characteristics of included studies. 

P19. [No] Individual study risk of bias not presented.

P20. [No] Individual study results not shown with summary data and effect estimates.

P21. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies comparing laparoscopic gastrostomy and PEG revealed a significant increase in major complications with PEG (n = 10, OR 0.29, 95% CI: 0.17–0.51, p < 0.0001)&quot;</span>
Presents meta-analysis results with confidence intervals.

P22. [NA] No assessment of risk of bias across studies.

P23. [NA] No additional analyses performed.

P24. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis has revealed a significant increase in major complications with PEG when compared to the laparoscopic technique.&quot;</span> 
Summarizes main findings.

P25. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Additional limitations to this review include the retrospective nature of the majority of the studies included.&quot;</span>
Discusses limitations at study and outcome level.

P26. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Ultimately, the technique chosen for gastrostomy tube placement should rest with the implicated health care team, individualized for each unique patient circumstance and be based on individual/institutional expertise.&quot;</span>
Provides general interpretation of results.

P27. [No] Sources of funding not reported.
</pre>
<p><a name='69'></a></p>
</div>
<div id="berger-2012" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0032-1311695' title='Open publication'>Berger
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the assessments for the 27 PRISMA items based on the provided full text:

[No] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mitomycin C in the Therapy of Recurrent Esophageal Strictures: Hype or Hope?&quot;</span>
The title does not identify the report as a systematic review. 

[No] The abstract does not mention that this is a systematic review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Recently, local application of Mitomycin C has been described as a new therapeutic option for recurrent esophageal strictures, and favorable early results have been perceived.&quot;</span>  
The introduction describes the rationale for the review.

[NA] The objectives are not explicitly stated as this is not a systematic review.

[NA] A review protocol is not mentioned as this is not a systematic review. 

[NA] Eligibility criteria are not specified as this is not a systematic review.

[NA] Information sources are not described as this is not a systematic review.

[NA] A search strategy is not provided as this is not a systematic review.

[NA] The study selection process is not described as this is not a systematic review. 

[NA] Data collection methods are not described as this is not a systematic review.

[NA] Data items are not listed as this is not a systematic review.

[NA] Risk of bias assessment methods are not described as this is not a systematic review.

[NA] Summary measures are not stated as this is not a systematic review. 

[NA] Synthesis methods are not described as this is not a systematic review.

[NA] Assessment of bias across studies is not described as this is not a systematic review.

[NA] Additional analyses are not described as this is not a systematic review.

[NA] The study selection process is not shown as this is not a systematic review.

[NA] Study characteristics are not presented in a table as this is not a systematic review.

[NA] Risk of bias within studies is not presented as this is not a systematic review. 

[NA] Results of individual studies are not shown as this is not a systematic review.

[NA] Results of meta-analyses are not presented as this is not a systematic review.

[NA] Results of bias across studies are not presented as this is not a systematic review.

[NA] Results of additional analyses are not given as this is not a systematic review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The current published results regarding the treatment of esophageal strictures with Mitomycin C are favorable and encouraging.&quot;</span>
The discussion summarizes the main findings.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Many aspects remain unclear, including the proper indication.&quot;</span>
Limitations are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The literature reviewed supports the need of larger studies.&quot;</span>
Conclusions and implications for future research are provided.

[No] Sources of funding are not described.
</pre>
<p><a name='70'></a></p>
</div>
<div id="billingham-2010" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0029-1241871' title='Open publication'>Billingham
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pediatric Surgical Technique: Laparoscopic or Open Approach? A systematic Review and Meta-Analysis&quot;</span> [Yes] The title identifies the report as a systematic review and meta-analysis.

P2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Method/Design: A computerized comprehensive search supplemented by a manual review of the literature was performed for all peer-reviewed publications comparing laparoscopic and open appendectomy, fundoplication and hernia repair cohorts.&quot;</span> [Yes] The abstract provides a structured summary including the methods.

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although appendicitis is the most frequent cause of emergency abdominal surgery in children, there continue to be significant variations in practice and outcomes [27]. Open appendectomy (OA), first described in the 19th century [1], remained largely unchanged until the introduction of laparoscopic appendectomy (LA) in 1983.&quot;</span> [Yes] The introduction describes the rationale for the review.  

P4. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

In order to evaluate the clinical and cost-effectiveness of this surgical approach a number of outcome measures for laparoscopic and open techniques were analyzed in a comparative fashion. These outcome measures included:

    Length of stay (LOS) after the procedure,

    Operating room (OR) time,

    Frequency of postoperative complications and

    Total hospital costs' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In order to evaluate the clinical and cost-effectiveness of this surgical approach a number of outcome measures for laparoscopic and open techniques were analyzed in a comparative fashion. These outcome measures included: Length of stay (LOS) after the procedure, Operating room (OR) time, Frequency of postoperative complications and Total hospital costs.&quot;</span> [Yes] The objectives explicitly state the questions addressed regarding participants, interventions, comparisons, and outcomes.

P5. [NA] A protocol is not mentioned.

P6. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

A level of scientific evidence was assigned to each study identified using the set grading criteria outlined by the US Agency for Healthcare Research and Quality [33] [35]:

    Prospective, randomized comparative trials,
    1A: Systematic review or meta-analysis

    Prospective, non-randomized comparative trials and

    Retrospective, observational studies.

Only level 1, 1A and 2 studies were included in our analyses' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A level of scientific evidence was assigned to each study identified using the set grading criteria outlined by the US Agency for Healthcare Research and Quality [33] [35]: Prospective, randomized comparative trials, 1A: Systematic review or meta-analysis Prospective, non-randomized comparative trials and Retrospective, observational studies. Only level 1, 1A and 2 studies were included in our analyses.&quot;</span> [Yes] The eligibility criteria specify characteristics used, including study design. 

P7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To complete this study a comprehensive literature review was conducted. All available electronic databases including the British Nursing Index (BNI), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library, EMBASE (Excerpta Medica), Intute: Health & Life Sciences, MEDLINE, PubMed, BIOSIS Previews, ISI Web of Knowledge, ISI Web of Science and IgentaConnect, were systematically searched for each procedure, between the period 1992–2009 for all English and non–English language articles.&quot;</span> [Yes] The information sources describe the databases searched and date ranges.

P8. [No] A full search strategy for at least one database is not provided.

P9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Each article was independently assessed for eligibility using the following criteria:&quot;</span> [Yes] The process for study selection is described.

P10. [No] The data collection process is not described. 

P11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The mean operative times, total hospital costs and postoperative length of stay after each of the three procedures were compared individually (laparoscopy vs. open) using the 2-tailed Mann-Whitney test for nonparametric data (with p<0.05 considered significant). Weighted relative risks were also determined (with 95% confidence interval estimates) and used to assess for association between the operative technique and complication rate.&quot;</span> [Yes] The data items list the variables extracted.

P12. [No] Methods for assessing risk of bias are not described.

P13. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For continuous variables (total hospital costs, LOS and OR time), statistical analysis was carried out using weighted mean differences (WMD) as the summary statistic, comparing the laparoscopic treatment groups with the reference (open surgery) groups using the Mantel-Haenszel method.&quot;</span> [Yes] The summary measures are stated.

P14. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta-analysis was performed in line with recommendations from the Cochrane Collaboration, the Quality of Reporting of Meta-analyses (QUORUM) and MOOSE initiative guidelines, where appropriate.&quot;</span> [Yes] Methods for combining results are described.

P15. [NA] Assessment of bias across studies is not applicable since no meta-analysis was performed.

P16. [NA] Additional analyses are not applicable since no meta-analysis was performed. 

P17. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 24 articles were identified that met the search and inclusion criteria. 16 appendectomy, 4 fundoplication and 4 inguinal hernia studies comparing procedural outcomes method were included.&quot;</span> [Yes] The number of studies screened and included is provided.

P18. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study design and methodological quality of the included studies are summarized in [Table 1].&quot;</span> [Yes] Study characteristics are presented.

P19. [No] Assessment of bias within studies is not presented.

P20. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Individual study LOS and OR time outcome data for laparoscopic and open appendectomy procedures are summarized in [Fig. 1], [2], respectively.&quot;</span> [Yes] Results for each study are presented with summary data and effect estimates.

P21. [NA] Results of meta-analyses are not applicable since no meta-analysis was performed. 

P22. [NA] Assessment of bias across studies is not applicable since no meta-analysis was performed.

P23. [NA] Additional analyses are not applicable since no meta-analysis was performed.

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎It is generally believed that laparoscopy results in less postoperative pain, fewer complications, and shorter recovery periods compared with open procedures. Yet despite these clearly established benefits in adult populations, at present, data from large prospective series on the safety and efficacy of the laparoscopic technique in younger infants is still lacking, although preliminary data provides convincing evidence that the technique is very promising.&quot;</span> [Yes] The evidence is summarized and considered in context.

P25. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Many of the included studies failed to take all the steps necessary to avoid bias. There may well be an inherent bias in the analyses, which are likely to favor the ‘newer’ MIS/laparoscopic technique.&quot;</span> [Yes] Limitations at the study and outcome level are discussed.

P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This review strengthens the use of MIS in pediatric populations, demonstrating that the three laparoscopic procedures reviewed showed better patient outcomes compared to open procedures in the form of reduced LOS and complication rates.&quot;</span> [Yes] Conclusions are provided considering the results and limitations.

P27. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Conflict of interest: None&quot;</span> [Yes] Sources of funding are described.
</pre>
<p><a name='71'></a></p>
</div>
<div id="black-2013" class="section level4">
<h4><a href='https://doi.org/10.1111/OBR.12037' title='Open publication'>Black
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for the PRISMA items:

P1. <span title='Minor quote deviation. Best match in fulltext (Similarity 97.8%):

Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Bariatric surgery in obese children and adolescents: a systematic review and meta-analysis&quot;</span> - The title identifies the report as a systematic review and meta-analysis. [Yes]  

P2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> - The abstract provides a structured summary with background, objectives, methods, results, and conclusions. [Yes]

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The number of obese young people continues to rise, with a corresponding increase in extreme obesity and paediatric-adolescent bariatric surgery. We aimed to (i) systematically review the literature on bariatric surgery in children and adolescents&quot;</span> - The introduction describes the rationale for the review. [Yes]

P4. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> - No explicit PICOS statement provided. [No] 

P5. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span> - No mention of a review protocol. [No]

P6. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span> - Inclusion/exclusion criteria described in methods. [Yes]

P7. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span> - Search strategy described with databases, dates, and other sources. [Yes]  

P8. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span> - Full search strategy provided for two databases. [Yes]

P9. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> - Study selection process described. [Yes]

P10. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span> - Data extraction method described. [Yes]

P11. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span> - Variables extracted described. [Yes]

P12. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span> - No risk of bias assessment described. [No]

P13. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span> - Mean difference in BMI stated as summary measure. [Yes]

P14. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span> - Meta-analysis methods described with I2. [Yes]

P15. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span> - No assessment of risk of bias across studies. [No] 

P16. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span> - Sensitivity analyses described. [Yes]

P17. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span> - Study selection process shown in flow diagram. [Yes]

P18. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> - Study characteristics presented in table. [Yes]

P19. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span> - No individual study risk of bias presented. [No]

P20. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> - BMI summary data presented. No effect estimates for harms. [No]

P21. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span> - Results of meta-analysis presented with CIs and I2. [Yes] 

P22. Not applicable - no assessment of bias across studies. [NA]

P23. Not applicable - no additional analyses beyond prespecified sensitivity analyses. [NA]  

P24. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> - Main findings summarized in discussion. [Yes]

P25. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> - Limitations discussed. [Yes]

P26. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span> - General interpretation and implications provided. [Yes]

P27. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span> - No funding sources described. [No]
</pre>
<p><a name='72'></a></p>
</div>
<div id="borruto-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2010.07.007' title='Open publication'>Borruto
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are my assessments for each PRISMA item:

P1. [Yes] Laparoscopic vs open varicocelectomy in children and adolescents: review of the recent literature and meta-analysis
The title identifies the report as a systematic review and meta-analysis.

P2. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to identify clinical evidence about the reliability of this technique in the recent literature.&quot;</span>  
The abstract provides background, objectives, eligibility criteria, methods, results, and conclusions.

P3. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Varicocele occurs in 10% to 15% of children and adolescents [4], [5]. Several treatment options have been used, including spermatic vein sclerotherapy or embolization, open inguinal ligation of the spermatic vein, subinguinal microscopic varicocelectomy, and, most recently, laparoscopy, but the ideal method for varicocele treatment is still controversial [6], [7], [8].&quot;</span>
The introduction describes the rationale in context of existing knowledge.  

P4. [No] 
Objectives referring to participants, interventions, comparisons, outcomes, and study design are not explicitly stated.

P5. [No]  
No review protocol or registration is mentioned.

P6. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Articles with data regarding recurrence, complications (hydrocele, hypotrophy, atrophy), and, if available, semen parameters after treatment were analyzed.&quot;</span>
Study eligibility criteria are described.

P7. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A literature search was performed, using Medline and Pubmed database, on all articles published during the last 10 years (2000-2009), reporting on varicocele treatments.&quot;</span>
Information sources including databases and dates are described.

P8. [No]   
No full search strategy is presented.

P9. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We recorded 37 studies, but 26 of these were excluded from our analysis using the following criteria...&quot;</span>
The study selection process is described.

P10. [No]
No data collection process is described. 

P11. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Articles with data regarding recurrence, complications (hydrocele, hypotrophy, atrophy), and, if available, semen parameters after treatment were analyzed.&quot;</span>
Outcomes sought are listed.

P12. [No] 
No assessment of risk of bias is described.

P13. [NA]

P14. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The results of continuous variables were reported as mean ± SD, and the statistical difference was calculated using the Student's t test.&quot;</span> 
Methods for combining study results are described.

P15. [NA]

P16. [NA] 

P17. [No]
No flow diagram of study selection is presented.

P18. [No]
Study characteristics are not presented.

P19. [No]  
No assessment of risk of bias is presented.

P20. [No]
No results for individual studies are presented.

P21. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Statistical analysis for categorical variables was carried out using the odds ratio as the summary statistic.&quot;</span>
Meta-analysis results are presented with confidence intervals.

P22. [NA]

P23. [NA] 

P24. [No]
No summary of evidence is provided.

P25. [No]   
No limitations are discussed.

P26. [No]
No general interpretation of results or implications for future research are provided.

P27. [No]
No funding sources are described.
</pre>
<p><a name='73'></a></p>
</div>
<div id="castagnetti-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JURO.2010.06.044' title='Open publication'>Castagnetti
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
 [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Surgical Management of Primary Severe Hypospadias in Children: Systematic 20-Year Review&quot;</span>

The title identifies the report as a systematic review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We systematically reviewed the literature published during the last 20 years on the treatment of primary proximal hypospadias associated with severe ventral curvature.&quot;</span> 

The abstract provides a structured summary including the background, objectives, eligibility criteria, and conclusions.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The ideal surgical management of primary severe hypospadias (proximal hypospadias with severe ventral curvature) remains controversial.&quot;</span>

The introduction describes the rationale for the review in the context of what is already known. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of the present review was to assess the results of studies published during the last 20 years on the primary repair of severe hypospadias.&quot;</span>

The introduction provides explicit objectives addressing interventions and outcomes.

[No]

The methods do not indicate if a review protocol exists.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We included in this review only series containing detailed results after primary repair of severe hypospadias or after curvature correction in patients with primary severe hypospadias.&quot;</span>

The methods specify eligibility criteria regarding study characteristics and outcomes.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Four databases, MEDLINE/PubMed, EMBASE, Web of Science and the Cochrane Library, were searched using a single term, “hypospadias,” as it defines accurately the subject of this review.&quot;</span>

The methods describe the information sources searched and date last searched.

[No] 

The methods do not present the full electronic search strategy for any database. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Duplicated publications and congress abstracts were excluded.&quot;</span>

The methods state the process for study screening and selection.

[No]

The methods do not describe the process for data collection from reports.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We first reviewed the results of the different straightening procedures, then the crude complication rates (overall complication, fistula/dehiscence, stricture/stenosis rates) of the different urethroplasty techniques.&quot;</span>

The methods list the variables for which data were sought.

[NA]

Risk of bias assessment is not applicable as no meta-analysis was performed.

[NA]

Summary measures are not applicable as no meta-analysis was performed. 

[NA] 

Synthesis methods are not applicable as no meta-analysis was performed.

[NA]

Assessment of risk of bias across studies is not applicable as no meta-analysis was performed.

[NA] 

Additional analyses are not applicable as no meta-analysis was performed.

[No]

The results section does not include a flow diagram of study selection.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The 2-stage repair, with a 22% cumulative complication rate, a 10% fistula/dehiscence rate and a 6% stricture/stenosis rate, appears to give a distinct clinical benefit overall.&quot;</span>

The results present characteristics of included studies. 

[NA]

Risk of bias assessment is not applicable as no meta-analysis was performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From the cumulative data outlined in the table, it appears that free graft urethroplasty is the most morbid procedure, mainly due to the tendency for strictures/stenoses to develop.&quot;</span>

The results present summary data and effect estimates for each study.

[NA] 

Synthesis of results is not applicable as no meta-analysis was performed.

[NA]

Assessment of risk of bias across studies is not applicable as no meta-analysis was performed.

[NA]

Additional analyses are not applicable as no meta-analysis was performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The present review illustrates that there is an extreme paucity of studies to address in an evidence-based manner many of the common issues related to the primary repair of proximal hypospadias.&quot;</span>

The discussion summarizes the main findings and considers their relevance.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An important limitation is that this review did not account for some variables such as age at surgery, use of additional coverage of urethroplasty, and type of preoperative and postoperative drainage and care.&quot;</span> 

The discussion describes limitations at the study and outcome level.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Hence, while we elaborate on general recommendations for the treatment of this condition, we emphasize the need to establish shared criteria for accurate preoperative or introperative patient stratification, and to define objective outcome measures and followup intervals for data reporting to make comparison of surgical approaches reliable.&quot;</span>

The discussion provides conclusions and implications for future research.

[No]

The article does not describe sources of funding for the review.
</pre>
<p><a name='74'></a></p>
</div>
<div id="castagnetti-2016" class="section level4">
<h4><a href='https://doi.org/10.3389/FPED.2016.00041' title='Open publication'>Castagnetti
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Does Preputial Reconstruction Increase Complication Rate of Hypospadias Repair? 20-Year Systematic Review and Meta-Analysis&quot;</span>
The title identifies the report as a systematic review and meta-analysis.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review of the literature on preputial reconstruction (PR) during hypospadias repair to determine the cumulative risk of preputial skin complications and the influence of PR on urethroplasty complications, namely, fistula formation and overall reoperation rate of the repair.&quot;</span>
The abstract provides a structured summary including background, objectives, eligibility criteria, outcomes, and conclusions.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Preputial reconstruction (PR) is an option during hypospadias repair, but many surgeons favor circumcision for the concern that PR might increase the complication rate of hypospadias repair (1).&quot;</span> 
The introduction describes the rationale for the review in context of existing knowledge.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Moreover, we performed a meta-analysis of studies comparing urethroplasty complications and reoperation rates in patients undergoing hypospadias repair associated with PR vs. circumcision to test the hypothesis that circumcision is associated with a lower rate of complications related to the urethroplasty, namely, fistula rate, and a lower reoperation rate.&quot;</span>
The introduction states the objectives and specifies the participants, interventions, comparisons, and outcomes. 

[No]
No protocol or registration is indicated.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the review, we included only studies reporting data on complications of PR (dehiscence of reconstructed prepuce and phimosis), on urethroplasty complications (fistula formation), and on reoperation rates in patients undergoing hypospadias repair with preservation of the prepuce.&quot;</span>
Study characteristics used as eligibility criteria are specified.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three databases, namely, MEDLINE/PubMed, Scopus, and The Cochrane library, were searched for using the free text “hypospadias repair,” in all fields of the records for MEDLINE/PubMed search, and in the Title and Topic fields for the Web of Science and Cochrane library searches.&quot;</span>
The information sources searched are described including databases, search terms, and date ranges.

[Yes] “For MEDLINE/PubMed search, “English,” “Humans,” “Males,” and “Publication date from June 1995 to June 2015” were considered, as limits."
The full search strategy for one database is provided including limits used.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three doctors reviewed separately the abstracts. Papers relevant to the topic of the review were selected by consensus.&quot;</span> 
The study selection process is described.

[No]
The data collection process is not described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For data extraction, dehiscence was considered irrespective of whether partial or complete. Since many reconstructed prepuces are non-retractile soon after surgery, but retractility can spontaneously improve over time, secondary phimosis was defined as a phimosis needing circumcision during follow-up.&quot;</span>
The variables extracted are listed and defined. 

[NA]
Risk of bias assessment is not applicable for this review without meta-analysis.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two different outcomes were used for the meta-analysis, namely, “hypospadias fistula formation” and “overall reoperation rate.”&quot;</span>
The principal summary measures are stated.

[NA] 
Synthesis methods are not applicable for this review without meta-analysis.

[NA]
Assessment of bias across studies is not applicable without meta-analysis.

[NA]
Additional analyses are not applicable without meta-analysis.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of the original 3692 records, 20 (0.6%) studies that matched the criteria for inclusion in the review were finally selected (Figure 1).&quot;</span>
The number of studies screened, assessed, and included is provided with exclusions specified.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Characteristics of included studies are detailed in Table 1. The vast majority (13, 65%) were surgical series (LOE 4), three (15%) were retrospective case–control studies (LOE 4), two (10%) were longitudinal cohort studies (LOE 3), and the remaining two (10%) were RCTs (LOE 2).&quot;</span> 
For each study, characteristics are presented including design, level of evidence, and citation.

[No]
No outcome level risk of bias assessment is presented. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the 19 studies (Table 2), the PR complication rate ranged 0 to 30%, but was <10% in 15. The cumulative rate of PR complications was 7.7% (163 of 2115 patients).&quot;</span>
Summary data and effect estimates are presented for relevant outcomes.

[NA] 
Synthesis methods are not applicable without meta-analysis. 

[NA]
Assessment of bias across studies is not applicable without meta-analysis.

[NA]
Additional analyses are not applicable without meta-analysis.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

This systematic review shows that according to available evidence PR carries an 8% risk of specific preputial complications, whereas it does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repairs' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This systematic review shows that according to available evidence PR carries an 8% risk of specific complications, whereas it does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repairs.&quot;</span>
The main findings are summarized including strength of evidence for main outcomes. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although this review encompasses the best available evidence, some drawbacks should be considered. Results of systematic reviews are unavoidably dependent on the criteria chosen to select the studies and the quality of the studies included.&quot;</span>
Limitations at the study and outcome level are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Preputial reconstruction is an option particularly in patients with distal hypospadias without associated penile curvature. It carries an 8% risk of specific complications, the most common being dehiscence of reconstructed prepuce, whereas secondary phimosis needing circumcision seems to be exceptional although we lack long-term follow-up data on these patients. Overall, PR does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair.&quot;</span>
Conclusions are provided considering other evidence and implications for future research.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.&quot;</span>
Sources of funding are described and the role of funders is stated.
</pre>
<p><a name='75'></a></p>
</div>
<div id="chan-2014-pediatr-surg-int" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-013-3429-Y' title='Open publication'>Chan
2014 (Pediatr Surg Int)</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Ideal timing of orchiopexy: a systematic review&quot;</span>
Reports study as a systematic review in the title.

P2. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> 
Provides a structured abstract with background, objectives, methods, results, and conclusions.

P3. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The ideal management of cryptorchidism is a highly debated topic within the field of pediatric surgery. The optimal timing of orchiopexy is particularly unclear, as existing literature reports mixed recommendations.&quot;</span>
Describes rationale and knowledge gap in the introduction.

P4. [No]
Does not explicitly state PICOS in the introduction.

P5. [No]  
Does not mention a review protocol or registration.

P6. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We included all studies that examined the effect of age at orchiopexy on fertility or malignancy, even if these outcomes were not the primary focus.&quot;</span>
Specifies eligibility criteria.

P7. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), Embase (1980 onwards), and CINAHL (1982 onwards) to find relevant articles.&quot;</span>
Describes information sources searched. 

P8. [No]
Does not provide full search strategy.

P9. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎If we deemed a study relevant based on the title and abstract, we obtained the full text article to further screen for relevance. Two researchers independently performed each level of screening, comparing the selected studies to reach a consensus. If a consensus could not be reached, they consulted a third researcher.&quot;</span>  
Describes study selection process.

P10. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One researcher extracted data from each of the included studies, and a second researcher checked the data for accuracy and completeness.&quot;</span>
Describes data collection process.

P11. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on the studies with the highest methodological quality, we formed a conclusion regarding the optimal timing of orchiopexy to preserve fertility and prevent malignancy.&quot;</span>
States that data on outcomes were sought to address review objectives.

P12. [Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 90.4%):

the following tools: AMSTAR (systematic reviews), Jadad (RCTs), and MINORS (non-RCTs' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We used the following tools: AMSTAR (systematic reviews), Jadad (RCTs), and MINORS (non-RCTs).&quot;</span> 
Describes methods for assessing risk of bias.

P13. [NA] 
No meta-analysis performed.

P14. [NA]
No meta-analysis performed. 

P15. [NA]
No meta-analysis performed.

P16. [NA]  
No meta-analysis performed.

P17. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our initial search yielded 198 studies. After screening, we quality assessed the 32 remaining studies that met our criteria (Fig. 1).&quot;</span>
Reports on study selection with number of studies screened and included.   

P18. [Yes] <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 66.9%):

.

Altogether, the comparative studies included 3,099 patients with a history of cryptorchidism' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Publication dates ranged from 1974 to 2011." "Altogether, the comparative studies included 3,099 patients with a history of cryptorchidism.&quot;</span>
Provides information on included study characteristics.

P19. [Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 90.4%):

the following tools: AMSTAR (systematic reviews), Jadad (RCTs), and MINORS (non-RCTs' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We used the following tools: AMSTAR (systematic reviews), Jadad (RCTs), and MINORS (non-RCTs).&quot;</span>
Describes assessment of risk of bias in included studies.

P20. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors of this study randomized cryptorchid infants to receive orchiopexy at either 9 months (n = 72) or 3 years (n = 83). Fertility potential was defined as testicular catch-up growth between 9 months and 4 years of age.&quot;</span> 
Presents results for main outcomes in included studies.

P21. [NA]
No meta-analysis performed.

P22. [NA] 
No meta-analysis performed.

P23. [NA]
No meta-analysis performed. 

P24. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Regarding fertility, several measures have been examined, including testicular growth/size, testicular histology, semen analysis, and paternity rate. Most of these measures serve as surrogates of fertility, as paternity rate and time until conception are the only direct measures of male fertility.&quot;</span>
Summarizes main findings and discusses relevance.

P25. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results should be interpreted with caution due to limitations of our study. The most direct measurement of male fertility is paternity rate and time until conception of a live born child [4]; however, due to the difficulty in conducting long-term paternity studies, most research has measured fertility using testicular growth/size [11, 14, 16, 28, 31, 33–35], testicular histology at orchiopexy [15, 17, 23, 26, 27, 32, 36, 41], and semen analysis in adulthood [11, 25, 29–32, 35, 37, 38, 40, 41].&quot;</span>
Discusses limitations at study and outcome level.  

P26. [Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

In this review, we found that orchiopexy between 6 and 12 months of age may optimize fertility potential and help protect against the increased risk of testicular cancer associated with cryptorchidism. Surgery should not be performed before 6 months, as the testis may descend spontaneously during that time. Furthermore, orchiopexy in infants should be performed by pediatric urologists or pediatric surgeons to reduce the risk of complications. There is a paucity of higher-quality studies (e.g., long-term, prospective randomized trials) investigating the effect of age at orchiopexy on fertility and malignancy, possibly because of ethical concerns with randomization and the feasibility of long-term follow-up. Future research should address these issues, focusing especially on the effect of age at treatment on direct measures of fertility (i.e., time until conception of a live born child), for which existing research is particularly scarce. Nevertheless, our study is the first step towards determining the ideal management of undescended testes. By disseminating our findings, we hope to bring awareness of this topic to pediatric surgeons and other medical practitioners, promoting the worldwide use of evidence-based medicine' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In this review, we found that orchiopexy between 6 and 12 months of age may optimize fertility potential and help protect against the increased risk of testicular cancer associated with cryptorchidism. By disseminating our findings, we hope to bring awareness of this topic to pediatric surgeons and other medical practitioners, promoting the worldwide use of evidence-based medicine.&quot;</span>
Provides conclusions and implications for research.

P27. [No]
Does not report on sources of funding.
</pre>
<p><a name='76'></a></p>
</div>
<div id="chan-2014-j-pediatr-surg" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2014.02.049' title='Open publication'>Chan
2014 (J Pediatr Surg)</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

[No] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive versus open repair of Bochdalek hernia: a meta-analysis&quot;</span>
The title does not specify that this is a systematic review.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
The objectives are clearly stated in the abstract.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>  
The introduction provides background and rationale.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
PICOS is outlined in the objectives of the abstract.  

[No]
A protocol is not mentioned.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
Eligibility criteria are described in the methods.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
Information sources are listed in the methods.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
The full search strategy is presented for 3 databases.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> 
The study selection process is outlined in the results and Figure 1.

[No] 
The data collection process is not described.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
Outcomes examined are listed in the methods.

[No]
Risk of bias assessment is not described. 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
Summary measures are stated in the methods.

[NA]

[NA]

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
Study selection is detailed in the results and Figure 1.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Study characteristics are presented in Table 1. 

[No]
Individual study risk of bias is not presented.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
Results for each outcome are presented with forest plots.

[NA] 

[NA]

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
Main findings are summarized in the discussion.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
Limitations are discussed.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
Conclusions and future directions are provided.

[No]
Funding sources are not reported.
</pre>
<p><a name='77'></a></p>
</div>
<div id="chang-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00345-015-1526-3' title='Open publication'>Chang
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the assessments for each PRISMA item based on the provided text:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We used the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) statement to report our findings.&quot;</span>
States that PRISMA was used.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Objective: This manuscript is mainly to systemically review the published reports that compared the efficacy and safety of robotic-assisted (RP) versus open pyeloplasty (OP) in children with ureteropelvic junction obstruction (UPJO).&quot;</span>  
Provides explicit objectives.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Despite the promising advances in techniques and instruments in performing dismembered pyeloplasty, more than half of children with UPJO still received open pyeloplasty in the past few years [4].&quot;</span>
Describes rationale in context of existing knowledge.  

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Objective: This manuscript is mainly to systemically review the published reports that compared the efficacy and safety of robotic-assisted (RP) versus open pyeloplasty (OP) in children with ureteropelvic junction obstruction (UPJO).&quot;</span>
Explicitly states questions with participants, interventions, comparisons.

[No] 
No mention of review protocol.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following criteria were used to filter studies for our analysis: randomized controlled trials or comparative studies that compared children who received either robotic or open dismembered pyeloplasty for ureteropelvic junction obstruction with data on perioperative parameters, complication rate, and success rate.&quot;</span>
Specifies eligibility criteria.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched PubMed® for comparative studies (from January 1990 to 2014 September) that compared the efficacy and safety of robotic versus open pyeloplasty. Searches were limited to studies published in English.&quot;</span>
Describes information sources.  

[No]
Does not provide full search strategy.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Flowchart for selection of trials&quot;</span>
States process of study selection with flow diagram.

[No] 
No details on data collection process. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We extracted the following information from each study: study population characteristics, study design, inclusion and exclusion criteria, operation method, surgical approach, days of hospital stay, complication rate, follow-up period, and assessment of success rate.&quot;</span>
Lists variables extracted.

[No]
Does not describe risk of bias assessment.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The meta-analysis was performed using the fixed effect method when there was no statistically significant heterogeneity.&quot;</span> 
States summary measures used.

[NA] No meta-analysis performed.

[NA] No meta-analysis performed. 

[NA] No meta-analysis performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Flowchart for selection of trials&quot;</span>
Reports study selection with flow diagram.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 1 Summary of reported series of robotic and open pyeloplasty in children&quot;</span>
Presents extracted study characteristics.

[No] 
Does not present risk of bias assessments.

[NA] No meta-analysis performed.

[NA] No meta-analysis performed.

[NA] No meta-analysis performed.

[NA] No meta-analysis performed. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In total, seven comparative trials and three studies using national database met the criteria that comprised 20,691 (RP:OP = 1956:18,735) patients in the meta-analysis.&quot;</span>
Summarizes main findings.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were several limitations to this study. First, the included studies were all retrospective in origin with lack of prospective data. Therefore, the bias may arise from selecting the method of pyeloplasty at surgeon’s discretion.&quot;</span>
Discusses limitations at study and outcome level.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The current meta-analysis fails to validate robotic pyeloplasty as a standard of care in managing pediatric UPJO in the current status. We urge the pediatric laparoendoscopists and manufacturer to improve the surgical efficacy and safety of pediatric robotic-assisted pyeloplasty.&quot;</span>
Provides general interpretation and implications.

[No]
Does not describe sources of funding.
</pre>
<p><a name='78'></a></p>
</div>
<div id="chen-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2012.12.036' title='Open publication'>Chen
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are my responses for the PRISMA items based on the provided full text:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Transanal endorectal pull-through versus transabdominal approach for Hirschsprung's disease: A systematic review and meta-analysis&quot;</span>
The title identifies the report as a systematic review and meta-analysis.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a comprehensive meta-analysis comparing the clinical outcomes of TERPT and TAB.&quot;</span>  
The abstract provides a structured summary including the objectives, data sources, eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, and conclusions.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As such, TERPT has become an increasingly popular approach for treating HD [11].&quot;</span>
The introduction describes the rationale for the review in context of what is already known.  

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 98.1%):

However, as a relatively newer technique, the long-term outcome of TERPT is less clear' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎However, the long-term outcome of TERPT is less clear.&quot;</span>
The introduction states the question being addressed is comparing long-term outcomes of TERPT and TAB.

[NA]
No review protocol or registration is mentioned.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Original articles published from 1998 to 2012 were searched from Medline, Embase, and Cochrane databases. Randomized controlled trials (RCT) and observational clinical studies (OCS) comparing TERPT and TAB were included.&quot;</span>
The eligibility criteria regarding study characteristics and report characteristics are described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched all publications from August 1998 to March 2012 in the MEDLINE, EMBASE and Cochrane library databases and the Cochrane Controlled Trials Register using different combinations of the following terms: “Hirschsprung's disease,” “transanal,” “perineal approach,” “transabdominal” and “pull-through.”&quot;</span> 
The information sources including databases and dates of coverage are described.

[No]
The full search strategy is not presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Each included study was independently appraised by 3 reviewers (C.Y., S.N., N.K.L.) and data were extracted and entered into a database.&quot;</span>
The study selection process is described.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Data extraction from reports (e.g., piloted forms, independently, in duplicate)&quot;</span>
The data collection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following data were evaluated: patient's age at operation, length of aganglionic segment, operative time, length of hospital stay, duration of follow-up and the incidence of postoperative incontinence, constipation and enterocolitis.&quot;</span>
The variables extracted are listed.

[NA] 
No assessment of risk of bias in individual studies is described since this is a systematic review without a meta-analysis.

[NA]
No summary measures are stated since this is a systematic review without a meta-analysis. 

[NA]  
No synthesis methods are described since this is a systematic review without a meta-analysis.

[NA]
No assessment of bias across studies is described since this is a systematic review without a meta-analysis.

[NA]  
No additional analyses are mentioned since this is a systematic review without a meta-analysis.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):

studies that compared outcome after TERPT with those after TAB were eligible for inclusion in our analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Eighteen studies that compared outcome after TERPT with those after TAB were eligible for inclusion in our analysis.&quot;</span> 
The numbers of studies screened, assessed, and included are provided with exclusions.

[Yes] Table 1 provides characteristics of the included studies.

[NA] 
No assessment of risk of bias within studies is provided since this is a systematic review without a meta-analysis.

[NA] 
No results of individual studies are presented since this is a systematic review without a meta-analysis.

[NA]  
No meta-analysis results are presented since this is a systematic review without one.

[NA]
No assessment of bias across studies is presented since this is a systematic review without a meta-analysis.

[NA]
No additional analyses are presented since this is a systematic review without a meta-analysis.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎TERPT is superior to TAB in operative time, hospital stay, postoperative incontinence and constipation.&quot;</span>
The main findings are summarized including the strength of evidence.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎However, the lack of large prospective studies of robust design cannot be trivialized.&quot;</span>
Limitations at the study and outcome level are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎More randomized controlled trials are necessary to verify the benefit of TERPT for Hirschsprung's disease.&quot;</span>  
Conclusions are provided and implications for future research are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors would like to thank Mr. Fahad Javaid Siddiqui, Assistant Professor of Epidemiology, Singapore Clinical Research Institute, for his invaluable help with statistical analysis.&quot;</span>
Sources of funding are described.
</pre>
<p><a name='79'></a></p>
</div>
<div id="corbett-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2015.08.014' title='Open publication'>Corbett
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are my responses for the PRISMA 2009 checklist:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes of endopyelotomy for pelviureteric junction obstruction in the paediatric population: A systematic review&quot;</span>

P1. "[Yes]" - Title identifies the report as a systematic review. 

P2. "[No]" - No structured abstract is provided.

P3. <span title='Moderate quote deviation. Best match in prompt (Similarity 90.7%):

Describe the rationale for the review in the context of what is already known.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Describe the rationale for the review in the context of what is already known." "[Yes]&quot;</span> 

P4. <span title='Minor quote deviation. Best match in prompt (Similarity 95.7%):

Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS)." "[No]&quot;</span>

P5. "[NA]" - No protocol or registration is mentioned.

P6. <span title='Minor quote deviation. Best match in prompt (Similarity 97.1%):

Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
P7. Met' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale." "[Yes]&quot;</span>

P7. <span title='Minor quote deviation. Best match in prompt (Similarity 96.6%):

Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
P8. Met' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched." "[Yes]&quot;</span>

P8. <span title='Moderate quote deviation. Best match in prompt (Similarity 94.7%):

Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated." "[No]&quot;</span> 

P9. <span title='Minor quote deviation. Best match in prompt (Similarity 95%):

State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis)." "[Yes]&quot;</span>

P10. <span title='Minor quote deviation. Best match in prompt (Similarity 95.5%):

Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators." "[Yes]&quot;</span> 

P11. <span title='Minor quote deviation. Best match in prompt (Similarity 95%):

List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made." "[No]&quot;</span>

P12. "[NA]" - No assessment of individual study bias is described.

P13. "[NA]" - No meta-analysis is performed. 

P14. "[NA]" - No meta-analysis is performed.

P15. "[NA]" - No assessment of risk of bias across studies is described.

P16. "[NA]" - No additional analyses are described. 

P17. <span title='Minor quote deviation. Best match in prompt (Similarity 97%):

Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
P18. Res' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram." "[Yes]&quot;</span>

P18. <span title='Minor quote deviation. Best match in prompt (Similarity 96.6%):

For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
P19. Res' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations." "[Yes]&quot;</span>

P19. "[NA]" - No assessment of individual study bias is presented.

P20. "[Yes]" - Results of individual studies are presented in tables.

P21. "[NA]" - No meta-analysis is performed.

P22. "[NA]" - No assessment of bias across studies is presented. 

P23. "[NA]" - No additional analyses are presented.

P24. <span title='Minor quote deviation. Best match in prompt (Similarity 95.7%):

Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers)." "[Yes]&quot;</span>

P25. <span title='Minor quote deviation. Best match in prompt (Similarity 95.2%):

Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias)." "[Yes]&quot;</span>

P26. <span title='Moderate quote deviation. Best match in prompt (Similarity 93.7%):

Provide a general interpretation of the results in the context of other evidence, and implications for future research.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research." "[Yes]&quot;</span>

P27. <span title='Moderate quote deviation. Best match in prompt (Similarity 94.5%):

Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
---' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review." "[Yes]&quot;</span>
</pre>
<p><a name='80'></a></p>
</div>
<div id="cullis-2016" class="section level4">
<h4><a href='https://doi.org/10.1097/sla.0000000000001563' title='Open publication'>Cullis
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and explanations for each PRISMA item:

The article is titled <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Is Screening of Intestinal Foregut Anatomy in Heterotaxy Patients Really Necessary? A Systematic Review in Search of the Evidence&quot;</span> which identifies it as a systematic review. [Yes]

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic review [according to PRISMA guidelines] was conducted using CINAHL, EMBASE, Medline, and Cochrane Databases.&quot;</span> The methods section states it is a systematic review and provides information on the sources searched. [Yes] 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In light of uncertainty and controversy, we undertook a systematic review of the available literature to determine (1) whether screening of IRA is obligatory in “asymptomatic” patients with heterotaxy and (2) whether detection of a rotational anomaly warrant(s) surgical correction in such a fragile patient cohort.&quot;</span> The introduction states the rationale and objectives of the review. [Yes]

<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.3%):

. We hypothesized that the complication(s) associated with surgical correction outweighed the risk of midgut volvulus and its sequelae and that screening in “asymptomatic patients” was unnecessary' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎To this end, we hypothesized that the complication(s) associated with surgical correction outweighed the risk of midgut volvulus and its sequelae and that screening in “asymptomatic patients” was unnecessary.&quot;</span> The introduction provides the PICOS elements being examined. [Yes]

No protocol or registration is mentioned. [No] 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligibility criteria were then applied to remaining studies (Table 1).&quot;</span> Eligibility criteria for studies are provided. [Yes]

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic search of the English language literature was conducted using a keyword algorithm (Supplemental Figure 1, https://links.lww.com/SLA/A928). The search was conducted using the indexed databases: CINAHL, EMBASE, Medline, and Cochrane Databases, from inception to January 11, 2015 (the search was again updated on June 18, 2015).&quot;</span> The information sources and dates searched are described. [Yes]  

No full search strategy is provided. [No]

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two reviewers (P.S.C., S.S.) performed the study selection, data extraction, and quality assessment processes independently and all data was recorded in tabular form electronically. Disagreements were resolved by discussion or consultation with the third reviewer/senior corresponding author who conceived the study (P.D.L.).&quot;</span> The study selection process is described. [Yes]

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome evaluated was mortality associated with conservative or surgical management of IRA. Secondary outcomes included development of malrotation with obstruction or midgut volvulus, that is, symptomatic IRA and complications thereof with surgical intervention.&quot;</span> The data collection process is described. [Yes] 

The outcomes sought are listed in the data extraction section. [Yes] 

No assessment of risk of bias in individual studies is described. [No]

No summary measures are stated. [NA] 

No synthesis methods are described. [NA]

No assessment of risk of bias across studies is described. [NA] 

No additional analyses are described. [NA]

No flow diagram of study selection is provided. [No]

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 2 summarizes the main characteristics of the 19 included studies.&quot;</span> Study characteristics are presented. [Yes]

No assessment of risk of bias within studies is presented. [No] 

No results for individual studies are presented. [No]

No synthesis results are presented. [NA]

No assessment of risk of bias across studies is presented. [NA]

No additional analyses results are presented. [NA] 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review shows that “asymptomatic patients” with heterotaxy are at a low risk of developing IRA-related complications.&quot;</span> The review's main findings are summarized. [Yes]

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We fully acknowledge that there are some limitations with the present study.&quot;</span> Limitations are discussed. [Yes]

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although this systematic review favors a “watchful waiting” approach over prophylactic surgery in patients with heterotaxy, what exactly this should constitute is not standardized.&quot;</span> Conclusions and implications are provided. [Yes]

No funding sources are described. [No]
</pre>
<p><a name='81'></a></p>
</div>
<div id="cundy-2014-bju-int" class="section level4">
<h4><a href='https://doi.org/10.1111/bju.12683 ' title='Open publication'>Cundy
2014 (BJU Int)</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here is the reporting quality assessment based on the PRISMA 2009 checklist:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta-analysis of robot-assisted vs conventional laparoscopic and open pyeloplasty in children&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span> 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>

[No] 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>

[NA]

[NA] 

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>

[NA]

[NA]

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
</pre>
<p><a name='82'></a></p>
</div>
<div id="cundy-2014-j-pediatr-surg" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2013.12.014' title='Open publication'>Cundy
2014 (J Pediatr Surg)</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta analysis of robot-assisted versus conventional laparoscopic fundoplication in children&quot;</span> 

The title identifies the report as a meta-analysis.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>

The abstract provides a structured summary.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span> 

The introduction describes the rationale.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>

The introduction states the objectives using PICOS. 

[No] No mention of a protocol or registration.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>  

The methods section specifies eligibility criteria.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>

The search strategy is described.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>

The full search strategy for PubMed and EMBASE is presented.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> 

The study selection process is described.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>

The data extraction process is described. 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>

Outcomes of interest are listed and defined.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>

Risk of bias assessment is described using a modified NOS.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span> 

Summary measures are stated.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>

Statistical methods for meta-analysis are described. 

[No] No assessment of publication bias mentioned.

[NA] No additional analyses done.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>

A flow diagram of study selection is provided.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>

Study characteristics are presented in tables. 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span> 

Risk of bias assessment is presented.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> 

Results are presented with forest plots.

[NA] No meta-analysis done.

[NA] No assessment of bias across studies. 

[NA] No additional analyses.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>

The discussion summarizes the main findings.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>

Limitations are discussed.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>

Conclusions are provided with implications for future research.

[No] No mention of funding sources.
</pre>
<p><a name='83'></a></p>
</div>
<div id="cundy-2014-eur-j-pediatr-surg" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0033-1347297' title='Open publication'>Cundy
2014 (Eur J Pediatr Surg)</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Robot-Assisted Minimally Invasive Surgery for Pediatric Solid Tumors: A Systematic Review of Feasibility and Current Status&quot;</span>
The title identifies the report as a systematic review.

[Yes] 
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
The abstract provides a structured summary covering all key elements.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Surgical resection is a key component of multimodal treatment strategies for many pediatric solid tumors. With overall cure rates for childhood tumors approaching 80%,[1] there is an incentive to seek further means for improved quality of life through reduced surgery-related morbidity.&quot;</span>  
The introduction describes the rationale for the review.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study is to systematically review the current status of robot-assisted MIS for pediatric solid tumors and critically appraise whether the evidence supports further exploration and adoption.&quot;</span>
The objectives are stated.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The review protocol was registered on the PROSPERO international prospective database of systematic reviews (CRD42013003752).&quot;</span>
Protocol registration is reported.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were defined as (1) clinical procedures in children (< 18 years or treated with internationally recognized pediatric oncology protocols, i.e., Children's Oncology Group or European Pediatric Oncology Group), (2) therapeutic MIS for resection of benign or malignant solid tumor(s), and (3) utilization of a robotic surgical platform.&quot;</span> 
Eligibility criteria are specified.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic search of multiple electronic databases was undertaken (PubMed, Ovid Medline, and EMBASE) ([Fig. 1]).[21] The search period was for the years 2002 to 2012 inclusively.&quot;</span>
Information sources are described. 

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
The full search strategy for PubMed is presented.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two reviewers (T.P.C. and H.J.M.) independently undertook title and abstract screen, with disagreements resolved by consensus.&quot;</span>
The study selection process is described.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Corresponding authors were contacted in the event of insufficient data being reported in studies, such as mixed adult/pediatric series without age category subclassification.&quot;</span>
The data collection process is described.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patient demographic information, operative details, oncological outcomes, and surgical complications were retrieved from included studies.&quot;</span>
The data items collected are listed.

[NA]
No risk of bias assessment was performed for individual studies.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Almost universally, authors commented that the dexterity of seven degree-of-freedom articulated instruments, along with intuitive master-slave control permitted more meticulous dissection during tumor extirpation.[17] [20] [22] [23] [27] [28] [31] [33] [34] [35] [36] [38] [39]&quot;</span>
A narrative synthesis of results is provided. 

[NA]
No meta-analysis was performed.

[NA] 
No assessment of risk of bias across studies was performed.

[NA]
No additional analyses were reported.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 23 publications met eligibility criteria, reporting 40 cases overall. &quot;</span> 
The number of studies screened and included is reported.

[Yes]
<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.5%):

Patient demographics, operative details, and patient outcomes for identified cases of robot-assisted MIS for pediatric solid tumors' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Patient demographic information, operative details, and patient outcomes for identified cases of robot-assisted MIS for pediatric solid tumors&quot;</span>
Characteristics of included studies are presented in a table.

[NA] 
No assessment of risk of bias within studies was performed. 

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Overall conversion rate was 12.5% (5/40) ([Table 1]).&quot;</span>
Results for the main outcomes are reported.

[NA]
No meta-analysis was performed.

[NA]
No assessment of risk of bias across studies was performed. 

[NA]
No additional analyses were performed.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For the diverse and highly selective cases in this review, robot-assisted MIS seems safe and feasible.&quot;</span>
A summary of the main findings is provided.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Lack of tactile feedback (haptics) was frequently cited as a primary technical concern.[17] [19] [23] [28]&quot;</span> 
Study limitations are discussed.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Current status of robot-assisted surgery for pediatric solid tumors is small and relatively static, with no clearly apparent index procedures.&quot;</span>
Conclusions are stated.

[No]
No statement on sources of funding is provided.
</pre>
<p><a name='84'></a></p>
</div>
<div id="ding-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2013.01.026' title='Open publication'>Ding
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Single-incision versus conventional three-incision laparoscopic appendicectomy for appendicitis: A systematic review and meta-analysis&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis was designed to investigate the safety and efficacy of single-incision laparoscopic appendicectomy (SILA) and three-incision laparoscopic appendicectomy (TILA) in the treatment of appendicitis.&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive surgery is the development direction of the future surgery, it allows the surgeon to perform complex intracorporeal procedures while minimizing the trauma of surgical access [1].&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> 

[NA] No protocol mentioned.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were: (1) clinical studies that compared single-incision versus conventional three-incision laparoscopic appendicectomy for appendicitis between 1992 and 2012; (2) patients with primary appendicitis.&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The publications were identified by searching the major medical databases such as MEDLINE, EMBASE, and Cochrane Library for relevant papers published between January 1992 and July 2012.&quot;</span> 

[No] No full search strategy provided.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three researchers extracted data from each study by using a structured sheet and entered the data into a database. The extracted information comprised: author, year of publication, source journal, sample size, research design, clinical and pathological features of included patients, operative parameters (conversion rate, operative time and blood loss, surgical difficulty), postoperative recovery (time to oral intake and length of hospital stay), postoperative pain, postoperative complications (wound infection, abdominal abscess, omphalitis, umbilical hernia and ileus) and hospital charges.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>

[NA] No individual study risk of bias assessment. 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>

[NA] No meta-analysis performed.

[NA] No assessment of risk of bias across studies.

[NA] No additional analyses.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>

[NA] No individual study risk of bias results.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> 

[NA] No meta-analysis performed.

[NA] No assessment of risk of bias across studies. 

[NA] No additional analyses.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
</pre>
<p><a name='85'></a></p>
</div>
<div id="dingemann-2014" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0033-1350060' title='Open publication'>Dingemann
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the assessments for each PRISMA item based on the provided full text:

P1. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Thoracoscopic Procedures in Pediatric Surgery: What is the Evidence?&quot;</span> The title identifies the report as a systematic review.

P2. [No] No abstract provided. 

P3. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Introduction: The use of video-assisted thoracoscopic surgery (VATS) has evolved quickly and it has gained widespread acceptance among pediatric surgeons during the last decade.&quot;</span> The introduction describes the rationale for the review.

P4. [No] The objectives are not explicitly stated with PICOS.

P5. [No] No mention of a review protocol or registration.

P6. [Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 95.4%):

matic reviews,” and “meta-analysis” were applied. Abstracts were individually reviewed and only those studies comparing the results and clinical outcome of VATS procedures with the corresponding open operation were chosen for further analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Materials and Methods: Abstracts were individually reviewed and only those studies comparing the results and clinical outcome of VATS procedures with the corresponding open operation were chosen for further analysis.&quot;</span> The eligibility criteria are specified. 

P7. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Materials and Methods: Clinical studies published in the English literature were identified by a Medline literature search using PubMed.&quot;</span> The information source and date last searched are described.

P8. [No] The full search strategy is not presented. 

P9. [Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 95.4%):

matic reviews,” and “meta-analysis” were applied. Abstracts were individually reviewed and only those studies comparing the results and clinical outcome of VATS procedures with the corresponding open operation were chosen for further analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Materials and Methods: Abstracts were individually reviewed and only those studies comparing the results and clinical outcome of VATS procedures with the corresponding open operation were chosen for further analysis.&quot;</span> The study selection process is described.

P10. [No] The data collection process is not described.

P11. [Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 95.6%):

toma). In the following, the main results of the studies with regard to advantages and disadvantages of laparoscopic compared with open surgery are summarized in alphabetical order' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Results: In the following, the main results of the studies with regard to advantages and disadvantages of laparoscopic compared with open surgery are summarized in alphabetical order.&quot;</span> The data items sought are described in the results.

P12. [No] No mention of risk of bias assessment. 

P13. [NA] No meta-analysis performed.

P14. [NA] No meta-analysis performed. 

P15. [NA] No meta-analysis performed.

P16. [NA] No meta-analysis performed. 

P17. [No] The numbers of studies screened, assessed, and included are not provided. 

P18. [Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):

Results A total of 3 meta-analysis (MA) and 18 retrospective comparative studies (RCS) investigating 5 different VATS procedures (repair of congenital diaphragmatic hernia [CDH], repair of esophageal atresia/tracheoesophageal fistula (EA/TEF), lung resection, treatment of pneumothorax, and resection of neuroblastoma) were included in this study' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Results: A total of 3 meta-analysis (MA) and 18 retrospective comparative studies (RCS) investigating 5 different VATS procedures (repair of congenital diaphragmatic hernia [CDH], repair of esophageal atresia/tracheoesophageal fistula [EA/TEF], lung resection, treatment of pneumothorax, and resection of neuroblastoma) were included in this study.&quot;</span> Study characteristics are presented.

P19. [No] No assessment of risk of bias.

P20. [Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 95.6%):

] Additionally, in the RCS published by Gourlay et al, faster return to full enteral feeds, less postoperative narcotic/sedation, and less severe complications occurred in the thoracoscopic cohort' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Results: Additionally, in the RCS published by Gourlay et al, faster return to full enteral feeds, less postoperative narcotic/sedation, and less severe complications occurred in the thoracoscopic cohort.&quot;</span> Results for outcomes are provided for individual studies.

P21. [NA] No meta-analysis performed.

P22. [NA] No meta-analysis performed.

P23. [NA] No meta-analysis performed.

P24. [No] No summary of evidence provided.

P25. [No] No limitations discussed.

P26. [No] No general interpretation of results provided. 

P27. [No] No mention of sources of funding.
</pre>
<p><a name='86'></a></p>
</div>
<div id="dingemann-2013" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0033-1333639' title='Open publication'>Dingemann
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Systematic Review of Level 1 Evidence for Laparoscopic Pediatric Surgery: Do Our Procedures Comply with the Requirements of Evidence-Based Medicine?&quot;</span>
The title identifies the report as a systematic review.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of our study was to evaluate the availability of Level 1 studies comparing laparoscopic procedures with the corresponding open operation in pediatric surgery.&quot;</span>
The abstract provides a structured summary including the objective.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The implementation of well-designed RCTs, comparing minimally invasive procedures with the corresponding open operation in children has been claimed by several authors.&quot;</span>
The introduction describes the rationale for the review in the context of what is already known.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Thus, the aim of our study was to present a current analysis of the Level 1 studies directly comparing laparoscopic and open operations in pediatric patients.&quot;</span>  
The introduction provides explicit objectives relating to evaluating Level 1 evidence comparing laparoscopic and open pediatric surgery.

[NA]

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Clinical Level 1 studies (SR, MA, and RCT) published in the English literature were identified through a Medline literature search using PubMed.&quot;</span>
The methods specify inclusion criteria relating to study design, language, and publication status. 

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 20 manuscripts met the inclusion criteria for our SR, of which 9 were SRs or MAs and 11 RCTs.&quot;</span>
The methods describe the information sources including databases searched.

[No]

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Abstracts were individually reviewed and only those of studies comparing the results and clinical outcome of laparoscopic procedures with the corresponding open operation were chosen for further analysis.&quot;</span>
The methods state the process for study screening and selection.

[NA]

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Endpoints of our analysis were advantages and disadvantages of laparoscopy compared with the open operation.&quot;</span>
The methods list the data variables sought relating to outcomes.

[NA] 

[NA]

[NA]

[NA]

[NA]

[Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 20 manuscripts met the inclusion criteria for our SR, of which 9 were SRs or MAs and 11 RCTs.&quot;</span>
The results report the number of records screened, assessed, and included with reasons for exclusions.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies providing evidence of Level 1a were identified for five different types of laparoscopic procedures (appendectomy, inguinal hernia repair, orchidopexy, pyloromyotomy, and varicocelectomy).&quot;</span> 
The results present key characteristics of the included studies.

[NA]

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The incidence of wound infection was 1.5% after laparoscopic versus 5% after open appendectomy.&quot;</span> 
The results present summary data and effect estimates for relevant outcomes.

[NA]

[NA] 

[NA]

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors wish to line out that it is neither their aim to condemn the evolving techniques in laparoscopic pediatric surgery nor the principles of evidence-based medicine.&quot;</span>
The discussion summarizes the main findings and considers their relevance.

[Yes]
<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.8%):

ever, our SR of the literature clearly showed that Level 1 evidence is only available for seven different procedures in pediatric surgery' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Nevertheless, our SR of the literature clearly showed that Level 1 evidence is only available for seven different procedures in pediatric surgery.&quot;</span>
The discussion acknowledges the limitation of few Level 1 studies available. 

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Effort has to be made to extend the existing Level 1 evidence to open questions concerning these seven procedures and to gain high level evidence for further laparoscopic procedures in pediatric surgery.&quot;</span>
The conclusion provides implications for future research.

[No]
</pre>
<p><a name='87'></a></p>
</div>
<div id="ells-2015" class="section level4">
<h4><a href='https://doi.org/10.1002/14651858.CD011740' title='Open publication'>Ells
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. Title: Identify the report as a systematic review, meta-analysis, or both.
<span title='Moderate quote deviation. Best match in fulltext (Similarity 90%):

i
Surgery for the treatment of obesity in children and adolescent' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Surgery for the treatment of obesity in children and adolescents&quot;</span>
The title identifies this as a systematic review.

P2. Abstract: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number. 
<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 44.4%):

This is the' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] This is the abstract.&quot;</span>
The abstract provides a structured summary covering all applicable elements.

P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.
<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.3%):

l

The prevalence of overweight and obese children and adolescents has increased throughout the world, presenting a global public health crisi' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] The prevalence of overweight and obese children and adolescents has increased throughout the world, presenting a global public health crisis...&quot;</span>
The introduction describes the rationale in the context of rising childhood obesity prevalence. 

P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.9%):

l

To assess the effects of surgery for treating obesity in children and adolescent' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] To assess the effects of surgery for treating obesity in children and adolescents.&quot;</span>
The objective clearly states the aim to assess the effects of obesity surgery in children and adolescents.

P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
"[NA]"
No protocol or registration is mentioned.

P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow‐up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
<span title='Moderate quote deviation. Best match in fulltext (Similarity 93%):

ia

We selected randomised controlled trials (RCTs) of surgical interventions for treating obesity in children and adolescents (age < 18 years) with a minimum of six months follow‐u' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] We included randomised controlled trials (RCTs) of surgical interventions for treating obesity in children and adolescents (age < 18 years) with a minimum of six months follow‐up.&quot;</span> 
Eligibility criteria for study design, participants, interventions, and follow-up are clearly specified.

P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
<span title='Moderate quote deviation. Best match in fulltext (Similarity 85.5%):

ods

We searched the Cochrane Library, MEDLINE, PubMed, EMBASE as well as LILACS, ICTRP Search Portal and ClinicalTrials.gov (all from database inception to March 201' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] We searched the Cochrane Library, MEDLINE, PubMed, EMBASE, LILACS, ClinicalTrials.gov, and WHO ICTRP from database inception to March 2015.&quot;</span>
A comprehensive list of information sources searched is provided.

P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
<span title='Moderate quote deviation. Best match in fulltext (Similarity 84.6%):

.

For detailed search strategies see Appendix' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] For detailed search strategies see Appendix 1.&quot;</span>
The appendix provides the full search strategy for MEDLINE. 

P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 30.9%):

is

Two review authors independently assessed' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎[Yes] Two review authors independently screened records, assessed full texts for eligibility, and resolved discrepancies through consensus.&quot;</span>
The process for study selection is clearly described.

P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
<span title='Moderate quote deviation. Best match in fulltext (Similarity 87.5%):

ia, two review authors (LJE, KR, or EM) independently extracted key participant and intervention characteristics and reported data on efficacy outcomes and adverse events using a standard data extraction form supplied by the CMED Grou' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Two review authors independently extracted data using a standard form from the CMED Group.&quot;</span> 
The data extraction process is described.

P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
<span title='Moderate quote deviation. Best match in fulltext (Similarity 81.4%):

y extracted key participant and intervention characteristics and reported data on efficacy outcomes and adverse event' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Data were extracted on participant and intervention characteristics, efficacy outcomes, and adverse events.&quot;</span>
Data items sought are listed.

P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.9%):

is

Two review authors independently assessed risk of bias' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎[Yes] Two review authors independently assessed risk of bias using the Cochrane risk of bias tool, and evaluated the impact of bias on study results.&quot;</span>
Methods for assessing individual study risk of bias are described.

P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.9%):

ct

For dichotomous outcomes we calculated odds ratio (OR) or risk ratio (RR) and corresponding 95% confidence interval (CI). For continuous outcomes we calculated the mean differenc' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] For dichotomous outcomes we calculated odds ratio or risk ratio and for continuous outcomes we calculated the mean difference.&quot;</span>
Summary measures used are stated.

P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.  
"[NA]" 
Not applicable as no meta-analysis was performed.

P15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
"[NA]"
Not applicable as only one study was included. 

P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
"[NA]"
No additional analyses were performed.

P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 52%):

es screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] 2405 records screened, 11 full texts assessed, and 1 study included. A flow diagram is provided.&quot;</span>
The study selection process is described and depicted in a flow diagram.

P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 62%):

ee Characteristics of included studies. For an overview of review authors&#39; judgments about each risk of bias item for the one included stu' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎[Yes] Characteristics including sample size, interventions, outcomes, and follow-up are presented for the included study.&quot;</span>
Study characteristics are presented. 

P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 37.7%):

/ Risk of bias within studies: Present d' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] Risk of bias is presented in a summary figure and detailed in the text.&quot;</span>
Risk of bias assessments are presented.

P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 46.6%):

summary data for each intervention group (b) effect estimates and confidence intervals,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] Summary data, effect estimates, and confidence intervals are presented for outcomes in the one included study.&quot;</span>
Results for each outcome are presented.

P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.
"[NA]" 
No meta-analysis was performed.

P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
"[NA]"
Only one study was included so this is not applicable.

P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
"[NA]"
No additional analyses were performed. 

P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 65.6%):

the main findings including the strength of evidence' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] The main findings and strength of evidence are summarized.&quot;</span>
The main findings and limitations are summarized.

P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 62.9%):

limitations at study and outcome level (e.g., risk of bias), and at review-level' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] Limitations at the study and review level are discussed.&quot;</span>
Limitations are discussed.

P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
<span title='Moderate quote deviation. Best match in prompt (Similarity 86.1%):

/ Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
P27. Funding: Describe' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes] Conclusions are provided in the context of other evidence and implications for future research are described.&quot;</span>
Conclusions and implications are discussed.

P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
"[No]"
Sources of funding are not described.
</pre>
<p><a name='88'></a></p>
</div>
<div id="elyas-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JURO.2010.01.035' title='Open publication'>Elyas
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Is Staging Beneficial for Fowler-Stephens Orchiopexy? A Systematic Review&quot;</span>

[Yes]
The abstract provides relevant background, objectives, eligibility criteria, interventions, study appraisal and results.

[Yes] 
Fowler-Stephens maneuver is described for high undescended testis. Prior evidence on single vs two-stage procedures is summarized.  

[Yes]  
The objective is to determine if single or two-stage Fowler-Stephens orchiopexy results in better testicular viability in children.

[No]

[Yes]  
Inclusion criteria specify patients <18 years with intra-abdominal testis undergoing single/two-stage Fowler-Stephens orchiopexy. 

[Yes]
Multiple databases were searched until February 2009. Reference lists were hand-searched.

[Yes]
The full search strategy for MEDLINE is provided.

[Yes] 
The process of screening, assessing eligibility, and inclusion is described and shown in a flow diagram.

[Yes]  
Data extraction was done independently in duplicate using piloted forms. Authors were contacted for missing data.

[Yes]
Variables sought included patient demographics, surgical details, outcomes like testicular viability and position.

[Yes] 
Risk of bias was assessed for each study with a quality assessment tool developed for this review.

[Yes]
Primary outcome is testicular viability, defined as adequate postoperative testicular size and position.

[NA]

[NA]

[NA]

[Yes] 
Numbers screened, assessed, and included are provided with reasons for exclusion. A flow diagram is presented.

[Yes] 
Study characteristics like design, sample size, follow-up are provided in a table. Citations are listed.

[Yes]
Risk of bias assessment for each study is presented in a table.

[Yes] 
Success rates with confidence intervals are presented in forest plots for primary outcome.

[NA]

[NA] 

[NA]

[Yes]
Main findings are higher success rate and lower complications with two-stage procedure. Results are clinically relevant.

[Yes] 
Limitations like retrospective designs, small samples, and lack of objective outcome assessments are discussed.

[Yes] 
Results are interpreted in context of prior evidence. Implications for future research are described. 

[Yes]
Funding sources are declared with no role in review.
</pre>
<p><a name='89'></a></p>
</div>
<div id="esposito-2014" class="section level4">
<h4><a href='https://doi.org/10.1089/lap.2014.0194' title='Open publication'>Esposito
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic Versus Open Inguinal Hernia Repair in Pediatric Patients: A Systematic Review&quot;</span>
The title identifies the report as a systematic review.

[Yes] The abstract provides a structured summary including background, objectives, data sources, eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, and conclusions.
It has a structured abstract.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The incidence of an inguinal hernia in children less than 18 years of age ranges from 0.8% to 4.4%.1 Eighty-five percent of patients with an inguinal hernia present with a unilateral hernia.1 The incidence of incarceration in the unrepaired hernia in infants and young children seems to vary between 6% and 18%, but it increases to approximately 30% in infancy, with a potential risk to the bowel and testicle.2 Bilateral inguinal hernia is significantly more common in younger patients (present in 50% if less than 1 year, 45% if less than 2 years, and 37% if less than 5 years).&quot;</span> 
The introduction describes the rationale and context for the review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This review aims to evaluate the role of LH in children and to compare LH with OH in regard to operative time, postoperative complications, recurrence rate, discovering of rare hernias, and incidence of contralateral patency.&quot;</span>
The introduction states the objectives and PICOS elements. 

[No] The methods do not indicate if a review protocol exists or provide registration information.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligibility criteria included all available studies focused on LH and/or OH and with quantitative data on outcome parameters. The pediatric population was defined as younger than 18 years when the patient underwent LH or OH.&quot;</span>
The eligibility criteria are specified.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A literature search was performed using PubMed, Cochrane, and Medline databases on all studies published during the last 20 years that described open or laparoscopic operation for inguinal hernia, and the latter was compared with conventional OH. The following key words were used: “inguinal hernia,” “herniorrhaphy,” “hernia repair,” “children,” “laparoscopic versus open herniorrhaphy,” “laparoscopic versus open hernia repair,” “contralateral patency,” “complications,” and “recurrence.”&quot;</span>
The information sources and search strategy are described.

[No] The full electronic search strategy is not provided for any database. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors independently assessed selected studies and tabulated data from each article with a predefined data extraction form. Data regarding the following factors were considered: first author, publication date, study method, participant features, intervention characteristics, definition of complications, and outcome measures. Outcome parameters for inclusion were patients' age, gender, affected side, operative time, time to resume full activity, duration of hospital stay, recurrence, metachronic contralateral hernia, and complications.&quot;</span>
The study selection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors independently assessed selected studies and tabulated data from each article with a predefined data extraction form.&quot;</span> 
The data collection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome parameters for inclusion were patients' age, gender, affected side, operative time, time to resume full activity, duration of hospital stay, recurrence, metachronic contralateral hernia, and complications.&quot;</span>
The data items extracted are listed. 

[No] The methods used for assessing risk of bias are not described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The chi-squared or Fisher's exact test was used to evaluate the significance of differences between the two groups: LH and OH.&quot;</span>
The principal summary measures are stated.

[NA] Synthesis methods are not described as no meta-analysis was performed.

[NA] Assessment of bias across studies is not described as no meta-analysis was performed. 

[NA] No additional analyses are described as no meta-analysis was performed.

[Yes] Figure 1 shows the flow diagram of study selection.

[Yes] Table 1 presents characteristics of the included studies such as sample sizes and operative times.

[No] Individual study risk of bias is not presented.

[Yes] Tables 1 and 2 present operative time and recurrence rate data for individual studies.

[NA] Results of meta-analyses are not presented as no meta-analysis was performed. 

[NA] Results of bias assessment across studies are not presented as no meta-analysis was performed.

[NA] Results of additional analyses are not presented as no meta-analysis was performed. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, we think that there is no evidence in the literature about which technique (laparoscopy or inguinal approach) is preferable to repair an inguinal hernia. Probably a surgeon has to offer to the patient both techniques, and above all, considering the importance of the parental role in the decision process, the parents have to know that two different approaches exist to repair an inguinal hernia and the advantages and disadvantages of both procedures.&quot;</span>
The conclusion summarizes the main findings and implications.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎However, the length of follow-up in reviewed series was less for the laparoscopic approach compared with the open operation (2.3 versus 4.2 years, respectively).&quot;</span>
Limitations at the study and outcome level are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In summary, LH appears faster for bilateral hernia repair when compared with the inguinal crease approach. Recurrence rates appear similar, but the follow-up is less in the LH studies. Wound infection appears more likely after OH, but the incidence is small. Time to resume normal activity is similar with both approaches. Further perspective investigation, including long-term follow-up, will be needed to accurately identify the optimal approach for inguinal hernia repair in infants and children.&quot;</span>
The conclusion provides an interpretation of the results and implications for future research.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No competing financial interests exist.&quot;</span> 
The sources of funding are described.
</pre>
<p><a name='90'></a></p>
</div>
<div id="feng-2016" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3845-2' title='Open publication'>Feng
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[Laparoscopic versus open splenectomy in children: a systematic review and meta-analysis]&quot;</span> - The title identifies the report as a systematic review and meta-analysis. [Yes]

P2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.]&quot;</span> - The abstract provides a structured summary covering the key elements. [Yes]

P3. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Describe the rationale for the review in the context of what is already known.]&quot;</span> - The introduction describes the rationale for comparing laparoscopic and open splenectomy. [Yes] 

P4. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).]&quot;</span> - No explicit PICOS statement provided. [No]

P5. No mention of a review protocol. [No] 

P6. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.]&quot;</span> - The eligibility criteria for studies are described. [Yes]

P7. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.]&quot;</span> - The search strategy is described including databases searched. [Yes]

P8. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.]&quot;</span> - No full search strategy provided. [No]

P9. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).]&quot;</span> - The study selection process is described and shown in a flow diagram. [Yes]

P10. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.]&quot;</span> - The data extraction process is described. [Yes]

P11. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.]&quot;</span> - The data items extracted are listed in tables. [Yes]

P12. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.]&quot;</span> - No risk of bias assessment described. [No]

P13. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[State the principal summary measures (e.g., risk ratio, difference in means).]&quot;</span> - The summary measures are described. [Yes] 

P14. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.]&quot;</span> - Methods for meta-analysis are described including assessment of heterogeneity. [Yes]

P15. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).]&quot;</span> - No assessment of risk of bias across studies. [No] 

P16. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.]&quot;</span> - No additional analyses described. [NA]

P17. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.]&quot;</span> - The study selection process is described and shown in a flow diagram. [Yes]

P18. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.]&quot;</span> - Study characteristics are presented in tables. [Yes]

P19. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).]&quot;</span> - No risk of bias assessment presented. [No]

P20. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.]&quot;</span> - Outcome data for each study are presented in tables and forest plots. [Yes]

P21. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Present results of each meta-analysis done, including confidence intervals and measures of consistency.]&quot;</span> - Results of the meta-analyses are presented with CIs and measures of heterogeneity. [Yes] 

P22. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Present results of any assessment of risk of bias across studies (see Item P15).]&quot;</span> - No assessment of risk of bias across studies presented. [No]

P23. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).]&quot;</span> - No additional analyses described. [NA]

P24. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).]&quot;</span> - The main findings are summarized in the discussion. [Yes]

P25. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).]&quot;</span> - Limitations are discussed. [Yes]

P26. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Provide a general interpretation of the results in the context of other evidence, and implications for future research.]&quot;</span> - Conclusions are provided considering other evidence. [Yes]

P27. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎[Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.]&quot;</span> - Sources of funding are described. [Yes]
</pre>
<p><a name='91'></a></p>
</div>
<div id="feng-2015" class="section level4">
<h4><a href='https://doi.org/10.1097/SLE.0000000000000161' title='Open publication'>Feng
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. "[Yes]" 
"Open Versus Laparoscopic Inguinal Herniotomy in Children
A Systematic Review and Meta-Analysis Focusing on Postoperative Complications"
The title identifies the report as a systematic review and meta-analysis.

P2. "[Yes]"
<span title='Minor quote deviation. Best match in prompt (Similarity 99.7%):

Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Abstract: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> 
The abstract provides a structured summary.

P3. "[Yes]" 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As one of the most frequently performed surgical procedures in infants and children, herniotomy is the standard procedure for pediatric inguinal hernia (PIH) because of its high success rate and low rate of complications.&quot;</span>
The introduction describes the rationale in context of existing knowledge.

P4. "[Yes]"  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to compare both of the surgical strategies as regards operative time, recurrence rate, postoperative complications by means of a systematic review, and meta-analysis of the available literatures.&quot;</span>
The objectives explicitly state the questions being addressed. 

P5. "[No]"
No protocol or registration is mentioned.

P6. "[Yes]"
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligibility criteria included total available studies comparing LH with OH for the repair of PIH. The children were younger than 18 years when they underwent LH or OH.&quot;</span> 
The eligibility criteria are specified.

P7. "[Yes]"
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We systematically searched PubMed for relevant studies reported from 2005 to 2014 with the keywords “laparoscopic herniorrhaphy”, “pediatric inguinal hernia,” and “open herniorrhaphy.” Total reference lists of selected articles were also included.&quot;</span>
The information sources are described.

P8. "[No]" 
No search strategy is presented.

P9. "[Yes]" 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two reviewers (S.F., Z.L.) screened the citation identified by the search strategy.&quot;</span> 
The study selection process is described.

P10. "[No]"
The data collection process is not described. 

P11. "[Yes]"
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Details of publication (type of repairing the internal ring, trocars, and follow-up duration), inclusion and exclusion criteria, and demographics of the enrolled patients were collected and collated.&quot;</span>
The data items are listed.

P12. "[No]"
No assessment of risk of bias is described.

P13. "[Yes]"
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Weighted mean differences and odds ratios were used for the analysis of continuous and dichotomous variables, respectively.&quot;</span>
The summary measures are stated.

P14. "[NA]" 
Not applicable since no meta-analysis was performed.

P15. "[NA]"
Not applicable since no assessment of bias across studies was done. 

P16. "[NA]" 
Not applicable since no additional analyses were done.

P17. "[Yes]"
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Five trials met the total inclusion criteria and had no exclusion criteria (Fig. 1): Chan et al,28 Koivusalo et al,29 Celebi et al,30 Shalaby et al,31 and Saranga et al.32&quot;</span>
The number of studies screened, assessed, and included is provided. 

P18. "[Yes]" 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The 5 selected trials included 553 participants. Two hundred and seventy-eight patients received OH and 275 received LH. Study details and the quality check of total RCTs are given in Tables 1 and 2, respectively.&quot;</span>
Study characteristics are presented.

P19. "[No]"
No assessment of risk of bias within studies is presented.

P20. "[Yes]" 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three of the 5 trials reported the operative time for children treated with unilateral laparoscopic and open inguinal herniotomy. The pooled data showed that there was no significant difference in operative time for children treated with unilateral hernias between laparoscopic and open group with unacceptably statistical heterogeneity(I2=94%) (95% CI, −9.08 to 5.50; with 119 in the laparoscopic and 123 in the open group; Fig. 2A).&quot;</span> 
Results for each study are presented.

P21. "[NA]"
Not applicable since no meta-analysis was performed.

P22. "[NA]"  
Not applicable since no assessment of bias across studies was done.

P23. "[NA]"
Not applicable since no additional analyses were done. 

P24. "[Yes]"
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results show that LH is superior for the inguinal hernia repair in children, with shorter operative time for unilateral hernias in extraperitoneal approaches group as well as for bilateral hernias. Besides, less total postoperative complications was found in the LH group, especially for major postoperative complications in male children. Yet there is no significant difference regarding recurrences.&quot;</span>
A summary of the evidence is provided.

P25. "[Yes]"  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎However, on one hand, because of the limited number of patients and studies, more RCTs need to be conducted to confirm these findings; on the other hand, the learning curve in the 5 RCTs may play an underestimated role in the study, which may weaken the results of the comparison.&quot;</span>
Limitations are discussed.

P26. "[Yes]"
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results show that LH is superior for the inguinal hernia repair in children, with shorter operative time for unilateral hernias in extraperitoneal approaches group as well as for bilateral hernias. Besides, less total postoperative complications was found in the LH group, especially for major postoperative complications in male children. Yet there is no significant difference regarding recurrences.&quot;</span>
Conclusions are provided.

P27. "[No]"
No funding sources are described.
</pre>
<p><a name='92'></a></p>
</div>
<div id="friedmacher-2011" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-011-2958-5' title='Open publication'>Friedmacher
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Residual aganglionosis after pull-through operation for Hirschsprung’s disease: a systematic review and meta-analysis&quot;</span>
The title identifies the report as a systematic review and meta-analysis.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We designed this meta-analysis to determine the incidence and outcome of RA among patients with HD following PT operation.&quot;</span>  
The abstract provides the objectives of the review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Most patients with Hirschsprung’s disease (HD) have a satisfactory outcome after pull-through (PT) operation. However, some children continue to have persistent bowel symptoms after the initial operation and may require redo PT.&quot;</span>
The introduction provides context about what is already known. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We designed this meta-analysis to determine the incidence and outcome of RA among patients with HD following PT operation.&quot;</span>
The objectives are explicitly stated in the abstract.

[No]
No protocol or registration is indicated.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Detailed information was recorded in patients with RA and transition-zone bowel (TZB), including recurrent bowel problems, histological findings on repeat rectal biopsy, type of redo PT operation and outcome.&quot;</span>
Eligibility criteria for studies are described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎PubMed® and MEDLINE® databases were searched for all studies that reported cases of patients with HD who had undergone redo PT operations for RA or transition-zone bowel (TZB) after initial operation between 1985 and 2011.&quot;</span> 
Information sources and dates searched are described.

[No] 
No search strategy is presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Detailed information was recorded regarding type of study, gender, recurrent bowel symptoms, histological findings on repeat rectal biopsy, patient’s age at initial PT and redo PT operation, type of surgical procedures performed and postoperative follow-up with recurrent symptoms. Only publications containing all the relevant details were included in the literature review.&quot;</span>
The process for study selection is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Detailed information was recorded regarding type of study, gender, recurrent bowel symptoms, histological findings on repeat rectal biopsy, patient’s age at initial PT and redo PT operation, type of surgical procedures performed and postoperative follow-up with recurrent symptoms.&quot;</span>
The data collection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Detailed information was recorded regarding type of study, gender, recurrent bowel symptoms, histological findings on repeat rectal biopsy, patient’s age at initial PT and redo PT operation, type of surgical procedures performed and postoperative follow-up with recurrent symptoms.&quot;</span> 
The data items extracted are listed.

[NA]
Risk of bias assessment is not applicable for this type of review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Detailed information was recorded in patients with RA and transition-zone bowel (TZB), including recurrent bowel problems, histological findings on repeat rectal biopsy, type of redo PT operation and outcome.&quot;</span>
The outcome measures are stated.

[NA]
Details of data synthesis methods are not applicable as no meta-analysis was performed. 

[NA] 
Assessment of bias across studies is not applicable without a meta-analysis.

[NA]  
Additional analyses are not applicable without a meta-analysis.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Between 1985 and 2011, 29 published articles reported 555 patients with HD who underwent redo PT operation. 193 (34.8%) patients demonstrated abnormal histological findings on repeat rectal biopsy.&quot;</span> 
The number of studies screened and included is provided. 

[Yes] Table 1 provides characteristics of the included studies.

[NA]
Assessment of bias within studies is not applicable for this type of review.

[Yes] Table 1 provides summary data for each included study.

[NA] 
Results of meta-analyses are not applicable as none were performed.

[NA]
Assessment of bias across studies is not applicable without a meta-analysis. 

[NA]
Additional analyses are not applicable without a meta-analysis.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis reveals that RA and TZB are the underlying causes of persistent bowel symptoms in one-third of all patients with HD requiring redo PT operation. Most patients have a satisfactory outcome after redo operation.&quot;</span>
Main findings and their relevance are summarized.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One major problem with the intraoperative frozen section biopsies is that it can indicate the presence of ganglion cells without differentiating between hypo- and dysganglionosis.&quot;</span>
Limitations at the study level are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Rectal biopsy should be performed in all patients with recurrent bowel problems after PT operation.&quot;</span>
Implications for future research are provided. 

[No]
No sources of funding are described.
</pre>
<p><a name='93'></a></p>
</div>
<div id="friedmacher-2012" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-012-3142-2' title='Open publication'>Friedmacher
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pediatric Surgery International volume 28, pages 899–906 (2012)&quot;</span>
The article is identified as a systematic review in the title.

[Yes] <span title='Moderate quote deviation. Best match in prompt (Similarity 92.4%):

: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Abstract...background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions...&quot;</span> 
The abstract provides a structured summary.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

Esophageal atresia (EA) is a relatively common congenital malformation of unknown etiology with an incidence of 1 in 3,500 live births [1]. Pure EA without tracheoesophageal fistula (Fig. 1) is an uncommon variant, comprising 8 % of all patients with EA, with an expected incidence of 1 in 40,000 live births [2]. Improvements in prenatal diagnosis [3, 4], advances in surgery, pediatric anesthesia, neonatal intensive care and parenteral nutrition have increased the survival rate in EA in recent years to approximately 95 % [5' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Esophageal atresia (EA) is a relatively common congenital malformation...Improvements in prenatal diagnosis [3, 4], advances in surgery, pediatric anesthesia, neonatal intensive care and parenteral nutrition have increased the survival rate in EA in recent years to approximately 95 % [5].&quot;</span>
The introduction provides context about what is already known.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis aimed to investigate the complications and long-term outcome in patients with LGEA managed by DPA.&quot;</span>  
The objectives are explicitly stated.

[No]
No review protocol or registration is mentioned.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Identified articles were reviewed by title, keywords and abstract by one of the authors (F.F.). All articles that did not contain original research data (e.g. letters, editorials, commentaries and reviews) and articles not giving adequate information regarding complication rates and outcome were excluded.&quot;</span>
Study eligibility criteria are described. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Common electronic databases as MEDLINE®, EMBASE®, ISI Web of ScienceSM and the Cochrane Library were searched in December 2011 using a combination of the following terms: “esophageal atresia”, “long-gap” and “delayed primary anastomosis”.&quot;</span> 
Information sources and dates searched are described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The literature search resulted in a total of 223 articles, of which 207 were identified by electronic database search and 16 by cross-referencing (Fig. 2).&quot;</span>
The full search strategy is presented for at least one database.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In total, data from 44 studies published from 1981 to 2010, were included in the quantitative synthesis.&quot;</span> 
The study selection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data extracted from each participating article included study characteristics (first author, publication year, sample size, follow-up time and mortality rate) and patient characteristics (gestational age, birth weight, type of LGEA and additional congenital anomalies).&quot;</span>
Data collection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome of this analysis was complication rates. Anastomotic leaks, anastomotic strictures, symptomatic gastroesophageal reflux (GER), dysphagia, esophagitis, recurrent fistula, recurrent aspiration pneumonia, growth retardation and Barrett’s metaplasia were considered as complications.&quot;</span>
Variables extracted are listed.

[No]
Risk of bias assessment for individual studies is not described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎incidences with a 95% confidence interval (CI) for each specific complication&quot;</span>
Summary measures are stated.

[NA] 
No meta-analysis was performed.

[NA]
No assessment of risk of bias across studies is described. 

[NA]
No additional analyses are mentioned.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The literature search resulted in a total of 223 articles, of which 207 were identified by electronic database search and 16 by cross-referencing (Fig. 2). After removal of 117 duplicates, 106 titles, key words and abstracts were reviewed. Of these, 60 articles were excluded because after screening it emerged that these studies clearly did not meet the inclusion criteria as described. Forty-six articles met our criteria for inclusion and the full-text was examined more in detail. Of these, two articles were excluded because they referred to results of already selected articles. In total, data from 44 studies published from 1981 to 2010, were included in the quantitative synthesis.&quot;</span>
The study selection process is described with a flow diagram.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The overall number of study subjects managed by DPA was 451, ranging from 1 to 74 newborns with LGEA per study. Study and patients characteristics are presented in Table 1.&quot;</span> 
Study characteristics are presented.

[No]
No assessment of risk of bias within studies is presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A cumulative meta-analysis revealed the incidences for each specific complication (Table 2).&quot;</span>
Results for each outcome are presented.

[NA]
No meta-analysis was performed. 

[NA] 
No assessment of risk of bias across studies is presented.

[NA]
No additional analyses are mentioned.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, this meta-analysis shows that the DPA provides good long-term functional results. However, the high incidence of GER and associated morbidities requires early intervention to prevent ongoing feeding problems due to strictures and esophagitis. Long-term follow-up is recommended because of the potential risk of Barrett’s metaplasia.&quot;</span>
A summary of the main findings and their relevance is provided.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The disadvantage of waiting for the esophageal segments to grow and hypertrophy is prolonged hospital stay and constant threat of aspiration pneumonia, which requires continuous skilled nursing supervision [21]. It may also be argued that the initial prolonged hospitalization is expensive. These factors must be balanced against reduced long-term morbidity in a child who should have a normal life expectancy and against the disadvantages of esophageal replacement.&quot;</span>
Limitations are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, this meta-analysis shows that the DPA provides good long-term functional results. However, the high incidence of GER and associated morbidities requires early intervention to prevent ongoing feeding problems due to strictures and esophagitis. Long-term follow-up is recommended because of the potential risk of Barrett’s metaplasia.&quot;</span>
Conclusions are provided.

[No]
No statement about sources of funding is provided.

In summary, the article reports 18 out of 27 PRISMA items. The key missing elements are a review protocol, assessment of risk of bias, funding, and details on some meta-analysis items that were not applicable. Overall, the systematic review has several deficiencies in reporting based on PRISMA, but provides a helpful quantitative synthesis of DPA outcomes in LGEA patients.
</pre>
<p><a name='94'></a></p>
</div>
<div id="frongia-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2013.05.018' title='Open publication'>Frongia
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Comparison of LILT and STEP procedures in children with short bowel syndrome — A systematic review of the literature&quot;</span>
The title identifies the report as a systematic review comparing LILT and STEP.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
The abstract provides a structured summary covering all key aspects. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Short bowel syndrome (SBS) is a serious disorder in which the intestinal resorptive capacity is insufficient to provide an adequate alimentary supply [1].&quot;</span>
The introduction describes the rationale and context.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> 
No explicit PICOS statement.

[No] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
No mention of a protocol. 

[NA]  

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One reviewer (GF) screened all titles and abstracts to assess whether each report was potentially eligible for inclusion, and whether or not the full text was available.&quot;</span>
The process for study selection is described.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
The full search strategy is presented.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>  
The study selection process is described.

[No] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
No details provided on data extraction process.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
Relevant data items are listed.

[NA] 

[NA] 

[NA] 

[NA] 

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
A flow diagram depicts the study selection process.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> 
Study characteristics are presented in Table 1.

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
Outcome data for each study are summarized in the text and tables.

[NA]

[NA] 

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
The discussion summarizes the key findings and implications.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
Limitations are discussed in the discussion section.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
Conclusions are provided considering other evidence and future research needs.

[No] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
No funding sources reported.
</pre>
<p><a name='95'></a></p>
</div>
<div id="gallo-2012" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0032-1331459' title='Open publication'>Gallo
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘missing-squared-brackets-in-numbered-list’,
‘missing-squared-brackets-pre-dash’</i>
<pre>
Here are the assessments for each PRISMA item:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Long-Gap Esophageal Atresia: a Meta-Analysis of Jejunal Interposition, Colon Interposition, and Gastric Pull-Up&quot;</span>
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Identifies the report as a meta-analysis in the title.

P2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Aim There is still no consensus about the optimal surgical approach for esophageal replacement in the case of long-gap esophageal atresia (LGEA) or extensive corrosive strictures.&quot;</span> 
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Provides a structured summary in the abstract covering background, objectives, eligibility criteria, interventions, methods, results, conclusions. 

P3. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

Introduction

There is still no consensus about the optimal surgical approach for esophageal replacement in the case of long-gap esophageal atresia (LGEA) or extensive corrosive strictures. This is reflected in the pediatric surgical literature, which mainly consists of retrospective case series' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Introduction There is still no consensus about the optimal surgical approach for esophageal replacement in the case of long-gap esophageal atresia (LGEA) or extensive corrosive strictures. This is reflected in the pediatric surgical literature, which mainly consists of retrospective case series.&quot;</span>
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Describes the rationale for the review in the context of what is already known in the introduction.

P4. <span title='Minor quote deviation. Best match in fulltext (Similarity 97.7%):

The aim of this article was to perform a meta-analysis comparing the most widely used techniques for esophageal replacement in children: jejunal interposition (JI), colon interposition (CI), and gastric pull-up (GPU' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Aim The aim of this article was to perform a meta-analysis comparing the most widely used techniques for esophageal replacement in children: jejunal interposition (JI), colon interposition (CI), and gastric pull-up (GPU).&quot;</span>
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Provides explicit objectives comparing interventions in the abstract.

P5. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - Does not indicate if a review protocol exists or provide registration information.

P6. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Definition of Outcomes

The articles were reviewed with a special focus on mortality, postoperative morbidity, and long-term follow-up. Main outcome parameters were postoperative survival rate, anastomotic complications (such as leakage and strictures recorded both postoperative and during the follow-up), and graft loss' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Definition of Outcomes The articles were reviewed with a special focus on mortality, postoperative morbidity, and long-term follow-up. Main outcome parameters were postoperative survival rate, anastomotic complications (such as leakage and strictures recorded both postoperative and during the follow-up), and graft loss.&quot;</span>
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Specifies eligibility criteria for outcomes in the methods section.

P7. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

Literature

A literature search (PubMed and Embase) was performed, and all human studies published in the English-language literature between 2006 and 2011 describing esophageal replacement for LGEA were identified, using the medical subject headings “Esophageal Atresia,” “Long-gap,” “Esophagoplasty,” “Replacement,” “Interposition,” “Substitution,” “Graft,” and their combinations' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Literature A literature search (PubMed and Embase) was performed, and all human studies published in the English-language literature between 2006 and 2011 describing esophageal replacement for LGEA were identified, using the medical subject headings “Esophageal Atresia,” “Long-gap,” “Esophagoplasty,” “Replacement,” “Interposition,” “Substitution,” “Graft,” and their combinations.&quot;</span>
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Describes literature search sources, years, and keywords. 

P8. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - Does not provide full electronic search strategy.

P9. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - Does not describe the study selection process.

P10. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - Does not describe data collection or extraction process. 

P11. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Definition of Outcomes

The articles were reviewed with a special focus on mortality, postoperative morbidity, and long-term follow-up. Main outcome parameters were postoperative survival rate, anastomotic complications (such as leakage and strictures recorded both postoperative and during the follow-up), and graft loss' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Definition of Outcomes The articles were reviewed with a special focus on mortality, postoperative morbidity, and long-term follow-up. Main outcome parameters were postoperative survival rate, anastomotic complications (such as leakage and strictures recorded both postoperative and during the follow-up), and graft loss.&quot;</span> 
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Lists variables and outcomes sought in the methods section.

P12. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - Does not describe methods for assessing risk of bias.

P13. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - Does not state summary measures. 

P14. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>]</span>

P15. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>]</span> 

P16. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>]</span>

P17. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - Does not provide a flow diagram or details on study selection.

P18. <span title='Minor quote deviation. Best match in fulltext (Similarity 98.5%):

Data Collection

The initial search yielded 187 potentially relevant articles, of which 172 articles were excluded because of the failure to meet the inclusion criteria. A total of 15 studies fulfilled the inclusion criteria and were analyzed in this review ([Table 1' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data Collection The initial search yielded 187 potentially relevant articles, of which 172 articles were excluded because of the failure to meet the inclusion criteria. A total of 15 studies fulfilled the inclusion criteria and were analyzed in this review ([Table 1]).&quot;</span>
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Provides citations for included studies in results section. 

P19. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - Does not assess risk of bias within studies.

P20. <span title='Minor quote deviation. Best match in fulltext (Similarity 96.4%):

Data about postoperative mortality and morbidity were given in 14 studies with a total of 470 patients (264 LGEA); 344 (73%) patients underwent CI, 99 (21%) children underwent GPU, and 27 (6%) patients underwent JI' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Results Data about postoperative mortality and morbidity were given in 14 studies with a total of 470 patients (264 LGEA); 344 (73%) patients underwent CI, 99 (21%) children underwent GPU, and 27 (6%) patients underwent JI.&quot;</span>
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Presents summary data for each intervention group in results section.

P21. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>]</span>  

P22. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>]</span>

P23. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>]</span>

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Conclusion Proper prospective comparative studies are lacking. GPU and CI appear comparable regarding postoperative mortality, anastomotic complications, and graft loss. On the long-term, GPU seems to be associated with a higher respiratory morbidity but fewer gastrointestinal complications than CI. Based on this article only two series provide data about JI, and they show highly divergent results. JI appears to be a valid replacement technique when performed by experienced centers; however larger numbers are needed to assess the outcomes of this procedure.&quot;</span>
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Summarizes main findings and discusses relevance in conclusion.

P25. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Discussion

The present article set out to perform a meta-analysis of the literature regarding esophageal replacement for LGEA or extensive corrosive strictures. There are few prospective series, amounting to only 37 patients. Well-designed prospective comparative studies are lacking, major and minor postoperative complications are sometimes not properly defined, follow-up data are often deficient and when presented they are not homogenously described in the different studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Discussion The present article set out to perform a meta-analysis of the literature regarding esophageal replacement for LGEA or extensive corrosive strictures. There are few prospective series, amounting to only 37 patients. Well-designed prospective comparative studies are lacking, major and minor postoperative complications are sometimes not properly defined, follow-up data are often deficient and when presented they are not homogenously described in the different studies.&quot;</span> 
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Discusses limitations at the study and outcome level in the discussion.

P26. <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.3%):

In the future, large series from these centers may offer a better insight in the results of care for this difficult patients group' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Conclusion In the future, large series from these centers may offer a better insight in the results of care for this difficult patients group.&quot;</span>
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Provides interpretation of results and implications for future research in the conclusion.

P27. <span title='Minor quote deviation. Best match in fulltext (Similarity 96%):

Conflict of Interest

None' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Conflict of Interest None&quot;</span>
<span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Describes sources of funding.
</pre>
<p><a name='96'></a></p>
</div>
<div id="gosemann-2013" class="section level4">
<h4><a href='https://doi.org/10.1055/s-0033-1343085 ' title='Open publication'>Gosemann
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘wrong-response-partial-unclear-etc’</i>
<pre>
Here are the assessments for each PRISMA item based on the provided full text:

P1. Title: Identify the report as a systematic review, meta-analysis, or both.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Open Versus Transanal Pull-Through for Hirschsprung Disease: A Systematic Review of Long-Term Outcome&quot;</span>
The title identifies the publication as a systematic review. 
[Yes]

P2. Abstract: Provide a structured summary including background, objectives, data sources, eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions.  
<span title='Minor quote deviation. Best match in fulltext (Similarity 98.1%):

We performed a systematic literature review of the long-term outcome of OPEN surgery compared with L-TERPT/TERPT.

Methods Our systematic review of the recent literature (2008 to 2012) included reports on long-term outcome of either OPEN surgery or L-TERPT/TERPT with a minimum follow-up period of 12 months' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We performed a systematic literature review of the recent literature (2008 to 2012) including reports on long-term outcome of either OPEN surgery or L-TERPT/TERPT with a minimum follow-up period of 12 months.&quot;</span>
The abstract describes the methods and results of a systematic literature review.
[Yes]

P3. Introduction: Describe the rationale for the review in context of what is already known.  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Therefore, the aim of this study was to review the available data on long-term functional results in HD patients operated with conventional transabdominal pull-through (OPEN) compared with transanal approaches with and without laparoscopy (laparoscopic-assisted transanal-endorectal pull-through [L-TERPT] and transanal-endorectal pull-through [TERPT]) reported in the recent literature.&quot;</span>  
The introduction describes the rationale for comparing long-term outcomes between open and transanal pull-through techniques.
[Yes]

P4. Objectives: Provide explicit questions addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[...] to review the available data on long-term functional results in HD patients operated with conventional transabdominal pull-through (OPEN) compared with transanal approaches [...]&quot;</span>
The objectives compare open vs transanal pull-through techniques for long-term outcomes.
[Yes] 

P5. Protocol and registration: Indicate if a protocol exists and if available, provide registration information including number.
No protocol or registration is mentioned.
[No]

P6. Eligibility criteria: Specify study characteristics and report characteristics used as inclusion criteria. 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Only articles comprehensively describing the surgical methods (OPEN, L-TERPT, TERPT) and reporting on major outcome parameters (soiling/incontinence, constipation, enterocolitis, and/or stricture) were included in this study.&quot;</span>
Inclusion criteria for study characteristics and outcomes are described.
[Yes]

P7. Information sources: Describe information sources and dates of coverage.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic PubMed search was performed to identify publications on outcome of children with HD, who underwent either OPEN, L-TERPT, or TERPT. This search was limited to the past 5 years (2008 to 2012) using the keywords “Hirschsprung” and “outcome.”&quot;</span>
Information sources and dates are specified.
[Yes]  

P8. Search: Present full search strategy for at least one database. 
The full search strategy for PubMed is not provided.
[No]

P9. Study selection: State process of screening, eligibility, inclusion.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eighteen articles finally met the inclusion criteria and were analyzed in detail.&quot;</span> And Figure 1 shows the screening process.
The process of study screening and selection is described.
[Yes]

P10. Data collection process: Describe method of data extraction and confirmation.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data extracted from included articles were study characteristics (authors, journal, publication year, sample size, surgical technique, and follow-up period) and patient characteristics (age at surgery, extent of aganglionosis).&quot;</span>
The data extraction process is described but not confirmation.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P11. Data items: List and define all variables extracted.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Specific information on the outcome parameters constipation, enterocolitis, stricture, incontinence, and soiling were collected and analyzed.&quot;</span>
Extracted variables related to outcomes are listed.
[Yes]

P12. Risk of bias (individual studies): Describe methods to assess risk of bias. 
No risk of bias assessment for individual studies is described.
[No]

P13. Summary measures: State principal summary measures.
<span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):

With these data, a cumulative meta-analysis was performed to compare long-term outcome of patients who underwent OPEN surgery with patients who underwent L-TERPT/TERPT surgery. The latter groups were analyzed as one group due to the transanal approach in both. Odds ratio (OR) with 95% confidence interval (CI) were calculated' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎With these data, a cumulative meta-analysis was performed to compare long-term outcome of patients who underwent OPEN surgery with patients who underwent L-TERPT/TERPT surgery." And "Odds ratio (OR) with 95% confidence interval (CI) were calculated.&quot;</span>
Principal summary measures are stated.
[Yes]

P14. Synthesis of results: Describe methods of combining results.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Since not all outcome parameters were reported in all articles, each specific parameter was analyzed according to the number of patients in whom that item was assessed. This enabled the calculation of the incidence of each specific outcome parameter.&quot;</span>
The methods for synthesizing results across studies are described.
[Yes]

P15. Risk of bias across studies: Specify assessment of bias across studies.
No assessment of risk of bias across studies is described. 
[No]

P16. Additional analyses: Describe methods of additional analyses.
No additional analyses beyond the primary synthesis are described.
[NA]

P17. Study selection: Provide numbers of studies screened, assessed, and included with reasons for exclusion, ideally with a flow diagram.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The initial literature search resulted in a total number of 148 articles published from 2008 to 2012. Of these, 130 articles were excluded because they did not fulfill the inclusion criteria ([Fig. 1]). Eighteen articles finally met the inclusion criteria and were analyzed in detail.&quot;</span> And Figure 1 shows the flow diagram.
The study selection process is described including flow diagram.
[Yes]

P18. Study characteristics: Present characteristics of included studies.
Table 1 shows study characteristics including sample sizes, surgical techniques, and follow-up periods.
[Yes]

P19. Risk of bias within studies: Present data on risk of bias for each study. 
No risk of bias assessment for individual studies is presented.
[No] 

P20. Results of individual studies: Present summary data and effect estimates for each study.
Results for each outcome are summarized in text and tables by surgical technique but not individually for each study.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P21. Synthesis of results: Present results of meta-analyses including confidence intervals and consistency.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Cumulative meta-analysis was performed to compare long-term outcome of patients who underwent OPEN surgery with patients who underwent L-TERPT/TERPT surgery. The latter groups were analyzed as one group due to the transanal approach in both. Odds ratio (OR) with 95% confidence interval (CI) were calculated.&quot;</span>
Quantitative synthesis is presented with confidence intervals but not measures of consistency.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P22. Risk of bias across studies: Present results of bias assessment across studies.  
No assessment of risk of bias across studies is presented.
[No]

P23. Additional analysis: Give results of additional analyses.
No additional analyses are described.
[NA]

P24. Summary of evidence: Summarize main findings including strength of evidence for each outcome.
The discussion summarizes the main findings but does not judge strength of evidence.
[Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P25. Limitations: Discuss limitations at study and outcome level and at review level.
A section describes limitations related to differences between studies and quality of studies.
[Yes]

P26. Conclusions: Provide general interpretation of results in context of other evidence. 
The conclusion provides an overall interpretation of the results.
[Yes]

P27. Funding: Describe funding sources and role of funders.
No information about sources of funding is provided.
[No]
</pre>
<p><a name='97'></a></p>
</div>
<div id="graziano-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.06.019' title='Open publication'>Graziano
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Asymptomatic malrotation: Diagnosis and surgical management: An American Pediatric Surgical Association outcomes and evidence based practice committee systematic review&quot;</span>
The title identifies the report as a systematic review.

P2. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
The abstract provides a structured summary covering the key elements. 

P3. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with malrotation, or an intestinal rotation abnormality (IRA), can experience serious adverse events.&quot;</span>  
The introduction describes the rationale for the review.

P4. [No]
The introduction does not provide explicit PICOS criteria.

P5. [No]  
The paper does not indicate if a protocol exists or provide registration details.

P6. [No]
The eligibility criteria are not specified. 

P7. [No]  
The information sources searched are not described.

P8. [No]
The full search strategy is not presented.

P9. [No]   
The study selection process is not described.

P10. [No]
The data collection process is not described.

P11. [No]
The data items collected are not listed or defined.

P12. [No] 
Methods for assessing risk of bias are not described.

P13. [NA]
This is not a meta-analysis so summary measures are not applicable.

P14. [NA] 
Synthesis methods are not described as this is not a meta-analysis.

P15. [NA]
Assessment of risk of bias across studies is not applicable without a meta-analysis.

P16. [NA] 
No additional analyses are mentioned.

P17. [No]
The study selection process and flow are not shown. 

P18. [No] 
Study characteristics are not presented.

P19. [No]
Risk of bias assessments are not presented.

P20. [No]
Results of individual studies are not shown.

P21. [NA] 
There are no meta-analysis results.

P22. [NA]
Assessment of bias across studies is not applicable.

P23. [NA]
No additional analyses are mentioned.

P24. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
The discussion summarizes the main findings and their relevance.

P25. [No]
Limitations are not discussed.

P26. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
The conclusion provides an interpretation and implications.

P27. [No]
Funding sources are not described.
</pre>
<p><a name='98'></a></p>
</div>
<div id="guo-2011" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-011-2889-1' title='Open publication'>Guo
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the assessments for the 27 PRISMA items based on the provided full text:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic versus open orchiopexy for non-palpable undescended testes in children: a systemic review and meta-analysis&quot;</span>
The title identifies the report as a systematic review and meta-analysis.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
The abstract provides a structured summary with background, objectives, methods, results, and conclusions.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The undescended testes (cryptorchidism) is one of the most common disorders of childhood, affecting 0.8–1.8% of infants at 1 year of age, 3% of full-term newborns, and 21% of premature babies [1, 2].&quot;</span> 
The introduction describes the rationale for the review in the context of what is already known about undescended testes.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
The objectives state the explicit question being addressed regarding laparoscopic vs open orchiopexy for non-palpable testes in children.

[No] 
The methods do not indicate if a review protocol exists.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligibility criteria included all available studies comparing LO with OO for the treatment of NPT in children.&quot;</span>
The eligibility criteria specify characteristics like interventions being compared and outcomes measured. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Published studies until August 31, 2010 were searched from Medline, Embase, Ovid, Web of Science, and Cochrane databases.&quot;</span>
The information sources describe the databases searched and date last searched.

[No]
The search strategy for at least one database is not provided.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After independent review, 18 publications dealing with comparison of LO and OO for the treatment of pediatric NPT were considered to be eligible for inclusion in the analysis.&quot;</span> 
The study selection process is described including screening, eligibility, and inclusion.

[No]
The data collection process is not described. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data regarding the following factors were considered: first author, study duration, methodology, participant features, intervention characteristics, and outcome measures.&quot;</span>
The data items list the variables extracted like interventions and outcomes.

[NA]
No assessment of risk of bias in individual studies is described since no meta-analysis was performed.

[NA] 
No summary measures are stated since no meta-analysis was performed. 

[NA]
No synthesis methods are described since no meta-analysis was performed.

[NA]  
No assessment of risk of bias across studies is described since no meta-analysis was performed.

[NA]
No additional analyses are described since no meta-analysis was performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two hundred and twenty-six studies were initially found to report the laparoscopy in the management of NPT using the keywords “laparoscopy” and “non-palpable testis”. Two hundred and three were published as complete manuscripts and 23 as abstracts.&quot;</span>
The study selection process is described including number of studies screened and excluded with reasons.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A summary of the studies’ methodology, intervention characteristics, and measured outcomes was provided in Tables 1 and 2, including 176 cases of LO and 263 cases of OO.&quot;</span>
The study characteristics like sample sizes and interventions are presented. 

[NA] 
No assessment of risk of bias within studies is presented since no meta-analysis was performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One RCT and one OCS reported the time to resume feeding and full activity in both LO and OO [9, 14].&quot;</span> 
The results for outcomes considered are presented for each study.

[NA]
No results of meta-analyses are presented since none were performed.

[NA]
No assessment of risk of bias across studies is presented since no meta-analysis was performed. 

[NA]
No results of additional analyses are presented since none were performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In this meta-analysis, we demonstrate that the operative time, time to resume feeding and full activity is similar between LO and OO.&quot;</span>
The discussion summarizes the main findings and considers their relevance.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎However, due to the publishing bias, a series of RCTs are still necessary to explore the efficiencies of LO in the management of NPT in children, especially in the true outcome of orchidopexy and fertility in adulthood.&quot;</span>
The limitations at the study and outcome level are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Conclusions: In this meta-analysis, we demonstrate that the operative time, time to resume feeding and full activity is similar between LO and OO.&quot;</span> 
The conclusions provide a general interpretation of the results in context of other evidence.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Acknowledgment: This work was supported by the National Natural Science Foundation of China (No. 30200284, No. 30600278, No. 30772359, No. 81071997, No. 81072073), Program for New Century Excellent Talents in University (NCET-06-0641), Scientific Research Foundation for the Returned Overseas Chinese Scholars (2008-889), and Fundamental Research Funds for the Central Universities (2010JC025).&quot;</span>
The funding sources are described.
</pre>
<p><a name='99'></a></p>
</div>
<div id="hall-2011" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2011.01.019' title='Open publication'>Hall
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘wrong-response-partial-unclear-etc’</i>
<pre>
Here is the assessment of reporting quality against the PRISMA 2009 checklist for the given systematic review:

P1. <span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):

interval appendicectomy justified after successful nonoperative treatment of an appendix mass in children? A systematic review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Is] interval appendicectomy justified after successful nonoperative treatment of an appendix mass in children? A systematic review&quot;</span> - Identifies the report as a systematic review. [Yes]

P2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> - Abstract provides background, objectives, eligibility criteria, participants, interventions, results, conclusions. [Yes] 

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this systematic review was to evaluate the evidence for IA in children after successful nonoperative treatment of an AM based on the current available literature.&quot;</span> - Describes rationale for review. [Yes]

P4. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> - No explicit PICOS statement. [No]

P5. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span> - No mention of protocol. [No] 

P6. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span> - Specifies inclusion criteria but no exclusions. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P7. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span> - Describes sources but no dates. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P8. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span> - No search strategy provided. [No]

P9. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> - Describes broadening of eligibility criteria but no details on selection process. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P10. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span> - States data extracted independently by two reviewers. [Yes] 

P11. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span> - Lists outcomes extracted but no other variables. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]  

P12. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span> - No risk of bias assessment mentioned. [No]

P13. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span> - States use of binomial multilevel modeling. [Yes]

P14. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span> [NA]

P15. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span> [NA] 

P16. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span> [NA]

P17. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span> - No flow diagram or details on screening and eligibility assessment. [No] 

P18. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> - Presents limited characteristics and citations for included studies. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P19. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span> - No risk of bias assessment. [No] 

P20. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> - Presents summary data and effect estimates with CIs, no forest plots. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P21. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span> [NA] 

P22. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span> [NA]

P23. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span> [NA]

P24. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> - Summarizes main findings but does not discuss strength of evidence or relevance to key groups. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>] 

P25. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> - Discusses limitations of included studies but not at review level. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P26. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span> - Provides interpretation and implications for future research. [Yes]

P27. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span> - No mention of funding or support. [No]
</pre>
<p><a name='100'></a></p>
</div>
<div id="healy-2015" class="section level4">
<h4><a href='https://doi.org/10.1097/MD.0000000000001352' title='Open publication'>Healy
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
 Here are the responses for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Systematic Review and Meta-Analysis on the Influence of Surgeon Specialization on Outcomes Following Appendicectomy in Children&quot;</span>

The title identifies the report as a systematic review and meta-analysis.  

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review and meta-analysis to determine the influence of surgeon subspecialty on outcomes following appendicectomy in children.&quot;</span> 

The abstract provides structured background, objectives, eligibility criteria, methods, results, and conclusions.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An expanding body of evidence suggests that surgeon subspecialization affects outcomes; studies found that colorectal surgery subspecialization4 and orthopedic surgery subspecialization5 lead to improved results and that outcomes from a variety of cancers are improved with subspecialization.&quot;</span>

The introduction describes the rationale in context of what is already known.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review and meta-analysis to determine the influence of surgeon subspecialty on outcomes following appendicectomy in children.&quot;</span>

The objectives relate to participants, interventions, outcomes, and study design.

[No]

No review protocol or registration is indicated.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible studies were comparative and provided data on children who had appendicectomy while under the care of general or pediatric surgical teams.&quot;</span> 

Eligibility criteria for studies and participants are described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In order to identify studies and determine eligibility, 2 authors (DD and MM) independently searched Medline and EMBASE up to June 24, 2015 using the following search strategy “([paediatric surgery OR pediatric surgery OR pediatric surgeon OR paediatric surgeon] AND (appendectomy OR appendicectomy)].&quot;</span>

Information sources and dates of coverage are described. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎“([paediatric surgery OR pediatric surgery OR pediatric surgeon OR paediatric surgeon] AND (appendectomy OR appendicectomy)]&quot;</span>

The full search strategy for one database is provided.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Titles and abstracts were examined initially and then full manuscripts were obtained to finalize eligibility.&quot;</span>

The study selection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors (DD and DH) independently extracted data from eligible studies using an electronic spreadsheet.&quot;</span>

Data extraction by two authors is described. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Extracted data comprised details on the following variables: lead author, publication date, study design, inclusion and exclusion criteria, outcomes reported, whether there was a specified primary endpoint, main results, numbers and characteristics of patients, surgical approach, rate of negative appendiceal histology, wound infections, intra-abdominal collections, readmissions, mortality, and length of stay.&quot;</span>

Variables extracted are listed.

[No] 

No assessment of individual study risk of bias is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pooled risk ratios and pooled mean differences were used to evaluate the effect of treatment by general surgery units or pediatric surgery units on dichotomous and continuous outcomes, respectively.&quot;</span>

Summary measures used are stated.

[NA]

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The potential for publication bias was evaluated by visually inspecting funnel plots.&quot;</span> 

Publication bias assessment is described.

[NA] 

[NA]

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Figure 1 summarizes the results of the search.&quot;</span>

A flow diagram depicting study selection is provided.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Characteristics of the 9 included studies8,11–18 are shown in Table 1 and results from the studies are provided in Table 2.&quot;</span>

Study characteristics are presented. 

[No]

No assessment of risk of bias within studies is presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Seven studies8,11–14,16,18 (62,865 children) reported on numbers of histologically negative appendicectomies.&quot;</span>

Results for outcomes are presented for each study.

[NA]

[No] 

No additional analyses are indicated.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We found that children who were managed by specialized pediatric surgery teams had lower rates of negative appendicectomy although mean length of stay was longer in this group.&quot;</span>

Main findings are summarized.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Regarding limitations, the main issue is the retrospective nature of most of the included studies.&quot;</span> 

Study and outcome level limitations are discussed. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We wish to encourage future research through the use of large-scale prospective multicenter registries.&quot;</span>

Implications for future research are discussed.

[No]

No sources of funding are described.
</pre>
<p><a name='101'></a></p>
</div>
<div id="healy-2016" class="section level4">
<h4><a href='https://doi.org/10.1007/s00383-015-3839-0' title='Open publication'>Healy
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pediatric incidental appendectomy: a systematic review&quot;</span>
[Yes] 
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
[Yes] The abstract provides a structured summary.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>  
[Yes] The rationale is described in the Background section.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
[No] The objectives do not explicitly state the PICOS.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
[No] A review protocol is not mentioned.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
[Yes] The Methods section specifies eligibility criteria.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
[Yes] The information sources are described in the Methods section. 

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
[No] The full search strategy is not provided.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> 
[Yes] The study selection process is described in the Methods section.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
[No] The data extraction method is not described.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
[No] The extracted variables are not explicitly listed.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
[NA] Risk of bias assessment is not mentioned.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span> 
[NA] Summary measures are not applicable since no meta-analysis was performed.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>
[NA] Methods for combining study results are not applicable.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
[NA] Assessment of risk of bias across studies is not applicable. 

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
[NA] Additional analyses were not done.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
[Yes] A flow diagram of study selection is provided.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
[Yes] Study characteristics are presented in Tables 1-3. 

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
[NA] Risk of bias was not assessed.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
[NA] Outcome data are not presented this way since no meta-analysis was done.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
[NA] Meta-analyses were not performed.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>  
[NA] Assessment across studies was not done.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>
[NA] Additional analyses were not performed.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
[Yes] The main findings are summarized in the Conclusion section.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
[No] Limitations are not explicitly discussed.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
[Yes] The results are interpreted in the Conclusion section.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
[No] Sources of funding are not reported.
</pre>
<p><a name='102'></a></p>
</div>
<div id="heloury-2012" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2011.08.003' title='Open publication'>Heloury
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘wrong-response-partial-unclear-etc’</i>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[Minimally invasive adrenalectomy in children]&quot;</span> - The title identifies the report as a systematic review. [Yes]

P2. No structured abstract provided. [No] 

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive adrenalectomy (MIA) is considered the criterion standard for adrenal surgery in adults [1], [2], where it is used for benign or malignant tumors.&quot;</span> - Provides rationale in context of current knowledge. [Yes]

P4. No explicit PICOS statement provided. [No]

P5. No mention of a review protocol. [No] 

P6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎NB is the most common abdominal tumor in children, with a prevalence of 1 case per 7000 live births.&quot;</span> - Specifies participants. [Partial Yes <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P7. No description of information sources. [No]

P8. No full electronic search strategy provided. [No]

P9. No description of study selection process. [No] 

P10. No description of data collection process. [No]

P11. No list of variables for which data were sought. [No]

P12. No assessment of risk of bias. [No]

P13. No summary measures stated. [NA]

P14. No description of synthesis methods. [NA]

P15. No assessment of bias across studies. [NA] 

P16. No additional analyses described. [NA]

P17. No study flow diagram. [No]

P18. No table with study characteristics. [No]

P19. No assessment of risk of bias within studies. [No]

P20. No forest plots with effect sizes. [No]

P21. No meta-analysis results. [NA]

P22. No assessment of bias across studies. [NA]

P23. No additional analysis results. [NA]

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive adrenalectomy is superior to OA for the removal of benign adrenal diseases (benign tumors or CAH). For malignant tumors, the use of MIA should be limited to selected cases (encapsulated tumors with favorable prognostic factors or metastatic NB).&quot;</span> - Summarizes main findings. [Yes] 

P25. No discussion of limitations. [No]

P26. <span title='Moderate quote deviation. Best match in fulltext (Similarity 94%):

Conclusions

Minimally invasive adrenalectomy is promising for removal of small adrenal tumors. Long-term follow-up is required to evaluate the efficacy of MIA in neuroblastomas' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎In conclusion, MIA is promising for removal of small adrenal tumors. Long-term follow-up is required to evaluate the efficacy of MIA in neuroblastomas.&quot;</span> - Provides interpretation and implications. [Yes]

P27. No funding sources described. [No]
</pre>
<p><a name='103'></a></p>
</div>
<div id="huang-2015" class="section level4">
<h4><a href='https://doi.org/pmid:26131065' title='Open publication'>Huang
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An updated meta-analysis of laparoscopic versus open pyeloplasty for ureteropelvic junction obstruction in children&quot;</span> - The title identifies the report as a systematic review and meta-analysis. [Yes]

P2. 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Purpose: To further explore the feasibility and safety of laparoscopic pyeloplasty (LP) in children with ureteropelvic junction obstruction compared with open pyeloplasty (OP).&quot;</span> - The abstract provides structured summary including objectives. [Yes]

P3.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Ureteropelvic junction (UPJ) obstruction is one of the commonest causes of hydronephrosis in adults, especially in children. And to date, open pyeloplasty (OP) has still been the gold standard for operative manage, though minimally invasive surgeries such as laparoscopic pyeloplasty (LP) and robot assisted laparoscopic pyeloplasty (RALP) have increasingly been adopted in pediatric practice.&quot;</span> - The introduction describes the rationale in context of what is already known. [Yes]

P4. 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Purpose: To further explore the feasibility and safety of laparoscopic pyeloplasty (LP) in children with ureteropelvic junction obstruction compared with open pyeloplasty (OP).&quot;</span> - The objectives state the questions addressed with reference to participants, interventions, comparisons, and outcomes. [Yes]

P5.
No mention of a review protocol. [No] 

P6.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies regardless of the sample size will be eligible for inclusion if they meet the following criteria: 1). comparative study; 2). compared standard LP with OP; 3). proved sufficient data on outcomes of interest; 4). procedures should perform in children (less than 18 years old).&quot;</span> - The eligibility criteria are specified including characteristics and report criteria. [Yes]

P7. 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic literature search of electronic databases including PUBMED, Web of science and Cochrane library was carried out between Jan. 1966 and Oct. 2014 to identify eligible studies, using the following words: “hydronephrosis OR ureteropelvic junction obstruction OR pelvi-ureteric junction obstruction OR ureteral obstruction”, “pyeloplasty”, “young OR children OR child OR kids OR pediatrics” and “laparoscopic”.&quot;</span> - The information sources are described including databases, dates, and search terms. [Yes]

P8.
No full electronic search strategy provided for any database. [No]

P9.
No explicit statement of the process for study selection. [No]

P10.
No description of data extraction methods. [No]

P11.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following outcome parameters were abstracted: author, year, study design, study periods, cases of LP and OP, age periods, gender distribution, sides of obstruction and number of patients with crossing-vessel. Besides, perioperative outcomes such as operative time, length of stay and overall complication rate were also abstracted.&quot;</span> - The data items list variables extracted. [Yes] 

P12.
No description of methods for assessing risk of bias. [No]

P13.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎WMD, OR, RD and their 95% CIs were used to estimate the difference.&quot;</span> - The summary measures are stated (risk ratio, difference in means). [Yes]

P14. [NA]

P15. [NA] 

P16. [NA]

P17.
No flow diagram of study selection. [No]

P18. 
Table 1 presents characteristics of included studies. [Yes]

P19.
No presentation of risk of bias within studies. [No]  

P20.
Table 2 and 3 present results for outcomes. [Yes]

P21. [NA]

P22. [NA]

P23. [NA]

P24.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our findings of this meta-analysis revealed that LP groups were with less length of hospital stay and lower complication rate than OP groups. Considering the similar success rate of these two approaches, the laparoscopic pyeloplasty is feasibility and safety in the treatment of UPJ obstruction in children, especially in high-volume centers with experienced experts.&quot;</span> - The discussion summarizes main findings including strength of evidence. [Yes]

P25.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There are several limitations which should be taken into account. Firstly, only one RCT was included in this meta-analysis and most of studies were retrospective, which may lead to select bias and recall bias. More large-scaled well-designed RCT are needed to explore the feasibility and safety of LP compared with OP.&quot;</span> - Limitations at study and outcome level are discussed. [Yes]

P26. 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Considering the select bias and recall bias, more RCTs are required to further explore the efficiencies of LP.&quot;</span> - Conclusions are made in context of other evidence and implications. [Yes]

P27.
No mention of sources of funding or role of funders. [No]
</pre>
<p><a name='104'></a></p>
</div>
<div id="ishii-2014" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2014.08.003' title='Open publication'>Ishii
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘wrong-response-partial-unclear-etc’</i>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[Flexible ureteroscopy and lasertripsy (FURSL) for paediatric renal calculi: Results from a systematic review]&quot;</span> - The title identifies the report as a systematic review. [Yes]

P2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> - The abstract provides background, objectives, eligibility criteria, participants, interventions, results, and conclusions. [Yes]

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To understand the role, safety and efficacy of flexible ureterorenoscopy and lasertripsy (FURSL) for paediatric renal stones.&quot;</span> - The rationale describes the context of what is already known. [Yes] 

P4. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> - No explicit PICOS statement is provided. [No]

P5. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span> - No review protocol or registration is mentioned. [No]

P6. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span> - Study characteristics like participants, interventions, language, and publication status are specified. [Yes]

P7. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span> - Information sources and dates searched are described. [Yes] 

P8. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span> - No full search strategy is presented. [No]

P9. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> - The process of study selection is described. [Yes]

P10. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span> - No data extraction process is described. [No] 

P11. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span> - Variables like stone size, location, complications, etc. are listed and defined. [Yes]

P12. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span> - No risk of bias assessment is described. [No]

P13. "[NA]"

P14. "[NA]" 

P15. "[NA]"

P16. "[NA]"

P17. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span> - A flow diagram shows numbers of studies screened, eligible, and included with exclusions. [Yes]

P18. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> - A table presents extracted characteristics like sample size, age, stone details, etc. for each study. [Yes]

P19. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span> - No risk of bias data is presented. [No] 

P20. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> - Outcomes like stone-free rates, complications, etc. are summarized for each study in tables. No effect estimates or forest plots. [Partial Yes <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P21. "[NA]"

P22. "[NA]" 

P23. "[NA]"

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The present review shows that FURSL for management of renal calculi in the paediatric population is an effective and safe procedure.&quot;</span> - A summary of the main findings and their relevance is provided. [Yes]

P25. <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.9%):

There are two main limitations to the present review. The first limitation is that all of the reviewed studies were retrospective studies and the results were not recorded in a uniform manner to allow the data to be meta-analysed. Second, the numbers involved in these studies were small and this may skew the results' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The main limitations to the present review [...] Second, the numbers involved in these studies were small and this may skew the results [...]&quot;</span> - Study level limitations like small sample sizes are discussed. [Yes]

P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To compare the effectiveness and safety of FURSL in the paediatric population with the more conventional methods of SWL and PCNL, large, multicentric trials would be required.&quot;</span> - Implications for future research are described. [Yes]

P27. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎None declared.&quot;</span> - Sources of funding are described. [Yes]
</pre>
<p><a name='105'></a></p>
</div>
<div id="ishii-2015" class="section level4">
<h4><a href='https://doi.org/10.1111/BJU.12927' title='Open publication'>Ishii
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
"[Yes]" The title identifies the report as a systematic review and meta-analysis.

"[Yes]" The abstract provides background, objectives, data sources, eligibility criteria, appraisal and synthesis methods, results, limitations, and conclusions.

"[Yes]" The introduction describes the rationale for the review in the context of existing knowledge.  

"[Yes]" The objectives explicitly state the questions addressed regarding participants, interventions, comparisons, outcomes, and study design.

"[No]" A review protocol and registration are not reported.

"[Yes]" Eligibility criteria are specified for study characteristics and report characteristics.

"[Yes]" Information sources are described including databases searched and date ranges. 

"[Yes]" The full search strategy is presented for one database. 

"[Yes]" The process for study selection (screening, eligibility, inclusion) is described.

"[Yes]" Methods of data extraction are described including use of piloted forms and independent duplicate extraction. 

"[Yes]" Extracted variables are listed and defined.

"[Yes]" Methods are described for assessing individual study risk of bias and using this information.

"[Yes]" Principal summary measures are stated.

"[NA]" 

"[NA]"

"[NA]"

"[Yes]" A flow diagram shows numbers screened, assessed, and included with reasons for exclusion.

"[Yes]" Extracted study characteristics are presented with citations.

"[Yes]" Risk of bias data are presented for each study. 

"[Yes]" For each outcome, study-level summary data, effect estimates, and confidence intervals are presented. 

"[NA]"

"[NA]" 

"[NA]"

"[Yes]" Key findings are summarized including strength of evidence and relevance.

"[Yes]" Limitations are discussed at the study and review levels.

"[Yes]" General interpretation is provided in context of other evidence and implications.

"[Yes]" Sources of funding are described for the review.
</pre>
<p><a name='106'></a></p>
</div>
<div id="ito-2014" class="section level4">
<h4><a href='https://doi.org/10.1111/PED.12429' title='Open publication'>Ito
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘missing-squared-brackets-in-numbered-list’</i>
<pre>
Here are the assessments for each PRISMA item based on the provided systematic review text:

P1. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Does frenotomy improve breast-feeding difficulties in infants with ankyloglossia?&quot;</span>  

P2. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>

P3. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>

P4. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>  

P5. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - No protocol or registration mentioned.

P6. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>

P7. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>

P8. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>

P9. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>

P10. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - No detailed data collection process described. 

P11. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>

P12. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>

P13. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>

P14. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No meta-analysis performed.

P15. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No assessment of bias across studies mentioned.

P16. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No additional analyses mentioned.

P17. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>

P18. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> 

P19. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>

P20. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>

P21. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No meta-analysis performed. 

P22. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No assessment of bias across studies mentioned.

P23. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No additional analyses mentioned.

P24. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>

P25. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>

P26. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>

P27. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - No funding sources reported.
</pre>
<p><a name='107'></a></p>
</div>
<div id="jia-2011" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0030-1261926' title='Open publication'>Jia
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
 [Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Open versus Laparoscopic Pyloromyotomy for Pyloric Stenosis: A Meta-analysis of Randomized Controlled Trials&quot;</span>
The title identifies the report as a systematic review and meta-analysis.

[Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Objective: Aim of the study was to compare the outcomes after laparoscopic pyloromyotomy (LP) with those of open pyloromyotomy (OP) for infantile pyloric stenosis.&quot;</span>
The abstract provides a structured summary including the objectives.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pyloromyotomy is an effective surgical intervention with rare mortality and has traditionally been performed via an open technique since the early 20th century.&quot;</span>  
The introduction describes the rationale for the review.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Given the conflicting evidence of prior studies, the aim of this meta-analysis was to systematically and quantitatively evaluate all the published randomized controlled trials comparing LP with OP for infantile pyloric stenosis.&quot;</span>
The introduction states the objective and specifies the intervention comparison being addressed. 

[No]
No protocol or registration is indicated.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible studies were those that compared LP with OP for the treatment of infants with IHPS, and only randomized controlled trials was reviewed. The included studies had to report at least one of the following outcomes: complications during and following pyloromyotomy, time to goal feeds, length of stay after surgery and operative time.&quot;</span>
The eligibility criteria are specified.

[Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An electronic literature search of all articles from inception to February 2009 was conducted using Medline, the Cochrane Library, SCI, EMBASE, and the Chinese Biomedical Literature Database, using the following text and keywords in combination both as MeSH terms and text words: “pyloric stenosis”, “pylorostenosis”, “pyloristenosis” and “pyloromyotomy” in combination with “laparoscop*”. The China Journal Fulltext Database (from 1994 to February 2009), Chinese biological medicine disc (from 1978 to February 2009), Chinese Scientific Journals Fulltext Database (from 1989 to February 2009) and Wanfang Database (from 1997 to February 2009) were also searched using the above terms.&quot;</span>
The information sources are described.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An electronic literature search of all articles from inception to February 2009 was conducted using Medline, the Cochrane Library, SCI, EMBASE, and the Chinese Biomedical Literature Database, using the following text and keywords in combination both as MeSH terms and text words: “pyloric stenosis”, “pylorostenosis”, “pyloristenosis” and “pyloromyotomy” in combination with “laparoscop*”. The China Journal Fulltext Database (from 1994 to February 2009), Chinese biological medicine disc (from 1978 to February 2009), Chinese Scientific Journals Fulltext Database (from 1989 to February 2009) and Wanfang Database (from 1997 to February 2009) were also searched using the above terms.&quot;</span>
The full search strategy is presented.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were finally eligible for this study ([Fig. 1]).&quot;</span> 
The study selection process is described.

[Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were extracted by 2 independent investigators, and discrepancies were discussed to reach consensus. For each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics and surgical features of the study.&quot;</span>
The data collection process is described.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary endpoints in this review were complications during and following pyloromyotomy, the secondary endpoints included time to goal feeds, length of stay after surgery and operative time.&quot;</span>
The data items sought are listed.

[No]
No assessment of risk of bias in individual studies is described. 

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For the purpose of meta-analysis, the standard deviation (SD) of continuous variables was required.&quot;</span>
The summary measures are stated.

[NA]
No meta-analysis was performed.

[NA]  
No assessment of risk of bias across studies is applicable.

[NA]
No additional analyses are reported.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were finally eligible for this study ([Fig. 1]).&quot;</span>
The study selection process, including numbers at each stage, is described.

[Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Baseline characteristics of included trials are summarized in [Table 1].&quot;</span> 
The characteristics of the included studies are presented. 

[No]
No assessment of risk of bias within studies is presented.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All 3 studies [9] [10] [13] reported complications during and following pyloromytomy.&quot;</span> 
The results for each intervention are summarized.

[NA] 
No meta-analysis was performed.

[NA]
No assessment of risk of bias across studies is applicable. 

[NA]  
No additional analyses are reported.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Overall, this systematic review has shown a similar frequency of complications for LP and OP procedures. Furthermore, it also showed a trend toward shorter times for LP.&quot;</span>
The main findings are summarized.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As with any systematic review, the limitations of this study reflect those of the individual studies. Most relied on information from databases. In this review, all trials included were obtained from online databases and no other articles were reviewed. Thus, a publication bias probably existed, although we did not assess this in detail because of the small numbers of trials that could be pooled.&quot;</span>
Study and outcome level limitations are discussed.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Overall, this systematic review has shown a similar frequency of complications for LP and OP procedures. Furthermore, it also showed a trend toward shorter times for LP. Nevertheless, the conclusions from this study remain somewhat limited due to the small sample size.&quot;</span> 
The results are interpreted in the context of the evidence and implications for future research are discussed.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Conflict of Interest: None&quot;</span>
The sources of funding are reported.
</pre>
<p><a name='108'></a></p>
</div>
<div id="kapralik-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.11.022' title='Open publication'>Kapralik
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item based on the provided full text:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Surgical versus conservative management of congenital pulmonary airway malformation in children: A systematic review and meta-analysis&quot;</span>
The title identifies the report as a systematic review and meta-analysis.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review and meta-analysis comparing elective resection versus expectant management.&quot;</span>  
The abstract provides a structured summary including the objectives, data sources, eligibility criteria, methods, results, and conclusions.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The ideal management of infants born with asymptomatic congenital pulmonary airway malformation (CPAM) is controversial.&quot;</span>
The introduction describes the rationale for the review in context of existing knowledge.  

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our objective was to conduct a systematic review and meta-analysis of all published literature comparing the postoperative outcomes associated with elective surgery (while asymptomatic) versus those following surgery as part of expectant management (i.e., performing surgery only upon the development of symptoms) in children born with asymptomatic CPAM lesions.&quot;</span>
The introduction provides explicit objectives with reference to participants, interventions, comparisons, and outcomes.

[NA] 
No statement about existence of a review protocol.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We excluded any studies on nonhuman subjects and those that did not focus on pediatric patients, as well as any studies that were not published in English, owing to resource limitations.&quot;</span>
Study characteristics used as eligibility criteria are specified.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To identify all studies on elective surgery and expectant management of asymptomatic CPAM lesions, we conducted an electronic literature search of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), EMBASE (1980 onwards), CINAHL (1982 onwards), and PubMed (1966 onwards) in January 2015.&quot;</span> 
Information sources including databases and dates searched are described. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We used the search terms (“asymptomatic” AND “congenital” AND “cystic” AND “adenomatoid malformation”) OR (“lung” AND “lesion”) AND (“management” OR “treatment” OR “therapy.”).&quot;</span>
The full search strategy for one database is presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two independent reviewers conducted all article screening; where consensus on an article could not be reached, a third reviewer was consulted.&quot;</span>  
The process of study selection including screening and eligibility is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One reviewer extracted all data from the included studies, and another checked it for accuracy and completeness. We extracted the following data exclusively on patients who were asymptomatic at birth: number of patients undergoing elective surgery, number undergoing surgery as part of expectant management (after symptom development), age at symptom development if applicable, postoperative complications, mortalities, and total length of postoperative hospital stay, as well as number of patients successfully managed conservatively at the end of follow-up, and length of follow-up for these patients.&quot;</span>
The data collection process including data extraction is described. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We extracted the following data exclusively on patients who were asymptomatic at birth: number of patients undergoing elective surgery, number undergoing surgery as part of expectant management (after symptom development), age at symptom development if applicable, postoperative complications, mortalities, and total length of postoperative hospital stay, as well as number of patients successfully managed conservatively at the end of follow-up, and length of follow-up for these patients.&quot;</span>
Variables extracted are listed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We used the Methodological Index for Non-Randomized Studies (MINORS) to assess the quality of the included studies, as all were nonrandomized [18].&quot;</span>
Methods for assessing risk of bias are described.

[NA] 
No summary measures stated as no meta-analysis performed.

[NA]
No methods described for combining study results as no meta-analysis performed. 

[NA]  
No assessment of risk of bias across studies described.

[NA]
No additional analyses described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Full-text review resulted in eight of these studies being included, while an additional one was identified from hand-searching the reference sections of included articles; nine studies were ultimately included [10], [11], [12], [14], [23], [24], [25], [26], [27]].&quot;</span>
Numbers of studies screened, assessed, and included are provided with reasons for exclusion.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We did not identify any RCTs; all but one of the included nine studies were retrospective [26]. Studies were published between 1996 and 2011 and were conducted in Australia [14], [27], Belgium [25], Canada [23], China [24], Israel [26], Italy [10], Japan [12], and the United States of America [11].&quot;</span>
Study characteristics are presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The MINORS scores for our included studies ranged from 7 to 14, with a median score of 9 (Table 1).&quot;</span>
Data on risk of bias assessment is presented.

[NA] 
No results of individual studies presented as no meta-analysis performed.

[NA] 
No results of meta-analyses presented as none performed. 

[NA]
No assessment of bias across studies presented.

[NA]
No results of additional analyses presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on our results, we recommend elective resection of asymptomatic CPAM lesions, rather than expectant management. Lung resection in an asymptomatic patient is quite safe, prevents the risk of symptom development later in life, and may help prevent the development of malignancy.&quot;</span>  
A summary of the main findings and their relevance is provided.

[Yes]  <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results should be interpreted with caution owing to the nature of the included studies (in that all but one were retrospective). We did not identify any RCTs evaluating the benefit of elective surgery compared to expectant management of asymptomatic CPAM lesions.&quot;</span>
Limitations at the study and outcome level are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on our results, we recommend elective resection of asymptomatic CPAM lesions, rather than expectant management. Lung resection in an asymptomatic patient is quite safe, prevents the risk of symptom development later in life, and may help prevent the development of malignancy. The ideal timing of elective resection will be the topic of a future review.&quot;</span>
Conclusions are provided with implications for future research.

[No]
No statement about sources of funding or support.
</pre>
<p><a name='109'></a></p>
</div>
<div id="kunz-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2013.01.020' title='Open publication'>Kunz
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the responses for each PRISMA item based on the provided full text:

P1. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary Fascial Closure versus Staged Closure with Silo in Patients with Gastroschisis: A Meta-Analysis&quot;</span> The title identifies the report as a systematic review and meta-analysis.

P2. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> The abstract provides a structured summary.

P3. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span> The introduction describes the rationale in context of current knowledge. 

P4. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> The introduction states the aim is to compare outcomes for primary fascial closure versus staged repair with a silo.

P5. [No] A protocol and registration are not mentioned.

P6. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span> The methods section specifies eligibility criteria. 

P7. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span> The methods describe the databases searched, search terms, and date ranges.

P8. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span> The methods provide the full search strategy.

P9. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> The methods describe the study selection process. 

P10. [No] The data collection process is not described.

P11. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span> The methods list the outcomes extracted.

P12. [No] Risk of bias assessment is not described. 

P13. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span> The methods state the summary measures used.

P14. [NA] No meta-analysis synthesis is described.

P15. [NA] Assessment of bias across studies is not applicable without a meta-analysis.  

P16. [NA] No additional analyses are mentioned.

P17. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span> The results provide a flow diagram of study selection.

P18. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> The results present study characteristics in a table.

P19. [No] Risk of bias within studies is not presented.

P20. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> The results present forest plots with effect estimates.

P21. [NA] No meta-analysis synthesis is presented.

P22. [NA] Assessment of bias across studies is not applicable without a meta-analysis.

P23. [NA] No additional analyses are presented. 

P24. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> The discussion summarizes the main findings.

P25. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> The discussion describes limitations.

P26. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span> The discussion provides an interpretation and implications.

P27. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span> The funding sources are described.
</pre>
<p><a name='110'></a></p>
</div>
<div id="landisch-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.08.002' title='Open publication'>Landisch
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[Observation versus prophylactic Ladd procedure for asymptomatic intestinal rotational abnormalities in heterotaxy syndrome: A systematic review]&quot;</span> - The title identifies the report as a systematic review. [Yes]

P2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> - No structured abstract provided. [No]

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The management of intestinal rotational abnormalities (IRA) in heterotaxy syndrome (HS) remains inconsistent. Because of the high incidence of malrotation in HS, screening of asymptomatic patients is standard of care in some institutions.&quot;</span> - Describes rationale in context of existing knowledge. [Yes] 

P4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our aim was to perform a complete and thorough review of all current literature on IRA in pediatric HS patients, to report the known incidence of volvulus among infants with HS, and to report the associated Ladd operative morbidity and mortality.&quot;</span> - Provides objectives with participants, interventions, and outcomes. [Yes]

P5. No mention of review protocol or registration. [No] 

P6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusion criteria were non-English language articles, case reports, case studies with three patients or less, and studies without outcomes data.&quot;</span> - Specifies eligibility criteria. [Yes]

P7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An online database search for all articles published between January 1993 and January 2014 on pediatric patients using the following keywords was performed: “heterotaxy”, “rotation”, “volvulus”, “Ladd procedure”, “Ivemark”, “asplenia”, and “polysplenia”. Searches were repeated in PubMed, Medline, CINAHL, and Cochrane library.&quot;</span> - Describes information sources and dates of coverage. [Yes]

P8. No full electronic search strategy provided. [No]

P9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two independent researchers (R.L. and R.M.) performed the search, critically reviewed and extracted eligible articles. Bibliographies of identified studies were examined to identify any additional eligible studies. Duplicate listed articles were deleted. Two other independent researchers (A.A. and A.W.) confirmed the inclusion of appropriate citations based on study definitions and aims.&quot;</span> - States process of study selection. [Yes]

P10. No description of data extraction or confirmation methods. [No] 

P11. No list of data items sought. [No]

P12. No methods for assessing risk of bias described. [No]

P13. No summary measures stated. [No] 

P14. [NA]

P15. [NA] 

P16. [NA]

P17. Figure 1 provides flow diagram of study selection. [Yes]

P18. Table 1 provides characteristics of included studies. [Yes]

P19. No assessment of risk of bias for individual studies. [No]

P20. Results summarize findings from individual studies in text and tables. [Yes]

P21. [NA]

P22. [NA]

P23. [NA]

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Ladd procedure is not without significant morbidity and mortality in heterotaxy patients. Further prospective studies should investigate predictors of mesenteric width to spare the unnecessary morbidity of surgery in patients who are at low risk for volvulus.&quot;</span> - Summarizes main findings and implications. [Yes]

P25. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review is limited by disparities and inconsistency of data extracted from principally retrospective studies which are discussed above.&quot;</span> - Discusses limitations. [Yes] 

P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A randomized, prospective trial to determine which subsets of patients with HS have the highest risk of volvulus is needed in order to optimize the care of this patient population.&quot;</span> - Provides interpretation and implications for research. [Yes]

P27. No mention of funding sources. [No]
</pre>
<p><a name='111'></a></p>
</div>
<div id="lane-2010" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-009-2475-Y' title='Open publication'>Lane
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Paediatric sutureless circumcision: a systematic literature review&quot;</span>

Identifies the report as a systematic review in the title.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We review the literature on recent advances that have been made in paediatric circumcision and the use of a sutureless technique with tissue glue for wound approximation.&quot;</span>  

Provides background and objectives in the abstract.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Circumcision can be undertaken using a variety of techniques. For the technique to be successful, it should be easy to perform, avoid excessive haemorrhage and achieve a good cosmetic and functional result with minimal postoperative care. Naturally, there are differences between circumcision in the paediatric and adult populations and here we review the literature on recent advances that have been made in paediatric circumcision and the use of a sutureless technique with tissue glue for wound approximation.&quot;</span>

Describes rationale for review in context of existing knowledge. 

[No]

Does not provide explicit PICOS statement.

[No] 

Does not indicate if a review protocol exists.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the last 20 years, surgeons have become increasingly interested in the use and application of adhesive bonds [4]. Tissue adhesives have been used in a number of medical applications, including traumatic lacerations, bronchopleural fistula repair, intestinal anastomosis and middle ear surgery [5–7] and for closure of the skin wounds following herniotomy [8] and recently advances have been made in the use of tissue glue in circumcision.&quot;</span>

Specifies study characteristics of interest - use of tissue glue in circumcision.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The technique of sutureless circumcision has been explained by several authors in the literature, with either a CO2 laser being used to cut the inner and outer layer of the prepuce [2] or a scalpel for the outer layer followed by bipolar diathermy scissors on the inner layer to achieve haemostasis [2].&quot;</span>

Describes information sources searched - literature/previous publications. 

[No]

Does not provide full search strategy.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The technique of sutureless circumcision has been explained by several authors in the literature, with either a CO2 laser being used to cut the inner and outer layer of the prepuce [2] or a scalpel for the outer layer followed by bipolar diathermy scissors on the inner layer to achieve haemostasis [2].&quot;</span>

States that relevant literature was reviewed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The technique of sutureless circumcision has been explained by several authors in the literature, with either a CO2 laser being used to cut the inner and outer layer of the prepuce [2] or a scalpel for the outer layer followed by bipolar diathermy scissors on the inner layer to achieve haemostasis [2].&quot;</span>  

Implies data was extracted from literature.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

Tissue adhesives have been used in a number of medical applications, including traumatic lacerations, bronchopleural fistula repair, intestinal anastomosis and middle ear surgery [5–7] and for closure of the skin wounds following herniotomy [8] and recently advances have been made in the use of tissue glue in circumcision' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Tissue glues have been used in a number of medical applications, including traumatic lacerations, bronchopleural fistula repair, intestinal anastomosis and middle ear surgery [5–7] and for closure of the skin wounds following herniotomy [8] and recently advances have been made in the use of tissue glue in circumcision.&quot;</span>

Specifies interventions of interest - tissue glues.

[NA]

 Does not assess risk of bias in individual studies.

[NA] 

Does not provide summary measures.

[NA]

Does not combine results quantitatively.

[NA]

No assessment of bias across studies. 

[NA]

No additional analyses performed.

[No] 

Does not provide study flow diagram.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In 2001, Subramaniam and Jacobsen looked at the advantages of tissue glue versus sutures for circumcision in children. They conducted a prospective randomised controlled study over a period of 3 months in 2001 and recruited 152 boys. Glue was used in 80 and sutures in 72 boys undergoing circumcision. There were a total of four postoperative complications including three patients with bleeding and one case of infection.&quot;</span>

Provides summary characteristics of included studies.

[NA] 

Does not assess risk of bias in individual studies.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In 2001, Subramaniam and Jacobsen looked at the advantages of tissue glue versus sutures for circumcision in children. They conducted a prospective randomised controlled study over a period of 3 months in 2001 and recruited 152 boys. Glue was used in 80 and sutures in 72 boys undergoing circumcision. There were a total of four postoperative complications including three patients with bleeding and one case of infection.&quot;</span>

Presents results for main outcomes.

[NA]

Does not provide quantitative synthesis. 

[NA]

No assessment of bias across studies.

[NA] 

No additional analyses.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, sutureless circumcision in children appears to have significant advantages to the standard closure using interrupted sutures. As reported there are advantages that include a better postoperative appearance and parental satisfaction, reduced inflammation and infection rates and a reduced operative time.&quot;</span>

Summarizes main findings.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The disadvantage is in the adolescent age group where tissue glue alone may not be an adequate form of closure due to the increased tension placed on the wound should the boys develop an erection. There is also a learning curve associated with the application of glue, but with experience a reproducible and reliable outcome should be expected.&quot;</span>

Discusses limitations around age groups and application of glue.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, sutureless circumcision in children appears to have significant advantages to the standard closure using interrupted sutures. As reported there are advantages that include a better postoperative appearance and parental satisfaction, reduced inflammation and infection rates and a reduced operative time.&quot;</span>

Provides general interpretation of results.

[No] 

Does not describe sources of funding.
</pre>
<p><a name='112'></a></p>
</div>
<div id="lansdale-2010" class="section level4">
<h4><a href='https://doi.org/10.1097/SLA.0B013E3181DCA0E8' title='Open publication'>Lansdale
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes, explanations, and assessments for each PRISMA item:

P1. <span title='Minor quote deviation. Best match in fulltext (Similarity 96%):

Neonatal Endosurgical Congenital Diaphragmatic Hernia Repair
A Systematic Review and Meta-Analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Neonatal] Endosurgical Congenital Diaphragmatic Hernia Repair: A Systematic Review and Meta-Analysis&quot;</span>
The title identifies the report as a systematic review and meta-analysis. [Yes]

P2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
No structured abstract provided. [No]  

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎CDH is a common birth defect in neonatology and pediatric surgical practice. In the context of persistently high morbidity and mortality, varied pre- and postnatal surgical strategies have been tried with limited success.&quot;</span>
The introduction provides context and rationale. [Yes]

P4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We have therefore asked whether MIS approaches to neonatal CDH repair are associated with changes in survival, CDH recurrence risk, operative time, and/or prosthetic patch usage.&quot;</span> 
The objectives relate to participants, interventions, comparisons, and outcomes. [Yes]

P5. No mention of a review protocol. [No] 

P6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were eligible for inclusion in the review and meta-analysis if they directly compared open and endosurgical CDH repair in the newborn infant and included outcome data regarding survival, CDH recurrence, prosthetic patch use, and operative time.&quot;</span>
Eligibility criteria for studies are provided. [Yes]

P7. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 68.5%):

MEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched using the' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎MEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched...The date of the last electronic search was 1st October 2009.&quot;</span>
Information sources and dates searched are described. [Yes]

P8. No full search strategy provided. [No]

P9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two independent reviewers reviewed all studies in abstract form. Exclusions were only made at this point if it was absolutely clear that the above criteria were met. Full-text versions of the remaining studies were retrieved and corresponding authors were contacted for further information if necessary.&quot;</span> 
The study selection process is described. [Yes]

P10. No mention of data extraction process. [No] 

P11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following demographic data was sought for each group: proportion of male sex, proportion with left-sided CDH, mean birth weight, mean gestational age, APGAR score at 1 minute, proportion requiring ECMO, and proportion with significant associated anomalies.&quot;</span>
Data items sought are listed. [Yes]

P12. No mention of risk of bias assessment. [No]

P13. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Weighted treatment effect was calculated using the fixed effects model. Treatment effect sizes were calculated and presented as relative risk (RR) for dichotomous variables and weighted mean difference (WMD) for continuous variables&quot;</span>
Summary measures are stated. [Yes] 

P14. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data meta-analysis was carried out using Review Manager (RevMan) Version 5.0 (The Nordic Cochrane Centre, The Cochrane Collaboration, 2008). Weighted treatment effect was calculated using the fixed effects model.&quot;</span>
Methods for combining study results are described. [Yes]

P15. No assessment of risk of bias across studies mentioned. [NA]

P16. No additional analyses mentioned. [NA]

P17. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The electronic search identified a total of 292 studies. Exclusions were made as detailed in the flow chart (Fig. 2).&quot;</span>
A study flow diagram is provided. [Yes]

P18. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analyzing the demographic data in each study, there were no statistically significant differences in proportion of male sex, mean birth weight, proportion of left sided CDH, or proportion of cases with significant associated anomalies between open and endosurgical groups.&quot;</span> 
Study characteristics are presented. [Yes]

P19. No assessment of risk of bias within studies presented. [No] 

P20. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Results from the individual studies for the primary and secondary outcome measures are included in forest plots (Fig. 3).&quot;</span>
Results for each study are presented in forest plots. [Yes]

P21. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta-analysis reveals that recurrence was higher (RR: 3.21 [1.11, 9.29], P = 0.03) and operative time was longer (WMD: 50.38 minutes [31.79, 68.97], P < 0.00001) in the endosurgical group.&quot;</span> 
Results of the meta-analyses are presented. [Yes]

P22. No assessment of bias across studies presented. [NA]

P23. No additional analyses presented. [NA]

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis of methodologically limited comparative studies indicates neonatal thoracoscopic CDH repair has increased recurrence risk and operative time compared with open repair: although survival and patch usage appear comparable, such similarities may be subject to type 2 error as well as biases.&quot;</span>
A summary of the evidence is provided. [Yes]

P25. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎However, these findings need to be considered in the context of the methodological limitations of the studies available for inclusion; for each outcome measure, we will discuss the potential for bias and other confounding factors.&quot;</span>
Study limitations are discussed. [Yes] 

P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Better quality evidence is therefore required. Systematic reviews and meta-analyses frequently conclude with calls for more randomized controlled trials (RCTs). In contrast, we call for prospective, comprehensive, multi-institutional registry data on neonatal endosurgical CDH repair.&quot;</span>
Conclusions and implications are discussed. [Yes]

P27. No funding sources reported. [No]
</pre>
<p><a name='113'></a></p>
</div>
<div id="lee-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2010.06.038' title='Open publication'>Lee
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
 Here are the relevant quotes and assessments for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Antibiotics and appendicitis in the pediatric population: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee Systematic Review☆&quot;</span>

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):

Objective

The aim of the study was to review evidence-based data regarding the use of antibiotics for the treatment of appendicitis in children' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Objective The aim of the study was to review evidence-based data regarding the use of antibiotics for the treatment of appendicitis in children.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> 

[No]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>

[No] 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>

[No] 

[No]

[No]

[NA]

[NA] 

[NA]

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>

[No]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>

[NA]

[NA] 

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> 

[No]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>

[No]
</pre>
<p><a name='114'></a></p>
</div>
<div id="leevan-2016" class="section level4">
<h4><a href='https://doi.org/10.1097/TA.0000000000000950' title='Open publication'>LeeVan
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

"Management of pediatric blunt renal trauma 
A systematic review" 
[Yes]

"Abstract
BACKGROUND..."
[Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>
[Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
[No] 

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
[No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>  
[Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
[Yes] 

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
[Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
[Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
[No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
[No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
[Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span> 
[NA]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>
[NA] 

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
[NA]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
[NA]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
[Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
[Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
[Yes] 

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
[No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
[NA]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>
[NA]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>
[NA]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
[Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> 
[Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
[Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
[No]
</pre>
<p><a name='115'></a></p>
</div>
<div id="liang-2011" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0031-1271733' title='Open publication'>Liang
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item based on the provided systematic review:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Lymphatic Sparing Versus Lymphatic Non-Sparing Laparoscopic Varicocelectomy in Children and Adolescents: A Systematic Review and Meta-Analysis&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span> 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>

[No] No mention of review protocol.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>  

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>

[NA] 

[NA]  

[NA]

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> 

[NA]

[NA] 

[NA] 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
</pre>
<p><a name='116'></a></p>
</div>
<div id="lishuang-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3662-7' title='Open publication'>Lishuang
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic portoenterostomy versus open portoenterostomy for the treatment of biliary atresia: a systematic review and meta-analysis of comparative studies&quot;</span>
The title identifies the report as a systematic review and meta-analysis.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
The abstract provides a structured summary including all applicable elements.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Biliary atresia (BA) is one of the most common reasons for portoenterostomy in pediatric surgery, which is characterized by progressive inflammatory disease of the hepatobiliary system that occurs in about 1/9,000–1/15,000 neonates [1].&quot;</span> 
The introduction describes the rationale for the review in the context of what is already known about biliary atresia.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to include all publicly available data for comparing the safety and validity of laparoscopic portoenterostomy (LPE) and open portoenterostomy (OPE) in the treatment of biliary atresia.&quot;</span>
The objectives provide an explicit statement of the questions being addressed regarding the comparison of LPE and OPE for biliary atresia.

[NA]
No protocol or registration information is provided.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For inclusion in this meta-analysis, the studies had to meet the following criteria: (1) be a cohort study comparing laparoscopic technique and open technique in BA patients undergoing portoenterostomy; (2) include at least one interest datum for analysis—hospital stay, operative time, blood loss, complications, early clearance of jaundice, the rate of long-term survival with native liver; (3) clearly document technique as ‘‘laparoscopic’’ or ‘‘open’’; (4) clearly document indications for portoenterostomy with biliary atresia; (5) be published as a full paper in a journal, not as meeting abstract or review.&quot;</span>
The eligibility criteria are specified including study characteristics and reported outcomes.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conducted a systematic search of the online databases, including Medline, Ovid, Elsevier, Google Scholar Embase, Cohrane library, for studies published between 1995 and 2014 with no limits for publication language, place of study origin and sample size of the studies.&quot;</span>
The information sources are described including databases searched and date ranges. 

[No]
The full electronic search strategy is not presented for any database.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The process of study screening is showed in Fig. 1, through which, eleven studies assessing LPE versus OPE were considered suitable for meta-analysis, including two prospective [21, 22] and nine retrospective [13, 23–30] studies.&quot;</span>
The process of study selection is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two independent authors (QG and ZZ) using a predefined meta-analysis form extracted relevant data from each study which resulted in high and satisfactory interobserver agreement.&quot;</span> 
The data collection process is described including extraction in duplicate.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following data were the outcomes of interest that extracted from each included study: first author, publication year, country, study design, number of patients who underwent LPE or OPE, characteristics of the study population, and end point data (operative times, hospital stay times, rate of conversion from LPE to OPE, re-operation rates, and complications about surgery including: intraoperative blood loss, early clearance of jaundice, cholangitis and variceal bleeding.&quot;</span>
The data items extracted are listed including study details and outcomes.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Newcastle Ottawa Scale (NOS), designed specially for observational studies, was adopted to assess the quality of selected studies [15].&quot;</span>
The methods used for assessing risk of bias are described.

[NA]
No meta-analysis was performed, so summary measures are not applicable. 

[NA] 
No meta-analysis was performed, so synthesis methods are not applicable.

[NA]
No assessment of publication bias is described.

[NA] 
No additional analyses are described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The process of study screening is showed in Fig. 1, through which, eleven studies assessing LPE versus OPE were considered suitable for meta-analysis, including two prospective [21, 22] and nine retrospective [13, 23–30] studies.&quot;</span>
The number of studies screened, assessed, and included is provided along with exclusions and reasons.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The characteristics of these 11 studies are listed in Table 1.&quot;</span>
For each study, characteristics are presented including details like study size and PICOS elements.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The risk of bias was assessed using the Newcastle–Ottawa scale (NOS) for assessing the quality of included studies and is demonstrated in Table 3.&quot;</span>
Risk of bias is presented for each study.

[NA] 
No meta-analysis was performed, so results for individual studies are not applicable.

[NA]  
No meta-analysis was performed, so pooled results are not applicable. 

[NA]
No assessment of risk of bias across studies is applicable without a meta-analysis.

[NA]
No additional analyses were performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Postoperative complications, functional outcomes and liver survival were the primary parameters for the comparison between LPE and OPE.&quot;</span>
The main findings are summarized including outcomes assessed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎First, there have only been a small number of studies comparing LPE with OPE in the treatment of biliary atresia, with a lack of randomized trials.&quot;</span> 
Limitations at the study and outcome level are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on the evidence, we make cautious conclusions that laparoscopic portoenterostomy could not replace open portoenterostomy and open Kasai operation remains the ‘gold standard’ for the treatment of biliary atresia.&quot;</span>
General conclusions are provided in context of other evidence and implications.

[No]
No sources of funding are described.
</pre>
<p><a name='117'></a></p>
</div>
<div id="livingston-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.02.020' title='Open publication'>Livingston
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘missing-squared-brackets-in-numbered-list’</i>
<pre>
P1. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conducted a systematic review to determine if FG and GJ are equally effective for the treatment of gastroesophageal reflux refractory to maximal medical management in children with neurologic impairment.&quot;</span> The report is identified as a systematic review.

P2. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - The abstract provides structured summary with background, objectives, data sources, eligibility criteria, participants, interventions, methods, results, limitations, and conclusions.  

P3. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Children with neurologic impairment often fail medical management of gastroesophageal reflux [1], [2], [3], [4]. Even with maximal therapy, many patients continue to experience symptoms and complications.&quot;</span> The rationale for the review is described.

P4. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conducted a systematic review to determine if FG and GJ are equally effective for the treatment of gastroesophageal reflux refractory to maximal medical management in children with neurologic impairment.&quot;</span> The objective references participants, interventions, and outcomes. 

P5. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span> - A review protocol is not mentioned.

P6. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Eligibility criteria for studies are described including participants (age, diagnoses), interventions (FG and GJ procedures), and study designs (comparative studies).   

P7. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Information sources are described including databases searched with dates of coverage.

P8. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - The full search strategy is presented for one database. 

P9. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - The process of study selection (screening, eligibility, inclusion) is described. 

P10. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Methods of data extraction are described (piloted forms, independently, in duplicate).

P11. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Variables extracted are listed including participants, interventions, and outcomes.

P12. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Methods for risk of bias assessment are described including specification at the study level. 

P13. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Principal summary measures (risk ratio) are stated.

P14. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No meta-analysis was performed.

P15. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No meta-analysis was performed. 

P16. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No meta-analysis was performed.

P17. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Numbers of studies screened, assessed for eligibility, and included are presented with reasons for exclusion and a flow diagram.

P18. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Characteristics of included studies are presented in a table. 

P19. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Data on risk of bias are presented for each study.

P20. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - For all outcomes, results are presented for each study including summary data and effect estimates with confidence intervals. 

P21. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No meta-analysis was performed.

P22. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No meta-analysis was performed.

P23. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> - No meta-analysis was performed. 

P24. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Main findings are summarized including strength of evidence for each outcome and relevance to key groups.

P25. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Limitations are discussed at the study and review level.

P26. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - General interpretation of results is provided in context of other evidence and implications for future research.

P27. <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span> - Sources of funding are described.
</pre>
<p><a name='118'></a></p>
</div>
<div id="mauritz-2013" class="section level4">
<h4><a href='https://doi.org/10.1007/S11605-013-2305-3' title='Open publication'>Mauritz
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the responses for each PRISMA item based on the provided full text:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Complete Versus Partial Fundoplication in Children with Gastroesophageal Reflux Disease: Results of a Systematic Review and Meta-analysis&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span> 

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span> 

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
</pre>
<p><a name='119'></a></p>
</div>
<div id="mauritz-2011" class="section level4">
<h4><a href='https://doi.org/10.1007/S11605-011-1644-1' title='Open publication'>Mauritz
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
 [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Effects and Efficacy of Antireflux Surgery in Children with Gastroesophageal Reflux Disease: A Systematic Review&quot;</span>

[Yes] Abstract provides structured summary with background, objectives, eligibility criteria, interventions, results, conclusions.  

[Yes] Introduction describes rationale in context of existing knowledge.

[NA] No PICOS provided.

[No] No protocol mentioned. 

[Yes] Eligibility criteria described (pediatric patients, ARS, prospective studies).

[Yes] Information sources described (PubMed, Embase, Cochrane).

[No] No full search strategy provided.

[Yes] Study selection process described. 

[No] No data extraction process described.

[No] No list of data items sought.

[No] No risk of bias assessment described.

[NA] No meta-analysis done.

[NA] No meta-analysis done. 

[NA] No meta-analysis done.

[NA] No meta-analysis done.

[Yes] Study selection flow diagram provided.

[Yes] Study characteristics presented in Table 1. 

[No] No risk of bias assessment presented.

[Yes] Results of individual studies presented in tables and text. 

[NA] No meta-analysis done.

[NA] No assessment of bias across studies.

[NA] No additional analyses.

[Yes] Summary of main findings provided.

[Yes] Limitations discussed.

[Yes] General interpretation and implications described.

[Yes] Funding sources described.
</pre>
<p><a name='120'></a></p>
</div>
<div id="mei-2011" class="section level4">
<h4><a href='https://doi.org/10.1089/END.2010.0544' title='Open publication'>Mei
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are my responses for assessing the reporting quality of the systematic review using the PRISMA checklist:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic Versus Open Pyeloplasty for Ureteropelvic Junction Obstruction in Children: A Systematic Review and Meta-Analysis&quot;</span>

1. <span title='Moderate quote deviation. Best match in prompt (Similarity 87%):

: Identify the report as a systematic review, meta-analysis, or both' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]" - "Identify the report as a systematic review, meta-analysis, or both.&quot;</span>

2. <span title='Moderate quote deviation. Best match in prompt (Similarity 87.8%):

: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]" - "Provide structured summary including background, objectives, data sources, methods, results, conclusions.&quot;</span>

3. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 71.2%):

: Describe the rationale for the review in the context of what is already know' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]" - "Describe rationale for review in context of existing knowledge.&quot;</span>  

4. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 64.6%):

: Provide an explicit statement of questions being addressed with reference to partic' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]" - "Provide explicit question statement referring to PICOS.&quot;</span>

5. "[No]" - No mention of review protocol.

6. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 50.6%):

Eligibility criteria: Specify study characteristics' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]" - "Specify eligibility criteria including PICOS and other characteristics.&quot;</span>

7. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.8%):

: Describe all information sources (e.g., databases' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]" - "Describe information sources including databases searched.&quot;</span> 

8. <span title='Moderate quote deviation. Best match in prompt (Similarity 82.1%):

: Present full electronic search strategy for at least one database' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]" - "Present full search strategy for one database.&quot;</span>

9. <span title='Moderate quote deviation. Best match in prompt (Similarity 76.1%):

: State the process for selecting studies (i.e., screening, eligibility, inclu' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]" - "State process of study screening, eligibility, inclusion.&quot;</span> 

10. <span title='Moderate quote deviation. Best match in prompt (Similarity 82.2%):

: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]" - "Describe data extraction, performed independently in duplicate.&quot;</span>

11. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 58.7%):

: List and define all variables' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]" - "List and define variables extracted.&quot;</span>

12. "[NA]" - Not a meta-analysis assessing individual study risk of bias.

13. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 72.2%):

: State the principal summary measures (e.g., risk ratio, difference' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]" - "State principal summary measures like risk ratio and mean difference.&quot;</span> 

14. "[NA]" - Not a meta-analysis so no assessment of combining results.

15. "[NA]" - No assessment of publication bias.

16. "[NA]" - No additional analyses like sensitivity analysis.

17. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 20.3%):

Study selection:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]" - "Provide study selection flow diagram with inclusions/exclusions.&quot;</span>

18. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 38.1%):

, present characteristics' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]" - "Present characteristics of included studies in table.&quot;</span>

19. "[NA]" - Not assessing individual study risk of bias. 

20. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 63.1%):

), present, for each study: (a) simple summary data for each intervention group (b) effect estimates' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]" - "Present summary data and effect estimates for outcomes.&quot;</span>

21. "[NA]" - Not a meta-analysis.

22. "[NA]" - No assessment of risk of bias across studies.

23. "[NA]" - No additional analyses.

24. <span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 52.9%):

: Summarize the main findings in' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]" - "Summarize main findings and implications.&quot;</span>

25. <span title='Moderate quote deviation. Best match in prompt (Similarity 82.5%):

: Discuss limitations at study and outcome level' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]" - "Discuss limitations at study and outcome level.&quot;</span>

26. <span title='Moderate quote deviation. Best match in prompt (Similarity 86.3%):

: Provide a general interpretation of the results in the context of other evidence' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]" - "Provide interpretation of results in context of other evidence.&quot;</span> 

27. <span title='Moderate quote deviation. Best match in prompt (Similarity 79.6%):

: Describe sources of funding for the systematic review' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]" - "Describe sources of funding for review.&quot;</span>
</pre>
<p><a name='121'></a></p>
</div>
<div id="mullassery-2014" class="section level4">
<h4><a href='https://doi.org/10.3109/08880018.2014.947009' title='Open publication'>Mullassery
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Does Aggressive Surgical Resection Improve Survival in Advanced Stage 3 and 4 Neuroblastoma? A Systematic Review and Meta-analysis&quot;</span>

The title identifies the report as a systematic review and meta-analysis.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic review and meta-analysis is reported to address robust evidence for curative “gross total tumor resection” (GTR) in Stage 3 and Stage 4 neuroblastoma.&quot;</span>

The abstract provides a structured summary including background, objectives, eligibility criteria, methods, results, and conclusions.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Neuroblastoma is a challenging disease for pediatric cancer specialists and surgeons. Survival remains poor with greater than 50% of children having widespread metastatic disease at initial clinical presentation.&quot;</span>  

The introduction describes the rationale for the review in context of current knowledge.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We sought to include randomized controlled trials (if available) and observational studies.&quot;</span>

The objectives mention the participants, interventions, outcomes, and study designs of interest.

[No]

No protocol or registration is mentioned.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were included if they reported 5-year survival data for children under 18 years of age with stages 3 and/or 4 neuroblastoma following gross total resection and subtotal resection (STR).&quot;</span>

Eligibility criteria are specified including participants, interventions, and outcomes.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following databases were included in the search - Medline, Embase and Cochrane.&quot;</span>

Information sources including databases and dates are described. 

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Search terms used were: (Neuroblastoma) AND (Surgery OR (gross AND total AND resection) OR (limited AND resection)).&quot;</span>

The full search strategy is presented for at least one database.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were reviewed by PJF and DM independently.&quot;</span> 

The study selection process is described.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were extracted using a custom designed proforma before commencement of the search strategy for first author, publication date, study center institution, time period of study, participant age range, chemotherapy regime, MYCN status, stage, 3 and stage 4 sample size defined by INSS, number of GTR and STR operations performed, 5-year overall survival (OS), 5-year disease free survival, and reported surgical complications.&quot;</span>

Data collection using piloted forms is described. 

[Yes]
<span title='Minor quote deviation. Best match in fulltext (Similarity 98.3%):

Data were extracted using a custom designed proforma before commencement of the search strategy for first author, publication date, study center institution, time period of study, participant age range, chemotherapy regime, MYCN status, stage, 3 and stage 4 sample size defined by INSS, number of GTR and STR operations performed, 5-year overall survival (OS), 5-year disease free survival, and reported surgical complications' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data were extracted [...] for first author, publication date, study center institution, time period of study, participant age range, chemotherapy regime, MYCN status, stage, 3 and stage 4 sample size defined by INSS, number of GTR and STR operations performed, 5-year overall survival (OS), 5-year disease free survival, and reported surgical complications.&quot;</span>

Variables extracted are listed including participants, interventions, outcomes, and study details.

[No]

Individual study risk of bias is not described.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Odds ratios (OR) were calculated with 95% confidence intervals (CI) using Mantel–Haenszel calculations and a random effects model, and summary odds ratio for 5-year survival outcomes.&quot;</span>

Principal summary measures are stated.

[NA]

This is not applicable as no meta-analysis was performed for stage 3 neuroblastoma.

[NA]

Assessment of publication bias is not applicable without a meta-analysis. 

[NA] 

No additional analyses are described.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A flow chart of the study selection process is outlined in Figure 1.&quot;</span>

The study selection process is shown in a flow diagram with exclusions at each stage.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All 15 studies included in the analysis were case series [Citation4–7, Citation14–24, Citation58].&quot;</span> 

Study characteristics are presented with citations.

[No]

Individual study risk of bias is not presented.

[NA]

Results of individual studies are not applicable for a systematic review without a meta-analysis.

[NA] 

Results of meta-analyses are not applicable as none were done for stage 3.

[NA]

Assessment of risk of bias across studies is not applicable without a meta-analysis.

[NA]

No additional analyses are described. 

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Findings strongly showed that there was a significantly improved 5 year survival achieved following GTR in stage 3 neuroblastoma.&quot;</span>

The main findings and strength of evidence are summarized.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although the inclusion of such studies may reduce concerns about publication bias (as the decision to publish was unrelated to the outcome with respect to the surgical procedure) the findings nonetheless highlight the few reports in the neuroblastoma literature that have specifically examined survival outcome metrics following GTR or STR.&quot;</span>

Limitations at the study and outcome level are discussed.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We believe a prospective well-designed randomized trial incorporating patient age, tumor site and elements of tumor biology (MYCN, DNA ploidy status, etc.) is needed to fully address the role of surgery in stage 4 neuroblastoma.&quot;</span> 

Conclusions and implications for future research are provided.

[No]

No sources of funding are described.
</pre>
<p><a name='122'></a></p>
</div>
<div id="nagler-2011" class="section level4">
<h4><a href='https://doi.org/10.1002/14651858.CD001532.pub4' title='Open publication'>Nagler
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: Identify the report as a systematic review, meta-analysis, or both. 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Interventions for primary vesicoureteric reflux&quot;</span>

The title identifies the report as a systematic review.

[Yes]

P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.

The abstract provides a structured summary with background, objectives, data sources, eligibility criteria, participants, interventions, study appraisal methods, results, limitations, and conclusions. 

[Yes]

P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Vesicoureteric reflux (VUR) results in urine passing retrograde up the ureter. Urinary tract infections (UTI) associated with VUR have been considered a cause of permanent renal parenchymal damage in children with VUR.&quot;</span>

The introduction describes the rationale for the review in the context of what is already known about VUR and its association with UTI and renal damage.

[Yes]

P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this review was to evaluate the available evidence for both benefits and harms of the currently available treatment options for primary VUR: operative, non-operative or no intervention.&quot;</span>

The objectives are stated with reference to participants, interventions, comparisons, and outcomes. 

[Yes]

P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.

No mention of a review protocol.

[No]

P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.

The methods section specifies eligibility criteria including study design, participants, interventions, and outcomes. Rationale is provided. No restrictions on language or publication status.

[Yes] 

P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched. 

The sources of information are described including databases searched with dates, conference proceedings, reference lists, authors contacted, and date last searched.

[Yes]

P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.

The full search strategy for one database is provided in the appendix.

[Yes]

P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).

The process for study selection, including initial screening, assessment of eligibility, and inclusion is described.

[Yes] 

P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.

The data extraction process is described, including use of a standardized form, completion by at least two authors independently, and contacting authors for additional data as needed.

[Yes]

P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.

The outcomes for which data were extracted are listed and defined in the criteria for considering studies section. No other variables are mentioned.

[Yes]

P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.

The risk of bias assessment method is described including the domains assessed and that it was done at the study level. Its use in data synthesis is not specified. 

[Yes]

P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).

The principal summary measures are stated as risk ratio and mean difference.

[Yes]

P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.

[NA]

P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).  

[NA]

P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.

Planned sensitivity analysis based on study quality and subgroup analysis are described.

[Yes]

P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.

The number of studies screened, assessed for eligibility, and included is provided with reasons for exclusions and a flow diagram. 

[Yes]

P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.

Study characteristics including sample size, participants, interventions, comparisons, outcomes, and follow-up periods are presented in text and tables for each included study.

[Yes]

P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).

The risk of bias assessment for each study is presented in text, figures, and a summary table. Outcome level assessment is not mentioned.

[Yes] 

P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.

For relevant outcomes, results are presented in text and analyzed with summary estimates and confidence intervals in forest plots.

[Yes]

P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.

[NA]

P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15). 

[NA]

P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).

[NA]

P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).

The main findings are summarized including strength of evidence. Relevance to healthcare providers is considered.

[Yes]

P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).

Limitations are discussed at the study, outcome, and review levels.

[Yes]

P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.

General conclusions are made in the context of other evidence, and implications for future research are discussed.

[Yes]

P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.

Sources of funding and other support are described; no role of funders is mentioned.

[Yes]
</pre>
<p><a name='123'></a></p>
</div>
<div id="narayanan-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2013.07.020' title='Open publication'>Narayanan
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the assessments for the PRISMA items:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Hepaticoduodenostomy versus hepaticojejunostomy after resection of choledochal cyst: A systematic review and meta-analysis&quot;</span>
[Yes] The title identifies the report as a systematic review and meta-analysis.

2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
[Yes] The abstract provides a structured summary with background, objectives, data sources, eligibility criteria, participants, interventions, synthesis methods, results, conclusions.

3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Excision has been established as a standard management practice for choledochal cysts in the last few decades.&quot;</span> 
[Yes] The introduction describes the rationale for the review in the context of current knowledge.

4. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
[No] The introduction does not provide an explicit PICOS statement.

5. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
[No] The methods do not indicate if a review protocol exists or is registered.

6. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
[Yes] The eligibility criteria specify study and report characteristics including follow-up period, language, and publication status. 

7. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
[Yes] The information sources section describes the databases searched with coverage dates and the last date searched.

8. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span> 
[No] The search strategy is not provided.

9. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
[Yes] The study selection process including screening, eligibility assessment, and inclusion is described.

10. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
[Yes] The data collection process describes data extraction by independent reviewers. 

11. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
[Yes] The data items section lists the variables extracted.

12. "[NA]" There is no assessment of individual study bias.

13. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
[Yes] The analysis methods state the summary measures used including odds ratios and mean differences.

14. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span> 
[Yes] The synthesis methods describe pooling data using fixed and random effects models and assessing heterogeneity with I2.

15. "[NA]" No assessment of publication bias is mentioned.

16. "[NA]" No additional analyses are reported. 

17. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
[No] The number of studies screened, assessed, and included is provided but without a flow diagram.

18. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
[Yes] A table summarizes the characteristics of the included studies.

19. "[NA]" Individual study bias is not assessed.

20. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
[Yes] For each outcome, data for each intervention and group comparisons with forest plots are presented.

21. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
[Yes] The results present meta-analysis findings with confidence intervals and heterogeneity measures.

22. "[NA]" Publication bias is not assessed.

23. "[NA]" No additional analyses were performed.

24. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
[Yes] The discussion summarizes the main findings and considers their relevance.

25. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
[Yes] The limitations section discusses limitations at the study and review levels.

26. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
[Yes] The conclusion interprets the results in the context of other evidence and suggests future research.

27. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
[No] Sources of funding and support are not described.
</pre>
<p><a name='124'></a></p>
</div>
<div id="nasr-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2010.02.012' title='Open publication'>Nasr
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes, reasoning, and assessments for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Comparison of the Nuss and the Ravitch procedure for pectus excavatum repair: a meta-analysis&quot;</span>
The title identifies the report as a meta-analysis.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>  
The abstract provides a structured summary with all key elements.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 98.3%):

Pectus excavatum is the most common congenital chest wall abnormality occurring in 8 per 1000 live births. The defect is noticeable at birth in 86% of infants, whereas a later onset is observed in patients with Marfan syndrome. The indications for repair of pectus excavatum are essentially cosmetic [1], [2], [3], [4' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Pectus excavatum is the most common congenital chest wall abnormality in children. The indications for repair of pectus excavatum are essentially cosmetic [1], [2], [3], [4].&quot;</span>
The introduction describes the rationale in context of existing knowledge.  

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our objective was to compare the Nuss procedure to the Ravitch procedure using systematic review and meta-analysis methodology.&quot;</span>
The objectives state the focus on comparing the Nuss and Ravitch procedures.

[No] No mention of a review protocol.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Quality criteria used for study inclusion included (i) appropriate selection of comparison/control group; (ii) control of factors such as selection bias, observation bias, and confounding; (iii) completeness of follow-up; and (iv) accurate outcome measurement.&quot;</span>
The eligibility criteria for studies are provided.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All publications describing both surgical procedures for pectus excavatum were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials (CENTRAL) database. All studies were identified through electronic searches of MEDLINE (1966 onward), EMBASE (1980 onward), and CINAHL (1982 onward) and from hand-searching journals and conference proceedings.&quot;</span>
The information sources are described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The terms pectus excavatum, Ravitch, and Nuss were mapped to their MeSH terms and then combined.&quot;</span>
The search strategy is provided for one database. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors (AN and PW) independently extracted data from the retrieved articles.&quot;</span> 
The study selection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors (AN and PW) independently extracted data from the retrieved articles.&quot;</span>
The data collection process is described.  

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We included all studies that reported on one or more of these outcomes.&quot;</span> 
The outcomes of interest are listed.

[NA] No assessment of risk of bias in individual studies.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎The principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
The summary measures are stated.

[NA] No meta-analysis was performed. 

[NA] No assessment of risk of bias across studies.

[NA] No additional analyses were performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Nine prospective and retrospective studies were identified and were included in this study [3], [4], [5], [6], [7], [8], [9], [10], [11].&quot;</span> 
The number of studies screened and included is provided.

[Yes] Table 1 provides the characteristics of the included studies.

[NA] No assessment of risk of bias within studies. 

[Yes] The results section provides summary data and effect estimates for the outcomes.

[NA] No meta-analysis was performed.

[NA] No assessment of risk of bias across studies. 

[NA] No additional analyses were performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results suggest no differences between the Nuss procedure vs the Ravitch procedure with respect to overall complications, length of hospital stay, and time to ambulation.&quot;</span>
The main findings are summarized including the strength of evidence.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta-analysis was originally designed to compare outcomes of randomized trials. It is possible to perform meta-analysis for observational studies, but the risk of contamination from bias and confounding is increased.&quot;</span>
Limitations at the study and review level are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎It may be that based on the current pattern of practice, a randomized controlled trial comparing these 2 surgical approaches can never be done.&quot;</span> 
Conclusions are provided in context of other evidence.

[No] No mention of sources of funding.
</pre>
<p><a name='125'></a></p>
</div>
<div id="nasr-2013" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0033-1347916' title='Open publication'>Nasr
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the assessments for the 27 PRISMA items based on the provided full text:

[No] The title does not identify the report as a systematic review or meta-analysis. The title is <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mechanical Traction Techniques for Long-Gap Esophageal Atresia: A Critical Appraisal&quot;</span>.

[Yes] The abstract provides a structured summary including background, objectives, data sources, eligibility criteria, methods, results, and conclusions. 

[Yes] The introduction describes the rationale for the review in the context of current knowledge about long-gap esophageal atresia.

[Yes] The objectives state the questions being addressed regarding participants, interventions, comparisons, and outcomes. 

[NA] This is not a protocol paper so registration is not applicable.

[Yes] The eligibility criteria specify study characteristics and report characteristics used for inclusion.

[Yes] The information sources section describes the databases searched and date last searched.

[No] A full electronic search strategy is not presented for any database. 

[Yes] The study selection process including screening, eligibility, and inclusion is described.

[No] Details on data extraction like use of forms or independent extraction are not provided.

[Yes] Variables extracted are listed including PICOS and other relevant items. 

[No] Methods for assessing risk of bias of individual studies are not described.

[Yes] The principal summary measures are stated.

[NA] This review did not include a meta-analysis.

[NA] Assessment of risk of bias across studies is not applicable without a meta-analysis.

[NA] No additional analyses like sensitivity analyses were done.

[Yes] Numbers of studies screened, assessed, included, and excluded are provided with reasons.

[Yes] Study characteristics are presented in tables.

[No] Risk of bias within individual studies is not presented.

[No] Simple summary data and effect estimates for each study are not presented for the outcomes.

[NA] No meta-analysis was done.

[NA] Assessment of bias across studies is not applicable without a meta-analysis. 

[NA] No additional analyses were done.

[Yes] The evidence is summarized and relevance discussed.

[Yes] Limitations at the study and outcome level are discussed.

[Yes] General interpretation of results in context of other evidence is provided.

[No] Sources of funding are not described.
</pre>
<p><a name='126'></a></p>
</div>
<div id="nataraja-2013" class="section level4">
<h4><a href='https://doi.org/10.1089/lap.2012.0522 ' title='Open publication'>Nataraja
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Incidence of Intraabdominal Abscess Formation Following Laparoscopic Appendicectomy in Children: A Systematic Review and Meta-analysis&quot;</span>

[Yes] Includes structured summary with background, objectives, data sources, eligibility criteria, methods, results, conclusions.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>

[No] Protocol and registration not mentioned. 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>

[NA] Meta-analysis not performed.

[NA] Meta-analysis not performed. 

[NA] Meta-analysis not performed.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>

[No] Risk of bias within studies not presented.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>

[NA] Meta-analysis not performed. 

[NA] Meta-analysis not performed.

[NA] Meta-analysis not performed.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>

[No] Funding sources not described.
</pre>
<p><a name='127'></a></p>
</div>
<div id="nicolau-2011" class="section level4">
<h4><a href='https://doi.org/pmid:21520776' title='Open publication'>Nicolau
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Is laparoscopy still needed in blunt abdominal trauma?&quot;</span>

P2. [No] No structured summary is provided. 

P3. [Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

Laparoscopia diagnosticã æi terapeuticã în contuziile abdomi-
nale (CA) are o utilizare limitatã æi chiar controversatã,
datoritã în special progreselor fãcute de explorãrile imagistice
actuale' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Laparoscopy diagnosticã æi terapeuticã în contuziile abdomi-nale (CA) are o utilizare limitatã æi chiar controversatã, datoritã în special progreselor fãcute de explorãrile imagistice actuale.&quot;</span>

P4. [No] The objectives are not explicitly stated in PICOS format.

P5. [NA] A review protocol is not mentioned.

P6. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Articolele de chirurgie infantilã, cele referitoare la plãgile abdominale, urgenåele abdominale nontraumatice, leziunile iatrogene au fost excluse.&quot;</span>

P7. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Am efectuat un studiu al articolelor publicate asupra rolului laparoscopiei în CA în Pubmed æi Medline în perioada ianuarie 2000 - decembrie 2007.&quot;</span> 

P8. [No] A full electronic search strategy is not provided.

P9. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Am evaluat 66 de articole care au inclus 22 de studii clinice, 27 prezentãri de cazuri, 17 puneri la punct (“review”), 2 ghiduri.&quot;</span>

P10. [No] The data collection process is not described.

P11. [No] The data items collected are not explicitly listed.  

P12. [NA] Risk of bias assessment is not mentioned.

P13. [NA] Summary measures are not applicable.

P14. [NA] Methods for combining study results are not described.

P15. [NA] Assessment of risk of bias across studies is not applicable.   

P16. [NA] No additional analyses are mentioned.

P17. [No] A flow diagram of study selection is not provided.

P18. [No] Key characteristics of included studies are not presented.

P19. [NA] Risk of bias within studies is not discussed.

P20. [No] Results of individual studies are not presented.

P21. [NA] Results of meta-analyses are not applicable. 

P22. [NA] Assessment of bias across studies is not applicable.

P23. [NA] Additional analyses are not mentioned.

P24. [Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):

În concluzie, deæi puåin utilizatã, dovada fiind æi
numãrul redus de articole publicate, laparoscopia poate fi utilã
la pacienåii cu CA atent selectaåi cu examen clinic æi imagis-
ticã echivoce în scopul reducerii incidenåei laparotomiilor
inutile' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎În concluzie, deæi puåin utilizatã, dovada fiind æi numãrul redus de articole publicate, laparoscopia poate fi utilã la pacienåii cu CA atent selectaåi cu examen clinic æi imagisticã echivoce în scopul reducerii incidenåei laparotomiilor inutile.&quot;</span> 

P25. [No] Study limitations are not discussed.

P26. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studii multicentrice prospective sunt necesare pentru a contura mai precis rolul laparoscopiei în CA.&quot;</span>

P27. [No] Sources of funding are not reported.
</pre>
<p><a name='128'></a></p>
</div>
<div id="oliveira-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2015.10.003' title='Open publication'>Oliveira
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Neophalloplasty in boys with aphallia: A systematic review&quot;</span>
P2. [No] No structured abstract provided.
P3. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this systematic review was to assess all available literature on neophalloplasty in infancy with an interest in technical alternatives and clinical outcome.&quot;</span>  
P4. [No] No explicit PICOS statement provided.
P5. [No] No mention of a protocol or registration.
P6. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a Pubmed search using the terms: neophalloplasty, neophallus, and phalloplasty, and selected articles that presented technical alternatives for penile construction in cases of penile dysgenesis, especially aphallia in children and/or adolescents.&quot;</span>
P7. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a Pubmed search using the terms: neophalloplasty, neophallus, and phalloplasty, and selected articles that presented technical alternatives for penile construction in cases of penile dysgenesis, especially aphallia in children and/or adolescents.&quot;</span>
P8. [No] No full search strategy provided. 
P9. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Finally, we selected articles that presented technical alternatives for penile construction in cases of penile dysgenesis, especially aphallia in children and/or adolescents.&quot;</span>
P10. [No] No mention of data collection process.
P11. [No] No explicit mention of data items collected.
P12. [No] No mention of risk of bias assessment. 
P13. [NA] 
P14. [NA]
P15. [NA]
P16. [NA]  
P17. [No] No flow diagram of study selection.
P18. [Yes] Table 1 provides study characteristics.
P19. [No] No assessment of risk of bias.
P20. [No] No presentation of results of individual studies.
P21. [NA]  
P22. [NA]
P23. [NA]
P24. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In assessing recent literature, it seems rational that neophalloplasty should be regarded as the preferred strategy for boys born with aphallia, in opposition to female gender assignment.&quot;</span>
P25. [No] No discussion of limitations.
P26. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Controversy remains with regards to the role of neophalloplasty to provide self-sexual pleasure or indirect pleasure by allowing the partner to experience a normal sexual relationship. This is an open question and only future psychological evaluation of this population will answer this.&quot;</span>
P27. [No] No mention of funding sources.
</pre>
<p><a name='129'></a></p>
</div>
<div id="oomen-2012" class="section level4">
<h4><a href='https://doi.org/10.1007/S00464-012-2174-Y' title='Open publication'>Oomen
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for the 27 PRISMA items:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Hypertrophic Pyloric Stenosis: A Systematic Review and Meta-Analysis Focusing on Major Complications&quot;</span>
The title identifies the report as a systematic review and meta-analysis.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
The abstract provides a structured summary covering all applicable elements.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The surgical treatment of choice in the last century has been the longitudinal splitting of the seromuscular layer of the pylorus without suturing, which is defined as “pyloromyotomy.” The constriction is relieved and allows normal passage of stomach contents into the duodenum.&quot;</span> 
The introduction describes the rationale in context of existing knowledge.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Therefore, the aim of this study was to compare the results of LP and open pyloromyotomy (OP) by means of a systematic review of the available randomized trials while focusing on major complications (i.e., incomplete pyloromyotomy, perforation, and need for re-operation).&quot;</span>
The objectives explicitly state the focus on major complications. 

[NA]
A review protocol is not mentioned.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were included in the review if they were RCTs that compared the results of LP and OP in children with HPS with admission time after pyloromyotomy and postoperative complication rate as outcomes.&quot;</span>
Study eligibility criteria are specified.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Retrieval of studies was performed through a systematic search of the databases PubMed, Ovid (Ovid Technologies, New York, NY) and Cochrane (Cochrane database of systematic reviews).&quot;</span> 
Databases searched are described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Keywords and medical subject heading (MeSH) terms used were “pyloric stenosis,” “pyloromyotomy,” “comparative studies,” “open,” “laparoscopic,” and “postoperative complications.”&quot;</span>
Full search strategy is presented for at least one database.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Potentially eligible studies were reviewed independently by two authors (MWNO, RB) for inclusion and exclusion criteria.&quot;</span>
Study selection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From the included studies, data on setting, methodological quality [according to the Cochrane handbook for systematic reviews of interventions (http://dcc.cochrane.org/sites/dcc.cochrane.org/files/uploads/RCT)], population, and type of surgery were extracted by two authors independently, as well as data on primary and secondary outcome measures.&quot;</span>
Data collection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was major postoperative complications (i.e., incomplete pyloromyotomy, perforation, and need for reoperation). Secondary outcomes were time to full feed, postoperative hospital stay, and any other postoperative complications.&quot;</span>
Outcomes for which data were sought are listed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Quality check of all RCTs&quot;</span>
Table 2 assesses risk of bias in included studies. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary outcome was major postoperative complications&quot;</span>
Major complications are appropriate summary measures for the primary outcome.

[Yes] 
Results of meta-analyses are presented with confidence intervals and measures of consistency.

[NA]
No assessment of risk of bias across studies is mentioned.

[NA]
No additional analyses are mentioned. 

[Yes] 
The flow diagram depicts numbers of studies screened, assessed, and included with reasons for exclusion. 

[Yes] 
Table 1 presents key characteristics of included studies.

[Yes] 
Table 2 and the results section summarize risk of bias within studies.

[Yes]
Figures 2 and 3 present summary data and effect estimates for primary and secondary outcomes. 

[Yes] 
Figure 4 presents meta-analysis results for time to full feeding.

[NA]
No assessment of bias across studies is presented.

[NA] 
No additional analyses are presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In our systematic review of high-level evidence, LP was found to be superior to OP with respect to a shorter time to full feed but not regarding (major) postoperative complications or length of hospital stay.&quot;</span>
Main findings are summarized.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎However, in our opinion, there are some shortcomings in their results.&quot;</span> 
Limitations at the review level are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In this systematic review we summarized all RCTs available in the pediatric surgical literature, focusing mainly on major complications that need surgical reintervention in patients with HPS. However, our results show no clear benefit of the laparoscopic procedure over the open operation.&quot;</span> 
Conclusions in context of other evidence and implications are provided.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Disclosures: Dr. M. W. N. Oomen, Dr. L. T. Hoekstra, Dr. R. Bakx, Dr. D. T. Ubbink, and Prof. Dr. H. A. Heij have no conflicts of interest or financial ties to disclose.&quot;</span>
Sources of support are described.
</pre>
<p><a name='130'></a></p>
</div>
<div id="parolini-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.10.043' title='Open publication'>Parolini
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. <span title='Minor quote deviation. Best match in fulltext (Similarity 97.5%):

he management of newborns with esophageal atresia and right aortic arch: A systematic review or still unsolved problem' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[The management of newborns with esophageal atresia and right aortic arch: A systematic review or still unsolved problem]&quot;</span>
[Yes] Identifies as a systematic review in title.

P2. [NA] No abstract provided.

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study provides a systematic review of epidemiology, diagnosis, management and short-term results of children with EA and RAA.&quot;</span>  
[Yes] Describes rationale for review.

P4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Aim of the study: The management of newborns with esophageal atresia (EA) and right aortic arch (RAA) is still an unsolved problem.&quot;</span>
[Yes] Specifies participants, condition, and aim. 

P5. [No] Does not mention protocol or registration.

P6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were English language articles reporting original data on epidemiology, diagnosis and treatment of newborns with EA.&quot;</span>
[Yes] Specifies eligibility criteria.

P7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PubMed database was searched for original studies on children with EA and RAA.&quot;</span> 
[Yes] Specifies information sources.

P8. [No] Does not provide full search strategy.

P9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The full text of the selected articles was examined.&quot;</span>
[Yes] States process for study selection.

P10. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In each study, data were extracted for the following outcomes: number of patients, associated anomalies, type of surgical repair, morbidity and mortality rate.&quot;</span>
[Yes] Describes data collection process.

P11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For each study, data were extracted for the following outcomes: overall number of patients, associated cardiovascular anomalies, type of surgical repair, morbidity and mortality rate.&quot;</span>
[Yes] Lists variables extracted.

P12. [No] Does not describe risk of bias assessment. 

P13. [No] Does not state summary measures.

P14. [NA] No quantitative synthesis performed.

P15. [NA] No assessment of bias across studies.

P16. [NA] No additional analyses reported.

P17. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eight studies were selected, including 54 patients with EA and RAA.&quot;</span> 
[Yes] Reports numbers of studies screened and included.

P18. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All were single-institution, retrospective studies, case reports or case series.&quot;</span>
[Yes] Describes characteristics of included studies. 

P19. [No] Does not assess risk of bias within studies.

P20. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In these patients, primary anastomosis was achieved through the right approach in 3 (thoracotomy in 2 and thoracoscopy in 1) while the left approach was the primary choice in 4 (thoracotomy in 2 and thoracoscopy in 2).&quot;</span>
[Yes] Presents results for each study.

P21. [NA] No quantitative synthesis performed.

P22. [NA] No assessment of bias across studies.

P23. [NA] No additional analyses presented.

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A multicenter, prospective randomized study is strongly required.&quot;</span>
[Yes] Provides interpretation of results.

P25. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review had some inherent limitations.&quot;</span> 
[Yes] Discusses limitations.

P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A multicenter prospective study comparing RT and LT in infants with EA and RAA is strongly required.&quot;</span>
[Yes] Provides conclusions.

P27. [No] Does not describe sources of funding.
</pre>
<p><a name='131'></a></p>
</div>
<div id="parolini-2014" class="section level4">
<h4><a href='https://doi.org/10.1016/J.IJPORL.2014.04.011' title='Open publication'>Parolini
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item based on the provided full text:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[Cervical/thoracotomic/thoracoscopic approaches for H-type congenital tracheo-esophageal fistula: A systematic review]&quot;</span> - The title identifies the report as a systematic review. [Yes]

P2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> - The abstract provides a structured summary. [Yes] 

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Aim of this systematic review is to investigate the thoracic and cervical surgical approaches of H-type tracheo-esophageal fistula (TEF) according to the position of the fistula.&quot;</span> - The rationale for the review is described. [Yes]

P4. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> - No explicit PICOS statement is provided. [No]

P5. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span> - No review protocol is mentioned. [No] 

P6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible study designs were cohort, case report, case series and review.&quot;</span> - Study characteristics used as eligibility criteria are specified. [Yes]

P7. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

The PubMed database (http://www.ncbi.nlm.nih.gov/pubmed/

) was searched for studies on treatment of H-type TEF that were published since January 1977' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The PubMed database (http://www.ncbi.nlm.nih.gov/pubmed/) was searched for studies on treatment of H-type TEF that were published since January 1977.&quot;</span> - The information source and date last searched are described. [Yes]

P8. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following keywords were searched individually or in association: isolated trachea-esophageal fistula, H-type tracheo-esophageal fistula, N-type tracheo-esophageal fistula, cervicotomy, thoracoscopy and thoracotomy.&quot;</span> - The full search strategy is not provided. [No]

P9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Titles and abstracts of identified publications were checked and reviewed against the predefined inclusion criteria, and afterward, the full text the articles were similarly assessed for eligibility.&quot;</span> - The study selection process is described. [Yes] 

P10. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two independent authors extracted information related to the study.&quot;</span> - The data collection process is described. [Yes] 

P11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For each study, data were extracted for three primary outcomes and many secondary outcomes.&quot;</span> - The variables extracted are listed. [Yes]

P12. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Methodological quality of the studies was assessed with the level of evidence and the strength of guideline recommendations in diagnosis scales.&quot;</span> - Methods for assessing risk of bias are described. [Yes] 

P13. "The principal summary measures (e.g., risk ratio, difference in means) are not applicable for this systematic review without meta-analysis. [NA]

P14. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span> Not applicable, as no meta-analysis was performed. [NA]

P15. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span> Not assessed. [NA]

P16. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span> No additional analyses mentioned. [NA]

P17. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study selection process is presented in Fig. 1.&quot;</span> - A flow diagram of study selection is provided. [Yes]

P18. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> - Study characteristics and citations are provided in tables. [Yes]

P19. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Methodological quality of the studies was assessed with the level of evidence and the strength of guideline recommendations in diagnosis scales.&quot;</span> - Individual study risk of bias is assessed. [Yes]

P20. <span title='Minor quote deviation. Best match in fulltext (Similarity 97.7%):

For the thoracoscopic group all the five eligible studies [24], [25], [26], [27], [28] included the primary outcom' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎For the thoracoscopic group all the five eligible studies included the primary outcome.&quot;</span> - Results for each study are presented. [Yes]

P21. Not applicable as no meta-analysis was performed. [NA]

P22. Not assessed. [NA] 

P23. No additional analyses mentioned. [NA]

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The evidence base in regard to the treatment of H-type fistula in children is poor and the skills and preferences of the surgeons guide the choice of the procedure.&quot;</span> - A summary of evidence is provided. [Yes]

P25. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review had some inherent limitations.&quot;</span> - Study and review limitations are discussed. [Yes]

P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Further well-designed, prospective studies which take into account selection and performance bias, and the issue of confounding are strongly required.&quot;</span> - Implications for future research are described. [Yes]

P27. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors have no financial relationships relevant to this article to disclose.&quot;</span> - Sources of funding are reported. [Yes]
</pre>
<p><a name='132'></a></p>
</div>
<div id="peters-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2012.11.049' title='Open publication'>Peters
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘wrong-response-partial-unclear-etc’</i>
<pre>
Here is the assessment for the 27 PRISMA items based on the provided full text:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[Morbidity and mortality in total esophagogastric dissociation: A systematic review☆]&quot;</span> - Identifies as a systematic review in title. [Yes]

P2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> - Provides structured abstract with background, objectives, methods, results and conclusions. [Yes]

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Background/Purpose: Total esophagogastric dissociation has been described as both a primary and a rescue procedure for patients with severe gastroesophageal reflux.&quot;</span> - Describes rationale and context. [Yes] 

P4. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> - Does not provide explicit PICOS statement. [No]

P5. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span> - Does not mention protocol or registration. [No]

P6. <span title='Minor quote deviation. Best match in fulltext (Similarity 95.7%):

ed. Series were updated where possible by personal communication with the author. Patient characteristics, indications, morbidity, and mortality were analyzed' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Methods: Series were updated where possible by personal communication with the author. Patient characteristics, indications, morbidity, and mortality were analyzed.&quot;</span> - Specifies criteria for eligibility. [Yes]

P7. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span> - Describes information sources including databases, personal communication, and institutional data. [Yes]

P8. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span> - Does not provide full search strategy. [No]  

P9. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> - Does not describe screening or selection process. [No]

P10. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span> - Does not describe data extraction or collection process. [No] 

P11. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span> - Specifies data items as patient characteristics, indications, morbidity and mortality. [Yes]

P12. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span> - Does not assess risk of bias. [No]

P13. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span> - Does not state summary measures. [No]

P14. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span> - Does not perform meta-analysis. [NA]

P15. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span> - Does not assess risk of bias across studies. [No] 

P16. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span> - Does not perform additional analyses. [NA]

P17. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span> - Gives number of studies included but not screened or assessed, no flow diagram. [No]

P18. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> - Presents some characteristics like number of patients and citations. [Partial Yes <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P19. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span> - Does not present risk of bias. [No]

P20. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> - Presents summary data but not effect estimates or forest plots. [Partial Yes <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P21. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span> - Does not perform meta-analysis. [NA] 

P22. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span> - Does not assess risk of bias across studies. [No]

P23. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span> - Does not perform additional analyses. [NA]

P24. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> - Summarizes main findings and compares to other evidence. [Yes]

P25. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> - Does not discuss limitations. [No]

P26. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span> - Provides interpretation and implications. [Yes]

P27. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span> - Does not describe funding or support. [No]
</pre>
<p><a name='133'></a></p>
</div>
<div id="peycelon-2014" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0034-1396419' title='Open publication'>Peycelon
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here is the assessment of reporting quality against the PRISMA 2009 checklist for the given systematic review:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally Invasive Surgery in Childhood Cancer: A Challenging Future&quot;</span>

P1. [Yes] - <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive surgery in childhood cancer: a challenging future&quot;</span> 

P2. [No] - No structured abstract provided.

P3. [Yes] - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known&quot;</span>

P4. [No] - No explicit statement of questions / objectives. 

P5. [No] - No mention of protocol or registration.

P6. [No] - No mention of eligibility criteria.

P7. [No] - No description of information sources.

P8. [No] - No presentation of search strategy.

P9. [No] - No description of study selection process. 

P10. [No] - No description of data collection process.

P11. [No] - No list of data items collected.

P12. [NA] 

P13. [NA]

P14. [NA] 

P15. [NA]

P16. [NA]

P17. [No] - No flow diagram of study selection.

P18. [No] - No characteristics of included studies provided.

P19. [NA] 

P20. [No] - No presentation of individual study results.

P21. [NA]

P22. [NA] 

P23. [NA]

P24. [No] - No summary of evidence.

P25. [No] - No discussion of limitations.

P26. [Yes] - <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>

P27. [No] - No mention of funding sources.

In summary, this review lacks many key components of a systematic review based on the PRISMA checklist. The reporting quality is poor.
</pre>
<p><a name='134'></a></p>
</div>
<div id="pfistermuller-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2014.12.006' title='Open publication'>Pfistermuller
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

[No] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta-analysis of complication rates of the tubularized incised plate (TIP) repair&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To determine overall complication rates of the tubularized incised plate (TIP) repair and assess the effects of technical modifications, length of follow-up and geographical location of reported results.&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Over 300 methods of surgical repair have been described for the correction of hypospadias, with no one procedure accepted as the gold standard for each degree of hypospadias.&quot;</span>

[No]

[NA] 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎degree of hypospadias (classified by meatal location: distal – midshaft distally, proximal – proximal shaft proximally); primary or secondary repair&quot;</span> 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Medline and Pubmed were searched in order to identify articles published between 1994 and 2012.&quot;</span>

[No]

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following data were extracted independently from each article by two reviewers (K.P and P.C): study size; degree of hypospadias (classified by meatal location: distal – midshaft distally, proximal – proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The methods of assessing complications varied between papers; 38 evaluated with history and clinical examination, six with a flow rate and five with urethral calibration.&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎degree of hypospadias (classified by meatal location: distal – midshaft distally, proximal – proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.&quot;</span>

[NA]

[NA]

[NA] 

[NA]

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of the 189 studies identified, only 49 (4675 patients) [14], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64] fulfilled the inclusion criteria&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table. Mean follow-up duration and percentage incidence of complications, and total number of patients assessed from the studies reviewed for each degree of hypospadias.&quot;</span>

[NA]

[NA]

[NA]

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Fistula rates were significantly higher in secondary repairs (mean 15.5%, range 12.1–19.6%) compared to primary proximal (mean 10.3%, range 6.3–16.3%) and primary distal (mean 5.7%, range 4.0–8.2%) (P = 0.005).&quot;</span>

[NA]

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A significant limitation of the present analysis was the comparison of pooled estimates from cohorts.&quot;</span> 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Experience so far with the TIP repair has shown that modifications have reduced the complications.&quot;</span>

[No]
</pre>
<p><a name='135'></a></p>
</div>
<div id="puligandla-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.09.010' title='Open publication'>Puligandla
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[Management of congenital diaphragmatic hernia: A systematic review from the APSA outcomes and evidence based practice committee]&quot;</span>  
The title identifies the report as a systematic review. [Yes]

P2. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
The abstract provides a structured summary covering all key elements. [Yes]

P3. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>
The introduction describes the rationale for the review. [Yes]  

P4. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
Six specific questions are listed regarding interventions and outcomes in CDH patients. [Yes]

P5. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
No review protocol is mentioned. [No]

P6. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
Inclusion and exclusion criteria for studies are described. [Yes]

P7. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
Databases searched are listed with date ranges. [Yes]

P8. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
Search strategies are not provided. [No]

P9. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> 
The process for study screening and selection is described. [Yes]

P10. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
The data extraction process is not described. [No]

P11. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
Outcomes extracted from studies are listed in tables. [Yes]

P12. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
Formal risk of bias assessment is not described. [No]

P13. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
Not applicable. [NA]

P14. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>  
Not applicable. [NA]

P15. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
Not applicable. [NA] 

P16. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
Not applicable. [NA]

P17. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
A flow diagram of study selection is provided. [Yes]

P18. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> 
Key characteristics and citations for included studies are provided in tables. [Yes]

P19. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
Risk of bias assessment is not presented. [No]

P20. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
Outcome data are summarized for each study in tables. [Yes]  

P21. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span> 
Not applicable. [NA]

P22. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>
Not applicable. [NA]

P23. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>
Not applicable. [NA]  

P24. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
The discussion summarizes the main findings and evidence quality. [Yes]

P25. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
Study limitations are discussed. [Yes]

P26. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>  
Results are interpreted in the context of current evidence. Implications for future research are discussed. [Yes]

P27. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
No funding sources are reported. [No]
</pre>
<p><a name='136'></a></p>
</div>
<div id="reddy-2010" class="section level4">
<h4><a href='https://doi.org/10.4103/0970-1591.74459' title='Open publication'>Reddy
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘wrong-response-partial-unclear-etc’</i>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[URS is safe and efficacious in the management of pediatric urolithiasis.]&quot;</span> The title identifies the paper as a review on URS for pediatric urolithiasis. [Yes] 

P2. No structured abstract provided. [No]

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[Advances in technology and the continued evolution in the design of ureteroscopes now permit a primary endoscopic approach to the upper urinary tract of pediatric patients on a routine basis to treat a diverse group of conditions that include urolithiasis, hematuria and strictures.]&quot;</span> Provides background on URS in pediatric patients. [Yes]  

P4. No explicit statement of objectives or PICOS provided. [No]

P5. No statement on protocol or registration provided. [No] 

P6. No explicit eligibility criteria provided. [No]

P7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[A systematic review of articles written about ureteroscopy (URS) in the contemporary urological literature (1990-2009) on PubMed was undertaken.]&quot;</span> States PubMed search but no other details on sources. [Partial Yes <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P8. No full search strategy provided. [No]

P9. No explicit statement on study selection process. [No] 

P10. No description of data collection process. [No]

P11. No list of variables extracted. [No]

P12. No assessment of risk of bias. [No]

P13. No summary measures stated. [NA]

P14. No synthesis methods described. [NA]

P15. No assessment of risk of bias across studies. [NA] 

P16. No additional analyses described. [NA] 

P17. No flow diagram or explicit numbers at each stage. [No]

P18. Table 1 provides some characteristics of included studies. [Partial Yes <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P19. No assessment of risk of bias in individual studies. [No]

P20. Table 1 provides some results for individual studies. [Partial Yes <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P21. No meta-analysis performed. [NA]

P22. No assessment of bias across studies. [NA]

P23. No additional analyses. [NA]

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[In this systematic review of the literature, URS is shown to be safer and more efficacious than ESWL in the management of pediatric urolithiasis.]&quot;</span> Provides a summary statement on main finding. [Yes]

P25. No discussion of limitations. [No] 

P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[URS is safe and efficacious in the management of pediatric urolithiasis. URS should be considered an essential part of the armamentarium of any urologist involved in the care of children and is now considered the standard of care for the management of pediatric urolithiasis.]&quot;</span> Provides conclusions. [Yes]

P27. No statement on sources of funding. [No]
</pre>
<p><a name='137'></a></p>
</div>
<div id="romao-2012" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2012.01.009' title='Open publication'>Romao
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎What is the best prosthetic material for patch repair of congenital diaphragmatic hernia? Comparison and meta-analysis of porcine small intestinal submucosa and polytetrafluoroethylene&quot;</span> [Yes]
Title identifies the report as a systematic review comparing two prosthetic materials.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span> [No] 
The abstract does not contain all elements of a structured summary.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span> [Yes]
<span title='Moderate quote deviation. Best match in fulltext (Similarity 95%):

Large defects of the diaphragm have been associated with more severe pulmonary hypoplasia and poorer survival [1]; the past 2 decades have witnessed an improvement in medical management of patients with CDH with the use of gentle ventilation and delayed surgical repair, thus leading to improved survival rates in many centers [2]. Concomitantly, there has been a rise in the incidence of patch repairs [3], [11] and also increased long-term morbidity [4' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Larger defects of the diaphragm in patients with CDH have been associated with more severe pulmonary hypoplasia and poorer survival [1]; the past 2 decades have witnessed an improvement in medical management of patients with CDH with the use of gentle ventilation and delayed surgical repair, thus leading to improved survival rates in many centers [2]. Concomitantly, there has been a rise in the incidence of patch repairs [3], [11] and also increased long-term morbidity [4].&quot;</span>
Provides context and rationale.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> [Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of our study was to compare recurrence, small bowel obstruction (SBO), and mortality rates for CDH repair between an absorbable (Surgisis [SIS]; Cook Biotech, Inc, West Lafayette, IN) and a nonabsorbable polytetrafluoroethylene (PTFE) (Gore-Tex; W.L. Gore & Associates, Inc, Neward, DE) material at our institution.&quot;</span>
States aim to compare two interventions for three outcomes.

"[NA]"
No protocol or registration mentioned.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span> [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To be selected, a study had to evaluate an absorbable (SIS) and a nonabsorbable (PTFE) material for CDH patch repair and provide relevant and interpretable data.&quot;</span>
Specifies intervention comparison and outcome eligibility criteria.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span> [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All publications describing both absorbable (SIS) and nonabsorbable (PTFE) material for treatment of CDH were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials (CENTRAL) database. All studies were identified through electronic searches of MEDLINE (1966 onwards), EMBASE (1980 onwards), and CINAHL (1982 onwards) and from hand-searching journals and conference proceedings.&quot;</span>
Lists databases searched without date ranges.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span> [No]
No search strategy provided.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three authors (RR, AN, and JL) independently assessed all published articles and identified as potentially relevant by the literature search for inclusion in the review.&quot;</span> 
Describes process of study screening and selection.

"[NA]"
No data collection process described.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span> [No]
No listing of data items sought.

"[NA]" 
No assessment of individual study bias mentioned.

"[NA]"
No summary measures described, as no meta-analysis performed.

"[NA]"
No synthesis methods described. 

"[NA]"
No assessment of publication bias mentioned.

"[NA]"
No additional analyses mentioned.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span> [No]
No flow diagram or details of screening and selection process provided.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> [No]
No table of study characteristics provided.

"[NA]"
No assessment of individual study bias presented.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta-analysis was performed combining our data with the data from this study (Fig. 1), which resulted in a total of 40 patients repaired with SIS and 54 patients repaired with PTFE.&quot;</span>
Provides summary data and forest plots.

"[NA]" 
No meta-analysis results presented.

"[NA]"
No assessment of publication bias presented. 

"[NA]"
No additional analyses presented.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our data further support the concept that there is no ideal prosthetic material for patch repair of CDH. Surgisis and PTFE had similarly high complication rates in terms of recurrence, SBO, and mortality. The meta-analysis performed further supported the lack of difference in these outcomes between absorbable and nonabsorbable materials.&quot;</span>
Summarizes main findings.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> [No]
No limitations discussed.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span> [Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎It is possible that development of new absorbable materials, which become replaced with scar tissue more quickly, or further development of composite patches will improve the recurrence risk for patch repair of CDH.&quot;</span>
Discusses implications for future research.

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span> [No]
No funding sources reported.
</pre>
<p><a name='138'></a></p>
</div>
<div id="ross-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3691-2' title='Open publication'>Ross
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review and meta-analysis of the literature comparing use of a PFS with alternate treatment strategies.&quot;</span>
Title identifies the report as a systematic review and meta-analysis.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

We performed a systematic review and meta-analysis of the literature comparing use of a PFS with alternate treatment strategies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We performed a systematic review and meta-analysis of the literature comparing the use of a PFS with alternate treatment strategies.&quot;</span>  
The abstract provides a structured summary including the review objectives, data sources, eligibility criteria, methods, and main results.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The pre-formed silo (PFS) is increasingly used in the management of gastroschisis, but its benefits remain unclear.&quot;</span>
The introduction describes the rationale for the review in the context of existing knowledge.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to evaluate current evidence comparing the use of a PFS with alternate treatment strategies in infants with gastroschisis.&quot;</span>
The introduction explicitly states the objectives, referring to participants, interventions, comparisons, and outcomes. 

[No]
No mention of a review protocol.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were selected for inclusion in the review if they reported comparative outcomes between infants treated with a PFS and infants treated with an alternate treatment strategy.&quot;</span>
The methods section specifies the eligibility criteria including participants, interventions, comparisons, and outcomes.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched Medline, Embase and the Cochrane controlled trials register from inception to July 2014 using the terms ‘gastroschisis’, ‘gastroschisis and silo’, ‘preformed silo’ and ‘silastic silo’.&quot;</span> 
The methods section describes the information sources searched including databases and dates.

[No]
The full search strategy for at least one database is not presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The literature search, assessment for inclusion and data extraction were performed independently by three reviewers and disagreements resolved by consensus.&quot;</span>
The methods section describes the study selection process including screening and eligibility assessment.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were extracted and entered into Review Manager (v5.1, The Cochrane Collaboration) and meta-analysis was performed using a random effects model due to variation in study design and reporting.&quot;</span>
The methods section describes the data collection process including data extraction and confirmation.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All outcomes were selected a priori. The primary outcome measure was time on a ventilator. Secondary outcomes were number of infants never ventilated, time on parenteral nutrition (PN), time to achieve full enteral feeds, length of hospital stay, incidence of necrotising enterocolitis, number of unplanned re-operations, infectious complications, mortality and occurrence of ventral hernia following repair.&quot;</span>
The methods section lists the variables, outcomes, and other data items collected. 

[NA]
No assessment of individual study risk of bias is described since no meta-analysis was performed.

[NA] 
No summary measures are stated since no meta-analysis was performed.

[NA]
No synthesis methods are described since no meta-analysis was performed.

[NA] 
No assessment of risk of bias across studies is described since no meta-analysis was performed.

[NA]
No additional analyses are described since no meta-analysis was performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One-thousand five-hundred and sixty-seven articles were identified using the specified search criteria and their abstracts reviewed. Following application against our inclusion criteria, 1440 were excluded on the basis of their abstract alone and the full text of 127 publications was scrutinised. One hundred and seven of these were subsequently excluded as they did not report a comparative group, did not use a PFS, or did not report outcomes from a group all treated with a PFS. Two further reports were excluded to avoid duplication of patients.&quot;</span>
The results section describes the study selection process including numbers screened, assessed, and included, with reasons for exclusions.

[Yes] Table 1 presents the characteristics of the included studies.

[NA]
No assessment of individual study risk of bias is presented since no meta-analysis was performed. 

[NA]
No results of individual studies are presented since no meta-analysis was performed.

[NA]  
No results of meta-analyses are presented since no meta-analysis was performed.

[NA]
No assessment of risk of bias across studies is presented since no meta-analysis was performed.

[NA]
No results of additional analyses are presented since no meta-analysis was performed.  

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review aimed to determine comparative outcomes for infants with gastroschisis treated with either a PFS or alternate treatment strategy.&quot;</span>
The discussion summarizes the main findings and considers their relevance.

[Yes] <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 72.1%):

t with a PFS or alternate strategy was poorly defined, if at all. As a result there is significant potential for both treatment and selection biases to influence the findings of this analysis' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎The quality of evidence comparing PFS with alternate treatment strategies for gastroschisis is poor." "As a result there is significant potential for both treatment and selection biases to influence the findings of this analysis.&quot;</span>
The discussion describes limitations at the study and outcome level.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Further investigation is required to identify not only the optimal treatment pathway for infants with gastroschisis which will likely include a case by case decision algorithm, but also the tools by which to measure success.&quot;</span> 
The conclusion provides a general interpretation of the results and implications for future research.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
The funding sources are described.
</pre>
<p><a name='139'></a></p>
</div>
<div id="ruttenstock-2010" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-010-2695-1' title='Open publication'>Ruttenstock
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are my responses for each PRISMA item:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Systematic review and meta-analysis of enterocolitis after one-stage transanal pull-through procedure for Hirschsprung’s disease&quot;</span>
The title identifies the report as a systematic review and meta-analysis.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 77%):

reports found the incidence of HAEC to be unrelated to type and timing of definitive surgery [15, 19, 30, 34, 36]. In the present review, postoperative HAEC occurred in 92 patients, which lead to an incidence rate of HAEC of 10.2' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The reported incidence of post pull-through HAEC ranges from 4.6 to 54% in various series... In the present review, postoperative HAEC occurred in 92 patients, which lead to an incidence rate of HAEC of 10.2%.&quot;</span>
The abstract provides a structured summary including background, objectives, data sources, eligibility criteria, results, and conclusions. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Hirschsprung’s disease associated with enterocolitis is the most serious and potentially life-threatening complication of HD, with significant morbidity and mortality [16, 29, 30].&quot;</span>
The introduction describes the rationale for the review in the context of what is already known.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis was designed to evaluate postoperative incidence of HAEC following TERPT procedure.&quot;</span>  
The introduction provides an explicit statement of the objective to evaluate the postoperative incidence of HAEC following TERPT.

[No]
No review protocol or registration is indicated.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Detailed information was recorded regarding the type of study, patient’s age and gender, intraoperative details, and postoperative complications with particular emphasis on the incidence and outcome of HAEC.&quot;</span>
The eligibility criteria specify that studies reporting TERPT procedures without additional laparotomy, laparoscopy or preoperative colostomy were included, with emphasis on postoperative HAEC.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎PubMed and Medline were searched for all studies that reported cases of patients who had undergone surgical correction of HD on transanal one-stage pull-through operation between 1998 and 2009.&quot;</span>
The information sources including PubMed and Medline databases are described. 

[No]
No full electronic search strategy is presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Out of these 54 articles, 27 articles, identified as reporting entirely TERPT without additional laparotomy, laparoscopy or preoperative colostomy, formed the basis of our study (Table 1).&quot;</span> 
The process for study selection is described.

[No] 
No data collection process is described. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Detailed information was recorded regarding the type of study, patient’s age and gender, intraoperative details, and postoperative complications with particular emphasis on the incidence and outcome of HAEC.&quot;</span>
The data items recorded are listed, including patient demographics, surgical details, and postoperative complications with emphasis on HAEC.

[No]
No methods for assessing risk of bias are described.

[NA]

[NA] 

[NA]

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were a total of 899 patients. Information about patient’s gender was reported in 760 (84.5%) patients. 563 (74.1%) patients were male and 197 (25.9%) patients were female. A male-to-female ratio of 2.8:1 was observed.&quot;</span> 
The number of studies screened and included is provided in a flow diagram and characteristics like sample size and gender are presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Postoperative complications occurred in 370 (41.2%). One hundred and eighty-five of the 370 patients had minor complications, such as perianal excoriation, constipation and increased stool frequency and 188 patients had major complications such as anastomotic strictures, which were reported in 72 (8%) of the patients and required anal dilatation.&quot;</span>
Complications for each study are presented.

[No]
No assessment of risk of bias is presented. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Postoperative HAEC occurred in 92 patients (10.2%), with an early onset of 2 weeks after surgery up to 18 months. Recurrent episodes of HAEC were reported in 18 patients (2%).&quot;</span>
Simple summary data and effect estimates for the main outcome of HAEC are presented.

[NA]

[NA]

[NA]

[NA] 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review reveals that the incidence of postoperative and recurrent HAEC after TERPT procedure is remarkably lower than incidence rates of HAEC reported after other procedures, confirming TERPT as a safe operation with a low incidence of postoperative HAEC.&quot;</span>
The main findings are summarized, including the low incidence of postoperative HAEC with TERPT compared to other procedures.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎However, the data are not consistent for other suggested predictive risk factors, such as type of repair.&quot;</span>
Limitations at the study level such as inconsistent data for risk factors are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Preventive measures and better treatment modalities will evolve out of a better understanding of the underlying pathophysiology.&quot;</span>
Conclusions and implications for future research are provided.

[No]
No sources of funding are described.
</pre>
<p><a name='140'></a></p>
</div>
<div id="rynja-2011" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2011.02.008' title='Open publication'>Rynja
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item based on the provided full text:

P1: [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Functional, cosmetic and psychosexual results in adult men who underwent hypospadias correction in childhood&quot;</span>
The title identifies the report as a systematic review.

P2: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
The abstract provides a structured summary.

P3: [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Hypospadias is one of the most common urologic congenital anomalies and occurs in approximately 1 out of 250 newborn boys [1]. Hypospadias surgery aims to attain a straight urinary stream from a meatus with a normal anatomical position, a straight penis in erection, and normal cosmetic penile appearance.&quot;</span>  
The introduction describes the rationale for the review.

P4: [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
The objectives are stated: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This review aims to present the results of long-term hypospadias studies in postpubertal men who had hypospadias correction at a young age.&quot;</span>

P5: [No] 
No review protocol or registration is mentioned.

P6: [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria stated that patients with hypospadias were operated before the age of 6 years and were older than 14 years at follow up.&quot;</span>
Eligibility criteria for studies are provided. 

P7: [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Pubmed/Medline and Embase databases were searched until February 2010.&quot;</span>
The information sources are described.

P8: [No]
The search strategy is not provided.

P9: [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎References of included papers were checked for possible missing studies.&quot;</span> 
The study selection process is described.

P10: [No]  
The data collection process is not described. 

P11: [No]
The data items are not listed.

P12: [NA] 
Risk of bias assessment not applicable since no meta-analysis was performed.

P13: [NA]
Summary measures not applicable since no meta-analysis was performed. 

P14: [NA]  
Synthesis methods not applicable since no meta-analysis was performed.

P15: [NA]  
Risk of bias assessment across studies not applicable since no meta-analysis was performed.

P16: [NA]
Additional analyses not applicable since no meta-analysis was performed.

P17: [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Twenty eligible studies investigating micturition, cosmesis and psychosexual functioning were found.&quot;</span>
The number of studies screened and included is provided. 

P18: [No]
Study characteristics are not presented in a table.

P19: [No]  
Risk of bias within individual studies is not presented.

P20: [No]
Results of individual studies are not shown with effect estimates.

P21: [NA] 
Results of meta-analyses not applicable since no meta-analysis was performed.

P22: [NA]
Risk of bias across studies not applicable since no meta-analysis was performed.

P23: [NA] 
Additional analyses not applicable since no meta-analysis was performed. 

P24: [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with hypospadias are arguably better off in experienced hands in terms of short-term complications [36], [37]. Whether this is also true for long-term results is uncertain, but more experienced centers do contain higher volumes of patients eligible for follow up.&quot;</span>
A summary of the evidence is provided.

P25: [Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

Studies on long-term outcomes after hypospadias repair in childhood are scarce. They are characterized by high loss to follow up (51.6%), and heterogeneous patients and data, and they lack validated questionnaires and control groups' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Studies on the long-term outcomes after hypospadias repair in childhood are scarce. They are characterized by high loss to follow up (51.6%), and heterogeneous patients and data, and they lack validated questionnaires and control groups.&quot;</span> 
Limitations are discussed.

P26: [Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 87.1%):

In future studies, the cosmetic aspect should be evaluated using validated questionnaires only. This rules out subjectivity as much as possible and leads to outcomes that can be compared.
Sexuality

Sexuality was thoroughly investigated in the eligible studies. However, none used an age-validated questionnaire and definitions used for' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎In future studies, the cosmetic aspect should be evaluated using validated questionnaires only. This rules out subjectivity as much as possible and leads to outcomes that can be compared. Sexual function should be evaluated with a sexual questionnaire validated for young adults.&quot;</span>
Conclusions and implications for future research are provided.

P27: [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎None.&quot;</span>
Funding sources are stated.
</pre>
<p><a name='141'></a></p>
</div>
<div id="saldaña-2013" class="section level4">
<h4><a href='https://doi.org/10.1089/lap.2012.0467' title='Open publication'>Saldaña
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the responses for the PRISMA items based on the provided systematic review text:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Single-Incision Pediatric Endosurgery: A Systematic Review&quot;</span> 

The title identifies the report as a systematic review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review of the literature to find out the current state of SIPES procedures, including age, technical aspects, and operative outcomes.&quot;</span>

The abstract describes the rationale, objectives, data sources, eligibility criteria, methods, and main results. 

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

In the search for less invasive procedures, ever since the development of laparoscopic surgery and with the limitations and equipment dependence of Natural Orifice Translumenal endoscopic surgery (NOTES®; American Society for Gastrointestinal Endoscopy [Oak Brook, IL] and Society of American Gastrointestinal and Endoscopic Surgeons [Los Angeles, CA]), this new approach through the umbilicus, a natural embrionary orifice,1 was first reported in 1992 by Pelosi and Pelosi' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In the search for less invasive procedures, ever since the development of laparoscopic surgery and with the limitations and equipment dependence of Natural Orifice Translumenal endoscopic surgery (NOTES®), this new approach through the umbilicus, a natural embrionary orifice,1 was first reported in 1992 by Pelosi and Pelosi.&quot;</span>

The introduction describes the rationale for the review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The objective of this review is to show the initial published experience about SIPES to evaluate its real benefits in terms of feasibility and clinical outcomes.&quot;</span>  

The introduction provides an explicit statement of the review questions.

[No]

The methods do not indicate if a review protocol exists.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Articles were considered eligible if they met the following inclusion criteria: (1) Operations were performed through a single incision. (2) The target population was children under 18 years of age. (3) Operations performed exclusively by pediatric surgeons. (4) Series larger than 100 patients were included for appendectomy operations. (5) Case reports, case series, and comparative and prospective randomized trials were included in other, nonappendectomy, operations because of their low incidence. (6) Articles should include age, operative technical aspects, and operative outcomes.&quot;</span>

The eligibility criteria relating to population, interventions, studies are described.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.8%):

mes. An electronic search in PubMed up to March 2012 was conducted with the following terms: “single” AND “incision” OR “site” OR “port” OR “trocar” AND “children.” Related articles were also reviewed' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We performed an electronic search in PubMed up to March 2012 with the following terms: “single” AND “incision” OR “site” OR “port” OR “trocar” AND “children.” Related articles were also reviewed.&quot;</span>

The information sources and search strategy are described.

[No] 

The search strategy is not presented in full for any database. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The initial reports consisted of extracorporeal appendectomies (laparoscopic-assisted procedures). However, fully laparoscopic SIPES appendectomies without any requirement of special flexible or articulated instruments had been reported as well.&quot;</span>

The process of study selection is described.

[No]

The data collection process is not described.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

Ports were defined as the access device chosen to perform the single-incision surgery. In pediatrics, these include multilumen devices such as the SILS™ Port (Covidien, Inc., Mansfield, MA) or the TriPort (Advanced Surgical Concepts, Bray, Ireland, United Kingdom) or the use of multiple cannulas or the combination of one-cannula and stab fascial incisions for passage of the instruments through a single skin incision' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Ports were defined as the access device chosen to perform the single-incision surgery. In pediatrics, these include multilumen devices such as the SILSTM Port (Covidien, Inc., Mansfield, MA) or the TriPort (Advanced Surgical Concepts, Bray, Ireland, United Kingdom) or the use of multiple cannulas or the combination of one-cannula and stab fascial incisions for passage of the instruments through a single skin incision.&quot;</span> 

The variables extracted are listed and defined.

[No]

Methods for assessing risk of bias are not described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Operative time was described as a median or medium (in minutes) and range when mentioned.&quot;</span>

The summary measures are stated.

[NA]

[NA] 

[NA]

[Yes]  <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We identified a total of 4212 patients operated on by SIPES.&quot;</span>

The number of studies screened, assessed, and included is provided, with reasons for exclusion.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Twelve articles fulfilled our inclusion criteria for SIPES appendectomy, including a total of 2422 patients.&quot;</span>

For each study, characteristics such as interventions, participants, and outcomes are presented.

[No]

A risk of bias assessment is not presented for the included studies.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

The mean operative time was longer with the SIPES approach in the prospective trial of St Peter et al.,6 where a 10% conversion rate was described, a value similar to our 10.7% conversion rate found in this review (Table 5' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The mean operative time was longer with the SIPES approach in the prospective trial of St Peter et al., where a 10% conversion rate was described, a value similar to our 10.7% conversion rate found in this review (Table 5).&quot;</span>

For each outcome, summary data and effect sizes are presented for each study. 

[NA]

[NA]

[NA] 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In terms of pain, it is believed that a larger umbilical incision may translate into more postoperative pain. However, others have speculated that limiting the number of incisions means decreasing trauma to the tissue and translates into reduced pain. Unfortunately, we did not find a uniform pain assessment among authors, and others did not even mention it.&quot;</span>

The synthesised findings are summarised, including the strength of evidence.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Further analysis could not be performed because of the weak nature of the evidence in the majority of publications and some methodological defects of the literature reviewed. The low incidence of some pediatric surgical diseases (favoring case series with low level of evidence) and the lack of uniformity in evaluating some measures among surgeons, like pain assessment or cosmesis, for example, are the main contributors to this limitation.&quot;</span> 

The limitations at the study and outcome level, as well as at the review level, are discussed. 

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

From this systematic review we conclude:

    • A wide experience in SIPES and its feasibility have already been described with good clinical outcomes and low rate of conversion' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎From this systematic review we conclude: A wide experience in SIPES and its feasibility have already been described with good clinical outcomes and low rate of conversion.&quot;</span>

The conclusions summarize the main findings and put them into context of other evidence.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No competing financial interests exist.&quot;</span>

Sources of funding are described.
</pre>
<p><a name='142'></a></p>
</div>
<div id="sauerland-2010" class="section level4">
<h4><a href='https://doi.org/10.1002/14651858.CD001546.PUB3' title='Open publication'>Sauerland
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘missing-squared-brackets-for-na’,
‘missing-squared-brackets-end-of-line’</i>
<pre>
P1 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic versus open surgery for suspected appendicitis&quot;</span>
Title identifies the report as a systematic review.

P2 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
Structured abstract provided.

P3 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Introduction / Rationale: Describe the rationale for the review in the context of what is already known.&quot;</span> 
Rationale described in Background section. 

P4 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
Objectives section provides explicit questions.

P5 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[No]</span>
Review protocol not reported.

P6 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
Eligibility criteria described in Methods section.

P7 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>  
Information sources described in Methods section. 

P8 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
Search strategy provided for MEDLINE.

P9 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
Study selection process described.

P10 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
Data collection process described.

P11 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>  
Data items listed and defined.

P12 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
Risk of bias assessment described and presented in results.

P13 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
Summary measures stated.

P14 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
No meta-analysis performed.

P15 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span> 
No meta-analysis performed.

P16 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
No meta-analysis performed. 

P17 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
Study selection process described and flow diagram provided.

P18 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Study characteristics presented in results.

P19 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
Risk of bias assessment presented.

P20 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
No meta-analysis performed.

P21 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
No meta-analysis performed. 

P22 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
No meta-analysis performed.

P23 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
No meta-analysis performed.

P24 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
Summary of evidence provided in discussion.

P25 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
Limitations discussed.

P26 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
Conclusions provided.

P27 - <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[Yes]</span>
> <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
Funding sources described.
</pre>
<p><a name='143'></a></p>
</div>
<div id="scholfield-2016" class="section level4">
<h4><a href='https://doi.org/10.1089/lap.2015.0121' title='Open publication'>Scholfield
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
1. <span title='Moderate quote deviation. Best match in prompt (Similarity 93.3%):

Identify the report as a systematic review, meta-analysis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Identify the report as a systematic review and meta-analysis&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our study is the first systematic review and meta-analysis comparing OD and LD pull-through techniques for HD.&quot;</span>
Reasoning: Title identifies the report as a systematic review and meta-analysis.
[Yes]

2. <span title='Minor quote deviation. Best match in prompt (Similarity 96.3%):

Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Provide a structured summary including background, objectives, data sources, eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications.&quot;</span>
Quote: <span title='Moderate quote deviation. Best match in prompt (Similarity 92.8%):

Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Abstract provides structured summary with background, objectives, data sources, eligibility criteria, participants, interventions, results, conclusions.&quot;</span>  
Reasoning: Abstract provides a structured summary.
[Yes]

3. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>  
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Despite the introduction of TERPT, the Duhamel technique still remains a relevant procedure favored by surgeons in both the open Duhamel (OD) and laparoscopic Duhamel (LD) forms, particularly for long segment and redo procedures.&quot;</span>
Reasoning: Introduction describes rationale for review.
[Yes]  

4. <span title='Minor quote deviation. Best match in prompt (Similarity 99.2%):

Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Provide explicit questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design.&quot;</span>
Quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 71.9%):

compared long-term outcomes for open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for HD, to identify any added advantage of the laparoscopic technique' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Our study is the first systematic review and meta-analysis comparing long-term outcomes for open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for HD, to identify any added advantage of the laparoscopic technique.&quot;</span>
Reasoning: Introduction provides explicit question comparing OD and LD procedures.
[Yes]

5. <span title='Minor quote deviation. Best match in prompt (Similarity 99.2%):

Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Indicate if a review protocol exists and if available, provide registration information including registration number.&quot;</span>
Quote: No mention of review protocol.
Reasoning: Review protocol not reported.  
[No]

6. <span title='Minor quote deviation. Best match in prompt (Similarity 98.9%):

Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Specify study characteristics and report characteristics used as criteria for eligibility.&quot;</span> 
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusion criteria included patients with total colonic aganglionosis, follow-up of less than 6 months, cohorts smaller than 10 patients, full articles not written in English, and non–peer-reviewed articles. Studies with insufficient operation details or those that did not differentiate between the two approaches were also excluded.&quot;</span>
Reasoning: Eligibility criteria specified.
[Yes]

7. <span title='Moderate quote deviation. Best match in prompt (Similarity 89.9%):

Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Describe all information sources including databases, contact with authors, and date last searched.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic PubMed search was performed to identify publications that analyzed outcomes for LD or OD pull-through procedures for HD. All studies between January 1994 and December 2014 were included in the search.&quot;</span> 
Reasoning: Information sources described.
[Yes]  

8. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used.&quot;</span>
Quote: No full search strategy presented.
Reasoning: Full search strategy not provided.
[No]

9. <span title='Moderate quote deviation. Best match in prompt (Similarity 86.9%):

State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎State process for selecting studies including screening, eligibility, inclusion in review, and inclusion in meta-analysis.&quot;</span>
Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Data collected included study characteristics (author, journal, publication year, sample size, length of follow-up, and operative technique) and patient demographics (sex and age at surgery). Outcome parameters included incidence of enterocolitis, constipation, fecal incontinence or soiling, and further surgery, length of operation, length of hospital stay, and time taken to tolerate full oral feeds' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data collected included study characteristics and patient demographics. Outcome parameters included incidence of enterocolitis, constipation, fecal incontinence or soiling, and further surgery, length of operation, length of hospital stay, and time taken to tolerate full oral feeds.&quot;</span>
Reasoning: Process for study selection described.
[Yes]

10. <span title='Minor quote deviation. Best match in prompt (Similarity 99%):

Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe method of data extraction and processes for obtaining and confirming data from investigators.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our review only included published studies, and no contact with authors was made to obtain unpublished data.&quot;</span>
Reasoning: Data extraction methods described. 
[Yes]

11. <span title='Minor quote deviation. Best match in prompt (Similarity 95.2%):

List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎List and define all variables for which data were sought including assumptions and simplifications made.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data collected included study characteristics (author, journal, publication year, sample size, length of follow-up, and operative technique) and patient demographics (sex and age at surgery). Outcome parameters included incidence of enterocolitis, constipation, fecal incontinence or soiling, and further surgery, length of operation, length of hospital stay, and time taken to tolerate full oral feeds.&quot;</span>
Reasoning: Variables defined.
[Yes]

12. <span title='Minor quote deviation. Best match in prompt (Similarity 98.8%):

Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe methods for assessing risk of bias and how this information is to be used.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Their risk of bias was assessed and summarized.&quot;</span> 
Reasoning: Risk of bias assessment described.
[Yes]

13. <span title='Minor quote deviation. Best match in prompt (Similarity 97%):

State the principal summary measures' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎State principal summary measures.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Odds ratios were calculated for dichotomous variables, and mean difference values were calculated for continuous variables.&quot;</span>
Reasoning: Principal summary measures stated.
[Yes]

14. <span title='Minor quote deviation. Best match in prompt (Similarity 98.2%):

Describe the methods of handling data and combining results' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe methods of handling data and combining results.&quot;</span> 
Quote: No meta-analysis performed.
Reasoning: Not applicable.
[NA]

15. <span title='Moderate quote deviation. Best match in prompt (Similarity 86%):

y assessment of risk of bias across studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Specify assessment of risk of bias across studies.&quot;</span>
Quote: No assessment of risk of bias across studies.
Reasoning: Not reported.
[No] 

16. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods of additional analyses.&quot;</span>
Quote: No additional analyses described.
Reasoning: Not applicable.
[NA]

17. <span title='Minor quote deviation. Best match in prompt (Similarity 99%):

Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusion' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included with reasons for exclusion.&quot;</span> 
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The initial literature search identified 132 articles published from 1994 to 2014. Of these, 114 did not fulfill the inclusion criteria and were excluded.&quot;</span>
Reasoning: Study selection process described.
[Yes]

18. <span title='Moderate quote deviation. Best match in prompt (Similarity 89.4%):

present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Present characteristics of included studies and provide citations.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eleven articles met our strict inclusion criteria and were included in the meta-analysis.&quot;</span> 
Reasoning: Included studies and citations provided in results.
[Yes]

19. <span title='Moderate quote deviation. Best match in prompt (Similarity 93.2%):

Present data on risk of bias of each study' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Present data on risk of bias for each study.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Their risk of bias was assessed and summarized.&quot;</span>
Reasoning: Risk of bias for each study presented.
[Yes]

20. <span title='Moderate quote deviation. Best match in prompt (Similarity 78.2%):

present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Present simple summary data, effect estimates, and confidence intervals for each study.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The mean incidence of enterocolitis in the OD group was 15% (range, 0%–36%) compared with 10% (range, 0%–46%) in the LD group.&quot;</span>
Reasoning: Summary data for studies presented. 
[Yes]

21. <span title='Minor quote deviation. Best match in prompt (Similarity 97.8%):

Present results of each meta-analysis done, including confidence intervals and measures of consistency' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Present results of meta-analyses including confidence intervals and measures of consistency.&quot;</span>
Quote: No meta-analysis performed.
Reasoning: Not applicable.
[NA]

22. <span title='Minor quote deviation. Best match in prompt (Similarity 98.4%):

Present results of any assessment of risk of bias across studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Present results of assessment of risk of bias across studies.&quot;</span> 
Quote: No assessment of risk of bias across studies.
Reasoning: Not applicable.
[NA]

23. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give results of additional analyses.&quot;</span>
Quote: No additional analyses performed.
Reasoning: Not applicable.
[NA]

24. <span title='Minor quote deviation. Best match in prompt (Similarity 98.6%):

Summarize the main findings including the strength of evidence for each main outcome' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Summarize main findings including strength of evidence for each outcome.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our meta-analysis convincingly demonstrates the superiority of LD over OD pull-through for HD.&quot;</span>
Reasoning: Main findings summarized.
[Yes]

25. <span title='Minor quote deviation. Best match in prompt (Similarity 97%):

Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Discuss limitations at study and outcome level and at review level.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The results of our meta-analysis should be carefully interpreted. The following are unavoidable limitations:&quot;</span>
Reasoning: Limitations discussed.
[Yes]

26. <span title='Minor quote deviation. Best match in prompt (Similarity 99.1%):

Provide a general interpretation of the results in the context of other evidence, and implications for future research' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Provide general interpretation of results in context of other evidence and implications for future research.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Prospective, randomized control trials are required to overcome limitations in the current literature.&quot;</span>
Reasoning: Results interpreted and implications described.
[Yes]

27. <span title='Minor quote deviation. Best match in prompt (Similarity 97.9%):

Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe sources of funding and role of funders.&quot;</span>
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No competing financial interests exist.&quot;</span> 
Reasoning: Funding sources described.
[Yes]
</pre>
<p><a name='144'></a></p>
</div>
<div id="sharp-2015" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0035-1544174' title='Open publication'>Sharp
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for the PRISMA items P1 to P27:

P1. <span title='Moderate quote deviation. Best match in fulltext (Similarity 89.1%):

Treatment of Idiopathic Achalasia in the Pediatric Population: A Systematic Review' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes]" - "Treatment of Idiopathic Achalasia in the Pediatric Population: A Systematic Review&quot;</span>
P2. "[No]" - No structured abstract provided.
P3. <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.8%):

Achalasia is a rare neuromuscular disorder of the esophagus, characterized as a syndrome of impaired relaxation of the lower esophageal sphincter (LES) and decreased peristalsis of the esophageal body' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes]" - "Achalasia is a rare neuromuscular disorder of the esophagus, characterized as a syndrome of impaired relaxation of the lower esophageal sphincter (LES) and decreased peristalsis of the esophageal body.&quot;</span>  
P4. <span title='Minor quote deviation. Best match in fulltext (Similarity 95.3%):

We intend to delineate the best initial treatment for achalasia and synthesize the current body of literature on outcomes from initial treatment of pediatric achalasia with pneumatic dilatation (PD) versus surgical Heller esophagomyotomy (HM' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes]" - "We intend to delineate the best initial treatment for achalasia and synthesize the current body of literature on outcomes from initial treatment of pediatric achalasia with pneumatic dilatation (PD) versus surgical Heller esophagomyotomy (HM).&quot;</span>
P5. "[No]" - No protocol mentioned.
P6. "[Yes]" - Eligibility criteria provided.  
P7. <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.9%):

Studies were identified by searching the electronic database MEDLINE (OVID), and by hand search of reference lists for further relevant articles' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes]" - "Studies were identified by searching the electronic database MEDLINE (OVID), and by hand search of reference lists for further relevant articles.&quot;</span>
P8. "[Yes]" - Search strategy provided.
P9. "[Yes]" - Study selection process described. 
P10. "[No]" - No data collection process described.
P11. "[Yes]" - Data items listed.
P12. "[No]" - No risk of bias assessment described for individual studies. 
P13. "[NA]" 
P14. "[NA]"
P15. "[No]" - No assessment of risk of bias across studies described.
P16. "[NA]"
P17. "[Yes]" - Study selection process shown in flow diagram. 
P18. "[Yes]" - Study characteristics presented in tables.
P19. "[No]" - No risk of bias results for individual studies presented.
P20. "[No]" - No results for individual studies presented.
P21. "[NA]"  
P22. "[NA]"
P23. "[NA]"
P24. "[Yes]" - Main findings summarized.
P25. "[Yes]" - Limitations discussed.
P26. "[Yes]" - Conclusions provided.
P27. "[Yes]" - Funding described.
</pre>
<p><a name='145'></a></p>
</div>
<div id="shawyer-2014" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-014-3548-0' title='Open publication'>Shawyer
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The management of postoperative reflux in congenital esophageal atresia–tracheoesophageal fistula: a systematic review&quot;</span>  [Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives&quot;</span>  [Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>  [Yes] 

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> [No]

"[No]"

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span> [Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span> [Yes]  

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span> [Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> [Yes]

"[No]" 

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span> [No]

"[NA]"

"[NA]" 

"[NA]"

"[NA]"

"[NA]"

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span> [Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> [Yes]

"[NA]"

"[No]"

"[NA]" 

"[NA]" 

"[NA]"

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> [Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> [Yes] 

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span> [Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span> [Yes]
</pre>
<p><a name='146'></a></p>
</div>
<div id="shawyer-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-014-3626-3' title='Open publication'>Shawyer
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and responses for each PRISMA item:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic versus open repair of recto-bladderneck and recto-prostatic anorectal malformations: a systematic review and meta-analysis&quot;</span> [Yes]
2. The title identifies the report as a systematic review and meta-analysis. [Yes]
3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The objective of this review was to better document the available data understanding the challenges of a variety of outcome measures, few and heterogeneous patient samples and poor reporting.&quot;</span> [Yes]   
4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The objective of this review was to better document the available data understanding the challenges of a variety of outcome measures, few and heterogeneous patient samples and poor reporting.&quot;</span> [Yes]
5. [No]
6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were included if they fulfilled the following criteria: (1) primary diagnosis of RB/RP-ARM; (2) male patients less than 18 years of age at the time of definitive repair of their RB/RP-ARM; (3) interventions include LAARP versus OPEN for ligation of the fistula and mobilization of the rectum;&quot;</span> [Yes]
7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A comprehensive search was conducted of MEDLINE/PubMed, EMBASE/OVID and CENTRAL (the Cochrane Library) electronic databases from 2000 to March 2014.&quot;</span> [Yes]  
8. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Grey literature was searched in PapersFirst, ProceedingsFirst and ProQuest electronic databases (keyword search).&quot;</span> [Yes]
9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Title and abstract screening was conducted independently and in duplicate (AS and ML).&quot;</span> [Yes]
10. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data abstraction was performed in duplicate (AS and ML) and verified for accuracy and quality via a pre-piloted standardized data abstraction form;&quot;</span> [Yes]
11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We planned to assess other outcomes and investigations; however, data on these were insufficiently reported in the included studies, which precluded comparisons (e.g., estimated blood loss during the operation, the time to achieve full diet, routine postoperative cross-sectional imaging or length of hospital stay).&quot;</span> [Yes]
12. [NA]
13. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎The principal summary measures (e.g., risk ratio, difference in means).&quot;</span> [Yes] 
14. <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span> [Yes]
15. [NA]
16. [NA]
17. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From 3681 retrieved articles, 7 studies enrolling 187 patients were analyzed.&quot;</span> [Yes]
18. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patient characteristics of the included studies are summarized in Tables 1 and 2.&quot;</span> [Yes]  
19. [NA]
20. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mucosal prolapse is common after repair of ARMs and can lead to bleeding and excoriation and may interfere with continence [19]. It is treated by excision and revision of the anorectal anastomosis to reduce mucosa soiling and improve sensation in the neoanal canal [19].&quot;</span> [Yes]
21. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There was no significant difference in operative time (p = 0.89).&quot;</span> [Yes]
22. [NA]  
23. [NA]
24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The pooled rate of mucosal prolapse and need for operative revision was not significantly different between LAARP compared to OPEN (p = 0.18)&quot;</span> [Yes]
25. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The overall quality of the evidence (GRADE) [29, 30] of the included articles was very low, and is summarized in the “GRADE Summary of Findings Table” (Table 3).&quot;</span> [Yes]
26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We followed rigorous systematic review methodology to assess the outcomes of children with RB/RP-ARMs undergoing LAARP and open surgical approaches as per the clinical studies available.&quot;</span> [Yes] 
27. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors would like to thank Neera Bhatnagar for her assistance with the search strategy, and Molly Barber for her assistance with editing the manuscript.&quot;</span> [Yes]
</pre>
<p><a name='147'></a></p>
</div>
<div id="shen-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3705-0' title='Open publication'>Shen
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here is my assessment of the PRISMA reporting for the provided publication:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic versus open surgery in children with choledochal cysts: a meta-analysis&quot;</span>
Clearly identified as a meta-analysis in the title.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Objective: To compare the safety and efficacy between laparoscopic and open cyst excision with hepaticojejunostomy for children with choledochal cysts using meta-analysis.&quot;</span>
Provided structured background, objectives, methods, results and conclusions in the abstract.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Choledochal cysts are rare congenital cystic dilations of the biliary tree that present primarily in female infants and young children and are more prevalent in East Asian populations [1, 2].&quot;</span>  
Described the rationale and context at the beginning of the introduction.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Objective: To compare the safety and efficacy between laparoscopic and open cyst excision with hepaticojejunostomy for children with choledochal cysts using meta-analysis.&quot;</span>
Stated the objectives with participants, interventions, comparisons, and outcomes (no study designs due to a meta-analysis). 

[No]
Did not indicate if a review protocol exists or provide registration information.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

inclusion criteria: (1) study reported on at least one of the outcome measures mentioned below: operative time, intraoperative blood loss, time to food intake, postoperative morbidity (including bile leakage, pancreatic leakage, cholangitis, pancreatitis, adhesive intestinal obstruction, abdominal bleeding, etc.,) and mortality, length of hospital stay; (2) population: children younger than 18 years with choledochal cysts; (3) intervention: laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy (LH) versus open cyst excision and Roux-en-Y hepaticojejunostomy (OH' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Inclusion criteria: (1) study reported on at least one of the outcome measures mentioned below: operative time, intraoperative blood loss, time to food intake, postoperative morbidity (including bile leakage, pancreatic leakage, cholangitis, pancreatitis, adhesive intestinal obstruction, abdominal bleeding, etc.) and mortality, length of hospital stay; (2) population: children younger than 18 years with choledochal cysts; (3) intervention: laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy (LH) versus open cyst excision and Roux-en-Y hepaticojejunostomy (OH).&quot;</span>
Specified eligibility criteria including participants, interventions, comparisons, and outcomes.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched databases, including PubMed, Embase, the Science Citation Index, and Cochrane Library updated to November 2014, to identify all related published studies comparing the laparoscopic and the open choledochal cyst excision with hepaticojejunostomy.&quot;</span>
Described the information sources including databases and dates searched.

[No]
Did not present the full electronic search strategy for any database. 

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

According to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract (Fig. 1). Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎According to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract. Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts.&quot;</span>
Stated the process of study screening and selection.

[No] 
Did not describe the data extraction process.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Information about the characteristics of the study population, authors, publication year, study period, country, sample size, interventions, outcomes details of the surgical techniques used, and relevant outcomes were recorded.&quot;</span>
Listed the data items extracted.

[NA]
No assessment of individual study bias (meta-analysis).

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The outcomes were operative time, intraoperative blood loss, time to food intake, postoperative morbidity and mortality, length of hospital stay.&quot;</span> 
Stated the summary measures used.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 87.8%):

heterogeneity and those >50 % as high heterogeneity. In case of lack of heterogeneity, fixed-effects model was used for the meta-analysis, or else random-effects model was used to explain it' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Heterogeneity was assessed using the I2 statistic. In case of lack of heterogeneity, fixed-effects model was used for the meta-analysis, or else random-effects model was used to explain it.&quot;</span>
Described methods for combining study results and assessing heterogeneity. 

[NA]
No assessment of publication bias (optional in meta-analyses).

[NA] 
No additional analyses mentioned.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

According to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract (Fig. 1). Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts. Reviewers had perfect agreement in selecting the 7 studies [9–15] considered to be suitable for the final meta-analysis using the stated eligibility criteria' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎According to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract. Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts. Reviewers had perfect agreement in selecting the 7 studies [9–15] considered to be suitable for the final meta-analysis using the stated eligibility criteria.&quot;</span> 
Presented the study selection process and numbers at each stage with reasons for exclusions.

[Yes] Table 1
Presented the characteristics of the included studies.

[NA] 
No assessment of individual study bias (meta-analysis).

[Yes] Figures 1-5
Presented simple summary data and effect estimates with confidence intervals for all outcomes.

[Yes] Figures 1-5
Presented results of each meta-analysis with confidence intervals and measures of heterogeneity.

[NA]
No assessment of bias across studies (optional in meta-analyses). 

[NA]
No additional analyses mentioned.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, laparoscopic cyst excision with Roux-en-Y hepaticojejunostomy is a safe and effective treatment option for choledochal cysts in children with comparable outcomes to open resection.&quot;</span>
Summarized the main findings and their relevance.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis has some limitations that should be taken into account when considering the results. First, there are no randomized trials comparing the two procedures. All seven included studies are retrospective studies which are prone to selection bias and may result in uneven distribution of confounding factors such as age of patient, duration of follow-up and type of choledochal cysts.&quot;</span>
Discussed limitations at the study and outcome level.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 98.3%):

my.

In conclusion, laparoscopic cyst excision with Roux-en-Y hepaticojejunostomy is a safe and effective treatment option for choledochal cysts in children with comparable outcomes to open resection. LH was associated with a shorter length of postoperative hospital stay and a lower blood loss when compared with open resection. With more refinement in equipment and technique, it will be possible to consider LH as a gold standard for treatment of pediatric choledochal' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In conclusion, laparoscopic cyst excision with Roux-en-Y hepaticojejunostomy is a safe and effective treatment option for choledochal cysts in children with comparable outcomes to open resection. With more refinement in equipment and technique, it will be possible to consider LH as a gold standard for treatment of pediatric choledochal cysts.&quot;</span>
Provided general interpretation and implications for future research.

[No]
No statement about sources of funding or other support.
</pre>
<p><a name='148'></a></p>
</div>
<div id="siddiqui-2011" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-010-2698-Y' title='Open publication'>Siddiqui
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[No]
The report does not identify itself as a systematic review, meta-analysis, or both.

[Yes] 
The abstract provides relevant background information and structured summary of the review.

[Yes]
The introduction describes the rationale for the review in context of existing knowledge.

[No]
The objectives do not provide an explicit statement of questions addressed with reference to PICOS.

[No] 
The methods do not indicate if a review protocol exists or provide registration information. 

[Yes]
The eligibility criteria specify study characteristics used, including PICOS and rationale.

[Yes]
The information sources describe databases searched with dates of coverage and date last searched.

[Yes]
The full search strategy for one database is presented. 

[Yes]  
The study selection process including screening, eligibility, and inclusion is described.

[Yes]  
The data collection process including extraction methods is described. 

[Yes]
The data items listing variables extracted are defined. 

[No] 
Methods for assessing individual study risk of bias are not described.

[Yes]
The principal summary measures are stated.

[NA]

[NA]

[NA]

[Yes]  
The study selection process is described with number of studies at each stage.

[Yes] 
Study characteristics are presented with citations for each study.

[No]
Risk of bias assessments for individual studies are not presented. 

[Yes] 
Results for outcomes are presented for each study with summary data and effect estimates.

[NA]

[NA] 

[NA]

[Yes] 
Key findings are summarized including strength of evidence and relevance to stakeholders.

[Yes] 
Limitations at study and outcome level are discussed.

[Yes]  
General interpretation of results in context of other evidence is provided with implications for future research.

[No]
Sources of funding are not described.
</pre>
<p><a name='149'></a></p>
</div>
<div id="siminas-2015" class="section level4">
<h4><a href='https://doi.org/10.1097/SLA.0000000000001191' title='Open publication'>Siminas
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Current Surgical Management of Pediatric Idiopathic Constipation A Systematic Review of Published Studies&quot;</span>
The title identifies the report as a systematic review.

[Yes] 
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
The abstract provides a structured summary with background, objectives, methods, results, and conclusions.

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>
The introduction describes the rationale and context for the review.

[Yes] 
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
The objectives in the abstract state the aim to evaluate surgical outcomes for pediatric idiopathic constipation.

[No]
The methods do not indicate if a review protocol exists or is registered.

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
The methods describe eligibility criteria including study design, participants, interventions, and outcomes. 

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
The search strategy is described including databases searched.

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
The search strategy for PubMed is provided.

[Yes] 
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
The selection process is described and depicted in a flow diagram.

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
The data extraction methodology is described.

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span> 
The extracted data including study characteristics and outcomes are listed.

[NA]
No meta-analysis was performed.

[NA]
No meta-analysis was performed. 

[NA]
No meta-analysis was performed.

[NA] 
No meta-analysis was performed. 

[NA]
No additional analyses performed.

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
A flow diagram depicts the study selection process including inclusions/exclusions.

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Study characteristics are summarized in tables. 

[No] 
Individual study risk of bias is not presented.

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
Study results are summarized for each intervention.

[NA] 
No meta-analysis was performed.

[NA]
No assessment of bias across studies was performed.

[NA]
No additional analyses were performed. 

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> 
The discussion summarizes the main findings and their relevance.

[Yes] 
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
Limitations at the study and review level are discussed.

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
The conclusions interpret the findings and provide implications for research.

[Yes]
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
No funding sources are declared.
</pre>
<p><a name='150'></a></p>
</div>
<div id="sklar-2014" class="section level4">
<h4><a href='https://doi.org/10.1089/lap.2013.0415 ' title='Open publication'>Sklar
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic Versus Open Reduction of Intussusception in Children: A Retrospective Review and Meta-analysis&quot;</span>
Reasoning: The title identifies the report as both a systematic review and meta-analysis.
[Yes]

Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎the results of these tests showed minimal heterogeneity (>0.10 for the Q test, >50% heterogeneity with the I2 statistic)&quot;</span>  
Reasoning: It describes synthesis methods.
[Yes]

Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We aimed to retrospectively review our institution's experience with the surgical treatment of intussusception, comparing the LAP and open approaches.&quot;</span>
Reasoning: It describes the rationale and context.  
[Yes]

Extracted quote: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 74.6%):

Our review identified five additional retrospective studies reporting on LAP versus open surgery. For' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Our review identified five additional retrospective studies reporting on LAP versus open surgery for the treatment of intussusception.&quot;</span>
Reasoning: It provides objectives relating to comparisons of interventions.
[Yes] 

Extracted quote: NA
Reasoning: No protocol described.
[No]

Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We only included comparative studies in the pediatric population (0–18 years of age)&quot;</span>
Reasoning: It specifies eligibility criteria relating to participants.
[Yes]

Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To identify all publications comparing LAP versus open surgery for intussusception in children, two researchers independently searched the electronic databases MEDLINE, Embase, CINAHL, and the Cochrane Library&quot;</span>
Reasoning: It describes information sources searched.
[Yes]

Extracted quote: NA 
Reasoning: No full search strategy provided.
[No]  

Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The researchers discussed any discrepancies to reach a mutual consensus regarding each study's eligibility for inclusion.&quot;</span>
Reasoning: It describes the study selection process.
[Yes]

Extracted quote: NA
Reasoning: No data collection process described. 
[No]

Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measure was the development of postoperative complications.&quot;</span>
Reasoning: It lists outcomes that were sought.
[Yes]

Extracted quote: NA
Reasoning: No assessment of risk of bias described.
[No]

Extracted quote: NA 
Reasoning: No summary measures stated.
[No] 

Extracted quote: NA
Reasoning: Not applicable - no meta-analysis performed.
[NA]

Extracted quote: NA
Reasoning: Not applicable - no assessment of bias across studies.
[NA]

Extracted quote: NA
Reasoning: Not applicable - no additional analyses described.  
[NA]

Extracted quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.8%):

FIG. 1.  Electronic search methodology and study selection' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Fig. 1. Electronic search methodology and study selection.&quot;</span>
Reasoning: It includes a flow diagram of study selection.
[Yes]

Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 2. MINORS Score for Each Study&quot;</span>
Reasoning: It presents study characteristics.
[Yes]

Extracted quote: NA
Reasoning: No assessment of risk of bias within studies presented.
[No] 

Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Individually, no studies found a statistically significant difference between groups with respect to overall complication rate.&quot;</span> 
Reasoning: It presents results for the complication outcome.
[Yes]

Extracted quote: NA 
Reasoning: Not applicable - no meta-analysis results.
[NA]

Extracted quote: NA
Reasoning: Not applicable - no assessment of bias across studies.
[NA] 

Extracted quote: NA
Reasoning: Not applicable - no additional analyses presented.
[NA]

Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In summary, our data suggest that LAP reduction of intussusception is as technically feasible, safe, and efficacious as the open approach and may even be beneficial in shortening LOS.&quot;</span>
Reasoning: It summarizes the main findings.
[Yes]

Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The current literature on this topic is limited to retrospective studies, which are inherently limited by methodological bias.&quot;</span>
Reasoning: It discusses limitations at the study level.
[Yes]

Extracted quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In summary, our data suggest that LAP reduction of intussusception is as technically feasible, safe, and efficacious as the open approach and may even be beneficial in shortening LOS.&quot;</span> 
Reasoning: It provides a general interpretation of the results.
[Yes]

Extracted quote: NA
Reasoning: No funding sources described.
[No]
</pre>
<p><a name='151'></a></p>
</div>
<div id="sola-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JSS.2009.05.007' title='Open publication'>Sola
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[No]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Peritoneal Drainage versus Laparotomy for Necrotizing Enterocolitis and Intestinal Perforation: A Meta-Analysis&quot;</span>
The title does not identify the report as a systematic review or meta-analysis.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective intervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).&quot;</span>
The abstract provides structured background, objectives, data sources, eligibility criteria, interventions, methods, results, conclusions and implications.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The surgical management of premature neonates with necrotizing enterocolitis (NEC) or isolated intestinal perforation (IP) remains controversial.&quot;</span>  
The introduction provides context about what is already known regarding the compared interventions.

[Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective intervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).&quot;</span>
The objectives specify the participants, interventions, outcomes, and study design (PICOS).

[No]
No statement about existence of a review protocol.

[Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies that evaluated only neonates with NEC and IP treated with either LAP (control) or PD (experimental treatment) were selected.&quot;</span>
The eligibility criteria specify characteristics of studies included. 

[Yes]   
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Ovid (Ovid Technologies New York, NY) and Medline search engines were used to examine both the Pubmed and Cochrane libraries from January 2000 to December 2008.&quot;</span>
The information sources and dates of coverage are described.

[No] 
The full search strategy for at least one database is not presented.

[Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two reviewers (JES, LGK), using a predefined data extraction form, extracted data from the publications related to gestational age, birth weight, type of operation, and mortality.&quot;</span> 
The process of study screening and selection is described.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two reviewers (JES, LGK), using a predefined data extraction form, extracted data from the publications related to gestational age, birth weight, type of operation, and mortality.&quot;</span>
The data collection process is described.

[Yes]   
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Gestational age, birth weight, type of operation, and mortality.&quot;</span>
The variables extracted are listed.

[NA]
No assessment of risk of bias in individual studies, as this is not mandatory for systematic reviews without meta-analysis.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Comparisons of dichotomous data were carried out using the Mantel-Haenszel statistical method under assumption of fixed effect analysis model.&quot;</span>
The principal summary measures are stated.

[NA] 
No synthesis of results, as this is a systematic review without meta-analysis.

[NA]  
No assessment of risk of bias across studies, as this is a systematic review without meta-analysis. 

[NA]
No additional analyses performed.

[No]
No flow diagram showing study selection. 

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 1 describes the characteristics of the included studies.&quot;</span>
Study characteristics are presented.

[NA] 
No assessment of risk of bias within studies, as this is not mandatory for systematic reviews without meta-analysis.

[No] 
No presentation of results of individual studies.

[NA]
No meta-analysis performed.

[NA]
No assessment of risk of bias across studies, as this is a systematic review without meta-analysis.

[NA]
No additional analyses performed.   

[No] 
No summary of main findings, including strength of evidence for each main outcome.

[No]
No discussion of limitations at study and outcome level or review level.

[No]
No general interpretation of results in context of other evidence. 

[No]
No statement about sources of funding.
</pre>
<p><a name='152'></a></p>
</div>
<div id="symeonidis-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.IJSU.2016.03.040' title='Open publication'>Symeonidis
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[Laparoendoscopic single-site surgery (LESS) for major urological procedures in the pediatric population: A systematic review]&quot;</span> - The title identifies the report as a systematic review. [Yes]

P2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In this review, we aim to elucidate the aspects of LESS for major urological procedures in the pediatric population.&quot;</span> - The abstract provides background and objectives. [Yes] 

P3. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 69%):

Recent improvements in laparoscopic surgical techniques have led to the introduction of laparoendoscopic single-site surgery (LESS), as an alternative to conventional laparoscopy (CL) conferring a number of possible advantages: better esthetic outcome, decreased incidence' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Recent improvements in laparoscopic surgical techniques have led to the introduction of laparoendoscopic single-site surgery (LESS), as an alternative to conventional laparoscopy (CL) conferring a number of possible advantages...As such, there is still a lack of comprehensive evidence regarding the feasibility, safety and efficacy of LESS for urologic procedures in children.&quot;</span> - The introduction describes the rationale in context of what is already known. [Yes]

P4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were: 1) pediatric patient population (age <18 years) 2) single site approach initially selected by the surgeon, 3) procedure carried out completely laparoendoscopically, 4) major urological procedure performed were limited to: nephrectomy, nephroureterectomy, pyeloplasty, varicocelectomy and partial nephrectomy 5) study population of more than one patient.&quot;</span> - The introduction provides objectives with reference to participants, interventions, outcomes, and study design. [Yes]

P5. "[Yes]" - A review protocol is not mentioned.  

P6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were: 1) pediatric patient population (age <18 years) 2) single site approach initially selected by the surgeon, 3) procedure carried out completely laparoendoscopically, 4) major urological procedure performed were limited to: nephrectomy, nephroureterectomy, pyeloplasty, varicocelectomy and partial nephrectomy 5) study population of more than one patient.&quot;</span> - Eligibility criteria for studies are specified. [Yes]

P7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An in-depth search of the literature was performed in the databases of PubMed and Scopus&quot;</span> - The information sources searched are described. [Yes]

P8. "[Yes]" - The full electronic search strategy is not presented. 

P9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two reviewers (ENS and DN) working independently extracted data from all eligible studies; any discrepancies were discussed and consensus was reached.&quot;</span> - The study selection process is described. [Yes] 

P10. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data on parameters such as operation time, instrumentation, perioperative complications, hospital stay and follow up period were collected and further analyzed cumulatively.&quot;</span> - The data collection process from studies is described. [Yes]  

P11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From each eligible study the following parameters were extracted when available: general study characteristics (author, date of publication), patient demographics (age and gender), procedure performed, indication, site of incision, details of surgical technique (entry device employed, access route, size of incision, laparoscopic instruments used, total operation time), intraoperative complications (including conversion to open surgery, use of additional ports and estimated blood loss (EBL)) and surgical outcome (length of hospital stay and post-operative complications).&quot;</span> - The variables extracted are listed. [Yes]

P12. "[Yes]" - Risk of bias assessment is not described. 

P13. "[Yes]" - Summary measures are not applicable for this descriptive review.  

P14. "[Yes]" - Methods of combining study results are not applicable. 

P15. "[Yes]" - Assessment of risk of bias across studies is not applicable. 

P16. "[Yes]" - Additional analyses are not described. 

P17. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Fig. 1. PRISMA flow diagram of Laparoendoscopic Single-Site Surgery (LESS) for major urologic procedures.&quot;</span> - The study selection process is presented in a figure. [Yes]

P18. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In total 29 studies met the inclusion criteria; these included data from 54 patients who underwent partial nephrectomy/nephroureterectomy, 165 and 19 patients who underwent transperitoneal and retroperitoneal nephrectomy/nephroureterectomy respectively, 91 patients who underwent pyeloplasty and 57 patients who underwent varicocelectomy.&quot;</span> - Study characteristics are presented. [Yes]

P19. "[Yes]" - Assessment of risk of bias within studies is not presented.  

P20. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 57.7%):

dren. Data on parameters such as operation time, instrumentation, perioperative complications, hospital stay' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Tables 1-6 present data on operation time, complications, hospital stay for the included studies.&quot;</span> - Results for individual studies are presented in tables. [Yes]

P21. "[Yes]" - Results of syntheses are not applicable. 

P22. "[Yes]" - Results of bias assessment across studies are not applicable. 

P23. "[Yes]" - Results of additional analyses are not applicable. 

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the hands of experienced surgeons LESS seems a feasible and attractive alternative to CL with comparable results.&quot;</span> - Main findings are summarized. [Yes]

P25. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎However given that the majority of studies included in this systematic review were either case-series or retrospective cohort studies with the risk of bias, especially publication-bias, remaining unambiguous, the results should be interpreted with caution.&quot;</span> - Study limitations are discussed. [Yes] 

P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There is an imperative need of well-designed prospective randomized trials, with large number of patients, in order to clarify the safety and long term efficacy of LESS for urological procedures in the pediatric population.&quot;</span> - Conclusions are provided. [Yes]

P27. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No funding received.&quot;</span> - Sources of funding are described. [Yes]
</pre>
<p><a name='153'></a></p>
</div>
<div id="tan-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDS.2015.12.074' title='Open publication'>Tan
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘wrong-response-partial-unclear-etc’</i>
<pre>
Here are the responses for the PRISMA 2009 checklist items:

The title identifies the report as a systematic review. [Yes]

Structured abstract provided background, objectives, data sources, eligibility criteria, appraisal and synthesis methods, results, limitations, conclusions. [Yes] 

The introduction describes the rationale in context of existing knowledge. [Yes]

The objectives specify the participants, interventions, comparisons, outcomes, and study designs. [Yes]

No protocol mentioned. [No]

Eligibility criteria described including study characteristics and report characteristics. [Yes] 

Information sources described including databases searched and dates. [Yes]

Full electronic search strategy provided for one database. [Yes]

Study selection process described including screening, eligibility, inclusion. [Yes]

Data extraction described including methods to obtain and confirm data. [Yes]

Variables extracted described including PICOS and funding sources. [Yes]

Individual study risk of bias assessment described but not at outcome level. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

Principal summary measures stated as risk ratio and difference in means. [Yes]

Study handling and synthesis methods described including measures of consistency. [Yes]

No assessment of risk of bias across studies. [NA] 

No additional analyses described. [NA]

Study selection process described using a flow diagram. [Yes]

Study characteristics presented for each study. [Yes]

Risk of bias presented for each study but not at outcome level. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>] 

Simple summary data presented for each intervention group in each study. [Yes]

Results of meta-analyses presented, including confidence intervals and consistency measures. [Yes]

No assessment of bias across studies. [NA]

No additional analyses. [NA]

Evidence summarized including strength and relevance. [Yes]

Limitations discussed at study and outcome level. [Yes]

General interpretation of results provided in context of other evidence. [Yes] 

Funding sources described. [Yes]
</pre>
<p><a name='154'></a></p>
</div>
<div id="terui-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3765-1' title='Open publication'>Terui
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. "[Yes]" - The title identifies the paper as a systematic review and meta-analysis.

P2. "[No]" - The abstract does not mention background, objectives, data sources, etc. as outlined in PRISMA. 

P3. "[Yes]" - The introduction describes the rationale for the review.

P4. "[No]" - The introduction does not explicitly state the PICOS framework.

P5. "[No]" - The methods do not mention a protocol or registration.

P6. "[Yes]" - The eligibility criteria are specified. 

P7. "[Yes]" - The information sources are described.

P8. "[Yes]" - The full search strategy is provided for one database.

P9. "[Yes]" - The study selection process is described.

P10. "[No]" - The data collection process is not described.

P11. "[No]" - The data items collected are not listed.

P12. "[No]" - Methods for assessing risk of bias are not described. 

P13. "[Yes]" - The summary measures are stated.

P14. "[NA]" - Not applicable since no meta-analysis was done.

P15. "[NA]" - Not applicable since no meta-analysis was done. 

P16. "[NA]" - Not applicable since no additional analyses were done.

P17. "[Yes]" - The study selection is shown in a flow diagram.

P18. "[Yes]" - Study characteristics are presented in a table.

P19. "[No]" - Risk of bias within studies is not presented.

P20. "[No]" - Results of individual studies are not shown.

P21. "[Yes]" - Results of the meta-analyses are presented. 

P22. "[NA]" - Not applicable since no assessment of bias across studies was done.

P23. "[NA]" - Not applicable since no additional analyses were done. 

P24. "[No]" - No summary of evidence is provided.

P25. "[No]" - Limitations are not discussed.

P26. "[No]" - No general interpretation of results is provided. 

P27. "[Yes]" - Funding is described.
</pre>
<p><a name='155'></a></p>
</div>
<div id="thomson-2015" class="section level4">
<h4><a href='https://doi.org/10.1136/BMJOPEN-2014-006063' title='Open publication'>Thomson
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic assistance for primary transanal pull-through in Hirschsprung's disease: a systematic review and meta-analysis&quot;</span>

The report is identified as a systematic review and meta-analysis. [Yes]

2. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

We present evidence from five retrospective studies of 405 patients.

    This is the first study to systematically review the available literature comparing totally transanal endorectal pull-through procedures with laparoscopically assisted pull-through procedures' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We present evidence from five retrospective studies of 405 patients. This is the first study to systematically review the available literature comparing totally transanal endorectal pull-through procedures with laparoscopically assisted pull-through procedures.&quot;</span>

The abstract provides a structured summary covering all key elements. [Yes]

3. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

In a recent survey of practice in the UK, the majority of responding surgeons who utilise an endorectal dissection employ laparoscopic surgery for biopsies or mobilisation.16

The aim of this study was to conduct a systematic review and meta-analysis to compare outcomes for infants with Hirschsprung&#39;s disease undergoing a TTERPT procedure with those undergoing a laparoscopically assisted transanal pull-through (LAPT' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In a recent survey of practice in the UK, the majority of responding surgeons who utilise an endorectal dissection employ laparoscopic surgery for biopsies or mobilisation. The aim of this study was to conduct a systematic review and meta-analysis to compare outcomes for infants with Hirschsprung's disease undergoing a TTERPT procedure with those undergoing a laparoscopically assisted transanal pull-through (LAPT).&quot;</span>  

The rationale and context for the review are described. [Yes]

4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to conduct a systematic review and meta-analysis to compare outcomes for infants with Hirschsprung's disease undergoing a TTERPT procedure with those undergoing a laparoscopically assisted transanal pull-through (LAPT).&quot;</span>

The objective comparing TTERPT and LAPT interventions is stated. [Yes]  

5. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A study protocol outlining the search strategy, outcomes, and methods of data extraction and statistical analysis was designed and prospectively registered with the Prospero database (CRD42013005698).&quot;</span>

The protocol registration is mentioned. [Yes]

6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Study inclusion and exclusion criteria are summarised in table 1.&quot;</span> 

Eligibility criteria are specified in Table 1. [Yes]

7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched all publications from 1 January 1998 to 1 January 2014 from EMBASE, MEDLINE and Cochrane library databases using the search strategy detailed in online supplementary appendix I.&quot;</span>

Information sources and search dates are described. [Yes]

8. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched all publications from 1 January 1998 to 1 January 2014 from EMBASE, MEDLINE and Cochrane library databases using the search strategy detailed in online supplementary appendix I.&quot;</span>

The full search strategy is provided in the appendix. [Yes] 

9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Titles and abstracts of potentially relevant papers were screened by two independent authors (DT and BA). The full texts of all identified studies were assessed against the criteria in table 1 by the two independent authors (DT and BA), and study reference lists were hand searched for potentially relevant studies.&quot;</span>

The study selection process is described. [Yes]

10. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were extracted by the two independent authors (DT and BA) using a predesigned proforma.&quot;</span>

Data extraction by two independent authors is mentioned. [Yes]

11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were collected regarding: age at gestation, diagnosis and surgery, level of anal dissection, length of mucosal cuff, length and location of aganglionosis, and any congenital abnormalities.&quot;</span> 

Variables extracted are listed. [Yes]

12. <span title='Moderate quote deviation. Best match in fulltext (Similarity 84.4%):

study quality using the Newcastle-Ottawa Scale for case–control and cohort studies' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Study quality was assessed using the Newcastle-Ottawa Scale for case–control and cohort studies.&quot;</span>

Risk of bias assessment is mentioned. [Yes] 

13. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Continuous data were analysed using an inverse variance model to produce a mean difference. Dichotomous variables were analysed using a Mantel-Haenszel model to produce ORs.&quot;</span>

Summary measures are stated. [Yes]

14. [NA] 

15. [NA] 

16. [NA]

17. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

A total of 2107 records were screened, of which 41 studies potentially met the eligibility criteria (figure 1). Thirty-one studies were excluded because there was no comparative study arm. Two were excluded because they used a posterior sagittal rather than a transanal approach.20 ,21 One study was excluded because it used a laparoscopic Duhamel-type anastomosis22 and one study because infants undergoing a staged procedure were pooled with primary procedure result' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A total of 2107 records were screened, of which 41 studies potentially met the eligibility criteria (figure 1). Thirty-one studies were excluded because there was no comparative study arm. Two were excluded because they used a posterior sagittal rather than a transanal approach. One study was excluded because it used a laparoscopic Duhamel-type anastomosis and one study because infants undergoing a staged procedure were pooled with primary procedure results.&quot;</span>

The results of the study selection process are summarized. [Yes]

18. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 2 summarises the characteristics of included studies.&quot;</span>

Study characteristics are presented in Table 2. [Yes]

19. <span title='Moderate quote deviation. Best match in fulltext (Similarity 84.4%):

study quality using the Newcastle-Ottawa Scale for case–control and cohort studies' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Study quality was assessed using the Newcastle-Ottawa Scale for case–control and cohort studies.&quot;</span> 

Risk of bias within studies is mentioned. [Yes]

20. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analysis using a fixed-effects model revealed a mean difference of 50.29 min shorter operative time with a totally transanal technique (95% CI 60.74 to 39.83, p<0.00001).&quot;</span>

Results for operative time are summarized. [Yes]

21. [NA]

22. [NA] 

23. [NA]

24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In general, these studies were of low quality, featuring heterogeneity with respect to outcome assessment, limited adjustment for potential confounders and inadequate long-term follow-up.&quot;</span> 

Key findings are summarized. [Yes]

25. <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

Despite acknowledgement that more complicated and extensive disease segments require some form of intra-abdominal approach, including laparoscopy, minilaparotomy, umbilical incision or formal laparotomy,11 ,12 there is currently a lack of guidance to determine when it is unsafe to attempt a TTERP' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Despite acknowledgement that more complicated and extensive disease segments require some form of intra-abdominal approach, including laparoscopy, minilaparotomy, umbilical incision or formal laparotomy, there is currently a lack of guidance to determine when it is unsafe to attempt a TTERPT.&quot;</span>

Limitations at study and outcome level are discussed. [Yes]

26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The issues we have raised regarding choice of operation would be best resolved by randomisation within a clinical trial of TTERPT versus LAPT approaches in patients with aganglionosis confined to the rectum and sigmoid colon on radiological assessment.&quot;</span> 

Implications for future research are described. [Yes]

27. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MK is funded by a National Institute for Health Research Professorship.&quot;</span>

Funding is stated. [Yes]
</pre>
<p><a name='156'></a></p>
</div>
<div id="thyoka-2013" class="section level4">
<h4><a href='https://doi.org/10.1007/S00247-013-2693-2' title='Open publication'>Thyoka
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia: a systematic review&quot;</span>
The title identifies the report as a systematic review.

[Yes]
<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.7%):

Here we review the current evidence of the outcomes of balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Here we review the current evidence of the outcomes of balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia in children.&quot;</span>  
The abstract provides a structured summary including background, objectives, and conclusions.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Benign oesophageal strictures in children may occur as a result of congenital anomalies or complications secondary to either caustic gastro-oesophageal reflux or surgical correction of oesophageal atresia.&quot;</span>
The introduction describes the rationale in context of existing knowledge.  

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In this review, we sought to review the current published evidence of the outcomes of balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia.&quot;</span>
The objectives are stated with reference to participants, interventions, and outcomes.

[No]
A review protocol was not mentioned.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes of interest were success of balloon dilatation (dysphagia improvement), incidence of oesophageal perforation and requirement of stent placement and/or oesophageal surgery (revision of anastomosis and/or oesophageal replacement).&quot;</span>
Eligibility criteria are specified including outcomes of interest.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched the standard databases (January, 1960–May, 2012): MEDLINE, EMBASE and Cochrane Library Controlled Trials Register (CENTRAL) using the MeSH Terms “esophageal stricture”, “esophageal stenosis” and “balloon dilatation” to identify the studies.&quot;</span> 
Information sources including databases and dates are described.

[No]
A full search strategy is not presented.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We decided, a priori, to limit our review to studies that reported outcomes of balloon dilatation (both endoscopically and under fluoroscopic control) of anastomotic strictures secondary to surgical repair of oesophageal atresia in children. There was no language restriction.&quot;</span>
The study selection process is described.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two reviewers (M.T. and A.T.) independently abstracted data from all studies onto a predefined data collection form.&quot;</span>
The data collection process is described.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes of interest were success of balloon dilatation (dysphagia improvement), incidence of oesophageal perforation and requirement of stent placement and/or oesophageal surgery (revision of anastomosis and/or oesophageal replacement).&quot;</span>
Variables extracted are listed.

[No] 
Risk of bias assessment is not described. 

[NA]
No meta-analysis was performed.

[NA]  
No meta-analysis was performed.

[NA]
No assessment of bias across studies is described.

[NA]
No additional analyses are mentioned. 

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We identified 26 studies from our search that were deemed relevant and these were further scrutinised for eligibility for inclusion in this review. Only five studies met the inclusion criteria; 21 studies were excluded for reasons outlined in the selection flow chart in Fig. 1.&quot;</span>
Study selection is depicted in a flow diagram.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 1 shows the characteristics of all the studies included in this review.&quot;</span> 
Study characteristics are presented in a table.

[No]
Risk of bias within studies is not presented.

[Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Tables 1 and 2.&quot;</span>
Summary data and effect estimates are presented for each study in tables. 

[NA] 
No meta-analysis results to synthesize.

[NA]
No assessment of bias across studies.

[NA]
No additional analyses mentioned.

[Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In total, at least 60% used general anaesthesia. The size of balloon catheter ranged from 4 mm to 22 mm (Tables 1 and 2).&quot;</span>
Main findings are summarized including outcomes.

[No]
Limitations are not discussed.

[Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Balloon dilatation for anastomotic strictures post-oesophageal atresia repair is safe, and associated with a low perforation and mortality rates, and approximately three dilatations are required per child. The perforation rates are very low and most perforations are amenable to non-operative management.&quot;</span>
Conclusions are provided in context of evidence.

[No]
Funding sources are not described.
</pre>
<p><a name='157'></a></p>
</div>
<div id="van-dalen-2015" class="section level4">
<h4><a href='https://doi.org/10.1002/14651858.CD008403.pub3' title='Open publication'>van
Dalen 2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the assessments for each PRISMA item based on the provided full text:

[No] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To ascertain differences in outcome between the minimally invasive and open surgical approaches for the treatment of solid intra‐abdominal or intra‐thoracic neoplasms in children.&quot;</span>
States the objective but not in the title.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After performing the searches of the electronic databases of CENTRAL, MEDLINE/PubMed AND EMBASE/Ovid, we identified 542 references (including 129 in the first update and 164 in the second update).&quot;</span>  
Reports the number of studies screened and included/excluded.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Even though results from adult RCTs in patients with colon cancer are promising (Buunen 2009; Lacy 2002; Leung 2004), the extrapolation of results from studies in adults to children is not possible, due to the different tumour biology of adult and paediatric malignancies, and the differences in the therapy and prognosis of cancer in children.&quot;</span>
Provides rationale for the review.

[No]
Does not explicitly state PICOS in objectives.

[No] 
Does not report whether a protocol exists.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies that compared MIS (e.g. laparoscopy or thoracoscopy) to open surgery (e.g. laparotomy or thoracotomy) were considered for inclusion.&quot;</span>
Specifies interventions compared. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched the following electronic databases: CENTRAL (The Cochrane Library 2014, Issue 1), MEDLINE/PubMed (from 1966 to 18 February 2014) and EMBASE/Ovid (from 1980 to 18 February 2014).&quot;</span>
Describes information sources.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The search strategies for the different electronic databases (using a combination of controlled vocabulary and text word terms) are reported in the Appendices (Appendix 1; Appendix 2; Appendix 3).&quot;</span>
Presents full search strategy.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After employing the search strategy described previously, two authors independently screened titles and abstracts to identify studies meeting the inclusion criteria.&quot;</span>
Describes study selection process. 

[NA]
No studies included.

[NA] 
No studies included.

[NA]
No studies included. 

[NA]
No studies included.

[NA]
No meta-analysis performed.

[NA]  
No assessment of bias across studies.

[NA]
No additional analyses.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎However, these studies were not randomised controlled trials (RCTs) or controlled clinical trials (CCTs) evaluating MIS in children with solid intra‐thoracic or intra‐abdominal neoplasms and were thus not eligible for inclusion in this review (See Figure 1 and the Characteristics of excluded studies table).&quot;</span>
Reports number of studies screened and excluded with reasons.

[NA] 
No studies included.

[NA]
No studies included. 

[NA]
No studies included.

[NA] 
No meta-analysis performed. 

[NA]
No assessment of bias across studies.

[NA]
No additional analyses.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In summary, our search did not identify any eligible RCTs or CCTs evaluating MIS for the treatment of solid intra‐thoracic or intra‐abdominal neoplasms in children.&quot;</span> 
Summarizes main findings.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Even though RCTs are the highest level of evidence, it should be recognised that data from non-randomised studies on the use of MIS in different types of solid intra‐thoracic and intra‐abdominal childhood tumours are available (Al‐Shanafey 2008; Castilho 2002; Duarte 2009; Iwanaka 2004; Leclair 2007; Metzelder 2007; Sailhamer 2003; Shanberg 2006; Spurbeck 2004; Varlet 2009; Warmann 2003). Although the results of these studies are promising they should be interpreted with caution due to the biases associated with non-randomised study designs.&quot;</span>
Discusses limitations at study level.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎However, the role of MIS as a primary curative technique compared to open surgery in children with solid intra‐thoracic or intra‐abdominal tumours can only be adequately determined through evaluation within prospective RCTs.&quot;</span>
Provides general interpretation and implications for research.

[No]
Does not describe sources of funding.
</pre>
<p><a name='158'></a></p>
</div>
<div id="vanden-berg-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.UROLONC.2015.07.003' title='Open publication'>Vanden
Berg 2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Nephron-sparing surgery for Wilms tumor: A systematic review☆&quot;</span>
The title identifies the report as a systematic review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched MEDLINE, EMBASE, the Cochrane Controlled Trials Register, Google Scholar, and Scopus electronic databases for studies published between 1980 and 2014 based on Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines [19].&quot;</span>
The abstract provides background, objectives, data sources, eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, and conclusions.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The major challenge in these children is to preserve renal function whereas adequately treating the tumors.&quot;</span> 
The introduction describes the rationale for the review in the context of what is already known.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

The objective of this systematic review was to examine the accumulated literature on the use of NSS among children with WT, both unilateral and bilateral' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The objective of this systematic review is to examine the accumulated literature on the use of NSS among children with WT, both unilateral and bilateral.&quot;</span>
The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, and outcomes. 

[NA] The methods do not indicate if a review protocol exists or provide registration information.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We included English-language studies of children (aged 18 y or younger) diagnosed with WT that compared the outcomes or effects of NSS vs. RN.&quot;</span>
The methods specify study characteristics used as criteria for eligibility.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched MEDLINE, EMBASE, the Cochrane Controlled Trials Register, Google Scholar, and Scopus electronic databases for studies published between 1980 and 2014 based on Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines [19].&quot;</span>
The methods describe information sources including databases searched and date last searched.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The exploded search terms were: “nephron-sparing surgery,” “partial nephrectomy,” or “nephron sparing surgery,” restricted to “tumor,” “mass,” “Wilms,” “cancer,” or “renal cell carcinoma.”&quot;</span>
The methods present the full electronic search strategy for at least one database.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The 2 reviewers, R.N.W.V. and E.N.B. independently reviewed all study abstracts in duplicate with disagreements resolved by the senior author (J.C.R.). Full-text articles appearing to meet selection criteria were reviewed, and study data was abstracted in the same manner.&quot;</span>
The methods state the process for selecting studies including screening, eligibility, and inclusion in the systematic review.

[Yes] <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 64.6%):

Full-text articles appearing to meet selection criteria were reviewed, and study data was abstracted in' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Full-text articles appearing to meet selection criteria were reviewed, and study data was abstracted in duplicate with differences resolved by the senior author.&quot;</span>
The methods describe the method of data extraction from reports and processes for obtaining and confirming data from investigators.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We included English-language studies of children (aged 18 y or younger) diagnosed with WT that compared the outcomes or effects of NSS vs. RN.&quot;</span>
The methods list variables for which data were sought including participants, interventions, comparisons, and outcomes. 

[NA] The methods do not describe methods used for assessing risk of bias of individual studies.

[NA] The methods do not state principal summary measures as no meta-analysis was performed. 

[NA] The methods do not describe methods of handling data and combining results of studies as no meta-analysis was performed.

[NA] The methods do not specify assessment of risk of bias across studies as no meta-analysis was performed.

[NA] The methods do not describe additional analyses such as sensitivity or subgroup analyses as no meta-analysis was performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We identified 694 articles, 118 of which were selected for full-text review and 66 of which were included in the final analysis.&quot;</span> 
The results give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 1. Included studies&quot;</span>
The results present characteristics of included studies such as sample size, interventions, and outcomes. 

[NA] The results do not present data on risk of bias within each study as no meta-analysis was performed.

[No] The results do not present summary data and effect estimates for each study.

[NA] The results do not present results of meta-analyses as no meta-analysis was performed. 

[NA] The results do not present assessment of risk of bias across studies as no meta-analysis was performed.

[NA] The results do not present additional analyses as no meta-analysis was performed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In summary, most contemporary studies reporting the use of NSS in children with WT report similar long-term outcomes to RN in regards to ESRD, tumor recurrence, tumor rupture and overall survival.&quot;</span>
The discussion summarizes the main findings including the strength of evidence for each main outcome.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Most included studies were retrospective case series with highly variable reporting quality; this made data abstraction particularly challenging.&quot;</span>
The discussion describes limitations at the study and outcome level such as risk of bias.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The short- and long-term risks and benefits of NSS and RN as “gold standard” treatments for all children, and for each individual child, are ripe areas for future comparative effectiveness research.&quot;</span>
The discussion provides a general interpretation of the results in the context of other evidence and implications for future research.

[No] The funding sources are not described.
</pre>
<p><a name='159'></a></p>
</div>
<div id="van-den-hondel-2014" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0033-1351663' title='Open publication'>van
den Hondel 2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the assessments for the 27 PRISMA items based on the provided full text:

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To Split or Not to Split: Colostomy Complications for Anorectal Malformations or Hirschsprung Disease: A Single Center Experience and a Systematic Review of the Literature&quot;</span>
The title identifies the report as a systematic review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Introduction The aim of this article is to identify the ideal type and location of colostomy in children with colorectal disease.&quot;</span>  
The abstract provides a structured summary including the objectives.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):

Introduction

Anorectal malformations and Hirschsprung disease are congenital malformations that show a wide clinical variety' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Introduction Anorectal malformations and Hirschsprung disease are congenital malformations that show a wide clinical variety.&quot;</span>
The introduction describes the rationale for the review. 

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 87.9%):

. The location of the stoma on the colon (or ileum) is determined by the position of the transition zon' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Introduction The location of the stoma on the colon (or ileum) is determined by the position of the transition zone.&quot;</span>
The introduction provides objectives with reference to participants, interventions, and outcomes.

[NA]
No review protocol or registration is mentioned.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Inclusion and Exclusion Criteria

Studies were eligible for inclusion when they reported a series of neonates (newborns under the age of 28 days) whose anorectal malformation or Hirschsprung disease was treated with a stoma, and reported on stoma type and location, complications of stoma formation or closure or mortality rates' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Inclusion and Exclusion Criteria Studies were eligible for inclusion when they reported a series of neonates (newborns under the age of 28 days) whose anorectal malformation or Hirschsprung disease was treated with a stoma, and reported on stoma type and location, complications of stoma formation or closure or mortality rates.&quot;</span>
The eligibility criteria are specified.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 86.1%):

The described search strategy yielded 877 citations in PubMed, 1,103 in Embase, and 367 in Web of Science' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Search Strategy The described search strategy yielded 877 citations in PubMed, 1,103 in Embase, and 367 in Web of Science.&quot;</span> 
The information sources are described.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.9%):

The general search terms were the same for the three databases, which are as follows: anorectal malformations, Hirschsprung disease, colostomy, and children. The exact search strategies are shown in Appendix 1' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Search Strategy The general search terms were the same for the three databases, which are as follows: anorectal malformations, Hirschsprung disease, colostomy, and children. The exact search strategies are shown in Appendix 1.&quot;</span>
The full electronic search strategy is presented for one database.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 91.8%):

ction

The two investigators selected the articles independently, extracted literature data, and recorded them in purpose-designed forms' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Study Selection The two investigators selected the articles independently, extracted literature data, and recorded them in purpose-designed forms.&quot;</span>
The study selection process is described.

[No] 
The data collection process is not described.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 86.9%):

These data concerned study design, study population, follow-up, survival, complications, and reoperations' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Data Extraction These data concerned study design, study population, follow-up, survival, complications, and reoperations.&quot;</span>
The data items are listed and defined. 

[NA] 
Individual study risk of bias is not discussed as no meta-analysis was performed.

[NA]
No meta-analysis was performed so summary measures are not applicable.

[NA] 
No meta-analysis was performed so synthesis methods are not applicable.

[NA]
No assessment of risk of bias across studies is presented.

[NA]
No additional analyses like sensitivity analyses were mentioned.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 95.3%):

Study Selection

The described search strategy yielded 877 citations in PubMed, 1,103 in Embase, and 367 in Web of Science. After deleting the duplicates, 1,325 publications remained. Eight of these met the inclusion and exclusion criteria ([Fig. 1' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Results Study Selection The described search strategy yielded 877 citations in PubMed, 1,103 in Embase, and 367 in Web of Science. After deleting the duplicates, 1,325 publications remained. Eight of these met the inclusion and exclusion criteria ([Fig. 1]).&quot;</span>
A flow diagram of study selection is provided.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 86.9%):

The eight studies included a total of 2,954 patients' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Results The eight studies included a total of 2,954 patients.&quot;</span> 
Study characteristics are presented.

[NA] 
No assessment of risk of bias within studies is presented.

[NA]
No meta-analysis was performed so results of individual studies are not applicable. 

[NA] 
No meta-analysis was performed so results of syntheses are not applicable.

[NA]
No assessment of bias across studies is presented. 

[NA]
No additional analyses are mentioned.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.7%):

Conclusion

A relatively high complication rate is described in colostomy formation in children with an anorectal malformation or Hirschsprung disea' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Discussion A relatively high complication rate is described in colostomy formation in children with an anorectal malformation or Hirschsprung disease.&quot;</span>
A summary of evidence is provided.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 90.4%):

The wide range of complication rates in the systematic review may be because of the inconsistency in defining complication' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Discussion The wide range of complication rates in the systematic review may be because of the inconsistency in defining complications.&quot;</span>
Limitations at the study and outcome level are discussed.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):

n. The procedure of colostomy formation in anorectal malformations and Hirschsprung disease is meticulous and should be performed with great ca' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Conclusion The procedure of colostomy formation in anorectal malformations and Hirschsprung disease is meticulous and should be performed with great care.&quot;</span> 
Conclusions are made including implications for practice.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎References&quot;</span>
Sources of funding are described.
</pre>
<p><a name='160'></a></p>
</div>
<div id="vernon-roberts-2013" class="section level4">
<h4><a href='https://doi.org/10.1002/14651858.CD006151.pub3 ' title='Open publication'>Vernon-Roberts
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Authors' declarations of interest&quot;</span>
Reports any potential conflicts of interest.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
Provides a structured abstract.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>  
Describes the rationale and background for the review.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
States the objectives using PICOS. 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
States no protocol was published.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
Specifies eligibility criteria using PICOS.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span>
Describes information sources and dates searched.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
Provides full search strategy for one database. 

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
Describes the study selection process. 

[No] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
Does not describe data extraction methods as no studies were included.

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>  
Not applicable as no data extracted.

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
Not applicable as no studies included.

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
Not applicable as no data synthesis performed.

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span> 
Not applicable as no meta-analysis performed.

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
Not applicable as no studies included. 

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
Not applicable as no additional analyses performed.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
Reports number of studies screened and excluded with reasons, and includes a flow diagram.

[No] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
Does not present study characteristics as no studies included.

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).&quot;</span>
Not applicable as no studies included.

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>  
Not applicable as no studies included.

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
Not applicable as no meta-analysis performed.

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of any assessment of risk of bias across studies (see Item P15).&quot;</span>  
Not applicable as no assessment of bias performed.

[NA] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).&quot;</span>
Not applicable as no additional analyses performed.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
Summarizes main findings and implications for practice and research.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
Discusses lack of evidence as a limitation.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
Provides interpretation and implications for future research.

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
Describes sources of funding.

</pre>
<p><a name='161'></a></p>
</div>
<div id="wang-2013" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-013-3335-3' title='Open publication'>Wang
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the assessments for each PRISMA item:

P1. “[Yes]” The title identifies the report as a systematic review. 

P2. “[Yes]” The abstract provides a structured summary including background, objectives, data sources, eligibility criteria, results, and conclusions.

P3. “[Yes]” The introduction describes the rationale for the review in context of existing knowledge.

P4. “[Yes]” The objectives explicitly state the PICOS elements being addressed. 

P5. “[No]” A review protocol is not mentioned.

P6. “[Yes]” Eligibility criteria are specified including PICOS and publication characteristics. 

P7. “[Yes]” The information sources searched are described including databases and dates.

P8. “[Yes]” The full search strategy is presented for one database. 

P9. “[Yes]” The study selection process is described including screening, eligibility, and inclusion.

P10. “[Yes]” The data collection process is described including extraction methods.

P11. “[Yes]” The data items sought are listed including outcomes.

P12. “[NA]” Risk of bias assessment is not applicable for this review without a meta-analysis.

P13. "[NA]" Summary measures are not applicable for this review without a meta-analysis.

P14. "[NA]" Synthesis methods are not applicable for this review without a meta-analysis. 

P15. "[NA]" Risk of bias across studies is not applicable for this review without a meta-analysis.

P16. "[NA]" Additional analyses are not applicable for this review without a meta-analysis.

P17. “[Yes]” The study selection is presented including a flow diagram of inclusions/exclusions.

P18. “[Yes]” Study characteristics are presented for which data were extracted. 

P19. "[NA]" Risk of bias within studies is not applicable for this review without a meta-analysis.

P20. "[NA]" Results of individual studies are not applicable for this review without a meta-analysis. 

P21. "[NA]" Synthesis of results is not applicable for this review without a meta-analysis.

P22. "[NA]" Risk of bias across studies is not applicable for this review without a meta-analysis.

P23. "[NA]" Additional analyses are not applicable for this review without a meta-analysis.

P24. “[Yes]” The main findings and limitations are summarized.

P25. “[Yes]” Limitations at the study and outcome level are discussed.

P26. “[Yes]” Conclusions are provided with implications for research.

P27. “[Yes]” Sources of funding are described.
</pre>
<p><a name='162'></a></p>
</div>
<div id="wayne-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3676-1' title='Open publication'>Wayne
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes]

[Yes] 

[Yes]

[Yes] 

[No]

[Yes]

[Yes] 

[No]

[Yes]

[Yes]

[Yes]

[No] 

[NA] 

[NA]

[NA]

[NA]

[Yes]

[Yes] 

[No]

[Yes]

[NA] 

[NA]

[NA]

[Yes]

[Yes]

[Yes] 

[Yes]
</pre>
<p><a name='163'></a></p>
</div>
<div id="weih-2012" class="section level4">
<h4><a href='https://doi.org/10.1007/S00423-011-0874-8' title='Open publication'>Weih
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the PRISMA assessments:

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Identify the report as a systematic review, meta-analysis, or both.&quot;</span>
The title states it is a systematic review. [Yes]  

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
The abstract provides background, objectives, eligibility criteria, results, and conclusions. [Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span>  
The introduction states <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although surgical and non-surgical therapeutic options have improved significantly in the last decade, various unsolved issues regarding the treatment of SBS persist.&quot;</span> [Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>
No explicit PICOS statement is provided. [No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.&quot;</span>
No mention of a protocol. [No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>
Eligibility criteria are not explicitly specified. [No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.&quot;</span> 
Only Medline is mentioned as the source. No dates provided. [No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.&quot;</span>
No full search strategy is presented. [No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
The process for study selection is not described. [No]  

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
No data extraction process described. [No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.&quot;</span>
No list of data items provided. [No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.&quot;</span>
No risk of bias assessment described. [No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span> 
Not applicable. [NA]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.&quot;</span>
Not applicable. [NA]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).&quot;</span>
Not applicable. [NA]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.&quot;</span>
Not applicable. [NA]  

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span>
No flow diagram or details on screening and exclusions provided. [No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> 
No study characteristics presented. [No]

<span title='Minor quote deviation. Best match in prompt (Similarity 96.2%):

Present data on risk of bias of each study and, if available, any outcome level assessment (see item' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).&quot;</span>
No assessment of risk of bias. [No]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> 
Not applicable. [NA]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present results of each meta-analysis done, including confidence intervals and measures of consistency.&quot;</span>
Not applicable. [NA]

<span title='Moderate quote deviation. Best match in prompt (Similarity 94.9%):

Present results of any assessment of risk of bias across studies (see Item' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Present results of any assessment of risk of bias across studies (see Item 15).&quot;</span>  
Not applicable. [NA]

<span title='Minor quote deviation. Best match in prompt (Similarity 95.7%):

Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).&quot;</span>
Not applicable. [NA]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
The discussion summarizes the main findings. [Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
No limitations discussed. [No]  

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
The conclusion provides an interpretation and implications. [Yes]

<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
Funding is acknowledged. [Yes]
</pre>
<p><a name='164'></a></p>
</div>
<div id="wenk-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.08.056' title='Open publication'>Wenk
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the assessments for each PRISMA item based on the provided full text:

P1. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Incidence of metachronous contralateral inguinal hernias in children following unilateral repair — A meta-analysis of prospective studies☆&quot;</span>
The title identifies the report as a systematic review and meta-analysis.

P2. [No] There is no structured abstract.

P3. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of the present meta-analysis study is to systematically appraise the incidence of metachronous contralateral childhood inguinal hernia following unilateral inguinal hernia repair using data from well-designed prospective studies.&quot;</span>  
The introduction describes the rationale for the review in the context of what is already known.

P4. [No] The objectives do not explicitly state the PICOS elements. 

P5. [NA] A review protocol is not mentioned.

P6. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria consisted of prospective observational studies (a), with minimal follow-up time of one year (b), assessing newborns, infants, children, adolescents and young adults, aged from 0 to 19 years (c), without contralateral groin exploration or laparoscopic closure of CPPV (d).&quot;</span>
The eligibility criteria relating to study characteristics and report characteristics are described.

P7. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Cochrane Central Register of Controlled Trials (The Cochrane library Issue 7 of 12, July 2014), MEDLINE (January 1966 to August 2014) and EMBASE (1947 to August 2014) were searched (Appendix 1 for detailed search strategy).&quot;</span>
The information sources including databases, dates of coverage, and search date are described.

P8. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For MEDLINE search the following search term was used: ‘(Infant OR Child OR Adolescent) AND ("inguinal Hernia" OR "processus vaginalis") AND (Incidence OR "Treatment Outcome" OR Recurrence OR Laparoscopy OR contralateral OR Surgery OR Examination) AND (english[Language] OR german[Language])’.&quot;</span>
The full electronic search strategy for one database is provided.

P9. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Six studies met the inclusion criteria [7], [28], [29], [30], [31], [32].&quot;</span> 
The process of study screening and selection is described.

P10. [No] The data collection process is not described.

P11. [No] The variables for which data were sought are not listed or defined.

P12. [No] Methods for assessing risk of bias are not described.

P13. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Since the test for heterogeneity was significant (p-value < 0.001), results from the random effect model were used.&quot;</span>
The principal summary measures are stated.

P14. [NA] There is no meta-analysis performed.

P15. [NA] Assessment of risk of bias across studies is not applicable without a meta-analysis.

P16. [NA] Additional analyses are not applicable without a meta-analysis. 

P17. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Six studies met the inclusion criteria [7], [28], [29], [30], [31], [32]. One study was restricted to male children aged 0.5 to 2 years [28]. In total 1669 children were included.&quot;</span>
The numbers of studies screened, assessed for eligibility, and included are described with reasons for exclusion.

P18. [Yes] Table 1 provides the characteristics of the included studies.

P19. [No] Risk of bias assessments for individual studies are not presented.

P20. [Yes] Figure 1 provides a forest plot with summary data and effect estimates with confidence intervals for each included study. 

P21. [NA] Results of meta-analyses are not applicable without a meta-analysis.

P22. [NA] Assessment of risk of bias across studies is not applicable without a meta-analysis.

P23. [NA] Additional analyses are not applicable without a meta-analysis.

P24. [Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):

The present meta-anlaysis shows that the overall risk of MCIH in children (aged 0–19 years) is 6' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The present meta-analysis shows that the overall risk of MCIH in children (aged 0–19 years) is 6%.&quot;</span>
A summary of the main findings and their relevance is provided.

P25. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Lack of uniformity in age restrictions and variation in inclusion and exclusion criteria (e.g. exclusion of patients with ascites) that were applied in different analyses may also have impacted on results [28], [29], [30], [31] (Table 1).&quot;</span>
Limitations at the study and outcome level are discussed.

P26. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The present meta-anlaysis shows that the overall risk of MCIH in children (aged 0–19 years) is 6%. The risk of MCIH development is significantly greater in children with initial left-sided hernia (8.5% vs. 3.3%) and in children with open CPV (13.8% vs. 3%).&quot;</span> 
The findings are interpreted in the context of other evidence and implications for future research are described.

P27. [Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There was no conflict of interest.&quot;</span>
Sources of funding and other support are described along with the role of funders.
</pre>
<p><a name='165'></a></p>
</div>
<div id="wilkinson-2012" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2010.11.008' title='Open publication'>Wilkinson
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are my responses for assessing the PRISMA items:

P1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎[Hypospadias]}&quot;</span> - The title identifies the report as a systematic review on hypospadias. [Yes]

P2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We report the findings of a systematic review of the postoperative complication rates following distal hypospadias surgery using these two techniques.&quot;</span> - The abstract summarizes the review including background, objectives, participants, interventions, and main results. [Yes] 

P3. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We report the findings of a systematic review of the postoperative complication rates following distal hypospadias surgery using these two techniques.&quot;</span> - The introduction describes the rationale for the review. [Yes]

P4. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To compare complication rates after distal hypospadias surgery using the tubularized incised plate (TIP) and Mathieu techniques.&quot;</span> - The objectives compare outcomes for two surgical techniques. [Yes]  

P5. "[Yes]" - The protocol and registration are not reported. 

P6. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Distal hypospadias was defined as preoperative meatal position distal to the mid-penile shaft.&quot;</span> - Eligibility criteria for studies are specified based on anatomy. [Yes]

P7. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For this meta-analysis, the Medline (1990–2009), Embase (1990–2009) and Cochrane databases were searched&quot;</span> - The information sources including databases and date ranges are described. [Yes]

P8. "[Yes]" - The full search strategy is not presented.  

P9. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All titles and abstracts were reviewed initially to select papers for full review if they contained results of distal hypospadias repairs using either the Mathieu or TIP repair.&quot;</span> - The study selection process is described. [Yes]

P10. "[Yes]" - The data collection process is not described. 

P11. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The presence or absence of urethral fistula or meatal/urethral stenosis was used as a primary outcome measure.&quot;</span> - The variables extracted are listed. [Yes]  

P12. "[Yes]" - Individual study bias assessment is not applicable without a meta-analysis. 

P13. "[Yes]" - Summary measures are not applicable without a meta-analysis. 

P14. "[Yes]" - Synthesis methods are not applicable without a meta-analysis.   

P15. "[Yes]" - Assessment of bias across studies is not applicable without a meta-analysis. 

P16. "[Yes]" - Additional analyses are not applicable without a meta-analysis. 

P17. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Following application of the inclusion and exclusion criteria, as previously described, 403 abstracts were reviewed and 129 papers retrieved for detailed analysis.&quot;</span> - The study selection process is described with numbers at each stage. [Yes]

P18. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 1. Included papers and summary of results.&quot;</span> - Study characteristics are presented in a table. [Yes]

P19. "[Yes]" - Individual study bias assessment is not applicable without a meta-analysis. 

P20. "[Yes]" - Results for each individual study are not presented.  

P21. "[Yes]" - Results of meta-analyses are not applicable without a meta-analysis.  

P22. "[Yes]" - Assessment of bias across studies is not applicable without a meta-analysis. 

P23. "[Yes]" - Additional analyses are not applicable without a meta-analysis. 

P24. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Both the Mathieu and TIP techniques have been shown to have low rates of postoperative complications.&quot;</span> - Main findings are summarized. [Yes]

P25. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Despite being perhaps the most common pathology dealt within paediatric urology, the level of evidence on which current practice is based remains limited to level 4, i.e. cases series [1].&quot;</span> - Limitations at the study and outcome level are discussed. [Yes]

P26. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There is no clear consensus on the ideal method of repair for distal hypospadias.&quot;</span> - Conclusions are provided. [Yes]

P27. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎None.&quot;</span> - Sources of funding are reported. [Yes]
</pre>
<p><a name='166'></a></p>
</div>
<div id="wright-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JURO.2013.02.3234' title='Open publication'>Wright
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. [Yes] <span title='Moderate quote deviation. Best match in prompt (Similarity 92.8%):

Identify the report as a systematic review, meta-analysis, or both' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎identified the report as a systematic review, meta-analysis, or both.&quot;</span> This study is identified as a systematic review and meta-analysis in the title.

P2. [No] There is no abstract or structured summary.

P3. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe the rationale for the review in the context of what is already known.&quot;</span> The introduction section provides background and rationale.

P4. [Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span> The objectives are clearly stated in the introduction. 

P5. [No] There is no mention of a review protocol.

P6. [Yes] The methods section specifies eligibility criteria including study characteristics and report characteristics.

P7. [Yes] The information sources including databases and dates searched are described.

P8. [No] The full search strategy is not presented.

P9. [Yes] The process of study selection including screening, eligibility assessment, and inclusion is described. 

P10. [Yes] The data collection process including extraction and confirmation is described.

P11. [Yes] Variables including outcomes sought are listed and defined. 

P12. [Yes] Methods for risk of bias assessment are described.

P13. [Yes] Principal summary measures are stated.

P14. [NA] No meta-analysis was done.

P15. [NA] No assessment of bias across studies was done. 

P16. [NA] No additional analyses were done.

P17. [Yes] Numbers of studies screened, assessed, and included are provided with exclusions and reasons.

P18. [Yes] Study characteristics are presented in tables.

P19. [Yes] Risk of bias is presented for each study.

P20. [Yes] Results are presented for each study.

P21. [NA] No meta-analysis results are presented.

P22. [NA] No assessment of bias across studies was done.

P23. [NA] No additional analyses were done. 

P24. [Yes] Main findings are summarized including strength of evidence. 

P25. [Yes] Limitations are discussed.

P26. [Yes] General interpretation and implications are provided.

P27. [No] No funding sources are described.
</pre>
<p><a name='167'></a></p>
</div>
<div id="yang-2011" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2011.04.001' title='Open publication'>Yang
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic vs open herniorrhaphy in the management of pediatric inguinal hernia: a systemic review and meta-analysis&quot;</span>
[Yes] The title identifies the report as a systematic review and meta-analysis.

P2: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
[No] The abstract does not contain all the recommended elements.

P3: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In recent years, LH has been evolved as a minimally invasive technique for PIH [7], [8]. In some centers, inguinal hernias have been treated routinely by the laparoscopic method, which is possible to discover the contralateral inguinal orifice [15].&quot;</span>  
[Yes] The introduction describes the rationale for the review.

P4: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎It has been believed that open hernia repair is still regarded as the gold standard for the treatment of PIH [9], [15]. It is important to critically evaluate the efficiency as well as the potential risks of laparoscopic techniques before they become the treatment modality of choice [9], [15].&quot;</span>
[No] The objectives do not explicitly mention PICOS.

P5: [NA] A review protocol is not mentioned. 

P6: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although no language restrictions were imposed initially, the search was limited to studies published in the English language for the full-text review and final analysis. Eligibility criteria included all available studies comparing LH with OH (without diagnostic hernioscopy) for the repair of PIH and with quantitative data on outcome parameters.&quot;</span>
[Yes] Eligibility criteria relating to PICOS and study characteristics are described.

P7: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All published studies until July 30, 2010, were searched with the terms laparoscopy, laparoscopic herniorrhaphy, pediatric inguinal hernia, and open herniorrhaphy from Medline (using PubMed as the search engine), Embase, Ovid, Web of Science, and Cochrane databases, without lower date limit.&quot;</span>
[Yes] Information sources including databases and dates are described. 

P8: [No] A full search strategy is not presented.

P9: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies with insufficient data for use in odds ratio (OR) analysis and 95% confidence interval (CI) or studies not providing adequate data to obtain mean values and standard deviation (SD) for continuous variables were excluded from the relevant calculations.&quot;</span> 
[Yes] The study selection process is described.

P10: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three reviewers (YCL, ZHY, and TQS) independently assessed selected studies, extracted, and tabulated data from each article with a predefined data extraction form.&quot;</span>
[Yes] Data collection process is described.

P11: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data regarding the following factors were considered: first author, publication date, study method, participant features, intervention characteristics, definition of complications, and outcome measures. Outcome parameters for inclusion were patients' age, sex, affected side, operative time, time to resume full activity, duration of hospital stay, recurrence, metachronic contralateral hernia, and complications.&quot;</span>
[Yes] Data items relating to PICOS are listed.

P12: [NA] Individual study bias assessment is not described.

P13: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Weighted mean differences (WMDs) and ORs were used for the analysis of continuous and dichotomous variables, respectively.&quot;</span>
[Yes] Summary measures are stated.

P14: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Statistical heterogeneity was assessed using the I2 statistics. If the I2 value was less than 50%, then a fixed effects meta-analysis was applied; if the I2 value was 50% or more, then the random effects meta-analysis was used [16], [17].&quot;</span> 
[Yes] Synthesis methods are described.

P15: [NA] No assessment of publication bias is mentioned.

P16: [NA] No additional analyses are mentioned. 

P17: [No] A study selection flow diagram is not provided.

P18: Table 1 provides summary characteristics for each included study.
[Yes] Study characteristics are presented.

P19: [NA] Individual study bias assessments are not presented.

P20: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although only one study provided the data in mean ± SD [18], with nonapplicable heterogeneity, the analysis revealed that the hospital stay of LH was not significantly different from that of OH (Fig. 3C; WMD = 0.01; 95% CI, −0.08 to 0.10; P = .83).&quot;</span>
[Yes] Results for each study are presented using summary data and effect estimates.

P21: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analysis of the pooled data revealed that the incidence of complications in OH group was not significantly different from that of LH group (OR, 0.80; 95% CI, 0.45–1.41; P = .44; Fig. 5A).&quot;</span>
[Yes] Results of syntheses are presented.

P22: [NA] No assessment of publication bias is presented.

P23: [NA] No additional analyses are presented.

P24: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, in this systemic review and meta-analysis, we demonstrated that LH is efficient for the inguinal hernia repair in children, with similar operative time for unilateral hernia, length of hospital stay, recurrence, and complication rates with OH. Laparoscopic herniorrhaphy is superior to OH in the repair of bilateral PIH and lower rates of metachronic contralateral hernia.&quot;</span>
[Yes] A summary of the main findings is provided.

P25: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Because of the limited case number and insufficient data, the current meta-analysis possesses potential shortcomings to exactly compare some essential parameters between LH and OH, such as theater time, cost, quality of treatment, and postoperative MCIH.&quot;</span> 
[Yes] Limitations at the study and outcome level are discussed.

P26: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We believe that until then, pediatric surgeons can make the better decision to choose LH or OH for the treatment of PIH.&quot;</span>
[Yes] Conclusions are made in the context of other evidence. 

P27: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Acknowledgment: This work was supported by the National Natural Science Foundation of China (no. 30200284, no. 30600278, no. 30772359, no. 81071997, no. 81072073), Program for New Century Excellent Talents in University (NCET-06-0641), Scientific Research Foundation for the Returned Overseas Chinese Scholars (2008-889), and Fundamental Research Funds for the Central Universities (2010JC025).&quot;</span>
[Yes] Sources of funding are described.
</pre>
<p><a name='168'></a></p>
</div>
<div id="yang-2013" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-013-3345-1' title='Open publication'>Yang
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes]

[Yes] 

[Yes]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).&quot;</span>

[NA]

[Yes] <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MEDLINE electronic database was searched in April 2013 using key words “postoperative intussusception”.&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MEDLINE electronic database was searched in April 2013 using key words “postoperative intussusception”.&quot;</span> 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All identified articles were independently assessed by three authors. The title and abstract of all potentially relevant articles were read to determine their relevance. Full articles were also scrutinized if the title and abstract were unclear.&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Detailed data regarding study design, patient characteristics, initial diagnoses, procedure types, time of POI onset, symptoms, treatment and type of intussusceptions were extracted into an electronic data sheet in a standardized manner.&quot;</span>

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data for each item were not available in every paper.&quot;</span>

[NA]

[NA]

[NA] 

[NA]

[Yes] 

[Yes] 

[Yes] 

[Yes] 

[Yes] 

[Yes] 

[Yes] 

[Yes] 

[Yes] 

[Yes]

[Yes] 

[Yes]
</pre>
<p><a name='169'></a></p>
</div>
<div id="youssef-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2016.02.010' title='Open publication'>Youssef
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
Here are the relevant quotes and assessments for each PRISMA item:

P1. [Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Flap versus fascial closure for gastroschisis: a systematic review and meta-analysis&quot;</span>
The title identifies the report as a systematic review and meta-analysis.

P2. [Yes]  
<span title='Minor quote deviation. Best match in prompt (Similarity 99.7%):

Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Abstract: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;</span>
The abstract provides a structured summary with all applicable elements.

P3. [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Gastroschisis (GS) is a congenital full thickness defect of the abdominal wall that is increasing in prevalence worldwide [1], [2].&quot;</span> 
The introduction describes the rationale for the review in context of existing knowledge.

P4. [Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The objective of this investigation was to compare the short-term outcomes of flap closure and fascial closure through a formal systematic literature review and meta-analysis.&quot;</span>
The introduction states the objective and specifies the population, interventions, and outcomes. 

P5. [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The protocol of this review was prospectively published in the PROSPERO registry (CRD42015016745) [13].&quot;</span>
The methods section indicates the review protocol was registered.

P6. [Yes]  
<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

Our inclusion criteria were formulated according to the ‘PICOS’ format as follows:

    •

    Population: All infants born alive with the diagnosis of GS and who underwent abdominal defect closure.
    •

    Intervention: Sutureless flap closure either primarily or after silo reduction, in simple and complex GS cases.
    •

    Control: Operative fascial closure under general anesthesia either primarily or after a silo, in simple and complex GS cases' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Our inclusion criteria were formulated according to the ‘PICOS’ format as follows: Population: All infants born alive with the diagnosis of GS and who underwent abdominal defect closure. Intervention: Sutureless flap closure either primarily or after silo reduction, in simple and complex GS cases. Control: Operative fascial closure under general anesthesia either primarily or after a silo, in simple and complex GS cases.&quot;</span>
The methods section specifies eligibility criteria regarding population, interventions, comparators, and study design.

P7. [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Papers with pertinent titles were systematically identified by searching the following sources: AMED, PubMed, MEDLINE, Cochrane, EMBASE, Africa-wide information, Biosys, Global Health, LLAOS, and Web of Science in November 2014 with no date or language restrictions.&quot;</span> 
The methods describe the information sources and date last searched.

P8. [Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For each of these databases, a search strategy guided by our institution's scientific librarian was established according to the database design (Appendix A).&quot;</span>
The methods provide the full search strategy for one database. 

P9. [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All of the resulting titles were twice inspected independently; papers were excluded if one of the following exclusion criteria were met: basic science or animal studies, non-comparative studies or case reports, or papers that did not include GS patients.&quot;</span>
The methods describe the study selection process including screening and eligibility.

P10. [No]
No quote provides details on data collection process.

P11. [Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes analyzed included: mortality, ventilation days, feeding parameters, length of stay (LOS), wound infection, resource utilization, and umbilical hernia incidence.&quot;</span> 
The methods list the variables extracted.

P12. [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Newcastle-Ottawa Scale (NOS) for case–control studies was used to critically appraise the quality of included papers [15].&quot;</span>
The methods describe the bias assessment at study level.

P13. [Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Given the presumed differences between study contexts, the random effects model (Mantel–Haenszel approach) was used to create standard forest plots of effect size and error bars, with heterogeneity reported for each analysis.&quot;</span>
The methods state the summary measures used in meta-analysis.

P14. [NA]
Not applicable, as no meta-analysis was performed.

P15. [NA]  
Not applicable, as no assessment of bias across studies was done. 

P16. [NA] 
Not applicable, as no additional analyses were reported.

P17. [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Out of 4494 titles found by electronic search and 4 by hand search, 1844 records were identified after duplicate removal. Title and abstracts screening subsequently excluded 1824 records. Twenty full-text papers were retrieved for further evaluation, of which 8 were also excluded. Finally, twelve studies (1 prospective [10] and 11 retrospective studies [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27]) were included for qualitative and quantitative analyses.&quot;</span>
The results provide study selection details with number excluded at each stage. 

P18. [No]
No quote provides summary data on study characteristics.

P19. [Yes]  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The quality of included studies was evaluated by the Newcastle-Ottawa Scale (NOS) for Assessing the case–control studies shown in Table 2. Included studies were of moderate to high quality, scoring between 6 and 9 out of possible nine stars.&quot;</span>
The results present assessment of bias risk within individual studies.

P20. [No] 
No quote provides summary data for each intervention group.

P21. [NA] 
Not applicable, as no meta-analysis was performed.

P22. [NA]
Not applicable, as no assessment of bias across studies was done.

P23. [NA]
Not applicable, as no additional analyses were reported. 

P24. [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis supports recent publications indicating that flap closure is associated with equivalent, if not superior outcomes, when compared to fascial closure.&quot;</span>
The discussion summarizes the main findings and considers their relevance.

P25. [Yes] 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The limitations of this review reflect the paucity of published comparative studies on the reviewed topic, the relatively low level of existing evidence, as well as a small sample size for most of the included studies.&quot;</span>
The discussion considers limitations at the study and outcome level.

P26. [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Further prospective evidence is needed to clarify the role of flap closure for patients with gastroschisis.&quot;</span> 
The conclusion provides implications for future research.

P27. [Yes]
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Acknowledgments: We are indebted to Elena Guadagno, the librarian at the Montreal Children's Hospital for her help with the literature search.&quot;</span>
The paper describes sources of funding and support.
</pre>
<p><a name='171'></a></p>
</div>
<div id="zhao-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3680-5' title='Open publication'>Zhao
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Single-incision versus conventional laparoscopic appendicectomy in children: a systematic review and meta-analysis&quot;</span>
The title identifies the report as a systematic review.

[Yes] <span title='Moderate quote deviation. Best match in fulltext (Similarity 76.4%):

Methods

An electronic search of EMBASE, PubMed, MEDLINE was performed' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Methods / Search strategy: An electronic search of EMBASE, PubMed, MEDLINE was performed.&quot;</span> 
The abstract describes the data sources.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Recently, with more and more surgeons focusing on single-incision laparoscopic surgery (SILS), this kind of surgical procedure has improved a lot in the minimally invasive surgical field [15]. Due to the advantage of reducing the trauma of surgical access and cosmetic benefits, single-incision laparoscopic appendicectomy (SILA) has been widely accepted in the past few years among surgeons [19, 20].&quot;</span>
The introduction describes the rationale for the review.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this systematic review and meta-analysis was to compare clinical outcomes between single-incision laparoscopic appendicectomy and conventional laparoscopic appendicectomy in children.&quot;</span>
The objectives are stated.

[No]
No protocol or registration is mentioned.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria: (1) clinical trails that compared single-incision versus conventional laparoscopic appendicectomy between 2000 and 2014; (2) children younger than 18 years with acute appendicitis; (3) original data included some of the following: operative time, length of hospital stay, postoperative recovery, and postoperative complications. Exclusion criteria: (1) no conventional laparoscopic appendicectomy as a control; (2) chronic appendicitis; and (3) duplicate publication or study did not provide sufficient original data.&quot;</span>
Eligibility criteria are described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An electronic search was performed using EMBASE, PubMed, MEDLINE from 2000 to 2014.&quot;</span> 
Information sources are described. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The search terms single-incision, transumbilical, three-port, conventional, laparoscopic surgery, children and appendectomy were used individually and in combination.&quot;</span>
The full search strategy is presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors independently extracted data from the list of the included studies, and a third reviewer was required for a final decision in the case of any discrepancies.&quot;</span>
The study selection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors independently extracted data from the list of the included studies, and a third reviewer was required for a final decision in the case of any discrepancies.&quot;</span>
The data collection process is described.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary objective of our analysis was to evaluate the operative time, length of hospital stay. Secondary objectives included an analysis of postoperative complications including wound infection, intra-abdominal infection, and ileus.&quot;</span> 
The data items are listed and defined. 

[No]
No risk of bias assessment is described.

[Yes] <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

For continuous variables, we calculated mean differences (MDs) with 95 % confidence intervals (CIs). For dichotomous variables, we used odds ratios (ORs' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎For continuous variables, we calculated mean differences (MDs) with 95% confidence intervals (CIs). For dichotomous variables, we used odds ratios (ORs).&quot;</span>
The summary measures are stated.

[NA]
No meta-analysis synthesis methods are described since there was only one meta-analysis.

[NA] 
No assessment of risk of bias across studies is described since there was only one meta-analysis.

[NA]
No additional analyses are described. 

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The initial search strategy identified 213 citations and 26 of them were retrieved for full text review. Twelve trials met total inclusion criteria (Fig. 1)&quot;</span>
The study selection process is summarized.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 1 outlines basic demographic data from each included study, including study style, male:female sex ratio and BMI (kg/m2) or weight (kg) in each group. Table 2 displays the primary and secondary outcome results from each study.&quot;</span>
Study characteristics are presented.

[No] 
No assessment of risk of bias within studies is presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta-analysis demonstrated no statistically significant in mean operating time for SILA compared with CLA (95 % CI −0.22 to 7.76; P = 0.06) (Fig. 2a).&quot;</span>
Results for operative time are presented.

[NA]
No synthesis of results is described since there was only one meta-analysis. 

[NA]
No assessment of risk of bias across studies is presented since there was only one meta-analysis.

[NA] 
No additional analyses are presented.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, our study suggests that SILA is a feasible and safe surgical procedure alternative to CLA for pediatric patients with appendicitis.&quot;</span> 
A summary of the evidence is provided.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our systematic review and meta-analysis does have some limitations. On one hand, the overall methodologic quality and reporting of the included trials in children was poor. Some included studies had rather small sample size. On the other hand, there was evidence of statistical heterogeneity among different studies in terms of operative time and length of hospital stay.&quot;</span>
Limitations at the study and outcome level are discussed.

[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, our study suggests that SILA is a feasible and safe surgical procedure alternative to CLA for pediatric patients with appendicitis. It reveals significantly shorter hospital stay and potential comparable operative time, postoperative complications such as wound infection, intra-abdominal infection, and ileus compared with CLA. However, most of the studies included in our meta-analysis were retrospective studies. Therefore, more prospective randomized controlled trials are needed in children to draw a more convincing conclusion.&quot;</span>
Conclusions and implications for future research are described.

[No]
No funding sources are described.
</pre>
<p><a name='172'></a></p>
</div>
<div id="zhu-2016" class="section level4">
<h4><a href='https://doi.org/10.1007/S10029-015-1423-0' title='Open publication'>Zhu
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Quote: Minimally invasive surgery for congenital diaphragmatic hernia: a meta-analysis
Reasoning: The title identifies the report as a meta-analysis.
[Yes]

P2. Quote: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
Reasoning: A structured abstract is provided.
[Yes]

P3. Quote: Describe the rationale for the review in the context of what is already known.
Reasoning: The rationale is described in the introduction. 
[Yes]

P4. Quote: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
Reasoning: No explicit PICOS statement provided.
[No]

P5. Quote: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
Reasoning: No mention of a protocol.
[No] 

P6. Quote: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
Reasoning: Eligibility criteria are specified.
[Yes]

P7. Quote: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.  
Reasoning: Information sources are described.
[Yes]

P8. Quote: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
Reasoning: No full search strategy provided.
[No]

P9. Quote: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
Reasoning: The study selection process is described.
[Yes]

P10. Quote: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
Reasoning: The data extraction process is not described.
[No] 

P11. Quote: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
Reasoning: Extracted variables are listed in Table 1.  
[Yes]

P12. Quote: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.  
Reasoning: Risk of bias assessment not described.
[No]

P13. Quote: State the principal summary measures (e.g., risk ratio, difference in means).
Reasoning: Summary measures stated.
[Yes]

P14. [NA]

P15. [NA] 

P16. [NA]

P17. Quote: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
Reasoning: A flow diagram of study selection is provided.
[Yes]

P18. Quote: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
Reasoning: Study characteristics presented in Table 1.
[Yes] 

P19. Quote: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
Reasoning: No risk of bias assessment presented.
[No]

P20. Quote: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
Reasoning: Outcome data presented with forest plots.
[Yes]

P21. [NA]

P22. [NA]

P23. [NA]

P24. Quote: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
Reasoning: Main findings are summarized in the discussion.
[Yes]

P25. Quote: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
Reasoning: Limitations are discussed.
[Yes]

P26. Quote: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
Reasoning: Conclusions are provided.
[Yes]

P27. Quote: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
Reasoning: No funding sources described.
[No]
</pre>
</div>
</div>
<div id="quote-accuracy" class="section level3">
<h3>Quote accuracy</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<ul>
<li>1573 quotes for 104 / 111 (93.7%) publications, median 15 (IQR
12-18, range 1-46)</li>
<li>819 / 1573 (52.1%) perfect <span
style="border-bottom: 1px dashed black;">quotes from the publication
fulltext</span></li>
<li>569 / 1573 (36.2%) perfect <span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">quotes from
the LLM prompt briefing</span></li>
<li>185 / 1573 (11.8%) quotes with deviations from source, where the
accuracy was measured by a <a
href="https://maxbachmann.github.io/RapidFuzz/Usage/distance/Levenshtein.html#normalized-similarity">“normalized
Levensthein similarity”</a> <span
style="border-bottom: 1px dashed black;"
title="Weights for insertion: 1, deletion: 0.5, substitution: 1.5. Penalizes &quot;positive hallucinations&quot; (insertions) more than omissions of e.g. brackets and references (deletions).">with
custom weights</span>, ranging from 0-100%
<ul>
<li><span style="background-color: #ffe9e2">90 minor</span> deviations
(95% ≤ similarity &lt; 100%); mean: 98%</li>
<li><span style="background-color: #ff9e81">66 moderate</span>
deviations (75% ≤ similarity &lt; 95%); mean: 89.1%</li>
<li><span style="background-color: red">29 major</span> deviations
(similarity &lt; 75%); mean: 57.5%</li>
</ul></li>
</ul>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-d226a1ddba808b13004c" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-d226a1ddba808b13004c">{"x":{"filter":"none","vertical":false,"fillContainer":false,"data":[["Heloury 2012","Ishii 2014","Lane 2010","Lansdale 2010","Lansdale 2010","Lee 2010","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mei 2011","Mullassery 2014","Nasr 2010","Nicolau 2011","Nicolau 2011","Parolini 2016","Parolini 2014","Parolini 2014","Peters 2013","Romao 2012","Ross 2015","Ross 2015","Ruttenstock 2010","Rynja 2011","Rynja 2011","Saldaña 2013","Saldaña 2013","Saldaña 2013","Saldaña 2013","Saldaña 2013","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Scholfield 2016","Sharp 2015","Sharp 2015","Sharp 2015","Sharp 2015","Shen 2015","Shen 2015","Shen 2015","Shen 2015","Shen 2015","Sklar 2014","Sklar 2014","Symeonidis 2016","Symeonidis 2016","Thomson 2015","Thomson 2015","Thomson 2015","Thomson 2015","Thomson 2015","Thomson 2015","Thyoka 2013","Vanden Berg 2016","Vanden Berg 2016","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","van den Hondel 2014","Weih 2012","Weih 2012","Weih 2012","Wenk 2015","Wright 2013","Youssef 2016","Youssef 2016","Zhao 2015","Zhao 2015","Al-Hozaim 2010","Al-Hozaim 2010","Apelt 2013","Apelt 2013","Aworanti 2014","Baker 2015","Billingham 2010","Billingham 2010","Black 2013","Castagnetti 2016","Chan 2014 (Pediatr Surg Int)","Chan 2014 (Pediatr Surg Int)","Chan 2014 (Pediatr Surg Int)","Chan 2014 (Pediatr Surg Int)","Chen 2013","Chen 2013","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Corbett 2015","Cullis 2016","Cundy 2014 (Eur J Pediatr Surg)","Dingemann 2014","Dingemann 2014","Dingemann 2014","Dingemann 2014","Dingemann 2014","Dingemann 2013","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Ells 2015","Feng 2015","Friedmacher 2012","Friedmacher 2012","Gallo 2012","Gallo 2012","Gallo 2012","Gallo 2012","Gallo 2012","Gallo 2012","Gallo 2012","Gallo 2012","Gallo 2012","Gallo 2012","Gosemann 2013","Gosemann 2013","Hall 2011"],["fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","prompt","prompt","prompt","fulltext","prompt","prompt","prompt","prompt","fulltext","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","prompt","prompt","fulltext","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","prompt","prompt","prompt","prompt","prompt","prompt","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext"],["<span title='Moderate quote deviation. Best match in fulltext (Similarity 94%):\n\nConclusions\n\nMinimally invasive adrenalectomy is promising for removal of small adrenal tumors. Long-term follow-up is required to evaluate the efficacy of MIA in neuroblastomas' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎In conclusion, MIA is promising for removal of small adrenal tumors. Long-term follow-up is required to evaluate the efficacy of MIA in neuroblastomas.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.9%):\n\nThere are two main limitations to the present review. The first limitation is that all of the reviewed studies were retrospective studies and the results were not recorded in a uniform manner to allow the data to be meta-analysed. Second, the numbers involved in these studies were small and this may skew the results' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The main limitations to the present review [...] Second, the numbers involved in these studies were small and this may skew the results [...]&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nTissue adhesives have been used in a number of medical applications, including traumatic lacerations, bronchopleural fistula repair, intestinal anastomosis and middle ear surgery [5–7] and for closure of the skin wounds following herniotomy [8] and recently advances have been made in the use of tissue glue in circumcision' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Tissue glues have been used in a number of medical applications, including traumatic lacerations, bronchopleural fistula repair, intestinal anastomosis and middle ear surgery [5–7] and for closure of the skin wounds following herniotomy [8] and recently advances have been made in the use of tissue glue in circumcision.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96%):\n\nNeonatal Endosurgical Congenital Diaphragmatic Hernia Repair\nA Systematic Review and Meta-Analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Neonatal] Endosurgical Congenital Diaphragmatic Hernia Repair: A Systematic Review and Meta-Analysis&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 68.5%):\n\nMEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched using the' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎MEDLINE (1950 to present), Embase (1980 to present) and Cochrane Controlled Trials Register databases were searched...The date of the last electronic search was 1st October 2009.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):\n\nObjective\n\nThe aim of the study was to review evidence-based data regarding the use of antibiotics for the treatment of appendicitis in children' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Objective The aim of the study was to review evidence-based data regarding the use of antibiotics for the treatment of appendicitis in children.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 87%):\n\n: Identify the report as a systematic review, meta-analysis, or both' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]\" - \"Identify the report as a systematic review, meta-analysis, or both.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 87.8%):\n\n: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]\" - \"Provide structured summary including background, objectives, data sources, methods, results, conclusions.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 71.2%):\n\n: Describe the rationale for the review in the context of what is already know' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]\" - \"Describe rationale for review in context of existing knowledge.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 64.6%):\n\n: Provide an explicit statement of questions being addressed with reference to partic' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]\" - \"Provide explicit question statement referring to PICOS.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 50.6%):\n\nEligibility criteria: Specify study characteristics' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]\" - \"Specify eligibility criteria including PICOS and other characteristics.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 61.8%):\n\n: Describe all information sources (e.g., databases' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]\" - \"Describe information sources including databases searched.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 82.1%):\n\n: Present full electronic search strategy for at least one database' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]\" - \"Present full search strategy for one database.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 76.1%):\n\n: State the process for selecting studies (i.e., screening, eligibility, inclu' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]\" - \"State process of study screening, eligibility, inclusion.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 82.2%):\n\n: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]\" - \"Describe data extraction, performed independently in duplicate.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 58.7%):\n\n: List and define all variables' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]\" - \"List and define variables extracted.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 72.2%):\n\n: State the principal summary measures (e.g., risk ratio, difference' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]\" - \"State principal summary measures like risk ratio and mean difference.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 20.3%):\n\nStudy selection:' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]\" - \"Provide study selection flow diagram with inclusions/exclusions.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 38.1%):\n\n, present characteristics' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]\" - \"Present characteristics of included studies in table.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 63.1%):\n\n), present, for each study: (a) simple summary data for each intervention group (b) effect estimates' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]\" - \"Present summary data and effect estimates for outcomes.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 52.9%):\n\n: Summarize the main findings in' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes]\" - \"Summarize main findings and implications.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 82.5%):\n\n: Discuss limitations at study and outcome level' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]\" - \"Discuss limitations at study and outcome level.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 86.3%):\n\n: Provide a general interpretation of the results in the context of other evidence' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]\" - \"Provide interpretation of results in context of other evidence.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 79.6%):\n\n: Describe sources of funding for the systematic review' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes]\" - \"Describe sources of funding for review.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.3%):\n\nData were extracted using a custom designed proforma before commencement of the search strategy for first author, publication date, study center institution, time period of study, participant age range, chemotherapy regime, MYCN status, stage, 3 and stage 4 sample size defined by INSS, number of GTR and STR operations performed, 5-year overall survival (OS), 5-year disease free survival, and reported surgical complications' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data were extracted [...] for first author, publication date, study center institution, time period of study, participant age range, chemotherapy regime, MYCN status, stage, 3 and stage 4 sample size defined by INSS, number of GTR and STR operations performed, 5-year overall survival (OS), 5-year disease free survival, and reported surgical complications.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.3%):\n\nPectus excavatum is the most common congenital chest wall abnormality occurring in 8 per 1000 live births. The defect is noticeable at birth in 86% of infants, whereas a later onset is observed in patients with Marfan syndrome. The indications for repair of pectus excavatum are essentially cosmetic [1], [2], [3], [4' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Pectus excavatum is the most common congenital chest wall abnormality in children. The indications for repair of pectus excavatum are essentially cosmetic [1], [2], [3], [4].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\nLaparoscopia diagnosticã æi terapeuticã în contuziile abdomi-\nnale (CA) are o utilizare limitatã æi chiar controversatã,\ndatoritã în special progreselor fãcute de explorãrile imagistice\nactuale' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Laparoscopy diagnosticã æi terapeuticã în contuziile abdomi-nale (CA) are o utilizare limitatã æi chiar controversatã, datoritã în special progreselor fãcute de explorãrile imagistice actuale.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):\n\nÎn concluzie, deæi puåin utilizatã, dovada fiind æi\nnumãrul redus de articole publicate, laparoscopia poate fi utilã\nla pacienåii cu CA atent selectaåi cu examen clinic æi imagis-\nticã echivoce în scopul reducerii incidenåei laparotomiilor\ninutile' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎În concluzie, deæi puåin utilizatã, dovada fiind æi numãrul redus de articole publicate, laparoscopia poate fi utilã la pacienåii cu CA atent selectaåi cu examen clinic æi imagisticã echivoce în scopul reducerii incidenåei laparotomiilor inutile.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.5%):\n\nhe management of newborns with esophageal atresia and right aortic arch: A systematic review or still unsolved problem' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[The management of newborns with esophageal atresia and right aortic arch: A systematic review or still unsolved problem]&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nThe PubMed database (http://www.ncbi.nlm.nih.gov/pubmed/\n\n) was searched for studies on treatment of H-type TEF that were published since January 1977' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The PubMed database (http://www.ncbi.nlm.nih.gov/pubmed/) was searched for studies on treatment of H-type TEF that were published since January 1977.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.7%):\n\nFor the thoracoscopic group all the five eligible studies [24], [25], [26], [27], [28] included the primary outcom' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎For the thoracoscopic group all the five eligible studies included the primary outcome.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.7%):\n\ned. Series were updated where possible by personal communication with the author. Patient characteristics, indications, morbidity, and mortality were analyzed' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Methods: Series were updated where possible by personal communication with the author. Patient characteristics, indications, morbidity, and mortality were analyzed.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 95%):\n\nLarge defects of the diaphragm have been associated with more severe pulmonary hypoplasia and poorer survival [1]; the past 2 decades have witnessed an improvement in medical management of patients with CDH with the use of gentle ventilation and delayed surgical repair, thus leading to improved survival rates in many centers [2]. Concomitantly, there has been a rise in the incidence of patch repairs [3], [11] and also increased long-term morbidity [4' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Larger defects of the diaphragm in patients with CDH have been associated with more severe pulmonary hypoplasia and poorer survival [1]; the past 2 decades have witnessed an improvement in medical management of patients with CDH with the use of gentle ventilation and delayed surgical repair, thus leading to improved survival rates in many centers [2]. Concomitantly, there has been a rise in the incidence of patch repairs [3], [11] and also increased long-term morbidity [4].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):\n\nWe performed a systematic review and meta-analysis of the literature comparing use of a PFS with alternate treatment strategies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We performed a systematic review and meta-analysis of the literature comparing the use of a PFS with alternate treatment strategies.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 72.1%):\n\nt with a PFS or alternate strategy was poorly defined, if at all. As a result there is significant potential for both treatment and selection biases to influence the findings of this analysis' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎The quality of evidence comparing PFS with alternate treatment strategies for gastroschisis is poor.\" \"As a result there is significant potential for both treatment and selection biases to influence the findings of this analysis.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 77%):\n\nreports found the incidence of HAEC to be unrelated to type and timing of definitive surgery [15, 19, 30, 34, 36]. In the present review, postoperative HAEC occurred in 92 patients, which lead to an incidence rate of HAEC of 10.2' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The reported incidence of post pull-through HAEC ranges from 4.6 to 54% in various series... In the present review, postoperative HAEC occurred in 92 patients, which lead to an incidence rate of HAEC of 10.2%.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\nStudies on long-term outcomes after hypospadias repair in childhood are scarce. They are characterized by high loss to follow up (51.6%), and heterogeneous patients and data, and they lack validated questionnaires and control groups' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Studies on the long-term outcomes after hypospadias repair in childhood are scarce. They are characterized by high loss to follow up (51.6%), and heterogeneous patients and data, and they lack validated questionnaires and control groups.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 87.1%):\n\nIn future studies, the cosmetic aspect should be evaluated using validated questionnaires only. This rules out subjectivity as much as possible and leads to outcomes that can be compared.\nSexuality\n\nSexuality was thoroughly investigated in the eligible studies. However, none used an age-validated questionnaire and definitions used for' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎In future studies, the cosmetic aspect should be evaluated using validated questionnaires only. This rules out subjectivity as much as possible and leads to outcomes that can be compared. Sexual function should be evaluated with a sexual questionnaire validated for young adults.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nIn the search for less invasive procedures, ever since the development of laparoscopic surgery and with the limitations and equipment dependence of Natural Orifice Translumenal endoscopic surgery (NOTES®; American Society for Gastrointestinal Endoscopy [Oak Brook, IL] and Society of American Gastrointestinal and Endoscopic Surgeons [Los Angeles, CA]), this new approach through the umbilicus, a natural embrionary orifice,1 was first reported in 1992 by Pelosi and Pelosi' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In the search for less invasive procedures, ever since the development of laparoscopic surgery and with the limitations and equipment dependence of Natural Orifice Translumenal endoscopic surgery (NOTES®), this new approach through the umbilicus, a natural embrionary orifice,1 was first reported in 1992 by Pelosi and Pelosi.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.8%):\n\nmes. An electronic search in PubMed up to March 2012 was conducted with the following terms: “single” AND “incision” OR “site” OR “port” OR “trocar” AND “children.” Related articles were also reviewed' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We performed an electronic search in PubMed up to March 2012 with the following terms: “single” AND “incision” OR “site” OR “port” OR “trocar” AND “children.” Related articles were also reviewed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nPorts were defined as the access device chosen to perform the single-incision surgery. In pediatrics, these include multilumen devices such as the SILS™ Port (Covidien, Inc., Mansfield, MA) or the TriPort (Advanced Surgical Concepts, Bray, Ireland, United Kingdom) or the use of multiple cannulas or the combination of one-cannula and stab fascial incisions for passage of the instruments through a single skin incision' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Ports were defined as the access device chosen to perform the single-incision surgery. In pediatrics, these include multilumen devices such as the SILSTM Port (Covidien, Inc., Mansfield, MA) or the TriPort (Advanced Surgical Concepts, Bray, Ireland, United Kingdom) or the use of multiple cannulas or the combination of one-cannula and stab fascial incisions for passage of the instruments through a single skin incision.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nThe mean operative time was longer with the SIPES approach in the prospective trial of St Peter et al.,6 where a 10% conversion rate was described, a value similar to our 10.7% conversion rate found in this review (Table 5' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The mean operative time was longer with the SIPES approach in the prospective trial of St Peter et al., where a 10% conversion rate was described, a value similar to our 10.7% conversion rate found in this review (Table 5).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nFrom this systematic review we conclude:\n\n    • A wide experience in SIPES and its feasibility have already been described with good clinical outcomes and low rate of conversion' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎From this systematic review we conclude: A wide experience in SIPES and its feasibility have already been described with good clinical outcomes and low rate of conversion.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 93.3%):\n\nIdentify the report as a systematic review, meta-analysis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Identify the report as a systematic review and meta-analysis&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 96.3%):\n\nProvide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Provide a structured summary including background, objectives, data sources, eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 92.8%):\n\nAbstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Abstract provides structured summary with background, objectives, data sources, eligibility criteria, participants, interventions, results, conclusions.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 99.2%):\n\nProvide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Provide explicit questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 71.9%):\n\ncompared long-term outcomes for open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for HD, to identify any added advantage of the laparoscopic technique' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Our study is the first systematic review and meta-analysis comparing long-term outcomes for open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for HD, to identify any added advantage of the laparoscopic technique.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 99.2%):\n\nIndicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Indicate if a review protocol exists and if available, provide registration information including registration number.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 98.9%):\n\nSpecify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Specify study characteristics and report characteristics used as criteria for eligibility.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 89.9%):\n\nDescribe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Describe all information sources including databases, contact with authors, and date last searched.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 86.9%):\n\nState the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎State process for selecting studies including screening, eligibility, inclusion in review, and inclusion in meta-analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nData collected included study characteristics (author, journal, publication year, sample size, length of follow-up, and operative technique) and patient demographics (sex and age at surgery). Outcome parameters included incidence of enterocolitis, constipation, fecal incontinence or soiling, and further surgery, length of operation, length of hospital stay, and time taken to tolerate full oral feeds' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data collected included study characteristics and patient demographics. Outcome parameters included incidence of enterocolitis, constipation, fecal incontinence or soiling, and further surgery, length of operation, length of hospital stay, and time taken to tolerate full oral feeds.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 99%):\n\nDescribe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe method of data extraction and processes for obtaining and confirming data from investigators.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 95.2%):\n\nList and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎List and define all variables for which data were sought including assumptions and simplifications made.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 98.8%):\n\nDescribe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe methods for assessing risk of bias and how this information is to be used.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 97%):\n\nState the principal summary measures' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎State principal summary measures.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 98.2%):\n\nDescribe the methods of handling data and combining results' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe methods of handling data and combining results.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 86%):\n\ny assessment of risk of bias across studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Specify assessment of risk of bias across studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 99%):\n\nGive numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusion' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included with reasons for exclusion.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 89.4%):\n\npresent characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Present characteristics of included studies and provide citations.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 93.2%):\n\nPresent data on risk of bias of each study' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Present data on risk of bias for each study.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 78.2%):\n\npresent, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Present simple summary data, effect estimates, and confidence intervals for each study.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 97.8%):\n\nPresent results of each meta-analysis done, including confidence intervals and measures of consistency' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Present results of meta-analyses including confidence intervals and measures of consistency.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 98.4%):\n\nPresent results of any assessment of risk of bias across studies' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Present results of assessment of risk of bias across studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 98.6%):\n\nSummarize the main findings including the strength of evidence for each main outcome' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Summarize main findings including strength of evidence for each outcome.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 97%):\n\nDiscuss limitations at study and outcome level (e.g., risk of bias), and at review-level' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Discuss limitations at study and outcome level and at review level.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 99.1%):\n\nProvide a general interpretation of the results in the context of other evidence, and implications for future research' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Provide general interpretation of results in context of other evidence and implications for future research.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 97.9%):\n\nDescribe sources of funding for the systematic review and other support (e.g., supply of data); role of funders' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe sources of funding and role of funders.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 89.1%):\n\nTreatment of Idiopathic Achalasia in the Pediatric Population: A Systematic Review' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes]\" - \"Treatment of Idiopathic Achalasia in the Pediatric Population: A Systematic Review&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.8%):\n\nAchalasia is a rare neuromuscular disorder of the esophagus, characterized as a syndrome of impaired relaxation of the lower esophageal sphincter (LES) and decreased peristalsis of the esophageal body' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes]\" - \"Achalasia is a rare neuromuscular disorder of the esophagus, characterized as a syndrome of impaired relaxation of the lower esophageal sphincter (LES) and decreased peristalsis of the esophageal body.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.3%):\n\nWe intend to delineate the best initial treatment for achalasia and synthesize the current body of literature on outcomes from initial treatment of pediatric achalasia with pneumatic dilatation (PD) versus surgical Heller esophagomyotomy (HM' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes]\" - \"We intend to delineate the best initial treatment for achalasia and synthesize the current body of literature on outcomes from initial treatment of pediatric achalasia with pneumatic dilatation (PD) versus surgical Heller esophagomyotomy (HM).&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.9%):\n\nStudies were identified by searching the electronic database MEDLINE (OVID), and by hand search of reference lists for further relevant articles' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes]\" - \"Studies were identified by searching the electronic database MEDLINE (OVID), and by hand search of reference lists for further relevant articles.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\ninclusion criteria: (1) study reported on at least one of the outcome measures mentioned below: operative time, intraoperative blood loss, time to food intake, postoperative morbidity (including bile leakage, pancreatic leakage, cholangitis, pancreatitis, adhesive intestinal obstruction, abdominal bleeding, etc.,) and mortality, length of hospital stay; (2) population: children younger than 18 years with choledochal cysts; (3) intervention: laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy (LH) versus open cyst excision and Roux-en-Y hepaticojejunostomy (OH' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Inclusion criteria: (1) study reported on at least one of the outcome measures mentioned below: operative time, intraoperative blood loss, time to food intake, postoperative morbidity (including bile leakage, pancreatic leakage, cholangitis, pancreatitis, adhesive intestinal obstruction, abdominal bleeding, etc.) and mortality, length of hospital stay; (2) population: children younger than 18 years with choledochal cysts; (3) intervention: laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy (LH) versus open cyst excision and Roux-en-Y hepaticojejunostomy (OH).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nAccording to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract (Fig. 1). Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎According to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract. Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 87.8%):\n\nheterogeneity and those >50 % as high heterogeneity. In case of lack of heterogeneity, fixed-effects model was used for the meta-analysis, or else random-effects model was used to explain it' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Heterogeneity was assessed using the I2 statistic. In case of lack of heterogeneity, fixed-effects model was used for the meta-analysis, or else random-effects model was used to explain it.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nAccording to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract (Fig. 1). Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts. Reviewers had perfect agreement in selecting the 7 studies [9–15] considered to be suitable for the final meta-analysis using the stated eligibility criteria' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎According to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract. Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts. Reviewers had perfect agreement in selecting the 7 studies [9–15] considered to be suitable for the final meta-analysis using the stated eligibility criteria.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.3%):\n\nmy.\n\nIn conclusion, laparoscopic cyst excision with Roux-en-Y hepaticojejunostomy is a safe and effective treatment option for choledochal cysts in children with comparable outcomes to open resection. LH was associated with a shorter length of postoperative hospital stay and a lower blood loss when compared with open resection. With more refinement in equipment and technique, it will be possible to consider LH as a gold standard for treatment of pediatric choledochal' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In conclusion, laparoscopic cyst excision with Roux-en-Y hepaticojejunostomy is a safe and effective treatment option for choledochal cysts in children with comparable outcomes to open resection. With more refinement in equipment and technique, it will be possible to consider LH as a gold standard for treatment of pediatric choledochal cysts.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 74.6%):\n\nOur review identified five additional retrospective studies reporting on LAP versus open surgery. For' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Our review identified five additional retrospective studies reporting on LAP versus open surgery for the treatment of intussusception.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.8%):\n\nFIG. 1.  Electronic search methodology and study selection' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Fig. 1. Electronic search methodology and study selection.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 69%):\n\nRecent improvements in laparoscopic surgical techniques have led to the introduction of laparoendoscopic single-site surgery (LESS), as an alternative to conventional laparoscopy (CL) conferring a number of possible advantages: better esthetic outcome, decreased incidence' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Recent improvements in laparoscopic surgical techniques have led to the introduction of laparoendoscopic single-site surgery (LESS), as an alternative to conventional laparoscopy (CL) conferring a number of possible advantages...As such, there is still a lack of comprehensive evidence regarding the feasibility, safety and efficacy of LESS for urologic procedures in children.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 57.7%):\n\ndren. Data on parameters such as operation time, instrumentation, perioperative complications, hospital stay' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Tables 1-6 present data on operation time, complications, hospital stay for the included studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nWe present evidence from five retrospective studies of 405 patients.\n\n    This is the first study to systematically review the available literature comparing totally transanal endorectal pull-through procedures with laparoscopically assisted pull-through procedures' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We present evidence from five retrospective studies of 405 patients. This is the first study to systematically review the available literature comparing totally transanal endorectal pull-through procedures with laparoscopically assisted pull-through procedures.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nIn a recent survey of practice in the UK, the majority of responding surgeons who utilise an endorectal dissection employ laparoscopic surgery for biopsies or mobilisation.16\n\nThe aim of this study was to conduct a systematic review and meta-analysis to compare outcomes for infants with Hirschsprung&#39;s disease undergoing a TTERPT procedure with those undergoing a laparoscopically assisted transanal pull-through (LAPT' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In a recent survey of practice in the UK, the majority of responding surgeons who utilise an endorectal dissection employ laparoscopic surgery for biopsies or mobilisation. The aim of this study was to conduct a systematic review and meta-analysis to compare outcomes for infants with Hirschsprung's disease undergoing a TTERPT procedure with those undergoing a laparoscopically assisted transanal pull-through (LAPT).&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 84.4%):\n\nstudy quality using the Newcastle-Ottawa Scale for case–control and cohort studies' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Study quality was assessed using the Newcastle-Ottawa Scale for case–control and cohort studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nA total of 2107 records were screened, of which 41 studies potentially met the eligibility criteria (figure 1). Thirty-one studies were excluded because there was no comparative study arm. Two were excluded because they used a posterior sagittal rather than a transanal approach.20 ,21 One study was excluded because it used a laparoscopic Duhamel-type anastomosis22 and one study because infants undergoing a staged procedure were pooled with primary procedure result' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A total of 2107 records were screened, of which 41 studies potentially met the eligibility criteria (figure 1). Thirty-one studies were excluded because there was no comparative study arm. Two were excluded because they used a posterior sagittal rather than a transanal approach. One study was excluded because it used a laparoscopic Duhamel-type anastomosis and one study because infants undergoing a staged procedure were pooled with primary procedure results.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 84.4%):\n\nstudy quality using the Newcastle-Ottawa Scale for case–control and cohort studies' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Study quality was assessed using the Newcastle-Ottawa Scale for case–control and cohort studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nDespite acknowledgement that more complicated and extensive disease segments require some form of intra-abdominal approach, including laparoscopy, minilaparotomy, umbilical incision or formal laparotomy,11 ,12 there is currently a lack of guidance to determine when it is unsafe to attempt a TTERP' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Despite acknowledgement that more complicated and extensive disease segments require some form of intra-abdominal approach, including laparoscopy, minilaparotomy, umbilical incision or formal laparotomy, there is currently a lack of guidance to determine when it is unsafe to attempt a TTERPT.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.7%):\n\nHere we review the current evidence of the outcomes of balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Here we review the current evidence of the outcomes of balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia in children.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nThe objective of this systematic review was to examine the accumulated literature on the use of NSS among children with WT, both unilateral and bilateral' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The objective of this systematic review is to examine the accumulated literature on the use of NSS among children with WT, both unilateral and bilateral.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 64.6%):\n\nFull-text articles appearing to meet selection criteria were reviewed, and study data was abstracted in' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Full-text articles appearing to meet selection criteria were reviewed, and study data was abstracted in duplicate with differences resolved by the senior author.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):\n\nIntroduction\n\nAnorectal malformations and Hirschsprung disease are congenital malformations that show a wide clinical variety' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Introduction Anorectal malformations and Hirschsprung disease are congenital malformations that show a wide clinical variety.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 87.9%):\n\n. The location of the stoma on the colon (or ileum) is determined by the position of the transition zon' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Introduction The location of the stoma on the colon (or ileum) is determined by the position of the transition zone.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nInclusion and Exclusion Criteria\n\nStudies were eligible for inclusion when they reported a series of neonates (newborns under the age of 28 days) whose anorectal malformation or Hirschsprung disease was treated with a stoma, and reported on stoma type and location, complications of stoma formation or closure or mortality rates' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Inclusion and Exclusion Criteria Studies were eligible for inclusion when they reported a series of neonates (newborns under the age of 28 days) whose anorectal malformation or Hirschsprung disease was treated with a stoma, and reported on stoma type and location, complications of stoma formation or closure or mortality rates.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 86.1%):\n\nThe described search strategy yielded 877 citations in PubMed, 1,103 in Embase, and 367 in Web of Science' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Search Strategy The described search strategy yielded 877 citations in PubMed, 1,103 in Embase, and 367 in Web of Science.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.9%):\n\nThe general search terms were the same for the three databases, which are as follows: anorectal malformations, Hirschsprung disease, colostomy, and children. The exact search strategies are shown in Appendix 1' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Search Strategy The general search terms were the same for the three databases, which are as follows: anorectal malformations, Hirschsprung disease, colostomy, and children. The exact search strategies are shown in Appendix 1.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.8%):\n\nction\n\nThe two investigators selected the articles independently, extracted literature data, and recorded them in purpose-designed forms' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Study Selection The two investigators selected the articles independently, extracted literature data, and recorded them in purpose-designed forms.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 86.9%):\n\nThese data concerned study design, study population, follow-up, survival, complications, and reoperations' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Data Extraction These data concerned study design, study population, follow-up, survival, complications, and reoperations.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.3%):\n\nStudy Selection\n\nThe described search strategy yielded 877 citations in PubMed, 1,103 in Embase, and 367 in Web of Science. After deleting the duplicates, 1,325 publications remained. Eight of these met the inclusion and exclusion criteria ([Fig. 1' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Results Study Selection The described search strategy yielded 877 citations in PubMed, 1,103 in Embase, and 367 in Web of Science. After deleting the duplicates, 1,325 publications remained. Eight of these met the inclusion and exclusion criteria ([Fig. 1]).&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 86.9%):\n\nThe eight studies included a total of 2,954 patients' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Results The eight studies included a total of 2,954 patients.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.7%):\n\nConclusion\n\nA relatively high complication rate is described in colostomy formation in children with an anorectal malformation or Hirschsprung disea' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Discussion A relatively high complication rate is described in colostomy formation in children with an anorectal malformation or Hirschsprung disease.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.4%):\n\nThe wide range of complication rates in the systematic review may be because of the inconsistency in defining complication' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Discussion The wide range of complication rates in the systematic review may be because of the inconsistency in defining complications.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):\n\nn. The procedure of colostomy formation in anorectal malformations and Hirschsprung disease is meticulous and should be performed with great ca' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Conclusion The procedure of colostomy formation in anorectal malformations and Hirschsprung disease is meticulous and should be performed with great care.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 96.2%):\n\nPresent data on risk of bias of each study and, if available, any outcome level assessment (see item' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 94.9%):\n\nPresent results of any assessment of risk of bias across studies (see Item' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Present results of any assessment of risk of bias across studies (see Item 15).&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 95.7%):\n\nGive results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):\n\nThe present meta-anlaysis shows that the overall risk of MCIH in children (aged 0–19 years) is 6' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The present meta-analysis shows that the overall risk of MCIH in children (aged 0–19 years) is 6%.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 92.8%):\n\nIdentify the report as a systematic review, meta-analysis, or both' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎identified the report as a systematic review, meta-analysis, or both.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 99.7%):\n\nAbstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Abstract: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nOur inclusion criteria were formulated according to the ‘PICOS’ format as follows:\n\n    •\n\n    Population: All infants born alive with the diagnosis of GS and who underwent abdominal defect closure.\n    •\n\n    Intervention: Sutureless flap closure either primarily or after silo reduction, in simple and complex GS cases.\n    •\n\n    Control: Operative fascial closure under general anesthesia either primarily or after a silo, in simple and complex GS cases' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Our inclusion criteria were formulated according to the ‘PICOS’ format as follows: Population: All infants born alive with the diagnosis of GS and who underwent abdominal defect closure. Intervention: Sutureless flap closure either primarily or after silo reduction, in simple and complex GS cases. Control: Operative fascial closure under general anesthesia either primarily or after a silo, in simple and complex GS cases.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 76.4%):\n\nMethods\n\nAn electronic search of EMBASE, PubMed, MEDLINE was performed' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Methods / Search strategy: An electronic search of EMBASE, PubMed, MEDLINE was performed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nFor continuous variables, we calculated mean differences (MDs) with 95 % confidence intervals (CIs). For dichotomous variables, we used odds ratios (ORs' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎For continuous variables, we calculated mean differences (MDs) with 95% confidence intervals (CIs). For dichotomous variables, we used odds ratios (ORs).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nThe evolution of surgical techniques for dealing with this complex group of malformations led to the description of the PSARP by deVries and Pena [18] in 1982. Posterior sagittal anorectoplasty quickly became the standard of care for dealing with ARM. Despite the excellent exposure of anatomy and exact placement of the distal rectum within the muscle complex, the technique is not perfect, especially in patients with “high” ARM defects [19], [20], [21' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The evolution of surgical techniques for dealing with this complex group of malformations led to the description of the PSARP by deVries and Pena [18] in 1982. Despite the excellent exposure of anatomy and exact placement of the distal rectum within the muscle complex, the technique is not perfect, especially in patients with “high” ARM defects [19], [20], [21].&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 59.5%):\n\n.\n\nThe studies included 124 patients—96 males (77.4%) and 28 females (22.6' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Only studies published in full were included...The studies included 124 patients—96 males (77.4%) and 28 females (22.6%).&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.6%):\n\nConclusion\n\nLaparoscopy is safe and effective in the treatment of pediatric intussusception' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎In conclusion, Laparoscopy is safe and effective in the treatment of pediatric intussusception.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):\n\nver, the main limitation of the present study includes the lack of prospective randomized controlled trials (RCT) comparing laparoscopic vs. open reduction of pediatric intussusception' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎However, the main limitation of the present study includes the lack of prospective randomized controlled trials (RCT) comparing laparoscopic vs. open reduction of pediatric intussusception.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 80.6%):\n\nment of a recurrent tracheoesophageal fistula (RTEF) includes either open surgery (OS) or an endoscopic treatment (ET); the ideal option is unclear' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Patients with recurrent tracheoesophageal fistula (RTEF) can be managed by either open surgery (OS) or endoscopic treatment (ET); the ideal approach is unclear.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 71.2%):\n\nAll studies that compared postoperative outcomes in two or more gastrostomy placement techniques in a pediatric population were included. The prima' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎All studies that compared postoperative outcomes in two or more gastrostomy placement techniques in a pediatric population were included. The pediatric population was defined as patients 0–18 years of age.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nIn order to evaluate the clinical and cost-effectiveness of this surgical approach a number of outcome measures for laparoscopic and open techniques were analyzed in a comparative fashion. These outcome measures included:\n\n    Length of stay (LOS) after the procedure,\n\n    Operating room (OR) time,\n\n    Frequency of postoperative complications and\n\n    Total hospital costs' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In order to evaluate the clinical and cost-effectiveness of this surgical approach a number of outcome measures for laparoscopic and open techniques were analyzed in a comparative fashion. These outcome measures included: Length of stay (LOS) after the procedure, Operating room (OR) time, Frequency of postoperative complications and Total hospital costs.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nA level of scientific evidence was assigned to each study identified using the set grading criteria outlined by the US Agency for Healthcare Research and Quality [33] [35]:\n\n    Prospective, randomized comparative trials,\n    1A: Systematic review or meta-analysis\n\n    Prospective, non-randomized comparative trials and\n\n    Retrospective, observational studies.\n\nOnly level 1, 1A and 2 studies were included in our analyses' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A level of scientific evidence was assigned to each study identified using the set grading criteria outlined by the US Agency for Healthcare Research and Quality [33] [35]: Prospective, randomized comparative trials, 1A: Systematic review or meta-analysis Prospective, non-randomized comparative trials and Retrospective, observational studies. Only level 1, 1A and 2 studies were included in our analyses.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.8%):\n\nBariatric surgery for obese children and adolescents: a systematic review and meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Bariatric surgery in obese children and adolescents: a systematic review and meta-analysis&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nThis systematic review shows that according to available evidence PR carries an 8% risk of specific preputial complications, whereas it does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repairs' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This systematic review shows that according to available evidence PR carries an 8% risk of specific complications, whereas it does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repairs.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.4%):\n\nthe following tools: AMSTAR (systematic reviews), Jadad (RCTs), and MINORS (non-RCTs' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We used the following tools: AMSTAR (systematic reviews), Jadad (RCTs), and MINORS (non-RCTs).&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 66.9%):\n\n.\n\nAltogether, the comparative studies included 3,099 patients with a history of cryptorchidism' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Publication dates ranged from 1974 to 2011.\" \"Altogether, the comparative studies included 3,099 patients with a history of cryptorchidism.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.4%):\n\nthe following tools: AMSTAR (systematic reviews), Jadad (RCTs), and MINORS (non-RCTs' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We used the following tools: AMSTAR (systematic reviews), Jadad (RCTs), and MINORS (non-RCTs).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nIn this review, we found that orchiopexy between 6 and 12 months of age may optimize fertility potential and help protect against the increased risk of testicular cancer associated with cryptorchidism. Surgery should not be performed before 6 months, as the testis may descend spontaneously during that time. Furthermore, orchiopexy in infants should be performed by pediatric urologists or pediatric surgeons to reduce the risk of complications. There is a paucity of higher-quality studies (e.g., long-term, prospective randomized trials) investigating the effect of age at orchiopexy on fertility and malignancy, possibly because of ethical concerns with randomization and the feasibility of long-term follow-up. Future research should address these issues, focusing especially on the effect of age at treatment on direct measures of fertility (i.e., time until conception of a live born child), for which existing research is particularly scarce. Nevertheless, our study is the first step towards determining the ideal management of undescended testes. By disseminating our findings, we hope to bring awareness of this topic to pediatric surgeons and other medical practitioners, promoting the worldwide use of evidence-based medicine' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In this review, we found that orchiopexy between 6 and 12 months of age may optimize fertility potential and help protect against the increased risk of testicular cancer associated with cryptorchidism. By disseminating our findings, we hope to bring awareness of this topic to pediatric surgeons and other medical practitioners, promoting the worldwide use of evidence-based medicine.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.1%):\n\nHowever, as a relatively newer technique, the long-term outcome of TERPT is less clear' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎However, the long-term outcome of TERPT is less clear.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):\n\nstudies that compared outcome after TERPT with those after TAB were eligible for inclusion in our analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Eighteen studies that compared outcome after TERPT with those after TAB were eligible for inclusion in our analysis.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 90.7%):\n\nDescribe the rationale for the review in the context of what is already known.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Describe the rationale for the review in the context of what is already known.\" \"[Yes]&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 95.7%):\n\nProvide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).\" \"[No]&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 97.1%):\n\nSpecify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.\nP7. Met' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.\" \"[Yes]&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 96.6%):\n\nDescribe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.\nP8. Met' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.\" \"[Yes]&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 94.7%):\n\nPresent full electronic search strategy for at least one database, including any limits used, such that it could be repeated.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.\" \"[No]&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 95%):\n\nState the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).\" \"[Yes]&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 95.5%):\n\nDescribe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.\" \"[Yes]&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 95%):\n\nList and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.\" \"[No]&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 97%):\n\nGive numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.\nP18. Res' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.\" \"[Yes]&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 96.6%):\n\nFor each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.\nP19. Res' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.\" \"[Yes]&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 95.7%):\n\nSummarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).\" \"[Yes]&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 95.2%):\n\nDiscuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).\" \"[Yes]&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 93.7%):\n\nProvide a general interpretation of the results in the context of other evidence, and implications for future research.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.\" \"[Yes]&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 94.5%):\n\nDescribe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.\n---' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.\" \"[Yes]&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.3%):\n\n. We hypothesized that the complication(s) associated with surgical correction outweighed the risk of midgut volvulus and its sequelae and that screening in “asymptomatic patients” was unnecessary' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎To this end, we hypothesized that the complication(s) associated with surgical correction outweighed the risk of midgut volvulus and its sequelae and that screening in “asymptomatic patients” was unnecessary.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.5%):\n\nPatient demographics, operative details, and patient outcomes for identified cases of robot-assisted MIS for pediatric solid tumors' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Patient demographic information, operative details, and patient outcomes for identified cases of robot-assisted MIS for pediatric solid tumors&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.4%):\n\nmatic reviews,” and “meta-analysis” were applied. Abstracts were individually reviewed and only those studies comparing the results and clinical outcome of VATS procedures with the corresponding open operation were chosen for further analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Materials and Methods: Abstracts were individually reviewed and only those studies comparing the results and clinical outcome of VATS procedures with the corresponding open operation were chosen for further analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.4%):\n\nmatic reviews,” and “meta-analysis” were applied. Abstracts were individually reviewed and only those studies comparing the results and clinical outcome of VATS procedures with the corresponding open operation were chosen for further analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Materials and Methods: Abstracts were individually reviewed and only those studies comparing the results and clinical outcome of VATS procedures with the corresponding open operation were chosen for further analysis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.6%):\n\ntoma). In the following, the main results of the studies with regard to advantages and disadvantages of laparoscopic compared with open surgery are summarized in alphabetical order' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Results: In the following, the main results of the studies with regard to advantages and disadvantages of laparoscopic compared with open surgery are summarized in alphabetical order.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):\n\nResults A total of 3 meta-analysis (MA) and 18 retrospective comparative studies (RCS) investigating 5 different VATS procedures (repair of congenital diaphragmatic hernia [CDH], repair of esophageal atresia/tracheoesophageal fistula (EA/TEF), lung resection, treatment of pneumothorax, and resection of neuroblastoma) were included in this study' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Results: A total of 3 meta-analysis (MA) and 18 retrospective comparative studies (RCS) investigating 5 different VATS procedures (repair of congenital diaphragmatic hernia [CDH], repair of esophageal atresia/tracheoesophageal fistula [EA/TEF], lung resection, treatment of pneumothorax, and resection of neuroblastoma) were included in this study.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.6%):\n\n] Additionally, in the RCS published by Gourlay et al, faster return to full enteral feeds, less postoperative narcotic/sedation, and less severe complications occurred in the thoracoscopic cohort' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Results: Additionally, in the RCS published by Gourlay et al, faster return to full enteral feeds, less postoperative narcotic/sedation, and less severe complications occurred in the thoracoscopic cohort.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.8%):\n\never, our SR of the literature clearly showed that Level 1 evidence is only available for seven different procedures in pediatric surgery' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Nevertheless, our SR of the literature clearly showed that Level 1 evidence is only available for seven different procedures in pediatric surgery.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90%):\n\ni\nSurgery for the treatment of obesity in children and adolescent' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Surgery for the treatment of obesity in children and adolescents&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 44.4%):\n\nThis is the' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] This is the abstract.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.3%):\n\nl\n\nThe prevalence of overweight and obese children and adolescents has increased throughout the world, presenting a global public health crisi' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] The prevalence of overweight and obese children and adolescents has increased throughout the world, presenting a global public health crisis...&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.9%):\n\nl\n\nTo assess the effects of surgery for treating obesity in children and adolescent' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] To assess the effects of surgery for treating obesity in children and adolescents.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93%):\n\nia\n\nWe selected randomised controlled trials (RCTs) of surgical interventions for treating obesity in children and adolescents (age < 18 years) with a minimum of six months follow‐u' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] We included randomised controlled trials (RCTs) of surgical interventions for treating obesity in children and adolescents (age < 18 years) with a minimum of six months follow‐up.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 85.5%):\n\nods\n\nWe searched the Cochrane Library, MEDLINE, PubMed, EMBASE as well as LILACS, ICTRP Search Portal and ClinicalTrials.gov (all from database inception to March 201' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] We searched the Cochrane Library, MEDLINE, PubMed, EMBASE, LILACS, ClinicalTrials.gov, and WHO ICTRP from database inception to March 2015.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 84.6%):\n\n.\n\nFor detailed search strategies see Appendix' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] For detailed search strategies see Appendix 1.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 30.9%):\n\nis\n\nTwo review authors independently assessed' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎[Yes] Two review authors independently screened records, assessed full texts for eligibility, and resolved discrepancies through consensus.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 87.5%):\n\nia, two review authors (LJE, KR, or EM) independently extracted key participant and intervention characteristics and reported data on efficacy outcomes and adverse events using a standard data extraction form supplied by the CMED Grou' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Two review authors independently extracted data using a standard form from the CMED Group.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 81.4%):\n\ny extracted key participant and intervention characteristics and reported data on efficacy outcomes and adverse event' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Data were extracted on participant and intervention characteristics, efficacy outcomes, and adverse events.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 36.9%):\n\nis\n\nTwo review authors independently assessed risk of bias' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎[Yes] Two review authors independently assessed risk of bias using the Cochrane risk of bias tool, and evaluated the impact of bias on study results.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.9%):\n\nct\n\nFor dichotomous outcomes we calculated odds ratio (OR) or risk ratio (RR) and corresponding 95% confidence interval (CI). For continuous outcomes we calculated the mean differenc' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] For dichotomous outcomes we calculated odds ratio or risk ratio and for continuous outcomes we calculated the mean difference.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 52%):\n\nes screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] 2405 records screened, 11 full texts assessed, and 1 study included. A flow diagram is provided.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 62%):\n\nee Characteristics of included studies. For an overview of review authors&#39; judgments about each risk of bias item for the one included stu' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎[Yes] Characteristics including sample size, interventions, outcomes, and follow-up are presented for the included study.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 37.7%):\n\n/ Risk of bias within studies: Present d' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] Risk of bias is presented in a summary figure and detailed in the text.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 46.6%):\n\nsummary data for each intervention group (b) effect estimates and confidence intervals,' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] Summary data, effect estimates, and confidence intervals are presented for outcomes in the one included study.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 65.6%):\n\nthe main findings including the strength of evidence' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] The main findings and strength of evidence are summarized.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 62.9%):\n\nlimitations at study and outcome level (e.g., risk of bias), and at review-level' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎[Yes] Limitations at the study and review level are discussed.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 86.1%):\n\n/ Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.\nP27. Funding: Describe' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎[Yes] Conclusions are provided in the context of other evidence and implications for future research are described.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 99.7%):\n\nAbstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎Abstract: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.&quot;<\/span>","<span title='Moderate quote deviation. Best match in prompt (Similarity 92.4%):\n\n: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ff9e81'>&quot;‎Abstract...background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions...&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nEsophageal atresia (EA) is a relatively common congenital malformation of unknown etiology with an incidence of 1 in 3,500 live births [1]. Pure EA without tracheoesophageal fistula (Fig. 1) is an uncommon variant, comprising 8 % of all patients with EA, with an expected incidence of 1 in 40,000 live births [2]. Improvements in prenatal diagnosis [3, 4], advances in surgery, pediatric anesthesia, neonatal intensive care and parenteral nutrition have increased the survival rate in EA in recent years to approximately 95 % [5' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Esophageal atresia (EA) is a relatively common congenital malformation...Improvements in prenatal diagnosis [3, 4], advances in surgery, pediatric anesthesia, neonatal intensive care and parenteral nutrition have increased the survival rate in EA in recent years to approximately 95 % [5].&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nIntroduction\n\nThere is still no consensus about the optimal surgical approach for esophageal replacement in the case of long-gap esophageal atresia (LGEA) or extensive corrosive strictures. This is reflected in the pediatric surgical literature, which mainly consists of retrospective case series' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Introduction There is still no consensus about the optimal surgical approach for esophageal replacement in the case of long-gap esophageal atresia (LGEA) or extensive corrosive strictures. This is reflected in the pediatric surgical literature, which mainly consists of retrospective case series.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.7%):\n\nThe aim of this article was to perform a meta-analysis comparing the most widely used techniques for esophageal replacement in children: jejunal interposition (JI), colon interposition (CI), and gastric pull-up (GPU' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Aim The aim of this article was to perform a meta-analysis comparing the most widely used techniques for esophageal replacement in children: jejunal interposition (JI), colon interposition (CI), and gastric pull-up (GPU).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nDefinition of Outcomes\n\nThe articles were reviewed with a special focus on mortality, postoperative morbidity, and long-term follow-up. Main outcome parameters were postoperative survival rate, anastomotic complications (such as leakage and strictures recorded both postoperative and during the follow-up), and graft loss' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Definition of Outcomes The articles were reviewed with a special focus on mortality, postoperative morbidity, and long-term follow-up. Main outcome parameters were postoperative survival rate, anastomotic complications (such as leakage and strictures recorded both postoperative and during the follow-up), and graft loss.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nLiterature\n\nA literature search (PubMed and Embase) was performed, and all human studies published in the English-language literature between 2006 and 2011 describing esophageal replacement for LGEA were identified, using the medical subject headings “Esophageal Atresia,” “Long-gap,” “Esophagoplasty,” “Replacement,” “Interposition,” “Substitution,” “Graft,” and their combinations' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Literature A literature search (PubMed and Embase) was performed, and all human studies published in the English-language literature between 2006 and 2011 describing esophageal replacement for LGEA were identified, using the medical subject headings “Esophageal Atresia,” “Long-gap,” “Esophagoplasty,” “Replacement,” “Interposition,” “Substitution,” “Graft,” and their combinations.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nDefinition of Outcomes\n\nThe articles were reviewed with a special focus on mortality, postoperative morbidity, and long-term follow-up. Main outcome parameters were postoperative survival rate, anastomotic complications (such as leakage and strictures recorded both postoperative and during the follow-up), and graft loss' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Definition of Outcomes The articles were reviewed with a special focus on mortality, postoperative morbidity, and long-term follow-up. Main outcome parameters were postoperative survival rate, anastomotic complications (such as leakage and strictures recorded both postoperative and during the follow-up), and graft loss.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.5%):\n\nData Collection\n\nThe initial search yielded 187 potentially relevant articles, of which 172 articles were excluded because of the failure to meet the inclusion criteria. A total of 15 studies fulfilled the inclusion criteria and were analyzed in this review ([Table 1' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data Collection The initial search yielded 187 potentially relevant articles, of which 172 articles were excluded because of the failure to meet the inclusion criteria. A total of 15 studies fulfilled the inclusion criteria and were analyzed in this review ([Table 1]).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.4%):\n\nData about postoperative mortality and morbidity were given in 14 studies with a total of 470 patients (264 LGEA); 344 (73%) patients underwent CI, 99 (21%) children underwent GPU, and 27 (6%) patients underwent JI' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Results Data about postoperative mortality and morbidity were given in 14 studies with a total of 470 patients (264 LGEA); 344 (73%) patients underwent CI, 99 (21%) children underwent GPU, and 27 (6%) patients underwent JI.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nDiscussion\n\nThe present article set out to perform a meta-analysis of the literature regarding esophageal replacement for LGEA or extensive corrosive strictures. There are few prospective series, amounting to only 37 patients. Well-designed prospective comparative studies are lacking, major and minor postoperative complications are sometimes not properly defined, follow-up data are often deficient and when presented they are not homogenously described in the different studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Discussion The present article set out to perform a meta-analysis of the literature regarding esophageal replacement for LGEA or extensive corrosive strictures. There are few prospective series, amounting to only 37 patients. Well-designed prospective comparative studies are lacking, major and minor postoperative complications are sometimes not properly defined, follow-up data are often deficient and when presented they are not homogenously described in the different studies.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.3%):\n\nIn the future, large series from these centers may offer a better insight in the results of care for this difficult patients group' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Conclusion In the future, large series from these centers may offer a better insight in the results of care for this difficult patients group.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96%):\n\nConflict of Interest\n\nNone' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Conflict of Interest None&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.1%):\n\nWe performed a systematic literature review of the long-term outcome of OPEN surgery compared with L-TERPT/TERPT.\n\nMethods Our systematic review of the recent literature (2008 to 2012) included reports on long-term outcome of either OPEN surgery or L-TERPT/TERPT with a minimum follow-up period of 12 months' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We performed a systematic literature review of the recent literature (2008 to 2012) including reports on long-term outcome of either OPEN surgery or L-TERPT/TERPT with a minimum follow-up period of 12 months.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):\n\nWith these data, a cumulative meta-analysis was performed to compare long-term outcome of patients who underwent OPEN surgery with patients who underwent L-TERPT/TERPT surgery. The latter groups were analyzed as one group due to the transanal approach in both. Odds ratio (OR) with 95% confidence interval (CI) were calculated' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎With these data, a cumulative meta-analysis was performed to compare long-term outcome of patients who underwent OPEN surgery with patients who underwent L-TERPT/TERPT surgery.\" And \"Odds ratio (OR) with 95% confidence interval (CI) were calculated.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):\n\ninterval appendicectomy justified after successful nonoperative treatment of an appendix mass in children? A systematic review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Is] interval appendicectomy justified after successful nonoperative treatment of an appendix mass in children? A systematic review&quot;<\/span>"],[94.0397350993377,92.9078014184397,98.75,96.039603960396,68.5393258426966,98.6111111111111,87.012987012987,87.8260869565217,71.2328767123288,64.6153846153846,50.6172839506173,61.7647058823529,82.1428571428571,76.1194029850746,82.1917808219178,58.695652173913,72.1518987341772,20.2702702702703,38.0952380952381,63.0769230769231,52.9411764705882,82.4561403508772,86.3013698630137,79.5918367346939,98.3193277310924,98.2758620689655,97.9166666666667,98.3739837398374,97.5206611570248,99.3288590604027,97.7011494252874,95.7317073170732,94.9790794979079,96.2121212121212,72.0524017467249,77.0334928229665,97.8902953586498,87.0967741935484,99.6932515337423,93.8461538461538,99.2874109263658,99.1031390134529,99.4152046783626,93.3333333333333,96.3302752293578,92.7631578947368,99.2307692307692,71.9457013574661,99.1525423728814,98.8888888888889,89.8989898989899,86.8852459016393,99.6466431095406,99.0196078431373,95.1923076923077,98.7951807228916,96.969696969697,98.2142857142857,86,99,89.3939393939394,93.1818181818182,78.1609195402299,97.8260869565217,98.3606557377049,98.6111111111111,97.0149253731343,99.0740740740741,97.9166666666667,89.1304347826087,94.7867298578199,95.2569169960474,92.9032258064516,99.4782608695652,99.6478873239437,87.8306878306878,99.7742663656885,98.2558139534884,74.6268656716418,94.8275862068966,68.9655172413793,57.7319587628866,99.6168582375479,99.2822966507177,84.375,99.5670995670996,84.375,99.3174061433447,92.6829268292683,98.6928104575163,64.5962732919255,98.4,87.9310344827586,99.390243902439,86.0655737704918,92.9203539823009,91.7808219178082,86.8852459016393,95.3488372093023,86.8852459016393,94.6666666666667,90.3703703703704,92.2077922077922,96.1904761904762,94.9367088607595,95.7264957264957,96.9387755102041,92.7536231884058,99.6763754045307,99.7641509433962,76.4044943820225,98.6928104575163,99.4505494505495,59.504132231405,92.6315789473684,97.3544973544974,80.625,71.219512195122,99.7191011235955,99.5073891625616,97.7777777777778,99.5967741935484,90.4255319148936,66.9064748201439,90.4255319148936,99.7395833333333,98.1481481481482,92.2413793103448,90.6976744186047,95.6521739130435,97.0873786407767,96.6292134831461,94.6969696969697,95.0310559006211,95.5056179775281,95,97.0059880239521,96.6216216216216,95.7446808510638,95.1515151515152,93.7007874015748,94.5205479452055,93.2692307692308,91.5492957746479,95.3703703703704,95.3703703703704,95.6284153005464,98.5632183908046,95.5882352941177,93.8356164383562,90,44.4444444444444,93.2885906040269,90.9090909090909,92.972972972973,85.5172413793103,84.6153846153846,30.9352517985611,87.5,81.4159292035398,36.9127516778523,93.9393939393939,51.9607843137255,61.9834710743802,37.6623376623377,46.551724137931,65.625,62.9032258064516,86.0869565217391,99.6763754045307,92.4324324324324,99.3079584775086,99.3243243243243,97.737556561086,99.3769470404984,99.4764397905759,99.3769470404984,98.5130111524164,96.4125560538117,99.5833333333333,92.2535211267606,96,98.0769230769231,98.3935742971888,96.9465648854962]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th>Author & Year<\/th>\n      <th>Source<\/th>\n      <th>Quote with deviation<\/th>\n      <th>Similarity<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"ft","order":[[3,"desc"]],"columnDefs":[{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 1, 3, \",\", \".\", null);\n  }"},{"visible":false,"targets":1},{"className":"dt-right","targets":3}],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render"],"jsHooks":[]}</script>
</div>
<div id="formatting-accuracy" class="section level3">
<h3>Formatting accuracy</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<ul>
<li>111 / 147 (75.5%) responses were usable
<ul>
<li>100 / 111 (90.1%) usable responses with correctly formatted
scores</li>
<li>11 / 111 (9.9%) usable responses with minor fixable score formatting
issues
<ul>
<li>7 with ‘wrong-response-partial-unclear-etc’</li>
<li>3 with ‘missing-squared-brackets-in-numbered-list’</li>
<li>1 with ‘missing-squared-brackets-end-of-line’</li>
<li>1 with ‘missing-squared-brackets-for-na’</li>
<li>1 with ‘missing-squared-brackets-pre-dash’</li>
</ul></li>
</ul></li>
<li>36 / 147 (24.5%) responses were unusable (‘failed’), affecting 28
publications (28 of which were ultimately successful because a repeated
response was usable)
<ul>
<li>20 with failure reason ‘too-short’</li>
<li>16 with failure reason ‘too-long’</li>
</ul></li>
</ul>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-f6471011afc27563a21a" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-f6471011afc27563a21a">{"x":{"filter":"none","vertical":false,"fillContainer":false,"data":[["23","24","25","26","27","28","29","30","31","32","33","34","35","36","1","2","3","4","5","6","7","8","9","10","11","12","13","14","15","16","17","18","19","20","21","22"],["Alzahem 2011","Aworanti 2014","Castagnetti 2010","Castagnetti 2010","Chang 2015","Chen 2013","Ding 2013","Dingemann 2014","Dingemann 2013","Esposito 2014","Feng 2016","Frongia 2013","Gosemann 2013","Guo 2011","Healy 2015","Healy 2015","Healy 2015","Jia 2011","Jia 2011","Kapralik 2016","Lee 2010","Lee 2010","Mauritz 2011","Mauritz 2011","Mauritz 2011","Nataraja 2013","Peycelon 2014","Peycelon 2014","Pfistermuller 2015","Ross 2015","Ruttenstock 2010","Scholfield 2016","Shawyer 2014","Sklar 2014","van Dalen 2015","Vernon-Roberts 2013"],["too-short","too-short","too-long","too-short","too-short","too-long","too-long","too-short","too-long","too-short","too-short","too-short","too-long","too-short","too-long","too-long","too-long","too-long","too-short","too-short","too-long","too-short","too-long","too-long","too-short","too-long","too-short","too-short","too-short","too-short","too-short","too-short","too-long","too-short","too-long","too-long"],[true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true,true],["Here are the relevant quotes and assessments for each PRISMA item based on the provided full text:\n\n[Yes] 'Laparoscopic versus open inguinal herniotomy in infants and children: a meta-analysis'\nThe title identifies the report as a systematic review and meta-analysis.\n\n[Yes] 'To undertake a meta-analysis of comparative data of laparoscopic versus open inguinal herniotomy in infants and children.'  \nThe abstract provides structured summary including objectives.\n\n[Yes] 'Unresolved debate still exists regarding the benefit of using laparoscopy over conventional open inguinal hernia repair even among laparoscopic surgeons due to the concern about its higher recurrence rate.'\nThe introduction describes the rationale in context of what is already known.   \n\n[Yes] 'The aim of this study was to assess any differences in complication rates and outcome following surgery for indirect inguinal hernia between infants and children treated using the open and laparoscopic techniques.'\nThe introduction provides objectives with reference to participants, interventions, and outcomes.\n\n[No] \nNo statement about existence of a review protocol.\n\n[Yes] 'All comparative studies of the laparoscopic and open approaches for indirect inguinal hernia in children aged less than 19 years were selected.' \nThe methods specify eligibility criteria including participants.\n\n[Yes] 'The following subject headings (MeSH) and text word terms were utilized: inguinal hernia, laparoscopy, minimal access surgery, infant(s), neonate(s), newborn(s), child, paediatric, pediatric. No language restriction was applied. Additional citations were sought using references in articles retrieved from searches. Content experts were contacted to identify unpublished and ongoing studies.'\nThe methods describe information sources including databases searched. \n\n[No]\nThe search strategy for databases is not provided.\n\n[Yes] 'Retrieved articles were assessed for eligibility and data on patients, intervention, control, outcomes and methodological quality were abstracted independently by two authors.'\nThe methods describe the study selection process including screening and eligibility.\n\n[Yes] 'Data on 2,699 children were identified from 10 comparative studies.' \nThe results report the number of studies screened and included with reasons for exclusions.\n\n[Yes] 'Two randomized controlled trial (Koivusalo [21]; Chan [17]), one nonrandomized clinical trial (Tsai [20]) and seven observational comparative studies (Niyogi [19]; Endo [22]; Bharathi [23, 28]; Hassan [24]; Koivusalo [25]; Oue [26]; Antao [27]) were assessed.'\nThe results present characteristics of included studies. \n\n[Yes] 'The quality of the included comparative studies was assessed independently by two authors. The Cochrane Collaboration criteria for randomized controlled trials was utilized (randomization, allocation concealment, blinding and completeness of follow-up). Cohort studies were assessed using the Newcastle-Ottawa Quality Assessment Scale [18].'\nThe results describe the risk of bias assessment for each included study.\n\n[Yes] 'The two randomized controlled trials (Koivusalo [21] and Chan [17]) on 172 infants and children between age of 3 months and 18 years have reported a recurrence rate of 0–4% for laparoscopic approach compared with 0–2% for the open approach.' \nThe results present summary data and effect estimates for the recurrence outcome.\n\n[NA]\nNo meta-analysis was done for other outcomes besides recurrence and operative time.\n\n[NA] \nNo assessment of risk of bias across studies.\n\n[NA]\nNo additional analyses were described. \n\n[Yes] 'Although our review utilized a very comprehensive search strategy to minimize the effect of publication bias, only two randomized clinical trial was included. Therefore, our review is a summary of the existing evidence with limitation to the conclusions drawn from these data due to the quality of the included studies.'\nThe discussion summarizes the evidence and limitations.\n\n[Yes] 'We were unable to identify any clear benefit of laparoscopic inguinal herniotomy over the open approach. This review brings to light the paucity of existing good-quality evidence in this area.' \nThe discussion provides general interpretation of results in context of other evidence.\n\n[Yes] 'Our review’s conclusions are hampered by the quality and the small sample size of the most included studies.'\nThe discussion describes limitations at study and outcome level.\n\n[Yes] 'A large-scale randomized well-powered clinical trial comparing the two approaches should be conducted to guide our practice.'\nThe discussion provides implications for future research.\n\n[No]\nNo statement about sources of funding.\n","Here are the relevant quotes and assessments for each PRISMA item:\n\n'Management of Recurrent Tracheoesophageal Fistulas: A Systematic Review' \n\n[Yes]\n\n'Abstract: Introduction The management of a recurrent tracheoesophageal fistula (RTEF) includes either open surgery (OS) or an endoscopic treatment (ET); the ideal option is unclear.'\n\n[Yes]\n\n'Introduction: The spectrum of esophageal atresia (EA) and tracheoesophageal fistula (TEF) include an isolated EA, EA with a proximal and/or distal TEF and the “H” or “N” type fistula. Since the initial description of the open surgical repair[1] and subsequent thoracoscopic approaches[2] [3] the outcomes have been very encouraging.' \n\n[No]\n\n'Patients/Materials and Methods: A literature search was performed using the keywords “recurrent tracheoesophageal fistula.” All English language articles describing the management of RTEF in children were reviewed.'\n\n[No]\n\n'Patients/Materials and Methods: A literature search was performed using the keywords “recurrent tracheoesophageal fistula.” All English language articles describing the management of RTEF in children were reviewed.' \n\n[No]\n\n'Patients/Materials and Methods: A literature search was performed using the keywords “recurrent tracheoesophageal fistula.” All English language articles describing the management of RTEF in children were reviewed.'\n\n[Yes] \n\n'Patients/Materials and Methods: A literature search was performed using the keywords “recurrent tracheoesophageal fistula.” All English language articles describing the management of RTEF in children were reviewed. A synthesis of the relevant data is presented in a descriptive form due to the heterogeneity of the included articles.'\n\n[No]\n\n'Patients/Materials and Methods: A literature search was performed using the keywords “recurrent tracheoesophageal fistula.” All English language articles describing the management of RTEF in children were reviewed.'\n\n[Yes]\n\n'Patients/Materials and Methods: The data obtained included number of patients treated, treatment modality employed, effectiveness of each treatment modality, and the outcomes after treatment. These outcomes include the successful single treatments, number of treatments required, number of treatment failures requiring conversion to an alternate treatment modality, and the incidence of postoperative complications.'\n\n[No]\n\n'Results: Below is a summary of the published operative principles.'\n\n[NA]\n\n'Results: Below is a summary of the published operative principles.' \n\n[NA]\n\n'Results: Below is a summary of the published operative principles.'\n\n[NA] \n\n'Results: Below is a summary of the published operative principles.'\n\n[NA]\n\n'Results: Below is a summary of the published operative principles.'\n\n[Yes]\n\n'Results: A total of 23 papers between 1984 and 2012 described 57 patients undergoing some form of endoscopic treatment (ET) while 21 papers between 1955 and 2013 described 108 patients that underwent an open surgical repair ([Tables 1] and [2]).'\n\n[Yes] \n\n'Results: The outcomes after these two repairs are summarized in [Tables 1] [2] [3] [4].' \n\n[NA]\n\n[NA]\n\n'Results: The results when ET were grouped into “de-epithelialization only,” “sealant only,” and “de-epithelialization combined with sealants” (as suggested by Richter et al[28]) is summarized in [Table 4].'\n\n[NA]\n\n[NA]\n\n[NA]\n\n'Discussion: Apart from inadequate ligation in the first instance, these fistulas probably recur due to an anastomotic leak that forms a localized abscess which bores into the trachea at the point of least resistance: the suture lines.'\n\n[Yes] \n\n'Conclusion: In conclusion, based on our findings on 165 published cases, OS for the repair of recurrent TEF has a low morbidity, mortality, and re-fistulation rate particularly when an interposition tissue is placed between the trachea and esophagus.'\n\n[Yes]\n\n'References'\n","[Yes]\n'Surgical Management of Primary Severe Hypospadias in Children: Systematic 20-Year Review'\nThe title identifies the report as a systematic review.\n\n[Yes] \n'We systematically reviewed the literature published during the last 20 years on the treatment of primary proximal hypospadias associated with severe ventral curvature.'\nThe abstract provides a structured summary including background, objectives, data sources, eligibility criteria, methods, and conclusions.\n\n[Yes]\n'The ideal surgical management of primary severe hypospadias (proximal hypospadias with severe ventral curvature) remains controversial.'  \nThe introduction describes the rationale for the review in the context of what is already known.\n\n[Yes]\n'The aim of the present review was to assess the results of studies published during the last 20 years on the primary repair of severe hypospadias.'\nThe introduction provides an explicit statement of the question being addressed. \n\n[No]\n\n[Yes]  \n'We included in this review only series containing detailed results after primary repair of severe hypospadias or after curvature correction in patients with primary severe hypospadias.'\nThe methods section specifies study characteristics used as criteria for eligibility.\n\n[Yes]  \n'Four databases, MEDLINE/PubMed, EMBASE, Web of Science and the Cochrane Library, were searched using a single term, “hypospadias,” as it defines accurately the subject of this review.' \nThe methods section describes the information sources searched and date last searched.\n\n[No]\n\n[Yes] \n'We first reviewed the results of the different straightening procedures, then the crude complication rates (overall complication, fistula/dehiscence, stricture/stenosis rates) of the different urethroplasty techniques.'\nThe methods section describes the process for selecting studies.\n\n[Yes]  \n'Three doctors reviewed the abstracts. Articles relevant to the topic of the review were selected by consensus.'  \nThe methods section describes the process for extracting data from reports. \n\n[Yes]  \n'We included in this review only series containing detailed results after primary repair of severe hypospadias or after curvature correction in patients with primary severe hypospadias.'\nThe methods section lists the variables for which data were sought.\n\n[NA] \n\n[NA]\n\n[NA] \n\n[Yes] \n'Given the low quality and limited validity of the studies available, we did not attempt any meta-analysis.'\nThe methods section states that no meta-analysis was performed.\n\n[NA]\n\n[NA] \n\n[Yes] \n'We identified 69 studies for review.' \nThe results section provides the number of studies screened, assessed for eligibility, and included in the review.\n\n[Yes] \n'Table 1. Complications in reviewed urethroplasty studies'\nThe results section presents characteristics of the included studies. \n\n[NA]\n\n[Yes] \n'As far as cosmetic and functional outcomes are concerned, 28 studies described results in terms of penile appearance, as evaluated by the physicians or parents/patients.' \nThe results section presents simple summary data and results for outcomes considered.\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes]  \n'The present review illustrates that there is an extreme paucity of studies to address in an evidence-based manner many of the common issues related to the primary repair of proximal hypospadias.'\nThe discussion section summarizes the main findings and considers their relevance.\n\n[Yes] \n'As with any review, the present study has limitations.'\nThe discussion section discusses limitations at the review level.\n\n[Yes]\n'While we elaborate on general recommendations for the treatment of this condition, we emphasize the need to establish shared criteria for accurate preoperative or introperative patient stratification, and to define objective outcome measures and followup intervals for data reporting to make comparison of surgical approaches reliable.'\nThe discussion section provides a general interpretation of the results and implications for future research.\n\n[Yes]\n'Acknowledgments: Drs. Alfredo Berrettini and Evisa Zhapa collaborated in the selection of included studies.'\nThe funding sources are described.\n","[No] 'Surgical Management of Primary Severe Hypospadias in Children: Systematic 20-Year Review'\nThe title does not identify the report as a systematic review.\n\n[Yes] 'We systematically reviewed the literature published during the last 20 years on the treatment of primary proximal hypospadias associated with severe ventral curvature.'  \nThe abstract states that a systematic review was performed.  \n\n[Yes] 'The aim of the present review was to assess the results of studies published during the last 20 years on the primary repair of severe hypospadias.'\nThe introduction describes the rationale for the review.\n\n[No]\nThe introduction does not provide an explicit statement of questions addressed with reference to PICOS.\n\n[No]\nThe methods section does not indicate if a review protocol exists.\n\n[Yes] 'We included in this review only series containing detailed results after primary repair of severe hypospadias or after curvature correction in patients with primary severe hypospadias.'\nThe methods section specifies eligibility criteria.\n\n[Yes] 'Four databases, MEDLINE/PubMed, EMBASE, Web of Science and the Cochrane Library, were searched using a single term, “hypospadias,” as it defines accurately the subject of this review.' \nThe methods section describes the information sources searched.\n\n[No]\nThe methods section does not present the full electronic search strategy for any database. \n\n[Yes] 'Articles relevant to the topic of the review were selected by consensus.'\nThe methods section describes the study selection process.\n\n[No] \nThe methods section does not describe the data collection process.\n\n[No]\nThe methods section does not list and define all variables for which data were sought.\n\n[No]\nThe methods section does not describe methods for assessing risk of bias of individual studies. \n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'A total of 1,868 records were retrieved through MEDLINE/PubMed, 3,786 through EMBASE, 2,544 through Web of Science and 1 through the Cochrane Library.'\nThe results section provides information on study selection.\n\n[Yes] 'These studies were generally of low quality (69.5% surgical series).' \nThe results section presents characteristics of the included studies.\n\n[No]\nThe results section does not present data on risk of bias within studies.\n\n[Yes] 'The 2-stage repair, with a 22% cumulative complication rate, a 10% fistula/dehiscence rate and a 6% stricture/stenosis rate, appears to give a distinct clinical benefit overall.'\nThe results section presents summary data and effect estimates for outcomes.\n\n[NA]\n\n[NA] \n\n[NA]\n\n[Yes] 'The present review illustrates that there is an extreme paucity of studies to address in an evidence-based manner many of the common issues related to the primary repair of proximal hypospadias.'\nThe discussion summarizes the main findings and considers their relevance.\n\n[Yes] 'As with any review, the present study has limitations. An important limitation is that this review did not account for some variables such as age at surgery, use of additional coverage of urethroplasty, and type of preoperative and postoperative drainage and care.'\nThe discussion examines limitations at the review level.\n\n[Yes] 'Hence, while we elaborate on general recommendations for the treatment of this condition, we emphasize the need to establish shared criteria for accurate preoperative or introperative patient stratification, and to define objective outcome measures and followup intervals for data reporting to make comparison of surgical approaches reliable.'\nThe conclusion provides a general interpretation of results and implications for future research.\n\n[No]\nThe paper does not describe sources of funding for the review.\n","Here are the assessments for each PRISMA item based on the provided full text:\n\n[Yes]\nThe title identifies the report as a systematic review and meta-analysis.\n\n[Yes] \n'This manuscript is mainly to systemically review the published reports that compared the efficacy and safety of robotic-assisted (RP) versus open pyeloplasty (OP) in children with ureteropelvic junction obstruction (UPJO).'\n\n[Yes]\nThe introduction describes the rationale for the review in context of current knowledge. \n\n[Yes]\nThe objectives state the questions addressed regarding participants, interventions, comparisons, outcomes, and study design.\n\n[No]\nThe protocol and registration are not reported.\n\n[Yes]  \n'Studies without control group or only comparing RP with LP were excluded.'\nThe eligibility criteria are specified.\n\n[Yes]\nThe information sources including databases and dates of coverage are described. \n\n[Yes]  \n'We searched PubMed® for comparative studies (from January 1990 to 2014 September) that compared the efficacy and safety of robotic versus open pyeloplasty.'\nThe full search strategy is provided for one database. \n\n[Yes]  \n'Two authors (Hsu and Chang) of the current study independently searched and reviewed the articles.' \nThe study selection process is described.\n\n[Yes]  \n'We extracted the following information from each study: study population characteristics, study design, inclusion and exclusion criteria, operation method, surgical approach, days of hospital stay, complication rate, follow-up period, and assessment of success rate.'\nThe data collection process is described.\n\n[Yes]\nThe data items including variables extracted are listed.\n\n[Yes] \n'Pooled data analysis showed that there was a significant higher overall complication rate in children undergoing RP.'\nMethods for assessing risk of bias are described.\n\n[Yes]\nThe summary measures including risk ratio are stated.\n\n[NA]\n\n[NA]\n\n[NA]\n\n[Yes]  \n'Flowchart for selection of trials'\nThe numbers of studies screened, assessed, and included are provided with reasons for exclusions.\n\n[Yes] \nThe characteristics of the included studies are presented in tables. \n\n[No]\nRisk of bias within studies is not presented.\n\n[Yes] \n'Among the seven comparative studies, six reported postoperative success rate.'\nSimple summary data and effect estimates are presented for outcomes considered.\n\n[NA]\n\n[NA]  \n\n[Yes]\nThe limitations at study and outcome level are discussed.\n\n[Yes]  \n'The current meta-analysis fails to validate robotic pyeloplasty as a standard of care in managing pediatric UPJO in the current status.'\nThe results are interpreted in context of other evidence and implications for future research are discussed.\n\n[Yes]\nThe sources of funding are described.\n","Here are the relevant quotes and assessments for each PRISMA item:\n\n[Yes] 'Transanal endorectal pull-through versus transabdominal approach for Hirschsprung's disease: A systematic review and meta-analysis' The title identifies the report as a systematic review and meta-analysis.\n\n[Yes] 'We performed a comprehensive meta-analysis comparing the clinical outcomes of TERPT and TAB.' The abstract mentions that a meta-analysis was performed.  \n\n[Yes] 'Aim: Transanal endorectal pull-through (TERPT) has become popular for single-stage treatment of Hirschsprung's disease. The benefits of TERPT over the conventional transabdominal approach (TAB) are still unclear. We performed a comprehensive meta-analysis comparing the clinical outcomes of TERPT and TAB.' The abstract provides structured summary including objectives, methods, results and conclusions.\n\n[Yes] 'As a less invasive procedure, the cited advantages of TERPT include better cosmetic results and shorter hospital stay, and many studies have documented its safety and efficiency [9], [10].' The introduction describes the rationale for the review.\n\n[Yes] 'We performed a comprehensive meta-analysis comparing the clinical outcomes of TERPT and TAB.' The objectives are to compare TERPT and TAB approaches.  \n\n[No] The methods do not mention a protocol or registration.\n\n[Yes] 'Original articles published from 1998 to 2012 were searched from Medline, Embase, and Cochrane databases. Randomized controlled trials (RCT) and observational clinical studies (OCS) comparing TERPT and TAB were included.' The eligibility criteria for studies are specified.\n\n[Yes] 'We searched all publications from August 1998 to March 2012 in the MEDLINE, EMBASE and Cochrane library databases and the Cochrane Controlled Trials Register using different combinations of the following terms: “Hirschsprung's disease,” “transanal,” “perineal approach,” “transabdominal” and “pull-through.”' The information sources including databases and search terms are described.\n\n[Yes] 'We searched all publications from August 1998 to March 2012 in the MEDLINE, EMBASE and Cochrane library databases and the Cochrane Controlled Trials Register using different combinations of the following terms: “Hirschsprung's disease,” “transanal,” “perineal approach,” “transabdominal” and “pull-through.”' The full search strategy for one database is provided.\n\n[Yes] 'Each included study was independently appraised by 3 reviewers (C.Y., S.N., N.K.L.) and data were extracted and entered into a database. Any disagreements were resolved by consensus.' The study selection process is described.\n\n[Yes] 'The following data were evaluated: patient's age at operation, length of aganglionic segment, operative time, length of hospital stay, duration of follow-up and the incidence of postoperative incontinence, constipation and enterocolitis.' The data collection process is described.\n\n[Yes] 'The following data were evaluated: patient's age at operation, length of aganglionic segment, operative time, length of hospital stay, duration of follow-up and the incidence of postoperative incontinence, constipation and enterocolitis.' The variables extracted are listed. \n\n[No] The methods do not describe assessment of risk of bias.\n\n[NA] No summary measures are stated since this is a systematic review without meta-analysis.\n\n[NA] The methods do not describe synthesis of results since this is a systematic review without meta-analysis. \n\n[NA] The methods do not describe assessment of risk of bias across studies since this is a systematic review without meta-analysis.\n\n[NA] The methods do not describe additional analyses since this is a systematic review without meta-analysis.\n\n[Yes] 'Of 93 studies, 1 RCT and 11 OCS were included, comprising 444 cases of TERPT and 348 cases of TAB (215 Soave, 94 Duhamel, 24 Swenson, 15 Rehbein procedures).' The number of studies screened, assessed, and included is provided with reasons for exclusion.\n\n[Yes] Table 1 provides the characteristics of the included studies.\n\n[No] The results do not describe risk of bias within studies.\n\n[NA] The results do not provide data on individual studies since this is a systematic review without meta-analysis. \n\n[NA] The results do not provide synthesized findings since this is a systematic review without meta-analysis.\n\n[NA] The results do not describe risk of bias across studies since this is a systematic review without meta-analysis.\n\n[NA] The results do not provide additional analyses since this is a systematic review without meta-analysis.\n\n[Yes] 'Our meta-analysis suggests that the TERPT is superior to the conventional TAB pull-through for Hirschsprung's disease.' The discussion summarizes the main findings.\n\n[Yes] 'The lack of randomized trials is a key problem.' Study limitations are discussed.\n\n[Yes] 'However, the lack of large prospective studies of robust design cannot be trivialized. More randomized controlled trials are necessary to verify the benefit of TERPT for Hirschsprung's disease.' Conclusions and implications for future research are stated.\n\n[No] The funding sources are not described.\n","Here are the relevant quotes and assessments for each PRISMA item:\n\n[Yes] 'Single-incision versus conventional three-incision laparoscopic appendicectomy for appendicitis: A systematic review and meta-analysis' \n\n[Yes] 'This meta-analysis was designed to investigate the safety and efficacy of single-incision laparoscopic appendicectomy (SILA) and three-incision laparoscopic appendicectomy (TILA) in the treatment of appendicitis.'\n\n[Yes] 'Minimally invasive surgery is the development direction of the future surgery, it allows the surgeon to perform complex intracorporeal procedures while minimizing the trauma of surgical access [1], [2], [3].'\n\n[No]\n\n[Yes] 'The publications were identified by searching the major medical databases such as MEDLINE, EMBASE, and Cochrane Library for relevant papers published between January 1992 and July 2012.' \n\n[Yes] 'Inclusion criteria were: (1) clinical studies that compared single-incision versus conventional three-incision laparoscopic appendicectomy for appendicitis between 1992 and 2012; (2) patients with primary appendicitis; and (3) raw data included some of the following: operative parameters, postoperative recovery, postoperative complications, postoperative pain and hospital charges.'\n\n[No] \n\n[Yes] 'Three researchers extracted data from each study by using a structured sheet and entered the data into a database. The extracted information comprised: author, year of publication, source journal, sample size, research design, clinical and pathological features of included patients, operative parameters (conversion rate, operative time and blood loss, surgical difficulty), postoperative recovery (time to oral intake and length of hospital stay), postoperative pain, postoperative complications (wound infection, abdominal abscess, omphalitis, umbilical hernia and ileus) and hospital charges.'\n\n[NA]\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'In this meta-analysis, weighted mean differences (WMD) were used for the analysis of continuous variables, and odds ratios (OR) were used for dichotomous variables.'\n\n[NA]\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'The funnel plot of standard of error by effect size for the measurements of wound infection, showed an equal distribution of studies around the middle line, indicating that publication bias was not evident (Fig. 6).'\n\n[Yes] 'Seventeen studies (1 randomized controlled trial and 16 retrospective studies) that included 1809 patients were studied. Of these patients, 793 and 1016 had undergone SILA and TILA, respectively.'\n\n[Yes] 'The characteristics of the 17 studies (1 randomized controlled trial [22] and 16 retrospective studies [5], [15], [16], [17], [18], [19], [20], [21], [23], [24], [25], [26], [27], [28], [29], [30]) are shown in Table 1.' \n\n[NA]\n\n[Yes] 'Fifteen studies [5], [15], [17], [18], [19], [20], [21], [22], [23], [24], [25], [27], [28], [29], [30] had data on conversion rate, in four of the studies [5], [18], [23], [27], three TILA and one SILA were converted to open appendectomy, and eighteen SILA were converted to TILA without conversion to open surgery.'\n\n[NA]\n\n[NA]\n\n[NA]\n\n[Yes] 'The meta-analysis revealed no significant differences in operative time and blood loss between SILA and TILA.'\n\n[Yes] 'The meta-analysis revealed that the incidences of wound infection, omphalitis, intraabdominal abscess and ileus were not significantly different between SILA and TILA.' \n\n[Yes] 'Our meta-analysis revealed no significant differences in VAS1 and VAS3 between SILA and TILA, although Peter et al [22] considered that the larger transumbilical fascial incision in SILA may translate into more postoperative pain.'\n\n[Yes] 'This study suggests that SILA is a safe technical alternative to TILA for patients with appendicitis. It involves significantly shorter hospital stay and possible improvement in cosmesis [22], and comparable operative time, blood loss, postoperative recovery, postoperative pain and complications with TILA.'\n\n[No]\n","Here are the assessments for the 27 PRISMA items based on the provided full text:\n\n[Yes] 'Thoracoscopic Procedures in Pediatric Surgery: What is the Evidence?' The title identifies the report as a systematic review.\n\n[Yes] 'Abstract / Structured summary: Provide a structured summary...' The abstract provides a structured summary with background, objectives, methods, results and conclusions. \n\n[Yes] 'Introduction / Rationale: Describe the rationale for the review in the context of what is already known.' The introduction describes the rationale for the review.\n\n[Yes] 'Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).' The introduction states the objective to identify studies comparing pediatric VATS with open procedures and classify them by CEBM criteria. \n\n[NA] This is not a protocol paper so registration is not applicable.\n\n[Yes] 'Methods / Eligibility criteria: Specify study characteristics...' The methods section specifies eligibility criteria for included studies.\n\n[Yes] 'Methods / Information sources: Describe all information sources...' The methods describe the information sources and search strategy.\n\n[Yes] 'Methods / Search: Present full electronic search strategy for at least one database...' The search strategy for PubMed is provided.\n\n[Yes] 'Methods / Study selection: State the process for selecting studies...' The study selection process is described. \n\n[Yes] 'Methods / Data collection process: Describe method of data extraction from reports...' The data extraction process is described.\n\n[Yes] 'Methods / Data items: List and define all variables for which data were sought...' The extracted data items are listed.\n\n[NA] Risk of bias assessment is not applicable for this type of systematic review. \n\n[NA] Meta-analysis methods are not applicable as no meta-analysis was performed.\n\n[NA] Assessment of risk of bias across studies is not applicable without a meta-analysis.\n\n[NA] Additional analyses are not applicable without a meta-analysis.\n\n[Yes] 'Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included...' The study selection process is described with number of studies at each stage.\n\n[Yes] 'Results / Study characteristics: For each study, present characteristics for which data were extracted...' Study characteristics are presented in Table 3. \n\n[NA] Risk of bias assessment is not applicable for this type of systematic review.\n\n[Yes] 'Results / Results of individual studies: For all outcomes considered...present, for each study: (a) simple summary data for each intervention group (b) effect estimates...' Results for individual studies are presented in Table 3.\n\n[NA] No meta-analysis results to present.\n\n[NA] No assessment of risk of bias across studies without a meta-analysis. \n\n[NA] No additional analyses without a meta-analysis.\n\n[Yes] 'Discussion / Summary of evidence: Summarize the main findings including the strength of evidence...' The discussion summarizes the main findings.\n\n[Yes] 'Discussion / Limitations: Discuss limitations at study and outcome level...' The lack of high quality studies is discussed as a limitation.\n\n[Yes] 'Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence...' The conclusion provides an interpretation of the results.\n\n[Yes] 'Funding: Describe sources of funding for the systematic review...' The lack of funding sources is stated.\n","[Yes]\nTitle identifies the report as a systematic review.\n\n[Yes] \nThe abstract provides relevant background, objectives, eligibility criteria, methods, results, conclusions and implications in a structured format.\n\n[Yes]\nThe introduction describes the rationale for the review and what is already known on the topic.  \n\n[Yes]\nThe objectives state the focus on randomized trials comparing laparoscopic vs open pediatric surgery.\n\n[No]\nA review protocol is not mentioned.\n\n[Yes]\nEligibility criteria specify inclusion of RCTs in English comparing laparoscopic with open pediatric surgery.\n\n[Yes]\nLiterature search in PubMed is described with limits applied. Search was performed on May 5, 2012.\n\n[Yes]\nThe full search strategy for PubMed is presented. \n\n[Yes] \nThe process for study selection is described.\n\n[NA]\n\n[Yes]\nOutcomes analyzed include operative time, complications, hospital stay, etc. \n\n[NA] \n\n[NA]\n\n[NA]\n\n[NA]\n\n[NA]\n\n[Yes] \nThe PRISMA flow diagram depicts the screening process and reasons for exclusion.\n\n[Yes] \nKey characteristics like sample size and outcomes are provided for included studies. \n\n[NA]\n\n[Yes] \nResults for relevant outcomes are summarized for individual studies.\n\n[NA]\n\n[NA]\n\n[NA] \n\n[NA]\n\n[Yes]\nThe discussion summarizes the main findings and limitations. \n\n[Yes]\nLimitations at study and review level are discussed.\n\n[Yes] \nConclusions interpret the results in context of other evidence.\n\n[Yes]\nSources of funding are described.\n","Here are the relevant quotes and assessments for the 27 PRISMA items:\n\n'Laparoscopic Versus Open Inguinal Hernia Repair in Pediatric Patients: A Systematic Review' [Yes]\n\n'Describe the rationale for the review in the context of what is already known.' [Yes] \n\n'Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).' [No]\n\n'Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.' [No] \n\n'Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.' [Yes]\n\n'Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.' [Yes]\n\n'Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.' [Yes]\n\n'State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).' [Yes] \n\n'Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.' [No]\n\n'List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.' [No]\n\n'Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.' [No]\n\n'[NA]'\n\n'[NA]' \n\n'[NA]'\n\n'Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.' [Yes]\n\n'For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.' [Yes] \n\n'Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).' [No]\n\n'For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.' [Yes]\n\n'[NA]'\n\n'[NA]'\n\n'[NA]'\n\n'Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).' [Yes]\n\n'Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).' [Yes]\n\n'Provide a general interpretation of the results in the context of other evidence, and implications for future research.' [Yes]\n\n'Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.' [No]\n","[No] 'Laparoscopic versus open splenectomy in children: a systematic review and meta-analysis'\nThe title does not identify the report as a systematic review or meta-analysis.\n\n[Yes] 'We conducted a systematic review and meta-analysis to compare the clinical outcomes between laparoscopic splenectomy and the traditional open splenectomy in children.'  \nThe abstract mentions it is a systematic review and meta-analysis.\n\n[Yes] 'Splenectomy is occasionally performed in children with various hematologic disorders such as sickle cell disease, idiopathic thrombocytopenic purpura, and so on [1].'\nThe introduction describes the context and rationale for the review.\n\n[No]  \nThe objectives stating PICOS are not provided.\n\n[No]\nRegistration information is not provided. \n\n[Yes] 'Literature searches were conducted to identify studies having compared the laparoscopic splenectomy (LS) and open splenectomy (OS) for children.'\nThe eligibility criteria for including studies is described.\n\n[Yes] 'Published records were searched using the MEDLINE, EMBASE, and Web of Science from 1993 to 2015.'\nThe information sources including databases and dates are described. \n\n[No]\nThe full search strategy is not presented.\n\n[Yes] 'Included studies were independently reviewed by two reviewers, and a third reviewer was required for a final decision in the case of any discrepancies.'  \nThe study selection process is described.\n\n[No] \nThe data collection process is not described.\n\n[Yes] 'The primary outcome measures of our analysis was to evaluate the operative time, blood loss, and length of postoperative stay. Secondary outcome measures included an analysis of the removal of accessory spleens and postoperative complications including postoperative high fever, acute chest syndrome (ACS), and ileus.'\nThe data items extracted are listed.\n\n[No]\nMethods for assessing risk of bias are not described.\n\n[Yes] 'For continuous data, we presented mean differences (MDs) with 95% confidence intervals (CIs). For dichotomous data, we calculated odds ratios (ORs).'\nThe summary measures are stated.\n\n[NA] \nMeta-analysis synthesis methods are not applicable since no meta-analysis was performed.\n\n[NA]  \nAssessment of risk of bias across studies is not applicable without a meta-analysis.\n\n[NA]\nAdditional analyses are not applicable without a meta-analysis.\n\n[Yes] 'As shown in Fig. 1 of the workflow, 21 of the 159 publications identified from the initial literature search were retrieved for full text review and 10 studies with 922 participants (508 received LS and 414 OS) met our total inclusion criteria as summarized in Table 1 together with basic demographic data from each included study, including age, male:female sex ratio and spleen size/weight/volume in each group.'  \nThe study selection process is described including numbers at each stage.\n\n[Yes] 'Tables 2 and 3 outlines the primary and secondary outcome results from each study.'\nStudy characteristics are presented in Tables 2 and 3. \n\n[No]\nIndividual study bias assessments are not presented.\n\n[Yes] 'Meta-analysis demonstrated that the LS approach had a significantly longer operative time than the OS approach with obvious statistical heterogeneity (I2 = 99%, WMD 42.22, 95% CI 7.69–76.74; P = 0.02; Fig. 2).'\nSummary data and effect estimates are presented for operative time.\n\n[NA] \nResults of meta-analyses are not applicable since no meta-analysis was performed. \n\n[NA]\nAssessment of bias across studies is not applicable without a meta-analysis.\n\n[NA]  \nAdditional analyses are not applicable without a meta-analysis. \n\n[Yes] 'In conclusion, our study suggests that LS is a feasible, safe, and effective surgical procedure alternative to OS for pediatric patients. LS is associated with shorter hospital stays, less blood loss, and longer operative times compared with OS.'\nA summary of the main findings is provided.\n\n[Yes] 'However, none of the ten studies included in our meta-analysis were randomized. Randomized controlled trials of high quality are definitely necessary and needed in the future to make our results more convincing and conclusive.'\nStudy limitations are discussed.\n\n[Yes] 'Acknowledgments: The manuscript had been proofread by Professor Xin-He Lai, Institute of Translational Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.'\nSources of funding are described.\n","Here are the step-by-step assessments for the 27 PRISMA items:\n\n[Yes] 'Comparison of LILT and STEP procedures in children with short bowel syndrome — A systematic review of the literature' \n\nThe title identifies the report as a systematic review.\n\n[Yes] 'Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).'\n\nThe objectives section states the questions addressed regarding interventions (LILT and STEP) and participants (children with short bowel syndrome). \n\n[No] The article does not mention whether a review protocol exists.\n\n[Yes] 'Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.'\n\nThe eligibility criteria section specifies characteristics like interventions, participants, outcomes, and study designs included.\n\n[Yes] 'Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.'\n\nThe search strategy is described including databases searched and date last searched.\n\n[No] The full electronic search strategy is not presented.\n\n[Yes] 'State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).' \n\nThe selection process including screening is described.\n\n[No] The data collection process is not described.\n\n[Yes] 'List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.'\n\nVariables like interventions, outcomes, and complications were defined and sought.\n\n[NA] Risk of bias assessment was not done.\n\n[NA] No meta-analysis was done. \n\n[NA] No meta-analysis was done.\n\n[NA] No additional analyses were stated to have been done.\n\n[Yes] The results section provides numbers of studies screened and included with exclusions and reasons.\n\n[Yes] Study characteristics like interventions and number of patients are presented. \n\n[NA] No risk of bias assessment was presented.\n\n[Yes] Results for outcomes like complications are presented for individual studies.\n\n[NA] No meta-analysis results are presented.\n\n[NA] No assessment of bias across studies is presented. \n\n[NA] No additional analyses are presented.\n\n[Yes] The discussion summarizes the main findings and outcomes.\n\n[Yes] Limitations at the study level like retrospective data are discussed.\n\n[Yes] Conclusions are made including implications for research.\n\n[No] Sources of funding are not described.\n","Here are the assessments for the 27 PRISMA items based on the provided full text:\n\n'Open Versus Transanal Pull-Through for Hirschsprung Disease: A Systematic Review of Long-Term Outcome'\n\nThe title identifies the report as a systematic review. [Yes]\n\n'We performed a systematic literature review of the long-term outcome of either OPEN surgery or L-TERPT/TERPT with a minimum follow-up period of 12 months.'\n\nThe abstract provides a structured summary. [Yes] \n\n'Various surgical procedures for the treatment of Hirschsprung disease (HD) have been proposed.'\n\nThe introduction describes the rationale for the review. [Yes]\n\n'Therefore, the aim of this study was to review the available data on long-term functional results in HD patients operated with conventional transabdominal pull-through (OPEN) compared with transanal approaches with and without laparoscopy (laparoscopic-assisted transanal-endorectal pull-through [L-TERPT] and transanal-endorectal pull-through [TERPT]).' \n\nThe introduction states the objectives and specifies the population, intervention, comparison, and outcomes. [Yes]\n\nNo mention of a review protocol. [No] \n\nNo registration information provided. [No]\n\n'Only articles comprehensively describing the surgical methods (OPEN, L-TERPT, TERPT) and reporting on major outcome parameters (soiling/incontinence, constipation, enterocolitis, and/or stricture) were included in this study.'\n\nThe eligibility criteria are specified. [Yes]\n\n'A systematic PubMed search was performed to identify publications on outcome of children with HD, who underwent either OPEN, L-TERPT, or TERPT. This search was limited to the past 5 years (2008 to 2012) using the keywords “Hirschsprung” and “outcome.”' \n\nThe information sources and search strategy are described. [Yes]\n\nNo full electronic search strategy provided. [No]\n\n'Data extracted from included articles were study characteristics (authors, journal, publication year, sample size, surgical technique, and follow-up period) and patient characteristics (age at surgery, extent of aganglionosis). Specific information on the outcome parameters constipation, enterocolitis, stricture, incontinence, and soiling were collected and analyzed.'\n\nThe study selection process is described. [Yes] \n\nThe data collection process is described. [Yes]\n\nThe variables extracted are listed. [Yes] \n\nNo assessment of risk of bias in individual studies described. [No]\n\nNo summary measures described. [NA]\n\nNo synthesis methods described. [NA] \n\nNo assessment of risk of bias across studies described. [NA]\n\nNo additional analyses described. [NA]\n\n'The initial literature search resulted in a total number of 148 articles published from 2008 to 2012. Of these, 130 articles were excluded because they did not fulfill the inclusion criteria ([Fig. 1]). Eighteen articles finally met the inclusion criteria and were analyzed in detail.'\n\nThe study selection process is described with a flow diagram. [Yes]\n\nTable 1 shows characteristics of included studies. [Yes]\n\nNo assessment of risk of bias within studies provided. [No] \n\nNo results for individual studies provided. [No]\n\nNo meta-analysis performed. [NA]\n\nNo assessment of bias across studies. [NA]\n\nNo additional analyses. [NA]\n\n'Functional outcome of surgical techniques for HD was highly variable.' \n\nThe results are summarized. [Yes]\n\n'Several limitations to this systematic review such as the different quality of studies and small cohort sizes need to be considered when interpreting these data.'\n\nLimitations at the study and outcome level are discussed. [Yes]\n\n'Hence, prospective, randomized, multicenter trials are urgently needed to overcome this weakness of the available reports in current literature.'\n\nImplications for future research are described. [Yes]\n\nNo funding sources described. [No]\n","Here are the assessments for the 27 PRISMA items based on the provided full text:\n\n[Yes] 'Laparoscopic versus open orchiopexy for non-palpable undescended testes in children: a systemic review and meta-analysis'\n\nThe title identifies the report as a systematic review.\n\n[Yes] 'Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.'\n\nThe abstract provides a structured summary with background, objectives, methods, results, and conclusions.\n\n[Yes] 'The undescended testes (cryptorchidism) is one of the most common disorders of childhood, affecting 0.8–1.8% of infants at 1 year of age, 3% of full-term newborns, and 21% of premature babies [1, 2].' \n\nThe introduction describes the rationale for the review in the context of existing knowledge.\n\n[Yes] 'Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).'\n\nThe objectives specify the participants, interventions, comparisons, and outcomes. \n\n[No]\n\nThe methods do not indicate if a protocol exists or provide registration information.\n\n[Yes] 'Eligibility criteria included all available studies comparing LO with OO for the treatment of NPT in children.'\n\nThe eligibility criteria are specified.\n\n[Yes] 'Published studies until August 31, 2010 were searched from Medline, Embase, Ovid, Web of Science, and Cochrane databases.'\n\nThe information sources including databases and date ranges are described.\n\n[Yes] 'After independent review, 18 publications dealing with comparison of LO and OO for the treatment of pediatric NPT were considered to be eligible for inclusion in the analysis.'\n\nThe study selection process is described.\n\n[No]\n\nThe methods do not describe the data collection process. \n\n[Yes] 'Data regarding the following factors were considered: first author, study duration, methodology, participant features, intervention characteristics, and outcome measures.'\n\nThe extracted data items are listed.\n\n[No]\n\nThe methods do not describe risk of bias assessment at study or outcome level.\n\n[Yes] 'Weighted mean differences (WMDs) and ORs were used for the analysis of continuous and dichotomous variables, respectively.'\n\nThe summary measures are stated.\n\n[NA]\n\nNot applicable since no meta-analysis was performed.\n\n[NA] \n\nNot applicable since no assessment of bias across studies was done.\n\n[NA]\n\nNot applicable since no additional analyses were done.\n\n[Yes] 'Two hundred and twenty-six studies were initially found to report the laparoscopy in the management of NPT using the keywords “laparoscopy” and “non-palpable testis”.' \n\nThe study selection process is described with number of studies screened, assessed, and included.\n\n[Yes] 'A summary of the studies’ methodology, intervention characteristics, and measured outcomes was provided in Tables 1 and 2, including 176 cases of LO and 263 cases of OO.'\n\nThe study characteristics are presented.\n\n[No]\n\nThe results do not present risk of bias assessments.\n\n[Yes] 'In two OCSs comparing the viable testis between LO and OO [10, 14], analysis of the pooled data revealed that the viable testis rate of LO was not significantly different from that of OO (Fig. 3, OR = 1.61; 95% CI = 0.30 to 8.52; P = 0.58), with significant statistical heterogeneity (I2 = 50.6%).'\n\nThe results present summary data and effect estimates for each outcome considered.\n\n[NA] \n\nNot applicable since no meta-analysis was performed.\n\n[NA]\n\nNot applicable since no assessment of bias across studies was done. \n\n[NA]\n\nNot applicable since no additional analyses were done.\n\n[Yes] 'Meta-analysis is a statistical technique for combining the findings from independent studies, which allows a comprehensive evaluation of the presence of heterogeneity [15].'\n\nThe discussion summarizes the main findings and considers their relevance.\n\n[Yes] 'Due to the paucity of available evidence addressing the study question, our search was not restricted to randomized controlled trials (RCTs).' \n\nThe limitations at the study and outcome level are discussed.\n\n[Yes] 'Thus, it is necessary to investigate the real advantages of interventional laparoscopy over traditional open orchidopexy (OO) or whether it can be regarded as a substitute for open procedures.'\n\nThe conclusions provide a general interpretation of the results.\n\n[No]\n\nNo sources of funding are described.\n","Here are my assessments for each PRISMA item based on the provided systematic review text:\n\n[Yes] 'Systematic Review and Meta-Analysis on the Influence of Surgeon Specialization on Outcomes Following Appendicectomy in Children' \n\nThe title identifies the report as a systematic review and meta-analysis.\n\n[Yes] 'We performed a systematic review and meta-analysis to determine the influence of surgeon subspecialty on outcomes following appendicectomy in children.'\n\nThe abstract provides background, objectives, eligibility criteria, participants, interventions, methods, results, conclusions. \n\n[Yes] 'An expanding body of evidence suggests that surgeon subspecialization affects outcomes; studies found that colorectal surgery subspecialization4 and orthopedic surgery subspecialization5 lead to improved results and that outcomes from a variety of cancers are improved with subspecialization.'\n\nThe introduction describes the rationale in context of existing evidence.\n\n[Yes] 'We performed a systematic review and meta-analysis to determine the influence of surgeon subspecialty on outcomes following appendicectomy in children.'  \n\nThe objectives reference the PICOS elements.\n\n[No]\n\nNo protocol or registration is indicated.\n\n[Yes] 'Eligible studies were comparative and provided data on children who had appendicectomy while under the care of general or pediatric surgical teams.' \n\nStudy characteristics including participants are described.\n\n[Yes] 'In order to identify studies and determine eligibility, 2 authors (DD and MM) independently searched Medline and EMBASE up to June 24, 2015 using the following search strategy...'\n\nInformation sources and search strategy are described. \n\n[Yes] 'In order to identify studies and determine eligibility, 2 authors (DD and MM) independently searched Medline and EMBASE up to June 24, 2015 using the following search strategy “([paediatric surgery OR pediatric surgery OR pediatric surgeon OR paediatric surgeon] AND (appendectomy OR appendicectomy)].'\n\nThe full search strategy for one database is provided.\n\n[Yes] 'Titles and abstracts were examined initially and then full manuscripts were obtained to finalize eligibility.'\n\nThe study selection process is described.\n\n[Yes] 'Two authors (DD and DH) independently extracted data from eligible studies using an electronic spreadsheet.' \n\nData collection by two authors is described. \n\n[Yes] 'Extracted data comprised details on the following variables: lead author, publication date, study design, inclusion and exclusion criteria, outcomes reported, whether there was a specified primary endpoint, main results, numbers and characteristics of patients, surgical approach, rate of negative appendiceal histology, wound infections, intra-abdominal collections, readmissions, mortality, and length of stay.'\n\nThe extracted variables are listed.\n\n[No]\n\nNo assessment of individual study bias is described.\n\n[Yes] 'Pooled risk ratios and pooled mean differences were used to evaluate the effect of treatment by general surgery units or pediatric surgery units on dichotomous and continuous outcomes, respectively.'\n\nThe summary measures are stated.\n\n[NA]\n\n[NA] \n\n[NA]\n\n[Yes] 'Figure 1 summarizes the results of the search. A total of 1841 citations were excluded based on titles and abstracts. A total of 27 full text manuscripts were examined and 9 studies were finally eligible for inclusion. No additional studies were identified from the gray literature search or from searching included article reference lists.'\n\nThe study selection process is described with number of studies at each stage.\n\n[Yes] 'Characteristics of the 9 included studies8,11–18 are shown in Table 1 and results from the studies are provided in Table 2.' \n\nStudy characteristics are presented in a table. \n\n[No]\n\nNo assessment of risk of bias within studies is presented.\n\n[Yes] 'Seven studies8,11–14,16,18 (62,865 children) reported on numbers of histologically negative appendicectomies. A normal appendix was removed in 4660/48,105 children treated by general surgery units and in 889/14,760 children treated by pediatric units (pooled risk ratio 1.79; 95%CI 1.26–2.54; P = 0.001) (Figure 2).'\n\nResults for the outcome of negative appendicectomy are presented with summary data and effect estimates.\n\n[Yes]  'Pooled risk ratios and pooled mean differences were used to evaluate the effect of treatment by general surgery units or pediatric surgery units on dichotomous and continuous outcomes, respectively.' \n\nPooled effect estimates are presented.\n\n[NA] \n\n[NA]\n\n[NA]\n\n[No] \n\nNo limitations at the review or outcome level are discussed.\n\n[Yes] 'Despite this, our findings must be interpreted with caution as our article is based entirely upon observational data.' \n\nLimitations of included studies are acknowledged. \n\n[Yes] 'We found that children who were managed by specialized pediatric surgery teams had lower rates of negative appendicectomy although mean length of stay was longer in this group. However, our article is based upon a group of heterogeneous and mostly retrospective studies, and therefore there is little external validity.'\n\nConclusions summarize the main findings and limitations.\n\n[No]\n\nNo sources of funding are described.\n"," Here are the assessments for each PRISMA item:\n\n[Yes] 'Systematic Review and Meta-Analysis on the Influence of Surgeon Specialization on Outcomes Following Appendicectomy in Children'\nThe title identifies the report as a systematic review and meta-analysis.\n\n[Yes] 'Two authors searched Medline and Embase to identify relevant studies.'  \nThe abstract provides information about the data sources.\n\n[Yes] 'An expanding body of evidence suggests that surgeon subspecialization affects outcomes; studies found that colorectal surgery subspecialization4 and orthopedic surgery subspecialization5 lead to improved results and that outcomes from a variety of cancers are improved with subspecialization.'\nThe introduction provides context about what is already known on the topic.\n\n[No]\nThe objectives are not explicitly stated in terms of participants, interventions, comparisons, outcomes, and study design.\n\n[No] \nThe protocol and registration are not mentioned.\n\n[Yes] 'Eligible studies were comparative and provided data on children who had appendicectomy while under the care of general or pediatric surgical teams.'\nThe eligibility criteria relating to participants, interventions, and comparisons are described.\n\n[Yes] 'In order to identify studies and determine eligibility, 2 authors (DD and MM) independently searched Medline and EMBASE up to June 24, 2015 using the following search strategy'\nThe information sources and search strategy are described. \n\n[Yes] 'using the following search strategy “([paediatric surgery OR pediatric surgery OR pediatric surgeon OR paediatric surgeon] AND (appendectomy OR appendicectomy)].'\nThe full search strategy for one database is provided.\n\n[Yes] 'Titles and abstracts were examined initially and then full manuscripts were obtained to finalize eligibility.' \nThe study selection process is described.\n\n[No]\nThe data collection process is not described.\n\n[Yes] 'Extracted data comprised details on the following variables: lead author, publication date, study design, inclusion and exclusion criteria, outcomes reported, whether there was a specified primary endpoint, main results, numbers and characteristics of patients, surgical approach, rate of negative appendiceal histology, wound infections, intra-abdominal collections, readmissions, mortality, and length of stay.'\nThe variables extracted are listed.\n\n[No]\nMethods for assessing risk of bias are not described.\n\n[Yes] 'Pooled risk ratios and pooled mean differences were used in analyses.'\nThe principal summary measures are stated.\n\n[NA]\n\n[NA] \n\n[NA]\n\n[Yes] 'Figure 1 summarizes the results of the search.'\nThe study selection process is summarized.\n\n[Yes] 'Characteristics of the 9 included studies8,11–18 are shown in Table 1 and results from the studies are provided in Table 2.' \nStudy characteristics are presented.\n\n[No]\nRisk of bias is not presented for individual studies.\n\n[Yes] 'Seven studies8,11–14,16,18 (62,865 children) reported on numbers of histologically negative appendicectomies.'\nResults for the main outcomes are presented for each study.\n\n[Yes] 'We found that children who were managed by specialized pediatric surgery teams had lower rates of negative appendicectomy although mean length of stay was longer in this group.'\nThe main results of the synthesis are summarized.\n\n[NA]\n\n[NA] \n\n[NA]\n\n[Yes] 'The principle strength of our review is our exhaustive search strategy which included a detailed gray literature search.' \nStrengths and limitations are discussed.\n\n[Yes] 'We also wish to highlight that a large proportion of our data came from discharge registries13,18 which are known to be prone to inaccuracies.'\nLimitations at the study and outcome level are discussed.\n\n[Yes] 'We wish to encourage future research through the use of large-scale prospective multicenter registries.'\nImplications for future research are discussed.\n\n[No]\nSources of funding are not described.\n","Here are the PRISMA assessments:\n\n[Yes] 'Systematic Review and Meta-Analysis on the Influence of Surgeon Specialization on Outcomes Following Appendicectomy in Children' \n\nTitle identifies the report as a systematic review and meta-analysis.\n\n[Yes] 'Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.'\n\nThe abstract provides a structured summary covering all key elements.\n\n[Yes] 'An expanding body of evidence suggests that surgeon subspecialization affects outcomes; studies found that colorectal surgery subspecialization4 and orthopedic surgery subspecialization5 lead to improved results and that outcomes from a variety of cancers are improved with subspecialization.'\n\nThe introduction describes the rationale in context of existing evidence.  \n\n[Yes] 'We performed a systematic review and meta-analysis to determine the influence of surgeon subspecialty on outcomes following appendicectomy in children.'\n\nThe objectives relate to participants, interventions, outcomes and study designs.\n\n[No]\n\nNo protocol or registration is mentioned.\n\n[Yes] 'Eligible studies were comparative and provided data on children who had appendicectomy while under the care of general or pediatric surgical teams.' \n\nEligibility criteria cover populations, interventions, comparators and outcomes. \n\n[Yes] 'In order to identify studies and determine eligibility, 2 authors (DD and MM) independently searched Medline and EMBASE up to June 24, 2015 using the following search strategy [search string].'\n\nInformation sources, search dates, and search strategy are described.\n\n[Yes] '[search string]'\n\nThe full search string for at least one database is provided.\n\n[Yes] 'Two authors initially screened titles and abstracts and then full text manuscripts were evaluated.'\n\nThe study selection process is described.\n\n[Yes] 'Two authors (DD and DH) independently extracted data from eligible studies using an electronic spreadsheet.'\n\nData collection process with duplicated extraction is described.\n\n[Yes] 'Extracted data comprised details on the following variables: lead author, publication date, study design, inclusion and exclusion criteria, outcomes reported, whether there was a specified primary endpoint, main results, numbers and characteristics of patients, surgical approach, rate of negative appendiceal histology, wound infections, intra-abdominal collections, readmissions, mortality, and length of stay.'\n\nExtracted variables relating to PICOS and other factors are described.\n\n[No]\n\nNo assessment of risk of bias in individual studies is described. \n\n[Yes] 'Pooled risk ratios and pooled mean differences were used in analyses.'\n\nSummary measures are stated.\n\n[NA]\n\n[Yes] 'The potential for publication bias was evaluated by visually inspecting funnel plots.' \n\nPublication bias assessment is described.\n\n[NA]\n\n[Yes] 'We identified 1035 Medline sources and 1868 Embase sources. Figure 1 summarizes the results of the search. A total of 1841 citations were excluded based on titles and abstracts. A total of 27 full text manuscripts were examined and 9 studies were finally eligible for inclusion.'\n\nThe study selection process, including numbers at each stage, is described.\n\n[Yes] 'Characteristics of the 9 included studies8,11–18 are shown in Table 1 and results from the studies are provided in Table 2.'\n\nStudy characteristics are presented. \n\n[No]\n\nNo assessment of risk of bias within studies is presented.\n\n[Yes] 'Pooled risk ratios and pooled mean differences were used to evaluate the effect of treatment by general surgery units or pediatric surgery units on dichotomous and continuous outcomes, respectively.'\n\nResults for each analysis are presented, including summary measures and confidence intervals.\n\n[Yes] 'Figure 2. Forest plot for negative appendicectomy rate.'\n\nPooled analyses are presented with forest plots.\n\n[Yes] 'Figure 3. Forest plot for wound infections.' \n\nPooled analyses are presented with forest plots.\n\n[No]\n\nNo assessment of risk of bias across studies is presented.\n\n[NA] \n\n[NA]\n\n[Yes] 'We found that children who were managed by specialized pediatric surgery teams had lower rates of negative appendicectomy although mean length of stay was longer in this group.'\n\nMain findings are summarized.\n\n[Yes] 'Regarding limitations, the main issue is the retrospective nature of most of the included studies.' \n\nLimitations at study and outcome level are discussed.\n\n[Yes] 'We wish to encourage future research through the use of large-scale prospective multicenter registries.'\n\nConclusions and implications for future research are provided.\n\n[No]\n\nNo sources of funding are described.\n","[Yes] 'Open versus Laparoscopic Pyloromyotomy for Pyloric Stenosis: A Meta-analysis of Randomized Controlled Trials'\n\n[Yes] 'Aim of the study was to compare the outcomes after laparoscopic pyloromyotomy (LP) with those of open pyloromyotomy (OP) for infantile pyloric stenosis.' \n\n[Yes] 'Pyloromyotomy is an effective surgical intervention with rare mortality and has traditionally been performed via an open technique since the early 20th century.'\n\n[No]\n\n[Yes] 'Further searches were done by manually reviewing abstract booklets, conference proceedings and review articles.'\n\n[Yes] 'Eligible studies were those that compared LP with OP for the treatment of infants with IHPS, and only randomized controlled trials was reviewed.'\n\n[Yes] 'An electronic literature search of all articles from inception to February 2009 was conducted using Medline, the Cochrane Library, SCI, EMBASE, and the Chinese Biomedical Literature Database, using the following text and keywords in combination both as MeSH terms and text words: “pyloric stenosis”, “pylorostenosis”, “pyloristenosis” and “pyloromyotomy” in combination with “laparoscop*”.'\n\n[Yes] 'The reference lists of the retrieved articles were examined for additional publications.'\n\n[Yes] 'Data were extracted by 2 independent investigators, and discrepancies were discussed to reach consensus.' \n\n[Yes] 'For each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics and surgical features of the study.'\n\n[Yes] 'Data were extracted by 2 independent investigators, and discrepancies were discussed to reach consensus. For each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics and surgical features of the study. Furthermore, we assessed the quality of the studies using guidelines published in the Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [11] (namely sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other potential threats to validity). Quality factors of each study were assessed separately.'\n\n[Yes] 'The primary endpoints in this review were complications during and following pyloromyotomy, the secondary endpoints included time to goal feeds, length of stay after surgery and operative time.' \n\n[Yes] 'For the purpose of meta-analysis, the standard deviation (SD) of continuous variables was required.'\n\n[NA]\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] '462 potentially relevant articles. After a review of the titles, abstracts and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were finally eligible for this study ([Fig. 1]).'\n\n[Yes] 'Baseline characteristics of included trials are summarized in [Table 1].' \n\n[Yes] 'All 3 studies [9] [10] [13] reported complications during and following pyloromytomy.'\n\n[Yes] 'All 3 studies [9] [10] [13] reported complications during and following pyloromyotomy.'\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'There was no difference in full time to feeds (SMD: 0.78, 95% CI: −0.50–2.06) between the groups in the 2 studies [9] [13]. However, in the third study [10], the full time to feeds showed a significant difference between the 2 approaches with a median time of 23.9 h in the OP group compared with 18.5 h in the LP group (p=0.002, [Table 4]).'\n\n[Yes] 'Our study also showed that, compared with OP procedures, LP procedures appear to be equal in terms of time-related results [9] [13]. However, there was a trend in the LP group towards shorter times, especially with regard to the full time to feeds, length of stay after surgery and operating time [10], suggesting that with more patients enrolled this difference would likely reach significance [13].'\n\n[Yes] 'Most relied on information from databases. In this review, all trials included were obtained from online databases and no other articles were reviewed. Thus, a publication bias probably existed, although we did not assess this in detail because of the small numbers of trials that could be pooled.'\n\n[Yes] 'Overall, this systematic review has shown a similar frequency of complications for LP and OP procedures. Furthermore, it also showed a trend toward shorter times for LP.'\n\n[Yes] 'Conflict of Interest: None'\n","[Yes] 'Open versus Laparoscopic Pyloromyotomy for Pyloric Stenosis: A Meta-analysis of Randomized Controlled Trials'\nThe title identifies the report as a systematic review and meta-analysis.\n\n[Yes] 'Aim of the study was to compare the outcomes after laparoscopic pyloromyotomy (LP) with those of open pyloromyotomy (OP) for infantile pyloric stenosis.' \nThe abstract provides a structured summary including background, objectives, eligibility criteria, interventions, methods, results, conclusions.\n\n[Yes] 'Pyloromyotomy is an effective surgical intervention with rare mortality and has traditionally been performed via an open technique since the early 20th century.'\nThe introduction describes the rationale for the review.  \n\n[Yes] 'The aim of this meta-analysis was to systematically and quantitatively evaluate all the published randomized controlled trials comparing LP with OP for infantile pyloric stenosis.'\nThe introduction states the objectives and refers to participants, interventions, comparisons, and outcomes.\n\n[No]\nNo review protocol or registration is mentioned.\n\n[Yes] 'Eligible studies were those that compared LP with OP for the treatment of infants with IHPS, and only randomized controlled trials was reviewed.' \nThe eligibility criteria are specified.\n\n[Yes] 'An electronic literature search of all articles from inception to February 2009 was conducted using Medline, the Cochrane Library, SCI, EMBASE, and the Chinese Biomedical Literature Database.'\nThe information sources are described. \n\n[Yes] 'The literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts and removal of duplicates, 17 articles were selected for further evaluation.'\nThe process of study selection is stated.\n\n[Yes] 'Data were extracted by 2 independent investigators, and discrepancies were discussed to reach consensus.' \nThe data collection process is described.\n\n[Yes] 'For each eligible study, we recorded the author, date of publication, institution, sample size, study design, patient characteristics and surgical features of the study.'\nThe data items extracted are listed.\n\n[Yes] 'Using the quality assessment instrument of the Cochrane Handbook version 5.0.1, we assigned ‘Yes’ for low risk of bias, ‘No’ for high risk of bias, or ‘Unclear’ for uncertain risk of bias.'\nThe methods for assessing risk of bias are described.\n\n[NA]\nNo summary measures are stated since no meta-analysis was performed.\n\n[NA] \nNo methods for synthesizing results are described since no meta-analysis was performed. \n\n[NA]\nNo assessment of risk of bias across studies is described since no meta-analysis was performed.\n\n[NA] \nNo additional analyses are mentioned since no meta-analysis was performed.\n\n[Yes] 'The literature searches yielded 461 potentially relevant articles. After a review of the titles, abstracts and removal of duplicates, 17 articles were selected for further evaluation. When inclusion criteria were applied, 3 randomized controlled trials with 492 infants were finally eligible for this study ([Fig. 1]).'\nA flow diagram of study selection is provided.\n\n[Yes] 'Baseline characteristics of included trials are summarized in [Table 1].' \nStudy characteristics are presented in a table.\n\n[Yes] 'Using the quality assessment instrument of the Cochrane Handbook version 5.0.1, we assigned ‘Yes’ for low risk of bias, ‘No’ for high risk of bias, or ‘Unclear’ for uncertain risk of bias.'  \nThe risk of bias within studies is presented.\n\n[Yes] 'All 3 studies [9] [10] [13] reported complications during and following pyloromytomy.'\nSimple summary data and effect estimates are presented for the outcomes.\n\n[NA]\nNo meta-analysis was performed.\n\n[NA]  \nNo assessment of risk of bias across studies is presented since no meta-analysis was performed.\n\n[NA]\nNo additional analyses are presented since no meta-analysis was performed.  \n\n[Yes] 'Overall, this systematic review has shown a similar frequency of complications for LP and OP procedures. Furthermore, it also showed a trend toward shorter times for LP.'\nA summary of the evidence is provided.\n\n[Yes] 'The conclusions from this study remain somewhat limited due to the small sample size.'\nLimitations are discussed.\n\n[Yes] 'These findings should encourage the development of future studies to assess the effect of the surgical approach on outcome measures such as postoperative pain, effect on growth and development, financial costs and the experience of the surgeons performing the technique in clinical practice.'\nConclusions and implications for future research are discussed.\n\n[No]\nNo sources of funding are reported.\n","Here are the relevant quotes and assessments for each PRISMA item based on the provided full text:\n\n[Yes] 'Surgical versus conservative management of congenital pulmonary airway malformation in children: A systematic review and meta-analysis'\nThe title identifies the report as a systematic review and meta-analysis.\n\n[Yes] 'We performed a systematic review and meta-analysis comparing elective resection versus expectant management.'  \nThe abstract summarizes that a systematic review and meta-analysis was performed. \n\n[Yes] 'The ideal management of infants born with asymptomatic congenital pulmonary airway malformation (CPAM) is controversial.'\nThe introduction describes the rationale in context of existing knowledge.\n\n[Yes] 'Our objective was to conduct a systematic review and meta-analysis of all published literature comparing the postoperative outcomes associated with elective surgery (while asymptomatic) versus those following surgery as part of expectant management (i.e., performing surgery only upon the development of symptoms) in children born with asymptomatic CPAM lesions.'\nThe introduction states the objective and specifies the population, interventions, outcomes, and study designs.\n\n[NA]\nNo protocol or registration is mentioned.\n\n[Yes] 'We excluded any studies on nonhuman subjects and those that did not focus on pediatric patients, as well as any studies that were not published in English, owing to resource limitations.' \nThe methods specify eligibility criteria regarding population, outcomes, and other characteristics.\n\n[Yes] 'To identify all studies on elective surgery and expectant management of asymptomatic CPAM lesions, we conducted an electronic literature search of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), EMBASE (1980 onwards), CINAHL (1982 onwards), and PubMed (1966 onwards) in January 2015.'\nThe methods describe the information sources and date last searched.\n\n[Yes] 'We used the search terms (“asymptomatic” AND “congenital” AND “cystic” AND “adenomatoid malformation”) OR (“lung” AND “lesion”) AND (“management” OR “treatment” OR “therapy.”).'\nThe methods provide the full search strategy for at least one database. \n\n[Yes] 'Two independent reviewers conducted all article screening; where consensus on an article could not be reached, a third reviewer was consulted.'\nThe methods describe the study selection process.\n\n[Yes] 'One reviewer extracted all data from the included studies, and another checked it for accuracy and completeness. We extracted the following data exclusively on patients who were asymptomatic at birth: number of patients undergoing elective surgery, number undergoing surgery as part of expectant management (after symptom development), age at symptom development if applicable, postoperative complications, mortalities, and total length of postoperative hospital stay, as well as number of patients successfully managed conservatively at the end of follow-up, and length of follow-up for these patients.'\nThe methods describe the data collection process and extracted data items.\n\n[No]\nThe methods do not describe risk of bias assessment at the study or outcome level.\n\n[Yes] “We produced Chi2 and I2 values to assess homogeneity.”\nThe methods state the summary measures used.\n\n[NA]\nNo synthesis methods are described since no meta-analysis was performed.\n\n[NA]  \nNo assessment of bias across studies is described since no meta-analysis was performed.\n\n[NA]\nNo additional analyses are mentioned. \n\n[Yes] 'Nine studies were ultimately included [10], [11], [12], [14], [23], [24], [25], [26], [27]].'\nThe number of studies screened, assessed, and included is provided.\n\n[Yes] 'We did not identify any RCTs; all but one of the included nine studies were retrospective [26].'\nStudy characteristics like design and citations are provided.\n\n[No]\nNo individual study risk of bias is presented.\n\n[NA]\nNo results for individual studies are presented since no meta-analysis was performed. \n\n[NA]  \nNo results of meta-analyses are presented since none were performed.\n\n[NA]\nNo assessment of bias across studies is presented since no meta-analysis was performed.\n\n[NA]  \nNo additional analyses are presented since none were mentioned.\n\n[Yes] “With the wide use of antenatal ultrasound, CPAM is often diagnosed before birth, and may remain asymptomatic for years. Whether asymptomatic children should undergo elective lung resection is disputed [6], [7]. We have attempted to compare patients who underwent resection of CPAM lesions while asymptomatic to those who were managed expectantly and had surgery only upon the development of symptoms, in terms of morbidity and length of stay in hospital.'\nThe discussion summarizes the main findings and their relevance.\n\n[Yes] 'Our results should be interpreted with caution owing to the nature of the included studies (in that all but one were retrospective).' \nThe discussion describes limitations at the study level.\n\n[Yes] 'Based on our results, we recommend elective resection of asymptomatic CPAM lesions, rather than expectant management.'\nThe discussion provides conclusions and implications.\n\n[Yes] “The University of Ottawa Summer Studentship program provided financial support for this project.”\nThe funding sources are described.\n"," [No]\nThe title does not identify the report as a systematic review.\n\n[Yes] \nThe abstract provides background, objectives, eligibility criteria, data sources, results, limitations, and conclusions.\n\n[Yes]\nThe introduction describes the rationale for the review in context of prior knowledge.\n\n[Yes]\nThe objectives explicitly state the questions addressed regarding participants, interventions, comparisons, outcomes, and study design. \n\n[No]\nA review protocol is not indicated.\n\n[Yes] \nThe eligibility criteria specify characteristics like PICOS and publication status.\n\n[Yes]\nThe information sources describe databases searched and date last searched.\n\n[No]\nA full search strategy is not presented.\n\n[Yes]\nThe process for study selection is described.\n\n[No]\nDetails on data collection process are not provided. \n\n[Yes]\nVariables extracted are listed.\n\n[NA]\n\n[Yes] \nPrincipal summary measures are stated.\n\n[NA]\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] \nA flow diagram of study selection is provided.\n\n[Yes] \nStudy characteristics are presented. \n\n[No]\nIndividual study risk of bias is not presented.\n\n[Yes]\nSimple summary data and effect estimates are provided for outcomes.\n\n[NA]\n\n[NA]\n\n[NA] \n\n[Yes]\nMain findings are summarized and clinical implications are discussed.\n\n[Yes] \nLimitations at the study and review level are discussed.\n\n[Yes]\nGeneral interpretation of results in context of other evidence is provided. \n\n[No]\nSources of funding are not described.\n","Here are the relevant quotes and assessments for each PRISMA item:\n\n[Yes] 'Antibiotics and appendicitis in the pediatric population: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee Systematic Review☆'\n\n[Yes] 'Objective: The aim of the study was to review evidence-based data regarding the use of antibiotics for the treatment of appendicitis in children.'\n\n[Yes] 'Describe the rationale for the review in the context of what is already known.'\n\n[Yes] 'We conducted a literature search using “appendicitis” combined with “antibiotics” with children as the target patient population. Studies were selected based on relevance for the following questions:'\n\n[No]\n\n[Yes] 'PubMed and other databases of the English literature (up to August 2009) were analyzed.' \n\n[Yes] 'PubMed and other databases of the English literature (up to August 2009) were analyzed. The Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, and the HTA Database were used as well.'\n\n[Yes] 'Once guidelines were established, grades were assigned based on the strength of the studies supporting the recommendation [3].'\n\n[Yes] 'We classified each study according to the classes of evidence and rating of evidence as outlined in Fig. 1[2].' \n\n[NA]\n\n[NA] \n\n[NA]\n\n[Yes] 'However, we only referenced those studies with the highest class data that were most relevant to answering the questions listed above.'\n\n[Yes] 'Overall, 126 studies were selected and reviewed.'\n\n[NA]\n\n[NA]\n\n[NA] \n\n[Yes] 'A Cochrane Database review looking at both adults and children support that a single dose of broad-spectrum antibiotics, given preoperatively is effective in decreasing wound infection and abscess formation [4].'\n\n[Yes] 'This meta-analysis demonstrated that preoperative antibiotics significantly decreased the risk of wound infection and postoperative abscess compared to placebo.' \n\n[NA]\n\n[NA]\n\n[NA]\n\n[Yes] 'A prospective, randomized trial conducted by St Peter et al [6] showed single daily dosing of ceftriaxone and metronidazole was more efficient, cost-effective, and had similar results compared to triple antibiotics.'\n\n[Yes] 'Fraser et al [11] conducted a well-powered, single-institution prospective, randomized trial that showed that when patients are able to tolerate a regular diet, completing the course of antibiotics orally had similar results compared to a minimum 5-day course of IV antibiotics (Grade B).' \n\n[Yes] 'The duration of intravenous antibiotics administered for perforated antibiotics had traditionally been 7 or 10 days. However, the severity of peritonitis and clinical illness in patients with perforated appendicitis vary. Therefore, an empiric length of time for antibiotics may result in many patients receiving IV antibiotics for a longer time than necessary. There is Grade B evidence that the length of administration of IV antibiotics should be based on clinical criteria, such as fever, pain, return of bowel function, and white blood cell (WBC) count [10], [11].'\n\n[Yes] 'Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.'\n"," [Yes] 'The Effects and Efficacy of Antireflux Surgery in Children with Gastroesophageal Reflux Disease: A Systematic Review'\n\n[Yes] 'This study aims to systematically review the efficacy of pediatric ARS and its effects on gastroesophageal function, as measured by gastroesophageal function tests.'\n\n[Yes] 'Gastroeophageal reflux disease (GERD) is a frequently encountered condition, affecting 7–20% of the pediatric population.'\n\n[No]\n\n[No] \n\n[Yes] 'Inclusion Criteria \nEach article was independently assessed for eligibility using the following criteria: study population—infants and children (0–18 years), who underwent ARS; type of intervention—open or laparoscopic Nissen, Thal, or Toupet fundoplication; study design—only prospective study format; study results—operative results reported using symptom questionnaires, or clearly defined reflux symptoms, or GE function tests, both before and after ARS.'\n\n[Yes] 'The following data were extracted from each selected article: Study design, study population, surgical method, outcome assessment techniques, duration of follow-up, and study outcomes of interest.' \n\n[Yes] 'Using predefined search terms, PubMed (from 1960), Embase (from 1980), and the Cochrane library (issue 11, 2010) were systematically searched for all articles published until November 10, 2010.'\n\n[No]\n\n[Yes] 'The titles and abstracts of all identified studies were reviewed by two independent authors (WS, MH) according to the MOOSE criteria.5 Full publications were obtained for articles that appeared potentially relevant. References in these selected articles were also screened for cross-reference.'\n\n[No] \n\n[Yes] 'Reflux specific symptom questionnaires; clearly defined reflux symptoms; reoperation rate; postoperative dilatations and GE functions tests: 24-h pH monitoring; combined 24-h pH-multichannel intraluminal impedance (pH-MII); manometry; endoscopy; scintigraphy of the stomach (gastric emptying studies) and barium swallow radiography.'\n\n[No]\n\n[No] \n\n[No] \n\n[No]\n\n[No]  \n\n[Yes] 'In total, 1,260 articles were identified and screened. Of these, 17 original prospective studies that met our criteria were selected for inclusion (Fig. 1).'\n\n[Yes] 'The following data were extracted from each selected article: Study design, study population, surgical method, outcome assessment techniques, duration of follow-up, and study outcomes of interest.'\n\n[No]\n\n[Yes] 'In 10 out of 17 (59%) studies (Table 3), the success rate of antireflux surgery in eliminating reflux symptoms was reported.' \n\n[No]\n\n[No]\n\n[No] \n\n[No]\n\n[Yes] 'In conclusion, ARS in children shows a good overall success rate (median 86%) in terms of complete relief of symptoms.'\n\n[Yes] 'However, these conclusions are bound by the lack of high-quality prospective studies on pediatric ARS.'\n\n[Yes] 'Therefore, future studies should be performed in a well-designed prospective format, either as an RCT comparing different types of ARS, or as a prospective, age- and sex-matched study comparing different patient groups.'\n\n[Yes] 'This study aims to systematically review the efficacy of pediatric ARS and its effects on gastroesophageal function, as measured by gastroesophageal function tests. This is the first systematic review comprising only prospective, longitudinal studies, minimizing the risk of bias.'\n\n[No]\n","[Yes] 'The Effects and Efficacy of Antireflux Surgery in Children with Gastroesophageal Reflux Disease: A Systematic Review'\n\n[Yes] 'Background: [...] Many studies have described the results of ARS in children, however, with a wide difference in outcome. This study aims to systematically review the efficacy of pediatric ARS and its effects on gastroesophageal function, as measured by gastroesophageal function tests.'\n\n[Yes] 'Gastroeophageal reflux disease (GERD) is a frequently encountered condition, affecting 7–20% of the pediatric population.1–3 Most symptomatic children respond well to medical treatment.3 However, when medical treatment fails and reflux symptoms persist, antireflux surgery (ARS) may be considered.4 ARS is one of the most frequently performed major operations in children, and over the last decades, numerous studies have been published on this subject.'\n\n[No]\n\n[Yes] 'Methods: [...] Inclusion Criteria [...] type of intervention—open or laparoscopic Nissen, Thal, or Toupet fundoplication [...]' \n\n[No]\n\n[Yes] 'Methods: [...] Inclusion Criteria [...] study population—infants and children (0–18 years), who underwent ARS [...]'\n\n[No] \n\n[Yes] 'Methods: [...] The titles and abstracts of all identified studies were reviewed by two independent authors (WS, MH) according to the MOOSE criteria.5 Full publications were obtained for articles that appeared potentially relevant. References in these selected articles were also screened for cross-reference.'\n\n[Yes] 'Methods: [...] Inclusion Criteria [...] study design—only prospective study format [...]' \n\n[Yes] 'Methods: [...] The following data were extracted from each selected article: Study design, study population, surgical method, outcome assessment techniques, duration of follow-up, and study outcomes of interest.'\n\n[Yes] 'Methods: [...] Outcomes of interest [...] reflux specific symptom questionnaires; clearly defined reflux symptoms; reoperation rate; postoperative dilatations and GE functions tests: 24-h pH monitoring; combined 24-h pH-multichannel intraluminal impedance (pH-MII); manometry; endoscopy; scintigraphy of the stomach (gastric emptying studies) and barium swallow radiography.'\n\n[NA]\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'Results: [...] In total, 17 eligible studies were identified, reporting on a total of 1,280 children.' \n\n[Yes] 'Results: [...] Table 1 Details on included prospective clinical trials on ARS in children'\n\n[NA]\n\n[Yes] 'Results: [...] Table 3 Success rate (complete resolution of gastroesophageal reflux symptoms) of ARS in children' \n\n[Yes] 'Results: [...] Table 4 Studies reporting reflux indices pre- and postoperatively in children'\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'Discussion: [...] In conclusion, ARS in children shows a good overall success rate (median 86%) in terms of complete relief of symptoms.'\n\n[Yes] 'Discussion: [...] Moreover, these tests may then also provide us with the opportunity to identify possible risk factors for failure of ARS in children.'  \n\n[Yes] 'Discussion: [...] The strength of these conclusions is, however, bound by the lack of high-quality prospective studies on pediatric ARS.'\n\n[Yes] 'Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.'\n","[Yes] 'The Effects and Efficacy of Antireflux Surgery in Children with Gastroesophageal Reflux Disease: A Systematic Review'\n\n[Yes] 'This article aims to systematically review all prospective, longitudinal studies, and randomized controlled trials (RCTs).'\n\n[Yes] 'when medical treatment fails and reflux symptoms persist, antireflux surgery (ARS) may be considered.' \n\n[Yes] 'In addition, this review aims to study the effects of ARS on GE function in children, as measured by pre- and postoperative assessment tests.'\n\n[No]\n\n[Yes] 'Inclusion Criteria: study population—infants and children (0–18 years), who underwent ARS; type of intervention—open or laparoscopic Nissen, Thal, or Toupet fundoplication'\n\n[Yes] 'The following data were extracted from each selected article: Study design, study population, surgical method, outcome assessment techniques, duration of follow-up, and study outcomes of interest.'  \n\n[No]\n\n[Yes] 'The titles and abstracts of all identified studies were reviewed by two independent authors (WS, MH) according to the MOOSE criteria.'\n\n[Yes] 'Data extraction: The following data were extracted from each selected article: Study design, study population, surgical method, outcome assessment techniques, duration of follow-up, and study outcomes of interest.'\n\n[Yes] 'Outcomes of interest: Reflux specific symptom questionnaires; clearly defined reflux symptoms; reoperation rate; postoperative dilatations and GE functions tests: 24-h pH monitoring; combined 24-h pH-multichannel intraluminal impedance (pH-MII); manometry; endoscopy; scintigraphy of the stomach (gastric emptying studies) and barium swallow radiography.'\n\n[NA]\n\n[NA] \n\n[NA]\n\n[NA] \n\n[NA]\n\n[Yes] 'In total, 1,260 articles were identified and screened. Of these, 17 original prospective studies that met our criteria were selected for inclusion (Fig. 1).'\n\n[Yes] 'The following data were extracted from each selected article: Study design, study population, surgical method, outcome assessment techniques, duration of follow-up, and study outcomes of interest.' \n\n[NA]\n\n[Yes] 'In 10 out of 17 (59%) studies (Table 3), the success rate of antireflux surgery in eliminating reflux symptoms was reported.' \n\n[NA] \n\n[NA]\n\n[Yes] 'Discussion: In conclusion, ARS in children shows a good overall success rate (median 86%) in terms of complete relief of symptoms.'\n\n[Yes] 'However, these conclusions are bound by the lack of high-quality prospective studies on pediatric ARS.'\n\n[Yes] 'Therefore, future studies should be performed in a well-designed prospective format, either as an RCT comparing different types of ARS, or as a prospective, age- and sex-matched study comparing different patient groups.'\n\n[Yes] 'No studies reported on barium swallow x-ray, endoscopy, or multichannel intraluminal impedance monitoring before and after ARS.'\n","[Yes]\n'The Incidence of Intraabdominal Abscess Formation Following Laparoscopic Appendicectomy in Children: A Systematic Review and Meta-analysis'\n\n[Yes] \n'Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.'\n\n[Yes]\n'Describe the rationale for the review in the context of what is already known.'\n'There has been much recent research and debate over the best operative modality for an appendicectomy in a pediatric patient, despite the laparoscopic approach gaining popularity among pediatric surgeons.'\n\n[Yes]  \n'Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).'\n'Our aim was to perform a comprehensive review of the current literature and to determine whether the laparoscopic approach leads to an increased incidence of IAA following appendicectomy in children.'  \n\n[No]\n\n[Yes]  \n'Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.'\n'Studies reporting data obtained from coding databases were not included, as the majority focused on the incidence of IAA drainage (rather than the incidence of IAA).'\n\n[Yes]\n'Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.'  \n'A review of the literature was performed to identify all published evidence relating to the development of a pediatric IAA postoperatively after either LA or OA. To ensure that all relevant articles were identified and included in the final analysis, broad search terms were used (including variations of the multiple key words), and multiple databases were screened (Table 1). The search was limited to journal articles from January 1990 to January 2012.'\n\n[Yes]\n'Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.'\n'Table 1. Summary of Screened Databases and Search Terminology'\n\n[Yes]\n'State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).'\n'Once the titles and abstracts had been screened and the relevant articles had been identified, full text articles in the English language were retrieved and screened in detail.'\n\n[Yes]  \n'Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.'\n'Data were extracted from the individual studies and collated on a database.'\n\n[Yes]\n'List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.'\n'The main analysis included data from all studies selected for our systematic review. Subset analyses were performed on (1) studies reporting direct comparisons between LA and OA and (2) patients with complicated appendicitis (presence of perforation, intraabdominal pus, or an intraoperative phlegmon/mass).'\n\n[Yes]\n'Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.' \n'The majority of the articles identified contained Level II-1 or II-2 evidence, with only seven articles containing Level I evidence.'\n\n[Yes]\n'State the principal summary measures (e.g., risk ratio, difference in means).'\n'Contingency tables were designed for each of the outcome measures, and data were analyzed using Fisher's exact test. ORs and 95% CIs were calculated (an OR of &gt;1 indicated a more favorable outcome for LA compared with OA), and corresponding Forrest plots were constructed using summary data.'\n\n[NA]\n\n[NA]\n\n[NA]  \n\n[Yes]\n'Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.' \n'Sixty-six of the latter studies contained data that was relevant to the formation of an IAA following a pediatric LA or OA and were therefore included in our analysis. The majority of the articles identified contained Level II-1 or II-2 evidence, with only seven articles containing Level I evidence. The search strategy and results are summarized in Figure 1.'\n\n[Yes]  \n'For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.'\n'Table 3 summarizes data from all studies included in our systematic review and meta-analysis.'\n\n[Yes] \n'Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).'\n'The majority of the articles identified contained Level II-1 or II-2 evidence, with only seven articles containing Level I evidence.'\n\n[Yes]\n'For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.' \n'Appendicectomy was complicated by IAA formation in a total of 615 of 22,060 patients (2.8%). There was no significant difference between LA and OA in the incidence of postoperative IAA: 2.9% (282/9600) for LA versus 2.7% (333/12,460) for OA (P=.25). The OR (95% CI) for IAA formation was 0.91 (0.77, 1.07) (Fig. 2).'\n\n[NA]  \n\n[NA]\n\n[NA]\n\n[Yes]  \n'Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).'\n'Overall, this systematic review of pediatric patients has shown that there is no difference between the LA and OA techniques in terms of IAA formation, which is different from the findings of the Cochrane review.'\n\n[Yes]\n'Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).'\n'With either an IAA or SBO the patient will be likely to re-present to the pediatric surgical center; with WI, however, different follow-up practices and treatment at the primary healthcare level will influence the accurate reporting of this complication.' \n\n[Yes]\n'Provide a general interpretation of the results in the context of other evidence, and implications for future research.'\n'As overall there is no difference in the IAA incidence, patients from these two subgroups may have been included in different analysis groups in the various studies, making the subset analysis potentially biased. This issue will need to be addressed in a future well-constructed prospective randomized trial using a standardized definition of complicated appendicitis.'\n\n[Yes] \n'Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.'\n'No competing financial interests exist.'\n\n[Yes]\n"," Here are the relevant quotes and assessments for each PRISMA item for the given systematic review:\n\n[Yes] 'Antibiotics and appendicitis in the pediatric population: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee Systematic Review☆' \n\n[Yes] 'Objective: The aim of the study was to review evidence-based data regarding the use of antibiotics for the treatment of appendicitis in children.'\n\n[Yes] 'Despite the widespread prevalence of the disease, there is little consensus regarding the diagnosis and management of appendicitis.'  \n\n[Yes] 'Data were obtained from PubMed, MEDLINE, and citation review.'\n\n[NA]\n\n[Yes] 'Studies were selected based on relevance for the following questions:'\n\n[Yes] 'PubMed and other databases of the English literature (up to August 2009) were analyzed.'  \n\n[No]\n\n[Yes] 'We classified each study according to the classes of evidence and rating of evidence as outlined in Fig. 1[2].'\n\n[Yes] 'Once guidelines were established, grades were assigned based on the strength of the studies supporting the recommendation [3].'\n\n[Yes] 'Appendicitis and antibiotics were selected as search terms, and the results were further narrowed as they related to the pediatric population.'\n\n[NA] \n\n[NA]\n\n[NA] \n\n[NA]\n\n[Yes] 'We only referenced those studies with the highest class data that were most relevant to answering the questions listed above.'\n\n[Yes] 'However, we only referenced those studies with the highest class data that were most relevant to answering the questions listed above.' \n\n[NA]\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'In patients with nonperforated appendicitis, there is strong evidence that children should receive preoperative broad-spectrum antibiotics (Grade A).' \n\n[Yes] 'This meta-analysis demonstrated that preoperative antibiotics significantly decreased the risk of wound infection and postoperative abscess compared to placebo.'\n\n[NA]\n\n[NA] \n\n[Yes] 'Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.' No funding source described.\n","Here are the relevant quotes, explanations, and assessments for each PRISMA item:\n\n[Yes] 'Objective: The aim of the study was to review evidence-based data regarding the use of antibiotics for the treatment of appendicitis in children.' The objective is clearly stated.\n\n[Yes] 'Data were obtained from PubMed, MEDLINE, and citation review.' The data sources are described. \n\n[Yes] 'Studies were selected based on relevance for the following questions:' The eligibility criteria are specified.\n\n[Yes] 'PubMed and other databases of the English literature (up to August 2009) were analyzed.' The information sources are described. \n\n[Yes] 'Appendicitis and antibiotics were selected as search terms, and the results were further narrowed as they related to the pediatric population.' The full search strategy is presented.\n\n[Yes] 'We classified each study according to the classes of evidence and rating of evidence as outlined in Fig. 1[2].' The study selection process is described. \n\n[Yes] 'Once guidelines were established, grades were assigned based on the strength of the studies supporting the recommendation [3].' The data collection process is described.\n\n[Yes] 'We only referenced those studies with the highest class data that were most relevant to answering the questions listed above.' The data items are listed.\n\n[NA] Not applicable - no assessment of individual study bias was done.\n\n[NA] Not applicable - no meta-analysis was performed. \n\n[NA] Not applicable - no meta-analysis was performed.\n\n[NA] Not applicable - no assessment of risk of bias across studies was done.\n\n[NA] Not applicable - no additional analyses were done.\n\n[Yes] 'However, we only referenced those studies with the highest class data that were most relevant to answering the questions listed above.' The study selection process is described.\n\n[Yes] 'Table 1. Summary of Cochran Database Review regarding use of antibiotics for nonruptured appendicitis' Study characteristics are presented in a table.\n\n[NA] Not applicable - no assessment of risk of bias within studies was done. \n\n[Yes] 'In patients with nonperforated appendicitis, there is strong evidence that children should receive preoperative broad-spectrum antibiotics (Grade A).' Results are summarized for the main outcomes.\n\n[NA] Not applicable - no meta-analysis was performed.\n\n[NA] Not applicable - no assessment of risk of bias across studies was done.\n\n[NA] Not applicable - no additional analyses were performed.\n\n[Yes] 'In summary, current evidence supports the use of guidelines as described above for antibiotic therapy in children with acute and perforated appendicitis.' The main findings are summarized.\n\n[Yes] 'However, newer antibiotics may decrease the number of days needed for antimicrobial therapy, the total number of doses required, and the side effects of therapy.' Study limitations are discussed.\n\n[Yes] 'Current evidence supports the use of guidelines as described above for antibiotic therapy in children with acute and perforated appendicitis.' Conclusions are provided.\n\n[No] No statement about sources of funding.\n","Here are the relevant quotes and assessments for each PRISMA item:\n\n[Yes] 'Meta-analysis of complication rates of the tubularized incised plate (TIP) repair'\n\n[Yes] 'To determine overall complication rates of the tubularized incised plate (TIP) repair and assess the effects of technical modifications, length of follow-up and geographical location of reported results.'\n\n[Yes] 'There is a wide discrepancy between published complication rates for different repair types [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16] and a poor evidence base for the current management of hypospadias.'  \n\n[Yes] 'Assessing the appropriateness of its application to all degrees of hypospadias.'\n\n[No] No mention of a review protocol.\n\n[Yes] 'Only 49 (4675 patients) [14], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64] fulfilled the inclusion criteria'\n\n[Yes] 'Medline and Pubmed were searched in order to identify articles published between 1994 and 2012.'\n\n[Yes] 'The search terms ‘tubularized incised plate urethroplasty/Snodgrass repair/technique ± outcomes/complications ± follow-up/long term follow-up’ were used.'\n\n[Yes] 'The following data were extracted independently from each article by two reviewers (K.P and P.C): study size; degree of hypospadias (classified by meatal location: distal – midshaft distally, proximal – proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.'\n\n[Yes] 'Where studies contained distal and proximal repairs and/or modified and standard techniques and/or primary and secondary repairs, the data were entered only if these were separable.' \n\n[NA] No risk of bias assessment mentioned.\n\n[Yes] 'Proportions were expressed on the logit scale for analysis'\n\n[NA] No meta-analysis performed.\n\n[NA] No assessment of risk of bias across studies mentioned. \n\n[NA] No additional analyses mentioned.\n\n[No] No flow diagram of study selection process.\n\n[Yes] Table provides characteristics of included studies. \n\n[NA] No assessment of risk of bias within studies.\n\n[NA] No meta-analysis performed.\n\n[NA] No meta-analysis performed. \n\n[NA] No assessment of risk of bias across studies mentioned.\n\n[NA] No additional analyses mentioned.\n\n[Yes] 'The present meta-analysis has shown that the lowest complication rates for the TIP repair are when it is applied to primary distal hypospadias.'\n\n[Yes] 'Documentation of follow-up duration was limited, making assessment of the impact of length of follow-up difficult.'\n\n[Yes] 'The dissimilarity in complication rates between geographical locations could be due to operative skill, case selection, publication bias or differences in follow-up duration.'\n\n[No] No mention of funding sources.\n","Here are the relevant quotes and assessments for each PRISMA item:\n\n[Yes] 'The role of preformed silos in the management of infants with gastroschisis: a systematic review and meta-analysis'\nThe title identifies the report as a systematic review and meta-analysis.\n\n[Yes] 'We performed a systematic review and meta-analysis of the literature comparing use of a PFS with alternate treatment strategies.'  \nThe abstract provides a structured summary including the objectives, data sources, eligibility criteria, methods, results, and conclusions.\n\n[Yes] 'The optimum surgical treatment of infants born with gastroschisis remains unclear.'\nThe introduction describes the rationale for the review in context of current knowledge.  \n\n[Yes] 'The aim of this study was to evaluate current evidence comparing the use of a PFS with alternate treatment strategies in infants with gastroschisis.'\nThe introduction provides explicit objectives comparing preformed silos (intervention) with alternate strategies (comparisons) for infants with gastroschisis (participants). \n\n[No]\nThere is no mention of a review protocol.\n\n[Yes] 'Studies were selected for inclusion in the review if they reported comparative outcomes between infants treated with a PFS and infants treated with an alternate treatment strategy.' \nThe methods specify the eligibility criteria.\n\n[Yes] 'We searched Medline, Embase and the Cochrane controlled trials register from inception to July 2014 using the terms ‘gastroschisis’, ‘gastroschisis and silo’, ‘preformed silo’ and ‘silastic silo’.'\nThe methods describe the information sources searched including databases and dates.\n\n[No]  \nThe full search strategy is not presented for any database.\n\n[Yes] 'Abstracts of the unfiltered literature were reviewed and full text versions of selected publications were assessed for inclusion.'\nThe methods describe the process of study screening and selection.\n\n[Yes] 'Data were extracted and entered into Review Manager (v5.1, The Cochrane Collaboration) and meta-analysis was performed using a random effects model due to variation in study design and reporting.'\nThe methods describe data extraction, but not in duplicate. \n\n[Yes] 'All outcomes were selected a priori. The primary outcome measure was time on a ventilator. Secondary outcomes were number of infants never ventilated, time on parenteral nutrition (PN), time to achieve full enteral feeds, length of hospital stay, incidence of necrotising enterocolitis, number of unplanned re-operations, infectious complications, mortality and occurrence of ventral hernia following repair.'\nThe methods list the variables extracted.\n\n[No]\nIndividual study risk of bias is not described.\n\n[Yes] 'Summary statistics for continuous variables are reported as mean difference (MD) with 95% confidence interval (95% CI) and dichotomous variables as risk difference (RD) with 95% CI in order to allow inclusion of studies with zero events [8].'\nThe methods state the summary measures used.\n\n[NA]\n\n[NA]  \n\n[NA]\n\n[Yes] 'The remaining 18 publications were included in this systematic review. Characteristics of included studies are shown in Table 1.' \nThe results report the number of studies screened and included with reasons for exclusion, along with study characteristics. \n\n[NA]\nIndividual study risk of bias is not presented.\n\n[Yes] 'Meta-analysis demonstrated no difference in days of ventilation, but a longer duration of parenteral nutrition (PN) requirement [MD 6.4 days (1.3, 11.5); p = 0.01] in infants who received a PFS.'\nThe results present summary data and effect estimates for the outcomes.\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'In summary, this review demonstrates that use of a PFS results in largely equivalent outcomes compared to alternate treatment approaches for infants with gastroschisis.'\nThe discussion summarizes the main findings and considers their relevance.\n\n[Yes] 'The results of this review and meta-analysis require careful interpretation in terms of implications for clinical practice.'\nThe discussion highlights limitations at the study and outcome level.\n\n[Yes] 'Further investigation is required to identify not only the optimal treatment pathway for infants with gastroschisis which will likely include a case by case decision algorithm, but also the tools by which to measure success.' \nThe discussion provides conclusions and implications for future research.\n\n[Yes] 'Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.'\nThe funding sources are described.\n","Here are the relevant quotes and assessments for each PRISMA item:\n\n[Yes] 'Systematic review and meta-analysis of enterocolitis after one-stage transanal pull-through procedure for Hirschsprung’s disease'\n\n[Yes] 'This meta-analysis was designed to evaluate postoperative incidence of HAEC following TERPT procedure.'\n\n[Yes] 'Hirschsprung’s disease associated with enterocolitis is the most serious and potentially life-threatening complication of HD, with significant morbidity and mortality [16, 29, 30].'  \n\n[Yes] 'This meta-analysis was designed to evaluate postoperative incidence and outcome of HAEC following TERPT procedure.'\n\n[No]\n\n[Yes] 'Detailed information was recorded regarding the type of study, patient’s age and gender, intraoperative details, and postoperative complications with particular emphasis on the incidence and outcome of HAEC.'\n\n[Yes] 'PubMed and Medline were searched for all studies that reported cases of patients who had undergone surgical correction of HD on transanal one-stage pull-through operation between 1998 and 2009.' \n\n[Yes] 'The search terms were “one-stage transanal pull-through”, “transanal one-stage endorectal pull-through”, “one-stage Soave pull-through”, “single-stage transanal endorectal pull-through”, “primary pull-through”, or “Soave procedure”.'\n\n[Yes] 'There were a total of 899 patients. Information about patient’s gender was reported in 760 (84.5%) patients. 563 (74.1%) patients were male and 197 (25.9%) patients were female. A male-to-female ratio of 2.8:1 was observed. Patient’s age at the time of operation was reported in 811 (90.2%) patients (median 9.2 months, range 6 days to 14 years).'\n\n[Yes] 'Detailed information was recorded regarding the type of study, patient’s age and gender, intraoperative details, and postoperative complications with particular emphasis on the incidence and outcome of HAEC.' \n\n[Yes] 'Detailed information was recorded regarding the type of study, patient’s age and gender, intraoperative details, and postoperative complications with particular emphasis on the incidence and outcome of HAEC. The diagnosis of HAEC in a HD patient was based on the clinical presentation of diarrhoea, abdominal distension, and fever.'\n\n[NA]\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'Of the 54 published articles worldwide, 27 articles, including 899 patients were identified as reporting entirely TERPT procedure.'\n\n[Yes] 'There were a total of 899 patients. Information about patient’s gender was reported in 760 (84.5%) patients. 563 (74.1%) patients were male and 197 (25.9%) patients were female. A male-to-female ratio of 2.8:1 was observed. Patient’s age at the time of operation was reported in 811 (90.2%) patients (median 9.2 months, range 6 days to 14 years).'\n\n[NA] \n\n[Yes] 'Postoperative complications occurred in 370 (41.2%). One hundred and eighty-five of the 370 patients had minor complications, such as perianal excoriation, constipation and increased stool frequency and 188 patients had major complications such as anastomotic strictures, which were reported in 72 (8%) of the patients and required anal dilatation. The occurrence of a cuff abscess was reported in 5 (0.6%) patients. Twenty-six (2.9%) patients presented with severe constipation requiring laxatives or enemas on regular basis.'\n\n[NA]\n\n[NA] \n\n[NA]\n\n[Yes] 'This systematic review reveals that the incidence of postoperative and recurrent HAEC after TERPT procedure is remarkably lower than incidence rates of HAEC reported after other procedures, confirming TERPT as a safe operation with a low incidence of postoperative HAEC.' \n\n[Yes] 'Despite many studies, the pathogenesis of HAEC is not fully understood. Various hypotheses regarding the etiology have been postulated. These include partial mechanical obstruction by the remaining aganglionic segment, spastic internal sphincter, and qualitative changes in the intestinal mucin [16, 22–26]. Increased risk of HAEC due to the presence of an anastomotic leak and postoperative stricture has been well documented [19, 27, 28].'\n\n[Yes] 'This systematic review reveals that TERPT is a safe and less-invasive procedure with a low incidence of postoperative HAEC.'\n\n[Yes] 'Access provided by University of Basel'\n","1. Laparoscopic Duhamel Procedure for Hirschsprung's Disease: Systematic Review and Meta-analysis\n\n2. This identifies the study as a systematic review and meta-analysis in the title. \n\n[Yes]\n\n3. Hirschsprung disease(HD) has undergone a significant evolution in management since Ehrenpreis first recognized aganglionosis as its cause in 1946, as noted by Carpenter.1 Several pull-through techniques of the normal ganglionic bowel have been described, including the most established procedures by Swenson and Bill,2 Soave,3 Duhamel,4 and Rehbein (as noted by Fuchs and Booss5). These pull-through operations were originally protected by prior colostomy. Earlier diagnosis, better understanding of pathogenesis, and technical refinements led to a subsequent advancement to single-stage pull-throughs in the early 1980s.6 With the introduction of minimally invasive surgery, classic pull-through techniques were modified and improved with laparoscopy,7 leading to the clear advantages of reduced pain and improved cosmesis in comparison with open surgery.8 Such advantages inspired the introduction of the single-stage transanal endorectal pull-through (TERPT) by de la Torre-Mondragón and Ortega-Salgado9 in 1998.\n\n4. This paragraph describes the rationale and background for the review.\n\n[Yes]\n\n5. Our study is the first systematic review and meta-analysis comparing long-term outcomes for open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for HD, to identify any added advantage of the laparoscopic technique.\n\n6. This states the objective of comparing open vs laparoscopic Duhamel procedures. \n\n[Yes]\n\n7. No review protocol or registration is mentioned.\n\n[No]\n\n8. All studies between January 1994 and December 2014 were included in the search, as the first LD pull-through was described in 1994.14 Combinations of the key words “Hirschsprung disease,” “Duhamel,” “pull-through,” “laparoscopic,” “minimally invasive” and “open” were used.\n\n9. The search strategy for one database is described.\n\n[Yes]\n\n10. Reference lists were then manually searched for additional studies.\nAll studies assessing functional outcome for OD and/or LD procedures were analyzed for eligibility, including randomized control trials and observational studies. Exclusion criteria included patients with total colonic aganglionosis, follow-up of less than 6 months, cohorts smaller than 10 patients, full articles not written in English, and non–peer-reviewed articles. Studies with insufficient operation details or those that did not differentiate between the two approaches were also excluded.\n\n11. The study selection process is described. \n\n[Yes]\n\n12. Data collected included study characteristics (author, journal, publication year, sample size, length of follow-up, and operative technique) and patient demographics (sex and age at surgery). Outcome parameters included incidence of enterocolitis, constipation, fecal incontinence or soiling, and further surgery, length of operation, length of hospital stay, and time taken to tolerate full oral feeds. \n\n13. The data collection process is described.\n\n[Yes]\n\n14. The data items collected are listed.\n\n[Yes] \n\n15. Our review only included published studies, and no contact with authors was made to obtain unpublished data, nor were conference abstracts included due to the limited data available.\n\n16. This mentions that unpublished data were not obtained.\n\n[Yes]\n\n17. A cumulative meta-analysis was then performed, to compare the incidence of each outcome in patients who underwent the OD procedure with those who underwent the LD procedure. Odds ratios (ORs) were calculated for dichotomous variables using the Mantel–Haenszel method, and mean difference values were calculated for continuous variables using the inverse variance method. A random-effects analysis model was used for all outcomes, as it acknowledges a degree of heterogeneity between studies that makes it well suited for meta-analysis in pediatric surgery.16 The confidence interval (CI) was established at 95%, and statistical differences were considered as significant for a value of P &lt; .05 (two tailed). Statistical heterogeneity was assessed using I2. Statistical analysis was performed using Review Manager version 5.2 software (Cochrane Collaboration, London, United Kingdom).\n\n18. The methods for synthesis of results are described.\n\n[Yes]\n\n19. None of the additional analyses mentioned in P16 were performed.\n\n[NA] \n\n20. PRISMA flow diagram provided. \n\n[Yes]\n\n21. Table 1 provides characteristics of included studies.\n\n[Yes] \n\n22. Not done.\n\n[NA]\n\n23. Not done. \n\n[NA]\n\n24. Our meta-analysis convincingly demonstrates the superiority of LD over OD pull-through for HD.\n\n25. Provides a summary of the main findings.\n\n[Yes]\n\n26. The results of our meta-analysis should be carefully interpreted. The following are unavoidable limitations:\n\n- None of the studies included prospective data or randomized control trials.\n\n- Data were not available for length of aganglionic segment, alongside other important outcomes such as anastomotic stricture and postoperative adhesions, which were not included in enough studies to be treated by meta-analysis.8,27,28 \n\n- The surgical learning curve has not been taken into account. \n\n27. Limitations are discussed.\n\n[Yes]\n\n28. Our meta-analysis proposes that LD pull-through is superior to OD pull-through for HD. The laparoscopic technique resulted in a significantly reduced incidence of postoperative soiling/incontinence and a reduced requirement for further surgery. Length of hospital stay and time to oral feed were also shown to be significantly shorter in the laparoscopic approach. There was no significant difference in incidence of postoperative enterocolitis and constipation, whereas operative time for an OD procedure was significantly shorter. However, the lack of large prospective studies remains a weakness, and randomized control trials with detailed follow-up and agreed definition of outcome parameters are required to overcome limitations in current studies.\n\n29. Provides conclusions and implications for future research.\n\n[Yes]\n\n30. No funding sources described. \n\n[No]\n","[Yes] 'The management of postoperative reflux in congenital esophageal atresia–tracheoesophageal fistula: a systematic review'\n\n[Yes] The abstract identifies the report as a systematic review in the title.\n\n[Yes] The abstract provides relevant background, objectives, data sources, eligibility criteria, methods, results, limitations, and conclusions. \n\n[Yes] The introduction describes the rationale for the review on postoperative reflux in EA-TEF patients.\n\n[Yes] The introduction states the objective is to determine the impact of anti-reflux medication on postoperative GER in EA-TEF patients. \n\n[NA]\n\n[Yes] The methods specify inclusion criteria such as diagnosis of EA-TEF, postoperative GER, and treatment with anti-reflux medications.\n\n[Yes] The methods describe the information sources including 4 electronic databases searched.\n\n[No] The full search strategy for databases is not provided.\n\n[Yes] The study selection process is described including screening, eligibility assessment, and inclusion.\n\n[No] Details on data extraction methods are not provided. \n\n[Yes] Extracted variables are listed such as patient characteristics, comorbidities, complications, and surgical details.\n\n[NA] \n\n[NA]\n\n[NA]\n\n[NA]\n\n[Yes] The results report the numbers screened, assessed for eligibility, and included with reasons for exclusion.\n\n[Yes] Study characteristics are presented in a table.\n\n[NA]\n\n[Yes] Results are presented for complications like strictures and need for surgery.\n\n[NA] \n\n[NA]\n\n[NA] \n\n[NA]\n\n[Yes] The discussion summarizes the main findings and limitations.\n\n[Yes] Limitations are discussed including study design, sample size, heterogeneity, and outcomes definition.\n\n[Yes] Conclusions discuss interpretation, context, and future research implications.\n\n[No] Sources of funding are not described.\n","Here are the relevant quotes, explanations, and responses for each PRISMA item:\n\n'Laparoscopic Versus Open Reduction of Intussusception in Children: A Retrospective Review and Meta-analysis' - Identifies the report as both a systematic review and meta-analysis. [Yes] \n\n'We aimed to conduct a systematic review and meta-analysis, combining our data with existing literature, in order to identify any differences in outcome measures across all identified comparative studies.' - States the objectives of conducting the systematic review and meta-analysis. [Yes]\n\n'Intestinal intussusception is a frequent cause of bowel obstruction in children. Initial treatment involves pneumatic reduction. If this fails, operative reduction is indicated. There is controversy regarding use of the laparoscopic (LAP) versus the conventional open approach.' - Describes the rationale and context for the review. [Yes] \n\n'We sought to conduct a systematic review and meta-analysis, combining our data with existing literature, in order to identify any differences in outcome measures across all identified comparative studies.' - Does not explicitly state the PICOS elements being addressed. [No]\n\n'To identify all publications comparing LAP versus open surgery for intussusception in children, two researchers independently searched the electronic databases MEDLINE, Embase, CINAHL, and the Cochrane Library, using the MeSH terms “intussusception,” “pediatric,” and “laparoscopic.”' - Indicates literature search methods but does not mention a review protocol. [No]\n\n'We only included comparative studies in the pediatric population (0–18 years of age), excluding letters, editorials, commentaries, reviews, and lectures that did not contain original research data. We did not exclude studies based on language, publication period, or sample size.' - Specifies eligibility criteria regarding types of studies, participants, and publication characteristics. [Yes]\n\n'To identify all publications comparing LAP versus open surgery for intussusception in children, two researchers independently searched the electronic databases MEDLINE, Embase, CINAHL, and the Cochrane Library, using the MeSH terms “intussusception,” “pediatric,” and “laparoscopic.” They then assessed the full-text articles for relevance and hand-searched the bibliographies of selected studies to identify additional articles.' - Describes the information sources searched and the last date searched. [Yes] \n\nDoes not present a full electronic search strategy. [No]\n\n'Two researchers independently screened the title and abstract of identified articles for potential eligibility and retrieved the full-text version of all articles deemed relevant. They then assessed the full-text articles for relevance and hand-searched the bibliographies of selected studies to identify additional articles. The researchers discussed any discrepancies to reach a mutual consensus regarding each study's eligibility for inclusion.' - Describes the study selection process. [Yes]\n\nDoes not describe the data collection process. [No] \n\nDoes not list or define the data items sought. [No]\n\nDoes not describe methods for assessing risk of bias. [No]\n\nDoes not state summary measures. [No] \n\n'If the results of these tests showed minimal heterogeneity (&gt;0.10 for the Q test, &gt;50% heterogeneity with the I2 statistic), we used a random effects model for meta-analysis.' - Partially describes synthesis methods. [Yes]\n\nDoes not describe assessment of risk of bias across studies. [NA]\n\nDoes not describe additional analyses performed. [NA]\n\n'Our electronic search identified 40 studies. After applying our exclusion criteria we excluded 35 studies, leaving five retrospective cohort studies for analysis (Fig. 1).' - Presents number of studies screened, assessed, and included with reasons for exclusion, along with the flow diagram. [Yes]\n\nTable 2 shows characteristics of the included studies. [Yes]\n\nDoes not present risk of bias within individual studies. [No] \n\nFigures 2a-2d show forest plots with effect estimates and confidence intervals for each outcome. [Yes]\n\nFigure 2 shows results of the meta-analyses performed. [Yes]\n\nDoes not present assessment of risk of bias across studies. [NA] \n\nDoes not present results of additional analyses. [NA]\n\n'Our results should be interpreted with caution, as there are some methodological limitations in our study.' - Discusses limitations at the study and outcome level. [Yes]\n\n'In summary, our data suggest that LAP reduction of intussusception is as technically feasible, safe, and efficacious as the open approach and may even be beneficial in shortening LOS.' - Provides a general interpretation of the results. [Yes]\n\nDoes not describe sources of funding or support. [No]\n","Here are the relevant quotes and assessments for each PRISMA item:\n\n[No]\n\n[Yes] 'This systematic review focused on randomised controlled trials (RCTs) and controlled clinical trials (CCTs).'\n\n[Yes] 'To evaluate the role of MIS for the treatment of solid intra‐thoracic and intra‐abdominal childhood tumours adequately the best study design, with the highest level of evidence, is a RCT.'\n\n[NA] \n\n[NA]\n\n[Yes] 'We searched the following electronic databases: CENTRAL (The Cochrane Library 2014, Issue 1), MEDLINE/PubMed (from 1966 to February 2014) and EMBASE/Ovid (from 1980 to February 2014).'\n\n[Yes] 'We searched the reference lists of relevant articles and reviews to identify additional studies.'\n\n[No]\n\n[Yes] 'Two authors performed the study selection independently.' \n\n[NA]\n\n[NA]  \n\n[NA]\n\n[NA]\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'After performing the searches of the electronic databases of CENTRAL, MEDLINE/PubMed AND EMBASE/Ovid, we identified 542 references.'\n\n[NA]\n\n[NA] \n\n[NA]\n\n[NA]\n\n[NA]\n\n[NA]\n\n[NA]\n\n[Yes] 'However, these studies were not randomised controlled trials (RCTs) or controlled clinical trials (CCTs) evaluating MIS in children with solid intra‐thoracic or intra‐abdominal neoplasms and were thus not eligible for inclusion in this review.'\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'In summary, our search did not identify any eligible RCTs or CCTs evaluating MIS for the treatment of solid intra‐thoracic or intra‐abdominal neoplasms in children.'\n\n[NA]\n\n[Yes] 'Scanning the reference lists of relevant studies and reviews, and scanning the conference proceedings of SIOP and ASCO, did not identify any other eligible studies.' \n\n[No]\n","[Yes] 'Fundoplication versus postoperative medication for gastro‐oesophageal reflux in children with neurological impairment undergoing gastrostomy.'\nThe title identifies the report as a systematic review.\n\n[Yes] 'We carried out this review to determine which was the safest and most effective form of treatment for children with neurological impairment and gastro‐oesophageal reflux undergoing gastrostomy.'\nThe abstract provides background, objectives, and conclusions. \n\n[Yes] 'Children with neurological impairments frequently experience profound feeding difficulties, which can lead to malnutrition and growth failure.'  \nThe introduction describes the rationale for the review.\n\n[Yes] 'To compare the effectiveness of antireflux surgery and antireflux medications for children with neurological impairment and GOR who are undergoing placement of a gastrostomy feeding tube.'\nThe objectives explicitly state the PICO elements being addressed.\n\n[NA] \n\n[Yes] 'Children up to 18 years of age with neurological impairments (as defined by trialists) and GOR who are undergoing insertion of a gastrostomy feeding tube.'\nThe eligibility criteria specify the PICO elements. \n\n[Yes] 'We searched the following databases on 23 March 2012: the Cochrane Central Register of Controlled Trials (CENTRAL), Ovid MEDLINE, EMBASE, CINAHL, LILACS and ISI Web of Science.' \nThe information sources describe the databases searched.\n\n[Yes] 'Please see Appendix 1 for the most recent search strategies and Appendix 2 for the original and 2009 update search strategies.'\nThe full search strategy for at least one database is provided.\n\n[Yes] 'Titles and abstracts of studies will be identified from the search and read independently by two review authors (AVR and PBS). Those that do not meet the inclusion criteria will be discarded and any disagreements over suitability for inclusion will be resolved by discussion or adjudication, or both by editors of the Cochrane Developmental, Psychosocial and Learning Problems Group.'\nThe study selection process is described.\n\n[Yes] 'Data extraction forms will be designed to include study design, participant characteristics, study setting, intervention type and outcomes. Data will be extracted independently by two review authors (AVR and PBS) and disagreements will be resolved through discussion or by contacting the study author for further information.' \nThe data collection process is described.\n\n[Yes] 'We sought to include randomised controlled trials that recruited children up to the age of 18 years with neurological impairments and GOR who were undergoing gastrostomy tube insertion.'\nThe data items sought are described.\n\n[Yes] 'Selected studies will be independently evaluated by two review authors (AVR and PBS) using The Cochrane Collaboration's tool for assessing the risk of bias.'\nMethods for assessing risk of bias are described.\n\n[NA]\n\n[NA] \n\n[NA]\n\n[NA]\n\n[Yes] 'Figure 1 shows a study flow diagram including the number of identified reports, duplicates and discarded studies.'\nA study flow diagram depicting the screening and selection process is provided.\n\n[NA] \n\n[NA]\n\n[NA]\n\n[NA]\n\n[NA] \n\n[NA]\n\n[Yes] 'Through our search of the grey literature, we identified one thesis that was an RCT of surgical versus medical management for clinically significant GOR, but this was in adults (Whelan 1979).'\nReasons for exclusion are described.\n\n[NA]\n\n[NA]\n\n[NA]\n\n[NA] \n\n[Yes] 'The objective of this review was to compare the effectiveness of antireflux fundoplication surgery with the use of antireflux medications in children with neurological impairments undergoing gastrostomy feeding tube insertion. We identified no relevant RCTs. This review has demonstrated that there is no evidence available from reliable sources on which to draw any conclusions. We cannot provide data on the comparable risks or benefits of either treatment and are subsequently unable to provide recommendations for the best approach in this group of children.'\nThe lack of evidence is summarized and implications are discussed.\n\n[Yes] 'This review aims to assess the efficacy of fundoplication for neurologically impaired children who are at a high risk of ARP failure compared with medical antireflux treatment.' \nLimitations at the review level are discussed.\n\n[Yes] 'A randomised controlled trial of fundoplication versus postoperative medication for children with neurological impairment and severe GOR undergoing gastrostomy should be undertaken to resolve the current uncertainties about the optimal management strategy, for preference, a large multicentre trial.'\nConclusions and implications for future research are provided.\n\n[Yes] 'We searched the following pharmaceutical websites in June 2012. International Federation of Pharmaceutical Manufacturers and Associations (www.ifpma.org/). GlaxoSmithKline (ctr.gsk.co.uk/welcome.asp). AstraZeneca (www.astrazenecaclinicaltrials.com/). Roche Pharmaceuticals (www.roche‐trials.com/).'\nSources of funding are described.\n"]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th> <\/th>\n      <th>Author &amp; Year<\/th>\n      <th>Failure reason (click to show LLM response)<\/th>\n      <th>Ultimately successful<\/th>\n      <th>LLM response<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"ft","columnDefs":[{"targets":2,"render":"function(data, type, row, meta) { return '<a onclick=\"javascript:alert(`'+row[4]+'`)\" style=\"cursor: pointer\">' + data + '<\/a>' }"},{"targets":[0,4],"visible":false},{"orderable":false,"targets":0}],"order":[],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render"],"jsHooks":[]}</script>
</div>
<div id="llm-prompt" class="section level3">
<h3>LLM prompt</h3>
<ul>
<li>Model: <a href="https://www.anthropic.com/index/claude-2">Claude
2</a></li>
<li>Temperature: Chat interface (<a
href="https://docs.anthropic.com/claude/reference/complete_post">probably
<code>1</code></a>)</li>
<li>Briefing derived from: <a
href="https://doi.org/10.1371/journal.pone.0175213">Cullis 2017</a>
Supporting information: <a
href="https://doi.org/10.1371/journal.pone.0175213.s004">S1
Dataset</a></li>
</ul>
<div id="user-prompt" class="section level4">
<h4>User prompt</h4>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<pre>
You are an expert in systematic reviews and are tasked to assess the reporting quality of a systematic review with the PRISMA 2009 tool based on the full text of its publication. PRISMA 2009 consist of the following items:

---
# PRISMA 2009
P1. Title: Identify the report as a systematic review, meta-analysis, or both.
P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.
P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.
P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
---

This is the full text to be assessed:
---
%FULLTEXT%
---

For each of the PRISMA items (P1 to P27) perform the following steps. Do not repeat the items' names / instructions.
1. Extract one relevant short quote from the full text.
2. Explain your reasoning in one short sentence.
3. Respond with either "[Yes]" if the item was reported, "[No]" if not reported, or "[NA]" if not applicable (for example, items P14, P15, P16, P21, P22, P23 in the context of a systematic review without a meta-analysis).

Be as concise as possible and avoid unnecessary repetitions. Before stopping, make sure you've processed all 27 PRISMA items. Do not provide a final summary paragraph in the end.
 
</pre>
</div>
</div>
</div>

</div>

<script>
$(document).ready(function() {
  // add bootstrap table styles to pandoc tables
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed table-sm');

  // initialize mathjax

});
</script>

<script type="text/javascript">
$(document).ready(function () {
  FlexDashboard.init({
    fillPage: true,
    orientation: "columns",
    storyboard: false,
    defaultFigWidth: 576,
    defaultFigHeight: 460,
    defaultFigWidthMobile: 360,
    defaultFigHeightMobile: 460,
    resize_reload: true
  });
  var navbar = $(".navbar").first();
  var body = $("body").first();
  var sidebar = $(".section.sidebar").first();
  function addNavbarPadding() {
    var navHeight = navbar.outerHeight();
    body.css("padding-top", (navHeight + 8) + "px");
    sidebar.css("top", navHeight + "px");
    var resizeEvent = window.document.createEvent("UIEvents");
    resizeEvent.initUIEvent("resize", true, false, window, 0);
    window.dispatchEvent(resizeEvent);
  }
  if (!window.Shiny) setTimeout(addNavbarPadding, 100);
  $(document).on("shiny:idle", function() {
    setTimeout(addNavbarPadding, 50);
  });
});
</script>

</body>
</html>
